Citrus Sinensis ID: 002331
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 935 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | yes | no | 0.958 | 0.960 | 0.576 | 0.0 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.260 | 0.297 | 0.674 | 2e-95 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.282 | 0.204 | 0.426 | 1e-61 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.255 | 0.372 | 0.473 | 1e-61 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.255 | 0.346 | 0.456 | 2e-59 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.249 | 0.311 | 0.459 | 3e-57 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.275 | 0.281 | 0.428 | 6e-57 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.260 | 0.147 | 0.372 | 6e-56 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.305 | 0.176 | 0.363 | 5e-55 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.258 | 0.146 | 0.392 | 2e-51 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 991 bits (2563), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 549/952 (57%), Positives = 679/952 (71%), Gaps = 56/952 (5%)
Query: 1 MRNIFKKLHIGSNHES-NRTNETLASTTSCATDHNR--TSSSSSNAAPPS-----PSASA 52
M++IFKKLH G N E NRTN+ + +D NR S++ A P S P A A
Sbjct: 1 MKHIFKKLHRGGNQEQQNRTNDA-----APPSDQNRIHVSANPPQATPSSVTETLPVAGA 55
Query: 53 ATAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL-N 111
++ +SPAP +S +R DYM+SEEE+QVQLA+AISAS+S + EK QIRAATLLSL +
Sbjct: 56 TSSMASPAPTAAS-NRADYMSSEEEYQVQLALAISASNSQSSEDPEKHQIRAATLLSLGS 114
Query: 112 NRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHL 171
++R D RD ++V A+ LSRQYWEY VLDYEE+VVD FYD+Y LSTD + QG++PSL L
Sbjct: 115 HQRMDSRRDSSEVVAQRLSRQYWEYGVLDYEEKVVDSFYDVYSLSTDSAKQGEMPSLEDL 174
Query: 172 ESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPV 231
ESN G GFE V+VNR ID +L EL+++A+CIAL T V +LVQ+LA+LV HMGG
Sbjct: 175 ESNHGTPGFEAVVVNRPIDSSLHELLEIAECIALGCSTTSVSVLVQRLAELVTEHMGGSA 234
Query: 232 KDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGS 291
+D++I+LARW E+S+E + +L T V PIG + IG+SRHRALLFKVLADS+RLPCRLVKGS
Sbjct: 235 EDSSIVLARWTEKSSEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVRLPCRLVKGS 294
Query: 292 HYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRT 351
HYTG EDDAVN I+LE+ERE+LVDLM PGTLIPAD SA + +P N +K P +
Sbjct: 295 HYTGNEDDAVNTIRLEDEREYLVDLMTDPGTLIPADFASASNNTVEPCNSNGNKFPTAQF 354
Query: 352 SNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGI 411
SND PK EGSS +S + S L+ + +E+ +S S+P S
Sbjct: 355 SNDV------PKLSEGEGSSHSSMANYSSSLDRRTEAERTDS--SYPKVGPLRNIDYSSP 406
Query: 412 SSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLN 471
SS + Q + SS+ IG KG RG A+ + +R N+N+VPY Q +ED K+LFADLN
Sbjct: 407 SSVTSSTQLENNSSTAIG----KGSRG--AIIECSRTNMNIVPYNQNSEEDPKNLFADLN 460
Query: 472 PFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYM 531
PFQ KGA K + + V++F + NP+ GR P PMM KN + NE P++KE SY+
Sbjct: 461 PFQNKGADKLYMPTKSGLNNVDDFHQQKNNPLVGRSPAPMMWKN-YSCNEAPKRKENSYI 519
Query: 532 EGILPKINREPN-NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSL 590
E +LPK++R+P N +S +TSS++ + +N+ +D+ + + S
Sbjct: 520 ENLLPKLHRDPRYGNTQSSYATSSSNGAIS---------SNVHGRDNVTFVSPVAVPSSF 570
Query: 591 ASSTSQLNGPPLVEDLSSNSKDE---NPKNV------EDHEIGYHDRRKCTHDRF-MGTN 640
S+ +Q P +VED++ N+ +E P ++ E HD RK T D G +
Sbjct: 571 TSTENQFR-PSIVEDMNRNTNNELDLQPHTAAVVHGQQNDESHIHDHRKYTSDDISTGCD 629
Query: 641 LKLRDLESPSSSVDSSTSKVD-QIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWN 698
+L+D ES SSS+DS++ + D Q+ DD DV ECEIPW DLV+ ERIGLGSYGEVYHADW+
Sbjct: 630 PRLKDHESTSSSLDSTSYRNDPQVLDDADVGECEIPWNDLVIAERIGLGSYGEVYHADWH 689
Query: 699 GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758
GTEVAVKKFLDQDFSGAAL EF+ EV+IMRRLRHPNVV F+GAVTRPPNLSI+TEFLPRG
Sbjct: 690 GTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRG 749
Query: 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 818
SL+RILHRP +DE+RRIKMALDVA GMNCLHTSTPTIVHRDLK+PNLLVD NWNVKV
Sbjct: 750 SLYRILHRPKSHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVG 809
Query: 819 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 878
DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW G
Sbjct: 810 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRG 869
Query: 879 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930
MNPMQVVGAVGFQNRRLEIPKELDP+V RII ECWQT ++R S AQL+
Sbjct: 870 MNPMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQT---DPNLRPSFAQLT 918
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 351 bits (901), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 166/246 (67%), Positives = 200/246 (81%), Gaps = 2/246 (0%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
+ +IPW DL + E+IG GS+G V+ A+W+G++VAVK ++QDF + EF REV IM+R
Sbjct: 543 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 602
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGM 787
LRHPN+VLFMGAVT+PPNLSI+TE+L RGSL+R+LH+ Q+DE+RR+ MA DVA+GM
Sbjct: 603 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 662
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
N LH P IVHRDLKSPNLLVDK + VKV DFGLSRLK +TFLSSKS AGTPEWMAPEV
Sbjct: 663 NYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 722
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
LR+EPSNEK DVYSFGVILWELATL+ PW +NP QVV AVGF+ +RLEIP+ L+P VA
Sbjct: 723 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 782
Query: 908 IIWECW 913
II CW
Sbjct: 783 IIEGCW 788
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (609), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 116/272 (42%), Positives = 172/272 (63%), Gaps = 8/272 (2%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVA 703
+D + P ++ + +V++ F E E+P ++ +G RIG G YG+V+ W GTEVA
Sbjct: 822 KDHQFPVPTIPAKIIEVEKPF-----EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVA 876
Query: 704 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 763
VK + + + + + ++EV ++ +LRHPN+VLFMGA T P + I+TE+L RGSL I
Sbjct: 877 VKMLFNDNVNLKLISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANI 936
Query: 764 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823
L ++D R+++ D ARGM LH+ P I+HRDLK+ NLLVD +W VKV+DFGL+
Sbjct: 937 LLDESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLA 996
Query: 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883
+K +TF +K+ GT W+APEVL E EK DVYS+ ++LWEL T +P+ G N MQ
Sbjct: 997 TVKSHTF--AKTMCGTTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQ 1054
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915
VV ++ + RL +P P A ++ CW+T
Sbjct: 1055 VVRSID-RGERLPMPAWCPPKYAALMNRCWET 1085
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (608), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 114/241 (47%), Positives = 160/241 (66%), Gaps = 2/241 (0%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
+I + +G RIG G+YGEVY W G++VAVKK + + L EF RE+ +M+ LR
Sbjct: 368 DIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 427
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HPNV+ F+G+ PP++ I TE++PRGSL+ ILH Q+ IKM +D A+G+ LH
Sbjct: 428 HPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVIYLH 487
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
STP I+HRDLKS NLLVD+NW VKV+DFGLS ++ ++ + GTP W +PEVLR++
Sbjct: 488 NSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQ 545
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
EK DVYSFG+ILWE AT + P+ G+ P QV+ AVG + R +P+ P +++ +
Sbjct: 546 RYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLLID 605
Query: 912 C 912
C
Sbjct: 606 C 606
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (588), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 110/241 (45%), Positives = 158/241 (65%), Gaps = 2/241 (0%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
+I + + +G RIG G++GEVY W G++VAVKK + + L EF RE+ +M+ LR
Sbjct: 385 DIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 444
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HPNV+ F+G+ P++ I TE++PRGSL+ ILH ++ +M +D A+G+ LH
Sbjct: 445 HPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGIIYLH 504
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
STP I+HRDLKS NLLVD+NW VKV+DFGLS ++ ++ + GTP W +PEVLR++
Sbjct: 505 GSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQ 562
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
EK DVYSFG+ILWE AT + P+ G+ P QV+ AVG + R PK P +++ +
Sbjct: 563 RYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLLKD 622
Query: 912 C 912
C
Sbjct: 623 C 623
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 224 bits (570), Expect = 3e-57, Method: Compositional matrix adjust.
Identities = 112/244 (45%), Positives = 152/244 (62%), Gaps = 11/244 (4%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFL-----DQDFSGAALLEFKREVKIMRRLR 731
++V+ RIG GS EV+ W G VA+KK D+DF L E +E IM +LR
Sbjct: 490 EIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDF----LNELAQEATIMSQLR 545
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HPN+ F+G PP + I+ E++P GSL+RILH P +D R MALD+A+GMN LH
Sbjct: 546 HPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMALDIAKGMNYLH 605
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLR 849
P ++HRDLKS NLLVD+++ VK+SDFGLS KH ++ + GTP W APEVLR
Sbjct: 606 CCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPCWTAPEVLR 665
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
N+P EK DV+SF ++LWE+ T + P+ GM Q+V +VG R +P ++ R+I
Sbjct: 666 NDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQVSAPFTRLI 725
Query: 910 WECW 913
ECW
Sbjct: 726 TECW 729
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (568), Expect = 6e-57, Method: Compositional matrix adjust.
Identities = 114/266 (42%), Positives = 170/266 (63%), Gaps = 8/266 (3%)
Query: 650 SSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKF-L 708
S SV S+ Q F D EI + +L + ++G G++G VY W G+ VA+K+ +
Sbjct: 638 SGSVVEPPSQQQQYFSD----IEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKI 693
Query: 709 DQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH 768
++D + L EF++E+ I+ RLRHPN+VL M A T PPNL ITE+LP GSL+ LH
Sbjct: 694 NEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKK 753
Query: 769 CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828
+++ + K+A+ +A+GMN LH S ++HRD+KS NLL+D++ NVK+ DFGLS+LK
Sbjct: 754 IKMNMQLYKKLAIQIAQGMNYLHLS--GVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSK 811
Query: 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 888
+ +KS G+P WM+PE+L E EK DVY+FG+ILWEL T +LP+ G++ +Q+ AV
Sbjct: 812 STEMTKSI-GSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAV 870
Query: 889 GFQNRRLEIPKELDPLVARIIWECWQ 914
++ R IP ++ +I CW
Sbjct: 871 TTKSLRPPIPNAWPYQLSHLIQACWH 896
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 219 bits (559), Expect = 6e-56, Method: Compositional matrix adjust.
Identities = 92/247 (37%), Positives = 165/247 (66%), Gaps = 3/247 (1%)
Query: 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIM 727
+C I ++++ +GE+IGLGSYG VY W +VA+KKF+ Q LL + E+ +
Sbjct: 1389 LCSWVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFL 1448
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
++L HPN++ +GA + PN+ I+TE++ +G+L + +++ ++IK+ +++A+G+
Sbjct: 1449 KKLHHPNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGI 1508
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
+ LH+ P I+HRD+K N+L+D+NWNVK++DFG +R+K + ++ GTP W APE+
Sbjct: 1509 SYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIMTR--CGTPCWTAPEI 1566
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
+RN+ +EK DV+SFG+++WE+ T K P+IG N M++ + ++ R +IP++ A+
Sbjct: 1567 IRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDI-LEDVRPKIPQDCPEEFAK 1625
Query: 908 IIWECWQ 914
++ +CW
Sbjct: 1626 LMRKCWH 1632
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 216 bits (551), Expect = 5e-55, Method: Compositional matrix adjust.
Identities = 112/308 (36%), Positives = 179/308 (58%), Gaps = 22/308 (7%)
Query: 625 YHDRRKCTHDRFMG--TNLKLRDLESPSSSVDSSTSKVDQIFDDD--------------- 667
Y + + +RF G T + D ++ S + D S +I D D
Sbjct: 1294 YEIKFEILKNRFFGGITYVNYND-DTDSGTADDSNYDSGKIIDIDYMADIDKEDSFLTSA 1352
Query: 668 -VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI 726
+C I ++++ +G++IGLGSYG V++ W G +VAVKKF+ Q S LLEF+ E+
Sbjct: 1353 NMCRWIINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAF 1412
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
+ L+H N+V F+GA + PN+ I+TE++ G+L +L P ++ ++K+ A G
Sbjct: 1413 LSELKHSNIVTFIGACIKKPNICIVTEYMRMGNLRDVLKNPDIKITFANKLKLLYGAAMG 1472
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 846
++ LH+S P IVHRD+K N+LVD+++NVK++DFG +R+K + ++ + GTP W APE
Sbjct: 1473 IDYLHSSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDN--TTMTRCGTPCWTAPE 1530
Query: 847 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906
V+R E EK DV+SFGV++WE+ T K P+ N M+V + + R IP + A
Sbjct: 1531 VIRGEKYCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDI-LEGGRPIIPSDCPHEFA 1589
Query: 907 RIIWECWQ 914
++I +CW
Sbjct: 1590 KLIKKCWH 1597
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (520), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 97/247 (39%), Positives = 151/247 (61%), Gaps = 5/247 (2%)
Query: 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIM 727
+C I ++D+ +G++IG+GSYG V W VAVKKF+ Q +LEF+ E+ +
Sbjct: 1384 LCRWIINYDDIQIGKQIGVGSYGIVNMGKWKNINVAVKKFVKQKIDEKQMLEFRAEIAFL 1443
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
+LRHP+++L +GA + PN+ I+TEF+ GSL ++ + + K +IKM A G+
Sbjct: 1444 SQLRHPHIILMIGACLKRPNICIVTEFMGNGSLRNVIKTT--KPEWKLKIKMLYQTALGI 1501
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
LH S P I+HRD+K N+LVD + NVK++DFG +R+K S + GTP W APE+
Sbjct: 1502 GYLHNSDPIIIHRDIKPSNILVDDSMNVKIADFGFARIKEEN--SVMTRCGTPCWTAPEI 1559
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
+R E EK DV+SFG+++WE+ T K P+ G N M+V + + R +IP + +
Sbjct: 1560 IRGEKYTEKVDVFSFGIVMWEVLTCKEPFSGCNFMKVSMDI-LEGARPQIPSDCPIDFTK 1618
Query: 908 IIWECWQ 914
++ +CW
Sbjct: 1619 LMKQCWH 1625
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 935 | ||||||
| 224130772 | 955 | predicted protein [Populus trichocarpa] | 0.974 | 0.953 | 0.675 | 0.0 | |
| 224125544 | 967 | predicted protein [Populus trichocarpa] | 0.974 | 0.942 | 0.669 | 0.0 | |
| 359487849 | 955 | PREDICTED: serine/threonine-protein kina | 0.961 | 0.941 | 0.667 | 0.0 | |
| 255542402 | 958 | map3k delta-1 protein kinase, putative [ | 0.944 | 0.921 | 0.669 | 0.0 | |
| 356535135 | 930 | PREDICTED: serine/threonine-protein kina | 0.928 | 0.933 | 0.642 | 0.0 | |
| 229335619 | 913 | EDR1 [Glycine max] | 0.928 | 0.950 | 0.642 | 0.0 | |
| 356576743 | 932 | PREDICTED: serine/threonine-protein kina | 0.928 | 0.931 | 0.639 | 0.0 | |
| 449435758 | 935 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.943 | 0.943 | 0.623 | 0.0 | |
| 262213688 | 871 | EDR1 [Glycine max] | 0.873 | 0.938 | 0.638 | 0.0 | |
| 298204924 | 876 | unnamed protein product [Vitis vinifera] | 0.887 | 0.947 | 0.629 | 0.0 |
| >gi|224130772|ref|XP_002328373.1| predicted protein [Populus trichocarpa] gi|222838088|gb|EEE76453.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1247 bits (3227), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 646/956 (67%), Positives = 752/956 (78%), Gaps = 45/956 (4%)
Query: 1 MRNIFKKLHIGSNHES--NRTNE--------TLASTTSCATDHNRTSSSSSNAAPPSPSA 50
M++IFKKLHIGSN+ES NRT+ SC++DH + +S A PPS S
Sbjct: 1 MKHIFKKLHIGSNNESSPNRTSNDTATSASTPPPPPPSCSSDHRAAGTGNSPANPPSTSP 60
Query: 51 SAATAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL 110
S AT A ++ G+RTDY SEE+FQVQLA+AISAS+S D +EKDQIRAATLLSL
Sbjct: 61 SPATTAQP----LAFGNRTDYFASEEDFQVQLALAISASNSEFRDDTEKDQIRAATLLSL 116
Query: 111 N--NRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSL 168
N R D+GR+K + E LSR YWEYNVLDY ERV+DGFYD++ T + QGK+PSL
Sbjct: 117 GGGNNRIDVGREKGEGKVEDLSRYYWEYNVLDYGERVMDGFYDVF--CTSSAVQGKMPSL 174
Query: 169 AHLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMG 228
LE+N G SGFE VIVNR +D ALEEL+Q+AQCIALD ATDV ILVQQLA+LV GHMG
Sbjct: 175 MDLETNAGGSGFEAVIVNRKVDPALEELMQIAQCIALDWLATDVTILVQQLAELVTGHMG 234
Query: 229 GPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLV 288
GPVKDAN++LA+WM+RSTELR SLQTSVLPIGSINIGLSRHRALLFKVLAD+I+LPCRLV
Sbjct: 235 GPVKDANLILAKWMDRSTELRTSLQTSVLPIGSINIGLSRHRALLFKVLADTIKLPCRLV 294
Query: 289 KGSHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPI 348
KGSHYTG+EDDAVNIIKLE+EREFLVDLMAAPGTLIPAD+ SAKDT FK IP
Sbjct: 295 KGSHYTGIEDDAVNIIKLEDEREFLVDLMAAPGTLIPADVPSAKDTTFK--------IPA 346
Query: 349 LRTSNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAAS 408
R SN++G V+++ KPL EG+SQNS+VDG PL+ SE AESLPSF S G S
Sbjct: 347 PR-SNETGVVFARSKPLTGEGTSQNSSVDGISPLDRILCSENAESLPSFSGSSNNAGVGS 405
Query: 409 SGISSRVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLF 467
SG+S++ P NQ ++S+ GTS+YKG RG +A+GDG RMNVNVVPY EDSK+LF
Sbjct: 406 SGVSNKTAPTNQLGNIASTAFGTSVYKGSRGVHAIGDGLRMNVNVVPYVPNTSEDSKNLF 465
Query: 468 ADLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKE 527
ADLNPFQIKG GK+ +H P E+K+ EFQ + NPV PP P+M KN+ YNEVPR+K+
Sbjct: 466 ADLNPFQIKGTGKSFMHNKPAENKINEFQGRKNNPVPS-PPAPLMWKNRFAYNEVPRRKD 524
Query: 528 YSYMEGILPKINREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSG 587
+EG+ P+INREPNN +S +++S SE P FK S++ N S+++S++R++ S +
Sbjct: 525 NDNVEGLYPRINREPNNYNHSSLASTSLSEKVYPQGFKSSSNLNTSNRESDTRNSASSAS 584
Query: 588 PSLASSTSQLNGPPLVEDLSSNSKDE--NPKNV-----------EDHEIGYHDRRKCTHD 634
L+S T+Q P VE+++SN +++ + KN+ ED+EIG+HDRRKC HD
Sbjct: 585 SELSSYTNQGYSLPSVEEVNSNFEEKLWDAKNLQNDMEASVKESEDNEIGFHDRRKCIHD 644
Query: 635 RFMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYH 694
RFMGTNLKL+ ESPS+SVDSST +VD+I DD EI WEDLV GERIGLGSYGEVYH
Sbjct: 645 RFMGTNLKLKGPESPSTSVDSSTHRVDRILDDVDVGDEICWEDLVFGERIGLGSYGEVYH 704
Query: 695 ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754
ADWNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEF
Sbjct: 705 ADWNGTEVAVKKFLDQDFSGAALDEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEF 764
Query: 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814
LPRGSL+RILHRP CQ+DEKRRIKMALDVARGMNCLH STPTIVHRDLKSPNLLVD+NW
Sbjct: 765 LPRGSLYRILHRPQCQIDEKRRIKMALDVARGMNCLHASTPTIVHRDLKSPNLLVDENWT 824
Query: 815 VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL 874
VKV DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK
Sbjct: 825 VKVCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKS 884
Query: 875 PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930
PW GMNPMQVVGAVGFQNRRLEIPKE+DPLVARIIWECWQT ++R S A+L+
Sbjct: 885 PWSGMNPMQVVGAVGFQNRRLEIPKEVDPLVARIIWECWQT---DPNLRPSFAELA 937
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224125544|ref|XP_002319612.1| predicted protein [Populus trichocarpa] gi|222857988|gb|EEE95535.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1244 bits (3219), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 639/954 (66%), Positives = 749/954 (78%), Gaps = 43/954 (4%)
Query: 1 MRNIFKKLHIGSNHES--NRTNETLASTTSCAT-----DHNRTSSSSSNAAPPSPSASAA 53
M++IFKKLHIGSNHES NRT+ A++ S D +++ +S A+PP S S A
Sbjct: 1 MKHIFKKLHIGSNHESSPNRTSNETATSASSPPPSGSSDQRASATINSPASPPLTSPSPA 60
Query: 54 TAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLN-- 111
T A + TDY TSEEEFQVQLA+AISAS+S D +EKDQIRAATLLSL
Sbjct: 61 TTVQPSA----ISNLTDYFTSEEEFQVQLALAISASNSEFRDDTEKDQIRAATLLSLGGG 116
Query: 112 NRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHL 171
N R D+ R+K + E +SR YWEYNVLDY E+V+DGFYD+ L T + QGK+PSL L
Sbjct: 117 NNRVDVDREKGEEKVEDMSRYYWEYNVLDYGEKVMDGFYDV--LCTSSAVQGKMPSLTDL 174
Query: 172 ESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPV 231
E+N +SGFE VIVNR ID LEEL+Q+AQCIALD PAT+V +LVQQLA+LV GHMGGPV
Sbjct: 175 ETNASSSGFEAVIVNRKIDPTLEELMQIAQCIALDCPATNVAVLVQQLAELVTGHMGGPV 234
Query: 232 KDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGS 291
KDAN++LA+W+ERS+ELR SLQTSVLPIGSINIGLSRHRALLFKVLAD+I+LPCRLVKGS
Sbjct: 235 KDANLILAKWIERSSELRTSLQTSVLPIGSINIGLSRHRALLFKVLADTIKLPCRLVKGS 294
Query: 292 HYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRT 351
HYTG+EDDAVNIIKL++EREFLVDLMAAPGTLIPAD+ SAKD+ FK IP LR+
Sbjct: 295 HYTGIEDDAVNIIKLKDEREFLVDLMAAPGTLIPADVPSAKDSTFK--------IPSLRS 346
Query: 352 SNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGI 411
+ND+G V+++P PL EG+SQ+S+VDG P N SE AESLP F S + G SSG+
Sbjct: 347 TNDTGVVFTRPNPLPGEGTSQSSSVDGISPFNSRLNSENAESLPFFSGSSSDAGVGSSGV 406
Query: 412 SSRVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADL 470
+++ P NQ +SS+ IGTS+YKG RG +AVGDG RMNVNVVPYG EDSK+LF+DL
Sbjct: 407 ANKAAPTNQFGNISSTAIGTSVYKGSRGGHAVGDGVRMNVNVVPYGPNSPEDSKNLFSDL 466
Query: 471 NPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSY 530
NPFQIKG GK+ +H P E+K+ EF + NPV G PP P++ KN++ YNEVPR+KE
Sbjct: 467 NPFQIKGTGKSFMHHKPVENKINEFPGRKNNPVPG-PPAPLVWKNRYAYNEVPRRKENEL 525
Query: 531 MEGILPKINREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSL 590
+EG+ P+INREPNN + ASTSS SE P FK S++ N S+K+S++R+ S +L
Sbjct: 526 VEGLYPRINREPNNYNQSLASTSS-SEKVYPQGFKSSSNFNPSNKESDTRNYASSVSSAL 584
Query: 591 ASSTSQLNGPPLVEDLSSNSKDE---NPKNV-----------EDHEIGYHDRRKCTHDRF 636
+S SQ P VE+ +SN K+ + KN+ ED+EI +HDRRKCT+DRF
Sbjct: 585 SSDPSQCYSFPSVEEANSNFKENKLWDAKNLQNDSEAMAKEHEDNEIDFHDRRKCTYDRF 644
Query: 637 MGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD 696
MGTNLKL+D ESPS+SVD + +VDQI DD EI WEDL++GERIGLGSYGEVYHAD
Sbjct: 645 MGTNLKLKDPESPSASVDPISHRVDQIMDDVDVGDEICWEDLIIGERIGLGSYGEVYHAD 704
Query: 697 WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756
WNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFLP
Sbjct: 705 WNGTEVAVKKFLDQDFSGAALDEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 764
Query: 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 816
RGSL+RILHRP CQ+DEKRRI+MALDVARGMNCLH S PTIVHRDLKSPNLLVDKNW VK
Sbjct: 765 RGSLYRILHRPQCQIDEKRRIRMALDVARGMNCLHASIPTIVHRDLKSPNLLVDKNWTVK 824
Query: 817 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
V DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFG+ILWELAT++LPW
Sbjct: 825 VCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGIILWELATIRLPW 884
Query: 877 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930
GMNPMQVVGAVGFQNRRLEIPKE+DPLVARIIWECWQT ++R S AQL+
Sbjct: 885 SGMNPMQVVGAVGFQNRRLEIPKEVDPLVARIIWECWQT---DPNLRPSFAQLT 935
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487849|ref|XP_002271755.2| PREDICTED: serine/threonine-protein kinase CTR1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1219 bits (3153), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 637/954 (66%), Positives = 746/954 (78%), Gaps = 55/954 (5%)
Query: 1 MRNIFKKLHIGSN-HESNRTNETLASTTS----CATDHNRTSSSSSNAAPPSPSASAATA 55
M++IFKKLHIGS+ H+ NR+NETL+S T+ CA+DH RTSS+ S+ +PPS S T
Sbjct: 1 MKHIFKKLHIGSSSHDPNRSNETLSSATTSSPACASDH-RTSSAQSSVSPPSSYPSPTT- 58
Query: 56 ASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNNRRS 115
FQVQLA+AISAS+S+ D SEKDQIRAATLLSL R+
Sbjct: 59 ----------------------FQVQLALAISASNSDFRDDSEKDQIRAATLLSLGRHRT 96
Query: 116 DLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLESNL 175
D RDK D +AE +SR+YW+YNVLDYEE+VVDGFYD+YGLSTDP QGK+PSL LE+NL
Sbjct: 97 DSVRDK-DESAESMSRRYWDYNVLDYEEKVVDGFYDVYGLSTDPVIQGKMPSLTDLETNL 155
Query: 176 GNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDAN 235
GNSGFEV++VNR ID ALEELVQVA CIALD PA +VG+LVQ+LA++V HMGGPV+DAN
Sbjct: 156 GNSGFEVIVVNRRIDPALEELVQVAHCIALDCPAAEVGVLVQRLAEIVTDHMGGPVRDAN 215
Query: 236 IMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTG 295
IML +WME +LR SL TS+LP+GS++IGLSRHRALLFK+LAD++ +PCRLVKGSHYTG
Sbjct: 216 IMLVKWMESRKDLRTSLHTSILPVGSLSIGLSRHRALLFKILADNVGVPCRLVKGSHYTG 275
Query: 296 VEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDS 355
VEDDAVNIIKL+ EREFLVDLM APGTLIPADILSAKD++ K YNP +SKIP L+ S D
Sbjct: 276 VEDDAVNIIKLDNEREFLVDLMGAPGTLIPADILSAKDSSLKSYNPKLSKIPTLQASKDP 335
Query: 356 GAVYSKPKPLHA--EGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISS 413
G VYS+PKPL EGSSQ ST++ SLP + ++SEK ESL SF S S + G +S IS
Sbjct: 336 GGVYSRPKPLLGDYEGSSQTSTIENSLPQDRKASSEKIESLDSFSSSSGDTGVGTSRISK 395
Query: 414 RVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNP 472
RVTP NQSD S IG S+YKG RG NAVGDG+RMNVN+VPY Q ED K+LFADLNP
Sbjct: 396 RVTPVNQSDLRPSLAIGASVYKGSRGANAVGDGSRMNVNIVPYNQNSTEDPKNLFADLNP 455
Query: 473 FQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYME 532
FQ+ G+ K S P E+KV+EFQ + + GRPP+P+M KN++ NEVPRKKE ++E
Sbjct: 456 FQMIGSSKASAQSKPMENKVDEFQREKNSAAPGRPPLPLMWKNRYANNEVPRKKENDFVE 515
Query: 533 GILPKINREPNN-NL-STSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSL 590
G+ PKINRE N+ NL S +++ ++TSE FK S +A +++K ++ +++ + L
Sbjct: 516 GLFPKINRETNDYNLPSLTSNNATTSEKVYSGVFKLSGNAYMNNKVNDDQNSSCNTTSML 575
Query: 591 ASSTSQLNGPPLVEDLSSNSKDENPKN-----------VEDH---EIGYHDRRKCTHDRF 636
A STSQ N L ED+++N ++ K+ ++H E G HD RK HD F
Sbjct: 576 APSTSQFNRLSLDEDVNANYNEKYHKDGKVFQSDMVDAAKEHDKNETGLHDHRKFRHDSF 635
Query: 637 MGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD 696
M NL R+ ESP SSVDS KVDQ+F+D V ECEIPWEDLVLGERIGLGSYGEVYH D
Sbjct: 636 MENNL--REAESPCSSVDSDAGKVDQMFED-VGECEIPWEDLVLGERIGLGSYGEVYHGD 692
Query: 697 WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756
WNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFLP
Sbjct: 693 WNGTEVAVKKFLDQDFSGAALAEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 752
Query: 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 816
RGSL+RILHRP CQ+DEKRRIKMALDVA+GMNCLHTS PTIVHRDLKSPNLLVDKNWNVK
Sbjct: 753 RGSLYRILHRPSCQIDEKRRIKMALDVAKGMNCLHTSLPTIVHRDLKSPNLLVDKNWNVK 812
Query: 817 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
V DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE SNEKCDVYSFG+ILWELATL+LPW
Sbjct: 813 VCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNENSNEKCDVYSFGIILWELATLRLPW 872
Query: 877 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930
GMNPMQVVGAVGFQNRRL+IPKE+DPLVARIIWECWQT ++R S AQL+
Sbjct: 873 SGMNPMQVVGAVGFQNRRLDIPKEVDPLVARIIWECWQT---DPNLRPSFAQLT 923
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542402|ref|XP_002512264.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223548225|gb|EEF49716.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1202 bits (3109), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 633/946 (66%), Positives = 741/946 (78%), Gaps = 63/946 (6%)
Query: 1 MRNIFKKLHIGSNHESN-RTNETLASTTSCATDHNRTSSSSSNAAPPSPSASAATAASSP 59
M++IFKKLHIGS HE N R NET + + SC++DH RTSS
Sbjct: 1 MKHIFKKLHIGSGHEPNHRPNETPSPSQSCSSDH-RTSS--------------------- 38
Query: 60 APVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPE--DFSEKDQIRAATLLSL----NNR 113
V + S +S E++Q+QLA+A+SAS+SN E + E DQIRAATLLSL NN
Sbjct: 39 --VNAPASPPSTSSSPEDYQIQLALALSASASNSEFREDHENDQIRAATLLSLGGNHNNH 96
Query: 114 ------RSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPS 167
R D+ R+K ++AAE LSRQYWEYNVLDYEE+V+DGFYD++ S P Q K+PS
Sbjct: 97 THNPTHRIDMPRNKGELAAEALSRQYWEYNVLDYEEKVMDGFYDVF--SRSPVVQAKMPS 154
Query: 168 LAHLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHM 227
L LE+N G+S FE V++NR +DHALEELVQVAQCIALD PATDVGILVQ+LA++V GHM
Sbjct: 155 LTELETNPGSSSFEAVVINRAMDHALEELVQVAQCIALDCPATDVGILVQRLAEVVTGHM 214
Query: 228 GGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRL 287
GGPVKDANIMLARWMERST+LR+SL TS LPIGSI+IGLSRHRALLFKVLAD+IR PCRL
Sbjct: 215 GGPVKDANIMLARWMERSTDLRKSLHTSALPIGSIDIGLSRHRALLFKVLADNIRFPCRL 274
Query: 288 VKGSHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIP 347
VKGSHYTG+EDDA+NIIKLE+EREFLVDLMA PGTLIPAD+LSAKDT FK YNP I+ I
Sbjct: 275 VKGSHYTGIEDDAINIIKLEDEREFLVDLMADPGTLIPADVLSAKDTTFKSYNPNINIIA 334
Query: 348 ILRTSNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAA 407
L++ N+S +Y++ P EGSSQNS++DGSLPL+ S++E AESL SF S G
Sbjct: 335 GLQSPNESEIIYTRSSPSFGEGSSQNSSMDGSLPLDRRSSNETAESLASFSGASSNVGVG 394
Query: 408 SSGISSRV-TPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSL 466
SSG S+V + NQ +SS IG YKGGRG +AV D RMNVNV+PYGQ EDS++L
Sbjct: 395 SSGGPSKVASSNQHGNISSLAIG---YKGGRGTHAVADAVRMNVNVIPYGQNSLEDSRNL 451
Query: 467 FADLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKK 526
F+DLNPFQIKG GK+ +H P E+KVE+F + N + GRPP P+ KN++ YNEVPRKK
Sbjct: 452 FSDLNPFQIKGTGKSFMHNKPAENKVEDFHGQKDNLLPGRPPAPLKWKNRYAYNEVPRKK 511
Query: 527 EYSYMEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALS 584
EY Y+EG+ P I+REPN N S ++S+S+ SE P S+ +N SS+D ++ ++ S
Sbjct: 512 EYDYIEGLFPGISREPNGYNQSSLASSSSTMSEKVYPQGLNSSSSSNTSSRDGDAWNSSS 571
Query: 585 GSGPSLASSTSQLNGPPLVEDLSSNSKDENPKNV--------------EDHEIGYHDRRK 630
G+ +LAS +Q LVE+ +S+ K E+P++ E++EIG+ DRRK
Sbjct: 572 GTNSALASGMNQCYKSSLVEEANSDFK-ESPRDAKNFQNDAEVTIRDDENNEIGFQDRRK 630
Query: 631 CTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSY 689
CTHDRFMG NLKL+ ES SSS+DS +KVDQIFDD DV ECEIPWEDL LGERIGLGSY
Sbjct: 631 CTHDRFMGINLKLK--ESSSSSIDSGKNKVDQIFDDVDVGECEIPWEDLDLGERIGLGSY 688
Query: 690 GEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749
GEVYHADWNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLS
Sbjct: 689 GEVYHADWNGTEVAVKKFLDQDFSGAALAEFKREVRIMRRLRHPNVVLFMGAVTRPPNLS 748
Query: 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 809
II+EFLPRGSL+RILHRPHCQ+DEKRRIKMALDVARGMNCLH+S PTIVHRDLKSPNLLV
Sbjct: 749 IISEFLPRGSLYRILHRPHCQIDEKRRIKMALDVARGMNCLHSSIPTIVHRDLKSPNLLV 808
Query: 810 DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 869
DKNWNVKV DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL
Sbjct: 809 DKNWNVKVCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 868
Query: 870 ATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915
ATL+LPW GMNPMQVVGAVGFQNRRLEIPK++DP VA IIW+CWQ+
Sbjct: 869 ATLRLPWSGMNPMQVVGAVGFQNRRLEIPKDIDPKVAMIIWQCWQS 914
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356535135|ref|XP_003536104.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1136 bits (2939), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 606/943 (64%), Positives = 707/943 (74%), Gaps = 75/943 (7%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLAS--TTSCATDHNRTSSSSSNAAPPSPSASAATAAS- 57
M+NIFKKLHIGS+H+ +R+NE S + SC D +++S+++ + + ++++ +
Sbjct: 18 MKNIFKKLHIGSSHDPHRSNEASPSVPSPSCVADQSQSSAATPASPSSASASASTVVVTP 77
Query: 58 -----SPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNN 112
+PV++ R D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL
Sbjct: 78 GGGGGGASPVMN---RQDFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSLGG 134
Query: 113 RRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLE 172
R D R+K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS LE
Sbjct: 135 HRIDSARNKDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTDLE 193
Query: 173 SNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVK 232
+N G G E+VIVNRTID +LEEL+Q+AQCIALD P V LVQ+LA+LV HMGGPVK
Sbjct: 194 ANPG--GSELVIVNRTIDPSLEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGPVK 248
Query: 233 DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSH 292
DA+IMLARW E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSH
Sbjct: 249 DASIMLARWTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSH 308
Query: 293 YTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTS 352
YTGVEDDAVNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++
Sbjct: 309 YTGVEDDAVNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPST 366
Query: 353 NDSGAVYSKP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSG 410
D+ YS+P +P H EGSSQNS V D SLP NG EK+E PS S + G S
Sbjct: 367 KDNEFSYSRPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEKSE--PSNLGLSRDSGVGPSK 424
Query: 411 ISSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADL 470
I ++ TPNQ + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADL
Sbjct: 425 IPNKGTPNQLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADL 483
Query: 471 NPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSY 530
NPFQIKG GK +H P E+K E +S + N VSGRPP+P+M KN+H YNE PRK
Sbjct: 484 NPFQIKGMGKAPVHNKPVENKPPELKSTKNNAVSGRPPVPLMWKNRHAYNEDPRK----- 538
Query: 531 MEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGP 588
N PN N ++ SS SE + S KP ++NI++ +
Sbjct: 539 -------TNHNPNEYNPPLFVSNGSSMSEIIDLSSSKPLYNSNINN---------DVNAQ 582
Query: 589 SLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLES 648
+LA T ++ P HD+R CT+DRFMG+NLKL+D ES
Sbjct: 583 TLAQVTGSVSPP------------------------NHDQRNCTYDRFMGSNLKLKDPES 618
Query: 649 PSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKF 707
PSSS+DS T++VDQI DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVKKF
Sbjct: 619 PSSSIDSITNRVDQILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVKKF 678
Query: 708 LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP 767
LDQDFSGAAL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHRP
Sbjct: 679 LDQDFSGAALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHRP 738
Query: 768 HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827
+CQ+DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKH
Sbjct: 739 NCQIDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKH 798
Query: 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 887
NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGA
Sbjct: 799 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVGA 858
Query: 888 VGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930
VGFQNRRL+IPKE+DP+VARIIWECWQ ++R S AQL+
Sbjct: 859 VGFQNRRLDIPKEVDPIVARIIWECWQ---QDPNLRPSFAQLT 898
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|229335619|gb|ACQ57002.1| EDR1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1132 bits (2928), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 606/943 (64%), Positives = 708/943 (75%), Gaps = 75/943 (7%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLAS--TTSCATDHNRTSSSSSNAAPPSPSASAATAAS- 57
M+NIFKKLHIGS+H+ +R+NE S + SC D +++S+++ + + ++++ +
Sbjct: 1 MKNIFKKLHIGSSHDPHRSNEASPSVPSPSCVADQSQSSAATPASPSSASASASTVVVTP 60
Query: 58 -----SPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNN 112
+PV++ R D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL
Sbjct: 61 GGGGGGASPVMN---RQDFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSLGG 117
Query: 113 RRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLE 172
R D R+K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS LE
Sbjct: 118 HRIDSARNKDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTDLE 176
Query: 173 SNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVK 232
+N G G E+VIVNRTID +LEEL+Q+AQCIALD P V LVQ+LA+LV HMGGPVK
Sbjct: 177 ANPG--GSELVIVNRTIDPSLEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGPVK 231
Query: 233 DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSH 292
DA+IMLARW E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSH
Sbjct: 232 DASIMLARWTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSH 291
Query: 293 YTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTS 352
YTGVEDDAVNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++
Sbjct: 292 YTGVEDDAVNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPST 349
Query: 353 NDSGAVYSKP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSG 410
D+ YS+P +P H EGSSQNS V D SLP NG EK+E PS S + G S
Sbjct: 350 KDNEFSYSRPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEKSE--PSNLGLSRDSGVGPSK 407
Query: 411 ISSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADL 470
I ++ TPNQ + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADL
Sbjct: 408 IPNKGTPNQLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADL 466
Query: 471 NPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSY 530
NPFQIKG GK +H P E+K E +S + VSGRPP+P+M KN+H YNE PRK
Sbjct: 467 NPFQIKGMGKAPVHNKPVENKPPELKSTKNYAVSGRPPVPLMWKNRHAYNEDPRK----- 521
Query: 531 MEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGP 588
N PN N ++ SS SE + S KP ++NI++ +
Sbjct: 522 -------TNHNPNEYNPPLFVSNGSSMSEIIDLSSSKPLYNSNINNDVN----------- 563
Query: 589 SLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLES 648
A + +Q+ G +P N HD+R CT+DRFMG+NLKL+D ES
Sbjct: 564 --AQTLAQVTG------------SVSPPN--------HDQRNCTYDRFMGSNLKLKDPES 601
Query: 649 PSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKF 707
PSSS+DS T++VDQI DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVKKF
Sbjct: 602 PSSSIDSITNRVDQILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVKKF 661
Query: 708 LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP 767
LDQDFSGAAL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHRP
Sbjct: 662 LDQDFSGAALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHRP 721
Query: 768 HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827
+CQ+DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKH
Sbjct: 722 NCQIDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKH 781
Query: 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 887
NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGA
Sbjct: 782 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVGA 841
Query: 888 VGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930
VGFQNRRL+IPKE+DP+VARIIWECWQ ++R S AQL+
Sbjct: 842 VGFQNRRLDIPKEVDPIVARIIWECWQ---QDPNLRPSFAQLT 881
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356576743|ref|XP_003556489.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1122 bits (2901), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 604/945 (63%), Positives = 700/945 (74%), Gaps = 77/945 (8%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLASTTS--CATDHNRTSSSSSNAAPPSPS--------A 50
M+NIFKKLHIGS+H+ +R+NE S CATD +++S+++ + +
Sbjct: 18 MKNIFKKLHIGSSHDPHRSNEPSPPVPSPSCATDQSQSSAATPPSPSSASPSPSPSTLVV 77
Query: 51 SAATAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL 110
+ + +PVV+ R D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL
Sbjct: 78 TPSCGGGGASPVVN---RQDFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSL 134
Query: 111 NNRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAH 170
R D R+K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS
Sbjct: 135 GGHRIDSTRNKDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTD 193
Query: 171 LESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGP 230
LE+N G G E+VIVN+TID ALEEL+Q+AQCIALD P V LVQ+LA+LV HMGGP
Sbjct: 194 LEANPG--GSELVIVNQTIDPALEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGP 248
Query: 231 VKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKG 290
VKDA IMLARW E ELR SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRL+KG
Sbjct: 249 VKDAGIMLARWTETRAELRTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLLKG 308
Query: 291 SHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILR 350
SHYTGVEDDAVNIIKLE EREFLVDLMAAPGTLIPADILS KD+AFK YNP I +P L
Sbjct: 309 SHYTGVEDDAVNIIKLEGEREFLVDLMAAPGTLIPADILSTKDSAFKSYNPKI--LPSLP 366
Query: 351 TSNDSGAVYSKP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAAS 408
++ D+ YS+P +P H EGSSQNS + D SLP NG EK+E PS S E G
Sbjct: 367 STKDNEFSYSRPIQPFHGEGSSQNSVIKDYSLPWNGKPYFEKSE--PSNLGLSRESGTGP 424
Query: 409 SGISSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFA 468
S I ++ TPNQ D L + + G SLYKG G N VGDG R+NVNVVPY DS++LFA
Sbjct: 425 SKIPNKGTPNQLDNLPALS-GASLYKGTLGMNTVGDGTRLNVNVVPYTNISPNDSRNLFA 483
Query: 469 DLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEY 528
DLNPFQIKG GK +H P E+K E +S + N VSGRPP+P+M KN+ YNE PRK
Sbjct: 484 DLNPFQIKGMGKAPVHNKPVENKPPELKSTKNNTVSGRPPVPLMWKNRPAYNEDPRK--- 540
Query: 529 SYMEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGS 586
N PN N ++ SSTSEN + S KP ++NI++ +
Sbjct: 541 ---------TNHNPNDYNPPLFVSNGSSTSENIDLSSSKPLYNSNINNDVN--------- 582
Query: 587 GPSLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDL 646
A + +Q+ G +P N HD+RKCT+DRFMG+NLKL+D
Sbjct: 583 ----AQTLAQVTG------------SVSPPN--------HDQRKCTYDRFMGSNLKLKDP 618
Query: 647 ESPSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVK 705
ESPSSS+DS T+++D I DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVK
Sbjct: 619 ESPSSSIDSITNRIDPILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVK 678
Query: 706 KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH 765
KFLDQDFSGAAL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILH
Sbjct: 679 KFLDQDFSGAALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILH 738
Query: 766 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825
R + Q+DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRL
Sbjct: 739 RSNYQIDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRL 798
Query: 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885
KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW MN MQVV
Sbjct: 799 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSEMNTMQVV 858
Query: 886 GAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930
GAVGFQNRRL+IPKE+DP+VARIIWECWQ ++R S AQL+
Sbjct: 859 GAVGFQNRRLDIPKEVDPIVARIIWECWQ---QDPNLRPSFAQLT 900
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435758|ref|XP_004135661.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase CTR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1118 bits (2891), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 594/953 (62%), Positives = 712/953 (74%), Gaps = 71/953 (7%)
Query: 1 MRNIFKKLHIGSNHESNRTNE-----TLASTTSCATDHNRTSSSSSNAAPPSPSASAATA 55
M++IFKK HIGSNHE NR+NE AS++ C +D NR + + + PP+
Sbjct: 1 MKHIFKKFHIGSNHEPNRSNENPSPVAAASSSPCVSD-NRGGNVTQVSVPPN-------- 51
Query: 56 ASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNNRRS 115
R+DY +SEEEFQVQLA+AISAS+S+ D EKDQIRAATLLSL N R
Sbjct: 52 ------------RSDYFSSEEEFQVQLALAISASNSDFRDDPEKDQIRAATLLSLGNHRI 99
Query: 116 D-LGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLESN 174
D RD+ D AAEVLSRQYWEYNVLDYEE+VV+GFYD+ LSTD + QGK+PSL+ +E++
Sbjct: 100 DSTARDQGD-AAEVLSRQYWEYNVLDYEEKVVNGFYDV--LSTDSAVQGKIPSLSDIEAS 156
Query: 175 LGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDA 234
G+SGFEVV+VN TID ALEELVQ+AQCIA D P T+V +LVQ+LA+LV GHMGGPVKDA
Sbjct: 157 FGSSGFEVVMVNMTIDPALEELVQIAQCIA-DCPGTEVRVLVQRLAELVMGHMGGPVKDA 215
Query: 235 NIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYT 294
+ MLARWMERSTELR SL TSVLPIGSINIGLSRHRALLFKVLADSI++PCRLVKGSHYT
Sbjct: 216 HFMLARWMERSTELRTSLHTSVLPIGSINIGLSRHRALLFKVLADSIKMPCRLVKGSHYT 275
Query: 295 GVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTA-FKPYNPLISKIPILRTSN 353
GVE+DAVNIIKLE+EREFLVDLMAAPGTL+PADI +AKDT FKPYNP +S+IP L SN
Sbjct: 276 GVEEDAVNIIKLEDEREFLVDLMAAPGTLLPADIFNAKDTTNFKPYNPKVSRIPSLHHSN 335
Query: 354 DSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISS 413
D G +KP EGSSQN + ++G + ES+PS SSG++
Sbjct: 336 DVGISSAKPTSGLEEGSSQNFGAEAISLMDGKLGYGRTESVPS-----------SSGVTC 384
Query: 414 RVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDG-ARMNVNVVPYGQTGQEDSKSLFADLNP 472
+ + LS GTS YKG GDG R+NVNVVP+GQ+ EDSK+LFADLNP
Sbjct: 385 XINSRLMENLSLLGTGTSRYKGAH----FGDGNVRLNVNVVPFGQS-SEDSKNLFADLNP 439
Query: 473 FQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYME 532
F I+G GK+ + +++K EE Q P G PP+P+ KN+ +N VP K EY YME
Sbjct: 440 FLIRGTGKSFIPNKFSDNKSEELQK----PTIGHPPVPLW-KNRFAFNAVPNKNEYDYME 494
Query: 533 GILPKINREPNN-NLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLA 591
G P+I+R PN+ N++ S+S S+ SE+ P SND + S + +E S+ S A
Sbjct: 495 GRFPRISRGPNDQNMALSSSNSTGSESVKPGGSGTSNDLSASVRSAEVGSSSSNMYAQPA 554
Query: 592 SSTSQLNGPPLVEDLSSNSKDENPKNVE------------DHEIGYHDRRKCTHDRFMGT 639
+ N P +++ + S E+ N + D+ I + +RRK T++R +GT
Sbjct: 555 FGMMEPNILPFIDEQNRKSNGEHSGNTDMEDEKVDAVDGRDNLIRFDNRRKFTYERSVGT 614
Query: 640 NLKLRDLESPSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWN 698
NL L+D +P V+ S+++ +Q++DD DV +CEI WEDLV+GERIGLGSYGEVYHADWN
Sbjct: 615 NLILKDSGNPGLLVNPSSNRFEQVYDDVDVGQCEIQWEDLVIGERIGLGSYGEVYHADWN 674
Query: 699 GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758
TEVAVKKFLDQDFSGAAL EFKREV IMR+LRHPN+VLFMGAVTRPPNLSI+TEFLPRG
Sbjct: 675 DTEVAVKKFLDQDFSGAALAEFKREVLIMRQLRHPNIVLFMGAVTRPPNLSIVTEFLPRG 734
Query: 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 818
SL+RI+HRP+CQ+DEKRRIKMALDVARGMNCLHTS PTIVHRDLKSPNLLVDKNWNVKVS
Sbjct: 735 SLYRIIHRPNCQIDEKRRIKMALDVARGMNCLHTSNPTIVHRDLKSPNLLVDKNWNVKVS 794
Query: 819 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 878
DFGLSRLKHNTFLSSKST GTPEWMAPEVLRNEPSNEKCDVYSFG+ILWELATL+LPW G
Sbjct: 795 DFGLSRLKHNTFLSSKSTGGTPEWMAPEVLRNEPSNEKCDVYSFGIILWELATLRLPWSG 854
Query: 879 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931
MNPMQVVGAVGF+N+RLEIPKE+DP VARIIWECWQT ++R S +QL++
Sbjct: 855 MNPMQVVGAVGFRNQRLEIPKEVDPTVARIIWECWQT---DPNLRPSFSQLAN 904
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|262213688|gb|ACY36006.1| EDR1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1117 bits (2889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 597/935 (63%), Positives = 680/935 (72%), Gaps = 118/935 (12%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLASTTSCATDHNRTSSSSSNAAPPSPSASAATAASSPA 60
M+NIFKKLHIGS+H+ +R+NE SPS
Sbjct: 18 MKNIFKKLHIGSSHDPHRSNEA------------------------SPS----------- 42
Query: 61 PVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNNRRSDLGRD 120
D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL R D R+
Sbjct: 43 ---------DFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSLGGHRIDSARN 93
Query: 121 KADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLESNLGNSGF 180
K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS LE+N G G
Sbjct: 94 KDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTDLEANPG--GS 150
Query: 181 EVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLAR 240
E+VIVNRTID +LEEL+Q+AQCIALD P V LVQ+LA+LV HMGGPVKDA+IMLAR
Sbjct: 151 ELVIVNRTIDPSLEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGPVKDASIMLAR 207
Query: 241 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 300
W E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSHYTGVEDDA
Sbjct: 208 WTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSHYTGVEDDA 267
Query: 301 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 360
VNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++ D+ YS
Sbjct: 268 VNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPSTKDNEFSYS 325
Query: 361 KP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTPN 418
+P +P H EGSSQNS V D SLP NG EK + G S I ++ TPN
Sbjct: 326 RPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEK------------DSGVGPSKIPNKGTPN 373
Query: 419 QSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGA 478
Q + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADLNPFQIKG
Sbjct: 374 QLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADLNPFQIKGM 432
Query: 479 GKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKI 538
GK +H P E+K E +S + N VSGRPP+P+M KN+H YNE PRK
Sbjct: 433 GKAPVHNKPVENKPPELKSTKNNAVSGRPPVPLMWKNRHAYNEDPRK------------T 480
Query: 539 NREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQ 596
N PN N ++ SS SE + S KP ++NI++ + +LA T
Sbjct: 481 NHNPNEYNPPLFVSNGSSMSEIIDLSSSKPLYNSNINN---------DVNAQTLAQVTGS 531
Query: 597 LNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSS 656
++ P HD+R CT+DRFMG+NLKL+D ESPSSS+DS
Sbjct: 532 VSPP------------------------NHDQRNCTYDRFMGSNLKLKDPESPSSSIDSI 567
Query: 657 TSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA 715
T++VDQI DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVKKFLDQDFSGA
Sbjct: 568 TNRVDQILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVKKFLDQDFSGA 627
Query: 716 ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR 775
AL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHRP+CQ+DEKR
Sbjct: 628 ALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHRPNCQIDEKR 687
Query: 776 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835
RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKHNTFLSSKS
Sbjct: 688 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKHNTFLSSKS 747
Query: 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 895
TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGAVGFQNRRL
Sbjct: 748 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVGAVGFQNRRL 807
Query: 896 EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930
+IPKE+DP+VARIIWECWQ ++R S AQL+
Sbjct: 808 DIPKEVDPIVARIIWECWQ---QDPNLRPSFAQLT 839
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204924|emb|CBI34231.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1107 bits (2863), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 593/942 (62%), Positives = 689/942 (73%), Gaps = 112/942 (11%)
Query: 1 MRNIFKKLHIGSN-HESNRTNETLASTTS----CATDHNRTSSSSSNAAPPSPSASAATA 55
M++IFKKLHIGS+ H+ NR+NETL+S T+ CA+DH RTSS+ S+ +PPS S T
Sbjct: 1 MKHIFKKLHIGSSSHDPNRSNETLSSATTSSPACASDH-RTSSAQSSVSPPSSYPSPTTV 59
Query: 56 ASSPAPVV------SSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLS 109
+S+ A + ++ +R+DY SEEEFQVQLA+AISAS+S+ D SEKDQIRAATLLS
Sbjct: 60 SSTAASTLPTATSPAASNRSDYFLSEEEFQVQLALAISASNSDFRDDSEKDQIRAATLLS 119
Query: 110 LNNRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLA 169
L R+D RDK D +AE +SR+YW+YNVLDYEE+VVDGFYD+YGLSTDP QGK+PSL
Sbjct: 120 LGRHRTDSVRDK-DESAESMSRRYWDYNVLDYEEKVVDGFYDVYGLSTDPVIQGKMPSLT 178
Query: 170 HLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGG 229
LE+NLGNSGFEV++VNR ID ALEELVQVA CIALD PA +VG+LVQ+LA++V HMGG
Sbjct: 179 DLETNLGNSGFEVIVVNRRIDPALEELVQVAHCIALDCPAAEVGVLVQRLAEIVTDHMGG 238
Query: 230 PVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVK 289
PV+DANIML +WME +LR SL TS+LP+GS++IGLSRHRALLFK+LAD++ +PCRLVK
Sbjct: 239 PVRDANIMLVKWMESRKDLRTSLHTSILPVGSLSIGLSRHRALLFKILADNVGVPCRLVK 298
Query: 290 GSHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPIL 349
GSHYTGVEDDAVNIIKL+ EREFLVDLM APGTLIPADILSAKD+
Sbjct: 299 GSHYTGVEDDAVNIIKLDNEREFLVDLMGAPGTLIPADILSAKDS--------------- 343
Query: 350 RTSNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASS 409
SSQ ST++ SLP + ++SEK ESL SF S S + G +S
Sbjct: 344 --------------------SSQTSTIENSLPQDRKASSEKIESLDSFSSSSGDTGVGTS 383
Query: 410 GISSRVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFA 468
IS RVTP NQSD S IG S+YKG RG NAVGDG+RMNVN+VPY Q ED K+LFA
Sbjct: 384 RISKRVTPVNQSDLRPSLAIGASVYKGSRGANAVGDGSRMNVNIVPYNQNSTEDPKNLFA 443
Query: 469 DLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEY 528
DLNPFQ+ G+ K S P E+KV+EFQ + S P
Sbjct: 444 DLNPFQMIGSSKASAQSKPMENKVDEFQREK---NSAAP--------------------- 479
Query: 529 SYMEGILPKINREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGP 588
+N + N++ +T++ + ++ FN S +AN + K
Sbjct: 480 ---------VNDDQNSSCNTTSMLAPSTSQFNRLSLDEDVNANYNEK------------- 517
Query: 589 SLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLES 648
+G D+ +K E+ KN E G HD RK HD FM N LR+ ES
Sbjct: 518 ------YHKDGKVFQSDMVDAAK-EHDKN----ETGLHDHRKFRHDSFMENN--LREAES 564
Query: 649 PSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFL 708
P SSVDS KVDQ+F +DV ECEIPWEDLVLGERIGLGSYGEVYH DWNGTEVAVKKFL
Sbjct: 565 PCSSVDSDAGKVDQMF-EDVGECEIPWEDLVLGERIGLGSYGEVYHGDWNGTEVAVKKFL 623
Query: 709 DQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH 768
DQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL+RILHRP
Sbjct: 624 DQDFSGAALAEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLYRILHRPS 683
Query: 769 CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828
CQ+DEKRRIKMALDVA+GMNCLHTS PTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKHN
Sbjct: 684 CQIDEKRRIKMALDVAKGMNCLHTSLPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKHN 743
Query: 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 888
TFLSSKSTAGTPEWMAPEVLRNE SNEKCDVYSFG+ILWELATL+LPW GMNPMQVVGAV
Sbjct: 744 TFLSSKSTAGTPEWMAPEVLRNENSNEKCDVYSFGIILWELATLRLPWSGMNPMQVVGAV 803
Query: 889 GFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930
GFQNRRL+IPKE+DPLVARIIWECWQT ++R S AQL+
Sbjct: 804 GFQNRRLDIPKEVDPLVARIIWECWQT---DPNLRPSFAQLT 842
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 935 | ||||||
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.960 | 0.962 | 0.554 | 9.2e-258 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.284 | 0.302 | 0.771 | 5.2e-175 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.287 | 0.261 | 0.722 | 1e-164 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.267 | 0.252 | 0.748 | 6.3e-155 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.260 | 0.297 | 0.674 | 5.1e-121 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.270 | 0.377 | 0.623 | 1.4e-85 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.272 | 0.329 | 0.610 | 1.7e-84 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.262 | 0.332 | 0.628 | 2.7e-84 | |
| TAIR|locus:2052786 | 775 | AT2G31010 [Arabidopsis thalian | 0.255 | 0.308 | 0.495 | 5.1e-83 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.271 | 0.332 | 0.603 | 6.4e-83 |
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2481 (878.4 bits), Expect = 9.2e-258, P = 9.2e-258
Identities = 527/950 (55%), Positives = 640/950 (67%)
Query: 1 MRNIFKKLHIGSNHES-NRTNETLASTTSCATDHNRXXXXXX------XXXXXXXXXXXX 53
M++IFKKLH G N E NRTN+ A+ S D NR
Sbjct: 1 MKHIFKKLHRGGNQEQQNRTND--AAPPS---DQNRIHVSANPPQATPSSVTETLPVAGA 55
Query: 54 XXXXXXXXXXXXGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL-NN 112
+R DYM+SEEE+QVQLA+AISAS+S + EK QIRAATLLSL ++
Sbjct: 56 TSSMASPAPTAASNRADYMSSEEEYQVQLALAISASNSQSSEDPEKHQIRAATLLSLGSH 115
Query: 113 RRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLE 172
+R D RD ++V A+ LSRQYWEY VLDYEE+VVD FYD+Y LSTD + QG++PSL LE
Sbjct: 116 QRMDSRRDSSEVVAQRLSRQYWEYGVLDYEEKVVDSFYDVYSLSTDSAKQGEMPSLEDLE 175
Query: 173 SNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVK 232
SN G GFE V+VNR ID +L EL+++A+CIAL T V +LVQ+LA+LV HMGG +
Sbjct: 176 SNHGTPGFEAVVVNRPIDSSLHELLEIAECIALGCSTTSVSVLVQRLAELVTEHMGGSAE 235
Query: 233 DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSH 292
D++I+LARW E+S+E + +L T V PIG + IG+SRHRALLFKVLADS+RLPCRLVKGSH
Sbjct: 236 DSSIVLARWTEKSSEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVRLPCRLVKGSH 295
Query: 293 YTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTS 352
YTG EDDAVN I+LE+ERE+LVDLM PGTLIPAD SA + +P N +K P + S
Sbjct: 296 YTGNEDDAVNTIRLEDEREYLVDLMTDPGTLIPADFASASNNTVEPCNSNGNKFPTAQFS 355
Query: 353 NDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGIS 412
ND PK EGSS +S + S L+ + +E+ +S S+P S S
Sbjct: 356 NDV------PKLSEGEGSSHSSMANYSSSLDRRTEAERTDS--SYPKVGPLRNIDYSSPS 407
Query: 413 SRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNP 472
S + Q + SS+ IG KG RG A+ + +R N+N+VPY Q +ED K+LFADLNP
Sbjct: 408 SVTSSTQLENNSSTAIG----KGSRG--AIIECSRTNMNIVPYNQNSEEDPKNLFADLNP 461
Query: 473 FQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYME 532
FQ KGA K + + V++F + NP+ GR P PMM KN + NE P++KE SY+E
Sbjct: 462 FQNKGADKLYMPTKSGLNNVDDFHQQKNNPLVGRSPAPMMWKN-YSCNEAPKRKENSYIE 520
Query: 533 GILPKINREPNNNLXXXXXXXXXXENFNPHSFKPSNDANISSKDXXXXXXXXXXXXXXXX 592
+LPK++R+P ++ S + +N+ +D
Sbjct: 521 NLLPKLHRDPRYG--------NTQSSYATSSSNGAISSNVHGRDNVTFVSPVAVPSSFTS 572
Query: 593 XXXQLNGPPLVEDLSSNSKDE---NPKNV------EDHEIGYHDRRKCTHDRFM-GTNLK 642
Q P +VED++ N+ +E P ++ E HD RK T D G + +
Sbjct: 573 TENQFR-PSIVEDMNRNTNNELDLQPHTAAVVHGQQNDESHIHDHRKYTSDDISTGCDPR 631
Query: 643 LRDLEXXXXXXXXXXXKVD-QIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT 700
L+D E + D Q+ DD DV ECEIPW DLV+ ERIGLGSYGEVYHADW+GT
Sbjct: 632 LKDHESTSSSLDSTSYRNDPQVLDDADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGT 691
Query: 701 EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760
EVAVKKFLDQDFSGAAL EF+ EV+IMRRLRHPNVV F+GAVTRPPNLSI+TEFLPRGSL
Sbjct: 692 EVAVKKFLDQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSL 751
Query: 761 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820
+RILHRP +DE+RRIKMALDVA GMNCLHTSTPTIVHRDLK+PNLLVD NWNVKV DF
Sbjct: 752 YRILHRPKSHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDF 811
Query: 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 880
GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMN
Sbjct: 812 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMN 871
Query: 881 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930
PMQVVGAVGFQNRRLEIPKELDP+V RII ECWQT ++R S AQL+
Sbjct: 872 PMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQT---DPNLRPSFAQLT 918
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1099 (391.9 bits), Expect = 5.2e-175, Sum P(2) = 5.2e-175
Identities = 209/271 (77%), Positives = 237/271 (87%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI 726
+ + EI WEDL +GERIG+GSYGEVY A+WNGTEVAVKKFLDQDFSG AL +FK E++I
Sbjct: 598 EAAKWEIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIEI 657
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
M RLRHPNVVLFMGAVTRPPN SI+TEFLPRGSL+R+LHRP+ Q+DEKRR++MALDVA+G
Sbjct: 658 MLRLRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQLDEKRRMRMALDVAKG 717
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 846
MN LHTS PT+VHRDLKSPNLLVDKNW VKV DFGLSR+KH+T+LSSKSTAGTPEWMAPE
Sbjct: 718 MNYLHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMAPE 777
Query: 847 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906
VLRNEP+NEKCDVYSFGVILWELAT ++PW G+NPMQVVGAVGFQNRRLEIP ++D VA
Sbjct: 778 VLRNEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDIDLTVA 837
Query: 907 RIIWECWQTGWSSLHIRTSQAQL--SHKRFQ 935
+II ECWQT H+R S QL S KR Q
Sbjct: 838 QIIRECWQT---EPHLRPSFTQLMQSLKRLQ 865
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1051 (375.0 bits), Expect = 1.0e-164, Sum P(4) = 1.0e-164
Identities = 195/270 (72%), Positives = 231/270 (85%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVK 725
DDV +CEI WE++ +GERIGLGSYGEVY DW+GTEVAVKKFLDQD +G AL EF+ EV+
Sbjct: 736 DDVSDCEILWEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVR 795
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 785
IM++LRHPN+VLFMGAVTRPPNLSI+TEFLPRGSL+R++HRP+ Q+DE+RR++MALD AR
Sbjct: 796 IMKKLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLRMALDAAR 855
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
GMN LH+ P IVHRDLKSPNLLVDKNW VKV DFGLSR+KH+T+LSSKSTAGT EWMAP
Sbjct: 856 GMNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAP 915
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
EVLRNEP++EKCDVYS+GVILWEL TL+ PW MNPMQVVGAVGFQ+RRL+IP +DP +
Sbjct: 916 EVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPAI 975
Query: 906 ARIIWECWQTGWSSLHIRTSQAQLSHKRFQ 935
A +I +CWQT S L ++ S KR Q
Sbjct: 976 ADLISKCWQTD-SKLRPSFAEIMASLKRLQ 1004
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1023 (365.2 bits), Expect = 6.3e-155, Sum P(2) = 6.3e-155
Identities = 187/250 (74%), Positives = 221/250 (88%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVK 725
DDV ECEI WE++ + ERIGLGSYGEVY DW+GT VAVKKF+DQD +G AL EF+ EV+
Sbjct: 703 DDVAECEILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVR 762
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 785
+MRRLRHPN+VLFMGAVTRPPNLSI+TEFLPRGSL+R++HRP+ Q+DE++R++MALD AR
Sbjct: 763 MMRRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERKRLRMALDAAR 822
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
GMN LH+ P IVHRDLKSPNLLVDKNW VKV DFGLSR+K +T+LSSKSTAGT EWMAP
Sbjct: 823 GMNYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAP 882
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
EVLRNEP++EKCDVYS+GVILWEL TL+ PW MNPMQVVGAVGFQ+RRL+IP+ +DP +
Sbjct: 883 EVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPGI 942
Query: 906 ARIIWECWQT 915
A II +CWQT
Sbjct: 943 ADIIRKCWQT 952
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 5.1e-121, Sum P(2) = 5.1e-121
Identities = 166/246 (67%), Positives = 200/246 (81%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
+ +IPW DL + E+IG GS+G V+ A+W+G++VAVK ++QDF + EF REV IM+R
Sbjct: 543 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 602
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGM 787
LRHPN+VLFMGAVT+PPNLSI+TE+L RGSL+R+LH+ Q+DE+RR+ MA DVA+GM
Sbjct: 603 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 662
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
N LH P IVHRDLKSPNLLVDK + VKV DFGLSRLK +TFLSSKS AGTPEWMAPEV
Sbjct: 663 NYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 722
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
LR+EPSNEK DVYSFGVILWELATL+ PW +NP QVV AVGF+ +RLEIP+ L+P VA
Sbjct: 723 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 782
Query: 908 IIWECW 913
II CW
Sbjct: 783 IIEGCW 788
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.4e-85, P = 1.4e-85
Identities = 159/255 (62%), Positives = 199/255 (78%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL 718
KVD D D E EI W+DL +GE+IG GS G VYH W G++VAVK F Q++S + +
Sbjct: 417 KVD--IDSDPLEHEILWDDLTIGEQIGRGSCGTVYHGIWFGSDVAVKVFSKQEYSESVIK 474
Query: 719 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
F++EV +M+RLRHPNV+LFMGAVT P L I++EF+PRGSLFR+L R ++D +RRI
Sbjct: 475 SFEKEVSLMKRLRHPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMSKLDWRRRIN 534
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 838
MALD+ARGMN LH +P I+HRDLKS NLLVD+NW VKV+DFGLSR+KH T+L+SKS G
Sbjct: 535 MALDIARGMNYLHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYLTSKSGKG 594
Query: 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
TP+WMAPEVLRNE ++EK D+YSFGV+LWELAT K+PW +N MQV+GAVGF N+RLEIP
Sbjct: 595 TPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVGFMNQRLEIP 654
Query: 899 KELDPLVARIIWECW 913
K+ DP +I CW
Sbjct: 655 KDTDPDWISLIESCW 669
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
Identities = 157/257 (61%), Positives = 200/257 (77%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL 718
KVD D + E EI W+DL +GE++G GS G VYH W G++VAVK F Q++S +
Sbjct: 477 KVDT--DSEGLEYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEYSAEVIE 534
Query: 719 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
FK+EV +M+RLRHPNV+LFMGAVT P L I++EFLPRGSLFR+L + ++D +RRI
Sbjct: 535 SFKQEVLLMKRLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTSKLDWRRRIH 594
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 838
MALD+ARGMN LH +P I+HRDLKS NLLVDKNW VKV+DFGLSR+KH T+L+SKS G
Sbjct: 595 MALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGKG 654
Query: 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
TP+WMAPEVLRNE ++EK D+YSFGV+LWELAT K+PW +N MQV+GAVGF ++RLEIP
Sbjct: 655 TPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFMDQRLEIP 714
Query: 899 KELDPLVARIIWECWQT 915
K++DP ++ CW +
Sbjct: 715 KDIDPRWISLMESCWHS 731
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 844 (302.2 bits), Expect = 2.7e-84, P = 2.7e-84
Identities = 154/245 (62%), Positives = 193/245 (78%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
CEI WEDL LGE +G GS+ V+ WNG++VA+K + D D++ L E K+E+ IM++L
Sbjct: 461 CEIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNAMTLTECKKEINIMKKL 520
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
RHPNV+LFMGAV +II E++PRGSLF+ILH + +D+KRR++MALDVARGMN L
Sbjct: 521 RHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILHNTNQPLDKKRRLRMALDVARGMNYL 580
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
H P IVHRDLKS NLLVDKNWNVKV DFGLS+ K+ TFLS+KS GTP+WMAPEVLR+
Sbjct: 581 HRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGTPQWMAPEVLRS 640
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910
EPSNEKCDV+SFGVILWEL T +PW +N +QVVG VGF +RRL++P+ L+P +A II
Sbjct: 641 EPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFMDRRLDLPEGLNPRIASIIQ 700
Query: 911 ECWQT 915
+CWQT
Sbjct: 701 DCWQT 705
|
|
| TAIR|locus:2052786 AT2G31010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 656 (236.0 bits), Expect = 5.1e-83, Sum P(3) = 5.1e-83
Identities = 122/246 (49%), Positives = 174/246 (70%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E +I + +L +G R+G+G +GEV+ WNGT+VA+K FL+QD + + +F E+ I+ R
Sbjct: 511 EWDIDFSELTVGTRVGIGFFGEVFRGVWNGTDVAIKLFLEQDLTAENMEDFCNEISILSR 570
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGM 787
+RHPNVVLF+GA T+PP LS+ITE++ GSL+ ++H ++ RR++M D+ RG+
Sbjct: 571 VRHPNVVLFLGACTKPPRLSMITEYMELGSLYYLIHMSGQKKKLSWHRRLRMLRDICRGL 630
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
C+H IVHRDLKS N LVDK+W VK+ DFGLSR+ + + S+AGTPEWMAPE+
Sbjct: 631 MCIHRMK--IVHRDLKSANCLVDKHWTVKICDFGLSRIMTDENMKDTSSAGTPEWMAPEL 688
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
+RN P EKCD++S GVI+WEL+TL+ PW G+ P +VV AV + RLEIP PL ++
Sbjct: 689 IRNRPFTEKCDIFSLGVIMWELSTLRKPWEGVPPEKVVFAVAHEGSRLEIPD--GPL-SK 745
Query: 908 IIWECW 913
+I +CW
Sbjct: 746 LIADCW 751
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 831 (297.6 bits), Expect = 6.4e-83, P = 6.4e-83
Identities = 155/257 (60%), Positives = 195/257 (75%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL 718
KVD D D + EI WEDL +GE+IG GS G VYH W G++VAVK F Q++S +
Sbjct: 470 KVDM--DSDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIIT 527
Query: 719 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
FK+EV +M+RLRHPNV+LFMGAV P L I+TEFLPRGSLFR+L R ++D +RRI
Sbjct: 528 SFKQEVSLMKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIH 587
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 838
MA D+ARGMN LH +P I+HRDLKS NLLVD+NW VKV+DFGLSR+KH T+L++ G
Sbjct: 588 MASDIARGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTNGR-G 646
Query: 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
TP+WMAPEVLRNE ++EK DVYSFGV+LWEL T K+PW +N MQV+GAVGF N+RLE+P
Sbjct: 647 TPQWMAPEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVP 706
Query: 899 KELDPLVARIIWECWQT 915
K++DP ++ CW +
Sbjct: 707 KDVDPQWIALMESCWHS 723
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FPR3 | EDR1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5766 | 0.9582 | 0.9603 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_scaffold_70000045 | hypothetical protein (955 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 935 | |||
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 2e-99 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-66 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-64 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-63 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-59 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-52 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-43 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-43 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-40 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-39 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-39 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-37 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-37 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-36 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-36 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-36 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-36 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-36 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-36 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-36 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-36 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-35 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-35 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-35 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-34 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-34 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-33 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-33 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-33 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-33 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-33 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-33 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-32 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-31 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-31 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-31 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-31 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-30 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-30 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-30 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-29 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-29 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-29 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-29 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-28 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-28 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-28 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-28 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-28 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-28 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-27 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-27 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-27 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-27 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-27 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-27 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-27 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-26 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-26 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-26 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-26 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-26 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-26 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-26 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-26 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-25 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-25 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-25 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-25 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-24 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-24 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-23 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-23 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-21 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-20 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-18 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-17 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-15 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-15 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-15 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-14 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-14 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 309 bits (793), Expect = 2e-99
Identities = 114/206 (55%), Positives = 146/206 (70%), Gaps = 6/206 (2%)
Query: 123 DVAAEVLSRQYWEYNVLDYEERVVDGFYDIYG--LSTDPSTQGKLPSLAHLES-NLGNSG 179
+AE LS +YW Y L Y++++ DGFYDIYG +D G++PSL L++ G+S
Sbjct: 1 RSSAEALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVPPGDSS 60
Query: 180 FEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLA 239
FEVV+V+R D L+EL Q+A+C+ T+ LVQ+LA LV+ HMGGPVKDA MLA
Sbjct: 61 FEVVLVDRRTDPKLKELEQLARCLVSGCG-TNTAALVQKLAGLVSDHMGGPVKDAESMLA 119
Query: 240 RWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDD 299
RW E S EL+ + V+P+GS+ IGL RHRALLFKVLADSI LPCRLVKG Y G +DD
Sbjct: 120 RWKECSNELKE--NSGVVPLGSLKIGLCRHRALLFKVLADSIGLPCRLVKGCKYCGSDDD 177
Query: 300 AVNIIKLEEEREFLVDLMAAPGTLIP 325
A N++K ++ RE+LVDLM APGTLIP
Sbjct: 178 ASNLVKFDDGREYLVDLMGAPGTLIP 203
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 2e-66
Identities = 93/246 (37%), Positives = 137/246 (55%), Gaps = 13/246 (5%)
Query: 678 LVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
L LG+++G G++GEVY G T+VAVK L + S EF E IM++L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKT-LKEGASEEEREEFLEEASIMKKLS 59
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HPN+V +G T+ L I+TE++P G L L + ++ K ++MAL +A+GM L
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLR 849
+ VHRDL + N LV +N VK+SDFGLSR + K G P +WMAPE L+
Sbjct: 120 SK--NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ K DV+SFGV+LWE+ TL + P+ GM+ +V+ + RL P+ + +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELYEL 236
Query: 909 IWECWQ 914
+ +CW
Sbjct: 237 MLQCWA 242
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 217 bits (556), Expect = 1e-64
Identities = 93/247 (37%), Positives = 131/247 (53%), Gaps = 16/247 (6%)
Query: 678 LVLGERIGLGSYGEVYHADWNGT------EVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
L LG+++G G++GEVY G EVAVK L +D S + EF RE +IMR+L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HPNVV +G T L I+ E++ G L L + ++ + AL +ARGM L
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE---WMAPEVL 848
S +HRDL + N LV +N VK+SDFGLSR ++ G WMAPE L
Sbjct: 120 -SKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYRKRGGKLPIRWMAPESL 175
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
+ K DV+SFGV+LWE+ TL + P+ GM+ +V+ + RL P P +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLPQPPNCPPELYD 234
Query: 908 IIWECWQ 914
++ +CW
Sbjct: 235 LMLQCWA 241
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 213 bits (546), Expect = 3e-63
Identities = 93/246 (37%), Positives = 134/246 (54%), Gaps = 13/246 (5%)
Query: 678 LVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
L LG+++G G++GEVY G EVAVK L +D S + EF RE +IMR+L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCL 790
HPN+V +G T L I+ E++P G L L + + + + AL +ARGM L
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 849
S +HRDL + N LV +N VK+SDFGLSR ++ P WMAPE L+
Sbjct: 120 E-SKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
K DV+SFGV+LWE+ TL + P+ GM+ +V+ + + RL P P + ++
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPNCPPELYKL 236
Query: 909 IWECWQ 914
+ +CW
Sbjct: 237 MLQCWA 242
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 4e-60
Identities = 69/208 (33%), Positives = 112/208 (53%), Gaps = 7/208 (3%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ E++G GS+G+VY A T VA+K + + RE+KI+++L+HPN+V
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKV-IKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
L ++ E+ G LF +L + ++ E + + LH+ I
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKG--I 118
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 857
VHRDLK N+L+D++ +VK++DFGL+R + GTPE+MAPEVL + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 858 DVYSFGVILWELATLKLPWIGMNPMQVV 885
D++S GVIL+EL T K P+ G + + +
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLEL 205
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 8e-59
Identities = 74/194 (38%), Positives = 113/194 (58%), Gaps = 7/194 (3%)
Query: 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G G +G VY A G +VA+K ++ S + L E RE++I+++L HPN+V G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 801
+L ++ E+ GSL +L ++ E +++ L + G+ LH S I+HRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-SNG-IIHRD 117
Query: 802 LKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDV 859
LK N+L+D N VK++DFGLS+L + K+ GTP +MAPEVL + +EK D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 860 YSFGVILWELATLK 873
+S GVIL+EL LK
Sbjct: 178 WSLGVILYELPELK 191
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 195 bits (499), Expect = 1e-56
Identities = 85/250 (34%), Positives = 129/250 (51%), Gaps = 22/250 (8%)
Query: 682 ERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+++G G++GEVY G TEVAVK L +D S +F +E ++M++L HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQ------VDEKRRIKMALDVARGMN 788
+G T L ++ E++ G L L RP + K + A+ +A+GM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE---WMAP 845
L + VHRDL + N LV ++ VK+SDFGLSR + G WMAP
Sbjct: 120 YLASK--KFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWMAP 176
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
E L++ K DV+SFGV+LWE+ TL P+ G++ +V+ + + RL P+
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDE 235
Query: 905 VARIIWECWQ 914
+ ++ CWQ
Sbjct: 236 LYELMLSCWQ 245
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 2e-56
Identities = 80/214 (37%), Positives = 119/214 (55%), Gaps = 9/214 (4%)
Query: 678 LVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
L ++G GS+G VY A GT VAVK + +RE++I+RRL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
V + A +L ++ E+ G LF L R + E K+AL + RG+ LH++
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR-NEPSN 854
I+HRDLK N+L+D+N VK++DFGL++ + S + GTP +MAPEVL
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 855 EKCDVYSFGVILWELATLKLPW---IGMNPMQVV 885
K DV+S GVIL+EL T K P+ ++ +Q++
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 3e-52
Identities = 81/234 (34%), Positives = 122/234 (52%), Gaps = 10/234 (4%)
Query: 677 DLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+ GE +G GS+G VY A G +AVK S L +RE++I+ L+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 735 VVLFMGA-VTRPPN-LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
+V + G+ N L+I E++ GSL +L + ++ E K + G+ LH+
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRN 850
+ IVHRD+K N+LVD + VK++DFG ++ + + S GTP WMAPEV+R
Sbjct: 120 NG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDP 903
E D++S G + E+AT K PW + NPM + +G EIP+ L
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSE 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 88/245 (35%), Positives = 131/245 (53%), Gaps = 13/245 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I ++L LG IG G +G+V D+ G +VAVK D A F E +M LR
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDD---STAAQAFLAEASVMTTLR 58
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCL 790
HPN+V +G V + L I+TE++ +GSL L R + +++ ALDV GM L
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 849
VHRDL + N+LV ++ KVSDFGL++ S K P +W APE LR
Sbjct: 119 EEK--NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK----LPVKWTAPEALR 172
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ + K DV+SFG++LWE+ + ++P+ + VV V + R+E P+ P V ++
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKV 231
Query: 909 IWECW 913
+ +CW
Sbjct: 232 MKDCW 236
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 83/253 (32%), Positives = 128/253 (50%), Gaps = 22/253 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L ++G G +GEV+ WNG T+VAVK S A L+ E +IM++L
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ---EAQIMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-------CQVDEKRRIKMALDV 783
RH +V + + I+TE++ +GSL L VD MA +
Sbjct: 59 RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD------MAAQI 112
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EW 842
A GM L + +HRDL + N+LV +N K++DFGL+RL + +++ A P +W
Sbjct: 113 AEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKW 170
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
APE K DV+SFG++L E+ T ++P+ GM +V+ V + R+ P
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNC 229
Query: 902 DPLVARIIWECWQ 914
+ ++ +CW
Sbjct: 230 PEELYDLMLQCWD 242
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 91/252 (36%), Positives = 136/252 (53%), Gaps = 13/252 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E+ D+ + ++G G YGEVY W VAVK L +D + EF +E +M+
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKED--TMEVEEFLKEAAVMKE 58
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMN 788
++HPN+V +G TR P IITEF+ G+L L + Q V+ + MA ++ M
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEV 847
L +HRDL + N LV +N VKV+DFGLSRL ++ + A P +W APE
Sbjct: 119 YLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906
L + K DV++FGV+LWE+AT + P+ G++ QV + + R+E P+ P V
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVY 235
Query: 907 RIIWECWQTGWS 918
++ CWQ W+
Sbjct: 236 ELMRACWQ--WN 245
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 76/257 (29%), Positives = 134/257 (52%), Gaps = 12/257 (4%)
Query: 680 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
LG+ IG G++G VY + G VA+K+ + AL +E+ +++ L+HPN+V
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
++G++ +L II E+ GSL +I+ + E V +G+ LH +
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGP-FPESLVAVYVYQVLQGLAYLHEQ--GV 120
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856
+HRD+K+ N+L K+ VK++DFG++ +L + S GTP WMAPEV+ ++
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGTPYWMAPEVIEMSGASTA 179
Query: 857 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTG 916
D++S G + EL T P+ +NPM + + Q+ +P+ + P + + +C+Q
Sbjct: 180 SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQ-- 236
Query: 917 WSSLHIRTSQAQL-SHK 932
++R + QL H
Sbjct: 237 -KDPNLRPTAKQLLKHP 252
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 64/211 (30%), Positives = 114/211 (54%), Gaps = 15/211 (7%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG GS+G+VY +G +K+ + + AL EVKI+++L HPN++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL----NEVKILKKLNHPNIIK 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQV--DEKRRIKMALDVARGMNCLHTST 794
+ + L I+ E+ G L +I + E++ + + + + LH+
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
I+HRD+K N+ + N VK+ DFG+S++ +T +K+ GTP +++PE+ +N+P N
Sbjct: 124 --ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYN 181
Query: 855 EKCDVYSFGVILWELATLKLPWIGMNPMQVV 885
K D++S G +L+EL TLK P+ G N +++
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPFEGENLLELA 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 6e-40
Identities = 73/211 (34%), Positives = 119/211 (56%), Gaps = 12/211 (5%)
Query: 675 WEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
+E L E+IG G +GEVY A G EVA+K + S + E++I+++ +H
Sbjct: 2 FEIL---EKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKH 56
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI-KMALDVARGMNCLH 791
PN+V + G+ + L I+ EF GSL +L + Q + +I + ++ +G+ LH
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
++ I+HRD+K+ N+L+ + VK+ DFGLS +T + + GTP WMAPEV+ +
Sbjct: 116 SNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-ARNTMVGTPYWMAPEVINGK 172
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPM 882
P + K D++S G+ ELA K P+ + PM
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPM 203
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 79/257 (30%), Positives = 126/257 (49%), Gaps = 28/257 (10%)
Query: 684 IGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G +G+V ++ G +VAVK L+ +F+RE++I+R L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKS-LNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 738 FMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+ G +P +L +I E+LP GSL L R Q++ KR + + + +GM+ L +
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR- 129
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEP 852
+HRDL + N+LV+ VK+SDFGL+++ + + K +P W APE LR
Sbjct: 130 -YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK 188
Query: 853 SNEKCDVYSFGVILWELAT------------LKLPWIGMNPMQVVGAVGF--QNRRLEIP 898
+ DV+SFGV L+EL T L++ I M V + + RL P
Sbjct: 189 FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRP 248
Query: 899 KELDPLVARIIWECWQT 915
V ++ CW+
Sbjct: 249 PSCPDEVYDLMKLCWEA 265
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 4e-39
Identities = 81/245 (33%), Positives = 125/245 (51%), Gaps = 8/245 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
E P E+ L ++G G +GEV+ W VA+K L D +F++EV+ ++RL
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIK-ILKSD-DLLKQQDFQKEVQALKRL 59
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNC 789
RH +++ + + IITE + +GSL L P QV I MA VA GM
Sbjct: 60 RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
L +HRDL + N+LV ++ KV+DFGL+RL S +W APE
Sbjct: 120 LEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ + K DV+SFG++L+E+ T ++P+ GMN +V + R+ P + + +I
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKI 236
Query: 909 IWECW 913
+ ECW
Sbjct: 237 MLECW 241
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 4e-39
Identities = 79/250 (31%), Positives = 123/250 (49%), Gaps = 14/250 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EI + L ++G G +GEV+ WN T VAVK +F E +IM++L
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGM 787
RHP ++ T + I+TE + GSL L ++ + I MA VA GM
Sbjct: 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL--IDMAAQVASGM 116
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 846
L +HRDL + N+LV +N KV+DFGL+R +K + + + + +W APE
Sbjct: 117 AYLEAQ--NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
Query: 847 VLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
+ K DV+SFG++L E+ T ++P+ GM +V+ V Q R+ P +
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKEL 233
Query: 906 ARIIWECWQT 915
I+ +CW+
Sbjct: 234 YDIMLDCWKE 243
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 6e-39
Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 15/224 (6%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKRE 723
D+ P E E+IG G+ GEVY A T EVA+KK E
Sbjct: 9 KDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINE 65
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783
+ IM+ +HPN+V + + L ++ E++ GSL I+ + +++E + + +V
Sbjct: 66 ILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREV 125
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG----LSRLKHNTFLSSKSTAGT 839
+G+ LH+ ++HRD+KS N+L+ K+ +VK++DFG L++ K S GT
Sbjct: 126 LQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK----RNSVVGT 179
Query: 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883
P WMAPEV++ + K D++S G++ E+A + P++ P++
Sbjct: 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 80/242 (33%), Positives = 120/242 (49%), Gaps = 14/242 (5%)
Query: 681 GERIGLGSYGEVYHADWN---GTEVAVK--KFLDQDFSG-AALLEFKREVKIMRRLRHPN 734
GE +G GS+G VY N G AVK D +G A+ + ++E+ ++ +L+HPN
Sbjct: 5 GELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V ++G NL I E +P GSL ++L + + E + G+ LH
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDR- 121
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-SKSTAGTPEWMAPEVLRNE-P 852
VHRD+K N+LVD N VK++DFG++ K S +KS G+P WMAPEV+ +
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMA--KQVVEFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
D++S G + E+AT K PW + + V +G IP L I +C
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKC 238
Query: 913 WQ 914
Q
Sbjct: 239 LQ 240
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 76/238 (31%), Positives = 123/238 (51%), Gaps = 28/238 (11%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
E L E IG GS+GEVY A T VA+K +D + + + + ++E++ + + R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV-IDLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+ + G+ + L II E+ GS +L +P ++DE + +V G+ LH
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KP-GKLDETYIAFILREVLLGLEYLHEE 117
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEV 847
+HRD+K+ N+L+ + +VK++DFG+S K NTF GTP WMAPEV
Sbjct: 118 GK--IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF------VGTPFWMAPEV 169
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
++ +EK D++S G+ ELA + P ++PM+V+ IPK P +
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL---------FLIPKNNPPSL 218
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 79/245 (32%), Positives = 126/245 (51%), Gaps = 13/245 (5%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+L + +G G +G V+ W G +VA+K + S +F E K+M +L HPN+
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNL 61
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
V G T+ + I+TE++ G L L ++ + + M DV M L ++
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN-- 119
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
+HRDL + N LV ++ VKVSDFGL+R + + + SS+ T +W PEV +
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 855 EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIWE 911
K DV+SFGV++WE+ + K+P+ + +VV +V G+ RL PK V I++
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY---RLYRPKLAPTEVYTIMYS 236
Query: 912 CWQTG 916
CW
Sbjct: 237 CWHEK 241
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 82/262 (31%), Positives = 132/262 (50%), Gaps = 23/262 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+P E + L +G GS+G VY G T VA+K ++++ S +EF E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKT-VNENASMRERIEFLNEA 60
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRP---HCQV----DEKR 775
+M+ +VV +G V+ ++ E + +G L L RP + ++
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 776 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835
I+MA ++A GM L VHRDL + N +V ++ VK+ DFG++R + T K
Sbjct: 121 FIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 836 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
G P WMAPE L++ K DV+SFGV+LWE+ATL + P+ G++ +V+ V
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DG 237
Query: 893 RRLEIPKELDPLVARIIWECWQ 914
L++P+ + ++ CWQ
Sbjct: 238 GHLDLPENCPDKLLELMRMCWQ 259
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 74/219 (33%), Positives = 116/219 (52%), Gaps = 13/219 (5%)
Query: 674 PWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVK--KFLDQDFSGAALLEFKREVKIMRR 729
P ED L +RIG G+YG+VY A G VA+K K D ++E+ +++
Sbjct: 1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD----DFEIIQQEISMLKE 56
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
RHPN+V + G+ R L I+ E+ GSL I + E + + + +G+
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAY 116
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL- 848
LH + +HRD+K N+L+ ++ +VK++DFG+S T KS GTP WMAPEV
Sbjct: 117 LHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 849 --RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885
R + KCD+++ G+ ELA L+ P ++PM+ +
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 81/242 (33%), Positives = 120/242 (49%), Gaps = 9/242 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+DL + +G G +G V + W G +VA+K + S EF E K+M +L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEK 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V G T+ + I+TE++ G L L + + ++M DV GM L +
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK- 119
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
+HRDL + N LVD VKVSDFGLSR + + + SS + W PEVL
Sbjct: 120 -QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 854 NEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
+ K DV++FGV++WE+ +L K+P+ N + V V Q RL P V I++ C
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSC 237
Query: 913 WQ 914
W
Sbjct: 238 WH 239
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 74/243 (30%), Positives = 116/243 (47%), Gaps = 14/243 (5%)
Query: 682 ERIGLGSYGEVYHADW---NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+++G GS+G V +W G VAVK L D + +F +E IM L H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI-KMALDVARGMNCLHTSTP 795
G V P L ++TE P GSL L + + A+ +A GM L +
Sbjct: 60 RLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR- 117
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+HRDL + N+L+ + VK+ DFGL R + ++ + W APE LR
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 853 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
+ DV+ FGV LWE+ T + PW G++ Q++ + + RLE P+ + ++ +
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236
Query: 912 CWQ 914
CW
Sbjct: 237 CWA 239
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 8/220 (3%)
Query: 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
P E + E++G GSYG VY A G VA+K L E +E+ I+++
Sbjct: 1 PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCD 56
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
P +V + G+ + +L I+ E+ GS+ I+ + + E+ + +G+ LH
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
++ +HRD+K+ N+L+++ K++DFG+S +T + GTP WMAPEV++
Sbjct: 117 SNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI 174
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 891
N K D++S G+ E+A K P+ ++PM+ + + +
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK 214
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 4e-36
Identities = 82/242 (33%), Positives = 132/242 (54%), Gaps = 13/242 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+ L LGE IG G +G V ++ G +VAVK + D + A LE E +M +L H N+
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKN-IKCDVTAQAFLE---ETAVMTKLHHKNL 61
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCLHTST 794
V +G + L I+ E + +G+L L R V + ++ +LDVA GM + +
Sbjct: 62 VRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME--YLES 118
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
+VHRDL + N+LV ++ KVSDFGL+R+ +SK +W APE L+++ +
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPEALKHKKFS 175
Query: 855 EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913
K DV+S+GV+LWE+ + + P+ M+ +V V + R+E P+ V ++ CW
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSCW 234
Query: 914 QT 915
+T
Sbjct: 235 ET 236
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 7e-36
Identities = 75/236 (31%), Positives = 123/236 (52%), Gaps = 8/236 (3%)
Query: 682 ERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
E+IG G++G+VY TEVAVK +F +E +I+++ HPN+V +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIG 59
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ + I+ E +P GSL L + ++ K+ ++M+LD A GM L + +HR
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK--NCIHR 117
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNT-FLSSKSTAGTP-EWMAPEVLRNEPSNEKCD 858
DL + N LV +N +K+SDFG+SR + + S P +W APE L + D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 859 VYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913
V+S+G++LWE +L P+ GM+ Q + R+ P+ + R++ +CW
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCW 232
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 88/252 (34%), Positives = 136/252 (53%), Gaps = 21/252 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L +++G G +GEV+ WNG T+VAVK S + LE E +IM++L
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK------MALDVA 784
RH +V V+ P + I+TE++ +GSL L + E R +K MA VA
Sbjct: 59 RHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-----KDGEGRALKLPNLVDMAAQVA 112
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 843
GM + +HRDL+S N+LV K++DFGL+RL + +++ A P +W
Sbjct: 113 AGM--AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
APE K DV+SFG++L EL T ++P+ GMN +V+ V + R+ P++
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCP 229
Query: 903 PLVARIIWECWQ 914
+ ++ +CW+
Sbjct: 230 ISLHELMLQCWK 241
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 80/249 (32%), Positives = 130/249 (52%), Gaps = 20/249 (8%)
Query: 680 LGERIGLGSYGEVYHA---DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
G +IG G++G+VY A D G +AVK+ QD + E E+K++ L+HPN+V
Sbjct: 4 RGNKIGGGTFGKVYTAVNLD-TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM-ALDVARGMNCLHTSTP 795
+ G + I E+ G+L +L H ++ ++ I++ L + G+ LH+
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNT---FLSSKSTAGTPEWMAPEVLRNE 851
IVHRD+K N+ +D N +K+ DFG + +LK+NT +S AGTP +MAPEV+
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 852 PSNEK---CDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPK--ELDPLV 905
D++S G ++ E+AT K PW + N Q++ VG ++ IP +L P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-PIPDSLQLSPEG 237
Query: 906 ARIIWECWQ 914
+ C +
Sbjct: 238 KDFLDRCLE 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 76/235 (32%), Positives = 116/235 (49%), Gaps = 17/235 (7%)
Query: 680 LGERIGLGSYGEVY---HADWNGTEVAVKKF-LDQDFSGAA--LLEFKREVKIMRRLRHP 733
G+ +G G++G VY D G E+AVK+ D D + + E+++++ L+H
Sbjct: 6 RGKLLGQGAFGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+V + G + LSI E++P GS+ L + R K + G+ LH++
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHSN 123
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLK----HNTFLSSKSTAGTPEWMAPEVL 848
IVHRD+K N+L D NVK+ DFG S RL+ T + KS GTP WM+PEV+
Sbjct: 124 M--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM--KSVTGTPYWMSPEVI 179
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
E K DV+S G + E+ T K PW M + + Q ++P + P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSP 234
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 76/267 (28%), Positives = 129/267 (48%), Gaps = 27/267 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKREV 724
+ + +VL +G G++G+V+ + + VAVK L + S A +F+RE
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKT-LKETASNDARKDFEREA 59
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR-------------PHCQV 771
+++ +H N+V F G T ++ E++ G L + L P ++
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 772 DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-F 830
+ +++A+ +A GM L ++ VHRDL + N LV + VK+ DFG+SR + T +
Sbjct: 120 TLSQLLQIAVQIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 831 LSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV 888
P WM PE + + DV+SFGV+LWE+ T K PW G++ +V+ +
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237
Query: 889 GFQNRRLEIPKELDPLVARIIWECWQT 915
Q R L+ P+ V I+ CW+
Sbjct: 238 T-QGRLLQRPRTCPSEVYDIMLGCWKR 263
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 84/268 (31%), Positives = 137/268 (51%), Gaps = 31/268 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
EIP + E +G G++G+VY + G T VA+K L ++ EF++E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKT-LKENAEPKVQQEFRQEA 59
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPHCQV---DEKRRIKM 779
++M L+HPN+V +G T+ ++ E+L G L F + + PH V +K
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 780 ALD----------VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829
+LD +A GM L S+ VHRDL + N LV + VK+SDFGLSR ++
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 830 -FLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVG 886
+ +S + P WM PE + + D++SFGV+LWE+ + L P+ G + +V+
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237
Query: 887 AVGFQNRR-LEIPKELDPLVARIIWECW 913
+ ++R+ L P++ V ++ ECW
Sbjct: 238 MI--RSRQLLPCPEDCPARVYALMIECW 263
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 80/253 (31%), Positives = 125/253 (49%), Gaps = 18/253 (7%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHADWNGT-----EVAVKKFLDQDFSGAALLEFKREVKIM 727
I + + + IG G +GEV +VA+K S L+F E IM
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIM 59
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
+ HPN++ G VT+ + IITE++ GSL + L + + + M +A GM
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG--TP-EWMA 844
L S VHRDL + N+LV+ N KVSDFGLSR ++ ++ +T G P W A
Sbjct: 120 KYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS-EATYTTKGGKIPIRWTA 176
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKEL 901
PE + DV+SFG+++WE+ + + P+ M+ V+ AV G+ RL P +
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY---RLPPPMDC 233
Query: 902 DPLVARIIWECWQ 914
+ +++ +CWQ
Sbjct: 234 PSALYQLMLDCWQ 246
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 82/242 (33%), Positives = 131/242 (54%), Gaps = 15/242 (6%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
++L L + IG G +G+V D+ G +VAVK + D + A F E +M +LRH N+
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVK-CIKNDATAQA---FLAEASVMTQLRHSNL 61
Query: 736 VLFMGA-VTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCLHTS 793
V +G V L I+TE++ +GSL L R + +K +LDV M L +
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNEP 852
VHRDL + N+LV ++ KVSDFGL++ S++ T P +W APE LR +
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREKK 175
Query: 853 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
+ K DV+SFG++LWE+ + ++P+ + VV V + +++ P P+V ++ +
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMKQ 234
Query: 912 CW 913
CW
Sbjct: 235 CW 236
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 84/247 (34%), Positives = 133/247 (53%), Gaps = 11/247 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L ++G G +GEV+ WNGT VA+K S A L+ E ++M++L
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNC 789
RH +V V+ P + I+TE++ +GSL L + + + + MA +A GM
Sbjct: 59 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM-- 115
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 848
+ VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W APE
Sbjct: 116 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHD 234
Query: 908 IIWECWQ 914
++ +CW+
Sbjct: 235 LMCQCWR 241
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 80/247 (32%), Positives = 133/247 (53%), Gaps = 11/247 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
E+P E L L +++G G +GEV+ +NG T+VA+K S A L E +M++L
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA---EANLMKQL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNC 789
+HP +V VT+ P + IITE++ GSL L P ++ + I MA +A GM
Sbjct: 59 QHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 848
+ +HRDL++ N+LV + K++DFGL+RL + +++ A P +W APE +
Sbjct: 118 IERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
K DV+SFG++L E+ T ++P+ GM +V+ + + R+ P +
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELYE 234
Query: 908 IIWECWQ 914
++ CW+
Sbjct: 235 LMRLCWK 241
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 82/270 (30%), Positives = 142/270 (52%), Gaps = 30/270 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREV 724
E+P + L LG+ +G G++G+V A+ G + VAVK L D + L + E+
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM-LKDDATEKDLSDLVSEM 66
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRP-------------H 768
++M+ + +H N++ +G T+ L ++ E+ G+L L RP
Sbjct: 67 EMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 769 CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828
+ +K + A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R H+
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 829 TFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVV 885
K+T G P +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P++ +
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEEL 243
Query: 886 GAVGFQNRRLEIPKELDPLVARIIWECWQT 915
+ + R+E P+ + ++ +CW
Sbjct: 244 FKLLKEGYRMEKPQNCTQELYHLMRDCWHE 273
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 75/236 (31%), Positives = 125/236 (52%), Gaps = 7/236 (2%)
Query: 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
E +G G++GEV+ + T VAVK +D ++F E +I+++ HPN+V +G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
T+ + I+ E +P G L + ++ K+ +K ALD A GM + + +HR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGM--AYLESKNCIHR 117
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDV 859
DL + N LV +N +K+SDFG+SR + + SS P +W APE L + + DV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 860 YSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+S+G++LWE +L + P+ GM Q V + R+ P++ V +++ CW
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWD 232
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 78/241 (32%), Positives = 121/241 (50%), Gaps = 9/241 (3%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+L + +G G +G V+ W +VA+K + S +F E K+M +L HP +
Sbjct: 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKL 61
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
V G T+ L I+TEF+ G L L + ++ + + M DV GM L +
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN-- 119
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNEPSN 854
+ +HRDL + N LV VKVSDFG++R + +S S A P +W PEV +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 855 EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913
K DV+SFGV++WE+ T K+P+ + +VV + + RL PK V +++ CW
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMYSCW 238
Query: 914 Q 914
Sbjct: 239 H 239
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 6e-32
Identities = 84/251 (33%), Positives = 134/251 (53%), Gaps = 17/251 (6%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L +++G G +GEV+ A +N T+VAVK S A L E +M+ L
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA---EANVMKTL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNC 789
+H +V VT+ P + IITEF+ +GSL L + + I + +A GM
Sbjct: 59 QHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM-- 115
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 848
+HRDL++ N+LV + K++DFGL+R+ + +++ A P +W APE +
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLE-IPKELDPL 904
K DV+SFG++L E+ T ++P+ GM+ +V+ A+ G++ R E P+EL
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL--- 232
Query: 905 VARIIWECWQT 915
I+ CW+
Sbjct: 233 -YNIMMRCWKN 242
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 82/247 (33%), Positives = 131/247 (53%), Gaps = 11/247 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L ++G G +GEV+ WNGT +VA+K A L+ E +IM++L
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ---EAQIMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNC 789
RH +V V+ P + I+TEF+ +GSL L + + + + MA +A GM
Sbjct: 59 RHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 848
+ +HRDL++ N+LV N K++DFGL+RL + +++ A P +W APE
Sbjct: 118 IERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
K DV+SFG++L EL T ++P+ GM +V+ V + R+ P+ +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHE 234
Query: 908 IIWECWQ 914
++ CW+
Sbjct: 235 LMKLCWK 241
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 83/250 (33%), Positives = 136/250 (54%), Gaps = 16/250 (6%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E + L +++G G +GEV+ + N T+VAVK S A LE E +M+ L
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNC 789
+H +V VT+ + IITE++ +GSL L +V + I + +A GM
Sbjct: 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM-- 116
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 848
+ +HRDL++ N+LV ++ K++DFGL+R+ + +++ A P +W APE +
Sbjct: 117 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLE-IPKELDPL 904
K DV+SFG++L+E+ T K+P+ GM+ V+ A+ G++ R+E P EL
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDEL--- 233
Query: 905 VARIIWECWQ 914
I+ CW+
Sbjct: 234 -YDIMKTCWK 242
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 65/226 (28%), Positives = 115/226 (50%), Gaps = 28/226 (12%)
Query: 682 ERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKR-----EVKIMRRLRH 732
E IG GS+G V D G + K+ D+ + E ++ EV I+R L+H
Sbjct: 6 ETIGKGSFGTVRKVRRKSD--GKILVWKEI---DYGN--MTEKEKQQLVSEVNILRELKH 58
Query: 733 PNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQ-----VDEKRRIKMALDVAR 785
PN+V + + N L I+ E+ G L +++ + C+ ++E+ ++ +
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQK--CKKERKYIEEEFIWRILTQLLL 116
Query: 786 GMNCLHT---STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 842
+ H T++HRDLK N+ +D N NVK+ DFGL+++ + +K+ GTP +
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 888
M+PE L + +EK D++S G +++EL L P+ N +Q+ +
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 78/244 (31%), Positives = 123/244 (50%), Gaps = 13/244 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+L L + IG G +G V+ W +VA+K + S +F E ++M +L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPK 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V G T + ++ EF+ G L L + ++ + M LDV GM L +S
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS- 119
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK-HNTFLSSKSTAGTPEWMAPEVLRNEPS 853
++HRDL + N LV +N VKVSDFG++R + + SS T +W +PEV
Sbjct: 120 -NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 854 NEKCDVYSFGVILWEL-ATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIW 910
+ K DV+SFGV++WE+ + K P+ + +VV + GF RL P+ V ++
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF---RLYKPRLASQSVYELMQ 235
Query: 911 ECWQ 914
CW+
Sbjct: 236 HCWK 239
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 75/245 (30%), Positives = 120/245 (48%), Gaps = 15/245 (6%)
Query: 682 ERIGLGSYGEVYHADW---NGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G G++G V + +G EV V K L Q+ A EF RE +M +L HP +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+G V + L ++ E P G L + L + ++ ++A VA GM L +
Sbjct: 61 LIG-VCKGEPLMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKH--F 116
Query: 798 VHRDLKSPN-LLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEPS 853
VHRDL + N LLV+++ K+SDFG+SR + + + + P +W APE +
Sbjct: 117 VHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 854 NEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
+ K DV+S+GV LWE + P+ M +V+ + RL P+E + I+ C
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSC 234
Query: 913 WQTGW 917
W+
Sbjct: 235 WKYRP 239
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 73/247 (29%), Positives = 125/247 (50%), Gaps = 23/247 (9%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKF------LDQDFSG-----AALLEFKREVK 725
V GE IG G+YG VY A G +AVK+ + S AL + E++
Sbjct: 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKAL---RSEIE 60
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 785
++ L H N+V ++G T LSI E++P GS+ L R + + +E+ V
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVLE 119
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWM 843
G+ LH+ I+HRDLK+ NLLVD + K+SDFG+S+ + + + ++ + G+ WM
Sbjct: 120 GLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 844 APEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
APEV+ + + K D++S G ++ E+ + PW + + +G + IP ++
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237
Query: 902 DPLVARI 908
++ +
Sbjct: 238 SMNLSPV 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 84/283 (29%), Positives = 143/283 (50%), Gaps = 35/283 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVY--HADWNGTE----VAVKKFLDQDFSGAALLEFKREVK 725
E+P + E +G ++G++Y H G + VA+K D + + EF++E
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEAS 59
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPH----CQVDEKRRIKM 779
+M L HPN+V +G VT+ + ++ E+L +G L F I+ PH C DE +K
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 780 ALD----------VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829
+LD +A GM L S+ VH+DL + N+L+ + +VK+SD GLSR ++
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 830 -FLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVG 886
+ + + P WM PE + + D++SFGV+LWE+ + L P+ G + +V+
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237
Query: 887 AVGFQNRRLEIPKELDPLVARIIWECWQTG------WSSLHIR 923
V + + L ++ P + ++ ECWQ G + +H R
Sbjct: 238 MVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 67/247 (27%), Positives = 121/247 (48%), Gaps = 19/247 (7%)
Query: 681 GERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGA----ALLEFKREVKIMRRLRHPN 734
G+++G G++ Y A GT +AVK+ + + + ++E+++M RL HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
++ +GA + ++ E++ GS+ +L + + E I + RG++ LH +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 795 PTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKST-----AGTPEWMAPEVL 848
I+HRD+K NLL+D ++++DFG + + + GT +MAPEVL
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFG-AAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWIG---MNPMQVVGAVGFQNRRLEIPKELDPLV 905
R E CDV+S G ++ E+AT K PW N + ++ + IP+ L P +
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240
Query: 906 ARIIWEC 912
+ C
Sbjct: 241 RDVTLRC 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRLR 731
DL + +G GS G VY G A+KK + LL RE+K +R
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCE 57
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
P VV GA + +SI+ E++ GSL L + ++ E +A + +G++ LH
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAP 845
T I+HRD+K NLL++ VK++DFG+S++ + NTF+ GT +M+P
Sbjct: 117 T-KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTYMSP 169
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLP 875
E ++ E + D++S G+ L E A K P
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 8e-30
Identities = 78/224 (34%), Positives = 119/224 (53%), Gaps = 22/224 (9%)
Query: 681 GERIGLGSYGEVYHADWN-GTEVAVKKF-LDQDFSGAALLEFKR---EVKIMRRLRHPNV 735
GE +G G+YG VY N G +AVK+ LD AA E+++ EV +++ L+H N+
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTS 793
V ++G +SI EF+P GS+ IL+R P + + K LD G+ LH +
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---GVAYLHNN 121
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--------LKHNTFLSSKSTAGTPEWMAP 845
+VHRD+K N+++ N +K+ DFG +R H+ L KS GTP WMAP
Sbjct: 122 C--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHGTPYWMAP 177
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG 889
EV+ K D++S G ++E+AT K P M+ + + +G
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 76/248 (30%), Positives = 116/248 (46%), Gaps = 10/248 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA---DWNGTEVAVK-KFLDQDFSGAALLEFKREVKIM 727
EI ED+ LG IG G +G+VY ++AV K S + +F +E IM
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
R+ HP++V +G +T P + I+ E P G L L +D I + ++ +
Sbjct: 62 RQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPE 846
L + VHRD+ + N+LV VK+ DFGLSR + S P +WMAPE
Sbjct: 121 AYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 847 VLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
+ DV+ FGV +WE+ L P+ G+ V+G + RL +P P +
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTL 237
Query: 906 ARIIWECW 913
++ +CW
Sbjct: 238 YSLMTKCW 245
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G GSYG VY A+K+ S + E++I+ + HPN++ + A
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTSTPTIV 798
L I+ E+ P G L + + + + + E+ ++ + + RG+ LH I+
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--IL 125
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 858
HRDLKS N+L+ N VK+ D G+S++ K+ GTP +MAPEV + P + K D
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMA--KTQIGTPHYMAPEVWKGRPYSYKSD 183
Query: 859 VYSFGVILWELATLKLP 875
++S G +L+E+AT P
Sbjct: 184 IWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 66/215 (30%), Positives = 110/215 (51%), Gaps = 20/215 (9%)
Query: 683 RIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFM 739
+IG G + VY A +G VA+KK + A A + +E+ ++++L HPNV+ ++
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTSTPT 796
+ L+I+ E G L R++ Q + E+ K + + + +H+
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR-- 126
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMAPEVLRNE 851
I+HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+PE +
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIG--MNPMQV 884
N K D++S G +L+E+A L+ P+ G MN +
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 79/263 (30%), Positives = 131/263 (49%), Gaps = 29/263 (11%)
Query: 676 EDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMR 728
D+VL +G G++G+V+ A + + VAVK ++ S +A +F+RE +++
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLT 62
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR---------- 776
L+H ++V F G T L ++ E++ G L R L H P ++
Sbjct: 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 777 --IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLS 832
+ +A +A GM ++ ++ VHRDL + N LV + VK+ DFG+SR ++T +
Sbjct: 123 QMLAIASQIASGM--VYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
Query: 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 891
T WM PE + + D++SFGV+LWE+ T K PW ++ + + + Q
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-Q 239
Query: 892 NRRLEIPKELDPLVARIIWECWQ 914
R LE P+ P V I+ CWQ
Sbjct: 240 GRELERPRTCPPEVYAIMQGCWQ 262
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 80/257 (31%), Positives = 131/257 (50%), Gaps = 39/257 (15%)
Query: 675 WEDLVLGERIGLGSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
WE ++GE +G G++G+VY A T + A K + + S L +F E+ I+ +HP
Sbjct: 7 WE--IIGE-LGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHP 62
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
N+V A L I+ EF G+L I+ + E + + + +N LH+
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEV 847
++HRDLK+ N+L+ + +VK++DFG+S K +TF+ GTP WMAPEV
Sbjct: 123 K--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEV 174
Query: 848 L-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
+ ++ P + K D++S G+ L ELA ++ P +NPM+V+ L+I K
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL---------LKILKSEP 225
Query: 903 PLVARIIWECWQTGWSS 919
P + + + WSS
Sbjct: 226 PTLDQ------PSKWSS 236
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 68/245 (27%), Positives = 117/245 (47%), Gaps = 14/245 (5%)
Query: 678 LVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
L + +G G++G VY W VA+K + + S A E E +M +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKEILDEAYVMASVD 67
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HP+VV +G + + +IT+ +P G L + + + + + +A+GM+ L
Sbjct: 68 HPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL- 125
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLR 849
+VHRDL + N+LV +VK++DFGL++L + G P +WMA E +
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ K DV+S+GV +WEL T P+ G+ +++ + + RL P V +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDVYMV 243
Query: 909 IWECW 913
+ +CW
Sbjct: 244 LVKCW 248
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 73/234 (31%), Positives = 123/234 (52%), Gaps = 21/234 (8%)
Query: 681 GERIGLGSYGEVY---HADWNGTEVAVKKF------LDQDFSGAALLE-FKREVKIMRRL 730
G IG GS+G VY +A +G +AVK+ ++L+ RE+ +++ L
Sbjct: 5 GALIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
+H N+V ++G+ +L+I E++P GS+ +L+ + +E + +G+N L
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYL 122
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK------STAGTPEWMA 844
H I+HRD+K N+LVD +K+SDFG+S+ LS+K S G+ WMA
Sbjct: 123 HNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
PEV++ K D++S G ++ E+ T K P+ +Q + +G +N EIP
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIP 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 78/233 (33%), Positives = 114/233 (48%), Gaps = 37/233 (15%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE------------------VAVKKFLDQDFS 713
E P + L E++G G +GEV+ + +G + VAVK L D S
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV-LRPDAS 59
Query: 714 GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE 773
A +F +EVKI+ RL PN+ +G T P L +I E++ G L + L + H
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQK-HVAETS 118
Query: 774 KRR-----------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822
+ MA +A GM + + VHRDL + N LV KN+ +K++DFG+
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMR--YLESLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 823 SR-LKHNTFLSSKSTAGTP-EWMAPE-VLRNEPSNEKCDVYSFGVILWELATL 872
SR L + + + A P WMA E VL + + K DV++FGV LWE+ TL
Sbjct: 177 SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTL 228
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 75/216 (34%), Positives = 117/216 (54%), Gaps = 8/216 (3%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
P ED L +RIG G+YG+VY A + N E+A K + + G ++E+ +M+ +H
Sbjct: 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEIIMMKDCKH 65
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
N+V + G+ R L I EF GSL I H + E + ++ + +G+ LH+
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHS 124
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL---R 849
+HRD+K N+L+ N +VK++DFG+S T KS GTP WMAPEV R
Sbjct: 125 KGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885
N+ CD+++ G+ ELA L+ P ++PM+ +
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 9e-29
Identities = 78/244 (31%), Positives = 119/244 (48%), Gaps = 15/244 (6%)
Query: 682 ERIGLGSYGEVY-----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
E IG G +GEV VA+K L ++ +F E IM + HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
G VT+ + IITEF+ G+L L + Q + + M +A GM L S
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--SEMN 126
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-----TFLSSKSTAGTPEWMAPEVLRNE 851
VHRDL + N+LV+ N KVSDFGLSR + T+ SS W APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 852 PSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910
DV+S+G+++WE+ + + P+ M+ V+ A+ Q+ RL P + + +++
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTALHQLML 245
Query: 911 ECWQ 914
+CWQ
Sbjct: 246 DCWQ 249
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 64/209 (30%), Positives = 108/209 (51%), Gaps = 9/209 (4%)
Query: 682 ERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRH---PNVVL 737
E IG G+YG VY T V K ++ D + + +REV ++ +LR PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+ G+ + P L II E+ GS+ R L + + EK + +V + +H +
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGP-IAEKYISVIIREVLVALKYIHKVG--V 122
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEK 856
+HRD+K+ N+LV NVK+ DFG++ L + + GTP WMAPEV+ + K
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK 182
Query: 857 CDVYSFGVILWELATLKLPWIGMNPMQVV 885
D++S G+ ++E+AT P+ ++ + +
Sbjct: 183 ADIWSLGITIYEMATGNPPYSDVDAFRAM 211
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 84/271 (30%), Positives = 143/271 (52%), Gaps = 32/271 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 722
E+P + LVLG+ +G G +G+V A+ G T+VAVK L D + L +
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK-MLKSDATEKDLSDLIS 72
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-----------HRPHCQ 770
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L + P
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 771 VDEKRRIK----MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
+E+ K A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 827 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
H+ K+T G +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P++
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVE 249
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + + R++ P + ++ +CW
Sbjct: 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWH 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 72/247 (29%), Positives = 118/247 (47%), Gaps = 20/247 (8%)
Query: 684 IGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G G +GEV+ A G E V VK EF+RE+ + R+L H NVV
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVV 71
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE--------KRRIKMALDVARGMN 788
+G +I E+ G L + L + ++ K+++ + +A GM+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEV 847
H S VHRDL + N LV VKVS LS+ +N+ A P W+APE
Sbjct: 132 --HLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 848 LRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906
++ + + K DV+SFGV++WE+ T +LP+ G++ +V+ + L +P+ +
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249
Query: 907 RIIWECW 913
+++ CW
Sbjct: 250 KLMTRCW 256
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 73/224 (32%), Positives = 118/224 (52%), Gaps = 24/224 (10%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+D L E IG+G+ VY A N +VA+K+ +D + ++ E ++EV+ M + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLH 791
NVV + + L ++ +L GSL I+ P +DE + +V +G+ LH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS----------RLKHNTFLSSKSTAGTPE 841
++ +HRD+K+ N+L+ ++ +VK++DFG+S R TF GTP
Sbjct: 120 SNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF------VGTPC 171
Query: 842 WMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQV 884
WMAPEV+ + K D++SFG+ ELAT P+ PM+V
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV 215
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 3e-28
Identities = 82/262 (31%), Positives = 133/262 (50%), Gaps = 23/262 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+ E + + +G GS+G VY G T VA+K +++ S +EF E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEA 60
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDE-------KR 775
+M+ +VV +G V++ +I E + RG L L RP + + K+
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 776 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835
I+MA ++A GM L+ + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 121 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 836 TAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
G WM+PE L++ DV+SFGV+LWE+ATL + P+ GM+ QV+ V +
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-MEG 237
Query: 893 RRLEIPKELDPLVARIIWECWQ 914
L+ P ++ ++ CWQ
Sbjct: 238 GLLDKPDNCPDMLFELMRMCWQ 259
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 55/203 (27%), Positives = 105/203 (51%), Gaps = 5/203 (2%)
Query: 677 DLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
D + +IG GS+G V+ + A+K+ + E E +++ +L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTS 793
++ + + L+I+ E+ G L ++L + + E + + + + G+ LH+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
I+HRD+KS NL +D NVK+ D G+++L + + + GTP +++PE+ ++P
Sbjct: 121 K--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 854 NEKCDVYSFGVILWELATLKLPW 876
NEK DV++ GV+L+E T K P+
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 67/210 (31%), Positives = 120/210 (57%), Gaps = 10/210 (4%)
Query: 682 ERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLE---FKREVKIMRRLRHPNVVL 737
++IG GS+G++Y A + +E V K + D + + E K+EV ++ +++HPN+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIK--EIDLTKMPVKEKEASKKEVILLAKMKHPNIVT 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPT 796
F + L I+ E+ G L + ++R E + + + ++ G+ +H
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK-- 121
Query: 797 IVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 855
I+HRD+KS N+ + KN V K+ DFG++R +++ + + GTP +++PE+ +N P N
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181
Query: 856 KCDVYSFGVILWELATLKLPWIGMNPMQVV 885
K D++S G +L+EL TLK P+ G N Q+V
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFEGNNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (284), Expect = 6e-28
Identities = 66/227 (29%), Positives = 112/227 (49%), Gaps = 16/227 (7%)
Query: 684 IGLGSYGEVY---HADWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVV-L 737
+G GS+G+V D G A+K L + + E I+ R+ HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKD-TGKLYAMKV-LKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTSTPT 796
T L ++ E+ P G LF L + E+R R A ++ + LH+
Sbjct: 59 HYAFQT-EEKLYLVLEYAPGGELFSHLSKEGR-FSEERARFYAA-EIVLALEYLHSLG-- 113
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856
I++RDLK N+L+D + ++K++DFGL++ + + + GTPE++APEVL + +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 857 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
D +S GV+L+E+ T K P+ + ++ + L P+ L P
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLSP 218
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 83/263 (31%), Positives = 128/263 (48%), Gaps = 30/263 (11%)
Query: 675 WEDLVLGERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
WED+ + IG G++G+V A D A+K L + S +F E++++ +L
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIK-MLKEFASENDHRDFAGELEVLCKL 59
Query: 731 -RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL---------------HRPHCQVDEK 774
HPN++ +GA L I E+ P G+L L H + +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 775 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834
+ ++ A DVA GM L S +HRDL + N+LV +N K++DFGLSR + + K
Sbjct: 120 QLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE---VYVK 174
Query: 835 STAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 891
T G WMA E L K DV+SFGV+LWE+ +L P+ GM ++ + Q
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 233
Query: 892 NRRLEIPKELDPLVARIIWECWQ 914
R+E P+ D V ++ +CW+
Sbjct: 234 GYRMEKPRNCDDEVYELMRQCWR 256
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 90/288 (31%), Positives = 139/288 (48%), Gaps = 38/288 (13%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHAD-WNGTE------VAVKKFLDQDFSGAALLEFKREVK 725
I D+VL +G G++G+V+ A+ +N + VAVK D AA +F+RE +
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAE 59
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQ--VDEKRR----- 776
++ L+H ++V F G L ++ E++ G L + L H P VD + R
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 777 ------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT- 829
+ +A +A GM ++ ++ VHRDL + N LV N VK+ DFG+SR ++T
Sbjct: 120 LGLSQMLHIASQIASGM--VYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
Query: 830 -FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGA 887
+ T WM PE + + DV+SFGVILWE+ T K PW ++ +V+
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237
Query: 888 VGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRFQ 935
+ Q R LE P+ V I+ CWQ R Q +L+ K
Sbjct: 238 IT-QGRVLERPRVCPKEVYDIMLGCWQ--------REPQQRLNIKEIY 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 77/243 (31%), Positives = 124/243 (51%), Gaps = 19/243 (7%)
Query: 682 ERIGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
ERIG G++GEV+ + T VAVK + L D +F +E +I+++ HPN+V
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA----KFLQEARILKQYSHPNIV 56
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+G T+ + I+ E + G L ++ K I+M + A GM L +
Sbjct: 57 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK--H 114
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WMAPEVLRNEP 852
+HRDL + N LV + +K+SDFG+SR + + + ST G + W APE L
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--STGGMKQIPVKWTAPEALNYGR 172
Query: 853 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
+ + DV+SFG++LWE +L +P+ ++ Q A+ Q RL P+ V R++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMER 231
Query: 912 CWQ 914
CW+
Sbjct: 232 CWE 234
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 75/230 (32%), Positives = 119/230 (51%), Gaps = 15/230 (6%)
Query: 680 LGERIGLGSYGEVY---HADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHP 733
LG+ +G G++GEVY AD G E+AVK+ D + + + E+++++ LRH
Sbjct: 6 LGKLLGRGAFGEVYLCYDAD-TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 734 NVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
+V + G + P LSI E++P GS+ L + + + E + + +G++ LH
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLH 123
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEVL 848
++ IVHRD+K N+L D NVK+ DFG S+ +S KS GTP WM+PEV+
Sbjct: 124 SNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
E K DV+S + E+ T K PW M + + Q + +P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 85/279 (30%), Positives = 135/279 (48%), Gaps = 40/279 (14%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE----------------VAVKKFLDQDFSGA 715
E P + L L E++G G +GEV+ + G VAVK L D +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKM-LRADVTKT 59
Query: 716 ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ----- 770
A +F +E+KIM RL++PN++ +G L +ITE++ G L + L + +
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 771 ------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824
V + MA+ +A GM L ++ VHRDL + N LV ++ +K++DFG+SR
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 825 -LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL--KLPWIGMN 880
L + + A P WMA E + DV++FGV LWE+ TL + P+ ++
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237
Query: 881 PMQVVGAVG--FQNRRLEIPKELDPL----VARIIWECW 913
QV+ G F+N+ +I PL V +++ CW
Sbjct: 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCW 276
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 682 ERIGLGSYGEVYHADWN---GTEVAVKKF-LDQD---FSGAALLEFKREVKIMRRLRHPN 734
E++G G+YG VY A + G VA+KK LD + AL RE+ +++ L+HPN
Sbjct: 5 EKLGEGTYGVVYKA-RDKKTGEIVALKKIRLDNEEEGIPSTAL----REISLLKELKHPN 59
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCLHTS 793
+V + + L ++ E+ L + L + + IK + + RG+ H+
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP-NLIKSIMYQLLRGLAYCHSH 117
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 848
I+HRDLK N+L++++ +K++DFGL+R T E W APE+L
Sbjct: 118 R--ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPEIL 170
Query: 849 RNEPS-NEKCDVYSFGVILWELATLK 873
+ D++S G I E+ T K
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 70/246 (28%), Positives = 115/246 (46%), Gaps = 17/246 (6%)
Query: 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHP-NVVL 737
+ ++G GS+GEVY A + VA+K + S + +E F RE++I+ L HP N+V
Sbjct: 4 ILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNCLHTSTP 795
+L ++ E++ GSL +L + + E + + + + LH+
Sbjct: 63 LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG- 121
Query: 796 TIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTA------GTPEWMAPEVL 848
I+HRD+K N+L+D++ VK+ DFGL++L + +S A GTP +MAPEVL
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 849 R---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
++ D++S G+ L+EL T P+ G L P PL
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240
Query: 906 ARIIWE 911
Sbjct: 241 PSNPEL 246
|
Length = 384 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 81/272 (29%), Positives = 132/272 (48%), Gaps = 44/272 (16%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHA----DWNGTEVAVKKFLD-------QDFSGAALLEFK 721
+ W D+ + IG G++G+V A D + A+K+ + +DF+G
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG------- 56
Query: 722 REVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILH 765
E++++ +L HPN++ +GA L + E+ P G+L F I +
Sbjct: 57 -ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 115
Query: 766 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825
+ ++ + A DVARGM+ L S +HRDL + N+LV +N+ K++DFGLSR
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRG 173
Query: 826 KHNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPM 882
+ + K T G WMA E L DV+S+GV+LWE+ +L P+ GM
Sbjct: 174 QE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230
Query: 883 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
++ + Q RLE P D V ++ +CW+
Sbjct: 231 ELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWR 261
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 78/241 (32%), Positives = 121/241 (50%), Gaps = 15/241 (6%)
Query: 684 IGLGSYGEVYHADWN---GTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
IG G +GEV+ EVAV K L ++ +F E IM + H N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
G VT+ IITE++ G+L + L + + + M +A GM L S VH
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL--SDMNYVH 130
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP---EWMAPEVLRNEPSNEK 856
RDL + N+LV+ N KVSDFGLSR+ + + +T+G W APE +
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA 190
Query: 857 CDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIWECW 913
DV+SFG+++WE+ + + P+ M+ +V+ A+ GF RL P + V +++ +CW
Sbjct: 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDCPSAVYQLMLQCW 247
Query: 914 Q 914
Q
Sbjct: 248 Q 248
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 74/239 (30%), Positives = 119/239 (49%), Gaps = 11/239 (4%)
Query: 684 IGLGSYGEVYHADW---NGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
IG G +GEV E+ V K L ++ +F E IM + HPN++
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
G VT+ + I+TE++ GSL L + Q + + M +A GM L S VH
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL--SDMGYVH 129
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP---EWMAPEVLRNEPSNEK 856
RDL + N+LV+ N KVSDFGLSR+ + ++ +T G W APE +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA 189
Query: 857 CDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
DV+S+G+++WE+ + + P+ M+ V+ A+ + RL P + + +++ +CWQ
Sbjct: 190 SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAALHQLMLDCWQ 247
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 80/271 (29%), Positives = 139/271 (51%), Gaps = 32/271 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFKR 722
E P + LVLG+ +G G +G+V A+ G + VAVK L + + L +
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK-MLKDNATDKDLADLIS 66
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILHR 766
E+++M+ + +H N++ +G T+ L +I E+ +G+L F I
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 767 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
P Q+ K + A VARGM L + +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 827 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
H+ K++ G +WMAPE L + + DV+SFG+++WE+ TL P+ G+ P++
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVE 243
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + + R++ P + ++ ECW
Sbjct: 244 ELFKLLREGHRMDKPSNCTHELYMLMRECWH 274
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 9e-27
Identities = 74/230 (32%), Positives = 115/230 (50%), Gaps = 15/230 (6%)
Query: 680 LGERIGLGSYGEVY---HADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHP 733
LG+ +G G++G VY AD G E+AVK+ + + + + E+++++ L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDAD-TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 734 NVVLFMGAVTRPP--NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
+V + G + P LSI E +P GS+ L + + + E K + G++ LH
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLH 123
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEVL 848
++ IVHRD+K N+L D NVK+ DFG S+ LS KS GTP WM+PEV+
Sbjct: 124 SNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
E K D++S G + E+ T K PW M + + Q +P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 69/261 (26%), Positives = 116/261 (44%), Gaps = 30/261 (11%)
Query: 678 LVLGERIGLGSYGEVYHADWNGTE-----VAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
L LG+ +G G +G V + + VAVK + + + EF E M+ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 733 PNVVLFMG------AVTRPPNLSIITEFLPRGSLFRILHRPHCQ-----VDEKRRIKMAL 781
PNV+ +G ++ + P +I F+ G L L + + +K +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-TFLSSKSTAGTP 840
D+A GM L S +HRDL + N ++ ++ V V+DFGLS+ ++ + A P
Sbjct: 121 DIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 841 -EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG-----AVGFQNRR 894
+W+A E L + K DV++FGV +WE+AT G P V R
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATR-----GQTPYPGVENHEIYDYLRHGNR 233
Query: 895 LEIPKELDPLVARIIWECWQT 915
L+ P++ + +++ CW+
Sbjct: 234 LKQPEDCLDELYDLMYSCWRA 254
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 77/242 (31%), Positives = 118/242 (48%), Gaps = 17/242 (7%)
Query: 684 IGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG G +G VYH D AVK L++ + +F +E IM+ HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKS-LNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 739 MGAVTRPPNLS-IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+G ++ ++ G L + K I L VA+GM L ++
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL--ASKKF 119
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTP-EWMAPEVLRNEPS 853
VHRDL + N ++D+++ VKV+DFGL+R K + + + A P +WMA E L+ +
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 854 NEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKEL-DPLVARIIWE 911
K DV+SFGV+LWEL T P+ ++ + + Q RRL P+ DPL ++
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEYCPDPLY-EVMLS 237
Query: 912 CW 913
CW
Sbjct: 238 CW 239
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 81/242 (33%), Positives = 127/242 (52%), Gaps = 27/242 (11%)
Query: 675 WEDLVLGERIGLGSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
WE ++GE +G G++G+VY A T V A K +D S L ++ E+ I+ HP
Sbjct: 7 WE--IIGE-LGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHP 62
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRI---LHRPHCQVDEKRRIKMALDVARGMNCL 790
N+V + A NL I+ EF G++ + L RP + + K L+ +N L
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYL 119
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL-- 848
H + I+HRDLK+ N+L + ++K++DFG+S T S GTP WMAPEV+
Sbjct: 120 HENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 849 ---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
++ P + K DV+S G+ L E+A ++ P +NPM+V+ L+I K P +
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL---------LKIAKSEPPTL 228
Query: 906 AR 907
A+
Sbjct: 229 AQ 230
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 79/273 (28%), Positives = 122/273 (44%), Gaps = 35/273 (12%)
Query: 684 IGLGSYGEVYHA-----DWNGTE---VAVKKF----LDQDFSGAALLEFKREVKIMRRLR 731
+G G++GEVY G+ VAVK DQ+ EF +E +M
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-----EFLKEAHLMSNFN 57
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ------VDEKRRIKMALDVAR 785
HPN+V +G II E + G L L + + K + + LDVA+
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLV-----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 839
G C++ +HRDL + N LV D + VK+ DFGL+R + + + +
Sbjct: 118 G--CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 840 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEI 897
P WMAPE L + + DV+SFGV++WE+ TL + P+ +N +V+ V RL+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQK 234
Query: 898 PKELDPLVARIIWECW-QTGWSSLHIRTSQAQL 929
P+ + +++ CW Q Q L
Sbjct: 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 89/281 (31%), Positives = 136/281 (48%), Gaps = 41/281 (14%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE------------------VAVKKFLDQDFS 713
E P + L E++G G +GEV+ + G E VAVK L +D +
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK-MLREDAN 59
Query: 714 GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQ- 770
A +F +E+KIM RL+ PN++ + L +ITE++ G L + L H P
Sbjct: 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119
Query: 771 VDEKRR-------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823
I MA +A GM L S+ VHRDL + N LV KN+ +K++DFG+S
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 824 R-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL--KLPWIGM 879
R L + + A P WM+ E + DV++FGV LWE+ TL + P+ +
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237
Query: 880 NPMQVVGAVG-F---QNRRLEIPKE-LDP-LVARIIWECWQ 914
+ QV+ G F Q R++ +PK L P + +++ CW+
Sbjct: 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWR 278
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 80/271 (29%), Positives = 138/271 (50%), Gaps = 32/271 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFKR 722
E + L LG+ +G G +G+V A+ G + VAVK L D + L +
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVK-MLKDDATEKDLSDLVS 69
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILHR 766
E+++M+ + +H N++ +GA T+ L +I E+ +G+L + I
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 767 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
P Q+ K + VARGM L ++ +HRDL + N+LV +N +K++DFGL+R
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 827 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
+N K+T G +WMAPE L + + DV+SFGV++WE+ TL P+ G+ P++
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVE 246
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + + R++ P + ++ +CW
Sbjct: 247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWH 277
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 14/207 (6%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFK---REVKIMRR 729
+DL +G G+ G V G +AVK L+ + K RE+ I+ +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-----EAIQKQILRELDILHK 55
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
P +V F GA ++SI E++ GSL +IL ++ E+ K+A+ V +G+
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTY 115
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
LH I+HRD+K N+LV+ +K+ DFG+S N+ +K+ GT +MAPE ++
Sbjct: 116 LH-EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERIQ 172
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPW 876
+ K D++S G+ L ELAT + P+
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 82/263 (31%), Positives = 125/263 (47%), Gaps = 23/263 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVY-----HADWNGTEVAVK-KFLDQDFSGAALLEFKREVK 725
E+P + + L +G G++GEVY D + E+ V K L + S +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 726 IMRRLRHPNVVLFMG-AVTRPPNLSIITEFLPRGSLFRILH--RPH----CQVDEKRRIK 778
IM + H N+V +G + R P I+ E + G L L RP + K +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPN-LLVDKNWN--VKVSDFGLSR-LKHNTFLSSK 834
A DVA+G L + +HRD+ + N LL K K++DFG++R + ++
Sbjct: 121 CARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 835 STAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
A P +WM PE + K DV+SFGV+LWE+ +L +P+ G +V+ V
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TGG 237
Query: 893 RRLEIPKELDPLVARIIWECWQT 915
RL+ PK V RI+ +CWQ
Sbjct: 238 GRLDPPKGCPGPVYRIMTDCWQH 260
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 78/256 (30%), Positives = 124/256 (48%), Gaps = 30/256 (11%)
Query: 684 IGLGSYGEV----YH--ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G++G V Y D G VAVKK Q + L +F+RE++I++ L+H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 738 FMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+ G NL ++ E+LP GSL L + ++D ++ + A + +GM L +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL--GSK 127
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPE-WMAPEVLRNEP 852
VHRDL + N+LV+ VK+ DFGL+++ + + + +P W APE L
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 853 SNEKCDVYSFGVILWELAT----------LKLPWIGMN---PMQVVGAVGF--QNRRLEI 897
+ DV+SFGV+L+EL T + +G + M V + N RL
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPA 247
Query: 898 PKELDPLVARIIWECW 913
P + I+ ECW
Sbjct: 248 PPGCPAEIYAIMKECW 263
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 75/251 (29%), Positives = 120/251 (47%), Gaps = 40/251 (15%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P ++ IG G++G V+ A G T VAVK L ++ S +F+RE
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREA 59
Query: 725 KIMRRLRHPNVVLFMG--AVTRPPNLSIITEFLPRGSLFRILHR---------------- 766
+M HPN+V +G AV +P + ++ E++ G L L
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 767 -----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
+ ++ +A VA GM + S VHRDL + N LV +N VK++DFG
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGM--AYLSERKFVHRDLATRNCLVGENMVVKIADFG 175
Query: 822 LSRLKHNT--FLSSKSTAGTPEWMAPE-VLRNEPSNEKCDVYSFGVILWELATLKL-PWI 877
LSR ++ + +S++ A WM PE + N + E DV+++GV+LWE+ + + P+
Sbjct: 176 LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES-DVWAYGVVLWEIFSYGMQPYY 234
Query: 878 GMNPMQVVGAV 888
GM +V+ V
Sbjct: 235 GMAHEEVIYYV 245
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-26
Identities = 84/275 (30%), Positives = 130/275 (47%), Gaps = 45/275 (16%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREV 724
EI + E +G +G+VY GT VA+K D+ G EFK E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-AEGPLREEFKHEA 59
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPHCQV---DEKRRIKM 779
+ RL+HPN+V +G VT+ LS+I + L F ++ PH V D+ + +K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 780 ALD----------VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR----- 824
L+ +A GM L S+ +VH+DL + N+LV NVK+SD GL R
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 825 ----LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGM 879
L N+ L + WM+PE + + D++S+GV+LWE+ + L P+ G
Sbjct: 178 DYYKLMGNSLLPIR-------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230
Query: 880 NPMQVVGAVGFQNRR-LEIPKELDPLVARIIWECW 913
+ V+ + +NR+ L P + V ++ ECW
Sbjct: 231 SNQDVIEMI--RNRQVLPCPDDCPAWVYTLMLECW 263
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 85/271 (31%), Positives = 141/271 (52%), Gaps = 32/271 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFKR 722
E+ L LG+ +G G +G+V A+ G + VAVK L D + L +
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK-MLKDDATDKDLSDLVS 66
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RP--------HCQV 771
E+++M+ + +H N++ +GA T+ L ++ E+ +G+L L RP C++
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 772 DE-----KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
E K + A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 827 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
HN K+T G +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P++
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVE 243
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + + R++ P + I+ ECW
Sbjct: 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWH 274
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 65/205 (31%), Positives = 115/205 (56%), Gaps = 5/205 (2%)
Query: 682 ERIGLGSYGEVYHADWNGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
ERIG GS+GEV+ N T+ V K +D + + + + ++E+ ++ + P V + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ + L II E+L GS +L DE + M ++ +G++ LH+ +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKK--IHR 125
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 860
D+K+ N+L+ + +VK++DFG++ +T + + GTP WMAPEV++ + K D++
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
Query: 861 SFGVILWELATLKLPWIGMNPMQVV 885
S G+ ELA + P M+PM+V+
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMRVL 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 64/205 (31%), Positives = 117/205 (57%), Gaps = 5/205 (2%)
Query: 682 ERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
ERIG GS+GEVY N T EV K +D + + + + ++E+ ++ + P + + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ + L II E+L GS +L +P ++E + ++ +G++ LH+ +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL-KPG-PLEETYIATILREILKGLDYLHSERK--IHR 125
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 860
D+K+ N+L+ + +VK++DFG++ +T + + GTP WMAPEV++ + K D++
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIW 185
Query: 861 SFGVILWELATLKLPWIGMNPMQVV 885
S G+ ELA + P ++PM+V+
Sbjct: 186 SLGITAIELAKGEPPNSDLHPMRVL 210
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 8e-26
Identities = 75/264 (28%), Positives = 129/264 (48%), Gaps = 27/264 (10%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHAD-------WNGTEVAVKKFLDQDFSGAALLEFKREVK 725
I ++VL +G G++G+V+ A+ + VAVK +D S A +F RE +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAE 59
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH------------RPHCQVDE 773
++ L+H ++V F G L ++ E++ G L + L ++ +
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 774 KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FL 831
+ + +A +A GM ++ ++ VHRDL + N LV +N VK+ DFG+SR ++T +
Sbjct: 120 SQMLHIAQQIAAGM--VYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177
Query: 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 890
T WM PE + + DV+S GV+LWE+ T K PW ++ +V+ +
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT- 236
Query: 891 QNRRLEIPKELDPLVARIIWECWQ 914
Q R L+ P+ V ++ CWQ
Sbjct: 237 QGRVLQRPRTCPKEVYDLMLGCWQ 260
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 66/234 (28%), Positives = 116/234 (49%), Gaps = 22/234 (9%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFMG 740
I G+YG V+ A T A+K D ++ E I+ + + P VV
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ NL ++ E+LP G L +L ++ RI +A ++ + LH++ I+HR
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLHSNG--IIHR 117
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRL--------KHNTFLSSKSTAGTPEWMAPEVLRNEP 852
DLK N+L+D N ++K++DFGLS++ ++ K GTP+++APEV+ +
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDP 903
++ D +S G IL+E P+ G P ++ FQN ++E P++++
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-----FQNILNGKIEWPEDVEV 226
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 54/196 (27%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 682 ERIGLGSYGE---VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
++IG GS+G+ V + +G + +K+ S E ++EV ++ ++HPN+V +
Sbjct: 6 KKIGEGSFGKAILVKSKE-DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 739 MGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+ NL I+ ++ G L+ +I + E + + + + + +H I
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--I 122
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 857
+HRD+KS N+ + K+ +K+ DFG++R+ ++T +++ GTP +++PE+ N P N K
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKS 182
Query: 858 DVYSFGVILWELATLK 873
D+++ G +L+E+ TLK
Sbjct: 183 DIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 74/258 (28%), Positives = 122/258 (47%), Gaps = 24/258 (9%)
Query: 678 LVLGERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
LG +G G +G V A D + +VAVK FS + + EF RE M+ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 733 PNVVLFMG------AVTRPPNLSIITEFLPRGSLF------RILHRPHCQVDEKRRIKMA 780
PNV+ +G A R P +I F+ G L RI P + + ++
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF-TLPLQTLVRFM 119
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 839
+D+A GM L S+ +HRDL + N ++++N V V+DFGLS+ + + +
Sbjct: 120 IDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 840 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEI 897
P +W+A E L + DV++FGV +WE+ T + P+ G+ ++ + + RL+
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-IKGNRLKQ 236
Query: 898 PKELDPLVARIIWECWQT 915
P + V ++ +CW
Sbjct: 237 PPDCLEDVYELMCQCWSP 254
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 73/224 (32%), Positives = 119/224 (53%), Gaps = 26/224 (11%)
Query: 675 WEDLVLGERIGLGSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
WE ++GE +G G++G+VY A T A K ++ S L ++ E++I+ HP
Sbjct: 14 WE--IIGE-LGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHP 69
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGS-------LFRILHRPHCQVDEKRRIKMALDVARG 786
+V +GA L I+ EF P G+ L R L P QV ++ ++
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE-------A 122
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 846
+ LH+ I+HRDLK+ N+L+ + ++K++DFG+S T S GTP WMAPE
Sbjct: 123 LQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180
Query: 847 V-----LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885
V +++ P + K D++S G+ L E+A ++ P +NPM+V+
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 224
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 70/224 (31%), Positives = 115/224 (51%), Gaps = 24/224 (10%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLD----QDFSGAALLEFKREVKIMR 728
P D L +R+G G+YG+VY A + + E+A K + DFS ++E+ +++
Sbjct: 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS-----LIQQEIFMVK 61
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH----RPHCQVDEKRRIKMALDVA 784
+H N+V + G+ L I E+ GSL I H Q+ + +
Sbjct: 62 ECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQI-----AYVCRETL 116
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844
+G+ LH+ +HRD+K N+L+ N +VK++DFG++ T KS GTP WMA
Sbjct: 117 QGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174
Query: 845 PEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885
PEV +N N+ CD+++ G+ ELA L+ P ++PM+ +
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 64/272 (23%), Positives = 112/272 (41%), Gaps = 57/272 (20%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFK-----REV 724
+D G+ IG GS+ V A E A+K + L + E K E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--------EKKVKYVKIEK 52
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK------RRI 777
+++ RL HP ++ NL + E+ P G L + + + + +DEK I
Sbjct: 53 EVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEI 111
Query: 778 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---- 833
+AL+ I+HRDLK N+L+DK+ ++K++DFG +++
Sbjct: 112 LLALEYLHSKG--------IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 834 ----------------KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877
S GT E+++PE+L +P+ + D+++ G I++++ T K P+
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
Query: 878 GMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
G N + P P +I
Sbjct: 224 GSNEYLTFQKI--LKLEYSFPPNFPPDAKDLI 253
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 19/222 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSG--AALLEFKR 722
E P +L G+ +G G++G+V A G +VAVK S AL+
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS--- 87
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMA 780
E+KIM L H N+V +GA T + +ITE+ G L L R + + + +
Sbjct: 88 ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 839
VA+GM L ++ +HRDL + N+L+ VK+ DFGL+R + +++ K A
Sbjct: 148 YQVAKGMAFL--ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205
Query: 840 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGM 879
P +WMAPE + N + DV+S+G++LWE+ +L P+ GM
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 64/213 (30%), Positives = 118/213 (55%), Gaps = 5/213 (2%)
Query: 674 PWEDLVLGERIGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
P E E+IG GS+GEV+ N T+ V K +D + + + + ++E+ ++ +
Sbjct: 2 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
P V + G+ + L II E+L GS +L +DE + + ++ +G++ LH+
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHS 119
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+HRD+K+ N+L+ ++ VK++DFG++ +T + + GTP WMAPEV++
Sbjct: 120 EKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885
+ K D++S G+ ELA + P ++PM+V+
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVL 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 62/205 (30%), Positives = 113/205 (55%), Gaps = 15/205 (7%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G G++G V+ + V +K+ + + L + E ++++ L HPN++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 742 VTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
L I+ E+ P G+L + R + +DE + + + ++ +HT I+HR
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHR 125
Query: 801 DLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTA----GTPEWMAPEVLRNEPSNE 855
DLK+ N+L+DK+ V K+ DFG+S++ LSSKS A GTP +++PE+ +P N+
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 856 KCDVYSFGVILWELATLKLPWIGMN 880
K D+++ G +L+ELA+LK + N
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 53/205 (25%), Positives = 108/205 (52%), Gaps = 5/205 (2%)
Query: 684 IGLGSYGE--VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G G++GE +Y + + V K+ S + E+ I+ L+HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 742 VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
L I E+ G+L+ +I+ + +E+ + + ++ +H + I+HR
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHR 125
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 860
D+K+ N+ + K +K+ DFG+S++ + + +++ GTP +M+PE+ + N K D++
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIW 185
Query: 861 SFGVILWELATLKLPWIGMNPMQVV 885
+ G +L+EL TLK + NP+ +V
Sbjct: 186 ALGCVLYELLTLKRTFDATNPLNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 78/262 (29%), Positives = 126/262 (48%), Gaps = 23/262 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+ E + L +G GS+G VY + T VAVK +++ S +EF E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKT-VNESASLRERIEFLNEA 60
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDE-------KR 775
+M+ +VV +G V++ ++ E + G L L RP + + +
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 776 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835
I+MA ++A GM L+ VHRDL + N +V ++ VK+ DFG++R + T K
Sbjct: 121 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 836 TAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
G WMAPE L++ D++SFGV+LWE+ +L + P+ G++ QV+ V
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 237
Query: 893 RRLEIPKELDPLVARIIWECWQ 914
L+ P V ++ CWQ
Sbjct: 238 GYLDQPDNCPERVTDLMRMCWQ 259
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+IG G+YG VY A G VA+KK F + AL RE+K+++ L HPN+
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELNHPNI 60
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+ + +L ++ EF+ L++++ + E + +G+ H+
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG- 118
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVLRN 850
I+HRDLK NLL++ +K++DFGL+R S T W APE+L
Sbjct: 119 -ILHRDLKPENLLINTEGVLKLADFGLARS-----FGSPVRPYTHYVVTRWYRAPELLLG 172
Query: 851 EPS-NEKCDVYSFGVILWELATLKLPWIGMN 880
+ + D++S G I EL + + + G +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 81/256 (31%), Positives = 127/256 (49%), Gaps = 28/256 (10%)
Query: 684 IGLGSYGEVY------HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G +G+V D G +VAVK L + G + + K+E++I+R L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 738 FMGAVTRPPNLSI--ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+ G T I I EFLP GSL L R +++ K+++K A+ + +GM+ L +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL--GSR 128
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNT-FLSSKSTAGTPE-WMAPEVLRNEP 852
VHRDL + N+LV+ VK+ DFGL++ ++ + + + K +P W APE L
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 853 SNEKCDVYSFGVILWELAT------------LKLPWIGMNPMQVVGAVGF--QNRRLEIP 898
DV+SFGV L+EL T LK+ M V V + +RL P
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRP 248
Query: 899 KELDPLVARIIWECWQ 914
V +++ +CW+
Sbjct: 249 PNCPEEVYQLMRKCWE 264
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 77/271 (28%), Positives = 130/271 (47%), Gaps = 37/271 (13%)
Query: 677 DLVLGERIGLGSYGEVYHA---DWNG----TEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
+LVLG+ +G G +G+V A G T VAVK L ++ S + L + E ++++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVK-MLKENASSSELRDLLSEFNLLKQ 59
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSL---FRILHRPHCQ---------------- 770
+ HP+V+ GA ++ L +I E+ GSL R +
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 771 ----VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-- 824
+ I A ++RGM L + +VHRDL + N+LV + +K+SDFGLSR
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQ 883
+ ++++ +WMA E L + + DV+SFGV+LWE+ TL P+ G+ P +
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + R+E P+ + ++ CW+
Sbjct: 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWK 267
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 15/229 (6%)
Query: 681 GERIGLGSYGEV---YHADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHPN 734
G+ +G G++G V Y D G E+A K+ + + + + E+++++ L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVD-TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 735 VVLFMGAVTR--PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
+V + G + L+I E++P GS+ L + + + E K + GM+ LH+
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEVLR 849
+ IVHRD+K N+L D NVK+ DFG S+ +S +S GTP WM+PEV+
Sbjct: 125 NM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
E K DV+S G + E+ T K PW M + + Q ++P
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 70/212 (33%), Positives = 108/212 (50%), Gaps = 8/212 (3%)
Query: 674 PWEDLVLGERIGLGSYGEV--YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
P L +IG GS G V G +VAVKK +D L F EV IMR +
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKK-MDLRKQQRRELLFN-EVVIMRDYQ 74
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HPN+V + L ++ EFL G+L I+ H +++E++ + L V + ++ LH
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLAVLKALSFLH 132
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
++HRD+KS ++L+ + VK+SDFG KS GTP WMAPEV+
Sbjct: 133 AQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL 190
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883
P + D++S G+++ E+ + P+ P+Q
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 77/253 (30%), Positives = 124/253 (49%), Gaps = 28/253 (11%)
Query: 684 IGLGSYGEVYHA--DWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739
IG G++G+V A +G + A K + + S +F E++++ +L HPN++ +
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 740 GAVTRPPNLSIITEFLPRGSLFRIL---------------HRPHCQVDEKRRIKMALDVA 784
GA L + E+ P G+L L + + ++ + A DVA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG--TPEW 842
RGM+ L S +HRDL + N+LV +N+ K++DFGLSR + + K T G W
Sbjct: 123 RGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRW 177
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
MA E L DV+S+GV+LWE+ +L P+ GM ++ + Q RLE P
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNC 236
Query: 902 DPLVARIIWECWQ 914
D V ++ +CW+
Sbjct: 237 DDEVYDLMRQCWR 249
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 76/230 (33%), Positives = 109/230 (47%), Gaps = 42/230 (18%)
Query: 680 LGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
L E IG G+YG+VY H G VA+K D E K E I+R+ HPN+
Sbjct: 10 LVEVIGEGTYGKVYKARHKK-TGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 736 VLFMGAVT--RPPN----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL------DV 783
F GA PP L ++ E GS+ ++ + +R+K +
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR---KKGKRLKEEWIAYILRET 122
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR------LKHNTFLSSKSTA 837
RG+ LH + ++HRD+K N+L+ KN VK+ DFG+S + NTF+
Sbjct: 123 LRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI------ 174
Query: 838 GTPEWMAPEVLRNEPSNE-----KCDVYSFGVILWELATLKLPWIGMNPM 882
GTP WMAPEV+ + + + DV+S G+ ELA K P M+PM
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 66/252 (26%), Positives = 121/252 (48%), Gaps = 41/252 (16%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFK------REVKIM 727
+D + +G GS+G V G+ A+K S A +++ K E +I+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL-----SKAKIVKLKQVEHVLNEKRIL 55
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR------PHCQVDEKRRIKMAL 781
+ +RHP +V G+ NL ++ E++P G LF L + P + A
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF-------YAA 108
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTP 840
V + LH+ IV+RDLK NLL+D + +K++DFG + R+K T+ + GTP
Sbjct: 109 QVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGTP 162
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEI 897
E++APE++ ++ + D ++ G++++E+ P+ NP+Q+ ++ ++
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-----YEKILEGKVRF 217
Query: 898 PKELDPLVARII 909
P P +I
Sbjct: 218 PSFFSPDAKDLI 229
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 67/230 (29%), Positives = 114/230 (49%), Gaps = 29/230 (12%)
Query: 682 ERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKR-----------EVKIM 727
E +G G++G VY + +A+K+ + A + KR EV I+
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEI---NVHNPAFGKDKRERDKSIGDIVSEVTII 62
Query: 728 R-RLRHPNVVLFMGAVTRPPNLSIITEFL---PRGSLFRILHRPHCQVDEKRRIKMALDV 783
+ +LRHPN+V + L I+ + + P G F L + E+R + + +
Sbjct: 63 KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH-NTFLSSKSTAGTPEW 842
+ LH IVHRDL N+++ ++ V ++DFGL++ K + L+S GT +
Sbjct: 123 VLALRYLHKEK-RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV--VGTILY 179
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAV 888
PE+++NEP EK DV++FG IL+++ TL+ P+ N ++V AV
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 76/255 (29%), Positives = 124/255 (48%), Gaps = 21/255 (8%)
Query: 678 LVLGERIGLGSYGEVYHADWNGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
L LG+ +G G +G V N + VAVK + + + +F E M+ HP
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 734 NVVLFMGAVTRP------PNLSIITEFLPRGSL--FRILHRPHCQ---VDEKRRIKMALD 782
NV+ +G + P+ +I F+ G L F + R + + +K D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-TFLSSKSTAGTP- 840
+A GM L S+ + +HRDL + N ++++N NV V+DFGLS+ +N + A P
Sbjct: 121 IASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK 899
+W+A E L + K DV+SFGV +WE+AT + P+ G+ ++ + NR + P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238
Query: 900 ELDPLVARIIWECWQ 914
LD L + ++ CW
Sbjct: 239 CLDGLYS-LMSSCWL 252
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 66/208 (31%), Positives = 108/208 (51%), Gaps = 18/208 (8%)
Query: 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLF 738
++IG G + EVY A +G VA+KK D A A + +E+ ++++L HPNV+ +
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTSTP 795
+ L+I+ E G L R++ Q + EK K + + + +H+
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR- 126
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMAPEVLRN 850
++HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+PE +
Sbjct: 127 -VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIG 878
N K D++S G +L+E+A L+ P+ G
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 69/238 (28%), Positives = 117/238 (49%), Gaps = 12/238 (5%)
Query: 684 IGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+G G++G VY W G V + K L++ A +EF E IM + HP++V
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 798
+G V P + ++T+ +P G L +H + + + + +A+GM ++ +V
Sbjct: 75 LG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGM--MYLEERRLV 131
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP--EWMAPEVLRNEPSNEK 856
HRDL + N+LV +VK++DFGL+RL + G +WMA E + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 857 CDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913
DV+S+GV +WEL T P+ G+ P + + + + RL P V ++ +CW
Sbjct: 192 SDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMVKCW 248
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 74/212 (34%), Positives = 107/212 (50%), Gaps = 27/212 (12%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE----FKREVKIMRRLRHPNVVL 737
IG GS+G VY A T VA+KK +SG E +EV+ +++LRHPN +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+ G R ++ E+ GS IL H+ Q E I +G+ LH+
Sbjct: 80 YKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAI--CHGALQGLAYLHSHE- 135
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVL--RNE 851
+HRD+K+ N+L+ + VK++DFG + L N+F+ GTP WMAPEV+ +E
Sbjct: 136 -RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDE 188
Query: 852 PS-NEKCDVYSFGVILWELATLKLPWIGMNPM 882
+ K DV+S G+ ELA K P MN M
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 64/207 (30%), Positives = 113/207 (54%), Gaps = 10/207 (4%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E+IG G+ G VY A G EVA+K+ Q L+ E+ +MR +HPN+V ++
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI--INEILVMRENKHPNIVNYL 82
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
+ L ++ E+L GSL ++ +DE + + + + + LH++ ++H
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ--VIH 138
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST-AGTPEWMAPEVLRNEPSNEKCD 858
RD+KS N+L+ + +VK++DFG + S +ST GTP WMAPEV+ + K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 859 VYSFGVILWELATLKLPWIGMNPMQVV 885
++S G++ E+ + P++ NP++ +
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 1e-22
Identities = 81/291 (27%), Positives = 131/291 (45%), Gaps = 49/291 (16%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE------------------VAVKKFLDQDFS 713
+ P L+ E++G G +GEV+ + + VAVK L D +
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVK-ILRPDAN 59
Query: 714 GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE 773
A +F +EVKI+ RL+ PN++ +G L +ITE++ G L + L +D+
Sbjct: 60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL--SSHHLDD 117
Query: 774 KRR--------------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 813
K + +AL +A GM L S+ VHRDL + N LV +N
Sbjct: 118 KEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENL 175
Query: 814 NVKVSDFGLSR-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
+K++DFG+SR L + + A P WMA E + DV++FGV LWE+
Sbjct: 176 TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
Query: 872 L--KLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARIIWECWQTGWS 918
L + P+ + QV+ G F+++ ++ P + ++E WS
Sbjct: 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWS 286
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
LGE G GS + N + K + D + + RE++I + + P +V +
Sbjct: 9 LGEGAG-GSVTKCRLK--NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 740 GAVTRPP--NLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCLHTST 794
GA ++ I E+ GSL I + + + EK K+A V +G++ LH+
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
I+HRD+K N+L+ + VK+ DFG+S N+ + + GT +MAPE ++ +P +
Sbjct: 126 --IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPYS 181
Query: 855 EKCDVYSFGVILWELATLKLPWI 877
DV+S G+ L E+A + P+
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 8/205 (3%)
Query: 683 RIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+IG GS G V A G +VAVKK +D L F EV IMR H NVV
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFN-EVVIMRDYHHENVVDMYN 86
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ L ++ EFL G+L I+ H +++E++ + L V R ++ LH ++HR
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQG--VIHR 142
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 860
D+KS ++L+ + +K+SDFG KS GTP WMAPEV+ P + D++
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 861 SFGVILWELATLKLPWIGMNPMQVV 885
S G+++ E+ + P+ P+Q +
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPPLQAM 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 27/205 (13%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQD---FSGAALLEFKREVKIMRRLRHPNV 735
+IG G+YG+VY A T VA+KK ++ + F A+ RE+K++++LRHPN+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI----REIKLLQKLRHPNI 60
Query: 736 VLFMGAVTRPPNLSI--ITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCLHT 792
V VT SI + E++ L +L P + E + IK + G+ LH+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQ-IKCYMKQLLEGLQYLHS 118
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 847
+ I+HRD+K N+L++ + +K++DFGL+R + S T W PE+
Sbjct: 119 NG--ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVITLWYRPPEL 172
Query: 848 LRNEPS-NEKCDVYSFGVILWELAT 871
L + D++S G IL EL
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 63/230 (27%), Positives = 119/230 (51%), Gaps = 7/230 (3%)
Query: 684 IGLGSYGEV--YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G GSYGEV +G + +KK ++ S ++E +++ +L+HPN+V + +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 742 VTRPPN-LSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNCLHTSTPTIVH 799
L I+ F G L+ L ++ E + ++ + +A + LH I+H
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILH 125
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 859
RDLK+ N+ + + +KV D G++R+ N + + GTP +M+PE+ N+P N K DV
Sbjct: 126 RDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDV 185
Query: 860 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
++ G ++E+ATLK + + +V + + + +PK+ P + +I
Sbjct: 186 WALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSPELGELI 234
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 6e-22
Identities = 66/236 (27%), Positives = 122/236 (51%), Gaps = 9/236 (3%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E+IG G+ G V+ A G EVA+K+ Q L+ E+ +M+ L++PN+V F+
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI--INEILVMKELKNPNIVNFL 82
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
+ L ++ E+L GSL ++ C +DE + + + + + LH + ++H
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTET-C-MDEAQIAAVCRECLQALEFLHANQ--VIH 138
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 859
RD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 860 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQ 914
+S G++ E+ + P++ NP++ + + L+ P++L P+ + C +
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE 254
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 58/197 (29%), Positives = 105/197 (53%), Gaps = 8/197 (4%)
Query: 684 IGLGSYGE---VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G GS+G V H N + K + S +A+ + ++E ++ +++HPN+V F
Sbjct: 8 VGEGSFGRALLVQHV--NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNCLHTSTPTIVH 799
+ +L I+ E+ G L + + ++ E ++ + + G+ +H ++H
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLH 123
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 859
RD+KS N+ + +N VK+ DFG +RL + + + GTP ++ PE+ N P N K D+
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDI 183
Query: 860 YSFGVILWELATLKLPW 876
+S G IL+EL TLK P+
Sbjct: 184 WSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-21
Identities = 66/242 (27%), Positives = 117/242 (48%), Gaps = 13/242 (5%)
Query: 684 IGLGSYG----EVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+G G++G VY +VA+K L + + E RE +IM +L +P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
G V L ++ E G L + L ++ +++ V+ GM L VH
Sbjct: 62 G-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVH 118
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEK 856
RDL + N+L+ K+SDFGLS+ +++ ++S P +W APE + + +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 857 CDVYSFGVILWE-LATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915
DV+S+G+ +WE + + P+ M +V+ + Q +RL+ P E P + ++ +CW
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWIY 237
Query: 916 GW 917
W
Sbjct: 238 KW 239
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 6e-21
Identities = 61/213 (28%), Positives = 110/213 (51%), Gaps = 18/213 (8%)
Query: 677 DLVLGERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHP 733
+ + ++IG G + EVY A + VA+KK + + A + +E+ ++++L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVARGMNCL 790
NV+ ++ + L+I+ E G L +++ Q + E+ K + + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMAP 845
H+ ++HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+P
Sbjct: 123 HSRR--VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSP 175
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 878
E + N K D++S G +L+E+A L+ P+ G
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-21
Identities = 67/205 (32%), Positives = 107/205 (52%), Gaps = 8/205 (3%)
Query: 683 RIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+IG GS G V A +G VAVKK +D L F EV IMR +H NVV
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKK-MDLRKQQRRELLFN-EVVIMRDYQHENVVEMYN 84
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ L ++ EFL G+L I+ H +++E++ + L V + ++ LH ++HR
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQG--VIHR 140
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 860
D+KS ++L+ + VK+SDFG KS GTP WMAPE++ P + D++
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 861 SFGVILWELATLKLPWIGMNPMQVV 885
S G+++ E+ + P+ P++ +
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAM 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-21
Identities = 80/264 (30%), Positives = 124/264 (46%), Gaps = 17/264 (6%)
Query: 681 GERI--GLGSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
GER+ G G+YG VY A T+V A+K+ ++D L E+ + L+H N+V
Sbjct: 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIV 68
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTST 794
++G+ + I E +P GSL +L + +E+ I + G+ LH +
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN- 127
Query: 795 PTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
IVHRD+K N+LV+ V K+SDFG S+ +++ GT ++MAPEV+ P
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 854 --NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910
D++S G + E+AT K P+I + P + VG EIP+ L I
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246
Query: 911 ECWQTGWSSLHIRTSQAQLSHKRF 934
C++ R S L F
Sbjct: 247 RCFEP---DPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 9e-21
Identities = 59/215 (27%), Positives = 109/215 (50%), Gaps = 11/215 (5%)
Query: 679 VLGERIGLGSYGEVY-----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+L +R+G GS+G VY A +K+ + + ++ +E +++ +L HP
Sbjct: 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQ--VDEKRRIKMALDVARGMNCL 790
+V F + IITE+ L ++ H + E + + + + G++ +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
H I+HRDLK+ N+ + N +K+ DFG+SRL + + + GTP +M+PE L++
Sbjct: 123 HQRR--ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885
+ + K D++S G IL+E+ L + G N + VV
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 9e-21
Identities = 68/238 (28%), Positives = 113/238 (47%), Gaps = 13/238 (5%)
Query: 684 IGLGSYGEV----YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+G G++G V Y + VAVK + + A E RE +M++L +P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
G + + ++ E G L + L + V EK ++ V+ GM L + VH
Sbjct: 63 G-ICEAESWMLVMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETN--FVH 118
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEK 856
RDL + N+L+ K+SDFGLS+ + +K+ P +W APE + + K
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178
Query: 857 CDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913
DV+SFGV++WE + P+ GM +V + R+E P+ P + ++ CW
Sbjct: 179 SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCW 235
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 9e-21
Identities = 61/206 (29%), Positives = 111/206 (53%), Gaps = 8/206 (3%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E+IG G+ G VY A G EVA+K+ Q L+ E+ +MR ++PN+V ++
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI--INEILVMRENKNPNIVNYL 82
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
+ L ++ E+L GSL ++ C +DE + + + + ++ LH++ ++H
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET-C-MDEGQIAAVCRECLQALDFLHSNQ--VIH 138
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 859
RD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 860 YSFGVILWELATLKLPWIGMNPMQVV 885
+S G++ E+ + P++ NP++ +
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 55/228 (24%), Positives = 111/228 (48%), Gaps = 12/228 (5%)
Query: 692 VYHADWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVV----LFMGAVTRPP 746
+Y +N EV ++ F L++ + E+K +RR+ N++ + V P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 806
LS+I E+ RG L +L + + K ++ MA+D +G+ L+ T +++L S +
Sbjct: 96 RLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNK-PYKNLTSVS 153
Query: 807 LLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGV 864
LV +N+ +K+ GL ++ + K+ + + ++L + K D+YS GV
Sbjct: 154 FLVTENYKLKIICHGLEKILSSP--PFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210
Query: 865 ILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
+LWE+ T K+P+ + ++ + +N L++P + + I+ C
Sbjct: 211 VLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258
|
Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 10/217 (4%)
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761
VA+ L S F E + + H N+V G +TR + I+TE++ G+L
Sbjct: 36 VAIHT-LRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 762 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
L + Q+ + + M +A GM L S VH+ L + +LV+ + K+S F
Sbjct: 95 SFLRKHEGQLVAGQLMGMLPGLASGMKYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 822 -LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 879
L K ++ S W APE ++ + DV+SFG+++WE+ + + P+ M
Sbjct: 153 RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212
Query: 880 NPMQVVGAV--GFQNRRLEIPKELDPLVARIIWECWQ 914
+ V+ AV GF RL P+ L+ +++ +CWQ
Sbjct: 213 SGQDVIKAVEDGF---RLPAPRNCPNLLHQLMLDCWQ 246
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 679 VLGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGA-------ALLEFKREVKIMRR 729
G+++G G+Y VY A D G VA+KK + A AL RE+K+++
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL----REIKLLQE 58
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC---QVDEKRRIKMALDVARG 786
L+HPN++ + N++++ EF+ L +++ D K + M L RG
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RG 114
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK----STAGTPEW 842
+ LH++ I+HRDLK NLL+ + +K++DFGL+R +F S T +
Sbjct: 115 LEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR----SFGSPNRKMTHQVVTRWY 168
Query: 843 MAPEVLRNEPS-NEKCDVYSFGVILWEL 869
APE+L D++S G I EL
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 4e-20
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 41/214 (19%)
Query: 684 IGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVV- 736
IG G+YG V A G +VA+KK F D + L RE+K++R LRH N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL----REIKLLRHLRHENIIG 63
Query: 737 LFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
L + RPP+ I+TE + L +++ P D+ + + + RG+ L
Sbjct: 64 LL--DILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFL-YQILRGLKYL 119
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM------- 843
H++ ++HRDLK N+LV+ N ++K+ DFGL+R ++
Sbjct: 120 HSAN--VIHRDLKPSNILVNSNCDLKICDFGLAR-------GVDPDEDEKGFLTEYVVTR 170
Query: 844 ---APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
APE+L + + D++S G I EL T K
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 5e-20
Identities = 64/234 (27%), Positives = 120/234 (51%), Gaps = 9/234 (3%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E+IG G+ G VY A G EVA+++ Q L+ E+ +MR ++PN+V ++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNYL 83
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
+ L ++ E+L GSL ++ C +DE + + + + + LH++ ++H
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTET-C-MDEGQIAAVCRECLQALEFLHSNQ--VIH 139
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 859
RD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 860 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWEC 912
+S G++ E+ + P++ NP++ + + L+ P++L + + C
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 5e-20
Identities = 75/262 (28%), Positives = 120/262 (45%), Gaps = 34/262 (12%)
Query: 679 VLGERIGLGSYGEV--YHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
VLGE G +G+V Y D G VAVK L ++ +K+E+ I++ L H
Sbjct: 11 VLGE----GHFGKVSLYCYDPANDGTGEMVAVKT-LKRECGQQNTSGWKKEINILKTLYH 65
Query: 733 PNVVLFMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
N+V + G + L +I E++P GSL L P +++ + + A + GM L
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMAPEV 847
H+ +HRDL + N+L+D + VK+ DFGL++ H + + W A E
Sbjct: 124 HSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 848 LRNEPSNEKCDVYSFGVILWELAT------------LKLPWIGMNPMQVVGAVGFQNRRL 895
L+ + DV+SFGV L+EL T ++ M VV + R +
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241
Query: 896 EIPKELD-PLVARIIWE-CWQT 915
+P + P I+ + CW+T
Sbjct: 242 RLPCPKNCPQEVYILMKNCWET 263
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 6e-20
Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 55/235 (23%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTE--VAVKKF-----LDQDFSGAALLEFKREVKIMR 728
+D + + IG G++GEV+ T A+K + ++ + E I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH----VRAERDILA 56
Query: 729 RLRHPNVV-LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKMALD 782
P +V L+ + +L ++ E++P G L +L R +E R + +ALD
Sbjct: 57 DADSPWIVKLYY-SFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------------------- 823
+ +HRD+K N+L+D + ++K++DFGL
Sbjct: 116 SVHKLGF--------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 824 ----------RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 868
R + + ST GTP+++APEVLR P +CD +S GVIL+E
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 7e-20
Identities = 69/244 (28%), Positives = 114/244 (46%), Gaps = 12/244 (4%)
Query: 684 IGLGSYGEVYHADWNGTEVAVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+G G++G VY W VK K L + S A E E +M + +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 798
+G + + +IT+ +P G L + + + + + +A+GMN L +V
Sbjct: 75 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LV 131
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLRNEPSNEK 856
HRDL + N+LV +VK++DFGL++L + G P +WMA E + + +
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ 191
Query: 857 CDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915
DV+S+GV +WEL T P+ G+ P + ++ + RL P V I+ +CW
Sbjct: 192 SDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 916 GWSS 919
S
Sbjct: 251 DADS 254
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 25/227 (11%)
Query: 684 IGLGSYGEVYHAD--WNGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH-PNVVLFM 739
I G++G VY A G A+K D + + K E IM P V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 740 GAVTRPPNLSIITEFLPRG---SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ L ++ E+L G SL + L + E + +V G+ LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQRG-- 117
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856
I+HRD+K NLL+D+ ++K++DFGLSR L +K GTP+++APE + ++
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNG----LENKKFVGTPDYLAPETILGVGDDKM 173
Query: 857 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKE 900
D +S G +++E P+ P V F N RR+ P+E
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAV-----FDNILSRRINWPEE 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-19
Identities = 76/244 (31%), Positives = 118/244 (48%), Gaps = 26/244 (10%)
Query: 656 STSKVDQIFDDDVCEC---EIPWEDLVLGERIGLGSYGEVYHA-DWNGTEV-AVKKFLDQ 710
STS+ + D ++ E E P + IG GS+G VY A D EV A+KK
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM--- 58
Query: 711 DFSGAALLE----FKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL--PRGSLFRIL 764
+SG E +EVK ++R++HPN + + G R ++ E+ L +
Sbjct: 59 SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH 118
Query: 765 HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824
+P +V+ AL +G+ LH+ ++HRD+K+ N+L+ + VK++DFG +
Sbjct: 119 KKPLQEVEIAAITHGAL---QGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSAS 173
Query: 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMNP 881
+ + S GTP WMAPEV+ + K DV+S G+ ELA K P MN
Sbjct: 174 IAS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229
Query: 882 MQVV 885
M +
Sbjct: 230 MSAL 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+G G+YG V T VA+KKF + + REVK++R+LRH N+V
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
A R L ++ E++ R +L +L + + + + H+ I+H
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIH 123
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA------GTPEWMAPEVLRNEPS 853
RD+K N+LV ++ +K+ DFG +R L ++ + T + APE+L + +
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 854 NEK-CDVYSFGVILWELAT 871
K DV++ G I+ EL
Sbjct: 179 YGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 52/155 (33%), Positives = 84/155 (54%), Gaps = 4/155 (2%)
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
RE++IM R P +V F GA N+ + EF+ GSL RI + + + K+A+
Sbjct: 52 RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY-KKGGPIPVEILGKIAV 110
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 841
V G+ L+ + I+HRD+K N+LV+ +K+ DFG+S N+ + + GT
Sbjct: 111 AVVEGLTYLY-NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTST 167
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
+M+PE ++ K DV+S G+ + ELA K P+
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKR------EVKIMR 728
D +GE +G GS+G V A GT A+K ++ +L+ K+ E I+
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE-----ILKMKQVQHVAQEKSILM 73
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR--- 785
L HP +V M + + + EF+ G LF L ++ + DVA+
Sbjct: 74 ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---------RKAGRFPNDVAKFYH 124
Query: 786 -----GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGT 839
LH+ I++RDLK NLL+D +VKV+DFG + ++ TF + GT
Sbjct: 125 AELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCGT 178
Query: 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884
PE++APEV++++ + D ++ GV+L+E P+ P ++
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223
|
Length = 329 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 68/254 (26%), Positives = 119/254 (46%), Gaps = 25/254 (9%)
Query: 682 ERIGLGSYGEVYHADWN-GTEVA--VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+ IG G +G+V + + G A V K L + L F +EV+ R L HPNV+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRI--KMALDVARGMNCLHTST 794
+G ++ EF P G L L R ++ + +MA +VA G+ LH +
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGL--SRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+H DL N + + +VK+ D+GL + + +++ A W+APE++
Sbjct: 120 -DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 853 SN-------EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK-ELD- 902
+ +K +++S GV +WEL T P+ ++ QV+ V + + +++PK +LD
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQDIKLPKPQLDL 237
Query: 903 PLVAR---IIWECW 913
R ++ CW
Sbjct: 238 KYSDRWYEVMQFCW 251
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 36/224 (16%)
Query: 687 GSYGEVYHADWNGT------EVAVKKFLDQDFSGAALLE---FKREVKIMRRLRHPNVVL 737
G++G +++ EV VK D A+ ++ +E ++ L H N++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 738 FMGAVTR---PP-------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
+ PP N + FL + L + ++ + MA+ +A GM
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRL--GEANNPQALSTQQLVHMAIQIACGM 130
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE-----W 842
+ LH ++H+D+ + N ++D+ VK++D LSR + F G E W
Sbjct: 131 SYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSR---DLFPMDYHCLGDNENRPVKW 185
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVV 885
MA E L N+ + DV+SFGV+LWEL TL + P++ ++P ++
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 679 VLGERIGLGSYGEVYHA-DWN-GTEVAVKKF---LDQDFSGAALLEFKREVKIMRRLR-- 731
IG G+YG VY A D N G VA+KK L ++ + L RE+ ++++L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL---REIALLKQLESF 58
Query: 732 -HPNVVLFMG-----AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVA 784
HPN+V + R L+++ E + + L L + IK + +
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM- 843
RG++ LH+ IVHRDLK N+LV + VK++DFGL+R+ +F + ++ W
Sbjct: 118 RGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYR 173
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATLK 873
APEVL D++S G I EL +
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 64/220 (29%), Positives = 113/220 (51%), Gaps = 18/220 (8%)
Query: 680 LGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 737
L E +G G+YG+VY T ++A K +D +G E K+E+ ++++ H N+
Sbjct: 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 738 FMGAVTR--PPNLS----IITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCL 790
+ GA + PP + ++ EF GS+ ++ ++ I + ++ RG++ L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
H ++HRD+K N+L+ +N VK+ DFG+S T + GTP WMAPEV+
Sbjct: 128 HQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 851 EPSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVV 885
+ + + K D++S G+ E+A P M+PM+ +
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 225
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 6e-19
Identities = 77/240 (32%), Positives = 112/240 (46%), Gaps = 29/240 (12%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRL-RHPNVV 736
E IG G+YG+VY +G+ AVK LD D E + E I++ L HPNVV
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDE----EIEAEYNILQSLPNHPNVV 82
Query: 737 LFMGAVTRPPNLS-----IITEFLPRGS---LFRILHRPHCQVDEKRRIKMALDVARGMN 788
F G + L ++ E GS L + L ++DE + G+
Sbjct: 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 848
LH + I+HRD+K N+L+ VK+ DFG+S +T L ++ GTP WMAPEV+
Sbjct: 143 HLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200
Query: 849 RNEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
E + +CDV+S G+ EL P M+P++ + F+ R P L P
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL----FKIPRNPPPTLLHP 256
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 6e-19
Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 8/205 (3%)
Query: 683 RIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+IG GS G V A +G +VAVK +D L F EV IMR +H NVV
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYK 85
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ L ++ EFL G+L I+ + +++E++ + V + + LH+ ++HR
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHR 141
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 860
D+KS ++L+ + VK+SDFG KS GTP WMAPEV+ P + D++
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 861 SFGVILWELATLKLPWIGMNPMQVV 885
S G+++ E+ + P+ +P+Q +
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAM 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 6e-19
Identities = 70/222 (31%), Positives = 110/222 (49%), Gaps = 24/222 (10%)
Query: 676 EDLVLG-ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE----FKREVKIMR 728
E++ +G IG GS+G VY A + T VAVKK +SG E +EVK ++
Sbjct: 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKM---SYSGKQTNEKWQDIIKEVKFLQ 76
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFL--PRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
+L+HPN + + G + ++ E+ L + +P +V+ AL +G
Sbjct: 77 QLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QG 133
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 846
+ LH+ ++HRD+K+ N+L+ + VK++DFG + + S GTP WMAPE
Sbjct: 134 LAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSFVGTPYWMAPE 187
Query: 847 VLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMNPMQVV 885
V+ + K DV+S G+ ELA K P MN M +
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 53/158 (33%), Positives = 88/158 (55%), Gaps = 3/158 (1%)
Query: 721 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
K E I+ + HP +V A L +I +FL G LF L + +E + +A
Sbjct: 46 KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 105
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 840
++A ++ LH+ I++RDLK N+L+D+ ++K++DFGLS+ + + S GT
Sbjct: 106 -ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 878
E+MAPEV+ + D +SFGV+++E+ T LP+ G
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-18
Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 17/195 (8%)
Query: 684 IGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIM-------RRLRHPN 734
IG GS+G+V A +G+ AVK + +L+ K + IM + L+HP
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKK-----TILKKKEQNHIMAERNVLLKNLKHPF 57
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V + L + +++ G LF L R C ++ + R A +VA + LH+
Sbjct: 58 LVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHSLN 116
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
I++RDLK N+L+D +V ++DFGL + ++ + GTPE++APEVLR EP +
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 855 EKCDVYSFGVILWEL 869
D + G +L+E+
Sbjct: 175 RTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 56/164 (34%), Positives = 87/164 (53%), Gaps = 23/164 (14%)
Query: 676 EDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
D + ++G G++GEVY A G VA+KK L + + RE+KI+++L+HP
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67
Query: 734 NVV-LFMGAVTRPPNLSIITEFLPRGSLFRI-----------LHRPHCQVDEKRRIK-MA 780
NVV L AV RP RGS++ + L P ++ E + IK
Sbjct: 68 NVVPLIDMAVERPDKSKRK-----RGSVYMVTPYMDHDLSGLLENPSVKLTESQ-IKCYM 121
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824
L + G+N LH + I+HRD+K+ N+L+D +K++DFGL+R
Sbjct: 122 LQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 35/238 (14%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFL-DQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G+G +G V A+K E +I+ HP +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GMNCLHT 792
+ ++ E+ G L+ IL R AR LH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD---------RGLFDEYTARFYIACVVLAFEYLHN 111
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGL-----SRLKHNTFLSSKSTAGTPEWMAPEV 847
I++RDLK NLL+D N VK+ DFG S K TF GTPE++APE+
Sbjct: 112 RG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GTPEYVAPEI 163
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQNRRLEIPKELDP 903
+ N+ + D +S G++L+EL T + P+ +PM++ + N +LE P +D
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDK 221
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 71/229 (31%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 676 EDLV-LGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVK-IMRRL 730
EDL LGE IG G++G V H +GT +AVK+ + ++ +MR
Sbjct: 4 EDLKDLGE-IGRGAFGTVNKMLHKP-SGTIMAVKR-IRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI------KMALDVA 784
P +V F GA+ R + I E L SL + + K I K+A+
Sbjct: 61 DCPYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEV--LKSVIPEEILGKIAVATV 117
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844
+ +N L I+HRD+K N+L+D+N N+K+ DFG+S ++ ++ AG +MA
Sbjct: 118 KALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMA 175
Query: 845 PEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-----QVV 885
PE + + + + DV+S G+ L+E+AT K P+ N + QVV
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV 224
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-18
Identities = 71/243 (29%), Positives = 105/243 (43%), Gaps = 30/243 (12%)
Query: 646 LESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAV 704
L PSSS SS+S +L RIG G+ G VY T +
Sbjct: 47 LPPPSSSSSSSSSSSAS---GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 705 KKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL 764
K + + + RE++I+R + HPNVV + ++ EF+ GSL
Sbjct: 104 LKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL---- 159
Query: 765 HRPHCQVDEKRRIKMAL---DVAR----GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 817
E I DVAR G+ LH IVHRD+K NLL++ NVK+
Sbjct: 160 --------EGTHIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKI 209
Query: 818 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC-----DVYSFGVILWELATL 872
+DFG+SR+ T S+ GT +M+PE + + ++ D++S GV + E
Sbjct: 210 ADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
Query: 873 KLP 875
+ P
Sbjct: 270 RFP 272
|
Length = 353 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 59/238 (24%), Positives = 118/238 (49%), Gaps = 13/238 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
+DL + +G G++G V+ + A+K + + E ++++ + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
P ++ L ++ E++P G LF L R + + A ++ + LH+
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNE 851
IV+RDLK N+L+DK ++K++DFG ++ L+ T+ + GTPE++APEV++++
Sbjct: 120 KE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTPEYLAPEVIQSK 173
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
N+ D ++ G++++E+ P+ NP + + +LE P+ LD +I
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--LAGKLEFPRHLDLYAKDLI 229
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 18/197 (9%)
Query: 684 IGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G GSYG V H + G VA+KKFL+ + RE++++++LRH N+V +
Sbjct: 9 VGEGSYGMVMKCKHKE-TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
R L ++ EF+ L + P+ +DE R K + RG+ H+ I+HR
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHN--IIHR 124
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT----PEWM-APEVLRNEPSNE 855
D+K N+LV ++ VK+ DFG +R L++ T W APE+L +
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 856 K-CDVYSFGVILWELAT 871
+ D+++ G ++ E+ T
Sbjct: 180 RAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVK-------IMRRLRH 732
++G G YG+V+ A T VA+K+ LL EV+ I+ +
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKS------LLFKLNEVRHVLTERDILTTTKS 60
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
+V + A L + E++P G +L+ ++ R MA ++ LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE-AVDALHE 119
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+HRDLK N L+D + ++K++DFGLS+ + S G+P++MAPEVLR +
Sbjct: 120 LG--YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884
+ D +S G +L+E P+ G P +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-18
Identities = 69/233 (29%), Positives = 118/233 (50%), Gaps = 40/233 (17%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIM----------RRL--- 730
+G GS+G+V+ A+ GT +Q F+ AL K++V +M +R+
Sbjct: 3 LGKGSFGKVFLAELKGT--------NQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSL 51
Query: 731 --RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGM 787
HP + NL + E+L G L + H C + D R A ++ G+
Sbjct: 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGL 109
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAP 845
LH+ IV+RDLK N+L+D + ++K++DFG+ K N +K+ GTP+++AP
Sbjct: 110 QFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAP 165
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
E+L + N D +SFGV+L+E+ + P+ G + ++ FQ+ R++ P
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-----FQSIRMDNP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 4e-18
Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 684 IGLGSYGEVYHA-DWNGTEV-AVKKFLDQDFSGAALLE----FKREVKIMRRLRHPNVVL 737
IG GS+G VY A D +EV A+KK +SG E +EV+ +++LRHPN +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 738 FMGAVTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ G R ++ E+ L S +H+ Q E + +G+ LH+
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG--ALQGLAYLHSH--N 135
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE- 855
++HRD+K+ N+L+ + VK+ DFG + + + GTP WMAPEV+ +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVILAMDEGQY 191
Query: 856 --KCDVYSFGVILWELATLKLPWIGMNPMQVV 885
K DV+S G+ ELA K P MN M +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 5e-18
Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 21/197 (10%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIM-------RRLRHPN 734
IG GS+G+V A E AVK + A+L+ K E IM + ++HP
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKK-----AILKKKEEKHIMSERNVLLKNVKHPF 57
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V + L + +++ G LF L R C ++ + R A ++A + LH+
Sbjct: 58 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSLN 116
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
IV+RDLK N+L+D ++ ++DFGL + ++HN ++ + GTPE++APEVL +P
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQP 172
Query: 853 SNEKCDVYSFGVILWEL 869
+ D + G +L+E+
Sbjct: 173 YDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSG---AALLEFKREVKIMRRLRHPNV 735
E+IG G+YG VY A G VA+KK L+ + G A+ RE+ +++ L HPN+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI----REISLLKELNHPNI 60
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMAL-DVARGMNCLHTS 793
V + V L ++ EFL L + + P +D IK L + +G+ H+
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDP-PLIKSYLYQLLQGIAYCHSH 118
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTPE----WM-AP 845
++HRDLK NLL+D+ +K++DFGL+R + T+ T E W AP
Sbjct: 119 R--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--------THEVVTLWYRAP 168
Query: 846 EVLRNEPS-NEKCDVYSFGVILWELATLK 873
E+L + D++S G I E+ +
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 64/222 (28%), Positives = 112/222 (50%), Gaps = 18/222 (8%)
Query: 684 IGLGSYGEVYHADWNGTEV-----AVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G GS+G+V A+ GT A+KK L+ D ++E R V + HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVE--RRVLALA-WEHPFLT 59
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+L + E+L G L + + DE R A ++ G+ LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKG-- 116
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856
I++RDLK N+L+DK+ ++K++DFG+ + N + + GTP+++APE+L+ + NE
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNES 176
Query: 857 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
D +SFGV+L+E+ + P+ G + ++ F + + P
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGEDEDEL-----FDSILNDRP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKR----R 776
E +I++ L HP +V + N+ ++ + L G L + + + ++ +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE 108
Query: 777 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 836
I +AL+ I+HRD+K N+L+D+ +V ++DF ++ L++ ST
Sbjct: 109 IVLALEYLHSKG--------IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-ST 159
Query: 837 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
+GTP +MAPEVL + + D +S GV +E K P+
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 64/214 (29%), Positives = 109/214 (50%), Gaps = 20/214 (9%)
Query: 676 EDLVLGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMRR 729
+DL + E +G G+YG V H GT +AVK+ S E KR ++ I R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVP-TGTIMAVKRIRATVNSQ----EQKRLLMDLDISMR 55
Query: 730 LRH-PNVVLFMGAVTRPPNLSIITEFLPRG--SLFRILHRPHCQVDEKRRIKMALDVARG 786
P V F GA+ R ++ I E + ++ ++ + E K+A+ + +
Sbjct: 56 SVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 846
+ LH S +++HRD+K N+L+++N VK+ DFG+S ++ ++ AG +MAPE
Sbjct: 116 LEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPE 173
Query: 847 VLRNEPS----NEKCDVYSFGVILWELATLKLPW 876
+ E + + K DV+S G+ + ELAT + P+
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 70/227 (30%), Positives = 106/227 (46%), Gaps = 24/227 (10%)
Query: 675 WEDLVLGERIGLGSYGEVY--HADWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRL 730
WE + E IG G+YG+V+ NG++ AVK LD D E + E I++ L
Sbjct: 20 WE---IIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDE----EIEAEYNILKAL 71
Query: 731 R-HPNVVLFMGA-----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
HPNVV F G V L ++ E GS+ ++ + + +A +
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 785 RG-MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 843
M H +HRD+K N+L+ VK+ DFG+S +T L ++ GTP WM
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191
Query: 844 APEVLRNEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885
APEV+ E + +CDV+S G+ EL P ++PM+ +
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ RIG G++G V+ A G VA+KK + G + RE+K ++ +HP VV
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTST 794
+ ++ E++P L +L RP + K ++M L G+ +H +
Sbjct: 64 LLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLK---GVAYMHANG 119
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----W-MAPEVLR 849
I+HRDLK NLL+ + +K++DFGL+RL F + + + W APE+L
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARL----FSEEEPRLYSHQVATRWYRAPELLY 173
Query: 850 NEPS-NEKCDVYSFGVILWEL 869
+ D+++ G I EL
Sbjct: 174 GARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 25/199 (12%)
Query: 684 IGLGSYGEVYHADWNGT-EV----AVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G GS+G+V A+ GT E+ +KK L D + E KR + + + HP +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE-KRVLALAGK--HPFLT 59
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
L + E++ G L + R + DE R A ++ G+ LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERG-- 116
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEVLRN 850
I++RDLK N+L+D ++K++DFG+ + +TF GTP+++APE+L
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF------CGTPDYIAPEILSY 170
Query: 851 EPSNEKCDVYSFGVILWEL 869
+P D ++ GV+L+E+
Sbjct: 171 QPYGPAVDWWALGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 46/154 (29%), Positives = 84/154 (54%), Gaps = 3/154 (1%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E ++++ RHP + + L + E++ G LF L R +++ R A +
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-E 103
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 842
+ ++ LH+ IV+RDLK NL++DK+ ++K++DFGL + + K+ GTPE+
Sbjct: 104 IVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEY 161
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
+APEVL + D + GV+++E+ +LP+
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 66/249 (26%), Positives = 118/249 (47%), Gaps = 20/249 (8%)
Query: 677 DLVLGERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLR 731
+L + +G G +G V+ W + ++ V QD SG E + M L
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
H +V +G + +L ++T+ P GSL + + +D +R + + +A+GM L
Sbjct: 68 HAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTP-EWMAP 845
+VHR+L + N+L+ + V+++DFG++ L K + S TP +WMA
Sbjct: 127 EHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY----SEHKTPIKWMAL 180
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
E + + DV+S+GV +WE+ + P+ GM P +V + + RL P+
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTID 239
Query: 905 VARIIWECW 913
V ++ +CW
Sbjct: 240 VYMVMVKCW 248
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 67/239 (28%), Positives = 115/239 (48%), Gaps = 12/239 (5%)
Query: 684 IGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+G G++G VY W +G V + K L ++ S A E E +M + P V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 798
+G + + ++T+ +P G L + ++ + + + +A+GM+ L +V
Sbjct: 75 LG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LV 131
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLRNEPSNEK 856
HRDL + N+LV +VK++DFGL+RL + G P +WMA E + + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ 191
Query: 857 CDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
DV+S+GV +WEL T P+ G+ P + + + + RL P V I+ +CW
Sbjct: 192 SDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWM 249
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 40/215 (18%)
Query: 683 RIGLGSYGEVYHAD--WNGTEVAVKKFL----DQDFSGAALLEFKREVKIMRRLRHPNVV 736
+IG G++GEV+ A VA+KK L + F AL RE+KI++ L+H NVV
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL----REIKILQLLKHENVV 74
Query: 737 LFMGAVTRPPN--------LSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVAR 785
+ ++ EF L +L + + K+ +KM L+
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLN--- 130
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG------- 838
G+ +H + I+HRD+K+ N+L+ K+ +K++DFGL+R F SK++
Sbjct: 131 GLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR----AFSLSKNSKPNRYTNRV 184
Query: 839 -TPEWMAPEVLRNEPS-NEKCDVYSFGVILWELAT 871
T + PE+L E D++ G I+ E+ T
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
E+IG G+YG VY T VA+KK L+ + G RE+ +++ L+HPN+V
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI-REISLLKELQHPNIVCL 64
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMAL-DVARGMNCLHTSTPT 796
+ + L +I EFL L + L P Q + +K L + +G+ H+
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR-- 121
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NE 855
++HRDLK NLL+D +K++DFGL+R T + APEVL P +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 856 KCDVYSFGVILWELATLK 873
D++S G I E+AT K
Sbjct: 182 PVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-17
Identities = 50/181 (27%), Positives = 93/181 (51%), Gaps = 4/181 (2%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E ++++ RHP + + L + E+ G LF L R +++ R A +
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-E 103
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 842
+ ++ LH S +V+RDLK NL++DK+ ++K++DFGL + + K+ GTPE+
Sbjct: 104 IVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 162
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
+APEVL + D + GV+++E+ +LP+ + ++ + + R P+ L
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLS 220
Query: 903 P 903
P
Sbjct: 221 P 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 9e-17
Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 21/197 (10%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIM-------RRLRHPN 734
IG GS+G+V A AVK A+L+ K + IM + ++HP
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVL-----QKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V + L + +++ G LF L R + + R A ++A + LH+
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHSLN 116
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEP 852
I++RDLK N+L+D +V ++DFGL K S ++ GTPE++APEVLR +P
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 853 SNEKCDVYSFGVILWEL 869
+ D + G +L+E+
Sbjct: 173 YDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 9e-17
Identities = 50/181 (27%), Positives = 93/181 (51%), Gaps = 5/181 (2%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E ++++ RHP + A L + E+ G LF L R +E+ R A +
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-E 103
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 842
+ + LH+ +V+RD+K NL++DK+ ++K++DFGL + + + K+ GTPE+
Sbjct: 104 IVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
+APEVL + D + GV+++E+ +LP+ + ++ + + R P+ L
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLS 219
Query: 903 P 903
P
Sbjct: 220 P 220
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 9e-17
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 679 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
+ +++G G++G VY A G VA+KK + +S + REVK +R+L HPN+
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPNI 60
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
V L + E++ G+L++ + R E + + +G+ +H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN--TFLSSKSTAGTPEWM-APEV-LRN 850
HRDLK NLLV VK++DFGL+R + + ST W APE+ LR+
Sbjct: 120 --FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST----RWYRAPEILLRS 173
Query: 851 EPSNEKCDVYSFGVILWELATLK 873
+ D+++ G I+ EL TL+
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 9e-17
Identities = 61/193 (31%), Positives = 105/193 (54%), Gaps = 18/193 (9%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFK-REVKIMRRLRHPNVVLFMG 740
+G+G++G V A G VA+KK + + FS L + RE+K+++ LRH N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIM-KPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 741 AVTRP-PNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIK-MALDVARGMNCLHTSTPTI 797
P ++ +TE L L R+L RP EK+ I+ + RG+ +H++ +
Sbjct: 77 IFISPLEDIYFVTELLGT-DLHRLLTSRPL----EKQFIQYFLYQILRGLKYVHSAG--V 129
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV-LRNEPSNEK 856
VHRDLK N+L+++N ++K+ DFGL+R++ ST + APE+ L + + +
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR---YYRAPEIMLTWQKYDVE 186
Query: 857 CDVYSFGVILWEL 869
D++S G I E+
Sbjct: 187 VDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 1e-16
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 39/208 (18%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG G+YG V A G +VA+KK F Q F L RE+KI+RR +H N++
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL----REIKILRRFKHENIIGI 68
Query: 739 MGAVTRPPNLS------IITEFLPRGSLFRI-----LHRPHCQVDEKRRIKMALDVARGM 787
+ + RPP+ I+ E + L+++ L H Q + RG+
Sbjct: 69 L-DIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQY-------FLYQILRGL 119
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTPEW 842
+H++ ++HRDLK NLL++ N ++K+ DFGL+R+ H FL+ T +
Sbjct: 120 KYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT--EYVATRWY 175
Query: 843 MAPEVLRNEPSNEKC-DVYSFGVILWEL 869
APE++ N K D++S G IL E+
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 63/220 (28%), Positives = 110/220 (50%), Gaps = 18/220 (8%)
Query: 680 LGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 737
L E +G G+YG+VY T ++A K +D + E K E+ ++++ H N+
Sbjct: 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 738 FMGAVTR--PP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCL 790
+ GA + PP L ++ EF GS+ ++ ++ I + ++ RG+ L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
H ++HRD+K N+L+ +N VK+ DFG+S T + GTP WMAPEV+
Sbjct: 138 HAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 851 EPSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVV 885
+ + + + D++S G+ E+A P M+PM+ +
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-16
Identities = 44/121 (36%), Positives = 71/121 (58%), Gaps = 3/121 (2%)
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAGTPEWMAPEVL 848
H + ++HRD+KS N+L+ N VK+ DFG S++ T ++ GTP ++APE+
Sbjct: 158 HVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW 217
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
R +P ++K D++S GV+L+EL TLK P+ G N M+ V R +P + P + I
Sbjct: 218 RRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAGRYDPLPPSISPEMQEI 276
Query: 909 I 909
+
Sbjct: 277 V 277
|
Length = 496 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 70/238 (29%), Positives = 112/238 (47%), Gaps = 41/238 (17%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLE-------FKREVKIMRRLRH-PNV 735
+G G+YG+V+ G A K + + A +++ + E +++ +R P +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKR----RIKMALDVARGMNCL 790
V A L +I +++ G LF L R H E R I +ALD L
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD------HL 121
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK-----STAGTPEWMAP 845
H I++RD+K N+L+D +V ++DFGLS+ FL+ + S GT E+MAP
Sbjct: 122 HQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKE----FLAEEEERAYSFCGTIEYMAP 175
Query: 846 EVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
EV+R ++ D +S GV+ +EL T G +P V G QN + EI + +
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLT------GASPFTVDGE---QNSQSEISRRI 224
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 684 IGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGA--ALLEFKREVKIMRRLRHPNVVLFMG 740
+G G +GEV T ++ K + + A + F+ E I+ P +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTSTPTIVH 799
A NL ++ E+ P G L +L+R Q DE + +A ++ ++ +H VH
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQMG--YVH 125
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK-- 856
RD+K N+L+D+ ++K++DFG + RL N ++SK GTP+++APEVL + K
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 857 ----CDVYSFGVILWEL 869
CD +S GVI +E+
Sbjct: 186 YGVECDWWSLGVIAYEM 202
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 61/194 (31%), Positives = 91/194 (46%), Gaps = 14/194 (7%)
Query: 684 IGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGA-----ALLEFKREVKIMRRLRHPNVVL 737
+G G +G+V A++ T E+ K L + A +L+ KR + RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
++ + E+ G L +H E R + A V G+ LH + I
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHENK--I 122
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-FLSSKST-AGTPEWMAPEVLRNEPSNE 855
V+RDLK NLL+D VK++DFGL K F ST GTPE++APEVL
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180
Query: 856 KCDVYSFGVILWEL 869
D + GV+++E+
Sbjct: 181 AVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-16
Identities = 62/239 (25%), Positives = 108/239 (45%), Gaps = 50/239 (20%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKF----------LDQDFSGAA 716
+ ++ +ED +G GS+G V A + + VA+K+F +D FS
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS--- 80
Query: 717 LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR- 775
E KI+ + HP V G+ L ++ EF+ G F L R KR
Sbjct: 81 ------ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR------NKRF 128
Query: 776 ----------RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825
+I + + + +N IV+RDLK NLL+DK+ +K++DFG +++
Sbjct: 129 PNDVGCFYAAQIVLIFEYLQSLN--------IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
Query: 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884
+ + GTPE++APE+L N + D ++ G+ ++E+ P+ P+ +
Sbjct: 181 VDT---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236
|
Length = 340 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 61/197 (30%), Positives = 90/197 (45%), Gaps = 21/197 (10%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFLD-------QDFSGAALLEFKREVKIMRRLRHPN 734
+G G +GEV G A KK LD + A E KI+ ++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALN-----EKKILEKVSSRF 54
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+V A +L ++ + G L + I + E R I A + G+ LH
Sbjct: 55 IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR 114
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
IV+RDLK N+L+D + NV++SD GL+ LK K AGTP +MAPEVL+ E
Sbjct: 115 R--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEV 170
Query: 853 SNEKCDVYSFGVILWEL 869
+ D ++ G L+E+
Sbjct: 171 YDFSVDWFALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 676 EDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+D+ E +G G+ G VY A + K + D + + E++I+ + P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI------KMALDVARGMN 788
++ F GA +SI TEF+ GSL D R+I ++A+ V +G+
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLT 109
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 848
L + I+HRD+K N+LV+ VK+ DFG+S N+ +K+ GT +MAPE +
Sbjct: 110 YLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERI 165
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPW 876
E DV+S G+ ELA + P+
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 9e-16
Identities = 61/239 (25%), Positives = 103/239 (43%), Gaps = 39/239 (16%)
Query: 680 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAALLEFK------------REVK 725
G +G G+YG+V A D G VA+KK + S + + RE+K
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 726 IMRRLRHPNVVLFMGAV---TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
IM ++H N+ MG V ++++ + + L +++ R + + + + L
Sbjct: 73 IMNEIKHENI---MGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-LQ 127
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG---- 838
+ G+N LH +HRDL N+ ++ K++DFGL+R S +
Sbjct: 128 ILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 839 -----TPE----WM-APEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 886
T + W APE+L E + D++S G I EL T K + G N + +G
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244
|
Length = 335 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 61/193 (31%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 683 RIGLGSYGEVYHA-DWNGTE-VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
RIG G+YG VY A D E VA+KK +D + G + RE+ ++ LRHPN+V
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REITLLLNLRHPNIVELK 72
Query: 740 GAVT--RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
V ++ ++ E+ + L +L E + + L + RG+ LH + I
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--I 129
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEK 856
+HRDLK NLL+ +K++DFGL+R T + APE+L
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTA 189
Query: 857 CDVYSFGVILWEL 869
D+++ G IL EL
Sbjct: 190 IDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 69/256 (26%), Positives = 117/256 (45%), Gaps = 29/256 (11%)
Query: 682 ERIGLGSYGEVY----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ IG G +G+V ++ + +V VK+ L S ++F E + R L+H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKE-LRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV------DEKRRIKMALDVARGMNCLH 791
+G T ++ EF P G L L C+ D +MA ++A G+ LH
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRS--CRKAELMTPDPTTLQRMACEIALGL--LH 115
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLR 849
+H DL N L+ + VK+ D+GLS K+ + +++ W+APE++
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 850 NEPSN-------EKCDVYSFGVILWELATL-KLPWIGMNPMQVVG-AVGFQNRRLEIPKE 900
N ++ +V+S GV +WEL L P+ ++ QV+ V Q +L P+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235
Query: 901 LDPLVAR---IIWECW 913
PL R ++ CW
Sbjct: 236 KLPLSDRWYEVMQFCW 251
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 40/228 (17%)
Query: 684 IGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFK----REVKIMRRLRHPNVVL 737
+G G+YG+V A T +VA+KK L + F A RE+++++ + H NV+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKK-LSRPFQSA---IHAKRTYRELRLLKHMDHENVIG 78
Query: 738 FMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNC 789
+ T +L ++T + L I+ CQ D+ + + + RG+
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVK---CQKLSDDHIQF-LVYQILRGLKY 133
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEV 847
+H++ I+HRDLK N+ V+++ +K+ DFGL+R + T T + APE+
Sbjct: 134 IHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEI 186
Query: 848 LRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGA 887
+ N N+ D++S G I+ EL T K + G + M +VG
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-15
Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 31/245 (12%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFK-----REVK--------IMRRL 730
IG GS+G+V A K+ LD +L+ K +E K +++ +
Sbjct: 3 IGKGSFGKVLLA---------KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV 53
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
+HP +V + L + +F+ G LF L R + + R A ++A + L
Sbjct: 54 KHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYL 112
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
H+ IV+RDLK N+L+D +V ++DFGL + ++ + GTPE++APEV+R
Sbjct: 113 HSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910
+P + D + G +L+E+ G+ P + L P L P + W
Sbjct: 171 QPYDNTVDWWCLGAVLYEML------YGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAW 224
Query: 911 ECWQT 915
+
Sbjct: 225 SILEE 229
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 45/155 (29%), Positives = 81/155 (52%), Gaps = 5/155 (3%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMAL 781
E ++++ RHP + + L + E+ G LF H +V E R
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA 102
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 841
++ + LH+ +V+RDLK NL++DK+ ++K++DFGL + + + K+ GTPE
Sbjct: 103 EIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
++APEVL + D + GV+++E+ +LP+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-15
Identities = 82/321 (25%), Positives = 136/321 (42%), Gaps = 81/321 (25%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREV 724
E P + L LG+ +G G++G+V AD G + VAVK L + + + E+
Sbjct: 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMSEL 61
Query: 725 KIMRRL-RHPNVVLFMGAVTRP--PNLSII----------------TEFLP---RGSLFR 762
KI+ + H NVV +GA T+P P + I+ EF+P + + FR
Sbjct: 62 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFR 121
Query: 763 -------------------------------ILHRPHCQVDEKRR--------------- 776
+ + V+E+
Sbjct: 122 QGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDL 181
Query: 777 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKS 835
I + VA+GM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K
Sbjct: 182 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239
Query: 836 TAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNR 893
A P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+ + +
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 299
Query: 894 RLEIPKELDPLVARIIWECWQ 914
R+ P P + + + +CW
Sbjct: 300 RMRAPDYTTPEMYQTMLDCWH 320
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-15
Identities = 58/187 (31%), Positives = 81/187 (43%), Gaps = 19/187 (10%)
Query: 699 GTEVAVKKFLDQDFSGAALL-EFKREVKIMRRLRHPNVV-LFMGAVTRPPNLSIITEFLP 756
G EVA+K F+RE + RL HPN+V L P L + E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 757 RGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DK 811
+L +L + R + LD + C H IVHRDLK N++V
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLD---ALACAHNQG--IVHRDLKPQNIMVSQTGV 117
Query: 812 NWNVKVSDFGLSRLKHNTFLSSKSTA-------GTPEWMAPEVLRNEPSNEKCDVYSFGV 864
+ KV DFG+ L + +T GTP + APE LR EP D+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 865 ILWELAT 871
I E T
Sbjct: 178 IFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-15
Identities = 65/253 (25%), Positives = 126/253 (49%), Gaps = 21/253 (8%)
Query: 638 GTNLKLRDLESPS----SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVY 693
G N + DL+ P+ ++D+ ++ ++I + + ++ ED + + IG G++GEV
Sbjct: 2 GLNSLVLDLDFPALRKNKNIDNFLNRYEKIVRK-IRKLQMKAEDYDVVKVIGRGAFGEVQ 60
Query: 694 HADWNGTE-VAVKKFLDQ----DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748
++ V K L + S +A F E IM P VV A L
Sbjct: 61 LVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFCAFQDDKYL 118
Query: 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 808
++ E++P G L ++ + V EK +V ++ +H+ ++HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNML 174
Query: 809 VDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN----EKCDVYSFG 863
+DK+ ++K++DFG ++ + + GTP++++PEVL+++ + +CD +S G
Sbjct: 175 LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 864 VILWELATLKLPW 876
V L+E+ P+
Sbjct: 235 VFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 49/146 (33%), Positives = 78/146 (53%), Gaps = 15/146 (10%)
Query: 777 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKS 835
I + VARGM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K
Sbjct: 176 ISYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 233
Query: 836 TAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR 893
A P +WMAPE + ++ + DV+SFGV+LWE+ +L P+ G+ + F R
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-----EFCRR 288
Query: 894 -----RLEIPKELDPLVARIIWECWQ 914
R+ P+ P + I+ +CW
Sbjct: 289 LKEGTRMRAPEYATPEIYSIMLDCWH 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 682 ERIGLGSYGEVY---HADWNGTEVAVKKFL----DQDFSGAALLEFKREVKIMRRLRHPN 734
+IG GSYG V+ + + G VA+KKF+ D AL RE++++++L+HPN
Sbjct: 7 SKIGEGSYGVVFKCRNRE-TGQIVAIKKFVESEDDPVIKKIAL----REIRMLKQLKHPN 61
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V + R L ++ E+ L + P V E K+ + +N H
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS- 853
+HRD+K N+L+ K +K+ DFG +R+ T + APE+L +
Sbjct: 121 --CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 854 NEKCDVYSFGVILWELATLKLPWIG 878
DV++ G + EL T + W G
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 61/195 (31%), Positives = 96/195 (49%), Gaps = 16/195 (8%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G G+YG V T+ VA+KKF D + + RE+K++R L+ N+V A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 801
R L ++ E++ + L + P+ EK R + + ++ H + IVHRD
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKND--IVHRD 125
Query: 802 LKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA------PEVLRNEPSNE 855
+K NLL+ N +K+ DFG +R LS S A E++A PE+L P +
Sbjct: 126 IKPENLLISHNDVLKLCDFGFAR-----NLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 856 KCDVYSFGVILWELA 870
D++S G IL EL+
Sbjct: 181 AVDMWSVGCILGELS 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-- 731
DL IG G+ G+VY + G +AVK+ E KR I+ L
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE----ENKR---ILMDLDVV 67
Query: 732 ---H--PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
H P +V G ++ I E L L ++L R + E KM + + +
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKA 126
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKS---TAGTPEW 842
++ L ++HRD+K N+L+D + NVK+ DFG+S RL + SK+ +AG +
Sbjct: 127 LHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL-----VDSKAKTRSAGCAAY 180
Query: 843 MAPEVLRNEPSNEK----CDVYSFGVILWELATLKLPWIGMN 880
MAPE + N K DV+S G+ L ELAT + P+
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 69/260 (26%), Positives = 111/260 (42%), Gaps = 46/260 (17%)
Query: 684 IGLGSYGEV---YHADWNGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFM 739
IG G++GEV D G A+KK + + + E I+ +P VV
Sbjct: 9 IGRGAFGEVRLVQKKD-TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
+ L +I E+LP G + +L + +E+ R +A + ++ +H +H
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIHKLG--YIH 124
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLS-------------RLKHN----------TFLSSK-- 834
RD+K NLL+D ++K+SDFGL L H +SSK
Sbjct: 125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 835 -------------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 881
ST GTP+++APEV N++CD +S GVI++E+ P+ NP
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244
Query: 882 MQVVGAVGFQNRRLEIPKEL 901
+ + L+ P E+
Sbjct: 245 QETYRKIINWKETLQFPDEV 264
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 61/197 (30%), Positives = 92/197 (46%), Gaps = 14/197 (7%)
Query: 684 IGLGSYGEVYHA---DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVL 737
IG G+YG+V+ A G VA+K+ Q L REV ++R L HPNVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 738 FMGAVT-----RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
T R L+++ E + + + P V + M + RG++ LH+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+VHRDLK N+LV + +K++DFGL+R+ + S T + APEVL
Sbjct: 129 HR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SVVVTLWYRAPEVLLQSS 185
Query: 853 SNEKCDVYSFGVILWEL 869
D++S G I E+
Sbjct: 186 YATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 48/138 (34%), Positives = 77/138 (55%), Gaps = 5/138 (3%)
Query: 780 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG 838
+ VARGM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K +A
Sbjct: 180 SFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 839 TP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLE 896
P +WMAPE + ++ + DV+SFGV+LWE+ +L P+ G+ + R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297
Query: 897 IPKELDPLVARIIWECWQ 914
P+ P + RI+ CWQ
Sbjct: 298 APENATPEIYRIMLACWQ 315
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-14
Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 39/222 (17%)
Query: 684 IGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG G++G V W +G VA+KK + + + RE+K++ +H NV
Sbjct: 8 IGYGAFGVV----WSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV-- 61
Query: 738 FMGA--VTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMN 788
+ A + +PP++ ++TE + + L +I+ P + +K+ L + RG+
Sbjct: 62 -LSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSD--HVKVFLYQILRGLK 117
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEW 842
LH++ I+HRD+K NLLV+ N +K+ DFGL+R+ KH T T +
Sbjct: 118 YLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT-----QEVVTQYY 170
Query: 843 MAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ 883
APE+L D++S G I EL ++ + +P+Q
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-14
Identities = 68/237 (28%), Positives = 100/237 (42%), Gaps = 59/237 (24%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNVVLFM 739
IG G GEVY + VA+KK + +D S LL+ F RE KI L HP +V
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKK-IREDLSENPLLKKRFLREAKIAADLIHPGIV--- 65
Query: 740 GAVTRPPNLSIITEFLP--------RG----SLFR------ILHRPHCQVDEKRRIKMAL 781
P SI ++ P G SL + L + EK + L
Sbjct: 66 ------PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKEL---AEKTSVGAFL 116
Query: 782 ----DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH---------- 827
+ + +H+ ++HRDLK N+L+ V + D+G + K
Sbjct: 117 SIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 828 ---NTFLSSKST-----AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
S T GTP++MAPE L P++E D+Y+ GVIL+++ TL P+
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 45/214 (21%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNVV 736
E IG G+YG V A +G +VA+KK + KR E+KI+R +H N++
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPH---AFDVPTLAKRTLRELKILRHFKHDNII 67
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRI-----------LHRP-HCQVD-EKRRIKMAL-D 782
+I P G+ F+ LH H + I+ L
Sbjct: 68 ------------AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKST 836
+ RG+ +H++ ++HRDLK NLLV+++ +++ DFG++R +H F++
Sbjct: 116 LLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 837 AGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 869
T + APE+L + P D++S G I E+
Sbjct: 174 --TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 60/230 (26%), Positives = 115/230 (50%), Gaps = 25/230 (10%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G GS+G+V A+ GT+ + K + QD + KR + + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK--PPFLTQ 65
Query: 738 FMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQV---DEKRRIKMALDVARGMNCLHTS 793
L + E++ G L + I QV E + A ++A G+ LH+
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNE 851
I++RDLK N+++D ++K++DFG+ K N F ++++ GTP+++APE++ +
Sbjct: 121 G--IIYRDLKLDNVMLDAEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEIIAYQ 176
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
P + D ++FGV+L+E+ + P+ G + ++ ++ N + PK L
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSL 224
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-14
Identities = 53/154 (34%), Positives = 81/154 (52%), Gaps = 12/154 (7%)
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTP 840
VA GM L ++ VHRDL + N+L+ + VK+ DFGL+R ++ + ++S ST
Sbjct: 248 VANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL---KLPWIGMNPMQVVGAVGFQNRRLEI 897
+WMAPE + N DV+SFG++LWE+ TL P + MN Q A+ + R+
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-QFYNAIK-RGYRMAK 363
Query: 898 PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931
P + I+ +CW+ IR +QL H
Sbjct: 364 PAHASDEIYEIMQKCWE---EKFEIRPDFSQLVH 394
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 60/242 (24%), Positives = 118/242 (48%), Gaps = 25/242 (10%)
Query: 644 RDLESPS----SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVY---HAD 696
D + P+ ++D+ S+ ++ + + + + ED + + IG G++GEV H
Sbjct: 8 YDCDIPALRKNKNIDNFLSRYEKAAEK-ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKS 66
Query: 697 WNGTEVAVKKFLDQD----FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752
+V K L + S +A F E IM +V A L ++
Sbjct: 67 SK--QVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122
Query: 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812
E++P G L ++ + + EK +V ++ +H+ +HRD+K N+L+DK+
Sbjct: 123 EYMPGGDLVNLM--SNYDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS 178
Query: 813 WNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN----EKCDVYSFGVILW 867
++K++DFG ++ N + + GTP++++PEVL+++ + +CD +S GV L+
Sbjct: 179 GHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 868 EL 869
E+
Sbjct: 239 EM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 8e-14
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPN 734
E VL E +G G+YG VY T V + K + + + + E+ I+ + P
Sbjct: 2 EIEVLDE-LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHT 792
+V F GA + + E++ GSL ++ + E ++ V +G+ L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-SKSTAGTPEWMAPEVLRNE 851
I+HRD+K N+LV+ N VK+ DFG+S N S +K+ G +MAPE +++
Sbjct: 121 EH-NIIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 852 PSNE------KCDVYSFGVILWELATLKLPW 876
N+ + DV+S G+ + E+A + P+
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 48/154 (31%), Positives = 82/154 (53%), Gaps = 4/154 (2%)
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
RE+K++ P +V F GA +SI E + GSL ++L + ++ E K+++
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPENILGKISI 106
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 841
V RG+ L I+HRD+K N+LV+ +K+ DFG+S ++ + S GT
Sbjct: 107 AVLRGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRS 163
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 875
+M+PE L+ + D++S G+ L E+A + P
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 16/219 (7%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
++G+ + T VAVKK S L ++E+ R+L+HPN++
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL---DVARGMNCLHTS 793
++ + L +++ + GS L + H + + +A DV ++ +H+
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSC-EDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK 120
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDF--GLSRLKHN-----TFLSSKSTAGTPEWMAPE 846
+HR +K+ ++L+ + V +S +S +KH KS+ W++PE
Sbjct: 121 --GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 847 VLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQ 883
VL+ NEK D+YS G+ ELA +P+ M Q
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 36/105 (34%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 772 DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831
E R + G+ LH I++RDLK N+L+D + NV++SD GL+ +
Sbjct: 95 PEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152
Query: 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
+K AGTP +MAPE+L+ E + D ++ GV L+E+ + P+
Sbjct: 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-13
Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 38/190 (20%)
Query: 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 806
NL +I EFLP G + +L + +E+ + +A + ++ +H +HRD+K N
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLG--FIHRDIKPDN 131
Query: 807 LLVDKNWNVKVSDFGL-------------SRLKHN-----TF--LSSK------------ 834
LL+D +VK+SDFGL L H+ TF ++SK
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 835 ---STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 891
ST GTP+++APEV N+ CD +S GVI++E+ P+ P + V
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNW 251
Query: 892 NRRLEIPKEL 901
L P E+
Sbjct: 252 KETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL-------EFKREVKIMRRLRHPNVV 736
+G G YG+V+ K F + A ++ K E I+ ++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK-----RRIKMALDVARGMNCLH 791
+ A L +I E+L G LF L R +++ I +AL+ H
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE--------H 115
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLR 849
I++RDLK N+L+D +VK++DFGL K + + + GT E+MAPE+L
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMN 880
+ D +S G +++++ T P+ N
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 57/197 (28%), Positives = 89/197 (45%), Gaps = 24/197 (12%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
E+IG G+YG VY A G VA+KK LD + G RE+ +++ L HPN+V
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKL 64
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL------DVARGMNCLHT 792
+ + L ++ EFL + + I + L + +G+ H+
Sbjct: 65 LDVIHTENKLYLVFEFLHQDL------KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
++HRDLK NLL++ +K++DFGL+R + T + APE+L
Sbjct: 119 H--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 174
Query: 853 SNEKCDVYSFGVILWEL 869
C YS V +W L
Sbjct: 175 ----CKYYSTAVDIWSL 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 683 RIGLGSYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVV--- 736
RI G+YG VY A T VA+KK ++++ G + RE+ I+ +L+HPN+V
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-REINILLKLQHPNIVTVK 70
Query: 737 -LFMGAVTRPPNLSIITEFLPRG--SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+ +G + + ++ E++ SL + +P Q + K + L G+ LH +
Sbjct: 71 EVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL---SGVAHLHDN 125
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----LKHNTFLSSKSTAGTPEWMAPEVL 848
I+HRDLK+ NLL++ +K+ DFGL+R LK T T + APE+L
Sbjct: 126 W--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT-----QLVVTLWYRAPELL 178
Query: 849 RNEPS-NEKCDVYSFGVILWELATLK 873
+ D++S G I EL T K
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 3/149 (2%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E ++ ++ P +V + P L ++ F+ G LF L R D R +
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAE 101
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 842
+ + LH +++RDLK N+L+D ++ + DFGL +L + + GTPE+
Sbjct: 102 LLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELAT 871
+APE+L + D ++ GV+L+E+ T
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-13
Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 38/190 (20%)
Query: 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 806
NL +I EFLP G + +L + +E + +A + ++ +H +HRD+K N
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQLG--FIHRDIKPDN 131
Query: 807 LLVDKNWNVKVSDFGL-------------SRLKHN-----TF--LSSK------------ 834
LL+D +VK+SDFGL L HN +F ++SK
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 835 ---STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 891
ST GTP+++APEV N+ CD +S GVI++E+ P+ P + V
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNW 251
Query: 892 NRRLEIPKEL 901
L P E+
Sbjct: 252 KETLVFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 54/209 (25%), Positives = 108/209 (51%), Gaps = 27/209 (12%)
Query: 684 IGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742
+G GS+G+V A+ GT E+ K L +D + + E ++ + V+ G
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKD---VVIQDDDVECTMVEK----RVLALSG-- 58
Query: 743 TRPPNLS-------------IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
+PP L+ + E++ G L + + + E + A ++A G+
Sbjct: 59 -KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFF 116
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
LH+ I++RDLK N+++D ++K++DFG+ + +++K+ GTP+++APE++
Sbjct: 117 LHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIG 878
+P + D ++FGV+L+E+ + P+ G
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 683 RIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFM 739
+IG G++ EV A G A+K + + F + RE++ +RRL HPN++ +
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKC-MKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 740 GAVTRPPN--LSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ L+++ E L +L+ I R + EKR + + ++ +H +
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP--------EWM-APEV 847
I HRD+K N+L+ + +K++DFG S + P W APE
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFG----------SCRGIYSKPPYTEYISTRWYRAPEC 169
Query: 848 LRNEPS-NEKCDVYSFGVILWELATLK 873
L + K D+++ G + +E+ +L
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-13
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 682 ERIGLGSYGEVYH--ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E++G GSY VY + NG VA+K Q+ G RE +++ L+H N+VL
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHANIVLLH 69
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-------RIKMAL-DVARGMNCLH 791
+ L+++ E++ H CQ +K +K+ L + RG++ +H
Sbjct: 70 DIIHTKETLTLVFEYV---------HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
I+HRDLK NLL+ +K++DFGL+R K + + T + P+VL
Sbjct: 121 QRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGS 178
Query: 852 PSNEKC-DVYSFGVILWELATLKLPWIGMNPMQ 883
C D++ G I E+ + GM +Q
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 42/219 (19%)
Query: 684 IGLGSYGEVYHADW----NGTEVAVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPN 734
IG G+YG VY A +G E A+KKF S +A RE+ ++R L+H N
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC----REIALLRELKHEN 63
Query: 735 VVLFMGAVTRPPNLSI-----ITEFLPRGSLFRIL--HRPH--CQVDE---KRRIKMALD 782
VV + + S+ E L++I+ HR + K + L+
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHN---TFLSSKS 835
G++ LH++ ++HRDLK N+LV + VK+ D GL+RL +
Sbjct: 120 ---GVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 836 TAGTPEWMAPEVLRNEPSNEKC-DVYSFGVILWELATLK 873
T + APE+L K D+++ G I EL TL+
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 61/225 (27%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 684 IGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRR------LRHPNVV 736
+G GS+G+V A+ G E K L +D L++ E ++ + +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKD---VVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 737 LFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+L + EFL G L F I + + D R A ++ G+ LH+
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPS 853
I++RDLK N+++D++ ++K++DFG+ K N F ++++ GTP+++APE+L+
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 854 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
D +SFGV+L+E+ + P+ G + ++ F++ R++ P
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-----FESIRVDTP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 31/202 (15%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG G+ G V A G VA+KK F + + A RE+ +M+ + H N++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY----RELVLMKLVNHKNIIG 79
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR----------GM 787
+ T +L EF + ++ CQV I+M LD R G+
Sbjct: 80 LLNVFTPQKSLE---EFQDVYLVMELMDANLCQV-----IQMDLDHERMSYLLYQMLCGI 131
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
LH++ I+HRDLK N++V + +K+ DFGL+R +F+ + T + APEV
Sbjct: 132 KHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEV 188
Query: 848 LRNEPSNEKCDVYSFGVILWEL 869
+ E D++S G I+ E+
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 36/210 (17%)
Query: 684 IGLGSYGEVYHADWNGT--EVAVKKF---LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG G+YG V A + T +VA+KK D L RE+K++R L H NV+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL---REIKLLRHLDHENVIA- 68
Query: 739 MGAVTRPPN------LSIITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDVARG 786
+ + PP+ + I+ E L L +I+ HCQ + RG
Sbjct: 69 IKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQY-------FLYQLLRG 120
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 846
+ +H++ ++HRDLK NLL++ N ++K+ DFGL+R T + APE
Sbjct: 121 LKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 847 VLRNEPSNE---KCDVYSFGVILWELATLK 873
+L N +E DV+S G I EL K
Sbjct: 179 LLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
IG G+YG+VY A G VA+KK LD + G + RE+KI+R+L H N+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI-REIKILRQLNHRNIVNLKE 73
Query: 741 AVT----------RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
VT ++ E++ L +L E + G+N
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYC 132
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-APEVLR 849
H +HRD+K N+L++ +K++DFGL+RL ++ + W PE+L
Sbjct: 133 HKK--NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLL 190
Query: 850 NE----PSNEKCDVYSFGVILWELATLK 873
E P+ DV+S G IL EL T K
Sbjct: 191 GEERYGPA---IDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 50/174 (28%), Positives = 90/174 (51%), Gaps = 4/174 (2%)
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761
+ +K + + A + RE++++ P +V F GA +SI E + GSL
Sbjct: 32 IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 91
Query: 762 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
++L ++ E+ K+++ V RG+ L I+HRD+K N+LV+ +K+ DFG
Sbjct: 92 QVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFG 149
Query: 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 875
+S ++ + S GT +M+PE L+ + + D++S G+ L ELA + P
Sbjct: 150 VSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 64/253 (25%), Positives = 122/253 (48%), Gaps = 21/253 (8%)
Query: 638 GTNLKLRDLESPS----SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVY 693
G + + DL+ P+ ++D+ ++ + + + + ED + + IG G++GEV
Sbjct: 2 GLDALVYDLDFPALRKNKNIDNFLNRYKDTINK-IRDLRMKAEDYEVVKVIGRGAFGEVQ 60
Query: 694 HADWNGT-EVAVKKFLDQ----DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748
T +V K L + S +A F E IM P VV A L
Sbjct: 61 LVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFYAFQDDRYL 118
Query: 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 808
++ E++P G L ++ + V EK +V ++ +H+ +HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNML 174
Query: 809 VDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN----EKCDVYSFG 863
+DK+ ++K++DFG ++ + + GTP++++PEVL+++ + +CD +S G
Sbjct: 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 864 VILWELATLKLPW 876
V L+E+ P+
Sbjct: 235 VFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 684 IGLGSYGEV--YHADWNGTEVAVKKFLDQDF----SGA--ALLEFKREVKIMRRLRHPNV 735
+G G +GEV G A KK LD+ SG ALLE +I+ ++ P +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLE----KEILEKVNSPFI 55
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
V A +L ++ + G L + I + ++ +R I + + G+ LH +
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI--LHLHS 113
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
IV+RD+K N+L+D N ++SD GL+ LK ++ + AGT +MAPE+L+ EP
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR--AGTNGYMAPEILKEEPY 171
Query: 854 NEKCDVYSFGVILWELATLKLPW 876
+ D ++ G ++E+ + P+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 9e-13
Identities = 52/192 (27%), Positives = 93/192 (48%), Gaps = 11/192 (5%)
Query: 684 IGLGSYGEVYHADWNGT-EVAVKKFLD-----QDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G GS+G+V A+ GT EV K L QD + KR + + + HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTA 60
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
L + E++ G L + R + DE R A +V + LH +
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHG--V 117
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 857
++RDLK N+L+D + K++DFG+ + +++ + GTP+++APE+L+
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
Query: 858 DVYSFGVILWEL 869
D ++ GV+++E+
Sbjct: 178 DWWALGVLMYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 18/179 (10%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 781
E +I+ ++ VV A L ++ + G L F I H +E R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 841
++ G+ LH IV+RDLK N+L+D + ++++SD GL+ + + K GT
Sbjct: 110 EICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVG 166
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
+MAPEV++NE D ++ G +L+E+ + G FQ R+ +I +E
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEM--------------IAGQSPFQQRKKKIKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 684 IGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLF 738
IG+G+YG VY A +G VA+K Q L REV +++RL HPN+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 739 MGAVT-----RPPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCL 790
M R ++++ E + + L L + P + + + RG++ L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF--LRGLDFL 124
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
H + IVHRDLK N+LV VK++DFGL+R+ ++ ++ T + APEVL
Sbjct: 125 HANC--IVHRDLKPENILVTSGGQVKLADFGLARI-YSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 851 EPSNEKCDVYSFGVILWEL 869
D++S G I E+
Sbjct: 182 STYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 48/141 (34%), Positives = 77/141 (54%), Gaps = 15/141 (10%)
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTP 840
VARGM L ++ VHRDL + N+L+ + VK+ DFGL+R + + ++S ST
Sbjct: 246 VARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR-----R 894
+WMAPE + + DV+S+G++LWE+ +L P+ GM +V + F N+ R
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM----IVDST-FYNKIKSGYR 358
Query: 895 LEIPKELDPLVARIIWECWQT 915
+ P V I+ +CW +
Sbjct: 359 MAKPDHATQEVYDIMVKCWNS 379
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 52/193 (26%), Positives = 99/193 (51%), Gaps = 5/193 (2%)
Query: 684 IGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742
+G G+ G V+ + + +K + + A + RE++++ P +V F GA
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 743 TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 802
+SI E + GSL ++L + ++ E+ K+++ V +G+ L I+HRD+
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH-KIMHRDV 130
Query: 803 KSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSF 862
K N+LV+ +K+ DFG+S ++ + S GT +M+PE L+ + + D++S
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188
Query: 863 GVILWELATLKLP 875
G+ L E+A + P
Sbjct: 189 GLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 63/238 (26%), Positives = 111/238 (46%), Gaps = 16/238 (6%)
Query: 684 IGLGSYGEVYHADWNGTE-----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG GSY +V TE VKK L D ++ ++ V + HP +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVGL 61
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 798
L + E++ G L + R +E R A +++ +N LH I+
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERG--II 118
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 858
+RDLK N+L+D ++K++D+G+ + ++ + GTP ++APE+LR E D
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 859 VYSFGVILWELATLKLPW--IGM--NPMQVVGAVGFQ---NRRLEIPKELDPLVARII 909
++ GV+++E+ + P+ +G NP Q FQ +++ IP+ L A ++
Sbjct: 179 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 29/205 (14%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G+YG V A G +VA+KK F + F+ A RE+++++ ++H NV+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMKHENVIG 78
Query: 738 FMGAVTRPPNLSIITEF---LP-----RGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
+ T +L +F +P G L + H ++ E R + + +G+
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKY 133
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
+H + I+HRDLK NL V+++ +K+ DFGL+R T T + APEV+
Sbjct: 134 IHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAPEVIL 188
Query: 850 N-EPSNEKCDVYSFGVILWELATLK 873
N + D++S G I+ E+ T K
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 14/196 (7%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSG---AALLEFKREVKIMRRLRHPNV 735
E+IG G+YG V+ A VA+K+ LD D G +AL RE+ +++ L+H N+
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKELKHKNI 61
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
V + L+++ E+ + L + + +D + + +G+ H+
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN- 119
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-SN 854
++HRDLK NLL++KN +K++DFGL+R + T + P+VL +
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 178
Query: 855 EKCDVYSFGVILWELA 870
D++S G I ELA
Sbjct: 179 TSIDMWSAGCIFAELA 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 5e-12
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 22/199 (11%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREV-------KIMRR---LR 731
IG G++G+VY T A+K + K+EV I+ R
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
P +V + +L ++T+++ G LF L + + E R ++ + LH
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLH 113
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
IV+RDLK N+L+D ++ + DFGLS+ ++ + GT E++APEVL +E
Sbjct: 114 KYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 852 PSNEK-CDVYSFGVILWEL 869
K D +S GV+++E+
Sbjct: 172 KGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
E++G G+Y VY G VA+K+ LD + G RE+ +M+ L+H N+V
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAI-REISLMKELKHENIVRL 63
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ L ++ E++ L + + H +D + +G+ H +
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-- 120
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTPEWM-APEVLRNEP 852
++HRDLK NLL++K +K++DFGL+R + NTF + T W AP+VL
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTL----WYRAPDVLLGSR 176
Query: 853 S-NEKCDVYSFGVILWELAT 871
+ + D++S G I+ E+ T
Sbjct: 177 TYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 16/230 (6%)
Query: 684 IGLGSYGEVYHADWNGTEVA-----VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG GSY +V + T +KK L D ++ ++ V HP +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHV-FETASNHPFLVGL 61
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 798
L + EF+ G L + R +E R A +++ +N LH I+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHERG--II 118
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 858
+RDLK N+L+D ++K++D+G+ + ++ + GTP ++APE+LR E D
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 859 VYSFGVILWELATLKLPW--IGM--NPMQVVGAVGFQ---NRRLEIPKEL 901
++ GV+++E+ + P+ +GM NP Q FQ +++ IP+ L
Sbjct: 179 WWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 35/212 (16%)
Query: 682 ERIGLGSYGEVY----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ IG G +G+V + D V VK+ L + S EF ++ R L+HPN++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKE-LKANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-------IKMALDVARGMNCL 790
+G ++ E+ G L L Q RR +MA ++A G+ +
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYL----SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL--SRLKHNTFLSSKSTAGTPEWMAPEVL 848
H +H DL N + + VKV D+G+ SR K + + W+APE++
Sbjct: 116 HKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 849 -----------RNEPSNEKCDVYSFGVILWEL 869
+ +PSN V++ GV LWEL
Sbjct: 174 GEFHGGLITAEQTKPSN----VWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 13/193 (6%)
Query: 684 IGLGSYGEVYHA------DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G GS+G+V A +V K + QD + KR + + R HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQ 60
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTSTPT 796
P L + EF+ G L + H + DE R A ++ + LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856
I++RDLK N+L+D + K++DFG+ + ++ + GTP+++APE+L+
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS 176
Query: 857 CDVYSFGVILWEL 869
D ++ GV+L+E+
Sbjct: 177 VDWWAMGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 31/212 (14%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--------PNV 735
+G G+YG+V+ K + + AAL++ + V+ R R+ P +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKR----RIKMALDVARGMNCL 790
V A L +I +++ G +F L+ R + DE R I +AL+
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE-------- 119
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK-----STAGTPEWMAP 845
H IV+RD+K N+L+D +V ++DFGLS+ FLS + S GT E+MAP
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK----EFLSEEKERTYSFCGTIEYMAP 175
Query: 846 EVLRNEPSNEKC-DVYSFGVILWELATLKLPW 876
E++R + + K D +S G++++EL T P+
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 48/201 (23%), Positives = 104/201 (51%), Gaps = 11/201 (5%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G GS+G+V A+ GT+ + K + QD + KR + + + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL--QDKPPFLTQ 65
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
L + E++ G L + + + E + + A +++ G+ LH I
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRG--I 122
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 857
++RDLK N+++D ++K++DFG+ + +++++ GTP+++APE++ +P +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 858 DVYSFGVILWELATLKLPWIG 878
D +++GV+L+E+ + P+ G
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
E+IG G+YG VY A T +A+KK L+Q+ G RE+ +++ ++H N+V
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQHGNIVRL 66
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLHTSTPTI 797
V L ++ E+L + P + R IK L + RG+ H+ +
Sbjct: 67 QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP-RLIKTYLYQILRGIAYCHSHR--V 123
Query: 798 VHRDLKSPNLLVDKNWN-VKVSDFGLSR---LKHNTFLSSKSTAGTPEWM-APEVLRNEP 852
+HRDLK NLL+D+ N +K++DFGL+R + TF T W APE+L
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL----WYRAPEILLGSR 179
Query: 853 S-NEKCDVYSFGVILWELATLK 873
+ D++S G I E+ K
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 40/125 (32%), Positives = 64/125 (51%), Gaps = 17/125 (13%)
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL---------------KHNTFLSSKSTAGTPE 841
IVHRDLK NLL+ ++K++DFGLS++ K K GTPE
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
++APEV+ + + D ++ G+IL+E +P+ G P ++ G V + +E P+
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--ISDDIEWPEGD 239
Query: 902 DPLVA 906
+ L A
Sbjct: 240 EALPA 244
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 18/175 (10%)
Query: 704 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 763
V K L D L F +M +L H ++V G R N+ ++ E++ G L
Sbjct: 34 VLKVLGSD--HRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVF 90
Query: 764 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-------VK 816
LHR V ++ +A +A ++ L +VH ++ N+LV + +K
Sbjct: 91 LHREKNNVSLHWKLDVAKQLASALHYLEDK--KLVHGNVCGKNILVARYGLNEGYVPFIK 148
Query: 817 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN--EKCDVYSFGVILWEL 869
+SD G+ T LS + W+APE +RN ++ D +SFG L E+
Sbjct: 149 LSDPGIPI----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 53/235 (22%), Positives = 110/235 (46%), Gaps = 11/235 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRLRH 732
ED + + IG G++GEV N +V K L+ + A F+ E ++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
+ A NL ++ ++ G L +L + ++ E ++ ++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
VHRD+K N+L+D N +++++DFG +L + + S GTP++++PE+L+
Sbjct: 121 LH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 852 PSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
+ +CD +S GV ++E+ + P+ + ++ G + R + P ++
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 47/234 (20%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFLDQDFSGAALLEFKR------------EVKIMRR 729
+G G +GEV G A KK LE KR E +I+ +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKK-----------LEKKRIKKRKGEAMALNEKQILEK 56
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDVARGMN 788
+ VV A L ++ + G L F I + + DE+R + A ++ G+
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEV 847
LH IV+RDLK N+L+D ++++SD GL+ + + + GT +MAPEV
Sbjct: 117 DLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI--RGRVGTVGYMAPEV 172
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQVVGAVGFQNRRLEIPKE 900
++NE Y+F W L L I G +P F+ R+ ++ +E
Sbjct: 173 VKNER-------YTFSPDWWGLGCLIYEMIEGKSP--------FRQRKEKVKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 69/293 (23%), Positives = 114/293 (38%), Gaps = 75/293 (25%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 740
IG+G++GEV T A+K D K E I+ + VV
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ NL + +++P G + +L R ++ R +A ++ + +H +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHKMG--FIHR 125
Query: 801 DLKSPNLLVDKNWNVKVSDFGLS---RLKHN----------------------------- 828
D+K N+L+D++ ++K++DFGL R H+
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRL 185
Query: 829 -----------TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877
+ S GTP ++APEVL + CD +S GVIL+E+ + P++
Sbjct: 186 KPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 245
Query: 878 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930
P + V I WE ++LHI SQA+LS
Sbjct: 246 ADTPAETQLKV-------------------INWE------TTLHI-PSQAKLS 272
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVV---- 736
+G GS G V+ A + VAVKK L S L RE+KI+RRL H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL---REIKIIRRLDHDNIVKVYE 69
Query: 737 -LFMGAVTRPPNLSIITEF--------LPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
L ++ +TE L +L + E+ + RG+
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGL 127
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRL-----KHNTFLSSKSTAGTPE 841
+H++ ++HRDLK N+ ++ V K+ DFGL+R+ H +LS T
Sbjct: 128 KYIHSA--NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV--TKW 183
Query: 842 WMAPEVLRNEPSN--EKCDVYSFGVILWELATLKLPWIGMNPMQ 883
+ +P +L + P+N + D+++ G I E+ T K + G + ++
Sbjct: 184 YRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 18/187 (9%)
Query: 687 GSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746
GS G V+ A G V + Q G L+E +++ + HP+V+ +
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQ--KGTTLIE----AMLLQNVNHPSVIRMKDTLVSGA 130
Query: 747 NLSIITEFLP--RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804
++ LP L+ L + + + + + + G+ LH I+HRD+K+
Sbjct: 131 ITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKT 185
Query: 805 PNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSF 862
N+ ++ V + D G ++ FL AGT E APEVL + N K D++S
Sbjct: 186 ENIFINDVDQVCIGDLGAAQFPVVAPAFLG---LAGTVETNAPEVLARDKYNSKADIWSA 242
Query: 863 GVILWEL 869
G++L+E+
Sbjct: 243 GIVLFEM 249
|
Length = 357 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 45/166 (27%), Positives = 83/166 (50%), Gaps = 5/166 (3%)
Query: 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810
++ + IL +D + + + VA+GM+ L ++ +HRDL + N+L+
Sbjct: 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL--ASKNCIHRDLAARNILLT 248
Query: 811 KNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWE 868
K+ DFGL+R +++++ K A P +WMAPE + N + DV+S+G++LWE
Sbjct: 249 HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 308
Query: 869 LATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913
+ +L P+ GM + + R+ P+ + I+ CW
Sbjct: 309 IFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCW 354
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 58/236 (24%), Positives = 108/236 (45%), Gaps = 14/236 (5%)
Query: 684 IGLGSYGEVYHADWNGTEV-----AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG GSY +V + VKK L D ++ ++ V + +P +V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHV-FEQASSNPFLVGL 61
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 798
L ++ E++ G L + R +E R A ++ +N LH I+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHERG--II 118
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 858
+RDLK N+L+D + ++K++D+G+ + ++ + GTP ++APE+LR E D
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVD 178
Query: 859 VYSFGVILWELATLKLPW--IGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARII 909
++ GV+++E+ + P+ I NP FQ + + IP+ L + ++
Sbjct: 179 WWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 5e-11
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 49/212 (23%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGA--ALLEFKREVKIMRRLR-HPNVV 736
+++G G+YG V+ A VA+KK D F A A F RE+ ++ L HPN+V
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTF-REIMFLQELGDHPNIV 70
Query: 737 LFMGAVTRPPN---LSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKMALDVARG 786
+ V + N + ++ E++ R ++ +H KR I L A
Sbjct: 71 KLL-NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH--------KRYIMYQLLKA-- 119
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP------ 840
+ +H+ ++HRDLK N+L++ + VK++DFGL+R + + P
Sbjct: 120 LKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR----SLSELEENPENPVLTDYV 173
Query: 841 --EWM-APEVLRNEPSNEKCDVYSFGVILWEL 869
W APE+L Y+ GV +W +
Sbjct: 174 ATRWYRAPEILLGSTR------YTKGVDMWSV 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 66/222 (29%), Positives = 98/222 (44%), Gaps = 52/222 (23%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRLRHPNVVL 737
E IG GSYG V A G +VA+KK D + S A RE+K++R LRHP++V
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDAT--RILREIKLLRLLRHPDIVE 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA------------R 785
+ + PP+ EF +F ++ QV IK D+ R
Sbjct: 64 -IKHIMLPPSRR---EFKDIYVVFELMESDLHQV-----IKANDDLTPEHHQFFLYQLLR 114
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-- 843
+ +HT+ + HRDLK N+L + + +K+ DFGL+R+ N T W
Sbjct: 115 ALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFN------DTPTAIFWTDY 166
Query: 844 -------APEVL-----RNEPSNEKCDVYSFGVILWELATLK 873
APE+ + P+ D++S G I E+ T K
Sbjct: 167 VATRWYRAPELCGSFFSKYTPA---IDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK-FLDQDFSG---AALLEFKREVKIMRRLRHPNV 735
E+IG G+YG+VY A G VA+KK L+ D G AL RE+ +++ L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL----REISLLQMLSESIY 62
Query: 736 VLFMGAVTR------PPNLSIITEFLPRG-SLFRILHR--PHCQVDEKRRIKMALDVARG 786
++ + V P+L ++ E+L F + P + K + +G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
+ H ++HRDLK NLLVDK + K++D GL R S T + AP
Sbjct: 123 VAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 846 EVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ 883
EVL + D++S G I E++ + + G + +Q
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+++G G+Y VY T+ VA+K+ + GA REV +++ L+H N+V
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLH 70
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMAL-DVARGMNCLHTSTPTI 797
+ +L+++ E+L + L + L C +K+ L + RG+N H +
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLD--DCGNSINMHNVKLFLFQLLRGLNYCHRRK--V 125
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEK 856
+HRDLK NLL+++ +K++DFGL+R K + + T + P++L + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 857 CDVYSFGVILWELAT 871
D++ G I +E++T
Sbjct: 186 IDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-11
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 23/159 (14%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-- 780
E I+R + HP+++ G T +I LPR ++ +C + KR I +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPR---YKT--DLYCYLAAKRNIAICDI 184
Query: 781 ----LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS----RLKHNTFLS 832
V R + LH + I+HRD+K+ N+ ++ +V + DFG + + N +
Sbjct: 185 LAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242
Query: 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
AGT APE+L +P D++S G++L+E+AT
Sbjct: 243 ---WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 9e-11
Identities = 62/235 (26%), Positives = 96/235 (40%), Gaps = 53/235 (22%)
Query: 684 IGLGSYGEV--YHADWNGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 740
IG G++GEV G A+K L + F L K E ++ P VV
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ L +I EFLP G L +L + ++ R MA + + +H +HR
Sbjct: 69 SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVLAIEAVHKLG--FIHR 125
Query: 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTF------------------------------ 830
D+K N+L+D+ ++K+SDFGLS H
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185
Query: 831 --LSSK---------------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 868
+SSK ST GTP+++APE+ + ++CD +S G I++E
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 19/180 (10%)
Query: 699 GTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754
G VAVKK F +Q + A RE+ +++ + H N++ + T +L EF
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAY----RELVLLKCVNHKNIISLLNVFTPQKSLE---EF 98
Query: 755 LPRGSLFRILHRPHCQV-----DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 809
+ ++ CQV D +R + + G+ LH++ I+HRDLK N++V
Sbjct: 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV 156
Query: 810 DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 869
+ +K+ DFGL+R F+ + T + APEV+ E D++S G I+ EL
Sbjct: 157 KSDCTLKILDFGLARTACTNFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 27/203 (13%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E++G G+Y V+ TE VA+K+ + GA REV +++ L+H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLH 70
Query: 740 GAVTRPPNLSIITEFLPR---------GSLFRILHRPHCQVDEKRRIKMAL-DVARGMNC 789
V +L+++ E+L + G++ + +K+ L + RG+
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM-----------HNVKIFLYQILRGLAY 119
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
H ++HRDLK NLL+++ +K++DFGL+R K + + T + P+VL
Sbjct: 120 CHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 177
Query: 850 NEPS-NEKCDVYSFGVILWELAT 871
+ + D++ G I +E+A+
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 31/206 (15%)
Query: 721 KREVKIMRRLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKR--- 775
+ E +++ +R P +V A L +I +++ G LF + R + E +
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 776 -RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-S 833
I +AL+ H I++RD+K N+L+D N +V ++DFGLS+ H + +
Sbjct: 112 GEIVLALE--------HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA 163
Query: 834 KSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 891
S GT E+MAP+++R ++ D +S GV+++EL T G +P V G Q
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT------GASPFTVDGEKNSQ 217
Query: 892 ---NRRL-----EIPKELDPLVARII 909
+RR+ P+E+ L II
Sbjct: 218 AEISRRILKSEPPYPQEMSALAKDII 243
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 29/191 (15%)
Query: 702 VAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757
VA+KK F +Q + A RE+ +M+ + H N++ + T +L EF
Sbjct: 45 VAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIISLLNVFTPQKSLE---EFQDV 97
Query: 758 GSLFRILHRPHCQVDEKRRIKMALDVAR----------GMNCLHTSTPTIVHRDLKSPNL 807
+ ++ CQV I+M LD R G+ LH++ I+HRDLK N+
Sbjct: 98 YLVMELMDANLCQV-----IQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNI 150
Query: 808 LVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILW 867
+V + +K+ DFGL+R +F+ + T + APEV+ E D++S G I+
Sbjct: 151 VVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 868 ELATLKLPWIG 878
E+ K+ + G
Sbjct: 210 EMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 7/199 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
E V +++G G+Y V+ TE VA+K+ + GA REV +++ L+H
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKHA 63
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
N+V + L+++ E+L + + + +I M + RG++ H
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM-FQLLRGLSYCHKR 122
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
I+HRDLK NLL+++ +K++DFGL+R K + + T + P+VL
Sbjct: 123 K--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 854 -NEKCDVYSFGVILWELAT 871
+ D++ G IL+E+AT
Sbjct: 181 YSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 684 IGLGSYGEVYHADWNGTE----VAVKKFLDQDFSGAALLEFK-REVKIMRRLR-HPNVV- 736
+G G+YG V A T VA+KK + FS L + RE+K++R R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKK-ITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 737 LF-MGAVTRPP-NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLHTS 793
L+ M V N + E L L +I+ Q + + + G+ +H++
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA 124
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS----KSTAGTPEWMAPEV-L 848
++HRDLK NLLV+ + +K+ DFGL+R + T + APE+ L
Sbjct: 125 N--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIML 182
Query: 849 RNEPSNEKCDVYSFGVILWELATLK 873
+ + DV+S G IL EL K
Sbjct: 183 SFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 23/200 (11%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNVVLF 738
+G G+YG V A G VAVKK L + F +++ KR E+++++ ++H NV+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKK-LSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGL 81
Query: 739 MGAVTRPPNLS-----IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLHT 792
+ T +L + L L I+ CQ ++ + + RG+ +H+
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS 138
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-E 851
+ I+HRDLK NL V+++ +K+ DFGL+R +T T + APE++ N
Sbjct: 139 AD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWM 193
Query: 852 PSNEKCDVYSFGVILWELAT 871
N+ D++S G I+ EL T
Sbjct: 194 HYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 26/203 (12%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G+YG V A G +VA+KK F + F+ A RE+ +++ ++H NV+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY----RELTLLKHMQHENVIG 78
Query: 738 FMGAVTRPPNLSIITEF---LP--RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
+ T + +F +P + L +I+ P + E + + + G+ +H+
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQMLCGLKYIHS 135
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-APEVLRN- 850
+ I+HRDLK NL V+++ +K+ DFGL+R T W APEV+ N
Sbjct: 136 AG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT----RWYRAPEVILNW 189
Query: 851 EPSNEKCDVYSFGVILWELATLK 873
N+ D++S G I+ E+ T K
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 29/193 (15%)
Query: 702 VAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757
VA+KK F +Q + A RE+ +M+ + H N++ + T +L EF
Sbjct: 52 VAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIIGLLNVFTPQKSLE---EFQDV 104
Query: 758 GSLFRILHRPHCQVDEKRRIKMALDVAR----------GMNCLHTSTPTIVHRDLKSPNL 807
+ ++ CQV I+M LD R G+ LH++ I+HRDLK N+
Sbjct: 105 YIVMELMDANLCQV-----IQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNI 157
Query: 808 LVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILW 867
+V + +K+ DFGL+R +F+ + T + APEV+ E D++S G I+
Sbjct: 158 VVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 868 ELATLKLPWIGMN 880
E+ + + G +
Sbjct: 217 EMIKGGVLFPGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-10
Identities = 34/99 (34%), Positives = 61/99 (61%), Gaps = 4/99 (4%)
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---SKSTAGTPEWMAPEVLRNEPS 853
++HRDLKS N+ + +K+ DFG S+ +++ +S + S GTP ++APE+ +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 854 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 892
++K D++S GVIL+EL TL P+ G + +++ V +
Sbjct: 249 SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK 287
|
Length = 478 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 24/199 (12%)
Query: 684 IGLGSYGEVY---HADWNGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRH----P 733
IG G +GEVY AD G A+K LD+ L +IM L P
Sbjct: 2 IGRGGFGEVYGCRKAD-TGKMYAMK-CLDKKRIKMKQGETLALNE--RIMLSLVSTGDCP 57
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+V A P LS I + + G L L + H E A ++ G+ +H
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK--STAGTPEWMAPEVL-RN 850
+V+RDLK N+L+D++ +V++SD GL+ F K ++ GT +MAPEVL +
Sbjct: 117 F--VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 851 EPSNEKCDVYSFGVILWEL 869
+ D +S G +L++L
Sbjct: 171 VAYDSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 35/106 (33%), Positives = 65/106 (61%), Gaps = 5/106 (4%)
Query: 777 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKS 835
++ + VA+GM+ L ++ +HRD+ + N+L+ K+ DFGL+R + +++ K
Sbjct: 215 LRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 836 TAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 879
A P +WMAPE + + + DV+S+G++LWE+ +L K P+ G+
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 67/279 (24%), Positives = 116/279 (41%), Gaps = 57/279 (20%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G+G++GEV A T+ A+K +D + K E I+ + VV
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ NL + +++P G + +L R ++ R +A ++ + +H +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHKMG--FIHR 125
Query: 801 DLKSPNLLVDKNWNVKVSDFGL-------------------------------------- 822
D+K N+L+D++ ++K++DFGL
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185
Query: 823 -SRLK---------HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL 872
RLK H L+ S GTP ++APEVL + CD +S GVIL+E+
Sbjct: 186 GDRLKPLERRAARQHQRCLA-HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 244
Query: 873 KLPWIGMNPMQVVGAVGFQNRRLEIPKE--LDPLVARII 909
+ P++ P++ V L IP + L P + +I
Sbjct: 245 QPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 55/278 (19%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G+G++GEV A T A+K +D + + K E I+ + VV
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800
+ NL + +++P G + +L R + R +A ++ + +H +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKMG--FIHR 125
Query: 801 DLKSPNLLVDKNWNVKVSDFGLS---RLKHNTFLSSK----------------------- 834
D+K N+L+D + ++K++DFGL R HN+ K
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRC 185
Query: 835 ---------------------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK 873
S GTP ++APEVL + + CD +S GVIL+E+ +
Sbjct: 186 GDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245
Query: 874 LPWIGMNPMQVVGAVGFQNRRLEIPKE--LDPLVARII 909
P++ P + V L IP + L P +I
Sbjct: 246 PPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 4/157 (2%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 781
E +I+ ++ VV A L ++ + G L F I + + +E+R + A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 841
++ G+ LH V+RDLK N+L+D ++++SD GL+ +K S + GT
Sbjct: 110 EILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVG 166
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 878
+MAPEVL N+ D + G +++E+ + P+ G
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+G G G V+ GT A+K K + + ++E I+ L HP +
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQE--ILATLDHPFLPTL 66
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ L ++ ++ P G LFR+L R C +E R A +V + LH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLLG-- 123
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLS------------------------RLKHNTFLS 832
IV+RDLK N+L+ ++ ++ +SDF LS + TF
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 833 -----SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 869
S S GT E++APEV+ + D ++ G++L+E+
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 3e-09
Identities = 47/196 (23%), Positives = 92/196 (46%), Gaps = 24/196 (12%)
Query: 687 GSYGEVY---HADWNGTEVAVKKFLD-QDFSGAALLEFKREV-KIMRRLRHPNVVLFMGA 741
G +G+V H ++ V+K + ++F+ +E V ++M+ +PN + +
Sbjct: 27 GKFGKVSVLKHKPTQ--KLFVQKIIKAKNFNA---IEPM--VHQLMKD--NPNFIKLYYS 77
Query: 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 801
VT +I +++ G LF +L + + E K+ + +N LH I+H D
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLHKHN--IIHND 134
Query: 802 LKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTA-GTPEWMAPEVLRNEPSNEKCDV 859
+K N+L D + + D+GL ++ + S GT ++ +PE ++ + D
Sbjct: 135 IKLENVLYDRAKDRIYLCDYGLCKIIG-----TPSCYDGTLDYFSPEKIKGHNYDVSFDW 189
Query: 860 YSFGVILWELATLKLP 875
++ GV+ +EL T K P
Sbjct: 190 WAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 33/111 (29%), Positives = 61/111 (54%), Gaps = 8/111 (7%)
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEPS-- 853
VHRD+K N+L+D N +++++DFG S LK N + S GTP++++PE+L+
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 854 ---NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
+CD +S GV ++E+ + P+ + ++ G + R + P +
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-09
Identities = 65/232 (28%), Positives = 106/232 (45%), Gaps = 44/232 (18%)
Query: 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKR-----EVKIMRRLRHPNVV 736
++IG G +GEV+ T+ + F + S L E ++ EV +MR L+H N+V
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQ---EFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIV 75
Query: 737 LFMGAVTRPPN--LSIITEFLPRGSLFRILHR---------PHCQVDEKRRIKMALDVAR 785
++ N L I+ EF G L R + + H VD R++ AL
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVD-------------KNWN----VKVSDFGLSRLKHN 828
+ + ++HRDLK N+ + N N K+ DFGLS+ N
Sbjct: 136 NLKD-GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK---N 191
Query: 829 TFLSS--KSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPW 876
+ S S GTP + +PE+L +E ++K D+++ G I++EL + K P+
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 699 GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758
GT V V+ ++ + L + EV + RHPN++ T L +I+ F+ G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 759 SLFRILHRPHCQVDEKRRIKMALDVA-RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 817
S +L + + I L A RG+N LH + +HR++K+ ++L+ + V +
Sbjct: 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSL 142
Query: 818 SDFGLSRL--------KHNTF--LSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVI 865
S GLS L K ST+ P W++PE+LR + N K D+YS G+
Sbjct: 143 S--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPELLRQDLYGYNVKSDIYSVGIT 199
Query: 866 LWELATLKLPWIGMNPMQVV 885
ELAT ++P+ M Q++
Sbjct: 200 ACELATGRVPFQDMLRTQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 25/199 (12%)
Query: 684 IGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNVVLF 738
+G G+YG V A +VAVKK L + F +L+ +R E+++++ ++H NV+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKK-LSRPFQ--SLIHARRTYRELRLLKHMKHENVIGL 79
Query: 739 MGAVTRPPNLSIITEF-----LPRGSLFRILHRPHCQVDEKRRIK-MALDVARGMNCLHT 792
+ T ++ E L L I+ CQ ++ + + RG+ +H+
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-APEVLRN- 850
+ I+HRDLK N+ V+++ +++ DFGL+R + +T W APE++ N
Sbjct: 137 AG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVAT----RWYRAPEIMLNW 190
Query: 851 EPSNEKCDVYSFGVILWEL 869
N+ D++S G I+ EL
Sbjct: 191 MHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 4/155 (2%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 781
E +I+ ++ VV A L ++ + G L F I + + DE+R I A
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 841
++ G+ L IV+RDLK N+L+D ++++SD GL+ ++ + + GT
Sbjct: 110 ELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGRVGTVG 166
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876
+MAPEV+ NE D + G +++E+ + P+
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 31/109 (28%), Positives = 61/109 (55%), Gaps = 6/109 (5%)
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE- 855
VHRD+K N+L+DKN +++++DFG RL + + S GTP++++PE+L+ +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 856 ----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
+CD +S GV ++E+ + P+ + ++ G + + P +
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD 232
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 7/191 (3%)
Query: 682 ERIGLGSYGEVYH--ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E++G GSY VY + NG VA+K + G RE +++ L+H N+VL
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKGLKHANIVLLH 69
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799
+ L+ + E++ ++ P R+ M + RG+ +H I+H
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFM-FQLLRGLAYIHGQH--ILH 126
Query: 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCD 858
RDLK NLL+ +K++DFGL+R K + S T + P+VL + D
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALD 186
Query: 859 VYSFGVILWEL 869
++ G I E+
Sbjct: 187 IWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 18/196 (9%)
Query: 684 IGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----PNVV 736
IG G +GEVY AD G A+K + +IM L P +V
Sbjct: 2 IGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
A P L I + + G L L + H EK A ++ G+ +H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRF-- 117
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK--STAGTPEWMAPEVLRNEPS- 853
+V+RDLK N+L+D++ +V++SD GL+ F K ++ GT +MAPEVL+ +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAY 173
Query: 854 NEKCDVYSFGVILWEL 869
+ D +S G +L++L
Sbjct: 174 DSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 22/155 (14%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+++G GSY VY G VA+K+ + GA RE +++ L+H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKDLKHANIVTLH 69
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK-------RRIKMAL-DVARGMNCLH 791
+ L+++ E+L Q + +++ L + RG+ H
Sbjct: 70 DIIHTKKTLTLVFEYL---------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
++HRDLK NLL+ + +K++DFGL+R K
Sbjct: 121 QRR--VLHRDLKPQNLLISERGELKLADFGLARAK 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 681 GERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
G ++G G+YG VY A + E A+K+ S +A RE+ ++R L+HPNV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNVI 61
Query: 737 LFMGAVTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GM 787
+ + F L+ I+ K+ +++ + + G+
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 788 NCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPE 841
+ LH + ++HRDLK N+LV + VK++D G +RL ++ L+
Sbjct: 122 HYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 842 WM-APEVLRNEPSNEKC-DVYSFGVILWELAT 871
W APE+L K D+++ G I EL T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 681 GERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
G ++G G+YG VY A + + A+K+ S +A RE+ ++R L+HPNV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNVI 61
Query: 737 LFMGAVTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GM 787
+ + F L+ I+ K+ +++ + + G+
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 788 NCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPE 841
+ LH + ++HRDLK N+LV + VK++D G +RL ++ L+
Sbjct: 122 HYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 842 WM-APEVLRNEPSNEKC-DVYSFGVILWELAT 871
W APE+L K D+++ G I EL T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-06
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E+ M +L+HPN+V +G +I E++ +L +L + +RR K+A+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIG 788
Query: 783 VARGMNCLHTS-TPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRLKHNTFLSSKSTAGT 839
+A+ + LH +P +V +L +++D ++++S GL F+SS
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA----- 843
Query: 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 875
++APE + EK D+Y FG+IL EL T K P
Sbjct: 844 --YVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 39/105 (37%), Positives = 55/105 (52%), Gaps = 13/105 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVK--KFLDQDFSGAALLEFKR 722
E+P ++LVLG +G G++G V A +G +VAVK K + AL+
Sbjct: 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMS--- 89
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 766
E+KIM L H N+V +GA T+ + IITE+ G L LHR
Sbjct: 90 ELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 47/279 (16%)
Query: 616 KNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPW 675
+++ +E H K +F + KL + E ++ +++ D+D+ P
Sbjct: 8 EDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRS--PN 65
Query: 676 EDLVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFK-REVKIMRRLRH 732
+ LG IG GS+G VY A T +VA+KK L QD ++K RE+ IM+ L H
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-QD------PQYKNRELLIMKNLNH 118
Query: 733 PNVVL-----FMGAVTRPPN---LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL--- 781
N++ + + L+++ EF+P+ H + R AL
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTV--------HKYMKHYARNNHALPLF 170
Query: 782 -------DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-VKVSDFGLSRLKHNTFLSS 833
+ R + +H+ I HRDLK NLL+D N + +K+ DFG ++ N
Sbjct: 171 LVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAGQ 225
Query: 834 KSTA--GTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 869
+S + + + APE++ + D++S G I+ E+
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 28/201 (13%)
Query: 681 GERIGLGSYGEVYHADWNGTEVAVKKFLD---QDFSGAALLEFKREVKIMRRLRHPNVVL 737
G R +G YGE++ TEV + K LD +++S + F +M +L H ++VL
Sbjct: 14 GIRREVGDYGELHK-----TEV-LLKVLDKSHRNYSES----FFEAASMMSQLSHKHLVL 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
G ++ E++ GSL L + ++ ++++A +A ++ L +
Sbjct: 64 NYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK--GL 121
Query: 798 VHRDLKSPNLLV-----DKNWN---VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
H ++ + N+L+ K N +K+SD G+S T L + W+ PE +
Sbjct: 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIPWVPPECIE 177
Query: 850 NEPS-NEKCDVYSFGVILWEL 869
N + + D +SFG LWE+
Sbjct: 178 NPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 718 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 777
L F +MR++ H ++VL G R ++ EF+ G L +HR + +
Sbjct: 49 LAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF 108
Query: 778 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-------NVKVSDFGLSRLKHNTF 830
K+A +A ++ L +VH ++ + N+L+ + +K+SD G+ T
Sbjct: 109 KVAKQLASALSYLEDK--DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI----TV 162
Query: 831 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 869
LS + W+APE + + + + D +SFG LWE+
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 31/163 (19%)
Query: 723 EVKIMRRLRHPNVVLFM-----GAVT---RPPNLSIITEFLPRGSLFRILHRPHCQVDE- 773
E +++RRL HP V+ + G +T P S + +L G+ R L QV
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYL--GARLRPLGLA--QVTAV 265
Query: 774 KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833
R++ A+D G I+HRD+K+ N+LV+ ++ + DFG + S
Sbjct: 266 ARQLLSAIDYIHGEG--------IIHRDIKTENVLVNGPEDICLGDFGAACFAR----GS 313
Query: 834 KST------AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELA 870
ST AGT + APEVL +P D++S G++++E A
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 687 GSYGEVY----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742
GS GEV+ H D +V VK +G RE+ I++ + H ++ + A
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAV-----TGGKTPG--REIDILKTISHRAIINLIHAY 155
Query: 743 TRPPNLSIITEFLP--RGSLFRILHRPHCQVDEKRRIKMALDVARGM----NCLHTSTPT 796
S + +P + LF + R ++ A+ + R + LH
Sbjct: 156 R---WKSTVCMVMPKYKCDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRG-- 205
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLS-RL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
I+HRD+K+ N+ +D+ N + DFG + +L H +GT E +PE+L +P
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265
Query: 855 EKCDVYSFGVILWELATLKLPWIG 878
K D++S G++L+E++ + G
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 6e-05
Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 6/173 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
E+ V+ + I G++G+VY N AVK D ++ + E + +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
P +V ++ N+ ++ E+L G + +LH + DE+ +K +VA ++ LH
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHR 122
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
I+HRDLK N+L+ ++K++DFGLS++ N L+ TP P
Sbjct: 123 HG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 857
+HR KS N+L+ W+ + G F + + + P +MAPEV++ + EK
Sbjct: 33 LHRQAKSGNILL--TWDGLLKLDGSV-----AFKTPEQSRPDPYFMAPEVIQGQSYTEKA 85
Query: 858 DVYSFGVILWELATLKLPWIGMNPM 882
D+YS G+ L+E +LP+ +
Sbjct: 86 DIYSLGITLYEALDYELPYNEEREL 110
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 35/157 (22%), Positives = 70/157 (44%), Gaps = 22/157 (14%)
Query: 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLE------FKREVKIMRRLRHPN 734
+ I G+ E+Y D+ G + +K + + + L E +RE +IM R R
Sbjct: 1 MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAG 60
Query: 735 V----VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
V V F+ P N I+ E++ L +++ ++++ ++ R + L
Sbjct: 61 VNVPAVYFVD----PENFIIVMEYIEGEPLKDLINSN-----GMEELELSREIGRLVGKL 111
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827
H++ I+H DL + N+++ + + DFGL+
Sbjct: 112 HSA--GIIHGDLTTSNMILSGG-KIYLIDFGLAEFSK 145
|
Length = 211 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 44/137 (32%), Positives = 62/137 (45%), Gaps = 12/137 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P + LVLG +G G++G+V G +VAVK L + E+
Sbjct: 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVK-MLKPTARSSEKQALMSEL 91
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMAL 781
KIM L H N+V +GA T+ + IITE+ G L LH R + + K L
Sbjct: 92 KIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDL 151
Query: 782 DVARGMNCLHTSTPTIV 798
D+ G+N ST + V
Sbjct: 152 DIF-GINPADESTRSYV 167
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 16/101 (15%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFK--- 721
E P + L LG+ +G G++G+V A G E VAVK + GA E+K
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKE----GATASEYKALM 58
Query: 722 REVKIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSL 760
E+KI+ + H NVV +GA T+P L +I E+ G+L
Sbjct: 59 TELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 698 NGTEVAVKKFLDQDFSGAALLEF-KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756
G V V++ ++ + ++ F + E+ + + HPN+V + L ++T F+
Sbjct: 24 TGEYVTVRR-INLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 757 RGSLFRILHRPHCQ--VDEKRRIKMA---LDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 811
GS ++ C +D + +A V + ++ +H VHR +K+ ++L+
Sbjct: 83 YGSAKDLI----CTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISV 136
Query: 812 NWNVKVSDF--GLSRLKHNTFLS-----SKSTAGTPEWMAPEVLRN--EPSNEKCDVYSF 862
+ V +S LS + H L K + W++PEVL+ + + K D+YS
Sbjct: 137 DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 863 GVILWELATLKLPWIGMNPMQV 884
G+ ELA +P+ M Q+
Sbjct: 197 GITACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGA--ALLEFKR 722
E P ++L G+ +G G++G+V A + N VAVK + AL+
Sbjct: 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMS--- 90
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 766
E+KI+ L +H N+V +GA T + +ITE+ G L L +
Sbjct: 91 ELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK 135
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 20/225 (8%)
Query: 698 NGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756
NG E+ V K LD AL F +M ++ H ++ G R ++ EF+
Sbjct: 41 NGRELRVVLKVLDPSHRDIAL-AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVE 99
Query: 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW--- 813
G L L + +V +I +A +A ++ L +VH ++ + N+L+ +
Sbjct: 100 HGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK--NLVHGNVCAKNILLARLGLAE 157
Query: 814 ----NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWE 868
+K+SD G+S T LS + W+APE + S + D +SFG L E
Sbjct: 158 GTSPFIKLSDPGVSF----TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE 213
Query: 869 LA-TLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
+ ++P P + F ++ +P+ +A +I +C
Sbjct: 214 ICFDGEVPLKERTPSE---KERFYEKKHRLPEPSCKELATLISQC 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 38/198 (19%), Positives = 56/198 (28%), Gaps = 58/198 (29%)
Query: 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-----PNVV 736
+ G+ Y +K A E +RE+ ++R L P V+
Sbjct: 3 RPLSGGASNRTYLVGTGDGRYVLKLAP----PAEAAEELRRELALLRHLAAAGIPVPRVL 58
Query: 737 LF------------------MGAVTRPPNLSIITEFLPR-GSLFRILHR-PHCQVDEKRR 776
+TRP + + L L LH P + RR
Sbjct: 59 AGGTDGGGLGLPFLLMEGLPGEVLTRPLDPAERGALLEALARLLARLHSVPPEALPLARR 118
Query: 777 IKMALDVARG----------------------------MNCLHTSTPTIVHRDLKSPNLL 808
++ L + R + L +VH DL NLL
Sbjct: 119 LRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLAALLALLPALPLVLVHGDLHPGNLL 178
Query: 809 VDKNWNVK-VSDFGLSRL 825
VD V V DF + L
Sbjct: 179 VDPGGRVTGVIDFEDAGL 196
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 37/154 (24%), Positives = 59/154 (38%), Gaps = 31/154 (20%)
Query: 684 IGLGSYGEVYHADWNGTEVAVK---------KFLDQDFSGAALLEFKREVKIMRRLRHPN 734
I G+ +Y D+ G VK LD+ +RE +I+ + R
Sbjct: 4 IKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRR---ERTRREARILAKAREAG 60
Query: 735 V----VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
V V P N I+ E++ G L + E+ R + +V R + L
Sbjct: 61 VPVPIVYD----VDPDNGLIVMEYIE-GELLK-------DALEEARPDLLREVGRLVGKL 108
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824
H + IVH DL + N+++ + DFGL
Sbjct: 109 HKA--GIVHGDLTTSNIILSGG-RIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 37/105 (35%), Positives = 52/105 (49%), Gaps = 16/105 (15%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFK--- 721
E P + L LG+ +G G++G+V A G + VAVK + GA E K
Sbjct: 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKE----GATASEHKALM 58
Query: 722 REVKIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRIL 764
E+KI+ + H NVV +GA T+P L +I EF G+L L
Sbjct: 59 SELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 935 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.31 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.9 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.63 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.57 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.47 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.37 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.34 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.28 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.26 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.19 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.04 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.03 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.99 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.95 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.9 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.83 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.83 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.79 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.74 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.7 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.67 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.67 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.54 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.47 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.36 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 97.33 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.31 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.21 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.14 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.96 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.93 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.78 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 96.67 | |
| COG5279 | 521 | CYK3 Uncharacterized protein involved in cytokines | 96.57 | |
| PLN02236 | 344 | choline kinase | 96.53 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.36 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.33 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.32 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.26 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.26 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.25 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.24 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.44 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.28 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.21 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.98 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.8 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.72 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.32 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.1 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-66 Score=537.27 Aligned_cols=198 Identities=51% Similarity=0.882 Sum_probs=188.3
Q ss_pred hHHHHHHHHhhccccccCCcccCceeeeccCCC--C-CCCCCCCCChhhhccc-cCCCCeEEEEEecccChHHHHHHHHH
Q 002331 125 AAEVLSRQYWEYNVLDYEERVVDGFYDIYGLST--D-PSTQGKLPSLAHLESN-LGNSGFEVVIVNRTIDHALEELVQVA 200 (935)
Q Consensus 125 ~~~~~s~~~w~~~~lsy~~~i~dGFY~i~~~~~--~-~~~~~~iPsl~~L~~~-~~~~~~EvIlVDr~~D~~L~~L~~~a 200 (935)
++|++|+|||++|+|+|+||||||||||||++. + ..+++|||+|++|++. +.+.++|||||||++|++|++|+++|
T Consensus 2 ~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~~~~~~~EvIlVDr~~D~~L~~L~~~a 81 (204)
T PF14381_consen 2 SAESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVPPDDSSREVILVDRRRDPSLKELEQRA 81 (204)
T ss_pred cHHHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCCCCCCCeeEEEEccccCHHHHHHHHHH
Confidence 689999999999999999999999999999974 3 4799999999999996 67889999999999999999999999
Q ss_pred HHHHhcCCCCchHHHHHHHHHHHHhhcCCCCCChhHHHHhHHHHHHHHHHhhCCceeEeeecccccchhhHHHHHHhhhc
Q 002331 201 QCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADS 280 (935)
Q Consensus 201 ~~~~~~l~~~~~~~~~~~LA~lV~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~s~v~plg~i~~G~~rhRalLfKvLaD~ 280 (935)
+++++++. .+.++++++||+|||++|||++.+++....+|++++++||+ +++|+|||+|++|+|||||||||||||+
T Consensus 82 ~~~~~~~~-~~~~~~v~~LA~lVa~~MGG~~~~~~~~~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLFKvLAD~ 158 (204)
T PF14381_consen 82 HELSKGLS-TNTKELVQKLAKLVADRMGGPVSDAEDMLFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRALLFKVLADR 158 (204)
T ss_pred HHHHhccc-cCHHHHHHHHHHHHHHHhCCCCCcchhhhHHHHHHHHHHHh--CCCeEEEeeecccchHHHHHHHHHHHHh
Confidence 99998765 36789999999999999999999999999999999888888 7899999999999999999999999999
Q ss_pred cCCCeeeecccCCCCC-CCCceEEEEecCcceeeeecccCCCcccC
Q 002331 281 IRLPCRLVKGSHYTGV-EDDAVNIIKLEEEREFLVDLMAAPGTLIP 325 (935)
Q Consensus 281 i~l~c~lv~G~~~~g~-~~~a~~~v~~~~~~~~ivDlm~~pg~L~~ 325 (935)
||||||||||+||||+ +|+|||+|++.+++|||||||++||+|+|
T Consensus 159 iglpCrLvrG~~y~g~~~~~a~~~V~~~~~~eyiVDLm~~PG~L~P 204 (204)
T PF14381_consen 159 IGLPCRLVRGCYYCGWDDDDASNLVKFDDGREYIVDLMGAPGQLIP 204 (204)
T ss_pred cCCCceEEeeccCCccCCCCceEEEEcCCCcEEEEEcCCCCCCcCC
Confidence 9999999999999999 89999999999999999999999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=440.42 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=234.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.+|..++.||+|||+.||.++. .|+.||+|++.+..+ .....+.+.+|++|.++|+|||||+++++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999976 799999999987654 3456778899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
|+|..++|..++++ ...++|.+++.+++||+.||.|||+++ |||||||..||||+++.+|||+|||+|.....+...
T Consensus 98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 99999999999985 568999999999999999999999999 999999999999999999999999999998877677
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qC 912 (935)
..+.||||.|+|||++....++..+||||+||+||.|+.|++||+..+-.+.+.+|. .....+|..++.+.++||.++
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--~~~Y~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--LNEYSMPSHLSAEAKDLIRKL 252 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--hcCcccccccCHHHHHHHHHH
Confidence 788999999999999999999999999999999999999999999999999999985 345567889999999999999
Q ss_pred HhhCCCCcCCCcCHHHHHhCcC
Q 002331 913 WQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 913 L~~D~ssP~kRPSa~EILqHPF 934 (935)
|+.+ |.+||++++||.|+|
T Consensus 253 L~~~---P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 253 LRPN---PSERPSLDEVLDHPF 271 (592)
T ss_pred hcCC---cccCCCHHHHhcCHh
Confidence 9999 999999999999998
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=423.30 Aligned_cols=252 Identities=31% Similarity=0.455 Sum_probs=230.7
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc-eE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-LS 749 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~-l~ 749 (935)
+...+++.++.||+|..|+||++++ +++.+|+|++ .-+.......++.+|+++++..+|||||++||+|..+.. ++
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 5567788889999999999999987 5889999998 444567778899999999999999999999999999985 99
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|+||||++|+|.+++++. ++++|.....|+.+|++||.|||+ ++ ||||||||+||||+..|+|||||||.+..+.+
T Consensus 155 I~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred eehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 999999999999999765 579999999999999999999996 66 99999999999999999999999999998776
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHhhccccccCCCCc-Cc
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-----NPMQVVGAVGFQNRRLEIPKE-LD 902 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~-----~~~eil~~I~~~~~r~~ip~~-ls 902 (935)
. ...+++||..|||||.+.+..|+.++||||||++++||++|++||... ...+++.+|. ...++.+|.. ++
T Consensus 232 S--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~fS 308 (364)
T KOG0581|consen 232 S--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGEFS 308 (364)
T ss_pred h--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCcccCC
Confidence 6 457799999999999999999999999999999999999999999874 6677887775 5577788887 99
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+++++||..||++| |.+||++.|+++|||
T Consensus 309 ~ef~~FV~~CL~Kd---p~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKD---PSERPSAKQLLQHPF 337 (364)
T ss_pred HHHHHHHHHHhcCC---cccCCCHHHHhcCHH
Confidence 99999999999999 999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=420.74 Aligned_cols=256 Identities=24% Similarity=0.393 Sum_probs=233.4
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
.+..++|++.++||+|+||+||+++. +++.||+|++++....+ ........|..||..++||+||+++..|++.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 35568999999999999999999965 68889999998876544 4677789999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|||+||+.||.|+.+|++. +.+++..+..++.+|+.||.|||++| ||||||||+|||||.+|+|+|+|||+++....
T Consensus 101 ylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999999874 57999999999999999999999999 99999999999999999999999999997766
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHH
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
......++|||+.|||||++.+..|+..+|||||||++|||++|.+||.+.+...+..++... .....|..++.+.++|
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~-k~~~~p~~ls~~ardl 256 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG-KLPLPPGYLSEEARDL 256 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC-cCCCCCccCCHHHHHH
Confidence 656667799999999999999999999999999999999999999999999999999988533 2355667799999999
Q ss_pred HHHHHhhCCCCcCCCc----CHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRT----SQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRP----Sa~EILqHPF 934 (935)
|+++|+.| |++|. ++.+|-+|||
T Consensus 257 l~~LL~rd---p~~RLg~~~d~~~ik~Hpf 283 (357)
T KOG0598|consen 257 LKKLLKRD---PRQRLGGPGDAEEIKRHPF 283 (357)
T ss_pred HHHHhccC---HHHhcCCCCChHHhhcCcc
Confidence 99999999 99995 8999999998
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=426.24 Aligned_cols=260 Identities=47% Similarity=0.774 Sum_probs=239.9
Q ss_pred ccccCCCCCCeeEEEEeeecCcEEEEEEEECCce-EEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 668 ~~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g~~-VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
...+.+.+.++.+.+.||+|+||+||+|.|+|+. ||||++............|.+|+.+|.+++|||||+|+|++..+.
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3456778888888899999999999999999998 999999988777666889999999999999999999999999988
Q ss_pred -ceEEEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC-cEEEEecccc
Q 002331 747 -NLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLS 823 (935)
Q Consensus 747 -~l~LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~VKL~DFGlA 823 (935)
.++|||||+++|+|.+++++ ....+++..++.|+.||++||.|||++++ ||||||||+||||+.++ ++||+|||++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccc
Confidence 79999999999999999987 46789999999999999999999999985 99999999999999998 9999999999
Q ss_pred ccccCCcccCCCCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcC
Q 002331 824 RLKHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (935)
Q Consensus 824 ~~~~~~~~~~~s~~GT~~Y~APEvl~--g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~l 901 (935)
+.............||+.|||||+++ ...|+.|+||||||++||||+||..||.+..+.++...+.....++.+|..+
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 98765433444478999999999999 5689999999999999999999999999999988888998899999999999
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
++.+..||++||+.| |.+||++.+|+.
T Consensus 272 ~~~l~~l~~~CW~~d---p~~RP~f~ei~~ 298 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVD---PSRRPSFLEIVS 298 (362)
T ss_pred CHHHHHHHHHhCCCC---CCcCCCHHHHHH
Confidence 999999999999999 999999999875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=417.18 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=216.7
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHH-----HHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-----ALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~-----~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
..+.|.+.+.||+|+||.|-+|.. +|+.||||++.++..... ....+.+|++||++|+|||||+++++|+.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346789999999999999999954 799999999987654332 2233579999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC---CcEEEEecccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLS 823 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~---g~VKL~DFGlA 823 (935)
..||||||++||+|++.+-.+ +.+.+..-..+++||+.||.|||+.| |+||||||+|||+..+ ..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999988664 46778888889999999999999999 9999999999999755 78999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhcccccc--CC
Q 002331 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRL--EI 897 (935)
Q Consensus 824 ~~~~~~~~~~~s~~GT~~Y~APEvl~g~~---~s~ksDIWSLG~ILyELLTG~~PF~~~~~~e-il~~I~~~~~r~--~i 897 (935)
+..++. ....+.|||+.|.|||++.+.. +..++|||||||+||-+++|.+||.+..... +...+....... ..
T Consensus 327 K~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 327 KVSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 998754 4567899999999999998655 3458999999999999999999999865544 444553222222 23
Q ss_pred CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 898 PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 898 p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...++++..+||.+||..| |++||++.|+|+|||
T Consensus 406 w~~Iseea~dlI~~mL~Vd---P~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVD---PENRPSADEALNHPW 439 (475)
T ss_pred hhhhhHHHHHHHHHhhEeC---cccCcCHHHHhcChh
Confidence 3568999999999999999 999999999999999
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=416.49 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=229.6
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~ 749 (935)
...+|.+++.||+|+|++|++|+. .++.||||++.+..+ .+...+-+.+|..+|.+| .||.|++||..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 457899999999999999999975 688999999877654 334455678899999999 8999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+|+||+++|+|.++|++. +.|++...+.++.||+.||+|||++| ||||||||+|||||++|++||+|||.|+.+...
T Consensus 151 FvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999999999885 58999999999999999999999999 999999999999999999999999999976432
Q ss_pred cc-------------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC
Q 002331 830 FL-------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE 896 (935)
Q Consensus 830 ~~-------------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ 896 (935)
.. ...+++||..|.+||+|.+...++.+|||+||||||+|+.|.+||.+.+...+.++|. .....
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--~l~y~ 305 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--ALDYE 305 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--Hhccc
Confidence 11 1256899999999999999999999999999999999999999999999988888874 55677
Q ss_pred CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 897 IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 897 ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+|..+++.+++||+++|..| |.+|++..+|-+|||
T Consensus 306 fp~~fp~~a~dLv~KLLv~d---p~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 306 FPEGFPEDARDLIKKLLVRD---PSDRLTSQQIKAHPF 340 (604)
T ss_pred CCCCCCHHHHHHHHHHHccC---ccccccHHHHhhCcc
Confidence 89999999999999999999 999999999999998
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=401.22 Aligned_cols=253 Identities=27% Similarity=0.443 Sum_probs=229.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
..+|.+.+.||+|+||+||+|++ .+..||||.+.+..+....++.+..|+.||+.++|||||++++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 36799999999999999999976 6789999999998887788888999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC------CcEEEEeccccccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN------WNVKVSDFGLSRLK 826 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~------g~VKL~DFGlA~~~ 826 (935)
|||.||+|.+||++. +.+++..++.++.||+.||++||+++ ||||||||.||||+.. -.+||+|||+|+..
T Consensus 89 EyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999875 47999999999999999999999999 9999999999999754 46999999999988
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-cCCCCcCcHHH
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-LEIPKELDPLV 905 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r-~~ip~~ls~~L 905 (935)
.+. ....+.||++.|||||++....|+.|+|+||+|+|||+|++|+.||...++.++...+...... +.++..++..+
T Consensus 166 ~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 166 QPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred Cch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 755 3456789999999999999999999999999999999999999999999999998877654443 34556678888
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+|+...++.+ |..|.++.+-+.|+|
T Consensus 245 ~~Ll~~ll~~~---~~~~~~~~~~~~~~~ 270 (429)
T KOG0595|consen 245 RELLISLLQRN---PKDRISFEDFFDHPF 270 (429)
T ss_pred hhhhhHHHhcC---ccccCchHHhhhhhh
Confidence 89999999999 999999999888876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=387.09 Aligned_cols=251 Identities=24% Similarity=0.447 Sum_probs=230.4
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
...++|++.+.||.|+||.|.+++. +|..||+|++.++..-. ...+...+|..+|+.+.||+++++++.|.+...+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 5568999999999999999999976 68899999998775533 44566789999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
|||||++||.|+.++++. +++++..++.++.||+.||+|||.++ |++|||||+|||||.+|++||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999999775 47999999999999999999999999 999999999999999999999999999987654
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
.-+.||||.|+|||++..+.|..++|+|+|||++|||+.|.+||...++.+++.+|. .....+|..+++++++||
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~--~~~v~fP~~fs~~~kdLl 272 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL--EGKVKFPSYFSSDAKDLL 272 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH--hCcccCCcccCHHHHHHH
Confidence 345899999999999999999999999999999999999999999999999999985 567788999999999999
Q ss_pred HHHHhhCCCCcCCC-----cCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIR-----TSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kR-----PSa~EILqHPF 934 (935)
+.+|+.| -.+| ...++|..|||
T Consensus 273 ~~LL~vD---~t~R~gnlknG~~dIk~H~w 299 (355)
T KOG0616|consen 273 KKLLQVD---LTKRFGNLKNGVEDIKNHPW 299 (355)
T ss_pred HHHHhhh---hHhhhcCcCCCccccccCcc
Confidence 9999999 8888 46778999998
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=394.95 Aligned_cols=252 Identities=27% Similarity=0.471 Sum_probs=226.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeec-ccccCCc-e
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG-AVTRPPN-L 748 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g-~~~~~~~-l 748 (935)
....+|+|.++||+|.||+||++.. +|..||.|.+.....+.........|+.+|++|+|||||++++ .|.+++. +
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 4457899999999999999999965 8999999999877778888888999999999999999999999 5666666 9
Q ss_pred EEEEeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CEEeeCCCCCCeeecCCCcEEEEecccc
Q 002331 749 SIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTP--TIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~--~IIHrDLKPeNILLd~~g~VKL~DFGlA 823 (935)
+||||||..|+|.+++++ .+..+++..+|+++.|++.||.++|..-+ .|+||||||.||+|+.+|.|||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999998853 45679999999999999999999999433 3999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC-CcCc
Q 002331 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-KELD 902 (935)
Q Consensus 824 ~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip-~~ls 902 (935)
+..........+.+|||.||+||++.+.+|+.++|||||||++|||+.-++||.+.+-.++..+|.. ...+++| ..++
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q-gd~~~~p~~~YS 254 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ-GDYPPLPDEHYS 254 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc-CCCCCCcHHHhh
Confidence 9988776667788999999999999999999999999999999999999999999999999988863 4555577 7899
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHH
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQ 928 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~E 928 (935)
.++..||..|+..| |+.||+.-.
T Consensus 255 ~~l~~li~~ci~vd---~~~RP~t~~ 277 (375)
T KOG0591|consen 255 TDLRELINMCIAVD---PEQRPDTVP 277 (375)
T ss_pred hHHHHHHHHHccCC---cccCCCcch
Confidence 99999999999999 999998433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=389.51 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=220.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
+.|+.+.++|+|+||+||++++ +|+.||||++....-+....+...+|+++|++|+|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 5688888999999999999976 68899999998887666677778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
||+. ++.+-+++.....+...+.++++|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+....+....
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 9987 555556665667899999999999999999999999 9999999999999999999999999999887665566
Q ss_pred CCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc-------------------ccc
Q 002331 834 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------------QNR 893 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~-------------------~~~ 893 (935)
+.++.|+||+|||.+.| ..|+..+|||++||++.||++|.+.|.+....+.+..|.. .+.
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 77889999999999988 6799999999999999999999999999888776655421 111
Q ss_pred ccCCC----------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 RLEIP----------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 r~~ip----------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+.+.| ..++..+.+|++.||+.| |.+|++.+++|+|+|
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~d---P~~R~sc~qll~H~y 286 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMD---PDDRLSCEQLLHHPY 286 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCC---ccccccHHHHhcChH
Confidence 11111 235567899999999999 999999999999997
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=403.68 Aligned_cols=254 Identities=30% Similarity=0.471 Sum_probs=228.6
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC---HHHHHHHHHHHHHHHHcC-CCceeeeecccccCC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP 746 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~---~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~ 746 (935)
.....|.+++.||+|+||+|++|.+ .+..||||++...... ......+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999976 6899999977654221 233456678999999998 999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC-CcEEEEecccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRL 825 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~VKL~DFGlA~~ 825 (935)
.+||||||+.+|+|++++.+ .+++.+..+..+++||+.|++|||++| |+||||||+|||++.+ +.+||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999999988 678999999999999999999999999 9999999999999999 9999999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCC-C-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcC-c
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRNEP-S-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL-D 902 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g~~-~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~l-s 902 (935)
.........+.+||+.|+|||++.+.. | ..++||||+|++||.|++|+.||.+.+...+..++ ......+|..+ +
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~~S 248 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYLLS 248 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCcCC
Confidence 743334567789999999999999977 7 58999999999999999999999999888888876 56778899999 9
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++++.||.+||..| |.+|+++.+|+.|||
T Consensus 249 ~~~~~Li~~mL~~~---P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 249 PEARSLIEKMLVPD---PSTRITLLEILEHPW 277 (370)
T ss_pred HHHHHHHHHHcCCC---cccCCCHHHHhhChh
Confidence 99999999999999 999999999999999
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=406.35 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=228.8
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
..+..++|++++.||+|+||.||+|+. +|..||+|++++.... ......++.|..+|....+|+||++|..|++.++
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 356779999999999999999999965 7889999999887653 3456678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+||||||++||++..+|.+. ..+++..+..++.+++.|++-||++| +|||||||+|+|||..|||||.||||+....
T Consensus 216 LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred eEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999999775 47999999999999999999999999 9999999999999999999999999986321
Q ss_pred C----------------------Cccc-------------------------CCCCCCCCCccCcccccCCCCCchhHHH
Q 002331 828 N----------------------TFLS-------------------------SKSTAGTPEWMAPEVLRNEPSNEKCDVY 860 (935)
Q Consensus 828 ~----------------------~~~~-------------------------~~s~~GT~~Y~APEvl~g~~~s~ksDIW 860 (935)
. .... ....+|||.|+|||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 0134699999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC--cCcHHHHHHHHHHHhhCCCCcCCCc---CHHHHHhCcC
Q 002331 861 SFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTGWSSLHIRT---SQAQLSHKRF 934 (935)
Q Consensus 861 SLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~--~ls~~L~dLI~qCL~~D~ssP~kRP---Sa~EILqHPF 934 (935)
|||||+||||.|.+||.+.++.+...+|......+.+|. .++++.++||.+||+ | |.+|. .++||-+|||
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d---~~~RLG~~G~~EIK~HPf 447 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-D---PENRLGSKGAEEIKKHPF 447 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-C---HHHhcCcccHHHHhcCCc
Confidence 999999999999999999999999999987776677774 477999999999999 9 99996 5999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=391.04 Aligned_cols=252 Identities=31% Similarity=0.523 Sum_probs=219.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC--ceEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLSII 751 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~--~l~LV 751 (935)
.+|..++.||+|+||.||++.. +|..+|||.+...... ..+.+.+|+.+|.+|+|||||+++|...... .++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 4577788899999999999977 3789999988766322 2667899999999999999999999854444 69999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC-CCcEEEEeccccccccC--
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHN-- 828 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~VKL~DFGlA~~~~~-- 828 (935)
|||+++|+|.+++.+.++.+++..+..+++||++||.|||++| ||||||||+||||+. ++.+||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999887668999999999999999999999999 999999999999999 79999999999987653
Q ss_pred -CcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhccccccCCCCcCcHHH
Q 002331 829 -TFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 829 -~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~-~~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
.........||+.|||||++.+. ....++|||||||++.||+||..||.. ....+.+..+......+.+|..++++.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 11224457899999999999953 345699999999999999999999998 566666666666666678999999999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++||.+|+..+ |.+|||++++|+|||
T Consensus 253 ~~Fl~~C~~~~---p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 253 KDFLRKCFKRD---PEKRPTAEELLEHPF 278 (313)
T ss_pred HHHHHHHhhcC---cccCcCHHHHhhChh
Confidence 99999999999 999999999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=408.13 Aligned_cols=250 Identities=29% Similarity=0.470 Sum_probs=231.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeecc-CCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQ-DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~-~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.-|++++.||+|+.|.|.+|++ +|+.+|||++.+. .........+.+|+-||+.+.||||+++|++|++..++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4588999999999999999987 7999999999876 555566778899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++|.|++++-++ +++.+..+.++++||+.|+.|+|..+ |+||||||+|+||+..+.|||+|||+|.+.... ..
T Consensus 92 Eyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-kl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KL 167 (786)
T ss_pred EecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC-cc
Confidence 999999999999774 57889999999999999999999999 999999999999999999999999999876554 34
Q ss_pred CCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~q 911 (935)
..+.||.+.|.+||++.|.+| +.++||||-|||||.|++|+.||.+.|...++.++ ..+.+.+|..++.++++||.+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCcccCCCcCCHHHHHHHHH
Confidence 567899999999999999998 67999999999999999999999999999999888 577889999999999999999
Q ss_pred HHhhCCCCcCCCcCHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPSa~EILqHPF 934 (935)
||.+| |.+|.+.++|++|||
T Consensus 246 ml~VD---p~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 246 MLDVD---PSTRITTEEILKHPF 265 (786)
T ss_pred HhccC---ccccccHHHHhhCch
Confidence 99999 999999999999999
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=399.38 Aligned_cols=257 Identities=38% Similarity=0.636 Sum_probs=228.1
Q ss_pred ccccCCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 668 ~~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
..+|+|..+++.+++.||+|.||+||+|+|.| .||||++.......+..+.|+.|+.+|++-+|.||+-|+|+|..+..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 46789999999999999999999999999987 79999999988888899999999999999999999999999999877
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
.||+.||+|-+|+.+|+-....|+....+.|++||++||.|||.++ |||||||..||||.+++.|||+|||++....
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeee
Confidence 9999999999999999987788999999999999999999999999 9999999999999999999999999987643
Q ss_pred CC--cccCCCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc---ccccCCCC
Q 002331 828 NT--FLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPK 899 (935)
Q Consensus 828 ~~--~~~~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~---~~r~~ip~ 899 (935)
.- ........|...|||||+++. .+|++.+|||||||++|||++|.+||...+..+++..+... .....+..
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence 21 111233457889999999874 45899999999999999999999999988888777666543 22334456
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 900 ELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+++.++++|+..||..+ +++||.|.+||.
T Consensus 620 ~~pk~mk~Ll~~C~~~~---~~eRP~F~~il~ 648 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFD---REERPLFPQLLS 648 (678)
T ss_pred cCHHHHHHHHHHHHhcC---cccCccHHHHHH
Confidence 78899999999999999 999999999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=403.02 Aligned_cols=250 Identities=28% Similarity=0.456 Sum_probs=232.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|.+.+.||+|+||.||+|+. +.+.||||.+.+....+..+..+.+|++|++.|+|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5788899999999999999965 56789999999988888888899999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
|+.| +|+.+|.. ++.++++.+..|+.|++.||.|||+++ |+|||+||.||||+..|.+|+||||+++.........
T Consensus 82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9977 99999976 457999999999999999999999999 9999999999999999999999999999887765556
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL 913 (935)
....|||.|||||++.+++|+..+|+||||||+|||+.|++||......++...|. ..+...|..++..+..||+.+|
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~--~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL--KDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh--cCCCCCcccccHHHHHHHHHHh
Confidence 67789999999999999999999999999999999999999999999999998884 4555667789999999999999
Q ss_pred hhCCCCcCCCcCHHHHHhCcC
Q 002331 914 QTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 914 ~~D~ssP~kRPSa~EILqHPF 934 (935)
++| |.+|.+..+++.|||
T Consensus 236 ~kd---P~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 236 IKD---PAQRLTWTDLLGHPF 253 (808)
T ss_pred hcC---hhhcccHHHHhcChH
Confidence 999 999999999999998
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=405.12 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=231.2
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~ 747 (935)
.+..++|.+.++||+|.||+|+++.. +++.||||++++... .++..+..+.|.+|+... +||++++++..|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 46678999999999999999999976 567899999998754 556778888999999888 69999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+|+||||+.||++..+++. ..+++..+..++..|+.||+|||++| |||||||.+|||||.+|++||+|||+++...
T Consensus 444 l~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999996555543 57999999999999999999999999 9999999999999999999999999999766
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
.......++||||.|||||++.+..|+..+|||+|||+||||+.|+.||.+.+..++...|. ...+.+|..++.+...
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--~d~~~yP~~ls~ea~~ 597 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSKEAIA 597 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCCCCCCcccHHHHH
Confidence 44556778999999999999999999999999999999999999999999999999999884 5567789999999999
Q ss_pred HHHHHHhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPS-----a~EILqHPF 934 (935)
+|+++|.++ |++|.. +++|..|||
T Consensus 598 il~~ll~k~---p~kRLG~~e~d~~~i~~hpF 626 (694)
T KOG0694|consen 598 IMRRLLRKN---PEKRLGSGERDAEDIKKHPF 626 (694)
T ss_pred HHHHHhccC---cccccCCCCCCchhhhhCCc
Confidence 999999999 999975 588999998
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=374.72 Aligned_cols=248 Identities=23% Similarity=0.423 Sum_probs=220.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||+|.+ .++.||||++...... ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4789999999999999999987 4889999998765432 234556889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 999999999999764 46899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qC 912 (935)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+. .....+|..+++.+++||++|
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL--AGKLEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCcCCCccCCHHHHHHHHHH
Confidence 223578999999999999999999999999999999999999999988887777664 345667888899999999999
Q ss_pred HhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 913 WQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 913 L~~D~ssP~kRPS-----a~EILqHPF 934 (935)
|+.| |.+||+ ++++++|||
T Consensus 233 l~~d---p~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 233 LVVD---RTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred cCCC---HHHccCCccCCHHHHhcCcc
Confidence 9999 999995 999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=397.46 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=219.1
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeecccccCC-ce
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP-NL 748 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~-~l 748 (935)
+..++|.++++||.|+||.||+|+. .+..||||+++.....-+.. .-.||++-|++|+ |||||++.+++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 4457899999999999999999965 68889999998776553322 3368999999997 999999999999888 89
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|+|||||+. +|+++++.++..|++..++.|+.||++||+|+|++| +.||||||+||||..+..|||+|||+|+.+..
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccccccccccc
Confidence 999999976 999999988889999999999999999999999999 99999999999999999999999999997754
Q ss_pred CcccCCCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-----------
Q 002331 829 TFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE----------- 896 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~-g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~----------- 896 (935)
.. ..+.++.|+||+|||++. ...|+.++|||++|||++|+++-++.|.|.+..+.+.+|..--+.+.
T Consensus 163 kp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 KP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred CC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 32 234578999999999875 56689999999999999999999999999988777766532111111
Q ss_pred ------CC-----------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 897 ------IP-----------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 897 ------ip-----------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+| ..++.++.+||.+||..| |.+||++.|+|+|||
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WD---P~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWD---PDKRPTASQALQHPF 293 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCC---CccCccHHHHhcCcc
Confidence 11 347789999999999999 999999999999998
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=381.78 Aligned_cols=251 Identities=26% Similarity=0.428 Sum_probs=223.1
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
+..++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++.+++.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 4458899999999999999999987 578899999876533 2234566889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999999999764 46889999999999999999999999 999999999999999999999999999866443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
. ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.++.+....+. .....+|..++..+++||
T Consensus 172 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li 246 (329)
T PTZ00263 172 T---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRARDLV 246 (329)
T ss_pred c---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHHHHH
Confidence 2 23579999999999999999999999999999999999999999988887777664 345667888999999999
Q ss_pred HHHHhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPS-----a~EILqHPF 934 (935)
.+||+.| |.+||+ +++|+.|||
T Consensus 247 ~~~L~~d---P~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 247 KGLLQTD---HTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred HHHhhcC---HHHcCCCCCCCHHHHhcCCc
Confidence 9999999 999986 899999998
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=397.23 Aligned_cols=257 Identities=27% Similarity=0.475 Sum_probs=231.0
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
+...-+...|...++||+|..|.||.++. +++.||||++...... ..+-+..|+.+|+.++|+|||++++.|...+
T Consensus 266 ~~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 266 VSQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred ccCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 33445567788889999999999999975 6778999998776543 3445789999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+|+|||||++|+|.+++.. ..++|.++..|+++++.||+|||.+| |||||||.+|||++.+|.+||+|||++..+
T Consensus 344 eLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred eeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 99999999999999999976 35999999999999999999999999 999999999999999999999999999988
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccCCCCcCcHHH
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLV 905 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~-~r~~ip~~ls~~L 905 (935)
........+.+||+.|||||++....|++++||||||++++||+.|.+||...++...+..+...+ .....+..+++.+
T Consensus 420 ~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~ 499 (550)
T KOG0578|consen 420 SEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPEL 499 (550)
T ss_pred ccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHH
Confidence 776666778999999999999999999999999999999999999999999999988887775333 2345668899999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++|+.+||+.| +.+|+++.+||+|||
T Consensus 500 kdFL~~cL~~d---v~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 500 KDFLDRCLVVD---VEQRASAKELLEHPF 525 (550)
T ss_pred HHHHHHHhhcc---hhcCCCHHHHhcChh
Confidence 99999999999 999999999999998
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=379.66 Aligned_cols=245 Identities=24% Similarity=0.413 Sum_probs=215.7
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 758 (935)
+.||+|+||.||++++ +++.||||++..... .......+.+|+.++++++||||+++++++...+.+||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 678999999876432 2334556788999999999999999999999999999999999999
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCC
Q 002331 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 838 (935)
Q Consensus 759 sL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~G 838 (935)
+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 999998764 47899999999999999999999999 999999999999999999999999998754333233345679
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCC
Q 002331 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWS 918 (935)
Q Consensus 839 T~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~s 918 (935)
|+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. .....+|..+++.+.+||.+||+.|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~d-- 233 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKD-- 233 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCC--
Confidence 999999999999999999999999999999999999999988777766653 3455678889999999999999999
Q ss_pred CcCCCc-----CHHHHHhCcC
Q 002331 919 SLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 919 sP~kRP-----Sa~EILqHPF 934 (935)
|.+|| ++.+|++|||
T Consensus 234 -P~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 234 -PKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred -HHHcCCCCCCCHHHHHcCCC
Confidence 99999 8999999999
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=378.99 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=220.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|.+.+.||+|+||.||+|++. ++.||||++....... .....+..|+.++..++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999874 8899999987654322 34567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc--
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 830 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~-- 830 (935)
||+++++|.+++.+. ..+++..++.++.||+.||.|||.+| |+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999999765 57899999999999999999999998 9999999999999999999999999998654432
Q ss_pred ---------------------------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 002331 831 ---------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883 (935)
Q Consensus 831 ---------------------------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~e 883 (935)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 12334579999999999999999999999999999999999999999998877
Q ss_pred HHHHhhccccccCCCC--cCcHHHHHHHHHHHhhCCCCcCCCcC-HHHHHhCcC
Q 002331 884 VVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTGWSSLHIRTS-QAQLSHKRF 934 (935)
Q Consensus 884 il~~I~~~~~r~~ip~--~ls~~L~dLI~qCL~~D~ssP~kRPS-a~EILqHPF 934 (935)
....+........+|. .+++.+.+||.+||. + |.+||+ ++++++|||
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-d---p~~R~~s~~~ll~hp~ 287 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-D---PEDRLGSFEEIKSHPF 287 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-C---hhhcCCCHHHHhcCCC
Confidence 7776654333444443 359999999999997 9 999999 999999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=394.75 Aligned_cols=255 Identities=35% Similarity=0.595 Sum_probs=230.0
Q ss_pred ccccCCCCCCeeEEEEeeecCcEEEEEEEECCc-eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 668 ~~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g~-~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
...++++.+.+++++.||+|-||.||+|.|++. .||||.++..... ...|.+|+++|++|+|+|||++++++..++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 455778888899999999999999999999887 9999999876443 346779999999999999999999999988
Q ss_pred ceEEEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 747 NLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
.+|||||||+.|+|.+||.. .+..+...+.+.++.|||+||+||++++ +|||||-.+||||++++.+||+|||+++.
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccc
Confidence 99999999999999999986 5677899999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCcccCC-CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 826 KHNTFLSSK-STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 826 ~~~~~~~~~-s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
..+..+... ...-...|.|||.+....++.++|||||||+||||+| |+.||.+....+++..+. .+.+..-|..||+
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPD 431 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCH
Confidence 665544322 2223458999999999999999999999999999998 799999999999999885 7889999999999
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
++.+|+..||+.+ |++||||+.+..
T Consensus 432 ~vY~lM~~CW~~~---P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 432 EVYELMKSCWHED---PEDRPTFETLRE 456 (468)
T ss_pred HHHHHHHHHhhCC---cccCCCHHHHHH
Confidence 9999999999999 999999997653
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=378.58 Aligned_cols=255 Identities=26% Similarity=0.382 Sum_probs=216.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||+||++++ +++.||||++..... .......+..|+.++..++|+||+++++.+.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999976 578999999876433 2234456788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 831 (935)
||+++|+|.+++.+. ..+++..+..++.||+.||.|||++| |+||||||+||||+.++++||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999999999764 47899999999999999999999999 99999999999999999999999999875432100
Q ss_pred ----------------------------------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002331 832 ----------------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877 (935)
Q Consensus 832 ----------------------------------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~ 877 (935)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0123579999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHhhccccccCCCC--cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 878 GMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 878 ~~~~~eil~~I~~~~~r~~ip~--~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+.+..+....+........+|. .+++++++||.+|+. +|..+..||++++|++|||
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~ 295 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPF 295 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCC
Confidence 9888887777654444444553 468999999999875 5344556799999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.57 Aligned_cols=253 Identities=23% Similarity=0.295 Sum_probs=211.1
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++.++||.|+||.||+|.. +++.||||++...... .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 47899999999999999999976 5788999998654322 22345678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++ +|.+++......+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 99975 899988766666889999999999999999999998 999999999999999999999999999765433333
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------------
Q 002331 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------------- 894 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r----------------- 894 (935)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 344568999999999875 56899999999999999999999999987765554433110000
Q ss_pred c-----------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 L-----------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ~-----------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. .....++.++++||.+||+.| |.+|||++|+|+|||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d---p~~R~t~~~~l~hp~ 287 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYE---TKSRISAEAALRHSY 287 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcC---cccCCCHHHHhcCCC
Confidence 0 011346788999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=374.79 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=217.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||+|++ .++.||||++...... ......+.+|+.++..++||||+++++++...+.+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3689999999999999999987 5789999998765332 234556889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++..... .
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y 154 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence 999999999999763 46889999999999999999999999 99999999999999999999999999986543 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC------cCcHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK------ELDPLVA 906 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~------~ls~~L~ 906 (935)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.........|. .+++++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 3456799999999999999999999999999999999999999999888777665543222222222 4689999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||.+||..+ |.+||++++|++|||
T Consensus 235 ~li~~~l~~~---~~rr~s~~~ll~h~~ 259 (333)
T cd05600 235 DLITKLINDP---SRRFGSLEDIKNHPF 259 (333)
T ss_pred HHHHHHhhCh---hhhcCCHHHHHhCcc
Confidence 9999999999 999999999999998
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.47 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=210.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|+||.||++++ +++.||||++............+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4799999999999999999987 46789999987665444455678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc-cc
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-LS 832 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~ 832 (935)
|++++.+..+.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 999876665543 3456899999999999999999999998 9999999999999999999999999998754321 12
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------------cc
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-----------------RL 895 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~-----------------r~ 895 (935)
.....|++.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+..... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 2345689999999999998899999999999999999999999998765443322211000 00
Q ss_pred C-------------CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 E-------------IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ~-------------ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. ....++.++.+||.+||+.| |.+||+++++|+|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~---P~~R~s~~~~l~hp~ 286 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLN---PTDRYLTEQCLNHPA 286 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCC---cccCCCHHHHhcCCC
Confidence 0 11236788999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=361.50 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=222.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
.+|...++||+|.||.||+|++ +|+.||||+++..+..+.......+|++.|+.++|+||+.++++|-+...+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677888999999999999976 78999999999887766666678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
|++. +|+..++.....+....+..++.++++||+|||.+. |+||||||.|+||+.+|.+||+|||+++.........
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 9975 999999988889999999999999999999999999 9999999999999999999999999999988766555
Q ss_pred CCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC---------CC-----
Q 002331 834 KSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE---------IP----- 898 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~---------ip----- 898 (935)
...+.|++|+|||.+.|.+ |+..+||||.|||+.||+-|.+.|.+.+..+.+..+-..-+.+. +|
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 5558899999999998854 89999999999999999999999999888776665521111110 11
Q ss_pred ------------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 ------------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 ------------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...+.++.+|+.+||..| |.+|+++.|+|+|+|
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~yn---P~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYN---PKKRITASQALKHPY 283 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccC---chhcccHHHHhcchh
Confidence 235677899999999999 999999999999997
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=371.38 Aligned_cols=243 Identities=23% Similarity=0.376 Sum_probs=214.2
Q ss_pred eeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCCH
Q 002331 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (935)
Q Consensus 684 LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL 760 (935)
||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++...+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999987 577899999875432 334456778899999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCCCC
Q 002331 761 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 840 (935)
Q Consensus 761 ~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~ 840 (935)
.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.............||+
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 9999764 46899999999999999999999999 99999999999999999999999999986433323334567999
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCc
Q 002331 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSL 920 (935)
Q Consensus 841 ~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP 920 (935)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....++..+++.+.+||.+||+.| |
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~d---p 232 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRD---P 232 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcCCC---H
Confidence 9999999999999999999999999999999999999988877766653 4466778889999999999999999 9
Q ss_pred CCCc---CHHHHHhCcC
Q 002331 921 HIRT---SQAQLSHKRF 934 (935)
Q Consensus 921 ~kRP---Sa~EILqHPF 934 (935)
.+|| ++.++++|||
T Consensus 233 ~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 233 TRRLGYNGAQEIKNHPF 249 (312)
T ss_pred HHcCCCCCHHHHHcCCC
Confidence 9997 5899999998
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=387.39 Aligned_cols=256 Identities=25% Similarity=0.339 Sum_probs=223.4
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC--Cce
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 748 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l 748 (935)
...+.|+.+++||+|+||.||+|++ +|+.||+|+++.....+.......+||.||++|+||||+++.+..... ..+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3346788899999999999999976 788899999998887777777888999999999999999999998776 679
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|||+|||+. +|.-++...+-.|++.++..|+.||+.||+|+|.+| |+|||||..|||||.+|.+||+|||+|+++..
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999999977 999999888888999999999999999999999999 99999999999999999999999999997754
Q ss_pred Ccc-cCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------c--CCC
Q 002331 829 TFL-SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------L--EIP 898 (935)
Q Consensus 829 ~~~-~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r------~--~ip 898 (935)
... ..+..+-|+||+|||.+.|.. |+.++|+||.||||.||+.|++.|.+.+..+.+..|-..-+- . .+|
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 432 245567899999999999865 899999999999999999999999999887777665211110 0 112
Q ss_pred -------------------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 -------------------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 -------------------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++....+|+..||..| |.+|.|+.++|++.|
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ld---P~kR~tA~~aL~sey 402 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLD---PDKRGTASSALQSEY 402 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccC---ccccccHHHHhcCcc
Confidence 357788999999999999 999999999999988
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=372.32 Aligned_cols=245 Identities=24% Similarity=0.413 Sum_probs=214.5
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 758 (935)
+.||+|+||.||+++. +++.||+|++..... .......+.+|+.+++.++||||++++++|...+.+||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999976 678999999876532 2334556778999999999999999999999999999999999999
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCC
Q 002331 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 838 (935)
Q Consensus 759 sL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~G 838 (935)
+|..++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++..............|
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 999988664 46899999999999999999999998 999999999999999999999999998754333233344679
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCC
Q 002331 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWS 918 (935)
Q Consensus 839 T~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~s 918 (935)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .....+|..+++.+.+||.+||+.|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~d-- 233 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKD-- 233 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCC--
Confidence 999999999999999999999999999999999999999988877766653 2345677889999999999999999
Q ss_pred CcCCCc-----CHHHHHhCcC
Q 002331 919 SLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 919 sP~kRP-----Sa~EILqHPF 934 (935)
|.+|+ ++.++++|||
T Consensus 234 -P~~R~~~~~~~~~~~l~h~~ 253 (323)
T cd05595 234 -PKQRLGGGPSDAKEVMEHRF 253 (323)
T ss_pred -HHHhCCCCCCCHHHHHcCCC
Confidence 99998 9999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=376.73 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=222.7
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEEC---CceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWN---GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~---g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
..+..++|++.+.||+|+||.||+|.+. +..||||++..... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4566789999999999999999999753 25799999875432 2334566889999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+|+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999999999764 46899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHH
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.++......+. .....+|..+++.+.
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~ 256 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL--EGIIYFPKFLDNNCK 256 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHH
Confidence 432 234679999999999999889999999999999999999999999988877776664 334567888999999
Q ss_pred HHHHHHHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 907 RIIWECWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
++|++||+.| |.+|+ +++++++|||
T Consensus 257 ~li~~~l~~d---p~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 257 HLMKKLLSHD---LTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred HHHHHHcccC---HHHcCCCCCCCHHHHHcCCC
Confidence 9999999999 99995 8999999998
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=362.19 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=212.8
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
|++.+.||+|+||.||++.+ +++.||||++....... .....+.+|+.++..++|+||+++++++.+.+.+++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 77889999999999999975 68899999987654332 2334577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 755 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 755 ~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
+++|+|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TV 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-ee
Confidence 9999999887542 346899999999999999999999998 9999999999999999999999999998654321 22
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh--ccccccCCCCcCcHHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~--~~~~r~~ip~~ls~~L~dLI~q 911 (935)
....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+. .......++..+++.+.+||.+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence 34578999999999999999999999999999999999999998765432221111 1233445677889999999999
Q ss_pred HHhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 912 CWQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPS-----a~EILqHPF 934 (935)
||+.| |.+||+ ++++++|||
T Consensus 239 ~l~~~---P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 239 LLTKN---PKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred HhhcC---HHHhcCCCCCCHHHHhcCHh
Confidence 99999 999997 899999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=371.10 Aligned_cols=255 Identities=31% Similarity=0.502 Sum_probs=211.1
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeeccc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 742 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~ 742 (935)
+++..++|++.++||+|+||.||+|.+ .++.||||++.... .......+.+|+.+|..+ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 567889999999999999999999964 24579999987542 334456788999999999 899999999988
Q ss_pred ccCC-ceEEEEeeCCCCCHHHHHcCCC-----------------------------------------------------
Q 002331 743 TRPP-NLSIITEFLPRGSLFRILHRPH----------------------------------------------------- 768 (935)
Q Consensus 743 ~~~~-~l~LVmEy~~gGsL~dlL~~~~----------------------------------------------------- 768 (935)
...+ .+++||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7644 5899999999999999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc--ccCCCCCC
Q 002331 769 --------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAG 838 (935)
Q Consensus 769 --------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~--~~~~s~~G 838 (935)
..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .......+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 23677888999999999999999998 9999999999999999999999999998653221 11223345
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 839 T~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
++.|+|||++.+..++.++|||||||+||||++ |..||.+....+..............+..+++.+.+||.+||+.|
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d- 317 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGD- 317 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCC-
Confidence 678999999999999999999999999999997 999998865443333333344455667888999999999999999
Q ss_pred CCcCCCcCHHHHHh
Q 002331 918 SSLHIRTSQAQLSH 931 (935)
Q Consensus 918 ssP~kRPSa~EILq 931 (935)
|.+||++.+|++
T Consensus 318 --p~~RPs~~el~~ 329 (338)
T cd05102 318 --PKERPTFSALVE 329 (338)
T ss_pred --hhhCcCHHHHHH
Confidence 999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=376.42 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=216.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||+|++ .++.||||++..... .......+.+|+.+|..++||||++++++|.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999987 578999999976533 2234556788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 831 (935)
||+++|+|.+++.+. ..+++..+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999999999998764 46899999999999999999999999 99999999999999999999999999875422100
Q ss_pred -------------------------------------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 002331 832 -------------------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL 874 (935)
Q Consensus 832 -------------------------------------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~ 874 (935)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112469999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhccccccCCCC--cCcHHHHHHHHHHHhhCCCCcCCCcC---HHHHHhCcC
Q 002331 875 PWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTGWSSLHIRTS---QAQLSHKRF 934 (935)
Q Consensus 875 PF~~~~~~eil~~I~~~~~r~~ip~--~ls~~L~dLI~qCL~~D~ssP~kRPS---a~EILqHPF 934 (935)
||...+..+....+........+|. .+++.+++||.+||. + |.+|++ +.++++|||
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~---p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-E---AERRLGNNGVNEIKSHPF 298 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-C---HhhcCCCCCHHHHhcCCC
Confidence 9999988877766654444444444 468999999999996 8 999997 999999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=372.64 Aligned_cols=245 Identities=23% Similarity=0.406 Sum_probs=215.0
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 758 (935)
+.||+|+||.||+++. +++.||||++..... .......+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 678999999876532 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCC
Q 002331 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 838 (935)
Q Consensus 759 sL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~G 838 (935)
+|..++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 999988664 46899999999999999999999999 999999999999999999999999998754332223344679
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCC
Q 002331 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWS 918 (935)
Q Consensus 839 T~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~s 918 (935)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....+|..+++++.+||.+||+.|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~d-- 233 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKD-- 233 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHcCCC--
Confidence 999999999999999999999999999999999999999888777766553 3455678889999999999999999
Q ss_pred CcCCCc-----CHHHHHhCcC
Q 002331 919 SLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 919 sP~kRP-----Sa~EILqHPF 934 (935)
|.+|+ ++.+|++|||
T Consensus 234 -P~~R~~~~~~~~~~il~h~~ 253 (328)
T cd05593 234 -PNKRLGGGPDDAKEIMRHSF 253 (328)
T ss_pred -HHHcCCCCCCCHHHHhcCCC
Confidence 99997 8999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=369.50 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=214.8
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHH---HHcCCCceeeeecccccCCceEEE
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIM---RRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL---~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
|++.+.||+|+||.||+|.+ +++.||||++..... .......+.+|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999976 578999999876532 223345566776665 456799999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+++++|..++.+ ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999999998865 46899999999999999999999998 99999999999999999999999999875433323
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~q 911 (935)
.....+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..+++.+.++|.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~ 234 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSREAISIMRR 234 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHH
Confidence 3345679999999999999999999999999999999999999999988887776664 33455778899999999999
Q ss_pred HHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
||+.| |.+|| ++.++++|||
T Consensus 235 ~L~~d---P~~R~~~~~~~~~~l~~~~~ 259 (324)
T cd05589 235 LLRRN---PERRLGSGEKDAEDVKKQPF 259 (324)
T ss_pred HhhcC---HhHcCCCCCCCHHHHhhCCC
Confidence 99999 99999 7999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=367.00 Aligned_cols=250 Identities=21% Similarity=0.348 Sum_probs=217.1
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCC-CceeeeecccccCCceEEEE
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~H-PNIVkl~g~~~~~~~l~LVm 752 (935)
+|++.+.||+|+||.||+|++ .++.||||++..... .......+..|+.++..+.| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 588999999999999999977 456899999876432 23445667889999999966 56889999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 999999999998653 46889999999999999999999998 999999999999999999999999998754322223
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qC 912 (935)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..++..+.++|.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~ 235 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGL 235 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence 344679999999999999999999999999999999999999999988887777664 345667888999999999999
Q ss_pred HhhCCCCcCCCcCH-----HHHHhCcC
Q 002331 913 WQTGWSSLHIRTSQ-----AQLSHKRF 934 (935)
Q Consensus 913 L~~D~ssP~kRPSa-----~EILqHPF 934 (935)
|+.| |.+|++. +++++|||
T Consensus 236 l~~~---P~~R~~~~~~~~~~~~~hp~ 259 (324)
T cd05587 236 LTKH---PAKRLGCGPTGERDIREHAF 259 (324)
T ss_pred hhcC---HHHcCCCCCCCHHHHhcCCC
Confidence 9999 9999976 89999998
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=369.63 Aligned_cols=245 Identities=25% Similarity=0.400 Sum_probs=213.9
Q ss_pred EEeeecCcEEEEEEEE-----CCceEEEEEeeccCCC--HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 682 ERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~--~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+.||+|+||.||+++. .++.||||++...... ......+..|+.+|+.++||||++++++|..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999964 4678999998764321 22344577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
+++++|.+++.+. ..+.+..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 9999999999764 46788888899999999999999999 99999999999999999999999999875433323334
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHh
Q 002331 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914 (935)
Q Consensus 835 s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~ 914 (935)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. .....+|..+++.+.+||.+||+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL--KGKLNLPPYLTPEARDLLKKLLK 236 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHcc
Confidence 4679999999999999889999999999999999999999999988877766663 34556788899999999999999
Q ss_pred hCCCCcCCCc-----CHHHHHhCcC
Q 002331 915 TGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 915 ~D~ssP~kRP-----Sa~EILqHPF 934 (935)
.+ |.+|| +++++++|||
T Consensus 237 ~~---p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 237 RN---PSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred cC---HhHcCCCCCCCHHHHhcCCC
Confidence 99 99999 8999999998
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=371.07 Aligned_cols=245 Identities=23% Similarity=0.413 Sum_probs=213.8
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 758 (935)
+.||+|+||.||++++ +++.||||++..... .......+..|++++..++||||+++++++...+.+||||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 678999999876533 2234556778999999999999999999999999999999999999
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 759 sL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
+|..++.+. ..+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++.............
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 999988664 468999999999999999999997 67 99999999999999999999999999875433222334467
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+. .....+|..+++++.+||.+||+.|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~d- 234 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKKD- 234 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhhcC-
Confidence 9999999999999999999999999999999999999999988877766653 3455678889999999999999999
Q ss_pred CCcCCCc-----CHHHHHhCcC
Q 002331 918 SSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 918 ssP~kRP-----Sa~EILqHPF 934 (935)
|.+|+ ++.++++|||
T Consensus 235 --P~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 235 --PKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred --HHHhCCCCCCCHHHHhcCCC
Confidence 99997 9999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=376.65 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=214.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|.+.+.||+|+||.||++.+ +++.||||++..... .......+.+|++++++++||||++++++|.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4789999999999999999976 688999999876432 3345567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 831 (935)
||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999999763 46889999999999999999999999 99999999999999999999999999863211000
Q ss_pred ----------------------------------------------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHH
Q 002331 832 ----------------------------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVI 865 (935)
Q Consensus 832 ----------------------------------------------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~I 865 (935)
.....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012469999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHhhccccccCCCC--cCcHHHHHHHHHHHhhCCCCcCC---CcCHHHHHhCcC
Q 002331 866 LWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTGWSSLHI---RTSQAQLSHKRF 934 (935)
Q Consensus 866 LyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~--~ls~~L~dLI~qCL~~D~ssP~k---RPSa~EILqHPF 934 (935)
+|||++|.+||.+.+..+....+........+|. .++.++.+||.+||+ + |.+ |+++.++++|||
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~---~~~r~~r~~~~~~l~hp~ 307 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-N---AENRLGRGGAHEIKSHPF 307 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-C---HhhcCCCCCHHHHhcCCC
Confidence 9999999999998888777666644334444554 478999999999997 6 565 469999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=370.86 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=218.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|.+.+.||+|+||.||++++ +++.||||++..... .......+.+|+.+++.++|+||+++++++.+.+.++|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4689999999999999999976 688999999886543 2334566889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 831 (935)
||+++++|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999999876567999999999999999999999999 99999999999999999999999999986543221
Q ss_pred cCCCCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC--cCcH
Q 002331 832 SSKSTAGTPEWMAPEVLR------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDP 903 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~------g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~--~ls~ 903 (935)
......||+.|+|||++. +..++.++|||||||++|+|++|+.||...+.......+........+|. .++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 223357899999999987 45678899999999999999999999998887777666543333333443 5789
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+.+||.+||+ + |.+||+++++++|||
T Consensus 239 ~~~~li~~ll~-~---p~~R~t~~~l~~h~~ 265 (330)
T cd05601 239 DFLDLIQSLLC-G---QKERLGYEGLCCHPF 265 (330)
T ss_pred HHHHHHHHHcc-C---hhhCCCHHHHhCCCC
Confidence 99999999997 9 999999999999998
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=361.32 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=206.1
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++.+.||+|+||.||+|+. +++.||||++...... .....+.+|+.+++.++||||+++++++.++...++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 36899999999999999999987 6789999998754322 22335678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||++ ++|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9996 5888888765567899999999999999999999999 999999999999999999999999998765433333
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccc----------------
Q 002331 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRR---------------- 894 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~-eil~~I~~~~~r---------------- 894 (935)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+..+......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 344678999999999876 45789999999999999999999999876442 222211100000
Q ss_pred ---cC--CC---------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 ---LE--IP---------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ---~~--ip---------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.. .+ ..+++.+.+||.+||+.| |.+|||+.++|+|||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d---p~~R~s~~~~l~h~~ 290 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCF---PKNRLSAQAALSHEY 290 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccC---chhccCHHHHhcCcc
Confidence 00 00 123467899999999999 999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=375.69 Aligned_cols=254 Identities=25% Similarity=0.369 Sum_probs=213.9
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
.|++++.||+|+||+||+|++ +++.||||++..... .......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588999999999999999976 677899999976543 33456678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc---
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--- 830 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~--- 830 (935)
|+++|+|.+++.+. ..+++..+..++.||+.||.|||..| |+||||||+||||+.++++||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 99999999999764 46889999999999999999999998 9999999999999999999999999975321000
Q ss_pred --------------------------------------------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHH
Q 002331 831 --------------------------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 866 (935)
Q Consensus 831 --------------------------------------------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~IL 866 (935)
......+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001235799999999999998899999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHhhccccccCCCC--cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 867 WELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 867 yELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~--~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|||++|..||...++.+....+........+|. .+++++.+||.+|+..+ ..+..|+++.+|++|||
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~-~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSA-EERLGRNGADDIKAHPF 307 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCc-ccccCCCCHHHHhcCcc
Confidence 999999999998887766665543344444443 57899999999966544 11556999999999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=364.10 Aligned_cols=254 Identities=25% Similarity=0.358 Sum_probs=214.2
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
+..++|++.+.||+|+||.||++++ .+..||+|++.... .......+.+|+++|+.++||||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4568999999999999999999987 47789999887542 34456678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred EeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 99999999999999764 46889999999999999999999853 3999999999999999999999999998765432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--------------------
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------------- 890 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~-------------------- 890 (935)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+..
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 22345789999999999999999999999999999999999999987665444322110
Q ss_pred -------------------------cccccCCC-CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 891 -------------------------QNRRLEIP-KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 891 -------------------------~~~r~~ip-~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...++..+ ..+++++++||.+||+.| |++||++++|++|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~---P~~Rpt~~ell~h~~ 303 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKN---PAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCC---cccCCCHHHHhcChH
Confidence 00111111 246789999999999999 999999999999998
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=364.89 Aligned_cols=249 Identities=29% Similarity=0.402 Sum_probs=208.3
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
..++|+++++||+|+||.||+|++ +++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+++|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 346778889999999999999987 57899999986543 334556788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+++++|... ....+..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 151 ~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 151 LEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999999998653 23567788899999999999999999 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhccccccCCCCcCcH
Q 002331 832 SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g-----~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~---eil~~I~~~~~r~~ip~~ls~ 903 (935)
......||..|+|||++.. ...+.++|||||||++|||++|+.||...... .....+. .......+..++.
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 302 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATASR 302 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCCCCccCH
Confidence 3345679999999998843 33456899999999999999999999854322 2222222 3344556778899
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++++||.+||+.| |.+||++.|||+|||
T Consensus 303 ~l~~li~~~l~~~---P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 303 EFRHFISCCLQRE---PAKRWSAMQLLQHPF 330 (353)
T ss_pred HHHHHHHHHccCC---hhhCcCHHHHhcCcc
Confidence 9999999999999 999999999999999
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.89 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=223.3
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|.+.+.||+|+||.||++.+ +++.|++|.+............+.+|+.+++.++||||+++++++...+.+++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 578899999999999999976 678999999887666666777889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 755 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 755 ~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 9999999999764 457899999999999999999999998 9999999999999999999999999988765443333
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL 913 (935)
....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+. ......++..++..+.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQCL 237 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHHc
Confidence 44578899999999999889999999999999999999999999888776666553 33344566678999999999999
Q ss_pred hhCCCCcCCCcCHHHHHhCcC
Q 002331 914 QTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 914 ~~D~ssP~kRPSa~EILqHPF 934 (935)
+.+ |++||++.++++|||
T Consensus 238 ~~~---p~~Rp~~~~ll~~~~ 255 (256)
T cd08529 238 TKD---YRQRPDTFQLLRNPS 255 (256)
T ss_pred cCC---cccCcCHHHHhhCCC
Confidence 999 999999999999998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=372.22 Aligned_cols=259 Identities=29% Similarity=0.419 Sum_probs=224.0
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
..+.+..++|++.++||.|.-++||+|+. .++.||||++........ ++.+.+|+..|..++||||++++..|..+.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 34667778999999999999999999977 678999999987765544 788999999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 747 NLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
.+|+||.||.+|++.++++. ....++|..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||.+..
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeee
Confidence 99999999999999999975 2345999999999999999999999999 99999999999999999999999998765
Q ss_pred ccCCccc----CCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc----
Q 002331 826 KHNTFLS----SKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---- 895 (935)
Q Consensus 826 ~~~~~~~----~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~---- 895 (935)
+.+.... ..++.||++|||||++.. ..|+.|+|||||||+..||.+|+.||....+++++-.-. ++.++
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t 254 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLT 254 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCccc
Confidence 5433221 156789999999999643 568999999999999999999999999999988775432 22222
Q ss_pred -CCC----CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 -EIP----KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 -~ip----~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.++ +.++..++.+|..||..| |.+||++.++|+|+|
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kD---P~kRptAskLlkh~F 295 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKD---PSKRPTASKLLKHAF 295 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcC---cccCCCHHHHhccHH
Confidence 111 346678999999999999 999999999999998
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=375.25 Aligned_cols=259 Identities=22% Similarity=0.360 Sum_probs=221.7
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
...++..++|++.+.||+|+||.||++++ .++.||||++...... ......+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 34566778999999999999999999976 5789999998754322 23344577899999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
+.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999999999965 35788899999999999999999998 99999999999999999999999999986
Q ss_pred ccCCc-ccCCCCCCCCCccCcccccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC-
Q 002331 826 KHNTF-LSSKSTAGTPEWMAPEVLRNE----PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK- 899 (935)
Q Consensus 826 ~~~~~-~~~~s~~GT~~Y~APEvl~g~----~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~- 899 (935)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+........+|.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence 54322 223456799999999998754 378899999999999999999999999888777777654444455554
Q ss_pred -cCcHHHHHHHHHHHhhCCCCcCC--CcCHHHHHhCcC
Q 002331 900 -ELDPLVARIIWECWQTGWSSLHI--RTSQAQLSHKRF 934 (935)
Q Consensus 900 -~ls~~L~dLI~qCL~~D~ssP~k--RPSa~EILqHPF 934 (935)
.++.++.+||.+||+.+ |.+ |+++++|++|||
T Consensus 272 ~~~s~~~~~li~~~L~~~---p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 272 IEISKQAKDLICAFLTDR---EVRLGRNGVDEIKSHPF 306 (370)
T ss_pred CCCCHHHHHHHHHHccCh---hhccCCCCHHHHhcCcc
Confidence 57899999999999988 888 999999999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=369.32 Aligned_cols=245 Identities=27% Similarity=0.427 Sum_probs=215.8
Q ss_pred EEeeecCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCC
Q 002331 682 ERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 756 (935)
+.||+|+||.||+++. .++.||||++............+.+|+++|++++||||+++++++..++.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999864 57899999998655444445567789999999999999999999999999999999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCC
Q 002331 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 836 (935)
Q Consensus 757 gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~ 836 (935)
+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.............
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 99999999663 46899999999999999999999999 9999999999999999999999999988654432333456
Q ss_pred CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhC
Q 002331 837 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTG 916 (935)
Q Consensus 837 ~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D 916 (935)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....+|..+++.+.+||.+||+.|
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 79999999999999889999999999999999999999999988877776653 3445678889999999999999999
Q ss_pred CCCcCCCcC-----HHHHHhCcC
Q 002331 917 WSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 917 ~ssP~kRPS-----a~EILqHPF 934 (935)
|.+||+ .+++++|||
T Consensus 237 ---P~~R~~a~~~~~~~~~~~~~ 256 (318)
T cd05582 237 ---PANRLGAGPDGVEEIKRHPF 256 (318)
T ss_pred ---HhHcCCCCCCCHHHHhCCCC
Confidence 999999 788999998
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=367.17 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=213.8
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.||+|+||.||+|++ +++.||||++..... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999976 578899999875432 223455677888888877 799999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.............
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 9999988764 46899999999999999999999999 99999999999999999999999999876433323334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. .....+|..++.++.+||.+||+.|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~d- 234 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTKN- 234 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHcccC-
Confidence 9999999999999999999999999999999999999999998888777664 3445677889999999999999999
Q ss_pred CCcCCCcCH------HHHHhCcC
Q 002331 918 SSLHIRTSQ------AQLSHKRF 934 (935)
Q Consensus 918 ssP~kRPSa------~EILqHPF 934 (935)
|.+||++ +++++|||
T Consensus 235 --P~~R~~~~~~~~~~~~~~h~~ 255 (320)
T cd05590 235 --PTMRLGSLTLGGEEAILRHPF 255 (320)
T ss_pred --HHHCCCCCCCCCHHHHHcCCC
Confidence 9999998 99999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=362.25 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=203.6
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC-----CceE
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNLS 749 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~-----~~l~ 749 (935)
+|++.+.||+|+||.||+|.+ ++..||||++............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999976 578999999875433333445688999999999999999999987533 3489
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||+. ++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 6899988654 46899999999999999999999999 999999999999999999999999999864322
Q ss_pred c---ccCCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--------------
Q 002331 830 F---LSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------- 890 (935)
Q Consensus 830 ~---~~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~-------------- 890 (935)
. .......|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 11234578999999999876 5788999999999999999999999987664332211100
Q ss_pred ------------cccccCC---CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 891 ------------QNRRLEI---PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 891 ------------~~~r~~i---p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
......+ -..+++.+.+||.+||+.| |.+||+++++|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFD---PKDRPTAEEALADPY 292 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcC---cccCCCHHHHhcCch
Confidence 0000000 1246788999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=355.86 Aligned_cols=252 Identities=28% Similarity=0.383 Sum_probs=206.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE---CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc---CCCceeeeecccc-----c
Q 002331 676 EDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVT-----R 744 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~---~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L---~HPNIVkl~g~~~-----~ 744 (935)
++|++.+.||+|+||.||+|++ .++.||||++............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4789999999999999999976 367899999876543333334556777777766 6999999999874 3
Q ss_pred CCceEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA 823 (935)
...+++||||++ ++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 456899999996 5898888653 345899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--------
Q 002331 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-------- 895 (935)
Q Consensus 824 ~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~-------- 895 (935)
+..... .......|++.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+......+
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 865433 22334578999999999998889999999999999999999999999887766555442111000
Q ss_pred -----------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 -----------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 -----------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+...+++.+++||.+||+.| |++||++.++|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~R~s~~~~l~hp~ 289 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN---PAKRISAYSALSHPY 289 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccC---chhcCCHHHHhcCCC
Confidence 011357788999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=364.71 Aligned_cols=250 Identities=21% Similarity=0.364 Sum_probs=217.2
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEE
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVm 752 (935)
+|.+.+.||+|+||.||+|++ +++.||||++..... .......+..|..++..+ +|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999977 467899999876532 223344567788888877 6899999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 999999999998664 46899999999999999999999998 999999999999999999999999998754433233
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qC 912 (935)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+. .....+|..++.++.+||.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~ 235 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAICKGL 235 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCcCCHHHHHHHHHH
Confidence 345679999999999999999999999999999999999999999998888777664 345567788999999999999
Q ss_pred HhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 913 WQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 913 L~~D~ssP~kRPS-----a~EILqHPF 934 (935)
|+.+ |.+|++ ..++++|||
T Consensus 236 l~~~---p~~R~~~~~~~~~~i~~h~~ 259 (323)
T cd05616 236 MTKH---PGKRLGCGPEGERDIKEHAF 259 (323)
T ss_pred cccC---HHhcCCCCCCCHHHHhcCCC
Confidence 9999 999997 489999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=356.92 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=231.0
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
-.+..++|++++.||+|.||.||+|+. ++-.||+|++.+..+ ......++.+|++|...|+||||+++|++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 346678999999999999999999976 566799999877654 22345578899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.|+++||...|+|+..|.. ...++++...+.++.|++.||.|+|..+ ||||||||+|+|++..+.+||+|||.+...
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999999873 3457999999999999999999999998 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHH
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
. .....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||......+.+.++ ...+..+|..++..+.
T Consensus 175 p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI--~k~~~~~p~~is~~a~ 250 (281)
T KOG0580|consen 175 P--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI--RKVDLKFPSTISGGAA 250 (281)
T ss_pred C--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH--HHccccCCcccChhHH
Confidence 4 34456789999999999999999999999999999999999999999999988888887 4567788899999999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||.+||..+ |.+|....|++.|||
T Consensus 251 dlI~~ll~~~---p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 251 DLISRLLVKN---PIERLALTEVMDHPW 275 (281)
T ss_pred HHHHHHhccC---ccccccHHHHhhhHH
Confidence 9999999999 999999999999999
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=374.46 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=213.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.+|++.+.||+|+||.||+++. .++.||||++..... .......+.+|+.+|+.++|+||+++++.|.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3699999999999999999976 578999999865432 2233456789999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC---
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--- 829 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~--- 829 (935)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999999764 46889999999999999999999999 999999999999999999999999997532100
Q ss_pred ----------------------------------------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHH
Q 002331 830 ----------------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 869 (935)
Q Consensus 830 ----------------------------------------~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyEL 869 (935)
.......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001234799999999999999999999999999999999
Q ss_pred HcCCCCCCCCChHHHHHHhhccccccCCC--CcCcHHHHHHHHHHHhhCCCCcCCCc---CHHHHHhCcC
Q 002331 870 ATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTGWSSLHIRT---SQAQLSHKRF 934 (935)
Q Consensus 870 LTG~~PF~~~~~~eil~~I~~~~~r~~ip--~~ls~~L~dLI~qCL~~D~ssP~kRP---Sa~EILqHPF 934 (935)
++|+.||.+.+..+....+........++ ..+++.+.++|.+|+ .+ |.+|+ ++.++++|||
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~---p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CG---AEDRLGKNGADEIKAHPF 303 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cC---HhhcCCCCCHHHHhCCCC
Confidence 99999999988877666554333333333 367899999999977 58 99999 9999999999
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=371.70 Aligned_cols=254 Identities=27% Similarity=0.435 Sum_probs=216.4
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHH------------HHHHHHHHHHHHHHcCCCceee
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA------------ALLEFKREVKIMRRLRHPNVVL 737 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~------------~~~~f~~Ei~iL~~L~HPNIVk 737 (935)
....++|++++.||+|.||.|-+|+. .++.||||++.+.....+ ..+.+.+|+.||++|+|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34568999999999999999999976 688999999876443211 2357899999999999999999
Q ss_pred eecccccC--CceEEEEeeCCCCCHHHHHcCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc
Q 002331 738 FMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814 (935)
Q Consensus 738 l~g~~~~~--~~l~LVmEy~~gGsL~dlL~~~~~~-lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~ 814 (935)
++++..+. +.+|||+|||..|.+...= .... +.+.++++|+++++.||+|||.+| ||||||||.|+||+++|+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCc
Confidence 99999775 4699999999988775432 2334 899999999999999999999999 999999999999999999
Q ss_pred EEEEecccccccc-----CCcccCCCCCCCCCccCcccccCC---C-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 002331 815 VKVSDFGLSRLKH-----NTFLSSKSTAGTPEWMAPEVLRNE---P-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885 (935)
Q Consensus 815 VKL~DFGlA~~~~-----~~~~~~~s~~GT~~Y~APEvl~g~---~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil 885 (935)
|||+|||.+.... .........+|||.|+|||.+.+. . .+.+.||||||++||.|+.|+.||.+....++.
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 9999999987652 111222346899999999998763 2 367899999999999999999999999999999
Q ss_pred HHhhccccccCCCCc--CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 886 GAVGFQNRRLEIPKE--LDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 886 ~~I~~~~~r~~ip~~--ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+|. ..++.+|.. +.+++++||.+||++| |++|.+..+|..|||
T Consensus 329 ~KIv--n~pL~fP~~pe~~e~~kDli~~lL~Kd---P~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 329 DKIV--NDPLEFPENPEINEDLKDLIKRLLEKD---PEQRITLPDIKLHPW 374 (576)
T ss_pred HHHh--cCcccCCCcccccHHHHHHHHHHhhcC---hhheeehhhheecce
Confidence 9985 456666654 7999999999999999 999999999999999
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=365.58 Aligned_cols=245 Identities=22% Similarity=0.341 Sum_probs=213.6
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
++||+|+||.||+|++ .++.||||++..... .......+..|..++..+ +||||++++++|...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3599999999999987 467899999876432 233455677888898876 899999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
++|..++.+. ..+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||++..............
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 9999988654 46889999999999999999999999 99999999999999999999999999876443333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .....+|..++.++.+||.+||+.|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ll~~~L~~d- 234 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL--HDDVLYPVWLSKEAVSILKAFMTKN- 234 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhccC-
Confidence 9999999999999999999999999999999999999999998888777764 3345567788999999999999999
Q ss_pred CCcCCCc-------CHHHHHhCcC
Q 002331 918 SSLHIRT-------SQAQLSHKRF 934 (935)
Q Consensus 918 ssP~kRP-------Sa~EILqHPF 934 (935)
|.+|| ++.++++|||
T Consensus 235 --p~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 235 --PNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred --HHHcCCCCCCCCCHHHHhcCCc
Confidence 99999 9999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=388.73 Aligned_cols=250 Identities=36% Similarity=0.614 Sum_probs=229.8
Q ss_pred cccccCCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 667 e~~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
....|+|+++.+.-++-||.|+.|.||+|+..++.||||+++... ..+++-|++|+||||+.|.|+|....
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCc
Confidence 345688999998889999999999999999999999999864322 35788899999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+|||||||..|-|..+|+. +..+.......|..+|+.||.|||.+. |||||||.-||||..+..|||+|||-++..
T Consensus 186 cyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhh
Confidence 99999999999999999976 457888999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHH
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
.+. .....++||..|||||++++++.++|+|||||||+||||+||..||.+.+...++.-+......+.+|..+++.++
T Consensus 263 ~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfk 341 (904)
T KOG4721|consen 263 SDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFK 341 (904)
T ss_pred hhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHH
Confidence 654 4456789999999999999999999999999999999999999999999999888888777778889999999999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
=||++||+.. |..||+|.+||.|
T Consensus 342 lL~Kqcw~sK---pRNRPSFrqil~H 364 (904)
T KOG4721|consen 342 LLLKQCWNSK---PRNRPSFRQILLH 364 (904)
T ss_pred HHHHHHHhcC---CCCCccHHHHHHH
Confidence 9999999999 9999999999988
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=373.53 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=213.8
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
.|+++++||+|+||.||+|++ +++.||||++..... .......+.+|+.+++.++|+|||++++.|.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999976 678899999876533 23445678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC----
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT---- 829 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~---- 829 (935)
||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 99999999999764 46889999999999999999999999 999999999999999999999999997532100
Q ss_pred -------------------------------------------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHH
Q 002331 830 -------------------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 866 (935)
Q Consensus 830 -------------------------------------------~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~IL 866 (935)
.......+||+.|+|||++.+..++.++|||||||+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001234689999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHhhccccccCCC--CcCcHHHHHHHHHHHhhCCCCcCCCcC---HHHHHhCcC
Q 002331 867 WELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTGWSSLHIRTS---QAQLSHKRF 934 (935)
Q Consensus 867 yELLTG~~PF~~~~~~eil~~I~~~~~r~~ip--~~ls~~L~dLI~qCL~~D~ssP~kRPS---a~EILqHPF 934 (935)
|||++|+.||.+.++.+....+........+| ..+++++.++|.+|+ .+ |.+|++ +++|++|||
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~---p~~R~~~~~~~ei~~hp~ 307 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RG---PEDRLGKNGADEIKAHPF 307 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cC---HhHcCCCCCHHHHhcCCC
Confidence 99999999999988877766664433444444 457899999999976 58 999987 999999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=369.56 Aligned_cols=259 Identities=25% Similarity=0.354 Sum_probs=226.9
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEECC--ceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~g--~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
..+..++|++++.||.|.-|+||+++..+ ..+|+|++.+..+. .....+++.|.+||..++||.++.+|..|+.+..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 44667889999999999999999998855 78999999887653 4566778889999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.|+|||||+||+|..++++ .+..+++..++.++.+++.||+|||..| ||+|||||+||||.++|+|.|.||.++...
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999876 4567999999999999999999999999 999999999999999999999999986521
Q ss_pred cC-----------------------------------C---------------------cccCCCCCCCCCccCcccccC
Q 002331 827 HN-----------------------------------T---------------------FLSSKSTAGTPEWMAPEVLRN 850 (935)
Q Consensus 827 ~~-----------------------------------~---------------------~~~~~s~~GT~~Y~APEvl~g 850 (935)
.. . ......++||-+|+|||++.|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 00 0 011235679999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcC----H
Q 002331 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTS----Q 926 (935)
Q Consensus 851 ~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPS----a 926 (935)
...+.++|||.|||+||||+.|..||.+.+..+.+..|..+...+.-...++..+++||+++|.+| |.+|.. +
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd---P~kRlg~~rGA 386 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD---PSKRLGSKRGA 386 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC---hhhhhccccch
Confidence 999999999999999999999999999999999998886444433333467899999999999999 999998 9
Q ss_pred HHHHhCcC
Q 002331 927 AQLSHKRF 934 (935)
Q Consensus 927 ~EILqHPF 934 (935)
.||-+|||
T Consensus 387 ~eIK~HpF 394 (459)
T KOG0610|consen 387 AEIKRHPF 394 (459)
T ss_pred HHhhcCcc
Confidence 99999998
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=364.41 Aligned_cols=245 Identities=24% Similarity=0.409 Sum_probs=211.2
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.||+|+||.||+|++ +++.||||++..... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 467899999876432 223344556677777655 899999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 9999998764 46899999999999999999999998 99999999999999999999999999986543333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. ...+.+|..++.++.+||.+||+.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~~- 234 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERD- 234 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCC-
Confidence 9999999999999999999999999999999999999999998887777663 3456678889999999999999999
Q ss_pred CCcCCCcCH-HHHHhCcC
Q 002331 918 SSLHIRTSQ-AQLSHKRF 934 (935)
Q Consensus 918 ssP~kRPSa-~EILqHPF 934 (935)
|.+||++ .++++|||
T Consensus 235 --P~~R~~~~~~l~~h~~ 250 (316)
T cd05592 235 --PTKRLGVDGDIRQHPF 250 (316)
T ss_pred --HHHcCCChHHHHcCcc
Confidence 9999986 58989998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.98 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=211.0
Q ss_pred CeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCC--CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCce
Q 002331 677 DLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~--~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l 748 (935)
+|++++.||+|+||.||+++. .++.||||++..... .......+..|+.+++.+ +|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999965 578899999875432 223345678899999999 599999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 9999999999999998653 46899999999999999999999999 99999999999999999999999999986433
Q ss_pred Cc-ccCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhccccccCCCCcCc
Q 002331 829 TF-LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQNRRLEIPKELD 902 (935)
Q Consensus 829 ~~-~~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~----~~eil~~I~~~~~r~~ip~~ls 902 (935)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.... ...+...+ ......++..++
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFIG 235 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCCC
Confidence 21 2223457999999999998754 7889999999999999999999997432 22233333 234456778899
Q ss_pred HHHHHHHHHHHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 903 PLVARIIWECWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
+.+.+||.+||+.| |.+|| +++++++|||
T Consensus 236 ~~~~~li~~~l~~d---p~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 236 PEAQDLLHKLLRKD---PKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred HHHHHHHHHHcCCC---HHHcCCCCCCCHHHHHcCCC
Confidence 99999999999999 99999 8999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=373.21 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=219.5
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
..++..++|++.+.||+|+||.||++++ +++.||+|++..... .......+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3456668999999999999999999987 577899999875432 2233456788999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999999999653 5889999999999999999999998 999999999999999999999999999876
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC--
Q 002331 827 HNTF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-- 899 (935)
Q Consensus 827 ~~~~-~~~~s~~GT~~Y~APEvl~g~~----~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~-- 899 (935)
.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+........+|.
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence 4322 2234567999999999997643 67899999999999999999999999888777777654444455554
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCC--CcCHHHHHhCcC
Q 002331 900 ELDPLVARIIWECWQTGWSSLHI--RTSQAQLSHKRF 934 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~k--RPSa~EILqHPF 934 (935)
.++..++++|.+||..+ +.+ |+++.++++|||
T Consensus 273 ~~s~~~~~li~~~L~~~---~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 273 EISKHAKNLICAFLTDR---EVRLGRNGVEEIKQHPF 306 (370)
T ss_pred cCCHHHHHHHHHHccCc---hhccCCCCHHHHhcCcc
Confidence 46899999999999865 544 899999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=342.93 Aligned_cols=253 Identities=30% Similarity=0.483 Sum_probs=220.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH---HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG---AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~---~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
+.|++.+.||+|+||.||++.. .++.||||.+....... .....+.+|+.++++++||||+++++++..++.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999965 67899999987553322 234568899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999998764 46889999999999999999999999 9999999999999999999999999987653321
Q ss_pred ccC---CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 831 LSS---KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 831 ~~~---~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
... ....++..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+........++..++..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 111 23467889999999999889999999999999999999999999887766665555555666788889999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+|.+||..+ |.+||++.++++|||
T Consensus 239 li~~~l~~~---p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 239 FLRRTFVEN---AKKRPSAEELLRHFF 262 (263)
T ss_pred HHHHHhhcC---cccCCCHHHHhhCCC
Confidence 999999999 999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=355.47 Aligned_cols=242 Identities=22% Similarity=0.354 Sum_probs=212.0
Q ss_pred EEeeecCcEEEEEEEECCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeeccccc----CCceEEEEeeCC
Q 002331 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSIITEFLP 756 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~----~~~l~LVmEy~~ 756 (935)
..||+|++|.||+|.++|+.||||++....... ...+.+.+|+.+|++++|||||++++++.+ ...+++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 569999999999999999999999987654332 335678899999999999999999999866 346899999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCC
Q 002331 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (935)
Q Consensus 757 gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s 835 (935)
+|+|.+++.+. ..+++...+.++.|++.||.|||.. + ++||||||+|||++.++.+||+|||+++...... ..
T Consensus 106 ~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~ 179 (283)
T PHA02988 106 RGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FK 179 (283)
T ss_pred CCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhcccc---cc
Confidence 99999999764 4688999999999999999999984 6 8899999999999999999999999988654332 23
Q ss_pred CCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHH
Q 002331 836 TAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (935)
Q Consensus 836 ~~GT~~Y~APEvl~g--~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL 913 (935)
..|+..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..++...+.....++.+|..+++.+++||.+||
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 568899999999976 678999999999999999999999999998888877775566677778789999999999999
Q ss_pred hhCCCCcCCCcCHHHHHhC
Q 002331 914 QTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 914 ~~D~ssP~kRPSa~EILqH 932 (935)
+.| |.+||++.+|++.
T Consensus 260 ~~d---p~~Rps~~ell~~ 275 (283)
T PHA02988 260 SHD---SIKRPNIKEILYN 275 (283)
T ss_pred cCC---cccCcCHHHHHHH
Confidence 999 9999999999863
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=363.84 Aligned_cols=245 Identities=25% Similarity=0.405 Sum_probs=209.7
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHH-HHHHcCCCceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~-iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.||+|+||+||+|++ +++.||||++...... ......+..|.. +++.++||||+++++.+...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999987 6889999998764322 222334445544 56788999999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
++|..++.+. ..+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.............+
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 9999998764 46889999999999999999999999 99999999999999999999999999875433333334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++...+. .....++..+++.+.+||.+||+.|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~- 234 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKPLRLKPNISVSARHLLEGLLQKD- 234 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcC-
Confidence 9999999999999999999999999999999999999999988887776663 3345566778999999999999999
Q ss_pred CCcCCCcCH----HHHHhCcC
Q 002331 918 SSLHIRTSQ----AQLSHKRF 934 (935)
Q Consensus 918 ssP~kRPSa----~EILqHPF 934 (935)
|.+||++ .++++|||
T Consensus 235 --p~~R~~~~~~~~~il~~~~ 253 (323)
T cd05575 235 --RTKRLGAKDDFLEIKNHVF 253 (323)
T ss_pred --HHhCCCCCCCHHHHHcCCC
Confidence 9999987 69999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=362.55 Aligned_cols=245 Identities=22% Similarity=0.354 Sum_probs=210.7
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.||+|+||.||+|++ +++.||||++..... .......+..|..++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 3699999999999987 578899999876432 122344566788888765 899999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
++|..++.+. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 9999998763 46889999999999999999999998 99999999999999999999999999875332222334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. ...+.+|..++.++++||.+||+.|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~d- 234 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFERD- 234 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccCC-
Confidence 9999999999999999999999999999999999999999988877776663 3445677889999999999999999
Q ss_pred CCcCCCcCH-HHHHhCcC
Q 002331 918 SSLHIRTSQ-AQLSHKRF 934 (935)
Q Consensus 918 ssP~kRPSa-~EILqHPF 934 (935)
|.+||++ +++++|||
T Consensus 235 --P~~R~~~~~~~~~h~~ 250 (316)
T cd05620 235 --PTRRLGVVGNIRGHPF 250 (316)
T ss_pred --HHHcCCChHHHHcCCC
Confidence 9999997 58999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=368.65 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=215.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||++.. .++.||||++..... .......+..|+.++..++|+||+++++.+.+.+.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999976 578999999875432 2334566788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc--
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 830 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~-- 830 (935)
||+++|+|.+++.+. ..+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999999999764 46899999999999999999999999 9999999999999999999999999987442110
Q ss_pred ---------------------------------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002331 831 ---------------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877 (935)
Q Consensus 831 ---------------------------------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~ 877 (935)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123579999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHhhccccccCCCC--cCcHHHHHHHHHHHhhCCCCcCCCc---CHHHHHhCcC
Q 002331 878 GMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTGWSSLHIRT---SQAQLSHKRF 934 (935)
Q Consensus 878 ~~~~~eil~~I~~~~~r~~ip~--~ls~~L~dLI~qCL~~D~ssP~kRP---Sa~EILqHPF 934 (935)
+.++......+........+|. .+++++++||.+|+ .+ |.+|+ ++++|++|||
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~---p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TD---SENRIGSNGVEEIKSHPF 295 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cC---hhhcCCCCCHHHHhcCCC
Confidence 9988887776654344444444 36899999999987 48 99998 5899999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=368.45 Aligned_cols=250 Identities=25% Similarity=0.435 Sum_probs=226.5
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
..+|++.+.||+|+||.|-++.. .|+.||||.|++... +++.+..+.+|++||..|+||||+.+|++|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 36799999999999999999954 799999999988765 456777899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||..+|.|++|+.+. +.+++.+.+.|++||+.|+.|+|+++ ++|||||.+|||||.++++||+|||++-++.+..
T Consensus 132 MEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k- 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK- 207 (668)
T ss_pred EEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhcccc-
Confidence 9999999999999875 47999999999999999999999999 9999999999999999999999999999887653
Q ss_pred cCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
...++||++-|.+||+++|.+| ++.+|.||||++||.|..|..||.+.+...++..|....++. ..-+.+..-||+
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~gLIR 284 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDASGLIR 284 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHHHHHH
Confidence 3567999999999999999998 789999999999999999999999999999998886444332 223567889999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||.++ |++|.++++|..|=|
T Consensus 285 wmLmVN---P~RRATieDiAsHWW 305 (668)
T KOG0611|consen 285 WMLMVN---PERRATIEDIASHWW 305 (668)
T ss_pred HHHhcC---cccchhHHHHhhhhe
Confidence 999999 999999999999977
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=363.56 Aligned_cols=245 Identities=21% Similarity=0.359 Sum_probs=208.7
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.||+|+||.||++++ +++.||||++...... ......+.+|..++..+ +||||++++++|.+.+.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999976 5788999999865432 23455678899999998 799999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 9999988654 47999999999999999999999999 99999999999999999999999999875332223334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------hHH-HHHHhhccccccCCCCcCcHHHHHH
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--------PMQ-VVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~--------~~e-il~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ... ....+ ......+|..++..+.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~l 235 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKASSV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCCHHHHHH
Confidence 9999999999999999999999999999999999999996321 111 22222 344566788899999999
Q ss_pred HHHHHhhCCCCcCCCcC------HHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTS------QAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPS------a~EILqHPF 934 (935)
|.+||+.| |.+|++ ++++++|||
T Consensus 236 i~~~L~~d---P~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05588 236 LKGFLNKD---PKERLGCHPQTGFRDIKSHPF 264 (329)
T ss_pred HHHHhccC---HHHcCCCCCCCCHHHHhcCCC
Confidence 99999999 999987 799999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.88 Aligned_cols=251 Identities=33% Similarity=0.486 Sum_probs=211.5
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeC
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
|++++.||+|+||+||+++. +++.||+|++..............+|+.++++++||||+++++++.+...+++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78999999999999999988 4567999999887655555555567999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCC
Q 002331 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (935)
Q Consensus 756 ~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s 835 (935)
++++|.+++.+ ...+++..++.++.||+.||.+||+.+ |+|+||||+|||++.++.++|+|||.+............
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred ccccccccccc-ccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence 99999999973 357899999999999999999999998 999999999999999999999999999764333333445
Q ss_pred CCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HHHhhccccccCCC--CcCcHHHHHHH
Q 002331 836 TAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV---VGAVGFQNRRLEIP--KELDPLVARII 909 (935)
Q Consensus 836 ~~GT~~Y~APEvl~-g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~ei---l~~I~~~~~r~~ip--~~ls~~L~dLI 909 (935)
..++..|+|||++. +..++.++||||||+++|+|++|..||...+.... .............. ......+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 67899999999998 88889999999999999999999999998843332 22221111111111 22348999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||+.| |.+||++.++++|||
T Consensus 238 ~~~l~~~---p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 238 KKMLSKD---PEQRPSAEELLKHPW 259 (260)
T ss_dssp HHHSSSS---GGGSTTHHHHHTSGG
T ss_pred HHHccCC---hhHCcCHHHHhcCCC
Confidence 9999999 999999999999999
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=361.70 Aligned_cols=256 Identities=21% Similarity=0.340 Sum_probs=215.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||+++. .++.||||++..... .......+.+|+.++..++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999976 578999999875332 2334556888999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 831 (935)
||+++++|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999999999999775667899999999999999999999999 99999999999999999999999999876543222
Q ss_pred cCCCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC---CcCcH
Q 002331 832 SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP---KELDP 903 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g-----~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip---~~ls~ 903 (935)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+........++ ..+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 2223468999999999863 446889999999999999999999999988777766664433333333 34789
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+++||++||+.+ ..+..|++++++++|||
T Consensus 239 ~~~~li~~ll~~~-~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 239 EAKDLIRRLICSP-ETRLGRNGLQDFKDHPF 268 (331)
T ss_pred HHHHHHHHHccCc-ccccCCCCHHHHhcCCC
Confidence 9999999999765 22444899999999999
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=361.21 Aligned_cols=245 Identities=23% Similarity=0.380 Sum_probs=213.5
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.||+|+||+||+|++ +++.||||++..... .......+.+|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 567899999876532 223455677888999888 799999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
++|..++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 9999988764 46899999999999999999999998 99999999999999999999999999875333223334457
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+. .....+|..++..+.+||++||+.|
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~d- 234 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAKSILKSFLTKN- 234 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHccCC-
Confidence 8999999999999999999999999999999999999999888877776653 3445677889999999999999999
Q ss_pred CCcCCCcCH-----HHHHhCcC
Q 002331 918 SSLHIRTSQ-----AQLSHKRF 934 (935)
Q Consensus 918 ssP~kRPSa-----~EILqHPF 934 (935)
|.+||++ .++++|||
T Consensus 235 --P~~R~s~~~~~~~~ll~~~~ 254 (318)
T cd05570 235 --PEKRLGCLPTGEQDIKGHPF 254 (318)
T ss_pred --HHHcCCCCCCCHHHHhcCCC
Confidence 9999999 99999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=380.08 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=225.0
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
...+...++|++.+.||+|+||+||++++ +++.||||++............+.+|+.++..++|+||+++++.+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34455568999999999999999999976 6889999999877766777778899999999999999999988775432
Q ss_pred --------ceEEEEeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcE
Q 002331 747 --------NLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 815 (935)
Q Consensus 747 --------~l~LVmEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~V 815 (935)
.+++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCE
Confidence 36899999999999999864 2346899999999999999999999998 9999999999999999999
Q ss_pred EEEeccccccccCC--cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc
Q 002331 816 KVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 893 (935)
Q Consensus 816 KL~DFGlA~~~~~~--~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~ 893 (935)
||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+.. ..
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~ 261 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GR 261 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CC
Confidence 99999999865432 1223346799999999999999999999999999999999999999999888777766543 33
Q ss_pred ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...++..+++.+.+||.+||+.| |.+||++.++++|||
T Consensus 262 ~~~~~~~~~~~l~~li~~~L~~d---P~~RPs~~ell~~p~ 299 (496)
T PTZ00283 262 YDPLPPSISPEMQEIVTALLSSD---PKRRPSSSKLLNMPI 299 (496)
T ss_pred CCCCCCCCCHHHHHHHHHHcccC---hhhCcCHHHHHhCHH
Confidence 44577889999999999999999 999999999999987
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=338.07 Aligned_cols=252 Identities=26% Similarity=0.428 Sum_probs=218.0
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc-CCceEEEEe
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIITE 753 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~-~~~l~LVmE 753 (935)
.|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++|+||+++++.+.. ...+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488999999999999999976 57789999987665555566678899999999999999999998764 445899999
Q ss_pred eCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 754 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 754 y~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
|+++++|.+++... ...+++..++.++.|++.||.|||+.| |+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99999999998653 345899999999999999999999999 999999999999999999999999999876543333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qC 912 (935)
.....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. ......++..+++.+.++|.+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATM 237 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHH
Confidence 344568899999999999989999999999999999999999999887766555443 2233456677899999999999
Q ss_pred HhhCCCCcCCCcCHHHHHhCcC
Q 002331 913 WQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 913 L~~D~ssP~kRPSa~EILqHPF 934 (935)
|+.+ |.+||++.++++|||
T Consensus 238 l~~~---p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 238 LSKR---PEKRPSVKSILRQPY 256 (257)
T ss_pred hccC---cccCCCHHHHhcCCC
Confidence 9999 999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=359.74 Aligned_cols=250 Identities=20% Similarity=0.357 Sum_probs=216.6
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcC-CCceeeeecccccCCceEEEE
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LVm 752 (935)
+|++.+.||+|+||.||+|++ +++.||||++..... .......+..|..++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999976 578999999876432 2334456778888998885 578889999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 999999999998664 46899999999999999999999998 999999999999999999999999998754333333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qC 912 (935)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+. .....+|..++..+.++|.+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~ 235 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGL 235 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHHHHHHH
Confidence 345679999999999999999999999999999999999999999998887777664 344567788999999999999
Q ss_pred HhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 913 WQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 913 L~~D~ssP~kRPS-----a~EILqHPF 934 (935)
|+.+ |.+|++ .+++++|||
T Consensus 236 l~~~---p~~R~~~~~~~~~~i~~h~~ 259 (323)
T cd05615 236 MTKH---PSKRLGCGPEGERDIREHAF 259 (323)
T ss_pred cccC---HhhCCCCCCCCHHHHhcCcc
Confidence 9999 999997 589999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=368.61 Aligned_cols=258 Identities=23% Similarity=0.376 Sum_probs=219.1
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
..++..++|++.+.||+|+||.||++++ .++.||+|++..... .......+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 4566778999999999999999999987 577899999875432 2233455788999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+|+||||+++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 999999999999999999753 5888899999999999999999999 999999999999999999999999999866
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--C
Q 002331 827 HNTF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--K 899 (935)
Q Consensus 827 ~~~~-~~~~s~~GT~~Y~APEvl~g~~----~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip--~ 899 (935)
.... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+........+| .
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcC
Confidence 4322 2234567999999999997643 7889999999999999999999999988877777775444444444 3
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCC--CcCHHHHHhCcC
Q 002331 900 ELDPLVARIIWECWQTGWSSLHI--RTSQAQLSHKRF 934 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~k--RPSa~EILqHPF 934 (935)
.++..+++||.+||..+ +.+ |+++++|++|+|
T Consensus 273 ~~s~~~~~li~~~L~~~---~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 273 DISKEAKNLICAFLTDR---EVRLGRNGVEEIKRHLF 306 (371)
T ss_pred CCCHHHHHHHHHHcCCh---hhhcCCCCHHHHhcCcc
Confidence 68999999999999844 433 789999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=370.73 Aligned_cols=250 Identities=19% Similarity=0.253 Sum_probs=198.0
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC------Cceeeeecccc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH------PNVVLFMGAVT 743 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~H------PNIVkl~g~~~ 743 (935)
++..++|++.++||+|+||+||+|.+ .++.||||+++... .....+..|+.+++.++| .+|++++++|.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34568899999999999999999976 57789999986432 123345567777776654 45889999887
Q ss_pred cC-CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCC--------
Q 002331 744 RP-PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW-------- 813 (935)
Q Consensus 744 ~~-~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g-------- 813 (935)
.+ .++|||||++ +++|.+++.+. ..+++..+..|+.||+.||.|||. .| ||||||||+||||+.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccc
Confidence 65 4688999988 67888888653 478999999999999999999997 58 99999999999998665
Q ss_pred --------cEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 002331 814 --------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885 (935)
Q Consensus 814 --------~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil 885 (935)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred cccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 499999998764322 234568999999999999999999999999999999999999999987765544
Q ss_pred HHhhcccccc-------------------------C-CC--------------CcCcHHHHHHHHHHHhhCCCCcCCCcC
Q 002331 886 GAVGFQNRRL-------------------------E-IP--------------KELDPLVARIIWECWQTGWSSLHIRTS 925 (935)
Q Consensus 886 ~~I~~~~~r~-------------------------~-ip--------------~~ls~~L~dLI~qCL~~D~ssP~kRPS 925 (935)
..+....+.+ . .+ ...++.+.+||.+||+.| |.+||+
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d---P~~R~t 431 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD---RQKRLN 431 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC---hhhCCC
Confidence 3321110000 0 00 012456789999999999 999999
Q ss_pred HHHHHhCcC
Q 002331 926 QAQLSHKRF 934 (935)
Q Consensus 926 a~EILqHPF 934 (935)
++|+|+|||
T Consensus 432 a~e~L~Hp~ 440 (467)
T PTZ00284 432 ARQMTTHPY 440 (467)
T ss_pred HHHHhcCcc
Confidence 999999999
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=360.12 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=210.2
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.||+|+||.||+|++ .++.||||++..... .......+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 467899999876532 122344566778888765 999999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 9999999753 46889999999999999999999998 99999999999999999999999999875432222234467
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.. ..+.+|..++..+++||.+||+.|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~- 234 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPCYPRWLTREAKDILVKLFVRE- 234 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHhccC-
Confidence 89999999999999999999999999999999999999999888877776642 334567788999999999999999
Q ss_pred CCcCCCcCHH-HHHhCcC
Q 002331 918 SSLHIRTSQA-QLSHKRF 934 (935)
Q Consensus 918 ssP~kRPSa~-EILqHPF 934 (935)
|.+||++. ++++|||
T Consensus 235 --P~~R~~~~~~l~~h~~ 250 (316)
T cd05619 235 --PERRLGVKGDIRQHPF 250 (316)
T ss_pred --HhhcCCChHHHHcCcc
Confidence 99999996 8999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.72 Aligned_cols=252 Identities=24% Similarity=0.420 Sum_probs=216.2
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
+...+|++.+.||+|+||.||+|.+ .+..||+|.+.... .......+.+|+.++.+++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 4567899999999999999999965 35689999887543 33445678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
.++||||+++++|.+++.+....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999999999776567899999999999999999999998 9999999999999999999999999876543
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHH
Q 002331 828 NTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 828 ~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. .......+..++..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCPNLL 237 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHH
Confidence 221 11112345678999999999999999999999999999775 999999988887777664 334456778899999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.++|.+||+.+ |.+||++++|++
T Consensus 238 ~~li~~c~~~~---p~~RP~~~~i~~ 260 (266)
T cd05064 238 HQLMLDCWQKE---RGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHcCCC---chhCCCHHHHHH
Confidence 99999999999 999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=378.17 Aligned_cols=251 Identities=28% Similarity=0.460 Sum_probs=226.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
..|...++||+|.||.||+|.+ .++.||||++..... +...+.+.+|+.+|.+++++||.++|+.|..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4566778999999999999976 578899999876543 3457788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
||.||++.++++.. ..+++..+.-|+++++.||.|||.++ .+|||||+.||||..+|.+||+|||.+....+.....
T Consensus 92 y~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 99999999999763 35588888889999999999999999 9999999999999999999999999999988877777
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL 913 (935)
.+++||+.|||||++.+..|+.++||||||++.+||++|.+||....++.++.-|. ...++.+...+++.+++||..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHHHHh
Confidence 89999999999999999999999999999999999999999999999976654443 44556666789999999999999
Q ss_pred hhCCCCcCCCcCHHHHHhCcC
Q 002331 914 QTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 914 ~~D~ssP~kRPSa~EILqHPF 934 (935)
+++ |+.||++.++|+|+|
T Consensus 248 ~k~---P~~RpsA~~LLKh~F 265 (467)
T KOG0201|consen 248 DKN---PEFRPSAKELLKHKF 265 (467)
T ss_pred hcC---cccCcCHHHHhhhHH
Confidence 999 999999999999998
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=350.16 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=207.3
Q ss_pred eeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCCH
Q 002331 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (935)
Q Consensus 684 LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL 760 (935)
||+|+||+||++.+ +++.||||++....... .....+..|+.+++.++|+||+++++++.....+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999976 67899999987654322 2345677899999999999999999999999999999999999999
Q ss_pred HHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 761 FRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 761 ~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
..++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 987743 3356899999999999999999999998 99999999999999999999999999976554333334467
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH----HHHHHhhccccccCCCCcCcHHHHHHHHHHH
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~----eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL 913 (935)
|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+ ......++..+++.+.++|.+||
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI--LNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh--cccCCCCcccCCHHHHHHHHHHh
Confidence 899999999999999999999999999999999999999865432 222222 23345567789999999999999
Q ss_pred hhCCCCcCCCc-----CHHHHHhCcC
Q 002331 914 QTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 914 ~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
+.| |.+|| +++++++|||
T Consensus 237 ~~~---P~~R~~~~~~~~~~~l~h~~ 259 (280)
T cd05608 237 AKD---PEKRLGFRDGNCDGLRTHPL 259 (280)
T ss_pred cCC---HHHhcCCCCCCHHHHhcChh
Confidence 999 99999 8899999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=377.24 Aligned_cols=254 Identities=23% Similarity=0.416 Sum_probs=234.1
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc-eEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-LSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~-l~LV 751 (935)
.+.|.+++.||+|+||.++++++ .++.|++|.+......+.......+|+.++++++|||||.+.+.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 46789999999999999999966 57789999999888777777788999999999999999999999999888 9999
Q ss_pred EeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 752 TEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
|+||+||+|.+.|.+.+ .-++++.+..|+.||+.|+.|||++. |+|||||+.|||++.++.|||+|||+++......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999997654 66899999999999999999999888 9999999999999999999999999999988775
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
....+..||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...+...+..++. ......+|...+.+++.||+
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-~~~~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-RGLYSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-hccCCCCCccccHHHHHHHH
Confidence 45677899999999999999999999999999999999999999999999999988875 33457789999999999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.||..+ |..||++.+||.+|.
T Consensus 240 ~~l~~~---P~~RPsa~~LL~~P~ 260 (426)
T KOG0589|consen 240 SMLRKN---PEHRPSALELLRRPH 260 (426)
T ss_pred HHhhcC---CccCCCHHHHhhChh
Confidence 999999 999999999999874
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=358.53 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=212.1
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
+..++|++.++||+|+||.||++.+ .+..||+|++... ........+.+|+++++.++|+||++++++|...+.+++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 5568899999999999999999987 4778999987654 234456678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
||||+++++|.+++.+. ..+++..+..++.||+.||.|||.. + |+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999999764 4688999999999999999999974 6 999999999999999999999999998765432
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh--------------------
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-------------------- 889 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~-------------------- 889 (935)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||......++...+.
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 1234578999999999999889999999999999999999999998765443322110
Q ss_pred -----------------------ccccccCCC-CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 890 -----------------------FQNRRLEIP-KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 890 -----------------------~~~~r~~ip-~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.....+.++ ..++.++++||.+||+.| |.+||++.+|++|||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~---P~~Rpt~~ell~h~~ 301 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKN---PAERADLKQLMVHAF 301 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCC---cccCcCHHHHhhCHH
Confidence 011111122 135788999999999999 999999999999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=353.81 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=209.6
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|.+.+.||+|+||.||+|++ .++.||||++...... .....+.+|+.++++++||||+++++++..++.+++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 47899999999999999999976 5778999998754322 22335678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++ +|.+++...+..+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.........
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 99975 888888766666899999999999999999999998 999999999999999999999999999765443333
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------------
Q 002331 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------------ 893 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~------------------ 893 (935)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 334568899999999865 4578999999999999999999999988766544332211000
Q ss_pred ---cc-------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 ---RL-------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 ---r~-------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+. .....+++++++||.+||+.| |.+||++.++|+|||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---p~~R~t~~e~l~h~~ 288 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYE---SKKRISAEEAMKHAY 288 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCC---hhhCCCHHHHhcChh
Confidence 00 011346889999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=360.21 Aligned_cols=245 Identities=26% Similarity=0.405 Sum_probs=209.0
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHH-HHHHcCCCceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~-iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
++||+|+||.||+|++ +++.||||++..... .......+..|.. +++.++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 578899999876432 2223344555554 57888999999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
++|..++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 9999888653 46888999999999999999999998 99999999999999999999999999875433333334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++...+. ..+..+|...+..+.++|.+||+.|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~- 234 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHKD- 234 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCC-
Confidence 9999999999999899999999999999999999999999988877766663 3456677888999999999999999
Q ss_pred CCcCCCcCH----HHHHhCcC
Q 002331 918 SSLHIRTSQ----AQLSHKRF 934 (935)
Q Consensus 918 ssP~kRPSa----~EILqHPF 934 (935)
|.+||+. .++++|+|
T Consensus 235 --p~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05603 235 --QRRRLGAKADFLEIKNHVF 253 (321)
T ss_pred --HhhcCCCCCCHHHHhCCCC
Confidence 9999864 69999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=360.55 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=205.0
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC------
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~------ 746 (935)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 47899999999999999999976 5789999998765444455667889999999999999999999886543
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999976 56666643 4788899999999999999999999 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc---------------
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--------------- 891 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~--------------- 891 (935)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 174 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 174 CTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 332 2233457899999999999999999999999999999999999999877653322111000
Q ss_pred -----cccc--------------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 892 -----NRRL--------------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 892 -----~~r~--------------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.... ......++.+++||.+||+.| |.+||++.|+|+|||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d---P~~R~t~~e~l~hp~ 317 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVID---PDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccC---cccCCCHHHHhcCch
Confidence 0000 011234678999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=359.93 Aligned_cols=256 Identities=20% Similarity=0.340 Sum_probs=215.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.++||+|+||.||++++ .++.||+|++..... .......+..|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4789999999999999999987 467899999865322 2233445788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc-c
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-L 831 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~-~ 831 (935)
||+++|+|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999999875567899999999999999999999999 9999999999999999999999999987543321 2
Q ss_pred cCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC---CcCcH
Q 002331 832 SSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP---KELDP 903 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip---~~ls~ 903 (935)
......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.....+..+| ..+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223457999999999986 3457889999999999999999999999998888777775444444444 45799
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++++||.+||..+ ..+..|++++++++|||
T Consensus 239 ~~~~li~~ll~~~-~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 239 DAKDLIRRLICSR-EHRLGQNGIEDFKQHPF 268 (332)
T ss_pred HHHHHHHHHccCh-hhhcCCCCHHHHhCCCC
Confidence 9999999999765 11334789999999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.47 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=213.6
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
.|++.++||+|+||.||++.+ +++.||||++....... .....+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478899999999999999976 57899999987654332 223456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 754 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 754 y~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
|+++++|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-T 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-c
Confidence 99999999888543 346899999999999999999999998 9999999999999999999999999987654321 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh--ccccccCCCCcCcHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~--~~~~r~~ip~~ls~~L~dLI~ 910 (935)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+. .......++..+++.+.+||.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 234578999999999998889999999999999999999999999865533222211 123344566778999999999
Q ss_pred HHHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
+||+.| |.+|| +++++++|||
T Consensus 238 ~~l~~~---P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05605 238 QLLTKD---PGFRLGCRGEGAEEVKAHPF 263 (285)
T ss_pred HHccCC---HHHhcCCCCCCHHHHhcCcC
Confidence 999999 99999 8999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=360.24 Aligned_cols=245 Identities=22% Similarity=0.363 Sum_probs=207.6
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.||+|+||.||++++ .++.||+|++..... .......+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999976 577899999886533 233455677899888877 899999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
++|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.............
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 9999988654 46899999999999999999999999 99999999999999999999999999875433323334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC--------ChHH-HHHHhhccccccCCCCcCcHHHHHH
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM--------NPMQ-VVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~--------~~~e-il~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
||+.|+|||++.+..++.++|||||||++|+|++|+.||... .... +...+ ......+|..++..+.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~l 235 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAASV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--hcCCCCCCCCCCHHHHHH
Confidence 999999999999999999999999999999999999999531 1111 22222 344566888899999999
Q ss_pred HHHHHhhCCCCcCCCcC------HHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTS------QAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPS------a~EILqHPF 934 (935)
|.+||+.| |.+||+ +.++++|||
T Consensus 236 l~~~L~~d---P~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05618 236 LKSFLNKD---PKERLGCHPQTGFADIQGHPF 264 (329)
T ss_pred HHHHhcCC---HHHcCCCCCCCCHHHHhcCCC
Confidence 99999999 999998 689999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=360.04 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=207.3
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHH-HHHHHcCCCceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREV-KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei-~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.||+|+||+||+|++ +++.||+|++...... ......+..|. .+++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 5678999998764322 12223344444 456788999999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
++|.+++.+. ..+.+..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.............
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 9999999764 46788888889999999999999999 99999999999999999999999999976433333344567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....++..+++.+.++|.+||+.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~- 234 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQKD- 234 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCcCCCCCCCHHHHHHHHHHcccC-
Confidence 9999999999999999999999999999999999999999988887776653 2345566788999999999999999
Q ss_pred CCcCCCcCHH----HHHhCcC
Q 002331 918 SSLHIRTSQA----QLSHKRF 934 (935)
Q Consensus 918 ssP~kRPSa~----EILqHPF 934 (935)
|.+|+++. ++++|+|
T Consensus 235 --p~~R~~~~~~~~~i~~~~~ 253 (325)
T cd05602 235 --RTKRLGAKDDFMEIKNHIF 253 (325)
T ss_pred --HHHCCCCCCCHHHHhcCcc
Confidence 99999765 8999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=359.78 Aligned_cols=254 Identities=20% Similarity=0.332 Sum_probs=215.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||++++ .++.||||++..... .......+..|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999976 567899999875322 2234455788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 831 (935)
||+++|+|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999999875567899999999999999999999999 99999999999999999999999999876543322
Q ss_pred cCCCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC---cCcH
Q 002331 832 SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK---ELDP 903 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g-----~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~---~ls~ 903 (935)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....+..+|. .+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2233579999999999876 4578899999999999999999999999888777776654444444443 4689
Q ss_pred HHHHHHHHHHhhCCCCcCC--CcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHI--RTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~k--RPSa~EILqHPF 934 (935)
.+++||.+||..+ +.+ |++++++++|||
T Consensus 239 ~~~~li~~ll~~~---~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 239 EAKDLIQRLICSR---ERRLGQNGIEDFKKHAF 268 (331)
T ss_pred HHHHHHHHHccCc---hhhcCCCCHHHHhcCCC
Confidence 9999999999876 544 579999999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=369.33 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=230.7
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeC
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
|.+.+.||+|-|..|-++++ .|..||||++.+..++......+.+|++.|+.++|||||++|++...+..+|||+|+-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 66778899999999999975 8999999999999988888888999999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec-CCCcEEEEeccccccccCCcccCC
Q 002331 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 756 ~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
++|+|++||-+....+.+....+++.||+.|+.|+|+.. +|||||||+||++. +-|-|||.|||++-.+... ....
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL~ 176 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKLT 176 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc-chhh
Confidence 999999999887788999999999999999999999998 99999999999886 5689999999999876654 4456
Q ss_pred CCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHH
Q 002331 835 STAGTPEWMAPEVLRNEPSN-EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (935)
Q Consensus 835 s~~GT~~Y~APEvl~g~~~s-~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL 913 (935)
+.||...|.|||++.|..|+ +++||||||+|||.|.+|++||+..+..+.+-.| ......+|..++.++++||..||
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--mDCKYtvPshvS~eCrdLI~sML 254 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--MDCKYTVPSHVSKECRDLIQSML 254 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--hcccccCchhhhHHHHHHHHHHH
Confidence 78999999999999998874 6899999999999999999999999998888777 46677889999999999999999
Q ss_pred hhCCCCcCCCcCHHHHHhCcC
Q 002331 914 QTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 914 ~~D~ssP~kRPSa~EILqHPF 934 (935)
..| |++|.+.++|..++|
T Consensus 255 vRd---PkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 255 VRD---PKKRASLEEIVSTSW 272 (864)
T ss_pred hcC---chhhccHHHHhcccc
Confidence 999 999999999999999
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=358.30 Aligned_cols=254 Identities=24% Similarity=0.286 Sum_probs=218.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccc--cCCceEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--RPPNLSI 750 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~--~~~~l~L 750 (935)
.++|+.+.+|++|+||.||+|++ +++.||+|+++.....+...-.-.+|+.+|.+++|||||.+-.++. +-+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 36788999999999999999976 6788999999876544433445679999999999999999988764 3456999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
|||||+. +|..++.....+|...++..++.|+++||+|||.+. |+||||||+|+|++..|.+||+|||+|+.+..+.
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9999976 999999987788999999999999999999999999 9999999999999999999999999999999887
Q ss_pred ccCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--------------
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-------------- 895 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~-------------- 895 (935)
...+..+.|.||+|||.+.|.+ |+.++|+||+|||+.||+++++.|.+....+.+.+|-..-+.+
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 7677778999999999998855 8999999999999999999999999987777666552111110
Q ss_pred ---------------CCCC-cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 ---------------EIPK-ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ---------------~ip~-~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.++. .++..-.+|+..+|..| |.+|.|+.+.|+|.|
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~d---P~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYD---PGKRITAEDGLKHEY 363 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccC---ccccccHHHhhcccc
Confidence 0111 15678899999999999 999999999999998
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=359.92 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=208.6
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHH-HHHHcCCCceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~-iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.||+|+||+||+|++ +++.||||++..... .......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3599999999999976 688999999876432 2233445555655 46778999999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
++|..++.+. ..+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.............
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 9999988653 47899999999999999999999999 99999999999999999999999999875433323334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
|++.|+|||++.+..++.++|||||||++|+|++|..||...+..++...+.. ....++..++..+.++|.+||+.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~ll~~~- 234 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH--KPLVLRPGASLTAWSILEELLEKD- 234 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--CCccCCCCCCHHHHHHHHHHhccC-
Confidence 99999999999999999999999999999999999999999888777766642 344555678899999999999999
Q ss_pred CCcCCCcCH----HHHHhCcC
Q 002331 918 SSLHIRTSQ----AQLSHKRF 934 (935)
Q Consensus 918 ssP~kRPSa----~EILqHPF 934 (935)
|.+||++ .++++|||
T Consensus 235 --p~~R~~~~~~~~~i~~h~~ 253 (325)
T cd05604 235 --RQRRLGAKEDFLEIQEHPF 253 (325)
T ss_pred --HHhcCCCCCCHHHHhcCCC
Confidence 9999866 69999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=335.42 Aligned_cols=252 Identities=27% Similarity=0.448 Sum_probs=219.5
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc--CCceEEEE
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSIIT 752 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~--~~~l~LVm 752 (935)
+|++.+.||.|+||.||++.+ .++.||+|++............+..|+++++.++|+||+++++++.. ...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999976 67889999988776666667788999999999999999999997753 45589999
Q ss_pred eeCCCCCHHHHHcCC---CCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 753 EFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLH-----TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~---~~~lse~~il~Ia~QIa~AL~yLH-----s~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
||+++++|.+++.+. ...+++..++.++.||+.||.||| ..+ |+|+||||+||+++.++.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999998642 457899999999999999999999 776 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
.............++..|+|||++.+..++.++|+||||+++|+|++|+.||...+...+...+. ......++..++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSE 237 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCCCCCccccCHH
Confidence 76544332344578999999999998889999999999999999999999999888766666554 33344577788999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+.++|.+||+.+ |.+||++.+|++|||
T Consensus 238 ~~~l~~~~l~~~---p~~Rp~~~~il~~~~ 264 (265)
T cd08217 238 LNEVIKSMLNVD---PDKRPSTEELLQLPL 264 (265)
T ss_pred HHHHHHHHccCC---cccCCCHHHHhhCCC
Confidence 999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=337.23 Aligned_cols=253 Identities=31% Similarity=0.509 Sum_probs=216.8
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++.+.||.|+||.||+|.+ .++.+++|++...... ....+.+|+.++++++||||+++++++...+.++++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 47899999999999999999976 5678999998765322 4567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++++|.+++......+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999999999999776567999999999999999999999998 999999999999999999999999998865543223
Q ss_pred CCCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---cCCCCcCcHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---LEIPKELDPLVA 906 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~---~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r---~~ip~~ls~~L~ 906 (935)
.....++..|+|||.+.+. .++.++|||||||++|+|++|..||....+......+...... ...+...+..+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 3445788899999999776 7889999999999999999999999988766555443322111 122344678899
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++|.+||..+ |.+||++.+|+.|+|
T Consensus 238 ~li~~~l~~~---p~~Rpt~~~il~~~~ 262 (262)
T cd06613 238 DFIKKCLTKD---PKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHcCCC---hhhCCCHHHHhcCCC
Confidence 9999999999 999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=345.10 Aligned_cols=251 Identities=27% Similarity=0.369 Sum_probs=202.4
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc---CCCceeeeeccccc-----CC
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVTR-----PP 746 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L---~HPNIVkl~g~~~~-----~~ 746 (935)
+|++.+.||+|+||+||+|++ +++.||||.+............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588999999999999999976 578899998875433222223455677776655 79999999998754 34
Q ss_pred ceEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
.+++||||+.+ +|..++.+. ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 58999999975 888888653 345899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc---------c--
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---------R-- 894 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~---------r-- 894 (935)
.... .......++..|+|||++.+..++.++|||||||++|+|++|++||.+.........+..... .
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 158 YSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred ccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 5433 222345689999999999998899999999999999999999999988766554433321000 0
Q ss_pred --------------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 --------------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 --------------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+...++..+.+||.+||+.| |.+||++.++++|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~R~t~~~~l~hp~ 287 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFN---PHKRISAFRALQHPF 287 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccC---cccCCCHHHHhcCCC
Confidence 0011346788999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=336.32 Aligned_cols=252 Identities=23% Similarity=0.438 Sum_probs=222.0
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|++.+.||+|+||.||+++. +++.||||.+............+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999976 678999999876655555667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 755 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 755 ~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
+.+++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||+|+|||++.++.++|+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 9999999998653 335789999999999999999999998 9999999999999999999999999998765433333
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL 913 (935)
....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+. .......+..++..+.++|.+||
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLF 237 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHh
Confidence 34568889999999998889999999999999999999999999888777776654 33445567788999999999999
Q ss_pred hhCCCCcCCCcCHHHHHhCcC
Q 002331 914 QTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 914 ~~D~ssP~kRPSa~EILqHPF 934 (935)
+.+ |.+||++.+|++|||
T Consensus 238 ~~~---p~~Rp~~~~vl~~~~ 255 (256)
T cd08218 238 KRN---PRDRPSVNSILEKNF 255 (256)
T ss_pred hCC---hhhCcCHHHHhhCcC
Confidence 999 999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=347.85 Aligned_cols=253 Identities=29% Similarity=0.463 Sum_probs=208.4
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEEC------------------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWN------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~------------------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPN 734 (935)
++.++|++.++||+|+||.||+|.+. +..||||++.... .......+.+|+.+|.+++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence 45678999999999999999999752 2369999887543 3445667899999999999999
Q ss_pred eeeeecccccCCceEEEEeeCCCCCHHHHHcCCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 002331 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH------------------CQVDEKRRIKMALDVARGMNCLHTSTPT 796 (935)
Q Consensus 735 IVkl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~------------------~~lse~~il~Ia~QIa~AL~yLHs~g~~ 796 (935)
|+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 158 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 9999999999999999999999999999985421 23677888999999999999999999
Q ss_pred EEeeCCCCCCeeecCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--C
Q 002331 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--L 872 (935)
Q Consensus 797 IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT--G 872 (935)
|+||||||+||||+.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 99999999999999999999999999976533211 1223345788999999998889999999999999999986 5
Q ss_pred CCCCCCCChHHHHHHhhc------cccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 873 KLPWIGMNPMQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 873 ~~PF~~~~~~eil~~I~~------~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
..||......+....+.. .......+..++..+.+||.+||..+ |.+||++.+|.+
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~---p~~RPs~~~i~~ 300 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRD---CRERPSFSDIHA 300 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCC---chhCcCHHHHHH
Confidence 688988776665543321 11122345678899999999999999 999999999965
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=361.53 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=208.4
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC-----ceE
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLS 749 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~-----~l~ 749 (935)
+|++++.||+|+||.||++.+ +++.||||++............+.+|+.+++.++|+||+++++++...+ .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999975 6889999998654434445567889999999999999999999998776 789
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999996 5788877553 46899999999999999999999999 999999999999999999999999999865432
Q ss_pred c-ccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc----------------
Q 002331 830 F-LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---------------- 891 (935)
Q Consensus 830 ~-~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~---------------- 891 (935)
. .......+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.++.+.+..+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 1 122334678999999999875 4789999999999999999999999988766544433110
Q ss_pred -------c-cc------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 892 -------N-RR------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 892 -------~-~r------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. .+ ..+....++++.+||.+||+.| |.+||++.++|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d---P~~R~t~~e~l~hp~ 290 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFD---PDKRISAADALAHPY 290 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCC---hhhCcCHHHHhcCHh
Confidence 0 00 0223456889999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=367.66 Aligned_cols=252 Identities=28% Similarity=0.447 Sum_probs=224.6
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcC-CCceeeeecccccCCceEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~L 750 (935)
...|++++.||+|.||.||+++. +|+.||+|++.+..... .....+.+|+.||+++. |||||.++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 35799999999999999999976 58899999998775533 34567899999999997 9999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC----CCcEEEEeccccccc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDFGLSRLK 826 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~----~g~VKL~DFGlA~~~ 826 (935)
|||+|.||.|++.+.+. .+++..+..++.||+.|+.|||..| |+||||||+|+|+.. ++.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999998765 3999999999999999999999999 999999999999953 358999999999988
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC--CCCcCcHH
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPL 904 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~--ip~~ls~~ 904 (935)
.. .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.........+......+. ....++..
T Consensus 190 ~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 190 KP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred cC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 76 4556678999999999999999999999999999999999999999999998887777754444332 22567899
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++++|..||..| |.+|+++.++|+|||
T Consensus 269 akd~i~~ll~~d---p~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 269 AKDFIRKLLEFD---PRKRLTAAQALQHPW 295 (382)
T ss_pred HHHHHHHhcccC---cccCCCHHHHhcCcc
Confidence 999999999999 999999999999999
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=342.03 Aligned_cols=252 Identities=26% Similarity=0.306 Sum_probs=207.6
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|++.+.||+|+||.||+|+. ++..||||++............+.+|+.++++++||||+++++++..++.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999976 578999999876543333445678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 755 LPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 755 ~~gGsL~dlL~~~--~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
++ ++|.+++... +..+++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 97 5888888643 256899999999999999999999998 999999999999999999999999998765433222
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-------------------
Q 002331 833 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------------- 892 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~------------------- 892 (935)
.....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 3344678899999998764 47889999999999999999999998765543322210000
Q ss_pred --------cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 --------RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 --------~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
........+++++.+||.+||+.| |.+||++.+|++|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d---P~~Rpt~~~ll~~~~ 284 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYD---PAKRISAKKALNHPY 284 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCC---hhhCCCHHHHhcCCC
Confidence 000112347889999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.01 Aligned_cols=253 Identities=30% Similarity=0.542 Sum_probs=216.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~g-------~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
+..++|++.+.||+|+||.||+|...+ ..||+|.+.... .......+.+|+.++..++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 456789999999999999999997632 469999876543 344556789999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec
Q 002331 746 PNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd 810 (935)
...+++|||+++++|.+++.+.. ..+++..++.++.||+.||.|||..+ |+||||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc
Confidence 99999999999999999986531 45788899999999999999999998 99999999999999
Q ss_pred CCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 002331 811 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 887 (935)
Q Consensus 811 ~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~ 887 (935)
.++.+||+|||++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....++...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999987653322 11233456788999999998889999999999999999998 9999999888887766
Q ss_pred hhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 888 VGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 888 I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+. .......+..+++.+.+|+.+||+.+ |.+||++.+|+++
T Consensus 239 i~-~~~~~~~~~~~~~~~~~l~~~c~~~~---p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IR-SRQLLPCPEDCPARVYALMIECWNEI---PARRPRFKDIHTR 279 (283)
T ss_pred HH-cCCcCCCcccCCHHHHHHHHHHccCC---hhhCcCHHHHHHH
Confidence 64 33445567889999999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=373.15 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=217.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--C-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--N-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
..|.+.+.||+|+||.||+|.. + +..||+|.+.... ......+.+|+.+|+.++|||||+++++|..++.+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 4599999999999999999965 3 5678888764432 334456788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 753 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 753 Ey~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999988753 2346889999999999999999999998 999999999999999999999999999876433
Q ss_pred cc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 830 FL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 830 ~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+... ....++..+++.+.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHHHHH
Confidence 21 234457999999999999999999999999999999999999999998887777766433 334566788999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
||.+||..+ |.+||++.++++|+|
T Consensus 302 li~~~L~~d---P~~Rps~~~~l~~~~ 325 (478)
T PTZ00267 302 LLDPLLSKN---PALRPTTQQLLHTEF 325 (478)
T ss_pred HHHHHhccC---hhhCcCHHHHHhCHH
Confidence 999999999 999999999999987
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=368.85 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=201.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC-----
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP----- 745 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~----- 745 (935)
....+|++++.||+|+||.||+|.+ .++.||||++.... ....+|+.+|+.++|||||+++++|...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3457899999999999999999976 67899999885432 1234799999999999999998876332
Q ss_pred ---CceEEEEeeCCCCCHHHHHc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC-cEEEE
Q 002331 746 ---PNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVS 818 (935)
Q Consensus 746 ---~~l~LVmEy~~gGsL~dlL~---~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~VKL~ 818 (935)
..+++||||+++ +|.+++. +....+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||+
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeee
Confidence 246799999975 6776664 23457899999999999999999999999 99999999999999664 79999
Q ss_pred eccccccccCCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-----
Q 002331 819 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----- 892 (935)
Q Consensus 819 DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~----- 892 (935)
|||+++..... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+.+..+....
T Consensus 214 DFGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 214 DFGSAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccccchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99999865432 223346789999999998764 68999999999999999999999999876655443332100
Q ss_pred ----------------------cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 ----------------------RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 ----------------------~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
....+|...++++.+||.+||+.| |.+||++.++|+|||
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~d---P~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYE---PLKRLNPIEALADPF 353 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCC---hhHCcCHHHHhCChh
Confidence 001134557889999999999999 999999999999999
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=334.19 Aligned_cols=252 Identities=21% Similarity=0.361 Sum_probs=222.3
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|++.+.||.|+||.||.++. +++.|++|.+............+.+|+.++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588999999999999998865 678899999877666666677788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 755 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 755 ~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 9999999999764 456899999999999999999999998 9999999999999999999999999998765443233
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL 913 (935)
....+++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.. ......+..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ-GNYTPVVSVYSSELISLVHSLL 237 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHHc
Confidence 445789999999999988889999999999999999999999998887777766643 3334455678899999999999
Q ss_pred hhCCCCcCCCcCHHHHHhCcC
Q 002331 914 QTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 914 ~~D~ssP~kRPSa~EILqHPF 934 (935)
+.+ |.+||++.++++|+|
T Consensus 238 ~~~---p~~R~s~~~ll~~~~ 255 (256)
T cd08221 238 QQD---PEKRPTADEVLDQPL 255 (256)
T ss_pred ccC---cccCCCHHHHhhCcC
Confidence 999 999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=357.29 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=205.7
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC------C
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~------~ 746 (935)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 47899999999999999999975 578899999876554445566778999999999999999999988543 3
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
..|+||||+++ +|.+++.. .+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 47999999975 67776643 4788999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc--------------
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------- 892 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~-------------- 892 (935)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 170 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 170 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 443 22344678999999999999999999999999999999999999998876543322111000
Q ss_pred ------cc--------------------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 ------RR--------------------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 ------~r--------------------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.. ...+...+..+++||.+||+.| |.+||++.|+|+|||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d---P~~Rps~~ell~hp~ 313 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID---PAKRISVDEALQHPY 313 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCC---chhcCCHHHHhcCcc
Confidence 00 0011224567899999999999 999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=343.88 Aligned_cols=255 Identities=29% Similarity=0.451 Sum_probs=216.3
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
.+.+.|++.++||.|+||.||+|++ .++.|++|++.... ......+.+|+.+++.++|+||+++++.+..+..+++
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 3446799999999999999999976 57889999986542 3456678889999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||+++++|..++.+....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 99999999999888665567899999999999999999999998 9999999999999999999999999987654333
Q ss_pred ccCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCcCcHH
Q 002331 831 LSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPL 904 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~-r~~ip~~ls~~ 904 (935)
.......++..|+|||++. ...++.++|||||||++|+|++|..||...+.......+..... ....+..++..
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence 3334456889999999985 34467899999999999999999999988776655544432211 22345678889
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+.++|.+||..+ |.+||+++++++|||
T Consensus 245 ~~~li~~~l~~~---p~~Rp~~~~il~~~~ 271 (292)
T cd06644 245 FRDFLKTALDKH---PETRPSAAQLLEHPF 271 (292)
T ss_pred HHHHHHHHhcCC---cccCcCHHHHhcCcc
Confidence 999999999999 999999999999998
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=357.35 Aligned_cols=250 Identities=23% Similarity=0.295 Sum_probs=206.6
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC------C
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~------~ 746 (935)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999976 578899999876544444556778999999999999999999987543 3
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+|+||||+++ +|.+++.. .+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 47999999975 77777753 4788899999999999999999998 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-------------
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 893 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~------------- 893 (935)
.... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 177 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 177 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 4432 23345789999999999999999999999999999999999999998776554443321100
Q ss_pred -------cc--------------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 -------RL--------------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 -------r~--------------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++ ......+..+++||.+||+.| |.+||++.++|+|||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d---P~~R~t~~e~L~hp~ 320 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID---ASKRISVDEALQHPY 320 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcC---cccCCCHHHHhcCcc
Confidence 00 001123467899999999999 999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=342.87 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=206.0
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|++.+.||+|+||.||+|++ +|+.||+|++............+.+|+.++++++||||+++++++.+...+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488999999999999999987 688999999876543333345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
+++ +|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 974 788887665567999999999999999999999998 99999999999999999999999999986544323233
Q ss_pred CCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhcc------------------ccc
Q 002331 835 STAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQ------------------NRR 894 (935)
Q Consensus 835 s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~-~~~~eil~~I~~~------------------~~r 894 (935)
...++..|+|||++.+.. ++.++|||||||++|+|++|..||.. .+..+.+..+... ...
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 456789999999987754 68999999999999999999888644 3333222221100 000
Q ss_pred ---------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 ---------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ---------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
......+++.+++||.+||+.| |.+||+++++++|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~R~t~~~il~h~~ 283 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCN---PVQRISAEEALQHPY 283 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCC---hhhcCCHHHHhcCCC
Confidence 0111346789999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=335.94 Aligned_cols=250 Identities=31% Similarity=0.517 Sum_probs=214.3
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
+.++|++.+.||+|+||.||++++. +..+|+|.+...... ...+.+|+.+|+.++||||+++++++...+..++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 3467999999999999999999874 458999987654432 346788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999999999765557899999999999999999999998 999999999999999999999999998765432221
Q ss_pred -CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 833 -SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 833 -~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.. ..+...|...+..+.+||.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHH
Confidence 122335568999999998889999999999999999999 8999999888777776643 3344556778899999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqH 932 (935)
+||+.+ |.+||++.+|++.
T Consensus 236 ~c~~~~---p~~Rps~~~l~~~ 254 (256)
T cd05114 236 SCWHEK---PEGRPTFAELLRA 254 (256)
T ss_pred HHccCC---cccCcCHHHHHHh
Confidence 999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=355.21 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=208.5
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.||+|+||.||+|+. +++.||||++...... ......+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999976 5778999999865432 33456688899999888 699999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
++|..++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 9999988653 46899999999999999999999998 99999999999999999999999999875433223334567
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC------ChHHHHHHhhccccccCCCCcCcHHHHHHHHH
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM------NPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~------~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~q 911 (935)
||+.|+|||++.+..++.++|||||||++|+|++|..||... +..+...... ...+..+|..++..+.++|.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-LEKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH-HhCCCCCCCCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999999642 2222222221 334566788899999999999
Q ss_pred HHhhCCCCcCCCcC------HHHHHhCcC
Q 002331 912 CWQTGWSSLHIRTS------QAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPS------a~EILqHPF 934 (935)
||+.| |.+|++ ++++++|||
T Consensus 237 ~L~~d---P~~R~~~~~~~~~~~i~~h~~ 262 (327)
T cd05617 237 FLNKD---PKERLGCQPQTGFSDIKSHTF 262 (327)
T ss_pred HhccC---HHHcCCCCCCCCHHHHHcCCC
Confidence 99999 999987 679999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=341.40 Aligned_cols=250 Identities=29% Similarity=0.469 Sum_probs=213.5
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeC
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
|++.+.||.|+||.||++.+ .+..+++|.+.... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 67888999999999999987 46678888875443 345567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCC
Q 002331 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (935)
Q Consensus 756 ~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s 835 (935)
++++|..++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++............
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 999999988765567899999999999999999999998 999999999999999999999999998765443333344
Q ss_pred CCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCcCcHHHHHHH
Q 002331 836 TAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARII 909 (935)
Q Consensus 836 ~~GT~~Y~APEvl~-----g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~-~~r~~ip~~ls~~L~dLI 909 (935)
..++..|+|||++. +..++.++|||||||++|+|++|+.||...+..+....+... ......+..++..+++||
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence 57899999999984 445778999999999999999999999988776665554322 122345667889999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||+.+ |.+||++.++++|||
T Consensus 243 ~~~l~~~---p~~Rp~~~~il~~~~ 264 (282)
T cd06643 243 KKCLEKN---VDARWTTTQLLQHPF 264 (282)
T ss_pred HHHccCC---hhhCcCHHHHhcCCC
Confidence 9999999 999999999999999
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=334.17 Aligned_cols=251 Identities=29% Similarity=0.484 Sum_probs=217.4
Q ss_pred CCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++.+.||.|+||.||++.+. +..|++|.+.... ....+.+|+++++.++|+||+++++.+.....+|+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 367899999999999999999873 6889999886542 1567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.........
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 999999999999766667899999999999999999999998 999999999999999999999999999876544323
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc-cccccCCCCcCcHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~-~~~r~~ip~~ls~~L~dLI~q 911 (935)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||....+......+.. .......+..++..+.++|.+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence 3345688899999999998999999999999999999999999988776554443321 112233455678899999999
Q ss_pred HHhhCCCCcCCCcCHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPSa~EILqHPF 934 (935)
||+.+ |.+||++.+||+|||
T Consensus 236 ~l~~~---P~~Rps~~~il~~~~ 255 (256)
T cd06612 236 CLVKD---PEERPSAIQLLQHPF 255 (256)
T ss_pred HHhcC---hhhCcCHHHHhcCCC
Confidence 99999 999999999999999
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=345.57 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=210.0
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
..++|++.+.||.|+||.||+|++ .++.||+|.+...... .....+.+|+.+++.++||||+++++++..++.+++|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 357899999999999999999976 5788999998654322 2233567899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||++ ++|.+++.+....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 99997 5899988766667899999999999999999999998 99999999999999999999999999976543322
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-----------------c
Q 002331 832 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-----------------R 893 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~-----------------~ 893 (935)
......+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+....+.... .
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 23345678899999998764 47889999999999999999999999877654433221100 0
Q ss_pred ccC-----------CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 RLE-----------IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 r~~-----------ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
... ....+++++++||.+||+.| |.+||++.++|+|||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~d---p~~R~t~~eil~h~~ 288 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFE---GRKRISAEEAMKHPY 288 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCC---cccCcCHHHHhcCcc
Confidence 001 11357889999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=351.37 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=224.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
+.|++.+.||+|.|+.||++.+ .|+.+|+|++....+.....+++.+|+.|.+.|+|||||++.+.+......|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 5678888999999999999955 78899999988777766678889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHH-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec---CCCcEEEEeccccccccCC
Q 002331 754 FLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 754 y~~gGsL~dlL-~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd---~~g~VKL~DFGlA~~~~~~ 829 (935)
+|.|++|..-| ++ ..+++..+-.+++||++||.|+|.++ |||||+||+|+||- ..--+||+|||++..+. .
T Consensus 91 ~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~ 165 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D 165 (355)
T ss_pred cccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence 99999997644 44 46788888999999999999999999 99999999999995 34569999999999887 3
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC--CCCcCcHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVAR 907 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~--ip~~ls~~L~d 907 (935)
......+.|||.|||||+++..+|+..+|||+-|+|||-|+.|++||.+.+...++..|........ ....++++.++
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 3556678999999999999999999999999999999999999999999999888888865444332 34678999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
||++||..| |.+|.|+.|.|+|||
T Consensus 246 LvrrML~~d---P~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 246 LIRRMLTVN---PKKRITADEALKHPW 269 (355)
T ss_pred HHHHHhccC---hhhhccHHHHhCCch
Confidence 999999999 999999999999999
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=338.58 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=210.7
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccC------
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP------ 745 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~------ 745 (935)
...|.+.+.||+|+||.||+|.+ .++.||||++..... ....+..|+.++.++ +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35688888999999999999976 577899999865432 234677899999998 799999999998653
Q ss_pred CceEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 746 PNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
..+|+||||+.+++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4589999999999999998763 346889999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 899 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~ 899 (935)
.............|+..|+|||++. +..++.++|||||||++|+|++|..||...........+.....+...+.
T Consensus 160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06637 160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 239 (272)
T ss_pred ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCC
Confidence 6544333334567899999999986 34578899999999999999999999987766555544433333333445
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 900 ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.++..+.+||.+||..+ |.+||++.++++|||
T Consensus 240 ~~~~~~~~li~~~l~~~---p~~Rpt~~~il~~~~ 271 (272)
T cd06637 240 KWSKKFQSFIESCLVKN---HSQRPTTEQLMKHPF 271 (272)
T ss_pred CcCHHHHHHHHHHcCCC---hhhCCCHHHHhhCCC
Confidence 67899999999999999 999999999999999
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=342.59 Aligned_cols=253 Identities=29% Similarity=0.454 Sum_probs=217.6
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++.+.||.|+||.||++.+ ++..||+|++... .......+..|+.++++++|+||+++++++..+..+|+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 46789999999999999999976 5788999988644 2345567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++++|.+++.+....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999999999776667999999999999999999999999 999999999999999999999999998765443333
Q ss_pred CCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCcCcHHHH
Q 002331 833 SKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVA 906 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~-r~~ip~~ls~~L~ 906 (935)
.....+++.|++||++. +..++.++|||||||++|+|++|+.||...+.......+..... ....+..++..+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 34456899999999975 34467899999999999999999999998887766555532211 2234567889999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++|.+||+.+ |.+||++.++++|||
T Consensus 240 ~li~~~l~~~---p~~Rps~~~il~~~~ 264 (280)
T cd06611 240 DFLKSCLVKD---PDDRPTAAELLKHPF 264 (280)
T ss_pred HHHHHHhccC---hhhCcCHHHHhcChh
Confidence 9999999999 999999999999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=338.49 Aligned_cols=252 Identities=29% Similarity=0.430 Sum_probs=209.9
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
..+|++.+.||+|+||.||+|++ +++.||+|++..... .....+.+|+.+++.++||||+++++++...+.+++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 46799999999999999999986 678899999865432 23346788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 86 EYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 999999999998653 46899999999999999999999998 999999999999999999999999999866433333
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---cCCCCcCcHHHH
Q 002331 833 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---LEIPKELDPLVA 906 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r---~~ip~~ls~~L~ 906 (935)
.....++..|+|||.+. ...++.++|||||||++|+|++|+.||....+......+...... ...+..++..+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 34456889999999985 344678999999999999999999999776654433322111111 112234678999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||.+||+.+ |.+||++++||+|+|
T Consensus 243 ~li~~~l~~~---P~~Rp~~~~il~~l~ 267 (267)
T cd06646 243 NFVKISLTKN---PKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHhhCC---hhhCcCHHHHhcCCC
Confidence 9999999999 999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=361.27 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=212.7
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~ 741 (935)
.+.++.++|++++.||+|+||.||+|++ .+..||||+++.... ......+.+|+.+|..+ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 4567778999999999999999999964 345799999865432 23445788999999999 89999999999
Q ss_pred cccCCceEEEEeeCCCCCHHHHHcCCC-----------------------------------------------------
Q 002331 742 VTRPPNLSIITEFLPRGSLFRILHRPH----------------------------------------------------- 768 (935)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~~~~----------------------------------------------------- 768 (935)
+...+..++|||||++|+|.+++.+..
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999999999886421
Q ss_pred ---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 769 ---------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 769 ---------------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 24678889999999999999999998 9999999999999999999999999998654
Q ss_pred CCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 828 NTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 828 ~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
.... ......++..|+|||++.+..++.++|||||||++|||++ |..||.................+...+...+.+
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE 345 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence 3211 1112334567999999999999999999999999999997 899998765443333333333445566778899
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+.+||.+||+.| |.+||++.+|++.
T Consensus 346 l~~li~~cl~~d---P~~RPs~~eil~~ 370 (375)
T cd05104 346 MYDIMKSCWDAD---PLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHccCC---hhHCcCHHHHHHH
Confidence 999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=341.07 Aligned_cols=246 Identities=34% Similarity=0.591 Sum_probs=208.9
Q ss_pred eEEEEeeecCcEEEEEEEEC------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 679 VLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 679 ~I~e~LG~G~fG~Vyka~~~------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++.+.||.|.||.||+|.+. +..|+||.+... ......+.+.+|++++++++||||+++++++...+.+++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence 56789999999999999886 678999998543 34455788999999999999999999999999888899999
Q ss_pred eeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC--
Q 002331 753 EFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-- 829 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~-- 829 (935)
||+++|+|.+++... ...+++..++.|+.||+.||.|||+++ |+|+||+++||||+.++.+||+|||++......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence 999999999999875 567999999999999999999999998 999999999999999999999999999876321
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
............|+|||.+.+..++.++||||||+++|||++ |+.||...+..++...+ ....+..++..++..+.++
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 237 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSL 237 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHH
Confidence 111223346678999999999889999999999999999999 68999999888888777 4556677888899999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHh
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILq 931 (935)
|.+||..+ |.+||++.+|++
T Consensus 238 i~~C~~~~---p~~RPs~~~i~~ 257 (259)
T PF07714_consen 238 IQQCWSHD---PEKRPSFQEILQ 257 (259)
T ss_dssp HHHHT-SS---GGGS--HHHHHH
T ss_pred HHHHcCCC---hhhCcCHHHHHh
Confidence 99999999 999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=357.31 Aligned_cols=243 Identities=25% Similarity=0.400 Sum_probs=205.9
Q ss_pred eeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHc---CCCceeeeecccccCCceEEEEeeCCC
Q 002331 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL---RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 684 LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L---~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
||+|+||+||+|++ .++.||||++...... ......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999976 5789999998754332 22334455677777665 699999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
++|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++.............+
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 9999988763 46899999999999999999999999 99999999999999999999999999876433333344567
Q ss_pred CCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC-cCcHHHHHHHHHHHhh
Q 002331 838 GTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-ELDPLVARIIWECWQT 915 (935)
Q Consensus 838 GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~-~ls~~L~dLI~qCL~~ 915 (935)
||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..++...+.... ..++. .+++++.+||.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK--VRFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHcCC
Confidence 99999999998765 47899999999999999999999999988887777664332 33343 4789999999999999
Q ss_pred CCCCcCCCc----CHHHHHhCcC
Q 002331 916 GWSSLHIRT----SQAQLSHKRF 934 (935)
Q Consensus 916 D~ssP~kRP----Sa~EILqHPF 934 (935)
| |.+|| ++.++++|||
T Consensus 236 ~---P~~R~~~~~~~~~ll~h~~ 255 (330)
T cd05586 236 N---PQHRLGAHRDAVELKEHPF 255 (330)
T ss_pred C---HHHCCCCCCCHHHHhcCcc
Confidence 9 99998 7999999998
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=355.07 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=210.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc-----CCce
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-----PPNL 748 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~-----~~~l 748 (935)
..|...+.||+|+||.|+.+.+ +|+.||||++.......-..+...+|+++|+.++|+||+.+++++.. -+.+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4455578999999999999976 78999999987655455567778899999999999999999999865 3459
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|+|+|+| +.+|.++++.. ..+++..+..+++||++||.|+|+.+ |+||||||.|+|++.+..+||||||+|+....
T Consensus 102 YiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeeccc
Confidence 9999999 55999999773 35999999999999999999999999 99999999999999999999999999998753
Q ss_pred C--cccCCCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc---------------
Q 002331 829 T--FLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--------------- 890 (935)
Q Consensus 829 ~--~~~~~s~~GT~~Y~APEvl~-g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~--------------- 890 (935)
. ....+..+.|.+|.|||++. ...|+.+.||||+||||.||++|++-|.|.+....+..+..
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 1 12235678899999999865 56799999999999999999999999999766444333211
Q ss_pred ---------cccccCCC-----CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 891 ---------QNRRLEIP-----KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 891 ---------~~~r~~ip-----~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
....+..| .+.++...+|+++||..| |.+|+|++|+|+|||
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fd---P~kRita~eAL~hPY 312 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFD---PKKRITAEEALAHPY 312 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccC---ccccCCHHHHhcChh
Confidence 11111111 468899999999999999 999999999999998
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=361.15 Aligned_cols=258 Identities=27% Similarity=0.429 Sum_probs=213.7
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeec
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 740 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g 740 (935)
..+.+..++|++++.||+|+||.||+|.+. +..||||++..... ......+.+|+.+++.+ +|+|||++++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 345677889999999999999999999752 24799999876543 33456788999999999 8999999999
Q ss_pred ccccCCceEEEEeeCCCCCHHHHHcCCC----------------------------------------------------
Q 002331 741 AVTRPPNLSIITEFLPRGSLFRILHRPH---------------------------------------------------- 768 (935)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~~~~---------------------------------------------------- 768 (935)
++...+.+++||||+++|+|.+++.+..
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 9999999999999999999999885321
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 769 -----------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 769 -----------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
..+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 24678889999999999999999998 99999999999999999999999999876543211
Q ss_pred --cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHH
Q 002331 832 --SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 832 --~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
......++..|+|||++.+..++.++|||||||++|+|++ |+.||...........+.........+..+++++.++
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSI 347 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHH
Confidence 1112234567999999998889999999999999999997 9999987765444333333344555667789999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqH 932 (935)
|.+||+.| |.+||++.+|++.
T Consensus 348 i~~cl~~d---p~~RPs~~~l~~~ 368 (374)
T cd05106 348 MKMCWNLE---PTERPTFSQISQL 368 (374)
T ss_pred HHHHcCCC---hhhCcCHHHHHHH
Confidence 99999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=339.26 Aligned_cols=252 Identities=30% Similarity=0.455 Sum_probs=210.9
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++.+.||+|+||.||+|++ +++.||+|+++.... .....+.+|+.+++.++||||+++++.+...+.+++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 35788899999999999999976 578999999875532 23456788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++++|.+++... ..+++..++.++.||+.||.|||++| |+|+||||+||+++.++.+||+|||++.........
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 86 EFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 999999999998654 46899999999999999999999998 999999999999999999999999998765443333
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-CC--CCcCcHHHH
Q 002331 833 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-EI--PKELDPLVA 906 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~-~i--p~~ls~~L~ 906 (935)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||....+.............. .. ...++..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 34557899999999974 4557889999999999999999999998766544433322111111 11 124678899
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++|.+||+.+ |++||++++|++|||
T Consensus 243 ~li~~~l~~~---P~~R~~~~~ll~~~~ 267 (267)
T cd06645 243 HFVKMALTKN---PKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHccCC---chhCcCHHHHhcCCC
Confidence 9999999999 999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.53 Aligned_cols=251 Identities=29% Similarity=0.503 Sum_probs=215.1
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-------HHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-------~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
+|.+++.||+|+||.||+|.+ .++.||+|.+...... ......+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477888999999999999976 5788999988654322 1234568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
.++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+++ |+||||+|+|||++.++.+||+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999999764 46889999999999999999999998 9999999999999999999999999988664
Q ss_pred CCc------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcC
Q 002331 828 NTF------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (935)
Q Consensus 828 ~~~------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~l 901 (935)
... .......|+..|+|||.+.+..++.++|||+|||++|+|++|+.||...+.......+. ......++..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNI 236 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCccc
Confidence 211 11123457889999999998889999999999999999999999999876655554443 23455677788
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+..+.++|.+||+.+ |.+||++.+|++|||
T Consensus 237 ~~~~~~li~~~l~~~---p~~Rp~~~~il~~~~ 266 (267)
T cd06628 237 SSEAIDFLEKTFEID---HNKRPTAAELLKHPF 266 (267)
T ss_pred CHHHHHHHHHHccCC---chhCcCHHHHhhCCC
Confidence 999999999999999 999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.20 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=209.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|+||.||+|++ +++.||+|++............+.+|+.++++++|+||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4689999999999999999987 57899999887554333334567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
|++++.|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 99998888877553 46899999999999999999999998 9999999999999999999999999998765443223
Q ss_pred CCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------------cc
Q 002331 834 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-----------------RL 895 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~-----------------r~ 895 (935)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34567889999999876 4578899999999999999999999988766444332210000 00
Q ss_pred CC------------CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 EI------------PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ~i------------p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+ -..++..+.+||.+||+.+ |.+||++.+++.|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---p~~Rp~~~eil~~~~ 285 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMD---PTERLSCEELLEHPY 285 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCC---ccccCCHHHHhcCCC
Confidence 00 1246788999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=334.00 Aligned_cols=252 Identities=30% Similarity=0.470 Sum_probs=214.1
Q ss_pred CeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCC----CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 677 DLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDF----SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~----~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
+|++++.||.|+||.||+|.. +++.+|||.+..... .......+.+|+.+++.++|+||+++++++.+.+.+++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 578889999999999999976 678899998865432 123345688999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC--
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-- 829 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~-- 829 (935)
|||+++++|.+++.+. ..+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999999764 46789999999999999999999998 999999999999999999999999998754211
Q ss_pred ----cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCcCcHH
Q 002331 830 ----FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPL 904 (935)
Q Consensus 830 ----~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~-~~r~~ip~~ls~~ 904 (935)
........++..|+|||++.+..++.++|||||||++|+|++|..||...+.......+... ...+.++..++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 11122346889999999999988999999999999999999999999887655444333222 2334577789999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+.++|.+||+.+ |.+||++.++++|||
T Consensus 238 ~~~~i~~~l~~~---p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 238 AIDFVTSCLTRD---QHERPSALQLLRHDF 264 (265)
T ss_pred HHHHHHHHhcCC---cccCCCHHHHhcCCC
Confidence 999999999999 999999999999999
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.80 Aligned_cols=252 Identities=31% Similarity=0.511 Sum_probs=216.5
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
..++|++.+.||+|+||.||+|.+. ...||||++.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 4568999999999999999999773 3479999876543 344566788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++||||+++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999999999776667899999999999999999999998 99999999999999999999999999987642
Q ss_pred C--cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHH
Q 002331 829 T--FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 829 ~--~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
. ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ...+...+..++..+
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 237 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSAL 237 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHH
Confidence 1 112222334678999999998889999999999999999998 999998888777766664 333445567789999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+||.+||+.+ |.+||++.+|+++
T Consensus 238 ~~li~~cl~~~---p~~Rp~~~ei~~~ 261 (266)
T cd05033 238 YQLMLDCWQKD---RNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHcCCC---cccCcCHHHHHHH
Confidence 99999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=337.66 Aligned_cols=253 Identities=28% Similarity=0.523 Sum_probs=214.9
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
+.+++|++.+.||+|+||.||+|.+ .+..|++|.+.... .......+.+|+.+++.++||||+++++++..+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4568899999999999999999974 35689999887543 3345567889999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec
Q 002331 747 NLSIITEFLPRGSLFRILHRP----------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~----------------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd 810 (935)
..|+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~ 158 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc
Confidence 999999999999999998532 124788889999999999999999998 99999999999999
Q ss_pred CCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 002331 811 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 887 (935)
Q Consensus 811 ~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~ 887 (935)
.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.....+...
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999997653321 11223445678999999988889999999999999999998 9999998887766665
Q ss_pred hhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 888 VGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 888 I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+. .......+..+++.+.++|.+||+.+ |.+||++.+|+++
T Consensus 239 ~~-~~~~~~~~~~~~~~~~~li~~cl~~~---p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VR-KRQLLPCSEDCPPRMYSLMTECWQEG---PSRRPRFKDIHTR 279 (283)
T ss_pred HH-cCCcCCCCCCCCHHHHHHHHHHcccC---cccCcCHHHHHHH
Confidence 54 33345567889999999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=334.37 Aligned_cols=250 Identities=33% Similarity=0.528 Sum_probs=214.6
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEECC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
..++|.+.+.||+|+||.||++++.+ ..||||.+...... ...+.+|+.++++++||||+++++++.....+++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 45689999999999999999998754 46999988755432 346889999999999999999999999989999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+.+++|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999999999765557899999999999999999999998 999999999999999999999999998765433221
Q ss_pred -CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 833 -SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 833 -~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
.....++..|++||++.+..++.++|||||||++|+|++ |..||...+.......+. ...+...+...+..+.++|.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHH
Confidence 112335568999999998889999999999999999998 999999888777666664 33445556678899999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqH 932 (935)
+||+.+ |.+||++.+|+++
T Consensus 236 ~cl~~~---p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEK---AEERPTFQQLLSS 254 (256)
T ss_pred HHcCCC---cccCCCHHHHHHh
Confidence 999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=332.75 Aligned_cols=252 Identities=30% Similarity=0.515 Sum_probs=215.3
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
|++..++|++.++||+|+||.||+|.. .+..||+|.+.... .....+.+|+.+++.++|+||+++++.+...+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 467789999999999999999999976 45679999876433 23467889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++|||+++++|.+++.+. ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....+
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999999998653 456888899999999999999999998 99999999999999999999999999987654
Q ss_pred Cccc-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHH
Q 002331 829 TFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 829 ~~~~-~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
.... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.. ..+...+..++..+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-GYRMPRMENCPDELY 234 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHH
Confidence 3211 122345668999999998889999999999999999998 9999998877776666542 334445567889999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
++|.+||+.+ |++||++++|++
T Consensus 235 ~li~~~l~~~---p~~Rp~~~~i~~ 256 (261)
T cd05072 235 DIMKTCWKEK---AEERPTFDYLQS 256 (261)
T ss_pred HHHHHHccCC---cccCcCHHHHHH
Confidence 9999999999 999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.59 Aligned_cols=251 Identities=24% Similarity=0.427 Sum_probs=218.7
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|++.+.||+|+||.||++.. .+..||||.+............+.+|+.+++.++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999965 678899999987666666677889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC-CcEEEEeccccccccCCccc
Q 002331 755 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 755 ~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~VKL~DFGlA~~~~~~~~~ 832 (935)
+++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.+ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 9999999999764 345899999999999999999999998 9999999999999854 5689999999987654322
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qC 912 (935)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+. ......++..++..+.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 236 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-SGTFAPISDRYSPDLRQLILSM 236 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH-hcCCCCCCCCcCHHHHHHHHHH
Confidence 223568889999999998888999999999999999999999999887766665553 2334456777899999999999
Q ss_pred HhhCCCCcCCCcCHHHHHhCcC
Q 002331 913 WQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 913 L~~D~ssP~kRPSa~EILqHPF 934 (935)
|+.+ |.+||++.+|++|||
T Consensus 237 l~~~---p~~Rpt~~~ll~~p~ 255 (256)
T cd08220 237 LNLD---PSKRPQLSQIMAQPI 255 (256)
T ss_pred ccCC---hhhCCCHHHHhhCCC
Confidence 9999 999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=339.52 Aligned_cols=248 Identities=25% Similarity=0.457 Sum_probs=219.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||++.+ .++.||||++...... ......+.+|++++++++||||+++++++...+.+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4789999999999999999977 5789999998765432 234567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+|+||+|.||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999999764 47899999999999999999999998 999999999999999999999999998876543
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qC 912 (935)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+. .....+|..++..++++|.+|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHH
Confidence 234568899999999988888999999999999999999999999888666655553 445667888899999999999
Q ss_pred HhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 913 WQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 913 L~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
|..+ |.+|+ +++++++|||
T Consensus 233 l~~~---p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 233 LQVD---LTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred ccCC---HHHccCcccCCHHHHHcCcc
Confidence 9999 99999 9999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=352.31 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=205.4
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC------C
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~------~ 746 (935)
.++|++.+.||+|+||.||+|.+ .++.||||++............+.+|+.+|+.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 47899999999999999999976 577899999876543334455677899999999999999999988543 3
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+|++||++ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCccceec
Confidence 478999998 6799988864 46899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------ 893 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~------------ 893 (935)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 169 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 432 234578999999999877 5688999999999999999999999988765544433211000
Q ss_pred ---------ccCC--------CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 ---------RLEI--------PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 ---------r~~i--------p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.... ....++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d---p~~R~s~~ell~hp~ 300 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLD---SDKRISASEALAHPY 300 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCC---hhhCCCHHHHhcCcc
Confidence 0001 1235677899999999999 999999999999998
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=329.03 Aligned_cols=251 Identities=32% Similarity=0.508 Sum_probs=218.3
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC---CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~---~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
+|++.+.||+|+||.||+|.. +++.|++|.+..... .......+.+|+.+++.++|+||+++++++.....+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 467788999999999999976 588999998865432 234556788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+++++|.+++.+. ..+++..++.++.||+.||.|||..+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 9999999999999764 46889999999999999999999998 9999999999999999999999999987654432
Q ss_pred cCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
......++..|++||.+.... ++.++|+|||||++|+|++|+.||...........+........++..+++.+.++|.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHH
Confidence 223456889999999987766 8899999999999999999999998877666655554434556677888999999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||+.+ |.+||++.++++|||
T Consensus 237 ~~l~~~---p~~Rp~~~~~l~~~~ 257 (258)
T cd06632 237 KCLQRD---PSLRPTAAELLEHPF 257 (258)
T ss_pred HHhhcC---cccCcCHHHHhcCCC
Confidence 999999 999999999999998
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.09 Aligned_cols=250 Identities=29% Similarity=0.460 Sum_probs=217.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||.|+||.||+|.+ +++.||+|++.... .......+.+|+++++.++|+||+++++++..+..+++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 4688889999999999999976 57899999987553 23345568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
|+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+++.........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 99999999999764 7899999999999999999999998 9999999999999999999999999998765543333
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCc-CcHHHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE-LDPLVARIIWEC 912 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~-ls~~L~dLI~qC 912 (935)
....++..|+|||.+.+..++.++|||||||++|+|++|..||...++......+.. .....++.. ++..+.++|.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh-cCCCCCcccccCHHHHHHHHHH
Confidence 445788899999999988899999999999999999999999988777666554432 233444444 889999999999
Q ss_pred HhhCCCCcCCCcCHHHHHhCcC
Q 002331 913 WQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 913 L~~D~ssP~kRPSa~EILqHPF 934 (935)
|..+ |.+||+++++++|||
T Consensus 235 l~~~---p~~Rpt~~~il~~~~ 253 (274)
T cd06609 235 LNKD---PKERPSAKELLKHKF 253 (274)
T ss_pred hhCC---hhhCcCHHHHhhChh
Confidence 9999 999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.20 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=210.7
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
.|++.+.||+|+||.||++.+ .++.||||.+....... .....+.+|+.++++++|+||+++++.+.+.+.+++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367889999999999999976 57899999987654332 234456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 754 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 754 y~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-c
Confidence 99999999988542 345899999999999999999999998 9999999999999999999999999987654321 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~---eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ....... ......++..+++++++||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHH
Confidence 23457899999999999989999999999999999999999999875432 1122111 1223345677899999999
Q ss_pred HHHHhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPS-----a~EILqHPF 934 (935)
.+||+.| |.+||+ ++++++|||
T Consensus 237 ~~~l~~~---p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 237 KMLLCKD---PKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred HHHhhcC---HHHccCCCCCchHHHHcChh
Confidence 9999999 999999 999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.94 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=217.1
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|++.+.||+|+||.||++.+ .+..||+|.+..... ......+.+|+.+++.++|+||+++++.+...+.+|+||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 588999999999999999976 678899999865432 23456778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 755 LPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 755 ~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++..........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 999999998864 3445789999999999999999999998 9999999999999999999999999987665433333
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL 913 (935)
....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. ......++..++..+.+||.+||
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 236 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMF 236 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHH
Confidence 44678899999999999889999999999999999999999999888777666554 33344567788999999999999
Q ss_pred hhCCCCcCCCcCHHHHHhCc
Q 002331 914 QTGWSSLHIRTSQAQLSHKR 933 (935)
Q Consensus 914 ~~D~ssP~kRPSa~EILqHP 933 (935)
+.| |.+||++.+|+..-
T Consensus 237 ~~~---P~~Rp~~~~il~~~ 253 (255)
T cd08219 237 KRN---PRSRPSATTILSRG 253 (255)
T ss_pred hCC---cccCCCHHHHhhcc
Confidence 999 99999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=331.87 Aligned_cols=252 Identities=29% Similarity=0.482 Sum_probs=213.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC---CHHHHHHHHHHHHHHHHcCCCceeeeecccccC--Cce
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 748 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~---~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l 748 (935)
.+|++++.||+|+||.||++.+ +++.||||++..... .......+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5789999999999999999976 578999998864321 223456788999999999999999999988764 458
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 8999999999999998754 35788999999999999999999999 99999999999999999999999999875432
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHH
Q 002331 829 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 829 ~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
.. .......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+......+.+|..++..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 11 112234688899999999988899999999999999999999999988766665555544444556777888999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.++|.+||. + |.+||++++|++|||
T Consensus 239 ~~~i~~~l~-~---p~~Rp~~~~il~~~~ 263 (265)
T cd06652 239 RDFLKRIFV-E---AKLRPSADELLRHTF 263 (265)
T ss_pred HHHHHHHhc-C---hhhCCCHHHHhcCcc
Confidence 999999994 8 999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=354.57 Aligned_cols=247 Identities=21% Similarity=0.282 Sum_probs=202.2
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
...+|.+++.||+|+||.||++.. .++.||||.+.... .+.+|+.+|+.++|||||++++++.....++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 346899999999999999999965 34679999875432 3457999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+|||++. ++|.+++.+ ...+++..++.|+.||+.||.|||.+| ||||||||+||||+.++.+||+|||+++.....
T Consensus 163 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999996 588888844 457899999999999999999999998 999999999999999999999999999765433
Q ss_pred cc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhc--cc----------
Q 002331 830 FL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGF--QN---------- 892 (935)
Q Consensus 830 ~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~---eil~~I~~--~~---------- 892 (935)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..+..+.. ..
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 22 123457999999999999999999999999999999999999999875421 11111100 00
Q ss_pred -------------cc--cCCC-----CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 -------------RR--LEIP-----KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 -------------~r--~~ip-----~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+ ..++ ..++.++.++|.+||+.| |++||++.++|.|||
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~d---p~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFD---QEFRPSAQDILSLPL 377 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccC---hhhCCCHHHHhhCch
Confidence 00 1111 235678899999999999 999999999999998
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.47 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=212.5
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|++.+.||.|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++..+..+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999986 678999999887665455567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-cC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-SS 833 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~ 833 (935)
+ +++|.+++......+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 99999999765567999999999999999999999998 99999999999999999999999999887654321 12
Q ss_pred CCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-----------------
Q 002331 834 KSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----------------- 895 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~----------------- 895 (935)
....++..|+|||++.+.. ++.++|||||||++|+|++|.+||.+.........+......+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 3456889999999987644 6899999999999999999998888766544433321100000
Q ss_pred -----------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 -----------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 -----------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+....+..+.+||.+||+.+ |.+||+++++|+|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---p~~R~~~~~~l~h~~ 284 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYD---PSKRLSAAEALRHPY 284 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccC---hhhCCCHHHHhhCcC
Confidence 011345789999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=332.35 Aligned_cols=253 Identities=35% Similarity=0.586 Sum_probs=217.1
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
|++...+|.+.+.||+|+||.||+|.+ .++.||+|++.... .....+.+|+++++.++|+||+++++++..++.+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 456778899999999999999999976 57889999876542 2345788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 749 SIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 9999999999999998653 345889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccC-CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHH
Q 002331 828 NTFLSS-KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 828 ~~~~~~-~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
...... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+. ...+...+..++..+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKV 234 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHH
Confidence 432211 12234567999999999899999999999999999998 999999887776665553 334556778899999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.++|.+||+.+ |.+||++.++++.
T Consensus 235 ~~li~~cl~~~---p~~Rp~~~~l~~~ 258 (263)
T cd05052 235 YELMRACWQWN---PSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHHHccCC---cccCCCHHHHHHH
Confidence 99999999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.46 Aligned_cols=252 Identities=23% Similarity=0.419 Sum_probs=212.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 6799999999999999999976 688999998875433 3445567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 753 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 753 Ey~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+||||+.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999988753 2345789999999999999999999998 999999999999999999999999998876543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--PMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~--~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
........+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... .......+.....+...+..++..+.+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 322334568889999999998888999999999999999999999997653 234444443222223333467889999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+|.+||+.+ |.+||++.++++.
T Consensus 240 li~~cl~~~---p~~Rp~~~~vl~~ 261 (267)
T cd08228 240 LVSMCIYPD---PDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHCCCC---cccCcCHHHHHHH
Confidence 999999999 9999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.88 Aligned_cols=252 Identities=29% Similarity=0.482 Sum_probs=213.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC---CHHHHHHHHHHHHHHHHcCCCceeeeeccccc--CCce
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNL 748 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~---~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~--~~~l 748 (935)
.+|++.+.||+|+||.||++.. .++.|++|++..... .......+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3678899999999999999976 578999998865432 22345568899999999999999999998865 3568
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
+++|||+++++|.+++... ..+++...+.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 8999999999999998764 35889999999999999999999998 99999999999999999999999999875532
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHH
Q 002331 829 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 829 ~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
.. .......++..|+|||++.+..++.++|||||||++|+|++|+.||..................+.++..+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 11 111234578899999999998899999999999999999999999998876666555544445567778889999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+++| +||..+ |.+||++++|++|||
T Consensus 239 ~~li-~~~~~~---p~~Rp~~~eil~hp~ 263 (266)
T cd06651 239 RDFL-GCIFVE---ARHRPSAEELLRHPF 263 (266)
T ss_pred HHHH-HHhcCC---hhhCcCHHHHhcCcc
Confidence 9999 688889 999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=332.19 Aligned_cols=255 Identities=29% Similarity=0.458 Sum_probs=210.4
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
+..+.+.....||+|+||.||+|.+ ++..|++|.+.... ......+.+|+.+++.++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3444455556899999999999976 56789999876543 2345578899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC-CCcEEEEecccccccc
Q 002331 751 ITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKH 827 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~l--se~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~VKL~DFGlA~~~~ 827 (935)
||||+++++|.+++......+ ++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999997643445 78888899999999999999998 999999999999976 6799999999987654
Q ss_pred CCcccCCCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccCCCCcCcHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~--~s~ksDIWSLG~ILyELLTG~~PF~~~~~~-eil~~I~~~~~r~~ip~~ls~~ 904 (935)
..........++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ..............++..+++.
T Consensus 161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06624 161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE 240 (268)
T ss_pred cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHH
Confidence 3322233346789999999986643 788999999999999999999999865432 2222232234455678889999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++++|.+||+.+ |.+||++.+|++|||
T Consensus 241 ~~~li~~~l~~~---p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 241 AKNFILRCFEPD---PDKRASAHDLLQDPF 267 (268)
T ss_pred HHHHHHHHcCCC---chhCCCHHHHHhCCC
Confidence 999999999999 999999999999999
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=359.25 Aligned_cols=248 Identities=21% Similarity=0.243 Sum_probs=201.5
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
.+...+|++.+.||+|+||.||++.+ .++.||||+.. ...+.+|+++|++|+|||||+++++|......+
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 35567899999999999999999976 57889999643 224678999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+|||++. ++|..++... ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 160 lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred EEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 9999995 6888888653 46889999999999999999999998 999999999999999999999999999754322
Q ss_pred -cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-------HHHHHHhhc-----------
Q 002331 830 -FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGAVGF----------- 890 (935)
Q Consensus 830 -~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~-------~eil~~I~~----------- 890 (935)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+..
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1122345799999999999999999999999999999999999988754321 011110000
Q ss_pred -----------------cccccCCC-----CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 891 -----------------QNRRLEIP-----KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 891 -----------------~~~r~~ip-----~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...+...+ ..++.++.+||.+||+.| |.+||+++|+|+|||
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~d---P~~Rpta~elL~hp~ 378 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFD---AHHRPSAEALLDFAA 378 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCC---hhhCCCHHHHhcChh
Confidence 00000001 135678999999999999 999999999999998
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.38 Aligned_cols=254 Identities=31% Similarity=0.459 Sum_probs=211.3
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCC---
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP--- 746 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~--- 746 (935)
...++|++.+.||.|+||.||+|.+ .++.|++|++..... ....+.+|+.+++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 3458899999999999999999987 567899998875532 345788999999999 7999999999986544
Q ss_pred ---ceEEEEeeCCCCCHHHHHcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 747 ---NLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 747 ---~l~LVmEy~~gGsL~dlL~~~---~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
.+++||||+++++|.+++... +..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+||
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCC
Confidence 489999999999999988642 357899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-c
Q 002331 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-R 894 (935)
Q Consensus 821 GlA~~~~~~~~~~~s~~GT~~Y~APEvl~g-----~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~-r 894 (935)
|++..............++..|+|||++.. ..++.++|||||||+||+|++|+.||...........+..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 998765543333344568899999998854 3467899999999999999999999987766555554432211 1
Q ss_pred cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...+..++..+.+||.+||..| |.+||++.+|++|||
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~d---p~~Rpt~~~ll~~~~ 274 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKN---YEQRPFMEELLEHPF 274 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcC---hhhCcCHHHHhcCCC
Confidence 1223346789999999999999 999999999999999
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.78 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=213.0
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
.|++.+.||+|+||+||++.+ +++.||+|++....... .....+.+|+.+|+.++|+||+.+++.+..++.+++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367889999999999999977 57899999987654432 234457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 754 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 754 y~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cc
Confidence 99999999888643 346899999999999999999999998 999999999999999999999999998754322 12
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--cccccCCCCcCcHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~--~~~r~~ip~~ls~~L~dLI~ 910 (935)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.. ......++..+++.+.+||.
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 2345789999999999988899999999999999999999999998766443332211 22234456778899999999
Q ss_pred HHHhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPS-----a~EILqHPF 934 (935)
+||+.| |.+||+ +.+++.|+|
T Consensus 238 ~~l~~~---P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05632 238 MLLTKD---PKQRLGCQEEGAGEVKRHPF 263 (285)
T ss_pred HHccCC---HhHcCCCcccChHHHHcChh
Confidence 999999 999999 899999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=351.95 Aligned_cols=254 Identities=26% Similarity=0.318 Sum_probs=214.9
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc-eeeeecccccCC-----
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPP----- 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPN-IVkl~g~~~~~~----- 746 (935)
...|...++||+|+||+||+|+. +|+.||+|+++.....+.......+|+.+|+.|+|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34567778899999999999965 7889999999876443334455689999999999999 999999998877
Q ss_pred -ceEEEEeeCCCCCHHHHHcCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccc
Q 002331 747 -NLSIITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (935)
Q Consensus 747 -~l~LVmEy~~gGsL~dlL~~~~---~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGl 822 (935)
.+++||||++. +|..++.... ..++...+..+++||+.||+|||+++ |+||||||.||||+++|.+||+|||+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccch
Confidence 79999999965 9999997654 35777899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------
Q 002331 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------ 895 (935)
Q Consensus 823 A~~~~~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~------ 895 (935)
|+...-+.......++|.+|+|||++.|. .|+..+||||+|||++||++++..|.+....+.+.+|-..-+.+
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 99777555556667899999999999987 58999999999999999999999999988877766652111111
Q ss_pred ----------CCC------------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 ----------EIP------------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ----------~ip------------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.++ ...++...+++.+||+.+ |.+|.+++.+|+|||
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~---p~~R~Sa~~al~h~y 304 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYD---PAKRISAKGALTHPY 304 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccC---cccCcCHHHHhcChh
Confidence 011 123357899999999999 999999999999997
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=333.46 Aligned_cols=255 Identities=30% Similarity=0.499 Sum_probs=218.1
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~ 743 (935)
+++..++|++.+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 4677889999999999999999999763 2579999876443 2334557889999999999999999999999
Q ss_pred cCCceEEEEeeCCCCCHHHHHcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc
Q 002331 744 RPPNLSIITEFLPRGSLFRILHRP---------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814 (935)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~~~---------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~ 814 (935)
.....++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCC
Confidence 999999999999999999998642 124678889999999999999999998 999999999999999999
Q ss_pred EEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 002331 815 VKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 891 (935)
Q Consensus 815 VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~ 891 (935)
+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+. .
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-c
Confidence 99999999876543321 1223456788999999988889999999999999999998 999999888877776665 4
Q ss_pred ccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 892 NRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 892 ~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.....+|..++..+.++|.+||+.+ |.+||++.+|++.
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~---p~~Rpt~~~l~~~ 274 (277)
T cd05032 237 GGHLDLPENCPDKLLELMRMCWQYN---PKMRPTFLEIVSS 274 (277)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCC---hhhCCCHHHHHHH
Confidence 4556678888999999999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=329.08 Aligned_cols=251 Identities=31% Similarity=0.516 Sum_probs=215.1
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|++.+.||+|+||.||++.. +++.|+||.+............+..|+.+++.++|+||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588999999999999999976 678999999887765555677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC-
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS- 833 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~- 833 (935)
+++++|.+++.+. ..+++..+..|+.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999999764 35788999999999999999999999 9999999999999999999999999988764432211
Q ss_pred ---CCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccccccCCCCcC--cHH
Q 002331 834 ---KSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKEL--DPL 904 (935)
Q Consensus 834 ---~s~~GT~~Y~APEvl~g~~---~s~ksDIWSLG~ILyELLTG~~PF~~~~~-~eil~~I~~~~~r~~ip~~l--s~~ 904 (935)
....++..|++||++.+.. ++.++|||+||+++|+|++|+.||..... ......+. ......+|... ++.
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSPE 236 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh-cCCCCCCCcccccCHH
Confidence 1246788999999998766 78999999999999999999999987643 33333332 24444555544 899
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+.++|.+||+.+ |.+||++.+++.|||
T Consensus 237 ~~~li~~~l~~~---p~~R~~~~~i~~~~~ 263 (264)
T cd06626 237 GKDFLDRCLESD---PKKRPTASELLQHPF 263 (264)
T ss_pred HHHHHHHHccCC---cccCCCHHHHhcCCC
Confidence 999999999999 999999999999999
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=335.48 Aligned_cols=254 Identities=31% Similarity=0.506 Sum_probs=213.0
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
++..++|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 455678999999999999999999753 3579999875433 22345568899999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcE
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 815 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~---------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~V 815 (935)
....++||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCE
Confidence 999999999999999999986422 23567888999999999999999998 9999999999999999999
Q ss_pred EEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc
Q 002331 816 KVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 892 (935)
Q Consensus 816 KL~DFGlA~~~~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~ 892 (935)
||+|||++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.........+. ..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~ 237 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EG 237 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999998755432211 112345678999999999889999999999999999999 789999888777666553 33
Q ss_pred cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 893 RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 893 ~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
....++..++..+.++|.+||+.+ |.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~---p~~Rps~~e~l~~ 274 (277)
T cd05062 238 GLLDKPDNCPDMLFELMRMCWQYN---PKMRPSFLEIISS 274 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 344567788999999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=329.78 Aligned_cols=252 Identities=32% Similarity=0.517 Sum_probs=215.4
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
+++..++|++.+.||+|+||.||+|.+ .++.||||.+...... ...+.+|+.++++++|+||+++++++...+.++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 356778999999999999999999976 4567999988754432 456788999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999999996533 56899999999999999999999998 99999999999999999999999999987653
Q ss_pred CcccC-CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHH
Q 002331 829 TFLSS-KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 829 ~~~~~-~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
..... .....+..|+|||++.+..++.++||||||+++|+|++ |+.||.+.........+. ...+...+..++..+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELY 234 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHH
Confidence 32211 11223457999999999889999999999999999999 999999888777766654 3334456677899999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
++|.+||+.+ |.+||++.+|++
T Consensus 235 ~li~~~l~~~---P~~Rp~~~~l~~ 256 (261)
T cd05068 235 DIMLDCWKED---PDDRPTFETLQW 256 (261)
T ss_pred HHHHHHhhcC---cccCCCHHHHHH
Confidence 9999999999 999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=341.93 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=210.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|+||.||++.+ ++..||+|.+... ........+.+|++++++++||||+++++.|..++.+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 4689999999999999999976 5678899887643 234456678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
|+++++|.+++.+. ..+++..+..++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999999764 468899999999999999999997 57 9999999999999999999999999987654332
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc----------------------
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF---------------------- 890 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~---------------------- 890 (935)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 2345789999999999888899999999999999999999999976654443322211
Q ss_pred -------------cccccCCCC-cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 891 -------------QNRRLEIPK-ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 891 -------------~~~r~~ip~-~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...++.+|. .++.++++||.+||..+ |.+||++.+|++|||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKN---PKERADLKELTKHPF 289 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCC---hhhCcCHHHHhcChh
Confidence 011112221 36788999999999999 999999999999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.98 Aligned_cols=250 Identities=31% Similarity=0.524 Sum_probs=213.7
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
...+|++.+.||+|+||.||++++. +..+|||++...... ...+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 3467889999999999999999874 457999988655433 235778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...+....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999999999765567899999999999999999999999 999999999999999999999999998765433221
Q ss_pred C-CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 833 S-KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 833 ~-~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
. ....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+. ...+...+..++..+.+||.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHH
Confidence 1 11223457999999999889999999999999999999 899999888777776664 33445667778999999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqH 932 (935)
+||+.+ |++||++.++++.
T Consensus 236 ~cl~~~---p~~Rpt~~~~l~~ 254 (256)
T cd05059 236 SCWHEK---PEDRPAFKKLLSQ 254 (256)
T ss_pred HHhcCC---hhhCcCHHHHHHH
Confidence 999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=340.25 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=216.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||+|.. .++.||||.+....... .....+..|+++++.++|+||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4789999999999999999977 47899999998765443 35567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc-
Q 002331 753 EFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 830 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~- 830 (935)
||+.+++|.+++.+. ...+++..+..++.||+.||.|||..+ |+|+||||+||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999998753 356899999999999999999999998 9999999999999999999999999987542211
Q ss_pred ----------------------------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 002331 831 ----------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 882 (935)
Q Consensus 831 ----------------------------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~ 882 (935)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0112346788999999999988999999999999999999999999988877
Q ss_pred HHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcC----HHHHHhCcC
Q 002331 883 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTS----QAQLSHKRF 934 (935)
Q Consensus 883 eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPS----a~EILqHPF 934 (935)
.....+............++..++++|.+||..+ |.+||+ ++++|+|||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKD---PSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred HHHHHHhcCCccCCCccccCHHHHHHHHHHccCC---HhHCCCchhhHHHHHcCch
Confidence 6665553222222222337899999999999999 999999 999999998
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=338.88 Aligned_cols=244 Identities=21% Similarity=0.301 Sum_probs=201.2
Q ss_pred eeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCCH
Q 002331 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (935)
Q Consensus 684 LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL 760 (935)
||+|+||.||+++. .++.||+|++....... .....+..|+++++.++||||+++++++..+..+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999976 58899999987544322 2233456799999999999999999999999999999999999999
Q ss_pred HHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCCC
Q 002331 761 FRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 839 (935)
Q Consensus 761 ~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT 839 (935)
.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCC
Confidence 9887543 345888999999999999999999998 9999999999999999999999999987654432 22345689
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccccCCCCcCcHHHHHHHHHHHhh
Q 002331 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915 (935)
Q Consensus 840 ~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~----~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~ 915 (935)
..|+|||++.+..++.++|||||||++|+|++|+.||..... .++..... ..........+++++++||.+||+.
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL-EDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh-ccccccccccCCHHHHHHHHHHhcc
Confidence 999999999998899999999999999999999999986533 22222221 1111112246889999999999999
Q ss_pred CCCCcCCCcCH----HHHHhCcC
Q 002331 916 GWSSLHIRTSQ----AQLSHKRF 934 (935)
Q Consensus 916 D~ssP~kRPSa----~EILqHPF 934 (935)
| |.+||++ ++++.|||
T Consensus 237 ~---P~~R~~~~~~~~~~~~h~~ 256 (277)
T cd05607 237 K---PEDRLGSREKNDDPRKHEF 256 (277)
T ss_pred C---HhhCCCCccchhhhhcChh
Confidence 9 9999999 67889988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=335.00 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=206.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 4688899999999999999976 67889999886543 33445678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
|+++++|..+. .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++....... .
T Consensus 80 ~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--~ 150 (279)
T cd06619 80 FMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--A 150 (279)
T ss_pred cCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--c
Confidence 99999987553 4678888999999999999999998 9999999999999999999999999997654332 2
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-------HHHHHHhhccccccCC-CCcCcHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGAVGFQNRRLEI-PKELDPLV 905 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~-------~eil~~I~~~~~r~~i-p~~ls~~L 905 (935)
....|+..|+|||++.+..++.++|||||||++|+|++|+.||..... ......+. ......+ ....++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCCCCcCCHHH
Confidence 345789999999999998899999999999999999999999975322 12222221 1122222 23478899
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.++|.+||+.+ |.+||+++++++|||
T Consensus 230 ~~li~~~l~~~---P~~Rp~~~eil~~~~ 255 (279)
T cd06619 230 VHFITQCMRKQ---PKERPAPENLMDHPF 255 (279)
T ss_pred HHHHHHHhhCC---hhhCCCHHHHhcCcc
Confidence 99999999999 999999999999998
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.36 Aligned_cols=252 Identities=32% Similarity=0.560 Sum_probs=217.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
....+|++++.||.|+||.||+|.+ .++.+++|++..... .....+..|+.+++.++|+||+++++++...+.+++|
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4456799999999999999999976 467899998876542 2345688899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 752 TEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
|||+++++|.+++.+. ...+++..++.++.||+.||.|||+.| |+|+||||+||||+.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999999753 346899999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
.......++..|++||++.+..++.++||||||+++|+|++ |+.||...+..+....+. ...+...+..+++.+.++|
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHH
Confidence 33333445678999999998889999999999999999998 899999888777776664 3445566778899999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+||+.+ |.+||++.+|++.
T Consensus 238 ~~~l~~~---p~~Rpt~~~l~~~ 257 (261)
T cd05148 238 LECWAAE---PEDRPSFKALREE 257 (261)
T ss_pred HHHcCCC---chhCcCHHHHHHH
Confidence 9999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=340.33 Aligned_cols=252 Identities=27% Similarity=0.464 Sum_probs=215.2
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
...+|++.+.||+|+||.||+|.+ +++.||||.+...... ....+.+|+.+++.++|+||+++++.|......++|
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 346899999999999999999975 6789999988765433 245678899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+++++|.+++.. ..+++..+..++.|++.||.|||..| |+||||||+|||++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 96 MEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred ecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999999999965 35789999999999999999999998 99999999999999999999999999876543322
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc-cccccCCCCcCcHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~-~~~r~~ip~~ls~~L~dLI~ 910 (935)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...++......+.. .......+..++..+.++|.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 23345788999999999988889999999999999999999999988776544333221 11223345678899999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||..+ |.+||++.+|++|||
T Consensus 252 ~~l~~~---p~~Rpt~~eil~~~~ 272 (296)
T cd06654 252 RCLDMD---VEKRGSAKELLQHQF 272 (296)
T ss_pred HHCcCC---cccCcCHHHHhhChh
Confidence 999999 999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=335.81 Aligned_cols=253 Identities=27% Similarity=0.432 Sum_probs=209.7
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeeccccc------
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR------ 744 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~------ 744 (935)
....|++.+.||.|+||.||+|.+ .++.||+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 446889999999999999999987 57889999875442 3345678899999998 79999999999853
Q ss_pred CCceEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA 823 (935)
...++++|||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcch
Confidence 45689999999999999998653 345788889999999999999999998 999999999999999999999999998
Q ss_pred ccccCCcccCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC
Q 002331 824 RLKHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (935)
Q Consensus 824 ~~~~~~~~~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip 898 (935)
..............|+..|+|||++. +..++.++|||||||++|+|++|..||....+......+..........
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS 248 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcc
Confidence 76543323334567899999999986 3457889999999999999999999998776654444332222222334
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++..+.+||.+||+.| |.+||++.+||+|||
T Consensus 249 ~~~~~~~~~li~~cl~~~---p~~Rp~~~ell~~~~ 281 (282)
T cd06636 249 KKWSKKFIDFIEGCLVKN---YLSRPSTEQLLKHPF 281 (282)
T ss_pred cccCHHHHHHHHHHhCCC---hhhCcCHHHHhcCCC
Confidence 568899999999999999 999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=325.33 Aligned_cols=252 Identities=28% Similarity=0.469 Sum_probs=224.5
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|.+.+.||.|+||.||++.+. +..|++|++............+.+|+++++.++|+|++++++.+......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999874 88999999987766556677888999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 755 LPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 755 ~~gGsL~dlL~~~---~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
+++++|.+++.+. ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9999999999764 367899999999999999999999998 99999999999999999999999999987655432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~q 911 (935)
......|++.|+|||.+.+..++.++|+|+||+++|+|++|+.||...+..++..... ......++..++..+.++|.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 237 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLVSS 237 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHH
Confidence 3344578899999999998889999999999999999999999999888777766654 334556777899999999999
Q ss_pred HHhhCCCCcCCCcCHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPSa~EILqHPF 934 (935)
||+.+ |.+||++.++|+|||
T Consensus 238 ~l~~~---p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 238 LLQKD---PEERPSIAQILQSPF 257 (258)
T ss_pred HcCCC---hhhCcCHHHHhcCCC
Confidence 99999 999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=329.34 Aligned_cols=252 Identities=30% Similarity=0.456 Sum_probs=214.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++++.||.|+||+||+|.+ ++..|++|++....... ....+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4789999999999999999976 67789999987554433 56778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 754 FLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 754 y~~gGsL~dlL~~~--~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|+++++|.+++... ...+++..+..++.||+.||.|||+.| |+||||||+||++++++.+||+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999999653 246899999999999999999999998 99999999999999999999999999876654322
Q ss_pred c----CCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC-----CcC
Q 002331 832 S----SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-----KEL 901 (935)
Q Consensus 832 ~----~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip-----~~l 901 (935)
. .....|+..|++||++... .++.++|+|||||++|+|++|+.||...+........... ....++ ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYKKY 236 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCccccccc
Confidence 1 2334688999999998776 6889999999999999999999999987766555443222 222222 256
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++.+.++|.+||+.+ |.+||++.+|++|||
T Consensus 237 ~~~~~~li~~~l~~~---p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 237 SKSFRKMISLCLQKD---PSKRPTAEELLKHKF 266 (267)
T ss_pred cHHHHHHHHHHcCCC---hhhCcCHHHHhhCCC
Confidence 789999999999999 999999999999999
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=328.53 Aligned_cols=252 Identities=27% Similarity=0.475 Sum_probs=217.1
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|.+.+.||+|+||.||++.+ .+..||+|.+............+.+|+.+++.++|+||+++++.+.....+++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588999999999999999976 578899999876554444556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC-cEEEEeccccccccCCccc
Q 002331 755 LPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 755 ~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~VKL~DFGlA~~~~~~~~~ 832 (935)
+++++|.+++.+.. ..+++..+..++.||+.||.|||+.+ |+|+||||+||++++++ .+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 99999999986533 35789999999999999999999998 99999999999999876 4699999998876543332
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qC 912 (935)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+. ......++..++..++++|.+|
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 237 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQL 237 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHHH
Confidence 333468889999999988889999999999999999999999999887766665543 2333445567889999999999
Q ss_pred HhhCCCCcCCCcCHHHHHhCcC
Q 002331 913 WQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 913 L~~D~ssP~kRPSa~EILqHPF 934 (935)
|..+ |.+||++.+|++|||
T Consensus 238 l~~~---p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 238 FKVS---PRDRPSITSILKRPF 256 (257)
T ss_pred hccC---hhhCcCHHHHhhCCC
Confidence 9999 999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=326.32 Aligned_cols=244 Identities=32% Similarity=0.556 Sum_probs=215.1
Q ss_pred EEeeecCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCC
Q 002331 682 ERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 756 (935)
+.||+|+||.||+|.+. +..|+||++....... ....+.+|+.+++.++|+||+++++++.....+++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 35899999999999774 7789999987654433 56778899999999999999999999999999999999999
Q ss_pred CCCHHHHHcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 757 RGSLFRILHRP--------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 757 gGsL~dlL~~~--------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
+++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||.+.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999999775 467999999999999999999999998 99999999999999999999999999987654
Q ss_pred Cc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHH
Q 002331 829 TF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 829 ~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
.. .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......++...+.. ..+...+..++.++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDEL 236 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHH
Confidence 32 22334567889999999998889999999999999999999 6999999988877777653 45666788889999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.++|.+||+.+ |.+||++.+++++
T Consensus 237 ~~li~~~l~~~---p~~Rps~~~l~~~ 260 (262)
T cd00192 237 YELMLSCWQLD---PEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHccCC---cccCcCHHHHHHh
Confidence 99999999999 9999999999976
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=336.88 Aligned_cols=251 Identities=23% Similarity=0.388 Sum_probs=212.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|+||.||++.+ .++.||+|.+... ........+.+|+.++++++|+||+++++.+...+.+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4688999999999999999987 5889999988654 334455678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCC--CCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 754 FLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 754 y~~gGsL~dlL~~~--~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
|+++++|..++... ...+++..+..++.||+.||.|||. ++ |+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999998763 2368999999999999999999996 57 999999999999999999999999998765432
Q ss_pred ccCCCCCCCCCccCcccccCCC------CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh--ccccccCCCCcCc
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELD 902 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~------~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~--~~~~r~~ip~~ls 902 (935)
......++..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+. ....+..++..++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence 123346788999999986543 4789999999999999999999998765544333221 1234456777799
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.++.+||.+||+.+ |.+||++.++++|||
T Consensus 236 ~~~~~li~~~l~~~---p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 236 DDAQDFVAKCLNKI---PNRRPTYAQLLEHPW 264 (286)
T ss_pred HHHHHHHHHHcccC---cccCCCHHHHhcChh
Confidence 99999999999999 999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=346.03 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=202.6
Q ss_pred EEEEeeec--CcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeC
Q 002331 680 LGERIGLG--SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 680 I~e~LG~G--~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
++++||+| +|++||++.. +|+.||||++............+.+|+.+++.++||||++++++|..++.+++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45779999 7899999976 6889999998766555556667888999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc---
Q 002331 756 PRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--- 831 (935)
Q Consensus 756 ~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~--- 831 (935)
++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++++|||..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999998653 345899999999999999999999999 99999999999999999999999986543321110
Q ss_pred ----cCCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------
Q 002331 832 ----SSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------- 894 (935)
Q Consensus 832 ----~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r----------- 894 (935)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.................+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 1122356778999999976 45889999999999999999999999876544332221100000
Q ss_pred ---------------------------------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 ---------------------------------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ---------------------------------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
......+++.+.+||.+||+.| |.+||++++|++|||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d---P~~Rpt~~ell~~p~ 309 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRN---PDARPSASTLLNHSF 309 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhC---chhcCCHHHHhcChh
Confidence 0011235678999999999999 999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=335.43 Aligned_cols=253 Identities=27% Similarity=0.361 Sum_probs=209.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|+||.||+|.+ .++.||+|++............+.+|+++++.++||||+++++++..++.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4689999999999999999987 57899999886654443445567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
|++++.|..+.... ..+++..++.++.||+.||.|||+.+ |+|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 99999998877653 35899999999999999999999998 9999999999999999999999999988764433333
Q ss_pred CCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------------
Q 002331 834 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------------ 894 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r------------------ 894 (935)
....++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 34568889999999876 44688999999999999999999999876544332222100000
Q ss_pred --c---------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 --L---------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 --~---------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. .....++..+.+||.+||+.+ |.+||++.+|++|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~Rp~~~~il~~~~ 285 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRID---PDDRPSSSQLLHHEF 285 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCC---cccchhHHHHhcCCC
Confidence 0 012356788999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=338.33 Aligned_cols=253 Identities=27% Similarity=0.472 Sum_probs=217.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
..+.+|++.+.||.|+||.||++.+ .++.|+||.+...... ....+.+|+.+++.++||||+++++++...+.+++
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 3457799999999999999999975 6889999988754332 34567889999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999999999865 35899999999999999999999999 9999999999999999999999999987654432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc-cccccCCCCcCcHHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARII 909 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~-~~~r~~ip~~ls~~L~dLI 909 (935)
.......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.. .......+..+++.+.++|
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 223345688999999999988899999999999999999999999998877655444322 2223345667899999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||..| |.+||++.+|++|||
T Consensus 250 ~~~l~~d---p~~Rpt~~~il~~~~ 271 (296)
T cd06655 250 NRCLEMD---VEKRGSAKELLQHPF 271 (296)
T ss_pred HHHhhcC---hhhCCCHHHHhhChH
Confidence 9999999 999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=322.35 Aligned_cols=252 Identities=33% Similarity=0.532 Sum_probs=221.8
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC--CceEEEE
Q 002331 677 DLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSIIT 752 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l~LVm 752 (935)
+|.+.+.||+|++|.||+|... ++.|++|++............+.+|+.++++++|+||+++++.+... ..+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999874 88999999877665556677889999999999999999999999888 8899999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 831 (935)
||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999997654 7899999999999999999999998 99999999999999999999999999987655432
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 832 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 832 -~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~-~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
......++..|++||.+.+...+.++|||+||+++|+|++|..||.... .......+........++..++..+.++|
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 1334578899999999998889999999999999999999999998776 44444444434556678888899999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||..+ |.+||++.++++|||
T Consensus 238 ~~~l~~~---p~~Rp~~~~ll~~~~ 259 (260)
T cd06606 238 RKCLRRD---PKKRPTADELLQHPF 259 (260)
T ss_pred HHhCcCC---hhhCCCHHHHhhCCC
Confidence 9999999 999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=333.46 Aligned_cols=256 Identities=28% Similarity=0.428 Sum_probs=210.3
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccc----
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVT---- 743 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~---- 743 (935)
+....++|++.+.||+|+||.||++.+ .++.||+|++..... ....+..|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 344668999999999999999999976 678899998754321 234577899999999 7999999999873
Q ss_pred -cCCceEEEEeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEe
Q 002331 744 -RPPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 819 (935)
Q Consensus 744 -~~~~l~LVmEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~D 819 (935)
.++.+++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEcc
Confidence 44568999999999999998752 2346888999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCcccCCCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-c
Q 002331 820 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-R 893 (935)
Q Consensus 820 FGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g-----~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~-~ 893 (935)
||++..............|++.|+|||++.+ ..++.++|||||||++|+|++|+.||................ .
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 9998866443333344578999999999853 447889999999999999999999998876655443332111 1
Q ss_pred ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
....+..++..+.+||.+||+.+ |.+||++.+|++|+|
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~---p~~Rps~~ell~~~~ 285 (286)
T cd06638 248 TLHQPELWSNEFNDFIRKCLTKD---YEKRPTVSDLLQHVF 285 (286)
T ss_pred cccCCCCcCHHHHHHHHHHccCC---cccCCCHHHHhhccc
Confidence 22345567889999999999999 999999999999998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=341.88 Aligned_cols=251 Identities=27% Similarity=0.464 Sum_probs=211.7
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~----~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
...+|++.+.||+|+||.||+|++ .++ .||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 446899999999999999999976 333 48999886432 334456788999999999999999999998764 5
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
.++|+||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEcccccccccc
Confidence 78999999999999999876667899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 828 NTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 828 ~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
.... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. .......+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTID 239 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHH
Confidence 3221 1122334678999999999999999999999999999997 999999887766554433 44455566778899
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+.++|.+||..+ |.+||++.+|+.+
T Consensus 240 ~~~li~~cl~~~---p~~Rps~~~l~~~ 264 (316)
T cd05108 240 VYMIMVKCWMID---ADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHccCC---hhhCcCHHHHHHH
Confidence 999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=358.23 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=217.7
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCce
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l 748 (935)
+.++...|++++.||+||-+.||++.. +.+.||+|++.....+.+.+.-|..|+..|.+| .|.+||++|+|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 456778899999999999999999976 456799998888888888999999999999999 699999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
||||||-+ .+|..+|++.....+...+..+..||+.|+.++|++| |||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 99999885 4999999876655554577889999999999999999 99999999999994 57999999999998765
Q ss_pred Cc--ccCCCCCCCCCccCcccccCCC-----------CCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccc
Q 002331 829 TF--LSSKSTAGTPEWMAPEVLRNEP-----------SNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRR 894 (935)
Q Consensus 829 ~~--~~~~s~~GT~~Y~APEvl~g~~-----------~s~ksDIWSLG~ILyELLTG~~PF~~~~-~~eil~~I~~~~~r 894 (935)
+. ....+.+||+.||+||.+.... .+.++||||||||||+|+.|+.||.... ...-+.++..-...
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 42 3345679999999999986432 3578999999999999999999998765 34444455433344
Q ss_pred cCCCCcCcHH-HHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 LEIPKELDPL-VARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ~~ip~~ls~~-L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.++|..-+.+ +.++++.||..| |.+||+..+||+|||
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rd---PkkR~si~eLLqhpF 629 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARD---PKKRWSIPELLQHPF 629 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcC---cccCCCcHHHhcCcc
Confidence 4566554444 999999999999 999999999999998
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=333.90 Aligned_cols=253 Identities=30% Similarity=0.525 Sum_probs=215.1
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
+..++|.+.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+++|+.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 34577899999999999999999752 3679999886543 233456889999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC
Q 002331 746 PNLSIITEFLPRGSLFRILHRPH-------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~-------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~ 812 (935)
...++||||+++++|.+++...+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD 158 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC
Confidence 99999999999999999996532 34788899999999999999999998 9999999999999999
Q ss_pred CcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhh
Q 002331 813 WNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 889 (935)
Q Consensus 813 g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~ 889 (935)
+.+||+|||++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999875432211 1223345778999999999999999999999999999998 999999888877777664
Q ss_pred ccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 890 FQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 890 ~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.......+..++..+.++|.+||+.| |.+||++.+|++.
T Consensus 239 -~~~~~~~~~~~~~~~~~li~~~l~~~---p~~Rp~~~eil~~ 277 (280)
T cd05049 239 -QGRLLQRPRTCPSEVYDIMLGCWKRD---PQQRINIKDIHER 277 (280)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCC---cccCCCHHHHHHH
Confidence 33334456778999999999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=326.80 Aligned_cols=249 Identities=35% Similarity=0.593 Sum_probs=217.2
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
.+..++|++.+.||.|+||.||+|...++.||||.+..... ....+.+|+.+++.++|+||+++++++......++|
T Consensus 2 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred ccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 34567899999999999999999999999999999875532 456788999999999999999999999998999999
Q ss_pred EeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 752 TEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
|||+++++|.+++.... ..+++..++.++.|++.||.|||.++ |+||||||+||+++.++.+||+|||.+.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999999997543 36899999999999999999999999 9999999999999999999999999998664321
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
. ....+..|+|||++.+..++.++|||||||++|+|++ |..||.......+...+. ...+...+..+++.+.++|
T Consensus 157 ~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 157 D---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred c---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCCHHHHHHH
Confidence 1 2334567999999988889999999999999999997 999999888777666553 3345566778899999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+||..+ |.+||++.+|+..
T Consensus 233 ~~~l~~~---p~~Rp~~~~l~~~ 252 (256)
T cd05039 233 KDCWELD---PAKRPTFKQLREQ 252 (256)
T ss_pred HHHhccC---hhhCcCHHHHHHH
Confidence 9999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=339.66 Aligned_cols=257 Identities=30% Similarity=0.503 Sum_probs=216.5
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeee
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl 738 (935)
..+++..++|.+++.||+|+||.||++++. ...||+|.+.... .......+.+|+.+++.+ +|+||+++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 356777899999999999999999999752 2469999887543 334456788899999999 89999999
Q ss_pred ecccccCCceEEEEeeCCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCC
Q 002331 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 803 (935)
Q Consensus 739 ~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLK 803 (935)
++++...+.+|+||||+++++|.+++.+.. ..+++..++.++.||+.||+|||++| |+|||||
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlk 167 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLA 167 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--ccccccc
Confidence 999999999999999999999999996532 24788899999999999999999998 9999999
Q ss_pred CCCeeecCCCcEEEEeccccccccCCcccC--CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 002331 804 SPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 880 (935)
Q Consensus 804 PeNILLd~~g~VKL~DFGlA~~~~~~~~~~--~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~ 880 (935)
|+|||++.++.+||+|||++.......... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred HHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 999999999999999999987654321111 11234568999999999889999999999999999998 889998887
Q ss_pred hHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 881 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 881 ~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
..++...+. ...+...+..++..+.+||.+||+.+ |.+||++.+++++
T Consensus 248 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~---p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAV---PSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccC---hhhCcCHHHHHHH
Confidence 766666553 33455677888999999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=366.80 Aligned_cols=246 Identities=26% Similarity=0.315 Sum_probs=207.9
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-C-----CceeeeecccccCCce
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H-----PNVVLFMGAVTRPPNL 748 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-H-----PNIVkl~g~~~~~~~l 748 (935)
+|.|++.||+|+||.|.+|.+ +++.||||+++... ....+...|+.+|..|+ | -|||+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 899999999999999999966 68899999997653 33445667999999996 4 3899999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC--CCcEEEEecccccc
Q 002331 749 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRL 825 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~--~g~VKL~DFGlA~~ 825 (935)
|||+|.+. .+|+++|+.++ ..++...++.|+.||+.||.+||+.+ |||+|||||||||.. ...|||+|||.++.
T Consensus 264 ciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 264 CIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999995 59999998643 46899999999999999999999999 999999999999964 34799999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc----------
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---------- 895 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~---------- 895 (935)
.....+ +.+.++.|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..+.+..|..-.+.+
T Consensus 341 ~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 341 ESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred cCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 776544 5788999999999999999999999999999999999999999988766655441100000
Q ss_pred ----------------------------------------CCC-----------CcCcHHHHHHHHHHHhhCCCCcCCCc
Q 002331 896 ----------------------------------------EIP-----------KELDPLVARIIWECWQTGWSSLHIRT 924 (935)
Q Consensus 896 ----------------------------------------~ip-----------~~ls~~L~dLI~qCL~~D~ssP~kRP 924 (935)
..| ..-...+.++|++||..| |.+|+
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d---P~~R~ 494 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD---PAERI 494 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC---chhcC
Confidence 011 012245799999999999 99999
Q ss_pred CHHHHHhCcC
Q 002331 925 SQAQLSHKRF 934 (935)
Q Consensus 925 Sa~EILqHPF 934 (935)
+..++|+|||
T Consensus 495 tp~qal~Hpf 504 (586)
T KOG0667|consen 495 TPAQALNHPF 504 (586)
T ss_pred CHHHHhcCcc
Confidence 9999999999
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=350.10 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=211.7
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeeccc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 742 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~ 742 (935)
|+++.++|++.+.||+|+||.||+|.+. ++.||+|++.... .......+.+|+.++.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 6778889999999999999999999642 3679999887543 233455678899999999 899999999987
Q ss_pred cc-CCceEEEEeeCCCCCHHHHHcCCC-----------------------------------------------------
Q 002331 743 TR-PPNLSIITEFLPRGSLFRILHRPH----------------------------------------------------- 768 (935)
Q Consensus 743 ~~-~~~l~LVmEy~~gGsL~dlL~~~~----------------------------------------------------- 768 (935)
.. +..++++|||+++++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 54 456889999999999999885321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc--ccCCCCCCC
Q 002331 769 -------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGT 839 (935)
Q Consensus 769 -------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT 839 (935)
..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++....... .......++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 25788999999999999999999998 9999999999999999999999999998653221 112233456
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCC
Q 002331 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWS 918 (935)
Q Consensus 840 ~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~s 918 (935)
..|+|||++.+..++.++|||||||++|||++ |..||.+....+..........+...+...++++.+++.+||+.+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~-- 316 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNN-- 316 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCC--
Confidence 78999999999999999999999999999997 999998765544333333334455566778899999999999999
Q ss_pred CcCCCcCHHHHHhC
Q 002331 919 SLHIRTSQAQLSHK 932 (935)
Q Consensus 919 sP~kRPSa~EILqH 932 (935)
|++||++.+|++|
T Consensus 317 -p~~RPs~~ell~~ 329 (337)
T cd05054 317 -PEDRPTFSELVEI 329 (337)
T ss_pred -hhhCcCHHHHHHH
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=356.80 Aligned_cols=259 Identities=31% Similarity=0.448 Sum_probs=215.0
Q ss_pred ccccCCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeee
Q 002331 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFM 739 (935)
Q Consensus 668 ~~~~ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~ 739 (935)
...++++.++|+++++||+|+||.||+|++. +..||||++.... .......+.+|+.+|+++. |||||+++
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 3567788899999999999999999999762 2369999986543 3344567889999999995 99999999
Q ss_pred cccccCCceEEEEeeCCCCCHHHHHcCCC---------------------------------------------------
Q 002331 740 GAVTRPPNLSIITEFLPRGSLFRILHRPH--------------------------------------------------- 768 (935)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~dlL~~~~--------------------------------------------------- 768 (935)
+++...+.+|||||||++|+|.+++.+..
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 99999999999999999999999885421
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCC
Q 002331 769 --------------------------------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (935)
Q Consensus 769 --------------------------------------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKP 804 (935)
..+++..++.++.||+.||.|||..+ |+||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp 265 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAA 265 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCh
Confidence 23677888899999999999999998 99999999
Q ss_pred CCeeecCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 002331 805 PNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 881 (935)
Q Consensus 805 eNILLd~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~ 881 (935)
+|||++.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 99999999999999999998654321 11223456778999999999889999999999999999997 8999987654
Q ss_pred HHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 882 ~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
............+...+..++..+.++|.+||+.+ |.+||++.+|.+.
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d---P~~RPt~~~l~~~ 393 (400)
T cd05105 346 DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSE---PEKRPSFLHLSDI 393 (400)
T ss_pred hHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccC---HhHCcCHHHHHHH
Confidence 43333322334455667788999999999999999 9999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=327.95 Aligned_cols=248 Identities=32% Similarity=0.569 Sum_probs=212.8
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccc-ccCCceEE
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV-TRPPNLSI 750 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~-~~~~~l~L 750 (935)
-+...+|++.+.||+|+||.||++...++.||+|.+.... ....+.+|+.++++++|+||+++++++ ...+..++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 3566789999999999999999999999999999875432 245688999999999999999999975 45567899
Q ss_pred EEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 751 ITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
||||+++++|.+++.+.. ..+++..++.++.||+.||+|||.+| |+||||||+|||++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999999987543 34789999999999999999999998 999999999999999999999999998754432
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
. ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+. .......+..+++.+.++
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDV 231 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHH
Confidence 1 22344568999999999889999999999999999997 999999888777766553 334456677889999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqH 932 (935)
|.+||+.+ |.+||++.++++.
T Consensus 232 i~~~l~~~---p~~Rpt~~~l~~~ 252 (256)
T cd05082 232 MKQCWHLD---AATRPSFLQLREQ 252 (256)
T ss_pred HHHHhcCC---hhhCcCHHHHHHH
Confidence 99999999 9999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=339.91 Aligned_cols=251 Identities=27% Similarity=0.454 Sum_probs=214.9
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
..+|++.+.||.|+||.||++.. .++.||||.+...... ....+.+|+.+++.++|+||++++++|...+.+++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 47899999999999999999975 6889999998765433 2456788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 96 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999999865 35788999999999999999999998 999999999999999999999999998765443333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc-cccccCCCCcCcHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~-~~~r~~ip~~ls~~L~dLI~q 911 (935)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...++......+.. .......+..++..+++||.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR 251 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHH
Confidence 3345688999999999998899999999999999999999999988765443322221 112223456788999999999
Q ss_pred HHhhCCCCcCCCcCHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPSa~EILqHPF 934 (935)
||..+ |.+||++.+|++|||
T Consensus 252 ~l~~~---p~~Rps~~~il~~~~ 271 (297)
T cd06656 252 CLEMD---VDRRGSAKELLQHPF 271 (297)
T ss_pred HccCC---hhhCcCHHHHhcCch
Confidence 99999 999999999999999
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=330.79 Aligned_cols=249 Identities=23% Similarity=0.339 Sum_probs=218.2
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
.|++.+.||.|+||.||+|.+ .++.||+|++....... .....+.+|++++++++||||+++++.+..+..+++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 488999999999999999977 48899999987654332 456788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
|+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ |+|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 99999999999764 57899999999999999999999998 9999999999999999999999999988665432 22
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~---~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
....|+..|+|||++.+..++.++|+||||+++|+|++|..||..... ..+.... ......+|..++..+.++|.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ETADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh--ccccccCcccCcHHHHHHHH
Confidence 345688899999999988899999999999999999999999998773 3333332 22556677889999999999
Q ss_pred HHHhhCCCCcCCCcCH--HHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQ--AQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa--~EILqHPF 934 (935)
+||+.| |.+||++ .++++|||
T Consensus 235 ~~l~~~---p~~R~~~~~~~l~~~~~ 257 (258)
T cd05578 235 KLLERD---PQKRLGDNLKDLKNHPY 257 (258)
T ss_pred HHccCC---hhHcCCccHHHHhcCCC
Confidence 999999 9999999 99999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.57 Aligned_cols=249 Identities=31% Similarity=0.510 Sum_probs=215.7
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|.+.+.||+|++|.||++.+ +++.|++|++..... .....+.+|+.+++.++|+||+++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 578889999999999999987 478899999876543 3456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
+++++|.+++......+++..++.++.|++.||.|||..+ ++||||+|+||+++.++.+||+|||.+........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 9999999999775567899999999999999999999988 99999999999999999999999999887654322 33
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCc--CcHHHHHHHHHH
Q 002331 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE--LDPLVARIIWEC 912 (935)
Q Consensus 835 s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~--ls~~L~dLI~qC 912 (935)
...++..|++||.+.+..++.++||||||+++|+|++|+.||...+.......... .....++.. ++..+.++|.+|
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHH
Confidence 45688999999999988889999999999999999999999998866555544432 223333333 388999999999
Q ss_pred HhhCCCCcCCCcCHHHHHhCcC
Q 002331 913 WQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 913 L~~D~ssP~kRPSa~EILqHPF 934 (935)
|+.| |.+||++.++++|||
T Consensus 235 l~~~---p~~R~t~~~~l~~~~ 253 (253)
T cd05122 235 LQKN---PEKRPTAEQLLKHPF 253 (253)
T ss_pred ccCC---hhhCCCHHHHhcCCC
Confidence 9999 999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.82 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=228.9
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
+..++|.++++||+|+||.|.+++. .++.||||++++... .......-..|-++|+..+||.+..+-..|+..+.+|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 4568899999999999999999965 688999999987654 3345556678999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||..||.|+-+|.+. ..+++...+.+-.+|+.||.|||..+ ||+||||.+|+|||.+|+|||+|||+++.-...
T Consensus 245 FVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhcccc
Confidence 999999999999999774 47889888889999999999999998 999999999999999999999999999876655
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
.....++||||.|+|||++....|+.++|+|.+|+++|||++|+.||...+...+..-|. -....+|..++++.+.|+
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--~ed~kFPr~ls~eAktLL 399 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--MEDLKFPRTLSPEAKTLL 399 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH--hhhccCCccCCHHHHHHH
Confidence 566788999999999999999999999999999999999999999999999887776663 356678999999999999
Q ss_pred HHHHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
..+|.+| |.+|. ++.||.+|+|
T Consensus 400 sGLL~kd---P~kRLGgGpdDakEi~~h~F 426 (516)
T KOG0690|consen 400 SGLLKKD---PKKRLGGGPDDAKEIMRHRF 426 (516)
T ss_pred HHHhhcC---hHhhcCCCchhHHHHHhhhh
Confidence 9999999 99994 6889999987
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=326.13 Aligned_cols=252 Identities=30% Similarity=0.465 Sum_probs=219.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|++|.||++.+ .++.|+||++...... .....+.+|+.++.+++|+||+++++++...+.+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 3688999999999999999976 4889999998766433 456678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
|+++++|.+++.+. ..+++..++.++.||+.||.|||. .+ ++||||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999764 578999999999999999999999 98 999999999999999999999999999876544333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHhhccccccCCCCc-CcHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM---NPMQVVGAVGFQNRRLEIPKE-LDPLVARI 908 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~---~~~eil~~I~~~~~r~~ip~~-ls~~L~dL 908 (935)
.....++..|+|||.+.+..++.++|+|+||+++|+|++|..||... ...+....+. ......++.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHH
Confidence 33456788999999999988999999999999999999999999877 4444444443 3344455666 88999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcCC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRFQ 935 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPFq 935 (935)
|.+||..+ |.+||++.++++|||.
T Consensus 236 i~~~l~~~---p~~R~~~~~ll~~~~~ 259 (264)
T cd06623 236 ISACLQKD---PKKRPSAAELLQHPFI 259 (264)
T ss_pred HHHHccCC---hhhCCCHHHHHhCHHH
Confidence 99999999 9999999999999994
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=327.90 Aligned_cols=251 Identities=30% Similarity=0.529 Sum_probs=214.6
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
|+|..++|+++++||+|+||.||+|.. +++.||+|.+...... ...+.+|+.++++++|+||+++++++. .+.++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 467788999999999999999999976 6688999998765433 346788999999999999999999875 45789
Q ss_pred EEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++|||+.+++|.+++.. .+..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999998865 3346889999999999999999999998 99999999999999999999999999976652
Q ss_pred Ccc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHH
Q 002331 829 TFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 829 ~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+. ...+...+..++.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence 222 1223345678999999998889999999999999999998 999999888777766653 3344566778899999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
++|.+||+.+ |++||++++|++
T Consensus 234 ~li~~~l~~~---p~~Rp~~~~l~~ 255 (260)
T cd05067 234 ELMRLCWKEK---PEERPTFEYLRS 255 (260)
T ss_pred HHHHHHccCC---hhhCCCHHHHHH
Confidence 9999999999 999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=334.14 Aligned_cols=251 Identities=31% Similarity=0.535 Sum_probs=213.4
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
|.+++|.+.+.||+|+||.||++.. .+..||+|.+.... ......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 5678999999999999999999974 23458899876442 34456788999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHcCCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC
Q 002331 746 PNLSIITEFLPRGSLFRILHRPH------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 813 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g 813 (935)
+.+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence 99999999999999999986422 24899999999999999999999998 99999999999999999
Q ss_pred cEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhc
Q 002331 814 NVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGF 890 (935)
Q Consensus 814 ~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~ 890 (935)
.+||+|||++....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~- 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT- 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 99999999987653321 11223345778999999999999999999999999999998 899999888877776664
Q ss_pred cccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 891 QNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 891 ~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.......+..++..+.+||.+||+.+ |.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~l~~li~~~l~~~---p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGRVLQRPRTCPKEVYDLMLGCWQRE---PHMRLNIKEIHS 274 (288)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCC---hhhCCCHHHHHH
Confidence 33334556678899999999999999 999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=332.07 Aligned_cols=254 Identities=29% Similarity=0.455 Sum_probs=213.0
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
++..++|.+.+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.+++.++|+||+++++++.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345678999999999999999999774 3578888765432 33445668899999999999999999999998
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC---cE
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NV 815 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g---~V 815 (935)
.+..++||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcce
Confidence 889999999999999999986543 25889999999999999999999998 99999999999998654 59
Q ss_pred EEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc
Q 002331 816 KVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 892 (935)
Q Consensus 816 KL~DFGlA~~~~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~ 892 (935)
||+|||+++........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||...........+. ..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999999865332111 112233567999999998889999999999999999997 999999887777666553 33
Q ss_pred cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 893 RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 893 ~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+...+..++..+.++|.+||+.+ |.+||++.+|++|
T Consensus 238 ~~~~~~~~~~~~~~~~i~~cl~~~---p~~Rps~~~vl~~ 274 (277)
T cd05036 238 GRLDPPKGCPGPVYRIMTDCWQHT---PEDRPNFATILER 274 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCC---cccCcCHHHHHHH
Confidence 455667888999999999999999 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=334.05 Aligned_cols=254 Identities=29% Similarity=0.488 Sum_probs=212.7
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~ 743 (935)
|++..++|++.+.||+|+||.||+|... +..||||.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4667789999999999999999999642 3479999876443 2233446788999999999999999999999
Q ss_pred cCCceEEEEeeCCCCCHHHHHcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc
Q 002331 744 RPPNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814 (935)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~~~~---------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~ 814 (935)
..+..++||||+++|+|.+++.+.. ..+....+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCc
Confidence 9999999999999999999996421 23466788899999999999999998 999999999999999999
Q ss_pred EEEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 002331 815 VKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 891 (935)
Q Consensus 815 VKL~DFGlA~~~~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~ 891 (935)
+||+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. .
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~ 236 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-D 236 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 999999998765432211 122345678999999998889999999999999999998 789999888877666553 3
Q ss_pred ccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 892 NRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 892 ~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
......+..+++.++++|.+||+.+ |.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~---p~~Rps~~~ll~ 273 (288)
T cd05061 237 GGYLDQPDNCPERVTDLMRMCWQFN---PKMRPTFLEIVN 273 (288)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCC---hhHCcCHHHHHH
Confidence 3445567778899999999999999 999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=329.36 Aligned_cols=252 Identities=30% Similarity=0.486 Sum_probs=210.2
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC--------HHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS--------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~--------~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
+|.+.+.||.|+||.||+|.. +++.||||.+...... ....+.+..|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478889999999999999965 6889999987643211 112356788999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||+|+||+++.++.+||+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999999765 47899999999999999999999998 999999999999999999999999998765
Q ss_pred cCCc--ccCCCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC----
Q 002331 827 HNTF--LSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP---- 898 (935)
Q Consensus 827 ~~~~--~~~~s~~GT~~Y~APEvl~g~~--~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip---- 898 (935)
.... .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+........++
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 4321 1123346788999999987654 7889999999999999999999998766655444433233333333
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++..+.++|.+||+.+ |.+||++++||+|||
T Consensus 239 ~~~~~~~~~li~~~l~~~---p~~Rps~~~il~~~~ 271 (272)
T cd06629 239 MNLSPVALDFLNACFTIN---PDNRPTARELLQHPF 271 (272)
T ss_pred ccCCHHHHHHHHHHhcCC---hhhCCCHHHHhhCCC
Confidence 346889999999999999 999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=325.83 Aligned_cols=242 Identities=30% Similarity=0.520 Sum_probs=206.5
Q ss_pred EeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCCH
Q 002331 683 RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL 760 (935)
.||+|+||.||+|++ +++.||+|.+... ........+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 589999999999976 6888999987644 3344556788999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC--CCCCC
Q 002331 761 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAG 838 (935)
Q Consensus 761 ~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~--~s~~G 838 (935)
.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....+..... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9999766667899999999999999999999998 9999999999999999999999999987544321111 11122
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 839 T~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
+..|+|||.+.+..++.++|||||||++|+|++ |..||...........+. ...+...+..++..+.+||.+||+.+
T Consensus 159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~- 236 (252)
T cd05084 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWEYD- 236 (252)
T ss_pred ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcCCC-
Confidence 456999999998889999999999999999997 899998877766655543 33455667788999999999999999
Q ss_pred CCcCCCcCHHHHHh
Q 002331 918 SSLHIRTSQAQLSH 931 (935)
Q Consensus 918 ssP~kRPSa~EILq 931 (935)
|.+||++.+|++
T Consensus 237 --p~~Rps~~~~~~ 248 (252)
T cd05084 237 --PGQRPSFSTVHQ 248 (252)
T ss_pred --hhhCcCHHHHHH
Confidence 999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=335.59 Aligned_cols=253 Identities=27% Similarity=0.469 Sum_probs=213.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
+...+|.+.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.++..++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 45567888899999999999999763 3679999987543 233456788999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec
Q 002331 746 PNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~---------------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd 810 (935)
...++++||+.+++|.+++... ...+++..++.++.|++.||.|||++| |+||||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~ 158 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec
Confidence 9999999999999999998421 234788889999999999999999998 99999999999999
Q ss_pred CCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 002331 811 KNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 887 (935)
Q Consensus 811 ~~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~ 887 (935)
.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999876543211 1123345778999999988889999999999999999998 8899998888777776
Q ss_pred hhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 888 VGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 888 I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+. ......++..++.++.+||.+||+.+ |.+||++.+|++.
T Consensus 239 i~-~~~~~~~~~~~~~~~~~li~~cl~~~---p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IR-NRQVLPCPDDCPAWVYTLMLECWNEF---PSRRPRFKDIHSR 279 (283)
T ss_pred HH-cCCcCCCCCCCCHHHHHHHHHHhCCC---cccCCCHHHHHHH
Confidence 64 33344567889999999999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=331.20 Aligned_cols=250 Identities=28% Similarity=0.465 Sum_probs=202.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHH-HHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~i-L~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||++.+ +|+.||||++........ ...+..|+.+ ++.++||||+++++++..++.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4789999999999999999987 588999999876544333 3344456554 56679999999999999999999999
Q ss_pred eeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 753 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 753 Ey~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
||++ ++|.+++.. ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9996 578777643 335689999999999999999999986 7 99999999999999999999999999886543
Q ss_pred CcccCCCCCCCCCccCcccccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccCCC-CcCc
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRN----EPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIP-KELD 902 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g----~~~s~ksDIWSLG~ILyELLTG~~PF~~~~-~~eil~~I~~~~~r~~ip-~~ls 902 (935)
.. ......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.... ..+....+. ......++ ..++
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (283)
T cd06617 157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFS 234 (283)
T ss_pred cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccC
Confidence 31 1223568889999999865 446889999999999999999999997532 233333332 22333343 3578
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.++.++|.+||..+ |.+||++.+|++|||
T Consensus 235 ~~l~~li~~~l~~~---p~~Rp~~~~il~~~~ 263 (283)
T cd06617 235 PEFQDFVNKCLKKN---YKERPNYPELLQHPF 263 (283)
T ss_pred HHHHHHHHHHccCC---hhhCcCHHHHhcCch
Confidence 99999999999999 999999999999998
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=331.25 Aligned_cols=250 Identities=29% Similarity=0.426 Sum_probs=213.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||.|+||.||++.+ +++.||+|++..... ......+.+|++++++++||||+++++.+...+.++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 3677888999999999999987 478899998876543 3455678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
|+++++|.+++......+++..+..++.|++.||.|||+ .+ |+|+||||+||+++.++.+||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999999999997654678999999999999999999999 88 99999999999999999999999999876543321
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHhhccccccCCCCc-CcHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-----NPMQVVGAVGFQNRRLEIPKE-LDPLVA 906 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~-----~~~eil~~I~~~~~r~~ip~~-ls~~L~ 906 (935)
....++..|+|||.+.+..++.++|||||||++|+|++|..||... ...+....+. ....+.++.. ++..+.
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDFQ 234 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHHHH
Confidence 1267888999999999999999999999999999999999999765 2333333332 2334445544 889999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++|.+||..+ |.+||++.+++.|||
T Consensus 235 ~li~~~l~~~---p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 235 DFVNLCLIKD---PRERPSYKELLEHPF 259 (265)
T ss_pred HHHHHHcCCC---chhCcCHHHHhhCch
Confidence 9999999999 999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=334.41 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=209.3
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC---HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~---~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
+|++.+.||+|+||.||+|.+ .++.||||++...... ......+..|+.+++.++|+||+++++++.+.+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999976 5789999999766543 22344567899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+ +++|.+++.+....+++..++.++.||+.||.|||.++ |+|+||||+|||++.++.+||+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 88999999775457899999999999999999999999 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc----------------
Q 002331 832 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---------------- 894 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r---------------- 894 (935)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.........+......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 3334456889999999865 45789999999999999999998888877665444333110000
Q ss_pred -----c-----CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 -----L-----EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 -----~-----~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. .+....+..+.++|.+||+.+ |.+||++.++++|+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~R~s~~e~l~~~~ 284 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLN---PNKRITARQALEHPY 284 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCC---cccCcCHHHHhhCcc
Confidence 0 011345788999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.01 Aligned_cols=252 Identities=31% Similarity=0.542 Sum_probs=216.0
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
+++..++|++.+.||+|+||.||++.+ .+..||||.+...... ...+.+|+.+++.++|+||+++++++.....++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 457789999999999999999999976 4567999988765433 356789999999999999999999999989999
Q ss_pred EEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||+||+|+.++.+||+|||++.....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999999997643 46899999999999999999999998 99999999999999999999999999876543
Q ss_pred Ccc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHH
Q 002331 829 TFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 829 ~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
... ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.........+. .......+...+..+.
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELY 234 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence 211 1112234568999999998889999999999999999998 999999888777766654 3334556677899999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
++|.+||+.+ |.+||+++++++
T Consensus 235 ~~i~~~l~~~---p~~Rp~~~~l~~ 256 (261)
T cd05034 235 DLMLQCWDKD---PEERPTFEYLQS 256 (261)
T ss_pred HHHHHHcccC---cccCCCHHHHHH
Confidence 9999999999 999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=332.32 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=207.4
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|++.+.||.|+||.||+|++ +++.||||++............+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999976 678999998876544333445788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 755 LPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 755 ~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
+. ++|..++... ...+++..++.++.||+.||+|||..+ |+||||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 96 5888887543 356899999999999999999999998 9999999999999999999999999987654332223
Q ss_pred CCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------------
Q 002331 834 KSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------------ 894 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r------------------ 894 (935)
....++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3345788999999987654 588999999999999999999999876654433222110000
Q ss_pred ---------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 ---------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ---------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+...+++.++++|.+||+.| |.+||+++++++|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~Rpt~~~~l~~~~ 283 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYD---PNKRISAKAALAHPF 283 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCC---cccCCCHHHHhcCCC
Confidence 0112346788999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=331.07 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=211.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|++++++++|+||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3689999999999999999977 57789999887654444455678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-c
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-S 832 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~ 832 (935)
|++++.+..++.+ ...+++..++.++.||+.||.|||..+ |+|+||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9998777666654 346899999999999999999999998 99999999999999999999999999887654432 2
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-------------------
Q 002331 833 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------------- 892 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~------------------- 892 (935)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||.+....+.+..+....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 2345678899999999887 78999999999999999999999998765544333221000
Q ss_pred -c----------ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 -R----------RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 -~----------r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. ....+..++..+.+||++||..+ |.+||+++++++|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---p~~Rps~~~il~~~~ 287 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMD---PKERLTCDELLQHPY 287 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccC---chhcccHHHHhcCCC
Confidence 0 00123345889999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=333.94 Aligned_cols=256 Identities=30% Similarity=0.530 Sum_probs=217.5
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~ 741 (935)
.+++..++|++.+.||+|+||.||++.+. ...||+|.+.... .......+.+|+.+++++ +|+||++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 45677889999999999999999999763 2578999887543 334456688999999999 89999999999
Q ss_pred cccCCceEEEEeeCCCCCHHHHHcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCC
Q 002331 742 VTRPPNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 806 (935)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~~~---------------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeN 806 (935)
+...+.++++|||+++++|..++.+. ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 99999999999999999999998632 346889999999999999999999998 9999999999
Q ss_pred eeecCCCcEEEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHH
Q 002331 807 LLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQ 883 (935)
Q Consensus 807 ILLd~~g~VKL~DFGlA~~~~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~e 883 (935)
||++.++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 99999999999999999876543211 112234567999999999899999999999999999997 999999888777
Q ss_pred HHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 884 il~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
....+. .......+..++..+.+||.+||..+ |.+||++.+++++
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~---p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEV---PSQRPTFKQLVED 287 (293)
T ss_pred HHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccC---cccCcCHHHHHHH
Confidence 766554 33455667788999999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.64 Aligned_cols=249 Identities=29% Similarity=0.476 Sum_probs=207.1
Q ss_pred eeEEEEeeecCcEEEEEEEECC--c--eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC------Cc
Q 002331 678 LVLGERIGLGSYGEVYHADWNG--T--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------PN 747 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~~g--~--~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~------~~ 747 (935)
|.+++.||+|+||.||+|.+.. . .||||.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999998632 2 589998876655556677889999999999999999999876422 24
Q ss_pred eEEEEeeCCCCCHHHHHcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccc
Q 002331 748 LSIITEFLPRGSLFRILHR-----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~-----~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGl 822 (935)
.+++|||+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCc
Confidence 7899999999999988732 2235789999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCC
Q 002331 823 SRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 899 (935)
Q Consensus 823 A~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~ 899 (935)
++....... ......+++.|++||.+.+..++.++|||||||++|+|++ |..||.+....+....+.. ......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 237 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-GNRLKQPP 237 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 987543221 1122345678999999999889999999999999999999 7999998887777666643 33445667
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 900 ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.++..+.++|.+||+.+ |++||++.+|+++
T Consensus 238 ~~~~~~~~li~~~l~~~---p~~Rps~~~l~~~ 267 (272)
T cd05075 238 DCLDGLYSLMSSCWLLN---PKDRPSFETLRCE 267 (272)
T ss_pred CCCHHHHHHHHHHcCCC---cccCcCHHHHHHH
Confidence 78899999999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=338.37 Aligned_cols=244 Identities=22% Similarity=0.338 Sum_probs=189.6
Q ss_pred EEEeeecCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc--CCceEEEEee
Q 002331 681 GERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSIITEF 754 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~--~~~l~LVmEy 754 (935)
+++||+|+||+||+|++ .++.||||.+...... ..+.+|+.+|++++||||+++++++.. +..+++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 45799999999999975 3568999998755432 246789999999999999999998854 4568999999
Q ss_pred CCCCCHHHHHcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee----cCCCcEEEEeccc
Q 002331 755 LPRGSLFRILHRP--------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGL 822 (935)
Q Consensus 755 ~~gGsL~dlL~~~--------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL----d~~g~VKL~DFGl 822 (935)
+.+ +|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||+
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 964 888877421 235889999999999999999999999 9999999999999 4568899999999
Q ss_pred cccccCCc---ccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChH---------HHHHHhh
Q 002331 823 SRLKHNTF---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM---------QVVGAVG 889 (935)
Q Consensus 823 A~~~~~~~---~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~---------eil~~I~ 889 (935)
++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||...... ..+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98764321 122345789999999999874 5899999999999999999999999754321 1111100
Q ss_pred c-cccc-------------------------c----------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCc
Q 002331 890 F-QNRR-------------------------L----------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKR 933 (935)
Q Consensus 890 ~-~~~r-------------------------~----------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHP 933 (935)
. ...+ . ......+..+.+||.+||+.| |.+|||++|+|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d---P~~R~t~~e~l~hp 315 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD---PIKRITSEQAMQDP 315 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccC---cccCCCHHHHhcCC
Confidence 0 0000 0 000123467889999999999 99999999999999
Q ss_pred C
Q 002331 934 F 934 (935)
Q Consensus 934 F 934 (935)
|
T Consensus 316 ~ 316 (317)
T cd07868 316 Y 316 (317)
T ss_pred C
Confidence 9
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=327.98 Aligned_cols=249 Identities=27% Similarity=0.460 Sum_probs=211.1
Q ss_pred eeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc-----
Q 002331 678 LVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----- 747 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~----- 747 (935)
|++++.||+|+||.||+|... +..||||++............+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999762 3679999988765555667788999999999999999999998765443
Q ss_pred -eEEEEeeCCCCCHHHHHcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecc
Q 002331 748 -LSIITEFLPRGSLFRILHR-----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (935)
Q Consensus 748 -l~LVmEy~~gGsL~dlL~~-----~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFG 821 (935)
.++||||+++++|..++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence 7999999999999998843 1235889999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCccc--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCC
Q 002331 822 LSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (935)
Q Consensus 822 lA~~~~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip 898 (935)
+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. ......++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 99865433211 112234678999999988889999999999999999999 899999888877776654 34456677
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
..++..+.++|.+||+.| |.+||++.+++++
T Consensus 238 ~~~~~~~~~li~~~l~~~---p~~Rp~~~e~~~~ 268 (273)
T cd05035 238 EDCLDELYDLMYSCWRAD---PKDRPTFTKLREV 268 (273)
T ss_pred cCCCHHHHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 889999999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.44 Aligned_cols=251 Identities=29% Similarity=0.536 Sum_probs=222.5
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|++.+.||+|++|.||++.+ .++.|+||.+............+.+|++++.+++|+||+++++++...+.++++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 588899999999999999976 577899999987766556677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
+++++|.+++.+. ..+++..++.++.|++.||.|||+.| |+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 9999999999764 57899999999999999999999998 99999999999999999999999999987655433334
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHh
Q 002331 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914 (935)
Q Consensus 835 s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~ 914 (935)
...++..|+|||.+.+..++.++|||+||+++|+|++|..||............. ......++..++..+.++|.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4568899999999988888999999999999999999999998877666555543 344456778889999999999999
Q ss_pred hCCCCcCCCcCHHHHHhCcC
Q 002331 915 TGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 915 ~D~ssP~kRPSa~EILqHPF 934 (935)
.+ |++||++.+++.|||
T Consensus 237 ~~---p~~R~~~~~~l~~~~ 253 (254)
T cd06627 237 KD---PNLRPTAKQLLKHPW 253 (254)
T ss_pred CC---hhhCcCHHHHhcCCC
Confidence 99 999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=332.57 Aligned_cols=250 Identities=28% Similarity=0.473 Sum_probs=216.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
..|+..+.||.|+||.||+|.+ .+..||||++..... ......+.+|+.+++.++|+||+++++.+.+.+..++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3577788899999999999976 578899998875432 3445678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 9999999999865 35888999999999999999999998 9999999999999999999999999997654433223
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL 913 (935)
....++..|+|||++.+..++.++|+|||||++|+|++|..||....+......+. ....+.++..++..+.++|.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHHc
Confidence 34467889999999998889999999999999999999999999887766555442 33445566678899999999999
Q ss_pred hhCCCCcCCCcCHHHHHhCcC
Q 002331 914 QTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 914 ~~D~ssP~kRPSa~EILqHPF 934 (935)
+.+ |.+||++.++++|+|
T Consensus 238 ~~~---p~~Rp~~~~il~~~~ 255 (277)
T cd06640 238 NKD---PSFRPTAKELLKHKF 255 (277)
T ss_pred ccC---cccCcCHHHHHhChH
Confidence 999 999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.17 Aligned_cols=242 Identities=28% Similarity=0.470 Sum_probs=207.0
Q ss_pred EeeecCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCC
Q 002331 683 RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 758 (935)
.||+|+||.||+|.+ .+..||||++............+..|+.+++.++||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999965 46789999987665555566788999999999999999999998764 5678999999999
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc---CCC
Q 002331 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---SKS 835 (935)
Q Consensus 759 sL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~---~~s 835 (935)
+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||.|||++.++.+||+|||++......... ...
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 999999653 46899999999999999999999999 999999999999999999999999999865433211 112
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHh
Q 002331 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914 (935)
Q Consensus 836 ~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~ 914 (935)
..++..|+|||.+.+..++.++|||||||++|||++ |..||...+.......+. ....+.+|..+++.+.+||.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHhc
Confidence 234578999999988889999999999999999998 999999888777776664 334566788899999999999999
Q ss_pred hCCCCcCCCcCHHHHHhC
Q 002331 915 TGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 915 ~D~ssP~kRPSa~EILqH 932 (935)
.| |.+||++.+|.+.
T Consensus 237 ~~---p~~Rp~~~~i~~~ 251 (257)
T cd05116 237 YG---VDERPGFAVVELR 251 (257)
T ss_pred cC---chhCcCHHHHHHH
Confidence 99 9999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.39 Aligned_cols=251 Identities=29% Similarity=0.480 Sum_probs=213.1
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
...+|++.+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3467899999999999999999752 2369999876543 344456788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++||||+++++|.+++.+....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999999876667899999999999999999999998 99999999999999999999999999986643
Q ss_pred Cccc---CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 829 TFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 829 ~~~~---~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
.... .....++..|++||.+.+..++.++|+|||||++|++++ |..||......+....+.. ..+...+..+++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-GYRLPAPMDCPAA 237 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC-CCcCCCCCCCCHH
Confidence 2211 111223568999999998889999999999999999886 9999998877766666542 3344556678899
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+.+++.+||+.+ |.+||++.++++
T Consensus 238 ~~~li~~~l~~~---p~~Rp~~~~i~~ 261 (267)
T cd05066 238 LHQLMLDCWQKD---RNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHcccC---chhCCCHHHHHH
Confidence 999999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=337.65 Aligned_cols=255 Identities=25% Similarity=0.324 Sum_probs=210.0
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC--CceE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLS 749 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l~ 749 (935)
..++|++.+.||+|+||.||+|.+ +++.||+|++............+.+|+.++++++|+||+++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 457899999999999999999976 588999999876543333333456799999999999999999998654 4689
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||+.+ +|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999975 888888765567899999999999999999999999 999999999999999999999999999876543
Q ss_pred cccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc---------------
Q 002331 830 FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--------------- 893 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~--------------- 893 (935)
........++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 222233446788999999876 4578999999999999999999999998887766554422110
Q ss_pred --ccCCC-----------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 --RLEIP-----------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 --r~~ip-----------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...++ ...++.+.+||.+||+.| |++||+++++++|||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~d---p~~R~t~~~il~h~~ 292 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYD---PKKRATAEEALESSY 292 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCC---hhhCcCHHHHhcChh
Confidence 00011 125788999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=335.34 Aligned_cols=249 Identities=26% Similarity=0.457 Sum_probs=213.7
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
.|++.+.||+|+||.||+|.+ .++.||||.+..... ......+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 466677899999999999976 577899998765432 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+|+||+|+||++++++.+||+|||++...........
T Consensus 84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 999999999865 46889999999999999999999998 99999999999999999999999999876554333333
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHh
Q 002331 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914 (935)
Q Consensus 835 s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~ 914 (935)
...++..|+|||++.+..++.++|+|||||++|+|++|+.||....+......+. ......++..++..+.++|.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHHcc
Confidence 4568889999999999889999999999999999999999998776665544432 233444556788899999999999
Q ss_pred hCCCCcCCCcCHHHHHhCcC
Q 002331 915 TGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 915 ~D~ssP~kRPSa~EILqHPF 934 (935)
.+ |.+||++.++++|||
T Consensus 239 ~~---p~~Rp~~~~il~~~~ 255 (277)
T cd06642 239 KD---PRFRPTAKELLKHKF 255 (277)
T ss_pred CC---cccCcCHHHHHHhHH
Confidence 99 999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=329.98 Aligned_cols=253 Identities=30% Similarity=0.464 Sum_probs=209.9
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccC-----
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP----- 745 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~----- 745 (935)
..++|.+.+.||+|+||.||++.. .++.||+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 457899999999999999999976 57899999886542 2234567899999999 899999999998643
Q ss_pred CceEEEEeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccc
Q 002331 746 PNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGl 822 (935)
+.+++||||+++++|.++++. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999999999998853 3456899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCC-----CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccC
Q 002331 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLE 896 (935)
Q Consensus 823 A~~~~~~~~~~~s~~GT~~Y~APEvl~g~~-----~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~-~r~~ 896 (935)
+..............|+..|+|||++.... ++.++|||||||++|+|++|+.||...+....+..+.... ....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (291)
T cd06639 175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254 (291)
T ss_pred chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 886554333334457889999999986432 5789999999999999999999999887765554442211 1122
Q ss_pred CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 897 IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 897 ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+......+.+||.+||+.+ |++||++.+|++|||
T Consensus 255 ~~~~~~~~l~~li~~~l~~~---p~~Rps~~~il~~~~ 289 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKD---FEARPSVTHLLEHPF 289 (291)
T ss_pred cccccCHHHHHHHHHHhhcC---hhhCcCHHHHhcCcc
Confidence 34556788999999999999 999999999999998
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=335.18 Aligned_cols=253 Identities=25% Similarity=0.303 Sum_probs=210.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC--CceEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSII 751 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l~LV 751 (935)
++|++.+.||.|+||.||+|++ .++.||||.++...........+.+|+.++++++||||+++++++... +.+|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5788899999999999999987 478899999876554433444567899999999999999999998777 889999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+++ +|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 999975 999988765557899999999999999999999998 99999999999999999999999999887655433
Q ss_pred cCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc------------------
Q 002331 832 SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------------ 892 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~------------------ 892 (935)
......+++.|+|||.+.+.. ++.++|||||||++|+|++|.+||......+....+....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 333456788999999987654 6889999999999999999999999877655544321100
Q ss_pred -----------cccCCCCc-CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 -----------RRLEIPKE-LDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 -----------~r~~ip~~-ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
....++.. +++.+.+||.+||+.+ |++||++.|+|+|||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---p~~R~t~~ell~~~~ 292 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYD---PAKRISAEDALKHPY 292 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccC---ccccCCHHHHhcCCC
Confidence 00112222 5888999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.02 Aligned_cols=244 Identities=25% Similarity=0.382 Sum_probs=214.2
Q ss_pred eeecCcEEEEEEEEC--CceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCCH
Q 002331 684 IGLGSYGEVYHADWN--GTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (935)
Q Consensus 684 LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL 760 (935)
||.|+||.||+++.. ++.||||++...... ......+.+|+.+++.++||||+++++.+.++..+++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999885 889999998765433 23456788999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCCCC
Q 002331 761 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 840 (935)
Q Consensus 761 ~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~ 840 (935)
.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....... ......++.
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 9999764 35889999999999999999999998 9999999999999999999999999998765432 223356889
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCC
Q 002331 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWS 918 (935)
Q Consensus 841 ~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~--~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~s 918 (935)
.|++||.+.+..++.++|+|+||+++|+|++|..||.... .......+........+|..+++.+.++|.+||+.+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~-- 234 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN-- 234 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC--
Confidence 9999999988889999999999999999999999998876 566665554445566777778999999999999999
Q ss_pred CcCCCcC-----HHHHHhCcC
Q 002331 919 SLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 919 sP~kRPS-----a~EILqHPF 934 (935)
|.+||+ ++|+++|||
T Consensus 235 -p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 235 -PEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred -hhhCcCCcccCHHHHhcChh
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.32 Aligned_cols=250 Identities=32% Similarity=0.553 Sum_probs=209.0
Q ss_pred CCCeeEEEEeeecCcEEEEEEEEC--Cc--eEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADWN--GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~~--g~--~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~ 749 (935)
|++|++.+.||+|+||.||+|... +. .+++|.++.. ........+.+|+.++.++ +||||+++++++...+.++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 578999999999999999999763 32 4688876532 2333456788999999999 7999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc
Q 002331 750 IITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~ 814 (935)
+||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence 9999999999999986422 24788999999999999999999998 999999999999999999
Q ss_pred EEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccc
Q 002331 815 VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNR 893 (935)
Q Consensus 815 VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~ 893 (935)
+||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||......+....+. ...
T Consensus 158 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 235 (297)
T ss_pred EEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCC
Confidence 999999998643221 11111223457999999998889999999999999999997 999999988877766654 334
Q ss_pred ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 894 RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 894 r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
...++..++..+.+||.+||+.+ |.+||++++|++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~---p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDR---PYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 45567789999999999999999 9999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.97 Aligned_cols=251 Identities=32% Similarity=0.548 Sum_probs=213.2
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
|++..++|++.++||+|+||.||+|.+ .+..||+|.+...... ...+.+|+.++++++|+||+++++++.. ...+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence 356778999999999999999999976 4567999988765443 3468899999999999999999998854 5689
Q ss_pred EEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999999998653 345899999999999999999999998 99999999999999999999999999986543
Q ss_pred Cccc-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHH
Q 002331 829 TFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 829 ~~~~-~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
.... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+. .......+...+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLH 233 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHH
Confidence 2211 112234567999999988889999999999999999999 899999888777776654 3345566778899999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+||.+||..+ |.+||++.++++
T Consensus 234 ~li~~~l~~~---p~~Rpt~~~l~~ 255 (260)
T cd05070 234 ELMLQCWKKD---PEERPTFEYLQS 255 (260)
T ss_pred HHHHHHcccC---cccCcCHHHHHH
Confidence 9999999999 999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=346.78 Aligned_cols=245 Identities=19% Similarity=0.264 Sum_probs=197.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
..+|++.+.||+|+||.||+|++ .++.||+|+.... ....|+.++++++|+||+++++++......++||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 35799999999999999999987 4568999974332 2346899999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+. ++|.+++......+++..++.|+.||+.||.|||.++ ||||||||+||||+.++.+||+|||+++..... ..
T Consensus 137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~ 212 (357)
T PHA03209 137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PA 212 (357)
T ss_pred EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccC-cc
Confidence 9995 5888888766677999999999999999999999998 999999999999999999999999999754322 12
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCC-CCCChH----------HHHHHhhc-cccccCCC--
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW-IGMNPM----------QVVGAVGF-QNRRLEIP-- 898 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF-~~~~~~----------eil~~I~~-~~~r~~ip-- 898 (935)
.....||+.|+|||++.+..++.++|||||||++|||+++..|+ ...... .+...+.. ...+..++
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 23456899999999999999999999999999999999865554 332110 11110100 00011111
Q ss_pred ----------------------------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 ----------------------------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 ----------------------------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++.++.+||.+||+.| |.+||++.|+|+|||
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d---P~~Rpta~e~l~hp~ 353 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFD---AAMRPSAEEILNYPM 353 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCC---cccCcCHHHHhcCch
Confidence 135667788999999999 999999999999999
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.74 Aligned_cols=252 Identities=27% Similarity=0.490 Sum_probs=212.6
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC----HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS----GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~----~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
+|+.++.||+|+||.||++.. +++.||+|++...... ......+.+|+.++++++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999975 6889999998754321 2245678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC-cEEEEeccccccccCC
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNT 829 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~VKL~DFGlA~~~~~~ 829 (935)
||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+|+||||+||+++.++ .+||+|||.+......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999763 46889999999999999999999998 99999999999998776 5999999998766432
Q ss_pred cc----cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhccccccCCCCcCc
Q 002331 830 FL----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKELD 902 (935)
Q Consensus 830 ~~----~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~---~eil~~I~~~~~r~~ip~~ls 902 (935)
.. ......++..|+|||++.+..++.++|||+|||++|+|++|..||..... ......+........++..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 11234678899999999988899999999999999999999999975443 222323333344566777889
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+++.++|.+||..+ |.+||++.++++|||
T Consensus 238 ~~~~~~i~~~l~~~---p~~R~~~~~ll~~~~ 266 (268)
T cd06630 238 PGLRDVTLRCLELQ---PEDRPPSRELLKHPV 266 (268)
T ss_pred HHHHHHHHHHcCCC---cccCcCHHHHhcCcc
Confidence 99999999999999 999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=374.26 Aligned_cols=256 Identities=23% Similarity=0.374 Sum_probs=211.8
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEE-CC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeeccc-cc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADW-NG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAV-TR 744 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~-~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~-~~ 744 (935)
..+++...+++|.+.|.+|||+.||+|+. .+ ..||+|++... ++..+..+++|+++|++|. |+|||.+++.. ..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 34566778899999999999999999987 33 89999998766 5678889999999999995 99999999932 11
Q ss_pred ------CCceEEEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEE
Q 002331 745 ------PPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 817 (935)
Q Consensus 745 ------~~~l~LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL 817 (935)
.-.++|.||||.||.|-+++.+ ....|++.++++|+.|+++|+.+||.+.++|||||||-|||||+.+|++||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 1247899999999999999963 344599999999999999999999999999999999999999999999999
Q ss_pred EeccccccccCCccc---------CCCCCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 002331 818 SDFGLSRLKHNTFLS---------SKSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885 (935)
Q Consensus 818 ~DFGlA~~~~~~~~~---------~~s~~GT~~Y~APEvl---~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil 885 (935)
||||.+......... .....-|+.|++||++ .+...++|+|||+|||+||-|+....||++.....++
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl 267 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL 267 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE
Confidence 999998754322111 1122468999999997 4778899999999999999999999999988554332
Q ss_pred HHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCc
Q 002331 886 GAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKR 933 (935)
Q Consensus 886 ~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHP 933 (935)
.....++-...++..+++||+.||+.+ |.+||++-+++.+-
T Consensus 268 ----ng~Y~~P~~p~ys~~l~~LI~~mL~~n---P~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 268 ----NGNYSFPPFPNYSDRLKDLIRTMLQPN---PDERPNIYQVLEEI 308 (738)
T ss_pred ----eccccCCCCccHHHHHHHHHHHHhccC---cccCCCHHHHHHHH
Confidence 222333333478999999999999999 99999999998753
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=328.45 Aligned_cols=251 Identities=24% Similarity=0.439 Sum_probs=210.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||++.+ +++.||||.+..... .......+.+|+.+++.++|+||+++++++..++.++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999975 788999998876443 3344567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 753 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 753 Ey~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999998863 2346899999999999999999999998 999999999999999999999999998766543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHhhccccccCCCCcCcHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~--~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
........++..|+|||++.+..++.++||||||+++|+|++|..||.+... ......+.....+...+..+++.+++
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 3323345688999999999988899999999999999999999999976543 23333333222222333568899999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+|.+||+.+ |.+||++.+|++
T Consensus 240 li~~~l~~~---p~~Rpt~~~i~~ 260 (267)
T cd08229 240 LVNMCINPD---PEKRPDITYVYD 260 (267)
T ss_pred HHHHhcCCC---cccCCCHHHHHH
Confidence 999999999 999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=380.89 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=212.6
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc--CC
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PP 746 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~--~~ 746 (935)
.+...++|++++.||+|+||+||+|++ .+..||+|++............+..|+.+|+.|+|||||+++++|.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 345668999999999999999999987 56789999988776666667788999999999999999999998854 35
Q ss_pred ceEEEEeeCCCCCHHHHHcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCEEeeCCCCCCeeecC-------
Q 002331 747 NLSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTST-----PTIVHRDLKSPNLLVDK------- 811 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~---~~~lse~~il~Ia~QIa~AL~yLHs~g-----~~IIHrDLKPeNILLd~------- 811 (935)
.+||||||+++++|.++|... ...+++..++.|+.||+.||.|||..+ .+||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 689999999999999998642 346899999999999999999999854 24999999999999964
Q ss_pred ----------CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002331 812 ----------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGM 879 (935)
Q Consensus 812 ----------~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLG~ILyELLTG~~PF~~~ 879 (935)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||+|++|..||...
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3459999999998664332 2234579999999999864 45789999999999999999999999876
Q ss_pred ChHHHHHHhhccccccCCC-CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 880 NPMQVVGAVGFQNRRLEIP-KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 880 ~~~eil~~I~~~~~r~~ip-~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+....+....... +.++ ...+.++.+||.+||..+ |.+||++.++|+|+|
T Consensus 247 ~~~~qli~~lk~~--p~lpi~~~S~eL~dLI~~~L~~d---PeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 247 NNFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLS---AKERPSALQCLGYQI 297 (1021)
T ss_pred CcHHHHHHHHhcC--CCCCcCCCCHHHHHHHHHHhcCC---hhHCcCHHHHhccHH
Confidence 5543332222111 2222 457899999999999999 999999999999987
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=328.30 Aligned_cols=251 Identities=27% Similarity=0.464 Sum_probs=211.3
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~----~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
+..++|++.++||+|+||+||+|++ ++. .||||++.... .......+.+|+.++..+.|+||+++++++.. .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 3457899999999999999999976 343 48999886543 33445678899999999999999999999875 4
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
..+++|||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeec
Confidence 578999999999999999776667899999999999999999999998 999999999999999999999999999866
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 827 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 827 ~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
..... ......++..|+|||++.+..++.++|||||||++|||++ |..||...........+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTI 238 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCCH
Confidence 43211 1122234678999999998889999999999999999998 899998877766655443 3344556677899
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.+.++|.+||+.| |.+||++.++++
T Consensus 239 ~~~~li~~~l~~d---p~~Rp~~~~l~~ 263 (279)
T cd05109 239 DVYMIMVKCWMID---SECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHHcCCC---hhhCcCHHHHHH
Confidence 9999999999999 999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=322.85 Aligned_cols=250 Identities=24% Similarity=0.445 Sum_probs=210.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||+|.. +++.||+|.++.... .......+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999977 588999998875433 2334667889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 753 EFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 753 Ey~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
||+++++|..++.. ....+++..++.++.||+.||.|||+.| |+||||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999998853 2345889999999999999999999998 999999999999999999999999998765443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHhhccccccCCCC-cCcHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--PMQVVGAVGFQNRRLEIPK-ELDPLVA 906 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~--~~eil~~I~~~~~r~~ip~-~ls~~L~ 906 (935)
........++..|+|||.+.+..++.++|||||||++|+|++|+.||.... ..+....+.. .....++. .++..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCCCChhhcCHHHH
Confidence 222334568889999999998889999999999999999999999996543 2333333322 22333444 6788999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
++|.+||..+ |.+||++.+|++
T Consensus 239 ~~i~~cl~~~---p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPD---PEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCC---cccCCCHHHHHH
Confidence 9999999999 999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=363.24 Aligned_cols=259 Identities=31% Similarity=0.540 Sum_probs=229.7
Q ss_pred ccccCCCCCCeeEEEEeeecCcEEEEEEEE--C-C--ce-EEEEEeec-cCCCHHHHHHHHHHHHHHHHcCCCceeeeec
Q 002331 668 VCECEIPWEDLVLGERIGLGSYGEVYHADW--N-G--TE-VAVKKFLD-QDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740 (935)
Q Consensus 668 ~~~~ei~~edy~I~e~LG~G~fG~Vyka~~--~-g--~~-VAVK~i~~-~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g 740 (935)
...|++..++..+.++||+|.||.||+|+. . + .. ||||..+. .......+.+|.+|+++|++++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 345788888999999999999999999975 2 2 23 89998875 3466778889999999999999999999999
Q ss_pred ccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
+......++||||+|.||+|.++|++....++..+...++.+.+.||+|||.++ +|||||-.+|||++.++.+||+||
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999999999987777999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCC
Q 002331 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 899 (935)
Q Consensus 821 GlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~ 899 (935)
|+++.............-...|+|||.+....|+.++|||||||++||+++ |..||.+....++..++.....+..+|.
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~ 386 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS 386 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC
Confidence 998764311111111123468999999999999999999999999999998 7889999999999999977889999999
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 900 ELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
..+.++..++.+||..+ |+.||++.++.+
T Consensus 387 ~~p~~~~~~~~~c~~~~---p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 387 KTPKELAKVMKQCWKKD---PEDRPTMSTIKK 415 (474)
T ss_pred CCHHHHHHHHHHhccCC---hhhccCHHHHHH
Confidence 99999999999999999 999999999865
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.37 Aligned_cols=251 Identities=32% Similarity=0.545 Sum_probs=210.9
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
|++..++|++.++||+|+||.||+|++. ...||||++...... ...+.+|+++++.++|+||+++++.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 3566788999999999999999999774 357999988754432 3467889999999999999999998754 5689
Q ss_pred EEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
+||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||.+.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999999999999753 345789999999999999999999998 99999999999999999999999999976543
Q ss_pred Cccc-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHH
Q 002331 829 TFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 829 ~~~~-~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
.... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. .......+..++..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 233 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLH 233 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccCHHHH
Confidence 3221 122345678999999988889999999999999999999 888998887777666553 2334445667899999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+||.+||+.+ |.+||++.++++
T Consensus 234 ~li~~~l~~~---p~~Rp~~~~~~~ 255 (262)
T cd05071 234 DLMCQCWRKE---PEERPTFEYLQA 255 (262)
T ss_pred HHHHHHccCC---cccCCCHHHHHH
Confidence 9999999999 999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=336.17 Aligned_cols=256 Identities=30% Similarity=0.518 Sum_probs=215.5
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeee
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~ 739 (935)
.+++..++|.+++.||+|+||.||+++.. ...||+|++.... .......+..|+.+++++ +||||++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 45677889999999999999999999752 3468999876543 344566788999999999 699999999
Q ss_pred cccccCCceEEEEeeCCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCC
Q 002331 740 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (935)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKP 804 (935)
+++...+.+++||||+++++|.+++.... ..+++..+..++.||+.||.|||++| |+||||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 162 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAA 162 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99999899999999999999999986421 34788889999999999999999998 99999999
Q ss_pred CCeeecCCCcEEEEeccccccccCCcccC--CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 002331 805 PNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 881 (935)
Q Consensus 805 eNILLd~~g~VKL~DFGlA~~~~~~~~~~--~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~ 881 (935)
+|||++.++.+||+|||+++......... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998654322111 11234467999999999889999999999999999999 8999998887
Q ss_pred HHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 882 ~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+....+. ......++..++..+++||.+||+.+ |.+||++.++++.
T Consensus 243 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~---p~~Rps~~~ll~~ 289 (314)
T cd05099 243 EELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAV---PTQRPTFKQLVEA 289 (314)
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCC---cccCcCHHHHHHH
Confidence 77766654 33445667788999999999999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=375.72 Aligned_cols=256 Identities=31% Similarity=0.531 Sum_probs=224.3
Q ss_pred ccccCCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeec
Q 002331 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740 (935)
Q Consensus 668 ~~~~ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g 740 (935)
....+|+..+.++.+.||+|.||+||+|+.. ...||||.++... ..+...+|++|+++|..|+|||||+|+|
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 3445678888999999999999999999752 3469999887654 4557889999999999999999999999
Q ss_pred ccccCCceEEEEeeCCCCCHHHHHcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCe
Q 002331 741 AVTRPPNLSIITEFLPRGSLFRILHRP-------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNL 807 (935)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~~~-------------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNI 807 (935)
+|..++.++||+|||..|+|.+||... ..+++..+.+.|+.|||.||.||-++. +|||||-.+|+
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNC 634 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNC 634 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhc
Confidence 999999999999999999999999531 123788999999999999999999998 99999999999
Q ss_pred eecCCCcEEEEeccccccccCCcccCC--CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 002331 808 LVDKNWNVKVSDFGLSRLKHNTFLSSK--STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQV 884 (935)
Q Consensus 808 LLd~~g~VKL~DFGlA~~~~~~~~~~~--s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~ei 884 (935)
||.++..|||+|||+++.+-...+... ...-..+||+||.|...+|+.++||||+||+|||+++ |..||++..+.++
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 999999999999999997654433221 1223469999999999999999999999999999997 8999999999999
Q ss_pred HHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHH
Q 002331 885 VGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930 (935)
Q Consensus 885 l~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EIL 930 (935)
+..+..... +..|.++|.++..||..||+.. |.+||+|.+|-
T Consensus 715 Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~---P~~RPsF~eI~ 756 (774)
T KOG1026|consen 715 IECIRAGQL-LSCPENCPTEVYSLMLECWNEN---PKRRPSFKEIH 756 (774)
T ss_pred HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcC---cccCCCHHHHH
Confidence 999875444 8899999999999999999999 99999999974
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=348.62 Aligned_cols=245 Identities=26% Similarity=0.360 Sum_probs=201.8
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC-----CceE
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNLS 749 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~-----~~l~ 749 (935)
.|.-.+++|.|+||.||+|.. .++.||||+.....- --.+|+++|+.+.|||||++..+|... -++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 467789999999999999976 578999998765421 113799999999999999999988532 2466
Q ss_pred EEEeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC-CcEEEEecccccc
Q 002331 750 IITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRL 825 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~VKL~DFGlA~~ 825 (935)
+|||||+. +|.++++. .+..++...+.-+.+||++||.|||..| |+||||||.|||||.+ |.+||||||.|+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 89999987 89988873 3457888888889999999999999998 9999999999999965 9999999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc---------
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--------- 895 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--------- 895 (935)
.... ....+..-|+.|+|||.+.|.. |+.+.||||.||++.||+-|++-|.+.+..+.+..+....+.+
T Consensus 176 L~~~-epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 176 LVKG-EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eccC-CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 7654 2335566799999999988754 8999999999999999999999999987755544331111110
Q ss_pred ------------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 ------------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ------------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+...+++++.+|+.++|..+ |.+|.++.|++.|||
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~---P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYS---PSKRLSALEALAHPF 308 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccC---hhhcCCHHHHhcchh
Confidence 033568899999999999999 999999999999997
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.43 Aligned_cols=250 Identities=27% Similarity=0.451 Sum_probs=220.0
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|++.+.||+|+||.||++++ +++.|+||++............+.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588999999999999999976 577899999887665555667788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 755 LPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 755 ~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
+++++|.+++.+ ....+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 999999998855 2346899999999999999999999998 999999999999999999999999999876554
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~q 911 (935)
......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+. ......++..++.+++++|.+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHH
Confidence 2233568899999999999889999999999999999999999999988776666553 333445666789999999999
Q ss_pred HHhhCCCCcCCCcCHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPSa~EILqHPF 934 (935)
||+.+ |.+||++.++++||+
T Consensus 236 ~l~~~---p~~Rp~~~~~l~~p~ 255 (256)
T cd08530 236 MLQVK---PKLRPNCDKILASPA 255 (256)
T ss_pred HcCCC---cccCCCHHHHhcCCC
Confidence 99999 999999999999997
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=324.32 Aligned_cols=252 Identities=29% Similarity=0.481 Sum_probs=215.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccC---CCHHHHHHHHHHHHHHHHcCCCceeeeecccccC--Cce
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 748 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~---~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l 748 (935)
.+|.+.+.||+|+||.||++.+ +++.||+|.+.... ........+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5789999999999999999975 67899999875432 2234556788999999999999999999998664 458
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
+++|||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 8999999999999998754 35889999999999999999999998 99999999999999999999999999986532
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHH
Q 002331 829 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 829 ~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
.. .......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.....+..+|..+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 11 111235688999999999998899999999999999999999999998877666666554555677888999999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.++|.+||+ + |.+||++.+++.|||
T Consensus 239 ~~~i~~~l~-~---~~~r~~~~~~~~~~~ 263 (264)
T cd06653 239 RDFLKQIFV-E---EKRRPTAEFLLRHPF 263 (264)
T ss_pred HHHHHHHhc-C---cccCccHHHHhcCCC
Confidence 999999998 6 799999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=330.39 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=204.6
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++.+.||.|+||.||+|.. +++.||||.+...... .....+.+|+.++++++|+||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 47899999999999999999976 5789999998754322 12234668999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+.+ +|.+++.+....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 99975 899998776667899999999999999999999998 999999999999999999999999998765432222
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhc-c------------------
Q 002331 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGF-Q------------------ 891 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~-~~eil~~I~~-~------------------ 891 (935)
.....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+....+.. .
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 233456889999999876 457899999999999999999999997665 2222211100 0
Q ss_pred cccc---------CCCCcCc--HHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 892 NRRL---------EIPKELD--PLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 892 ~~r~---------~ip~~ls--~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.... .....++ ..+.++|.+||+.+ |.+||++.++++|||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~---p~~Rps~~e~l~~~~ 290 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYE---PKKRISAAEAMKHPY 290 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccC---cccccCHHHHhcCCC
Confidence 0000 0001233 78899999999999 999999999999999
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=332.67 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=213.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||++.+ .++.|+||.+...... ......+.+|+.+++.++||||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4689999999999999999976 5678999988765432 234557789999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc--
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 830 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~-- 830 (935)
||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999999764 46899999999999999999999998 9999999999999999999999999986421100
Q ss_pred -------------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccC
Q 002331 831 -------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLE 896 (935)
Q Consensus 831 -------------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~-r~~ 896 (935)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+..+.++...+..... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 011123578899999999988899999999999999999999999998887776665533221 222
Q ss_pred CCCcCcHHHHHHHHHHHhhCCCCcCCCcC---HHHHHhCcC
Q 002331 897 IPKELDPLVARIIWECWQTGWSSLHIRTS---QAQLSHKRF 934 (935)
Q Consensus 897 ip~~ls~~L~dLI~qCL~~D~ssP~kRPS---a~EILqHPF 934 (935)
.+..++.++.++|.+||+.+ |.+||+ +.++|+|||
T Consensus 238 ~~~~~~~~~~~li~~~l~~~---P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 238 GDEALPADAQDLISRLLRQN---PLERLGTGGAFEVKQHRF 275 (305)
T ss_pred ccccCCHHHHHHHHHHhccC---hhhccCccCHHHHHhCcc
Confidence 23367899999999999999 999998 799999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=327.87 Aligned_cols=249 Identities=26% Similarity=0.467 Sum_probs=215.6
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
-|++.+.||+|+||.||+|.+ +++.||||++..... ......+.+|+.++.+++||||+++++++..++..++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 367788999999999999975 578999998765432 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...........
T Consensus 84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 999999999865 35889999999999999999999998 99999999999999999999999999876544322233
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHh
Q 002331 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914 (935)
Q Consensus 835 s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~ 914 (935)
...++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+. ......++..++..+.++|.+||+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHcc
Confidence 4568889999999988888999999999999999999999998877766555543 334455667789999999999999
Q ss_pred hCCCCcCCCcCHHHHHhCcC
Q 002331 915 TGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 915 ~D~ssP~kRPSa~EILqHPF 934 (935)
.+ |.+||++.++++|||
T Consensus 239 ~~---p~~Rp~~~~~l~~~~ 255 (277)
T cd06641 239 KE---PSFRPTAKELLKHKF 255 (277)
T ss_pred CC---hhhCcCHHHHHhCHH
Confidence 99 999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.73 Aligned_cols=251 Identities=33% Similarity=0.518 Sum_probs=212.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
+...+|.+.+.||+|+||.||+|++. +..+++|.+.... ......+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 45678999999999999999999752 3458888875433 23345688999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec
Q 002331 746 PNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd 810 (935)
+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~ 157 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG 157 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence 99999999999999999986422 34788999999999999999999999 99999999999999
Q ss_pred CCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 002331 811 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 887 (935)
Q Consensus 811 ~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~ 887 (935)
.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999997654321 11233456788999999999999999999999999999998 9999998888777665
Q ss_pred hhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 888 VGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 888 I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+. .......+..++..+.++|.+||+.+ |.+||++.+|++
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~---P~~Rpt~~~v~~ 277 (291)
T cd05094 238 IT-QGRVLERPRVCPKEVYDIMLGCWQRE---PQQRLNIKEIYK 277 (291)
T ss_pred Hh-CCCCCCCCccCCHHHHHHHHHHcccC---hhhCcCHHHHHH
Confidence 53 33444556778899999999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.28 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=208.9
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~----~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
..++|++.+.||+|+||+||+|.+ .++ .|++|.+... ........+..|+.++..++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 346889999999999999999987 444 4777776432 223345677888889999999999999998754 56
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
.++++||+++|+|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 78999999999999999876667899999999999999999999998 9999999999999999999999999998653
Q ss_pred CCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 828 NTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 828 ~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
... .......++..|++||++.+..++.++|||||||++|||++ |..||.+..+..+...+. ...+...+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTID 239 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCCCCCHH
Confidence 321 12223456778999999998889999999999999999998 999999887766554443 34455566778889
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+.+++.+||..+ |.+||++.++++
T Consensus 240 ~~~li~~c~~~~---p~~Rps~~el~~ 263 (279)
T cd05111 240 VYMVMVKCWMID---ENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHcCCC---cccCcCHHHHHH
Confidence 999999999999 999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=330.50 Aligned_cols=253 Identities=23% Similarity=0.262 Sum_probs=204.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCc-----
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN----- 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~----- 747 (935)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.+ +|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999976 578999998765433333345678899999999 46999999999877665
Q ss_pred eEEEEeeCCCCCHHHHHcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC-CCcEEEEeccc
Q 002331 748 LSIITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGL 822 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~----~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~VKL~DFGl 822 (935)
+|+||||+++ +|.+++... ...+++..++.++.||+.||.|||..+ |+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999986 788887542 245799999999999999999999998 999999999999998 89999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--------
Q 002331 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------- 893 (935)
Q Consensus 823 A~~~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~-------- 893 (935)
+..............+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8765433222233457889999998865 4578999999999999999999999988766554433211000
Q ss_pred --------------cc----CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 --------------RL----EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 --------------r~----~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.. .....++..+.+||.+||+.+ |.+||++.+++.|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~---P~~R~~~~eil~~~~ 293 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYD---PAKRISAKAALTHPY 293 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCC---hhhcCCHHHHhcCCC
Confidence 00 011347888999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=333.16 Aligned_cols=256 Identities=29% Similarity=0.501 Sum_probs=216.8
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE---------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeee
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~---------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~ 739 (935)
.+++..++|.+++.||+|+||.||++++ .+..||+|++.... .......+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 4667788999999999999999999964 13468999876442 334556788999999999 899999999
Q ss_pred cccccCCceEEEEeeCCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCC
Q 002331 740 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (935)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKP 804 (935)
+++......++||||+++++|.+++.+.. ..+++..+..++.||+.||.|||++| |+||||||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 165 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99999999999999999999999986532 24677888999999999999999998 99999999
Q ss_pred CCeeecCCCcEEEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 002331 805 PNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 881 (935)
Q Consensus 805 eNILLd~~g~VKL~DFGlA~~~~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~ 881 (935)
+|||++.++.+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999999999866432211 122345678999999999889999999999999999998 7899998888
Q ss_pred HHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 882 ~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.++...+. ...+...+..++..+++||.+||+.+ |.+||++.+|++.
T Consensus 246 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~---p~~Rps~~e~l~~ 292 (304)
T cd05101 246 EELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAI---PSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccC---hhhCCCHHHHHHH
Confidence 77776664 33445567788999999999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=321.14 Aligned_cols=250 Identities=32% Similarity=0.524 Sum_probs=214.2
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
...+|++.+.||+|+||.||++.+. +..+|||++...... ...+.+|++++++++||||+++++++......++||
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 3468999999999999999999774 788999988755443 235788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++++|.+++......+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999999999999765567889999999999999999999998 999999999999999999999999998765432211
Q ss_pred -CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 833 -SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 833 -~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||...........+.. ..+...+...+..+.+|+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-CCCCCCCCCCCHHHHHHHH
Confidence 122334568999999998889999999999999999998 9999998887777766542 2344456667899999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqH 932 (935)
+||+.+ |++||++.+++++
T Consensus 236 ~~l~~~---p~~Rp~~~~~l~~ 254 (256)
T cd05112 236 HCWKER---PEDRPSFSLLLHQ 254 (256)
T ss_pred HHcccC---hhhCCCHHHHHHh
Confidence 999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.96 Aligned_cols=252 Identities=31% Similarity=0.561 Sum_probs=210.2
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCce--EEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~--VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~ 747 (935)
+.+++|++.+.||+|+||.||+|.+ ++.. +++|.+... ........+.+|+.++.++ +|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 5578999999999999999999976 3443 567765432 2344556788999999999 89999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC
Q 002331 748 LSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~ 812 (935)
+|+||||+++++|.+++.+.+ ..+++..++.++.||+.||+|||++| |+||||||+|||++.+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~ 160 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 160 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC
Confidence 999999999999999996432 25788999999999999999999998 9999999999999999
Q ss_pred CcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 002331 813 WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 891 (935)
Q Consensus 813 g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~ 891 (935)
+.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+. .
T Consensus 161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~ 238 (303)
T cd05088 161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 238 (303)
T ss_pred CcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-c
Confidence 99999999998643211 11122234567999999988889999999999999999998 999999887777666553 2
Q ss_pred ccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 892 NRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 892 ~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
......+..+++.+.+||.+||+.+ |.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~---p~~Rp~~~~il~~ 276 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREK---PYERPSFAQILVS 276 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 2344556678899999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=336.93 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=219.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC------CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCC
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF------SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~------~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~ 746 (935)
+.|.-.+.||.|..+.|.++.+ .+..+|+|++..... .....+...+|+.||+++ .||+|+++.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4556667899999999998854 788999998865322 123345567899999998 8999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+++|+|.|+.|.|+++|... -.++++...+|++|++.|++|||.++ ||||||||+|||++++.+|||.|||+++.+
T Consensus 97 F~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceeecc
Confidence 999999999999999999763 47899999999999999999999999 999999999999999999999999999988
Q ss_pred cCCcccCCCCCCCCCccCcccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRN------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-- 898 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g------~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip-- 898 (935)
... ......||||.|+|||.+.. ..|+..+|+|++|+|||.|+.|.+||......-++..|...+..+.-|
T Consensus 174 ~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 174 EPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred CCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 665 33456899999999999864 357889999999999999999999999998888888886665555444
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+++...++||.+||+.| |.+|.+++|+|.|||
T Consensus 253 adis~~~KdLIsrlLqVd---p~~Ritake~LaHpf 285 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVD---PTKRITAKEALAHPF 285 (411)
T ss_pred hhccccHHHHHHHHHeeC---chhcccHHHHhcChH
Confidence 568899999999999999 999999999999998
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=329.59 Aligned_cols=252 Identities=32% Similarity=0.527 Sum_probs=213.4
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
+.+.+|.+.++||+|+||.||++.. .+..+|+|.+... .......+.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 5667899999999999999999963 3457888887643 344556789999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC
Q 002331 746 PNLSIITEFLPRGSLFRILHRPH--------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 811 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~--------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~ 811 (935)
+..+++|||+++++|.+++.+.. ..+++..++.++.||+.||.|||+++ |+||||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence 99999999999999999986532 24788999999999999999999998 999999999999999
Q ss_pred CCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHh
Q 002331 812 NWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAV 888 (935)
Q Consensus 812 ~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I 888 (935)
++.+||+|||++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999999999875532211 1122345678999999999999999999999999999998 89999888777766655
Q ss_pred hccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 889 GFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 889 ~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
. .......+..+++.+.+||.+||+.| |.+||++.+|++.
T Consensus 238 ~-~~~~~~~~~~~~~~~~~li~~cl~~~---P~~Rp~~~~l~~~ 277 (280)
T cd05092 238 T-QGRELERPRTCPPEVYAIMQGCWQRE---PQQRMVIKDIHSR 277 (280)
T ss_pred H-cCccCCCCCCCCHHHHHHHHHHccCC---hhhCCCHHHHHHH
Confidence 4 33445667788999999999999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=322.37 Aligned_cols=250 Identities=32% Similarity=0.545 Sum_probs=210.6
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEECC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
++..++|.+.+.||+|+||.||++.+.+ ..||+|++..... ....+.+|+.+++.++|+||+++++++.. +..++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYI 77 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEE
Confidence 4566789999999999999999998743 5799998765432 23467889999999999999999998754 56899
Q ss_pred EEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 751 ITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
||||+++++|.+++.+. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999999999653 345789999999999999999999998 999999999999999999999999999765433
Q ss_pred ccc-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 830 FLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 830 ~~~-~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+. .......+..++..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHE 234 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHH
Confidence 211 122345678999999998889999999999999999999 899999887776666553 33445567788999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+|.+||+.+ |.+||++++|++
T Consensus 235 li~~~l~~~---p~~Rp~~~~i~~ 255 (260)
T cd05069 235 LMKLCWKKD---PDERPTFEYIQS 255 (260)
T ss_pred HHHHHccCC---cccCcCHHHHHH
Confidence 999999999 999999999876
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=325.22 Aligned_cols=251 Identities=26% Similarity=0.442 Sum_probs=219.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcC-CCceeeeecccccCCceEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LV 751 (935)
++|.+.+.||.|+||.||++.. ++..||+|++..... .......+.+|+.++++++ |+||+++++++...+.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4789999999999999999976 688999999876433 3344567889999999998 99999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc-
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 830 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~- 830 (935)
|||+++++|.+++.+. ..+++..++.|+.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999999999764 37999999999999999999999999 9999999999999999999999999988654322
Q ss_pred -------------------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc
Q 002331 831 -------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 891 (935)
Q Consensus 831 -------------------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~ 891 (935)
.......++..|++||++.+..++.++|||+||+++|+|++|+.||...........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-- 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-- 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--
Confidence 11223457889999999988888999999999999999999999999887665555443
Q ss_pred ccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCH----HHHHhCcC
Q 002331 892 NRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQ----AQLSHKRF 934 (935)
Q Consensus 892 ~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa----~EILqHPF 934 (935)
.....++..+++.+.+||.+||+.+ |.+||++ +++++|||
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~~---p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 236 KLEYSFPPNFPPDAKDLIEKLLVLD---PQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred hcCCCCCCccCHHHHHHHHHHhcCC---HhhCCCcccCHHHHhcCCC
Confidence 4455677888999999999999999 9999999 99999999
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=322.94 Aligned_cols=253 Identities=29% Similarity=0.467 Sum_probs=213.7
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CC---ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NG---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g---~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
|..++|+..+.||+|+||.||+|+. .+ ..||||++.... .......+..|+.+++.++|+||+++++++...+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 4456889999999999999999976 23 368999876542 33445678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
.++||||+++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999999999776667899999999999999999999998 9999999999999999999999999987654
Q ss_pred CCcccC---CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 828 NTFLSS---KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 828 ~~~~~~---~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
...... .....+..|+|||++.+..++.++|||||||++|+|++ |+.||...+.......+.. ..+...+..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~ 237 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPS 237 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCCCH
Confidence 321111 11123457999999998889999999999999999997 9999998887777766643 334455567899
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+.++|.+||+.+ |.+||++.+|++.
T Consensus 238 ~~~~li~~c~~~~---p~~Rp~~~~i~~~ 263 (268)
T cd05063 238 AVYQLMLQCWQQD---RARRPRFVDIVNL 263 (268)
T ss_pred HHHHHHHHHcCCC---cccCcCHHHHHHH
Confidence 9999999999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=329.19 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=206.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|++|+||+|++ +++.||||++............+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 6799999999999999999976 57889999886654444445667889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC-CCcEEEEeccccccccCCcc
Q 002331 754 FLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 754 y~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~VKL~DFGlA~~~~~~~~ 831 (935)
|+++ +|.+++... ...+++..++.++.||+.||.|||+++ |+||||+|+||+++. ++.+||+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 9964 787777543 334688888999999999999999998 999999999999985 56799999999976543322
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-cc----------------
Q 002331 832 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NR---------------- 893 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~-~~---------------- 893 (935)
......+++.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+... ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 22334678899999998764 5789999999999999999999999887665444332100 00
Q ss_pred ------cc----CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 ------RL----EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 ------r~----~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+. .....+++.+.++|.+||+.+ |++||++.++++|||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~---P~~Rps~~~~l~~~~ 286 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLD---PSKRITARAALEHEY 286 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCC---hhhCcCHHHHhcCch
Confidence 00 012346788999999999999 999999999999998
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=350.97 Aligned_cols=258 Identities=32% Similarity=0.477 Sum_probs=216.6
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeec
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMG 740 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g 740 (935)
..+++..++|.++++||+|+||.||+|++. ++.||||++..... ......+.+|+.+|.++. |||||++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 457888899999999999999999999864 35799999976432 333456889999999996 999999999
Q ss_pred ccccCCceEEEEeeCCCCCHHHHHcCCC----------------------------------------------------
Q 002331 741 AVTRPPNLSIITEFLPRGSLFRILHRPH---------------------------------------------------- 768 (935)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~~~~---------------------------------------------------- 768 (935)
++.....++|||||+++|+|.+++++..
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999986532
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCC
Q 002331 769 ---------------------------------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 803 (935)
Q Consensus 769 ---------------------------------------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLK 803 (935)
..+++..++.|+.||+.||.|||..+ |+|||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlk 266 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLA 266 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCC
Confidence 13566778889999999999999998 9999999
Q ss_pred CCCeeecCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 002331 804 SPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 880 (935)
Q Consensus 804 PeNILLd~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~ 880 (935)
|+|||++.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999998653221 11223456788999999998889999999999999999998 899998766
Q ss_pred hHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 881 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 881 ~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
..+..........++..|..++..+.+||.+||+.+ |.+||++.+|++.
T Consensus 347 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~---P~~RPs~~ell~~ 395 (401)
T cd05107 347 MNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEK---FEIRPDFSQLVHL 395 (401)
T ss_pred chHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCC---hhHCcCHHHHHHH
Confidence 555544443344556677888999999999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=333.51 Aligned_cols=256 Identities=29% Similarity=0.440 Sum_probs=214.2
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~ 741 (935)
.+++.+++|.+.+.||+|+||.||++.+ .+..||||++..... ......+.+|+.+++++ +|+||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 4567778999999999999999999964 234799998775432 34456788999999999 79999999999
Q ss_pred cccCCceEEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 742 VTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
+...+.+++||||+.+++|.+++.+.. ..+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCC
Confidence 999999999999999999999997533 34899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCC
Q 002331 821 GLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEI 897 (935)
Q Consensus 821 GlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~i 897 (935)
|++........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||.................+...
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 99876543211 1122345678999999999889999999999999999998 99999887655444333323334455
Q ss_pred CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 898 PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 898 p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+...++.+.+||.+||..+ |++||++.+|++
T Consensus 266 ~~~~~~~~~~li~~cl~~~---p~~Rpt~~ell~ 296 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDAD---PLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCHHHHHHHHHHcCCC---chhCcCHHHHHH
Confidence 6678899999999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.47 Aligned_cols=254 Identities=31% Similarity=0.485 Sum_probs=210.9
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEECC------------------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWNG------------------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~g------------------~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPN 734 (935)
+..++|++.+.||+|+||.||+++... ..||+|++.... .......+.+|++++++++|||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCC
Confidence 356789999999999999999997532 458999877553 2345667889999999999999
Q ss_pred eeeeecccccCCceEEEEeeCCCCCHHHHHcCCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCC
Q 002331 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH----------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (935)
Q Consensus 735 IVkl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~----------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKP 804 (935)
|+++++++..++..++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+++ |+||||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp 158 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLAT 158 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccch
Confidence 9999999999999999999999999999986533 26899999999999999999999998 99999999
Q ss_pred CCeeecCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCC
Q 002331 805 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGMN 880 (935)
Q Consensus 805 eNILLd~~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT--G~~PF~~~~ 880 (935)
+|||++.++.+||+|||++........ ......++..|+|||++.+..++.++|||||||++|+|++ +..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999876533221 1223446778999999998889999999999999999998 778998877
Q ss_pred hHHHHHHhhcc------ccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 881 PMQVVGAVGFQ------NRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 881 ~~eil~~I~~~------~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
..+....+... ......+..++.++.+||.+||+.| |.+||++.+|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~---p~~Rpt~~el~~~ 293 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRD---EEDRPTFREIHLF 293 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccC---hhcCCCHHHHHHH
Confidence 66665544211 1112334567889999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=324.21 Aligned_cols=251 Identities=31% Similarity=0.519 Sum_probs=213.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEEC--C---ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADWN--G---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~~--g---~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
..+|++.+.||+|+||.||+|.+. + ..||||++... ........|..|+.+++.++||||+++++++..+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 467899999999999999999763 2 35999987654 34555678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||+++++|.+++......+++..++.++.|++.||.|||++| |+|+||||+|||++.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999999999876667899999999999999999999998 999999999999999999999999998765432
Q ss_pred ccc--CCCCC---CCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 830 FLS--SKSTA---GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 830 ~~~--~~s~~---GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
... ..... .+..|+|||.+.+..++.++|||||||++|||++ |..||...+.......+. ...+...+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 238 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPT 238 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCH
Confidence 111 01111 2357999999998889999999999999999886 999999888777776663 3344555677899
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+.+++.+||..+ |.+||++++|+..
T Consensus 239 ~~~~li~~~l~~~---p~~Rp~~~~i~~~ 264 (269)
T cd05065 239 ALHQLMLDCWQKD---RNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 9999999999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=323.67 Aligned_cols=241 Identities=26% Similarity=0.461 Sum_probs=204.6
Q ss_pred eeecCcEEEEEEEEC----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCC
Q 002331 684 IGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 759 (935)
Q Consensus 684 LG~G~fG~Vyka~~~----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGs 759 (935)
||+|+||.||+|.+. +..||||++.... .......+.+|+.++++++|+||+++++++.. ...++||||+++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 899999999999652 4469999886543 34455678999999999999999999998864 57899999999999
Q ss_pred HHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc---CCCC
Q 002331 760 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---SKST 836 (935)
Q Consensus 760 L~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~---~~s~ 836 (935)
|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 99999765567899999999999999999999998 999999999999999999999999999765432111 1112
Q ss_pred CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhh
Q 002331 837 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915 (935)
Q Consensus 837 ~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~ 915 (935)
.++..|+|||++.+..++.++|||||||++|+|++ |..||.......+...+. ...+..++..+++.+.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 23568999999998889999999999999999996 999999988877766554 3445667788899999999999999
Q ss_pred CCCCcCCCcCHHHHHhC
Q 002331 916 GWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 916 D~ssP~kRPSa~EILqH 932 (935)
+ |.+||++.+|++.
T Consensus 238 ~---~~~Rp~~~~i~~~ 251 (257)
T cd05115 238 K---WEDRPNFAKVEER 251 (257)
T ss_pred C---hhhCcCHHHHHHH
Confidence 9 9999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=362.61 Aligned_cols=246 Identities=30% Similarity=0.449 Sum_probs=218.8
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
|.-++.||.|+||.||.+++ +...||||++....- .......+.+|+..|++++|||+|.+-|+|-.+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55567899999999999976 678899999976543 445677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
| -|+-.+++.-...++-+..+..|+.+.+.||.|||+++ .||||||..||||++.|.|||+|||.+..... ..
T Consensus 108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----An 180 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP----AN 180 (948)
T ss_pred H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc----hh
Confidence 9 55888888766678999999999999999999999999 99999999999999999999999999986643 35
Q ss_pred CCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC-CcCcHHHHHHHH
Q 002331 835 STAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-KELDPLVARIIW 910 (935)
Q Consensus 835 s~~GT~~Y~APEvl~---g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip-~~ls~~L~dLI~ 910 (935)
+++|||.|||||++. .+.|+-++|||||||+..||...++|+..++.+..+..|... ..+.++ ...+..+++|+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCCCCCchhHHHHHHHHH
Confidence 689999999999974 467899999999999999999999999999999999888644 444444 458899999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.||++- |.+||+.+++|+|+|
T Consensus 260 ~CLqKi---pqeRptse~ll~H~f 280 (948)
T KOG0577|consen 260 SCLQKI---PQERPTSEELLKHRF 280 (948)
T ss_pred HHHhhC---cccCCcHHHHhhcch
Confidence 999999 999999999999998
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=365.85 Aligned_cols=249 Identities=33% Similarity=0.508 Sum_probs=218.8
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccC--CCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc--eEEE
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN--LSII 751 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~--~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~--l~LV 751 (935)
.++..+||+|+|-+||+|.+ .|..||--.++..+ .....+..|..|+.+|+.|+|||||++|.+|.+... +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 35677899999999999966 56666643333322 244556889999999999999999999999987766 8899
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec-CCCcEEEEeccccccccCCc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~VKL~DFGlA~~~~~~~ 830 (935)
+|.+..|+|+.|+++. +..+.+.+..|++||++||.|||.+.|||||||||-+||+|+ ..|.|||+|+|+|.......
T Consensus 122 TEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999999874 578999999999999999999999999999999999999998 56999999999999887654
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC-CCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~-~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
. ....|||.|||||++. ..|++.+||||||++|.||+|+.+||. ..++.++++++.....+-.+.+--++++++||
T Consensus 201 a--ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 201 A--KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred c--ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHH
Confidence 4 3478999999999998 779999999999999999999999997 57899999999877777777777899999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||... ..||++.|||.|||
T Consensus 278 ekCl~~~----~~R~sa~eLL~d~F 298 (632)
T KOG0584|consen 278 EKCLATK----SERLSAKELLKDPF 298 (632)
T ss_pred HHHhcCc----hhccCHHHHhhChh
Confidence 9999875 89999999999998
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=328.03 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=202.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
.+|.+.+.||+|+||.||+|.. +++.||||++...... .....+.+|+.+++.++|+||+++++++..++..|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 6799999999999999999975 5889999998654322 223356789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
|+. ++|.+++......+.+..+..++.||+.||.|||.++ |+|+||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 996 5777776554456788888899999999999999998 9999999999999999999999999987654332233
Q ss_pred CCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHh-hcccc-----------------
Q 002331 834 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAV-GFQNR----------------- 893 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~-eil~~I-~~~~~----------------- 893 (935)
....+++.|+|||++.+. .++.++|||||||++|+|++|..||...... +.+..+ .....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 345678999999998764 4788999999999999999999999865432 111111 00000
Q ss_pred ---ccCCC---------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 ---RLEIP---------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 ---r~~ip---------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
....+ ...++.+.++|.+||..| |.+||++.+++.|||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d---p~~R~t~~~~l~h~~ 290 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMF---PKDRISAQDALLHPY 290 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcC---cccCcCHHHHhcCCC
Confidence 00000 013578999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=331.22 Aligned_cols=255 Identities=30% Similarity=0.489 Sum_probs=209.5
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEECC----------------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWNG----------------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~g----------------~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNI 735 (935)
|++.++|++.+.||+|+||.||++.+.+ ..||||++... ........+.+|++++++++|+||
T Consensus 1 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred CCchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCc
Confidence 3567899999999999999999986532 24899988654 334456678999999999999999
Q ss_pred eeeecccccCCceEEEEeeCCCCCHHHHHcCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCC
Q 002331 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-----------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (935)
Q Consensus 736 Vkl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~-----------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKP 804 (935)
+++++++...+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp 157 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLAT 157 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccCh
Confidence 999999999999999999999999999985421 23678889999999999999999998 99999999
Q ss_pred CCeeecCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCC
Q 002331 805 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGMN 880 (935)
Q Consensus 805 eNILLd~~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT--G~~PF~~~~ 880 (935)
+|||++.++.+||+|||++........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999999876533211 1122345678999999998889999999999999999988 678998877
Q ss_pred hHHHHHHhhc------cccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 881 PMQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 881 ~~eil~~I~~------~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
..+....+.. .......+..+++.+.+||.+||..+ |.+||++++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~---p~~RPs~~~i~~~ 292 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRD---IKDRPTFNKIHHF 292 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCC---chhCcCHHHHHHH
Confidence 7665543321 11123345567899999999999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.71 Aligned_cols=256 Identities=30% Similarity=0.464 Sum_probs=209.2
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeeccc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 742 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~ 742 (935)
|+++.++|++++.||+|+||.||+|.+ .++.||||+++... .......+.+|+.+|.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 567788999999999999999999964 45789999987543 233456788999999999 689999999987
Q ss_pred ccC-CceEEEEeeCCCCCHHHHHcCCC-----------------------------------------------------
Q 002331 743 TRP-PNLSIITEFLPRGSLFRILHRPH----------------------------------------------------- 768 (935)
Q Consensus 743 ~~~-~~l~LVmEy~~gGsL~dlL~~~~----------------------------------------------------- 768 (935)
... ..+++||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 46889999999999999985421
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc--cC
Q 002331 769 -------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SS 833 (935)
Q Consensus 769 -------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~~ 833 (935)
..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 23577788899999999999999998 99999999999999999999999999876532211 11
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qC 912 (935)
....++..|+|||++.+..++.++|||||||++|+|++ |..||.................+...|..+++.+.+++.+|
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 22345677999999999889999999999999999996 89999876543333332233445566777889999999999
Q ss_pred HhhCCCCcCCCcCHHHHHhC
Q 002331 913 WQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 913 L~~D~ssP~kRPSa~EILqH 932 (935)
|+.+ |.+||++.+|++|
T Consensus 319 l~~~---p~~Rps~~eil~~ 335 (343)
T cd05103 319 WHGE---PSQRPTFSELVEH 335 (343)
T ss_pred ccCC---hhhCcCHHHHHHH
Confidence 9999 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=326.60 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=206.9
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeC
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
|++.+.||.|++|.||+|.+ +|+.||||++............+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999976 6889999998765444334456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCC
Q 002331 756 PRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 756 ~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
+ ++|.+++.... ..+++..++.++.||+.||.|||+++ ++||||+|+||+++.++.+||+|||++...........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 5 58999886533 46899999999999999999999998 99999999999999999999999999976543322223
Q ss_pred CCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc---------------------
Q 002331 835 STAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------------------- 892 (935)
Q Consensus 835 s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~--------------------- 892 (935)
...++..|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+....
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 34568899999988764 46889999999999999999999998876644332221100
Q ss_pred ------cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 ------RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 ------~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
........++..+.++|.+||+.+ |.+||+++++++|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~Rpt~~~il~~~~ 282 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYD---PAKRISAKAALQHPY 282 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCC---hhhCcCHHHHhcCCC
Confidence 000122456789999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=328.40 Aligned_cols=248 Identities=31% Similarity=0.509 Sum_probs=208.9
Q ss_pred CeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 677 DLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
+|++.+.||+|+||.||+|... ...+++|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999753 2468888776543 2344567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCC
Q 002331 750 IITEFLPRGSLFRILHRP-----------------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 806 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~-----------------------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeN 806 (935)
++|||+.+++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence 999999999999988532 134788899999999999999999998 9999999999
Q ss_pred eeecCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHH
Q 002331 807 LLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQ 883 (935)
Q Consensus 807 ILLd~~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~e 883 (935)
|||+.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+..+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999876432211 1222345678999999988889999999999999999998 999999888877
Q ss_pred HHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 884 il~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+...+. .......+..++..+.++|.+||+.+ |.+||++.+|++
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~---P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQE---PDKRPTFADISK 281 (290)
T ss_pred HHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCC---cccCCCHHHHHH
Confidence 666553 33445567788999999999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=325.65 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=211.2
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeC
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
|++.+.||.|++|.||++.. +++.+++|++............+.+|+.++++++|+||+++++++..++.+++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778899999999999976 5888999998766554445567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCC
Q 002331 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (935)
Q Consensus 756 ~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s 835 (935)
++ +|.+++......+++..+..++.||+.||.|||..+ |+|+||||+||+++.++.+||+|||.+............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 75 888888765567899999999999999999999999 999999999999999999999999999876554322233
Q ss_pred CCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--------------------
Q 002331 836 TAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-------------------- 894 (935)
Q Consensus 836 ~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r-------------------- 894 (935)
..++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5678899999999876 6899999999999999999999999887765544333211000
Q ss_pred --------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 --------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 --------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+...++..++++|.+||+.| |.+||++.+|+.|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~---P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYD---PHKRITAEQALAHPY 282 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccC---cccCcCHHHHhhCCC
Confidence 0012346789999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=327.76 Aligned_cols=252 Identities=29% Similarity=0.472 Sum_probs=212.6
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
+..++|++.+.||+|+||.||++.+ .+..||||++.... .......+.+|+.+++.++||||+++++++.++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4567899999999999999999976 35689999886543 344556788999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCC
Q 002331 746 PNLSIITEFLPRGSLFRILHRPH---------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~---------------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKP 804 (935)
...++||||+++++|.+++.... ..+++..++.++.||+.||.|||..+ |+||||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p 158 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLAT 158 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccH
Confidence 99999999999999999986321 24678888999999999999999998 99999999
Q ss_pred CCeeecCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 002331 805 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 881 (935)
Q Consensus 805 eNILLd~~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~ 881 (935)
+|||++.++.+||+|||++........ .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999875432211 1122234567999999998899999999999999999997 8889998888
Q ss_pred HHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 882 ~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.+....+. .......+..++..+.+||.+||+.+ |.+||++.||++
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~---p~~Rpt~~el~~ 284 (288)
T cd05050 239 EEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKL---PSDRPSFASINR 284 (288)
T ss_pred HHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccC---cccCCCHHHHHH
Confidence 87776664 23334456778999999999999999 999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=318.07 Aligned_cols=243 Identities=30% Similarity=0.542 Sum_probs=207.6
Q ss_pred EeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCCHH
Q 002331 683 RIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL~ 761 (935)
+||+|+||.||+|.. .+..||+|++.... .......+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 589999999999976 56789999876543 3444556889999999999999999999999999999999999999999
Q ss_pred HHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC-CCCCCCC
Q 002331 762 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS-KSTAGTP 840 (935)
Q Consensus 762 dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~-~s~~GT~ 840 (935)
+++......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......... ....++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 999765567899999999999999999999998 9999999999999999999999999987544322211 1223456
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCC
Q 002331 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSS 919 (935)
Q Consensus 841 ~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ss 919 (935)
.|+|||++.+..++.++||||||+++|+|++ |..||...........+. ...+...+..++..+.++|.+||+.+
T Consensus 159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~--- 234 (250)
T cd05085 159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYK--- 234 (250)
T ss_pred cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccC---
Confidence 7999999998889999999999999999998 999999887777666554 33455667778999999999999999
Q ss_pred cCCCcCHHHHHhC
Q 002331 920 LHIRTSQAQLSHK 932 (935)
Q Consensus 920 P~kRPSa~EILqH 932 (935)
|++||++.++++.
T Consensus 235 p~~Rp~~~~l~~~ 247 (250)
T cd05085 235 PENRPKFSELQKE 247 (250)
T ss_pred cccCCCHHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=329.24 Aligned_cols=254 Identities=24% Similarity=0.296 Sum_probs=203.7
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC------
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~------ 746 (935)
.++|++.+.||+|+||.||+|.. +++.||||++............+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 46799999999999999999976 5789999988755433333345568999999999999999999876543
Q ss_pred --ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 747 --NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 747 --~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
..++||||+.+ +|.+++......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 35999999965 888888765567899999999999999999999998 9999999999999999999999999997
Q ss_pred cccCCcc----cCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----
Q 002331 825 LKHNTFL----SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----- 894 (935)
Q Consensus 825 ~~~~~~~----~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r----- 894 (935)
....... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+.......+......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 6543221 112345788999999987654 688999999999999999999999887665433322110000
Q ss_pred ------------cCCC-------------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 ------------LEIP-------------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ------------~~ip-------------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++ ...+..+.+||.+||+.| |.+||+++++|+|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~---P~~R~t~~e~l~h~~ 309 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLD---PAKRIDADTALNHDF 309 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCC---hhhccCHHHHhcCCC
Confidence 0011 113567889999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=325.65 Aligned_cols=251 Identities=23% Similarity=0.328 Sum_probs=206.9
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|++.+.||.|++|.||+|++ +++.||||++...... .....+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588999999999999999987 5889999998765322 2234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 755 LPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 755 ~~gGsL~dlL~~~~--~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 985 8888876533 46899999999999999999999998 999999999999999999999999999765443222
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc----------------ccc
Q 002331 833 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------------RRL 895 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~----------------~r~ 895 (935)
.....++..|++||++.+. .++.++|||+|||++|+|++|..||.+.+..+....+.... ...
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 3345678899999998664 46889999999999999999999999877655443321100 000
Q ss_pred C-----------CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 E-----------IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ~-----------ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. +...++..+.++|.+||+.| |.+||++.+|++|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~---p~~R~~~~~~l~~~~ 283 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLN---PELRISAHDALQHPW 283 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCC---cccCCCHHHHhcCCC
Confidence 0 11245788999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=323.33 Aligned_cols=253 Identities=30% Similarity=0.507 Sum_probs=213.1
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEECC-----ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~g-----~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
++..++|.+.+.||+|+||.||+|.+.. ..|+||...... .....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 4556789999999999999999997632 368889775442 24455678899999999999999999998876 4
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
..++||||+++++|.+++.+....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeec
Confidence 578999999999999999876567899999999999999999999998 999999999999999999999999998765
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 827 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 827 ~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
..... ......+...|+|||.+.+..++.++|||||||++|+|++ |..||......+....+. ...+...+..++..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPT 236 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHH
Confidence 43321 1222334568999999988889999999999999999986 999999887776665554 33455677889999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+.++|.+||..+ |.+||++.++++.
T Consensus 237 ~~~li~~~l~~~---P~~Rpt~~~~~~~ 261 (270)
T cd05056 237 LYSLMTKCWAYD---PSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 999999999999 9999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.38 Aligned_cols=252 Identities=28% Similarity=0.374 Sum_probs=211.6
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
+..++|++.+.||+|+||+||++.+ .++.||+|++.... .......+.+|+++++.++||||+++++++...+.+++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3457899999999999999999987 48899999876543 33456678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
||||+++++|.+++.+. ..+++..+..++.+++.||.|||+ ++ |+||||||+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999999998763 468999999999999999999997 56 999999999999999999999999998654322
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-----------HHHHHhhccccccCCC
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-----------QVVGAVGFQNRRLEIP 898 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~-----------eil~~I~~~~~r~~ip 898 (935)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+. ...+..++
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 234 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRLP 234 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCCC
Confidence 123457899999999998888899999999999999999999999865542 2222221 12223333
Q ss_pred Cc-CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 KE-LDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 ~~-ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.. ++..+.+||.+||+.| |.+||++.++++|+|
T Consensus 235 ~~~~~~~~~~li~~~l~~d---p~~Rpt~~e~~~~~~ 268 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKD---PTERPTPQQLCAMPP 268 (284)
T ss_pred chhcCHHHHHHHHHHhcCC---cccCcCHHHHhcCcc
Confidence 33 7889999999999999 999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=323.97 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=201.7
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccC--CceEEEE
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP--PNLSIIT 752 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~--~~l~LVm 752 (935)
|++.+.||+|+||.||+|.. +++.||||++........ .....+|+.++.++ +|+||+++++++.+. +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67889999999999999976 678899998875432222 22345788899988 499999999999887 8899999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++ +|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||+++. +.+||+|||++........
T Consensus 80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 80 ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99974 788887665557899999999999999999999998 999999999999999 9999999999987644322
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc----------------ccc
Q 002331 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------------RRL 895 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~----------------~r~ 895 (935)
.....++..|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+.... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 233567899999997654 556889999999999999999999998877655433321100 011
Q ss_pred CC-----------CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 EI-----------PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ~i-----------p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+ ...++..+.+||.+||+.+ |.+||+++++++|||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~R~~~~~~l~~~~ 281 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYD---PDERITAKQALRHPY 281 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccC---cccccCHHHHhhCCC
Confidence 11 1346789999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.35 Aligned_cols=244 Identities=24% Similarity=0.365 Sum_probs=189.1
Q ss_pred EEEeeecCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccc--cCCceEEEEee
Q 002331 681 GERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--RPPNLSIITEF 754 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~--~~~~l~LVmEy 754 (935)
+.+||+|+||.||+|+. .+..||+|.+...... ..+.+|+.+++.++||||+++++++. .+..+++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 46799999999999975 3467999988655432 34678999999999999999999884 35568999999
Q ss_pred CCCCCHHHHHcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee----cCCCcEEEEeccc
Q 002331 755 LPRGSLFRILHR--------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGL 822 (935)
Q Consensus 755 ~~gGsL~dlL~~--------~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL----d~~g~VKL~DFGl 822 (935)
+.+ +|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 965 77777642 1235788999999999999999999998 9999999999999 5678999999999
Q ss_pred cccccCCcc---cCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChH----------HHHHHh
Q 002331 823 SRLKHNTFL---SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM----------QVVGAV 888 (935)
Q Consensus 823 A~~~~~~~~---~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~----------eil~~I 888 (935)
++....... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||...... +.....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 987644321 12345689999999998764 5789999999999999999999999754321 000000
Q ss_pred hccc-----------------------ccc------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCc
Q 002331 889 GFQN-----------------------RRL------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKR 933 (935)
Q Consensus 889 ~~~~-----------------------~r~------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHP 933 (935)
.... ... ......+..+.+||.+||+.| |.+|||+.|+|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d---P~~R~t~~e~l~hp 315 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMD---PTKRITSEQALQDP 315 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccC---cccccCHHHHhcCC
Confidence 0000 000 001123567889999999999 99999999999999
Q ss_pred C
Q 002331 934 F 934 (935)
Q Consensus 934 F 934 (935)
|
T Consensus 316 ~ 316 (317)
T cd07867 316 Y 316 (317)
T ss_pred C
Confidence 9
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=320.60 Aligned_cols=241 Identities=29% Similarity=0.488 Sum_probs=204.3
Q ss_pred EEeeecCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCC
Q 002331 682 ERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 756 (935)
++||+|+||.||+|.+. +..||+|.+...... .....+.+|+.+++.+.|+||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 36999999999999752 267999998766543 44567889999999999999999999876 456899999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC---
Q 002331 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--- 833 (935)
Q Consensus 757 gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~--- 833 (935)
+++|.+++.+.. .+++..++.++.|++.||.|||..+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 999999997644 7899999999999999999999998 9999999999999999999999999998654322111
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qC 912 (935)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..++...+. ...+...+..++..++++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHH
Confidence 11223467999999998889999999999999999998 999999888777766654 3345567778899999999999
Q ss_pred HhhCCCCcCCCcCHHHHHh
Q 002331 913 WQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 913 L~~D~ssP~kRPSa~EILq 931 (935)
|+.+ |.+||++.+|++
T Consensus 235 l~~~---p~~Rp~~~~l~~ 250 (257)
T cd05060 235 WKYR---PEDRPTFSELES 250 (257)
T ss_pred hcCC---hhhCcCHHHHHH
Confidence 9999 999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=324.09 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=212.8
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEEC------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc-
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR- 744 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~- 744 (935)
.+..++|++.+.||+|+||.||+|.+. +..|++|++... ........+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 356789999999999999999999763 477889887643 344556778899999999999999999998665
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEE
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPH-------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 817 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~-------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL 817 (935)
+...++++||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEE
Confidence 567899999999999999986532 45889999999999999999999998 999999999999999999999
Q ss_pred EeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccc
Q 002331 818 SDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRR 894 (935)
Q Consensus 818 ~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r 894 (935)
+|||+++....... ......++..|+|||++.+..++.++|||||||++|++++ |+.||...++.++...+. ...+
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGYR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-cCCC
Confidence 99999986533211 1122345678999999999889999999999999999998 999999888877666554 2334
Q ss_pred cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 895 LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 895 ~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+..+..+++.+.++|.+||..+ |++||++.++++
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~---p~~Rps~~~~~~ 271 (280)
T cd05043 238 LAQPINCPDELFAVMACCWALD---PEERPSFSQLVQ 271 (280)
T ss_pred CCCCCcCCHHHHHHHHHHcCCC---hhhCCCHHHHHH
Confidence 4456678899999999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=320.81 Aligned_cols=244 Identities=31% Similarity=0.521 Sum_probs=210.0
Q ss_pred EEeeecCcEEEEEEEEC---Cc--eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCC
Q 002331 682 ERIGLGSYGEVYHADWN---GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~---g~--~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 756 (935)
+.||+|+||.||+|.+. ++ .||||.+...... .....+.+|+.++++++||||+++++.+.. ..+++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 35899999999999762 22 6899998776544 556788999999999999999999999988 88999999999
Q ss_pred CCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc---c
Q 002331 757 RGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL---S 832 (935)
Q Consensus 757 gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~---~ 832 (935)
+++|.+++.+.. ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++........ .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999997654 56899999999999999999999998 99999999999999999999999999987643211 1
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~q 911 (935)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+.........+..++..+.++|.+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 122456778999999999899999999999999999998 9999998888877766654445555677789999999999
Q ss_pred HHhhCCCCcCCCcCHHHHHhC
Q 002331 912 CWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 912 CL~~D~ssP~kRPSa~EILqH 932 (935)
||+.+ |.+||++.+|++.
T Consensus 237 ~l~~~---p~~Rps~~~~~~~ 254 (257)
T cd05040 237 CWAHN---PADRPTFAALREF 254 (257)
T ss_pred HCCCC---cccCCCHHHHHHH
Confidence 99999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=330.60 Aligned_cols=249 Identities=29% Similarity=0.430 Sum_probs=211.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
+.|.+.+.||+|+||.||+|.+ .++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5688999999999999999976 688999999865433 3344567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||++ |+|.+++......+++..+..++.||+.||.|||..+ |+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 9997 5777777654557899999999999999999999998 999999999999999999999999998755322
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
....++..|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+.........+..++..+.++|
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV 247 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence 2356788999999874 355788999999999999999999999988877665555333222223345788999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||+.+ |.+||++.+|++|||
T Consensus 248 ~~~l~~~---p~~Rp~~~~il~~~~ 269 (307)
T cd06607 248 DSCLQKI---PQDRPSSEELLKHRF 269 (307)
T ss_pred HHHhcCC---hhhCcCHHHHhcChh
Confidence 9999999 999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=360.89 Aligned_cols=252 Identities=28% Similarity=0.438 Sum_probs=222.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEECC--ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~g--~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
+.|.|+..||.|+||.||++.... -..|.|+|... .+..++.+.-|+.||..+.||+||++++.|..++.+||+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 457788889999999999997543 33466776544 35678889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
||.||-+..++-.-+..+.+.++..+++|++.||.|||+++ |||||||..|||++-+|.|+|+|||.+..........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99999999998877889999999999999999999999999 9999999999999999999999999987655444556
Q ss_pred CCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCcCcHHHHH
Q 002331 834 KSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVAR 907 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~-r~~ip~~ls~~L~d 907 (935)
.++.|||+|||||+.. ..+|++++|||||||+|.||..+.+|-...+++.++-++..... .+-.|...+..+.+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 6789999999999864 56799999999999999999999999999999999888753332 23457888999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++.+||.+| |..||++.+||+|||
T Consensus 268 fLk~cL~Kn---p~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 268 FLKRCLVKN---PRNRPPAAQLLKHPF 291 (1187)
T ss_pred HHHHHHhcC---CccCCCHHHHhhCcc
Confidence 999999999 999999999999999
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.18 Aligned_cols=251 Identities=30% Similarity=0.537 Sum_probs=212.6
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
|++..++|++.+.||+|+||.||++.+ .+..||+|.+.... .....+.+|+.+++.++|+||+++++.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 467789999999999999999999976 45679999876432 235678899999999999999999999887 7789
Q ss_pred EEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++|||+++++|.+++.+ ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999999965 3456788899999999999999999998 99999999999999999999999999876543
Q ss_pred Cccc-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHH
Q 002331 829 TFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 829 ~~~~-~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
.... .....++..|+|||++.+..++.++|+|||||++|+|++ |+.||...+.......+. .......+...+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHHH
Confidence 2211 122345677999999998889999999999999999998 999999887776666553 3334455677889999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+++.+||+.+ |.+||++.++++
T Consensus 234 ~~i~~~l~~~---p~~Rp~~~~l~~ 255 (260)
T cd05073 234 NIMMRCWKNR---PEERPTFEYIQS 255 (260)
T ss_pred HHHHHHcccC---cccCcCHHHHHH
Confidence 9999999999 999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.83 Aligned_cols=248 Identities=28% Similarity=0.412 Sum_probs=210.0
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeC
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
|.....||+|+||.||++.. .+..||||++.... ......+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 44456799999999999976 67889999876543 234556889999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCC
Q 002331 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (935)
Q Consensus 756 ~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s 835 (935)
++++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++............
T Consensus 102 ~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 102 EGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 99999998865 35889999999999999999999998 999999999999999999999999998765433222334
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCcCcHHHHHHHHHHHh
Q 002331 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWECWQ 914 (935)
Q Consensus 836 ~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~-~~r~~ip~~ls~~L~dLI~qCL~ 914 (935)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+... .........++..+.++|.+||.
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 257 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV 257 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHcc
Confidence 56889999999998888999999999999999999999999988776655544211 11222233578899999999999
Q ss_pred hCCCCcCCCcCHHHHHhCcC
Q 002331 915 TGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 915 ~D~ssP~kRPSa~EILqHPF 934 (935)
.| |.+||+++++++|||
T Consensus 258 ~~---P~~Rpt~~~il~~~~ 274 (292)
T cd06658 258 RE---PSQRATAQELLQHPF 274 (292)
T ss_pred CC---hhHCcCHHHHhhChh
Confidence 99 999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=325.25 Aligned_cols=249 Identities=27% Similarity=0.476 Sum_probs=211.4
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC---CCceeeeecccccCCceEEE
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~---HPNIVkl~g~~~~~~~l~LV 751 (935)
.|++.+.||.|+||.||+|.+ .++.||||.+.... .......+.+|+.+++.++ ||||+++++++......++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 467788999999999999986 67899999886543 2334567888999999996 99999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999999865 36899999999999999999999998 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC-cCcHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-ELDPLVARII 909 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~-~ls~~L~dLI 909 (935)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+. ......++. .++.++.++|
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-KSKPPRLEDNGYSKLLREFV 235 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc-cCCCCCCCcccCCHHHHHHH
Confidence 3344578899999999865 456889999999999999999999998877665544332 222333444 3788999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||+.| |.+||++.++++|+|
T Consensus 236 ~~~l~~~---p~~R~~~~~il~~~~ 257 (277)
T cd06917 236 AACLDEE---PKERLSAEELLKSKW 257 (277)
T ss_pred HHHcCCC---cccCcCHHHHhhChH
Confidence 9999999 999999999999998
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=328.38 Aligned_cols=253 Identities=30% Similarity=0.485 Sum_probs=207.7
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEEC------------------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWN------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~------------------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPN 734 (935)
++.++|++.+.||+|+||.||++++. ...||||++.... .......+.+|+.+++.++|+|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCC
Confidence 45678999999999999999998542 2358999876543 3445667889999999999999
Q ss_pred eeeeecccccCCceEEEEeeCCCCCHHHHHcCCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCC
Q 002331 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH----------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (935)
Q Consensus 735 IVkl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~----------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKP 804 (935)
|+++++++...+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp 158 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLAT 158 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCh
Confidence 9999999999999999999999999999986532 23667889999999999999999999 99999999
Q ss_pred CCeeecCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCC
Q 002331 805 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGMN 880 (935)
Q Consensus 805 eNILLd~~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT--G~~PF~~~~ 880 (935)
+|||++.++.+||+|||++........ ......++..|++||++.+..++.++|||||||++|||++ |..||...+
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 999999999999999999876533211 1112334678999999888889999999999999999998 779998877
Q ss_pred hHHHHHHhhc------cccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 881 PMQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 881 ~~eil~~I~~------~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
..+....... .......+..+++.+.+||.+||+.| |.+||++.+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~---p~~Rp~~~~i~~ 292 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRN---AKERPSFQEIHA 292 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCC---cccCCCHHHHHH
Confidence 6665543211 11123345668899999999999999 999999999976
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=348.34 Aligned_cols=252 Identities=34% Similarity=0.506 Sum_probs=201.7
Q ss_pred CCCeeEEEEeeecCcEEEEEEEECC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc-eEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-LSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~-l~LVm 752 (935)
.+.|.-..+||+|+||.||+|...+ +.||||++....... ..+|..|+.++.+++|||+|+++|||.+.+. .+||+
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY 151 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY 151 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence 3667777889999999999998754 899999876654332 4459999999999999999999999999884 99999
Q ss_pred eeCCCCCHHHHHcCCCC-CCCHHHHHHHHHHHHHHHHHHHhcC-CCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 753 EFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTST-PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~-~lse~~il~Ia~QIa~AL~yLHs~g-~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
|||++|+|.++|+.... .++|..+++|+.++|+||+|||... ++|||||||+.|||||+++..||+|||+++......
T Consensus 152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD 231 (361)
T ss_pred EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence 99999999999987655 8999999999999999999999954 489999999999999999999999999997654311
Q ss_pred ccCCCC-CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hHHHHH---Hhhccc-----cccCCC
Q 002331 831 LSSKST-AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVG---AVGFQN-----RRLEIP 898 (935)
Q Consensus 831 ~~~~s~-~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~---~~eil~---~I~~~~-----~r~~ip 898 (935)
...... .||..|+|||.+.....+.++||||||++|.||++|+.+..... ...... ...... ..+.+.
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~ 311 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLK 311 (361)
T ss_pred cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCcc
Confidence 111222 79999999999998889999999999999999999998876432 111111 111111 111111
Q ss_pred -CcCc-----HHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 899 -KELD-----PLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 899 -~~ls-----~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
...+ ..+..+..+|++.+ |.+||++.++++
T Consensus 312 ~~~~~~~~~~~~~~~~a~~C~~~~---~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 312 EGEYPDEKEVKKLAELALRCLRPD---PKERPTMSQVVK 347 (361)
T ss_pred CCCCChHHHHHHHHHHHHHHcCcC---CCcCcCHHHHHH
Confidence 1222 23678889999999 999999999865
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=335.81 Aligned_cols=257 Identities=30% Similarity=0.496 Sum_probs=216.7
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeee
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl 738 (935)
.++++...+|++++.||+|+||.||++.+. ...||+|.+... ........+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 456777789999999999999999999752 236899987643 3344567788999999999 89999999
Q ss_pred ecccccCCceEEEEeeCCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCC
Q 002331 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 803 (935)
Q Consensus 739 ~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLK 803 (935)
++++...+.++++|||+++++|.+++.+.. ..+++..++.++.||+.||.|||.+| |+|||||
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlk 161 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLA 161 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccc
Confidence 999999999999999999999999986522 24778888999999999999999998 9999999
Q ss_pred CCCeeecCCCcEEEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 002331 804 SPNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 880 (935)
Q Consensus 804 PeNILLd~~g~VKL~DFGlA~~~~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~ 880 (935)
|+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999765432211 122234567999999999999999999999999999998 889999888
Q ss_pred hHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 881 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 881 ~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
..+....+. .......+..++..+.+||.+||+.+ |.+||++.+|+++
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~---p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAV---PSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccC---hhhCcCHHHHHHH
Confidence 777766654 33455667788999999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=327.22 Aligned_cols=253 Identities=29% Similarity=0.479 Sum_probs=216.3
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
..+.|++.+.||.|+||.||++.+. +..|++|++..... ....+.+|+++++.++|+||+++++.+......++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4466888899999999999999874 88999999876543 455678999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
+||+++++|.+++......+++..++.++.||+.||.|||+.| |+|+||+|+||+++.++.+||+|||++........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999999875447899999999999999999999998 99999999999999999999999998875543322
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCcCcHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIW 910 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~-r~~ip~~ls~~L~dLI~ 910 (935)
......++..|++||++.+..++.++|+||||+++|+|++|..||...++......+..... ....+..++..+.++|.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 22344578899999999988899999999999999999999999998877655554432221 11223347899999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||+.+ |.+||++.+|++|+|
T Consensus 252 ~~l~~~---p~~Rpt~~~il~~~~ 272 (286)
T cd06614 252 KCLVKD---PEKRPSAEELLQHPF 272 (286)
T ss_pred HHhccC---hhhCcCHHHHhhChH
Confidence 999999 999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=381.86 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=232.0
Q ss_pred ccccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 668 VCECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 668 ~~~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
........++|.|+++||+|+||.|.++++ .++.||+|++.+-... .....-|..|..+|..-+.+=|++++.+|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 345667789999999999999999999977 5778999998764432 3344568889999998899999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
++++|+|||||+||+|..++.+.. ++++.+++.++..|+.||.-||+.| +|||||||+|||||..|||||+|||.+.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHH
Confidence 999999999999999999998876 8999999999999999999999999 9999999999999999999999999887
Q ss_pred ccc-CCcccCCCCCCCCCccCccccc----C-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC
Q 002331 825 LKH-NTFLSSKSTAGTPEWMAPEVLR----N-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (935)
Q Consensus 825 ~~~-~~~~~~~s~~GT~~Y~APEvl~----g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip 898 (935)
.+. +....+...+|||.|++||++. + ..|+..+|||||||++|||+.|..||+...-.+.+.+|...+..+.+|
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 665 4455566789999999999985 3 568999999999999999999999999999999999998887888888
Q ss_pred --CcCcHHHHHHHHHHHhhCCCCcCCCcC---HHHHHhCcC
Q 002331 899 --KELDPLVARIIWECWQTGWSSLHIRTS---QAQLSHKRF 934 (935)
Q Consensus 899 --~~ls~~L~dLI~qCL~~D~ssP~kRPS---a~EILqHPF 934 (935)
..+++..++||++.++. |+.|.. ++++-.|||
T Consensus 304 ~~~~VSeeakdLI~~ll~~----~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 304 DETDVSEEAKDLIEALLCD----REVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred cccccCHHHHHHHHHHhcC----hhhhcccccHHHHHhCcc
Confidence 56899999999999965 688888 999999998
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=319.18 Aligned_cols=243 Identities=27% Similarity=0.440 Sum_probs=209.8
Q ss_pred eeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCCH
Q 002331 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (935)
Q Consensus 684 LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL 760 (935)
||.|+||.||++++ +++.|++|++...... ......+.+|++++++++||||+++++.+.....+|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999987 4889999998765432 24456788999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc--------c
Q 002331 761 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--------S 832 (935)
Q Consensus 761 ~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~--------~ 832 (935)
.+++.+.. .+++..++.++.||+.||.|||..+ |+|+||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99997644 7899999999999999999999998 99999999999999999999999999875433211 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcC--cHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL--DPLVARIIW 910 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~l--s~~L~dLI~ 910 (935)
.....++..|++||.+.+..++.++||||||+++|+|++|..||......+....+.. .....+..+ +..+.++|.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~ 235 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIEWPEDVEVSDEAIDLIS 235 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcCCCccccCCHHHHHHHH
Confidence 2334678899999999888889999999999999999999999998888777766643 233344444 899999999
Q ss_pred HHHhhCCCCcCCCcCH---HHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQ---AQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa---~EILqHPF 934 (935)
+||+.+ |.+||++ .++|+|||
T Consensus 236 ~~l~~~---p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 236 KLLVPD---PEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred HHhcCC---HhhcCCCccHHHHhcCcc
Confidence 999999 9999999 99999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=320.00 Aligned_cols=246 Identities=33% Similarity=0.564 Sum_probs=210.2
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
+..++|++.+.||+|+||.||++...++.||+|++.... ....+.+|+.+++.++||||+++++++... ..++||
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 345789999999999999999999999999999886432 235678899999999999999999998764 579999
Q ss_pred eeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 753 EFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
||+++++|.+++... ...+++..++.++.|++.||.|||+.| ++||||||+|||++.++.+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999754 335789999999999999999999998 999999999999999999999999998764332
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..+....+. ...+...+..+++.+.++|.
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 231 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMT 231 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHH
Confidence 112334568999999998889999999999999999997 999999888777666554 33444556778999999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqH 932 (935)
+||+.+ |.+||++.+|++.
T Consensus 232 ~~l~~~---p~~Rp~~~~l~~~ 250 (254)
T cd05083 232 SCWETE---PKKRPSFHKLREK 250 (254)
T ss_pred HHcCCC---hhhCcCHHHHHHH
Confidence 999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=338.03 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=205.0
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC------C
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~------~ 746 (935)
.++|++.+.||+|+||.||+|.. .++.||||++............+.+|+.++++++|+||++++++|... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 47899999999999999999976 688999999865543444556677899999999999999999987643 3
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
..|+||||+.+ +|.+++... +++..+..++.||+.||+|||..| |+||||||+|||++.++.+||+|||++...
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 57999999964 888887652 889999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-------------
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 893 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~------------- 893 (935)
.... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 169 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 5432 23345678999999999999999999999999999999999999987664333222110000
Q ss_pred -------ccC--------------C-------CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 -------RLE--------------I-------PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 -------r~~--------------i-------p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+.. . +...+..+++||.+||+.| |.+||++.++|+|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~R~t~~eiL~~~~ 313 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVID---PEKRISVDDALQHPY 313 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCC---hhhCcCHHHHhcChh
Confidence 000 0 1234667899999999999 999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=332.49 Aligned_cols=248 Identities=28% Similarity=0.412 Sum_probs=211.2
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeC
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
|.....||+|+||.||++.. .++.||||++...... ....+.+|+.++..++||||+++++.+..++..++||||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 44455799999999999976 6889999998654322 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCC
Q 002331 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (935)
Q Consensus 756 ~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s 835 (935)
++++|..++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++............
T Consensus 101 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 101 QGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred CCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 99999998865 35889999999999999999999998 999999999999999999999999998765443333344
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccCCCCcCcHHHHHHHHHHHh
Q 002331 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWECWQ 914 (935)
Q Consensus 836 ~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~-~r~~ip~~ls~~L~dLI~qCL~ 914 (935)
..++..|+|||++.+..++.++|||||||++|+|++|+.||......+....+.... .....+..++..+.++|.+||+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 256 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence 678999999999998889999999999999999999999999887766655543211 1223345678899999999999
Q ss_pred hCCCCcCCCcCHHHHHhCcC
Q 002331 915 TGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 915 ~D~ssP~kRPSa~EILqHPF 934 (935)
.+ |.+||++.+|++|||
T Consensus 257 ~~---P~~Rps~~~ll~~~~ 273 (297)
T cd06659 257 RE---PQERATAQELLDHPF 273 (297)
T ss_pred CC---cccCcCHHHHhhChh
Confidence 99 999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=327.63 Aligned_cols=256 Identities=24% Similarity=0.298 Sum_probs=208.6
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC----
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP---- 746 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~---- 746 (935)
...++|++.+.||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3457899999999999999999987 5789999998765433333456778999999999999999999987654
Q ss_pred ------ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 747 ------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 747 ------~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
.+++||||+++ ++..++......+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999976 777777665567899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCcc-cCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc---
Q 002331 821 GLSRLKHNTFL-SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--- 895 (935)
Q Consensus 821 GlA~~~~~~~~-~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--- 895 (935)
|++........ ......++..|+|||++.+. .++.++|||||||++|+|++|++||...+....+..+.......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99986643321 11223457789999988654 46889999999999999999999998776655443332110000
Q ss_pred -------------------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 -------------------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 -------------------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.....++..+.++|.+||+.+ |.+||++.+|++|||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~Rp~~~~il~~~~ 301 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLD---PSKRCTAEEALNSPW 301 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCC---hhhCCCHHHHhcCCC
Confidence 011246889999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=330.03 Aligned_cols=252 Identities=27% Similarity=0.472 Sum_probs=213.2
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
..++|.+.+.||.|+||.||++.. +++.||+|.+..... .....+.+|+.+++.++||||+++++.+...+..|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 347899999999999999999965 678899998864432 2345678899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
+||+++++|.+++.+. .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 95 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999999999753 4788899999999999999999998 99999999999999999999999998876544333
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCcCcHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~-~~r~~ip~~ls~~L~dLI~ 910 (935)
......+++.|++||.+.+..++.++|||||||++|+|++|+.||...+.......+... ......+..++..++++|.
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence 333456888999999998888899999999999999999999999887665443332211 1122234557889999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||..+ |.+||++.+++.|+|
T Consensus 251 ~~l~~~---p~~Rp~~~~il~h~~ 271 (293)
T cd06647 251 RCLEMD---VEKRGSAKELLQHPF 271 (293)
T ss_pred HHccCC---hhhCcCHHHHhcCHH
Confidence 999999 999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.49 Aligned_cols=244 Identities=30% Similarity=0.538 Sum_probs=208.1
Q ss_pred EEeeecCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCCH
Q 002331 682 ERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL 760 (935)
++||.|+||.||++.+. ++.|++|++...... .....+.+|++++++++|+||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36899999999999764 889999988765433 4556788999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC--CCCCC
Q 002331 761 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAG 838 (935)
Q Consensus 761 ~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~--~s~~G 838 (935)
.+++.+....+++..++.++.|++.||.|||+++ |+||||||+||||+.++.+||+|||++.......... .....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9999765567889999999999999999999998 9999999999999999999999999987654221111 11223
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 839 T~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
+..|+|||.+.+..++.++|||||||++|+|++ |..||...........+. .......+..++..+.++|.+||+.+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~- 235 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAYD- 235 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHhccC-
Confidence 567999999998889999999999999999998 889998887766665553 22345567788999999999999999
Q ss_pred CCcCCCcCHHHHHhC
Q 002331 918 SSLHIRTSQAQLSHK 932 (935)
Q Consensus 918 ssP~kRPSa~EILqH 932 (935)
|.+||++.+|++.
T Consensus 236 --p~~Rp~~~ell~~ 248 (251)
T cd05041 236 --PENRPSFSEIYNE 248 (251)
T ss_pred --hhhCcCHHHHHHH
Confidence 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=375.23 Aligned_cols=252 Identities=31% Similarity=0.533 Sum_probs=222.9
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE---CCc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW---NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~---~g~----~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
+++...++.+.||+|.||.||.|.. .+. .||||.+... .+.+...+|.+|..+|+.++|||||+++|++.+.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 6678899999999999999999976 233 4888887544 3567788999999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHcCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEe
Q 002331 746 PNLSIITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 819 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~D 819 (935)
...+|++|||++|+|..||++. ...+.....+.|+.||++|+.||+++. +|||||..+|+||++...|||+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999999876 567889999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCcccCCCCCC--CCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccC
Q 002331 820 FGLSRLKHNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLE 896 (935)
Q Consensus 820 FGlA~~~~~~~~~~~s~~G--T~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ 896 (935)
||+|+.+.+..+......+ -..|||||.+....++.++|||||||+|||+++ |..||.+.++.+++..+.. +.++.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~-ggRL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE-GGRLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh-CCccC
Confidence 9999954443333222222 358999999999999999999999999999998 7899999999999886654 44999
Q ss_pred CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 897 IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 897 ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.|..|+..+.+||.+||+.+ |++||+|..|++
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~---pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHD---PEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCChHHHHHHHHHccCC---hhhCccHHHHHh
Confidence 99999999999999999999 999999999986
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=353.79 Aligned_cols=246 Identities=22% Similarity=0.290 Sum_probs=199.7
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
...|.+.+.||+|+||.||++.+ .++.||||.... ..+.+|+++|++|+|+|||++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 35799999999999999999987 467899996322 23568999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 831 (935)
|++. ++|..++......+++..++.|+.||+.||.|||.+| ||||||||+||||+.++.+||+|||+++.......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9995 6888888765567999999999999999999999998 99999999999999999999999999986543211
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------hHHHHHHhhccccc-cCCC---
Q 002331 832 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--------PMQVVGAVGFQNRR-LEIP--- 898 (935)
Q Consensus 832 -~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~--------~~eil~~I~~~~~r-~~ip--- 898 (935)
......||+.|+|||++.+..++.++|||||||+||||++|..|+.... ..++...+...... ..++
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1224579999999999999999999999999999999999876554321 12222221110000 0000
Q ss_pred ----------------------------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 ----------------------------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 ----------------------------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++..+.+||.+||+.| |.+||++.|||+|||
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~D---P~~RPsa~elL~hp~ 457 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFD---GARRPSAAELLRLPL 457 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccC---hhhCcCHHHHhhCcc
Confidence 134568999999999999 999999999999998
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.54 Aligned_cols=248 Identities=36% Similarity=0.611 Sum_probs=212.0
Q ss_pred eeEEEEeeecCcEEEEEEEECC------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 678 LVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~~g------~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
+++.+.||.|+||.||++.+.. ..||+|++..... ......+..|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567889999999999998753 7899999865432 22556788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 752 TEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~-lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
|||+++++|.+++...... +++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999999764434 899999999999999999999998 9999999999999999999999999998665432
Q ss_pred ccCC-CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHH
Q 002331 831 LSSK-STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 831 ~~~~-s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
.... ...++..|+|||.+.+..++.++|||+|||++|+|++ |.+||...+...+...+.. ......+..++.++.++
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCHHHHHH
Confidence 2111 2336789999999988889999999999999999998 7899988877777766643 34455667789999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqH 932 (935)
|.+||+.+ |.+||++.++++.
T Consensus 237 i~~~l~~~---p~~Rpt~~~ll~~ 257 (258)
T smart00219 237 MLQCWAED---PEDRPTFSELVEI 257 (258)
T ss_pred HHHHCcCC---hhhCcCHHHHHhh
Confidence 99999999 9999999999863
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.45 Aligned_cols=248 Identities=29% Similarity=0.414 Sum_probs=211.2
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
.|...+.||+|++|.||++.+ .++.|+||++.... ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 344557899999999999975 57889999876443 23345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
+++++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||+|+||+++.++.+||+|||++...........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999999999976 46889999999999999999999999 99999999999999999999999998875543322233
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC--CCCcCcHHHHHHHHHH
Q 002331 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVARIIWEC 912 (935)
Q Consensus 835 s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~--ip~~ls~~L~dLI~qC 912 (935)
...|+..|+|||.+.+..++.++|||||||++|+|++|+.||...++......+... .... .+..++..+.++|.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHHHH
Confidence 456889999999999888999999999999999999999999988777666555322 2222 2234788999999999
Q ss_pred HhhCCCCcCCCcCHHHHHhCcC
Q 002331 913 WQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 913 L~~D~ssP~kRPSa~EILqHPF 934 (935)
|+.+ |.+||++.+|++|||
T Consensus 253 l~~~---p~~Rpt~~~il~~~~ 271 (285)
T cd06648 253 LVRD---PAQRATAAELLNHPF 271 (285)
T ss_pred cccC---hhhCcCHHHHccCcc
Confidence 9999 999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.00 Aligned_cols=253 Identities=29% Similarity=0.489 Sum_probs=214.4
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
..++|++.+.||+|+||.||+|+.. .+.|++|.+.... .......+.+|+.++++++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4578999999999999999999752 3568999875443 2335667899999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEE
Q 002331 747 NLSIITEFLPRGSLFRILHRPH--------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 818 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~--------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~ 818 (935)
..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEc
Confidence 9999999999999999997533 15899999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCC-cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccC
Q 002331 819 DFGLSRLKHNT-FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLE 896 (935)
Q Consensus 819 DFGlA~~~~~~-~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ 896 (935)
|||++...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 99998654322 112233456778999999988888999999999999999998 7889988877777776654444555
Q ss_pred CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 897 IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 897 ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+..++..+.++|.+||+.+ |.+||++.++++.
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~---p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVN---PKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCC---cccCCCHHHHHHH
Confidence 66778999999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=327.27 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=203.0
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeecccccCCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LV 751 (935)
.++|++.+.||+|+||.||++.+ +++.||||++...... .....+.+|+.++.++. |+||+++++++..++..+++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 35677778899999999999977 5789999998765433 44567889999999995 99999999999999999999
Q ss_pred EeeCCCCCHHHHH---c-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 752 TEFLPRGSLFRIL---H-RPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 752 mEy~~gGsL~dlL---~-~~~~~lse~~il~Ia~QIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
|||+.. +|.++. . .....+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 999864 555433 2 2235689999999999999999999974 7 999999999999999999999999998765
Q ss_pred cCCcccCCCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccccccCC----C
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEI----P 898 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~---~~s~ksDIWSLG~ILyELLTG~~PF~~~~~-~eil~~I~~~~~r~~i----p 898 (935)
.... ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||..... .+....+. ....+.+ +
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (288)
T cd06616 159 VDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEE 236 (288)
T ss_pred ccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCC
Confidence 4432 22334688999999999876 688999999999999999999999987652 22222221 1122222 2
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++..+.+||.+||+.+ |.+||++++|+.|||
T Consensus 237 ~~~~~~l~~li~~~l~~~---p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 237 REFSPSFVNFINLCLIKD---ESKRPKYKELLEHPF 269 (288)
T ss_pred CccCHHHHHHHHHHccCC---hhhCcCHHHHhcChh
Confidence 347889999999999999 999999999999998
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=324.45 Aligned_cols=243 Identities=26% Similarity=0.347 Sum_probs=205.4
Q ss_pred eeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCCH
Q 002331 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (935)
Q Consensus 684 LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL 760 (935)
||+|+||+||++.+ +++.||+|++....... .....+..|+.+|++++||||+++++.+...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999975 58899999987643322 2344567899999999999999999999999999999999999999
Q ss_pred HHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCCC
Q 002331 761 FRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 839 (935)
Q Consensus 761 ~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT 839 (935)
.+++.+.. ..+++..++.++.|++.||.|||..+ |+||||+|+|||++.++.+||+|||++...... .......++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCC
Confidence 99986543 36899999999999999999999999 999999999999999999999999998765432 222345678
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccccCCCCcCcHHHHHHHHHHHhh
Q 002331 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915 (935)
Q Consensus 840 ~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~----~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~ 915 (935)
..|+|||++.+..++.++|||||||++|+|++|+.||..... ..+...+ ......++..+++.+.++|.+||+.
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT--LEMAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc--ccccccCCccCCHHHHHHHHHHccC
Confidence 899999999888899999999999999999999999987644 2222221 2334556777899999999999999
Q ss_pred CCCCcCCCc-----CHHHHHhCcC
Q 002331 916 GWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 916 D~ssP~kRP-----Sa~EILqHPF 934 (935)
+ |.+|| ++.++++|||
T Consensus 236 ~---p~~R~~~~~~~~~~ll~h~~ 256 (277)
T cd05577 236 D---PEKRLGCRGGSADEVREHPL 256 (277)
T ss_pred C---hhHccCCCcccHHHHHhChh
Confidence 9 99999 8888999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.61 Aligned_cols=251 Identities=27% Similarity=0.482 Sum_probs=213.3
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~----~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
+...+|++.+.||+|+||.||+|.+ .+. .||+|.+..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 3457899999999999999999975 232 589998765532 4455678899999999999999999999887 7
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
..++||||+++|+|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 899999999999999999876667999999999999999999999988 999999999999999999999999999865
Q ss_pred cCCccc--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 827 HNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 827 ~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......++...+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTI 238 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCH
Confidence 432111 111223568999999988889999999999999999998 999999988877766664 3445566777889
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.+.++|.+||..+ |.+||++.++++
T Consensus 239 ~~~~~~~~~l~~~---p~~Rp~~~~l~~ 263 (279)
T cd05057 239 DVYMVLVKCWMID---AESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHHcCCC---hhhCCCHHHHHH
Confidence 9999999999999 999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.31 Aligned_cols=244 Identities=29% Similarity=0.486 Sum_probs=201.1
Q ss_pred EEeeecCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccc-cCCceEEEEeeC
Q 002331 682 ERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT-RPPNLSIITEFL 755 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~-~~~~l~LVmEy~ 755 (935)
+.||+|+||.||+|.+. ...||||++.... .......+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 35899999999999752 3469999875432 2344567889999999999999999999765 455689999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc----
Q 002331 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL---- 831 (935)
Q Consensus 756 ~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~---- 831 (935)
.+++|.+++.+....+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999999765556778888899999999999999998 99999999999999999999999999875543211
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG-~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
......++..|+|||.+.+..++.++|||||||++|||++| .+||...+..+....+. ...+...+..+++.+.++|.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHH
Confidence 11233456789999999888899999999999999999995 66787777776665553 33445566778899999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqH 932 (935)
+||+.+ |++||++.+|++.
T Consensus 237 ~cl~~~---p~~Rp~~~~il~~ 255 (262)
T cd05058 237 SCWHPK---PEMRPTFSELVSR 255 (262)
T ss_pred HHcCCC---hhhCCCHHHHHHH
Confidence 999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.27 Aligned_cols=256 Identities=23% Similarity=0.373 Sum_probs=214.9
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~ 747 (935)
+....++++++..||.|+-|+|++++. .|...|||.+......+ ..+.+...++++... .+|+||+++|+|..+..
T Consensus 87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke-e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH-HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 334456777888899999999999987 46899999998876544 345556666665554 58999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
.+|.||.| ...+..++++-..+++|..+-++..-++.||.||..+. +|||||+||+|||+|+.|.|||||||++-.+.
T Consensus 166 V~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 166 VFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccceee
Confidence 99999998 45788888887778999999999999999999998743 49999999999999999999999999998877
Q ss_pred CCcccCCCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccCCCC--cC
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPK--EL 901 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLG~ILyELLTG~~PF~~~~-~~eil~~I~~~~~r~~ip~--~l 901 (935)
+.. ......|.+.|||||.+.- ..|+.++||||||++|+||.||+.||.+.+ ..+++.++.. ..++.++. .+
T Consensus 244 dSk-AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gF 321 (391)
T KOG0983|consen 244 DSK-AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGF 321 (391)
T ss_pred ccc-ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCc
Confidence 653 3445689999999999964 458999999999999999999999999853 4555656653 55565653 47
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++++.+|+..||++| +.+||.+.++|+|||
T Consensus 322 Sp~F~~fv~~CL~kd---~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKD---HRKRPKYNKLLEHPF 351 (391)
T ss_pred CHHHHHHHHHHhhcC---cccCcchHHHhcCcc
Confidence 999999999999999 999999999999998
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.63 Aligned_cols=246 Identities=28% Similarity=0.417 Sum_probs=199.5
Q ss_pred eeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC--CceE
Q 002331 678 LVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLS 749 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l~ 749 (935)
|++.+.||+|+||+||++.+ .+..||+|.+.... .......+.+|+++|+.++||||+++++++... ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 48899999999999988753 46789999887553 223456788999999999999999999987653 4589
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||+++++|.+++... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 85 lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 999999999999999763 5899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccc---CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHH------------HHhhccc
Q 002331 830 FLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QVV------------GAVGFQN 892 (935)
Q Consensus 830 ~~~---~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~--eil------------~~I~~~~ 892 (935)
... .....++..|+|||++.+..++.++|||||||++|+|++|..||...... ... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 211 12234566799999999888999999999999999999999998654321 000 0011112
Q ss_pred cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 893 RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 893 ~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.....+..++..+.+++.+||+.+ |.+||++++|++
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~---p~~Rps~~~i~~ 276 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETE---AKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccC---hhhCCCHHHHHH
Confidence 233456678899999999999999 999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.93 Aligned_cols=251 Identities=25% Similarity=0.439 Sum_probs=211.0
Q ss_pred CeeEEEEeeecCcEEEEEEEEC--CceEEEEEeec---cCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 677 DLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLD---QDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~---~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
+|.+.+.||+|+||.||++.+. +..+++|+++. ..........+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999764 34455665543 223333445677899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 752 TEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 752 mEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|||+++++|.+++.+ ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++. +.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999988853 3456899999999999999999999998 999999999999975 5799999999887654
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHH
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+. ....+.++..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHH
Confidence 4333344568899999999988888999999999999999999999998777666555543 334455677889999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||+.+ |.+||++.++++|||
T Consensus 237 i~~~l~~~---p~~Rp~~~~il~~~~ 259 (260)
T cd08222 237 MQSMLNKD---PSLRPSAAEILRNPF 259 (260)
T ss_pred HHHHhcCC---hhhCcCHHHHhhCCC
Confidence 99999999 999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=321.34 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=206.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC--CceEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSII 751 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l~LV 751 (935)
++|.+.+.||.|++|.||++.+ .++.||+|.+..... ......+.+|++++++++||||++++++|... +.+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4688999999999999999987 578899998875433 24456788999999999999999999988543 468999
Q ss_pred EeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 752 TEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 752 mEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|||+++++|.+++.+ ....+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988643 3456889999999999999999999998 99999999999999999999999999875543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHhhccccccCCC-----
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-----NPMQVVGAVGFQNRRLEIP----- 898 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~-----~~~eil~~I~~~~~r~~ip----- 898 (935)
... ....++..|+|||.+.+..++.++|||+|||++|+|++|..||... ...+....+.. ...+.++
T Consensus 158 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (287)
T cd06621 158 SLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGN 234 (287)
T ss_pred ccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCC
Confidence 221 2345788999999999988999999999999999999999999865 22333333321 1112222
Q ss_pred -CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 -KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 -~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...++.+.+||.+||..+ |.+||++.||++|||
T Consensus 235 ~~~~~~~~~~li~~~l~~~---p~~Rpt~~eil~~~~ 268 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKD---PTRRPTPWDMLEHPW 268 (287)
T ss_pred CCchHHHHHHHHHHHcCCC---cccCCCHHHHHhCcc
Confidence 234678999999999999 999999999999999
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=319.61 Aligned_cols=250 Identities=30% Similarity=0.482 Sum_probs=202.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc--CCc
Q 002331 676 EDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPN 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~--~~~ 747 (935)
.+|++.+.||+|+||.||++.. .+..||||++.... ......+.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5789999999999999999964 46789999976543 3445678899999999999999999997643 346
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+++||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 89999999999999999765567899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccc---CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---------------HHHhh
Q 002331 828 NTFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV---------------VGAVG 889 (935)
Q Consensus 828 ~~~~~---~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~ei---------------l~~I~ 889 (935)
..... .....++..|+|||++.+..++.++|||||||++|||++|..|+........ ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 32111 1112234569999999988899999999999999999998777653321100 00111
Q ss_pred ccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 890 FQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 890 ~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
........+..++..+.+||.+||..+ |.+||++.+|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~---p~~Rpt~~ei~~~ 279 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNND---PSQRPSFSELALQ 279 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCC---hhhCCCHHHHHHH
Confidence 122334455678899999999999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=356.35 Aligned_cols=246 Identities=29% Similarity=0.481 Sum_probs=217.7
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 759 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGs 759 (935)
-+||+|+||+||.|++ +...+|||.+...+. ....-+..|+.+.++|+|.|||+++|.+..++++-|.||.++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 4699999999999987 455678898765542 234457889999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec-CCCcEEEEeccccccccCCcccCCCC
Q 002331 760 LFRILHRPHCQV--DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKST 836 (935)
Q Consensus 760 L~dlL~~~~~~l--se~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~VKL~DFGlA~~~~~~~~~~~s~ 836 (935)
|..++...=+++ ++..+-.+..||++||.|||.+. |||||||-+||||+ -.|.+||.|||-++....-.-...++
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 999998765666 88889999999999999999998 99999999999996 67999999999998765444456778
Q ss_pred CCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhccccccCCCCcCcHHHHHHHHHHH
Q 002331 837 AGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (935)
Q Consensus 837 ~GT~~Y~APEvl~g~--~~s~ksDIWSLG~ILyELLTG~~PF~~~-~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL 913 (935)
.||..|||||++..+ .|+.++|||||||++.||.||++||... ++...+.++.+.+..+++|..++.+++.+|.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 999999999999754 4899999999999999999999999865 5666677888888889999999999999999999
Q ss_pred hhCCCCcCCCcCHHHHHhCcC
Q 002331 914 QTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 914 ~~D~ssP~kRPSa~EILqHPF 934 (935)
..| |..||++.++|+.||
T Consensus 817 epd---~~~R~sA~~LL~DpF 834 (1226)
T KOG4279|consen 817 EPD---PCDRPSAKDLLQDPF 834 (1226)
T ss_pred CCC---cccCccHHHhccCcc
Confidence 999 999999999999998
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=354.22 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=227.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
.-|.+.+.||+|.|+.|.++++ .+..||||.+.+.......+..+.+|+++|+.|+|||||+++.+......+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 5688999999999999999976 78899999999988777777779999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
|+.+|.+++++.+.+ ...+..+..++.|++.|++|||.++ |||||||++||||+.+..+||+|||++..+... ...
T Consensus 136 ya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-~~l 211 (596)
T KOG0586|consen 136 YASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDYG-LML 211 (596)
T ss_pred eccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeeccc-ccc
Confidence 999999999998755 5555888899999999999999999 999999999999999999999999999987643 345
Q ss_pred CCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qC 912 (935)
.+.+|++.|.|||++.|..| ++.+|+|+||++||.|+.|.+||.+.+..+...++. .+...+|-.++.++.+||+++
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl--~gk~rIp~~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL--RGKYRIPFYMSCDCEDLLRKF 289 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe--eeeecccceeechhHHHHHHh
Confidence 67899999999999999887 789999999999999999999999998887777664 345566777899999999999
Q ss_pred HhhCCCCcCCCcCHHHHHhCcC
Q 002331 913 WQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 913 L~~D~ssP~kRPSa~EILqHPF 934 (935)
|-.+ |.+|+++++|..|+|
T Consensus 290 lvl~---Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 290 LVLN---PSKRGPCDQIMKDRW 308 (596)
T ss_pred hccC---ccccCCHHHhhhhcc
Confidence 9999 999999999999999
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=328.02 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=212.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
..|...+.||+|+||.||++++ ++..||||++..... .......+.+|+.+++.++|+||+++++++..++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4577889999999999999976 678899999875433 3344567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+.+ +|.+++......+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 99975 788877655567899999999999999999999998 999999999999999999999999998754322
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
....++..|+|||++. +..++.++|||||||++|+|++|+.||...+.......+.........+..+++.+.+||
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 2356888999999974 456788999999999999999999999988776666655433333444456788999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcCC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRFQ 935 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPFq 935 (935)
.+||+.+ |.+||++.+|++|+|.
T Consensus 258 ~~~l~~~---p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 258 DSCLQKI---PQDRPTSEELLKHMFV 280 (317)
T ss_pred HHHccCC---cccCcCHHHHHhChhh
Confidence 9999999 9999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.44 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=210.8
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC-----ceE
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLS 749 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~-----~l~ 749 (935)
+|++.+.||.|+||.||+|+. .++.||||++............+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 588999999999999999986 4789999998765433445567889999999999999999999998775 789
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||++ ++|.+++.+.. .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999997 48999887643 7999999999999999999999999 999999999999999999999999999876544
Q ss_pred c---ccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc----------
Q 002331 830 F---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---------- 895 (935)
Q Consensus 830 ~---~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~---------- 895 (935)
. .......++..|+|||++.+. .++.++|||||||++|+|++|.+||...+..+....+......+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 2 122345678899999999887 78999999999999999999999999877655444332111100
Q ss_pred -------------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 -------------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 -------------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+...++..+.++|.+||+.+ |.+||+++++++|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFD---PKKRITADEALAHPY 291 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCC---hhhCCCHHHHHhCcc
Confidence 012346788999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=324.11 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=208.8
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCC
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~ 746 (935)
.+.+..++|++.+.||+|+||.||+|.+. ++.||||++....... ....+..|+.++..+ .|+||+++++++....
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 45677799999999999999999999885 8899999987654332 344556677766666 5999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
.+|+||||+. +.|..++......+++..+..++.||+.||.|||+ ++ |+||||+|+||+++.++.+||+|||++..
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9999999985 47888776655578999999999999999999997 57 99999999999999999999999999876
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccccccCCC--
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIP-- 898 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g~~----~s~ksDIWSLG~ILyELLTG~~PF~~~~~-~eil~~I~~~~~r~~ip-- 898 (935)
...... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+.+..+... ....++
T Consensus 165 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 242 (296)
T cd06618 165 LVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE-EPPSLPPN 242 (296)
T ss_pred ccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC-CCCCCCCC
Confidence 543322 22345788999999987654 78899999999999999999999976433 3333333222 222222
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++..+.+||.+||+.| |.+||+++++++|||
T Consensus 243 ~~~~~~l~~li~~~l~~~---p~~Rp~~~~il~~~~ 275 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKD---HRKRPKYRELLQHPF 275 (296)
T ss_pred CCCCHHHHHHHHHHccCC---hhhCCCHHHHhcChh
Confidence 347899999999999999 999999999999998
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.03 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=200.1
Q ss_pred CeeEEEEeeecCcEEEEEEEE----CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccC--CceE
Q 002331 677 DLVLGERIGLGSYGEVYHADW----NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLS 749 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~----~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l~ 749 (935)
+|.+.+.||+|+||.||+|.+ .++.||||.+..... .......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 478899999999999999987 468999999876431 112234567899999999999999999999888 7899
Q ss_pred EEEeeCCCCCHHHHHcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC----CCcEEEEecc
Q 002331 750 IITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDFG 821 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~----~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~----~g~VKL~DFG 821 (935)
+||||+++ +|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999975 67766642 1236889999999999999999999998 999999999999999 9999999999
Q ss_pred ccccccCCcc---cCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHH---------HHHHh
Q 002331 822 LSRLKHNTFL---SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---------VVGAV 888 (935)
Q Consensus 822 lA~~~~~~~~---~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~e---------il~~I 888 (935)
++........ ......++..|+|||++.+. .++.++|||||||++|+|++|++||.+..... .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9986543321 22344678899999988764 57899999999999999999999998654322 00000
Q ss_pred -hc-----------------------cccccCCC-----------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCc
Q 002331 889 -GF-----------------------QNRRLEIP-----------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKR 933 (935)
Q Consensus 889 -~~-----------------------~~~r~~ip-----------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHP 933 (935)
.. ......++ ...+..+.++|.+||+.| |++||++.++++||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~---P~~Rps~~eil~~~ 314 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYD---PTKRITAEEALEHP 314 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCC---cccCcCHHHHhcCC
Confidence 00 00001111 146678999999999999 99999999999999
Q ss_pred C
Q 002331 934 F 934 (935)
Q Consensus 934 F 934 (935)
|
T Consensus 315 ~ 315 (316)
T cd07842 315 Y 315 (316)
T ss_pred C
Confidence 9
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=323.76 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=203.9
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC-------
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------- 745 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~------- 745 (935)
.++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999987 578899999876543333334567899999999999999999987443
Q ss_pred -CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 746 -PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 746 -~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
..+++||||+.+ +|..++......+++..+..++.||++||.|||..| |+|+||||+|||+++++.+||+|||++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccch
Confidence 346999999965 777777665567999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCccc-----------CCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc
Q 002331 825 LKHNTFLS-----------SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 892 (935)
Q Consensus 825 ~~~~~~~~-----------~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~ 892 (935)
........ .....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 65432111 1223567889999988654 57899999999999999999999999877655443321100
Q ss_pred cc---------------------cCCC-------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 RR---------------------LEIP-------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 ~r---------------------~~ip-------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.. ...+ ..+.+.+.++|.+||+.+ |.+||++.+++.|||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~---p~~R~t~~ell~~~~ 310 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLD---PYKRLTASDALEHPY 310 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccC---cccCcCHHHHhcCCC
Confidence 00 0000 234467899999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.82 Aligned_cols=243 Identities=25% Similarity=0.363 Sum_probs=203.1
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHH-HcCCCceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMR-RLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~-~L~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.||.|+||.||+|.+ .++.||||.+....... .....+..|..++. .++|+||+++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999976 67899999987654322 22334455555444 45899999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||+|+|||++.++.+||+|||++..... .....
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 154 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV 154 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence 9999999764 46889999999999999999999998 99999999999999999999999999875433 23356
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--ccCCCCcCcHHHHHHHHHHHhh
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEIPKELDPLVARIIWECWQT 915 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~--r~~ip~~ls~~L~dLI~qCL~~ 915 (935)
++..|++||.+.+..++.++||||||+++|+|++|..||...+.......+..... .......++..+.++|.+||+.
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 88899999999888889999999999999999999999998887776655432221 2234446889999999999999
Q ss_pred CCCCcCCCc---CHHHHHhCcC
Q 002331 916 GWSSLHIRT---SQAQLSHKRF 934 (935)
Q Consensus 916 D~ssP~kRP---Sa~EILqHPF 934 (935)
+ |.+|| +++|++.|||
T Consensus 235 ~---p~~R~~~~~~~~~l~~~~ 253 (260)
T cd05611 235 D---PAKRLGANGYQEIKSHPF 253 (260)
T ss_pred C---HHHccCCCcHHHHHcChH
Confidence 9 99999 5589999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=332.98 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=205.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC-----Cce
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 748 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~-----~~l 748 (935)
.+|.+.+.||+|+||+||++.+ +++.||||++............+.+|+.+++.++|+||+++++++... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5799999999999999999976 578999999876433333445677899999999999999999988654 348
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999996 6898888764 46999999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc-----------------
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF----------------- 890 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~----------------- 890 (935)
.........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 3223334568899999998865 4588999999999999999999999987654322211100
Q ss_pred -------cc--cc---cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 891 -------QN--RR---LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 891 -------~~--~r---~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.. .. ......+++.+.+||.+||+.+ |.+||+++++++|||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~Rps~~ell~h~~ 293 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFD---PSKRITVEEALAHPY 293 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCC---hhhccCHHHHHcCcc
Confidence 00 00 0122457889999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.48 Aligned_cols=250 Identities=26% Similarity=0.323 Sum_probs=204.8
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc---CCCceeeeecccccCCc-----
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVTRPPN----- 747 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L---~HPNIVkl~g~~~~~~~----- 747 (935)
|++.+.||+|+||.||+|++ +++.||||++............+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67889999999999999987 478999999875543333344566788877766 59999999999988776
Q ss_pred eEEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
++++|||+.+ +|.+++.+.. ..+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999999975 8988886533 36899999999999999999999998 999999999999999999999999998776
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------ 894 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r------------ 894 (935)
.... ......++..|+|||++.+..++.++|||||||++|+|++|++||.+....+....+......
T Consensus 158 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 158 SFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred cCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 4332 122345788999999999988999999999999999999999999988766554443211000
Q ss_pred -------------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 -------------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 -------------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
......+++.+.++|.+||+.| |.+||++.++++|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d---p~~Rp~~~~il~~~~ 286 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFN---PHKRISAFEALQHPY 286 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccC---CccCCCHHHHhcCcC
Confidence 0001235678899999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=317.64 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=207.1
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC--CceEEEEe
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSIITE 753 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l~LVmE 753 (935)
|++.+.||.|+||.||+|.+ +++.||||++............+.+|+.+++.++|+||+++++++... +.+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67889999999999999987 468999999987643333445678899999999999999999999887 78999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-c
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-S 832 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~ 832 (935)
|+++ +|.+++.+....+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9975 899988775567899999999999999999999998 99999999999999999999999999986654321 1
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc----------------
Q 002331 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---------------- 895 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~---------------- 895 (935)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+......+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 223456788999998775 457899999999999999999999998877655444332100000
Q ss_pred -------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 -------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 -------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+...++..+.++|.+||+.+ |.+||++.++++|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~---P~~Rp~~~~~l~~~~ 286 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLD---PKKRISADQALQHEY 286 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCC---hhhCcCHHHHhhCcC
Confidence 011113788999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=341.07 Aligned_cols=248 Identities=27% Similarity=0.453 Sum_probs=222.9
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeC
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
|.++++||+|+||.||++.+ .|..+|||++... ..+.++.+|+.||++++.|++|++||.+.....+|||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 55778899999999999955 7889999987533 35678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCC
Q 002331 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (935)
Q Consensus 756 ~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s 835 (935)
..|++.+++.-++.++.+.++..+++..++||+|||... -||||||..||||+.+|+.||+|||.+-.+.+......+
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 999999999877889999999999999999999999987 899999999999999999999999999988887777788
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccCCCCcCcHHHHHHHHHHHh
Q 002331 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWECWQ 914 (935)
Q Consensus 836 ~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~-~r~~ip~~ls~~L~dLI~qCL~ 914 (935)
..||+.|||||++..-.|+.++||||||++..||..|++||.+..++..+..+.... ..+..|...+.++-++|++||-
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi 268 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI 268 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence 999999999999999999999999999999999999999999999886655443211 1123456778899999999999
Q ss_pred hCCCCcCCCcCHHHHHhCcC
Q 002331 915 TGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 915 ~D~ssP~kRPSa~EILqHPF 934 (935)
+. |++|-++.++++|||
T Consensus 269 K~---PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 269 KK---PEERKTALRLCEHTF 285 (502)
T ss_pred CC---HHHHHHHHHHhhhhh
Confidence 99 999999999999998
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=311.71 Aligned_cols=243 Identities=27% Similarity=0.420 Sum_probs=214.4
Q ss_pred eeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCCH
Q 002331 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (935)
Q Consensus 684 LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL 760 (935)
||.|+||.||++.+ .++.||+|++...... ......+..|+.++++++|+||+++++.+..+..+++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999987 4789999998766443 23566788999999999999999999999999999999999999999
Q ss_pred HHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCCCC
Q 002331 761 FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 840 (935)
Q Consensus 761 ~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~ 840 (935)
.+++... ..+++..+..++.||+.||.|||..+ ++|+||+|+||+++.++.++|+|||++..............++.
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 9999764 36899999999999999999999998 99999999999999999999999999987654323334567888
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCc
Q 002331 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSL 920 (935)
Q Consensus 841 ~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP 920 (935)
.|++||.+.+...+.++|+|+||+++|+|++|..||...+.......+.. ....++..++..+.++|++||..| |
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~---p 232 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKD---P 232 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCC---H
Confidence 99999999888889999999999999999999999988877666665532 556788888999999999999999 9
Q ss_pred CCCcCH---HHHHhCcC
Q 002331 921 HIRTSQ---AQLSHKRF 934 (935)
Q Consensus 921 ~kRPSa---~EILqHPF 934 (935)
++||++ +++++|||
T Consensus 233 ~~R~~~~~~~~l~~~~~ 249 (250)
T cd05123 233 TKRLGSGGAEEIKAHPF 249 (250)
T ss_pred hhCCCcccHHHHHhCCC
Confidence 999999 99999999
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=318.09 Aligned_cols=242 Identities=31% Similarity=0.551 Sum_probs=200.6
Q ss_pred EeeecCcEEEEEEEEC--Cc--eEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEEeeCCC
Q 002331 683 RIGLGSYGEVYHADWN--GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~~--g~--~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
.||+|+||.||+|.+. +. .+++|.+.... .......+.+|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 5899999999999763 33 46788765332 334456788999999999 899999999999999999999999999
Q ss_pred CCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccc
Q 002331 758 GSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (935)
Q Consensus 758 GsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGl 822 (935)
++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCCC
Confidence 99999986432 24788999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcC
Q 002331 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (935)
Q Consensus 823 A~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~l 901 (935)
+...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+. ...+...+..+
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (270)
T cd05047 159 SRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNC 236 (270)
T ss_pred ccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCCCCCCCCcC
Confidence 8643211 11112233567999999998889999999999999999997 999999887777666553 23344566778
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+..+.+||.+||+.+ |.+||++.+++..
T Consensus 237 ~~~~~~li~~~l~~~---p~~Rps~~~il~~ 264 (270)
T cd05047 237 DDEVYDLMRQCWREK---PYERPSFAQILVS 264 (270)
T ss_pred CHHHHHHHHHHcccC---hhhCCCHHHHHHH
Confidence 899999999999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.15 Aligned_cols=244 Identities=24% Similarity=0.349 Sum_probs=198.3
Q ss_pred EeeecCcEEEEEEEE--CCceEEEEEeeccCCCHH-HHHHHHHHHHHHH---HcCCCceeeeecccccCCceEEEEeeCC
Q 002331 683 RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMR---RLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~-~~~~f~~Ei~iL~---~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 756 (935)
.||+|+||.||++.. +++.||||.+........ ....+.+|..+++ ..+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999976 578999998876543221 2222344444443 3479999999999999999999999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCC
Q 002331 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 836 (935)
Q Consensus 757 gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~ 836 (935)
+++|.+++... ..+++..+..++.||+.||.|||..+ |+||||||+|||+++++.+||+|||++...... .....
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 155 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCc
Confidence 99999998654 46899999999999999999999999 999999999999999999999999998755432 12335
Q ss_pred CCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHhhccccccCCCCcCcHHHHHHHHHHH
Q 002331 837 AGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (935)
Q Consensus 837 ~GT~~Y~APEvl~-g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~--eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL 913 (935)
.|+..|+|||.+. +..++.++|||||||++|+|++|..||...... ...... .......++..+++.+.++|.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKSLLEGLL 234 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHHHHHHHh
Confidence 6899999999986 456889999999999999999999999764321 122222 123445677889999999999999
Q ss_pred hhCCCCcCCCc-----CHHHHHhCcCC
Q 002331 914 QTGWSSLHIRT-----SQAQLSHKRFQ 935 (935)
Q Consensus 914 ~~D~ssP~kRP-----Sa~EILqHPFq 935 (935)
+.| |.+|| ++.++++|||.
T Consensus 235 ~~~---p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 235 QRD---VSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred cCC---HHHhcCCCCCCHHHHHhCccc
Confidence 999 99999 69999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=321.46 Aligned_cols=250 Identities=30% Similarity=0.482 Sum_probs=204.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC--Cc
Q 002331 676 EDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PN 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~--~~ 747 (935)
.-|++.+.||+|+||.||++++ .+..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3478889999999999999974 46789999986543 234456789999999999999999999988765 56
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
.++||||+++++|.+++.+....+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccccc
Confidence 89999999999999999765556899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---------------hHHHHHHhh
Q 002331 828 NTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---------------PMQVVGAVG 889 (935)
Q Consensus 828 ~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~---------------~~eil~~I~ 889 (935)
.... ......++..|+|||++.+..++.++|||||||++|+|++++.|+.... .......+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL- 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH-
Confidence 3211 1123456778999999998889999999999999999999876643211 01111111
Q ss_pred ccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 890 FQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 890 ~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
....+...+..++..+.+||.+||+.+ |.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~---p~~Rpt~~~il~~ 279 (284)
T cd05079 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQ---PSKRTTFQNLIEG 279 (284)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCC---cccCcCHHHHHHH
Confidence 223344556778999999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.03 Aligned_cols=251 Identities=31% Similarity=0.466 Sum_probs=207.5
Q ss_pred CCCeeEEEEeeecCcEEEEEEEEC------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc--CC
Q 002331 675 WEDLVLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PP 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~~------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~--~~ 746 (935)
.++|++.+.||+|+||.||++++. ++.||||++...... .....+.+|+++++.+.|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 356888899999999999999763 678999998765433 456678999999999999999999999877 55
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
..++||||+++++|.+++.+....+++..++.++.||+.||.|||+.| |+|+||||+|||++.++.+||+|||++...
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 789999999999999999876657999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCccc---CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH---------------HHHHh
Q 002331 827 HNTFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---------------VVGAV 888 (935)
Q Consensus 827 ~~~~~~---~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~e---------------il~~I 888 (935)
...... .....++..|++||.+.+..++.++|||||||++|+|++|..||....... +...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 532111 112234567999999988889999999999999999999999987542221 11112
Q ss_pred hccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 889 GFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 889 ~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
....+...+..++..+.+||.+||+.+ |.+||++.+|++.
T Consensus 240 -~~~~~~~~~~~~~~~~~~li~~cl~~~---p~~Rpt~~ei~~~ 279 (284)
T cd05038 240 -KEGERLPRPPSCPDEVYDLMKLCWEAE---PQDRPSFADLILI 279 (284)
T ss_pred -HcCCcCCCCccCCHHHHHHHHHHhccC---hhhCCCHHHHHHH
Confidence 223334445677899999999999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=318.26 Aligned_cols=237 Identities=21% Similarity=0.328 Sum_probs=194.4
Q ss_pred EEeeecCcEEEEEEEEC--------------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 682 ERIGLGSYGEVYHADWN--------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~--------------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
+.||+|+||.||+|++. ...|++|.+.... ......+..|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 35899999999999742 2258888765432 2344567889999999999999999999999899
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc-------EEEEec
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-------VKVSDF 820 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~-------VKL~DF 820 (935)
.++||||+++++|..++.+....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++. +|++||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999999998776667899999999999999999999998 999999999999987654 899999
Q ss_pred cccccccCCcccCCCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHH-cCCCCCCCCChHHHHHHhhccccccCCC
Q 002331 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (935)
Q Consensus 821 GlA~~~~~~~~~~~s~~GT~~Y~APEvl~-g~~~s~ksDIWSLG~ILyELL-TG~~PF~~~~~~eil~~I~~~~~r~~ip 898 (935)
|++...... ....++..|+|||++. +..++.++|||||||++|+|+ .|..||......+..... .....+.
T Consensus 157 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~~~~~ 229 (262)
T cd05077 157 GIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---EGQCMLV 229 (262)
T ss_pred CCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---hcCccCC
Confidence 998654322 2346788999999987 566889999999999999998 588898876654443221 1222233
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
...++++.+||.+||+.| |.+||++.+|+++
T Consensus 230 ~~~~~~~~~li~~cl~~d---p~~Rp~~~~il~~ 260 (262)
T cd05077 230 TPSCKELADLMTHCMNYD---PNQRPFFRAIMRD 260 (262)
T ss_pred CCChHHHHHHHHHHcCCC---hhhCcCHHHHHHh
Confidence 445688999999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=326.30 Aligned_cols=252 Identities=23% Similarity=0.287 Sum_probs=205.3
Q ss_pred eeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCC
Q 002331 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.+++.+|.|+++.||+++.+++.||||++............+.+|+.+++.++|+||+++++++...+..+++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 44566677778888888877899999999987655566777899999999999999999999999999999999999999
Q ss_pred CCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-----
Q 002331 758 GSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL----- 831 (935)
Q Consensus 758 GsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~----- 831 (935)
++|.+++.+. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999999753 346889999999999999999999999 99999999999999999999999998875432111
Q ss_pred --cCCCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--------------
Q 002331 832 --SSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------------- 893 (935)
Q Consensus 832 --~~~s~~GT~~Y~APEvl~g~--~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~-------------- 893 (935)
......++..|+|||++.+. .++.++|||||||++|+|++|..||.................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 12234567789999998763 478899999999999999999999987765443221110000
Q ss_pred ------------------ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 ------------------RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 ------------------r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
....+..++.++.+||.+||+.| |.+||+++++|+|||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRD---PESRPSASQLLNHSF 297 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcC---CCcCcCHHHHhcCch
Confidence 00111234567899999999999 999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=314.92 Aligned_cols=243 Identities=25% Similarity=0.414 Sum_probs=194.4
Q ss_pred EeeecCcEEEEEEEE-C---CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCC
Q 002331 683 RIGLGSYGEVYHADW-N---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~-~---g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 758 (935)
.||+|+||.||+|.. + ...+++|.+.... .......+.+|+.+++.++|+||+++++.+.....+++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 589999999999964 2 3468888765433 3444567889999999999999999999999999999999999999
Q ss_pred CHHHHHcCCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc--c
Q 002331 759 SLFRILHRPH----CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--S 832 (935)
Q Consensus 759 sL~dlL~~~~----~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~ 832 (935)
+|.+++.... ...++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999986532 23467788899999999999999998 99999999999999999999999999865432211 1
Q ss_pred CCCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccc----ccCCCCc
Q 002331 833 SKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNR----RLEIPKE 900 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g-------~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~----r~~ip~~ 900 (935)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||......+....+..... .+.++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 223345678999999753 346789999999999999999 7889988876665554422211 1234456
Q ss_pred CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 901 LDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 901 ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
++..+.+++..|| .| |.+||++++|++.
T Consensus 239 ~~~~~~~~~~~~~-~d---p~~Rpt~~~v~~~ 266 (269)
T cd05042 239 YSDRWYEVMQFCW-LD---PETRPTAEEVHEL 266 (269)
T ss_pred CCHHHHHHHHHHh-cC---cccccCHHHHHHH
Confidence 8899999999999 58 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=315.29 Aligned_cols=243 Identities=26% Similarity=0.377 Sum_probs=194.3
Q ss_pred EeeecCcEEEEEEEEC----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCC
Q 002331 683 RIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~~----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 758 (935)
.||+|+||.||+|.+. +..+|+|.+..... ......+.+|+.++++++||||+++++++.+...+++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 5899999999999763 34689998766543 234456888999999999999999999999999999999999999
Q ss_pred CHHHHHcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc--c
Q 002331 759 SLFRILHRP----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--S 832 (935)
Q Consensus 759 sL~dlL~~~----~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~ 832 (935)
+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999998642 124567778889999999999999998 99999999999999999999999999875433221 1
Q ss_pred CCCCCCCCCccCcccccCC-------CCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhc-ccc---ccCCCCc
Q 002331 833 SKSTAGTPEWMAPEVLRNE-------PSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGF-QNR---RLEIPKE 900 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~-------~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~-~~~---r~~ip~~ 900 (935)
.....++..|+|||++.+. .++.++|||||||++|||++ |..||......+....... ... .+.+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 2234577889999998643 35789999999999999996 9999988776655433211 111 1222335
Q ss_pred CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 901 LDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 901 ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.++.+.++|.+|| .+ |.+||++++|++.
T Consensus 239 ~~~~~~~l~~~c~-~~---P~~Rpt~~~l~~~ 266 (269)
T cd05087 239 LSDRWYEVMQFCW-LQ---PEQRPSAEEVHLL 266 (269)
T ss_pred CChHHHHHHHHHh-cC---cccCCCHHHHHHH
Confidence 6788999999999 68 9999999999853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=318.62 Aligned_cols=241 Identities=20% Similarity=0.345 Sum_probs=197.5
Q ss_pred CeeEEEE--eeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEE
Q 002331 677 DLVLGER--IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 677 dy~I~e~--LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LV 751 (935)
+|.+.+. ||.|+||.||++.. ++..+|+|.+........ |+.....+ +||||+++++.|...+.+++|
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 4555555 49999999999975 678899999876543221 22222222 799999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC-cEEEEeccccccccCCc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~VKL~DFGlA~~~~~~~ 830 (935)
|||+++++|.+++.+.. .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 99999999999997653 7899999999999999999999999 99999999999999988 9999999998765432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH--HHhhccccccCCCCcCcHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV--GAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil--~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
....++..|+|||++.+..++.++|||||||++|+|++|..||.......+. ............+..+++.+.++
T Consensus 164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDF 240 (267)
T ss_pred ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHH
Confidence 2346889999999999988999999999999999999999999865433211 11111133445566789999999
Q ss_pred HHHHHhhCCCCcCCCcC-HHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTS-QAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPS-a~EILqHPF 934 (935)
|.+||+.+ |.+||+ +++||+|||
T Consensus 241 i~~~l~~~---p~~R~~~~~~~l~h~~ 264 (267)
T PHA03390 241 VQSMLKYN---INYRLTNYNEIIKHPF 264 (267)
T ss_pred HHHHhccC---hhhCCchHHHHhcCCc
Confidence 99999999 999995 699999999
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=330.97 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=205.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc----CCceE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLS 749 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~----~~~l~ 749 (935)
++|++.+.||.|+||.||+|.. +++.||+|++............+.+|+.+|+.++||||+++++++.. ...++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6799999999999999999975 58899999987653333345567789999999999999999998753 34689
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999996 5899988664 45899999999999999999999998 999999999999999999999999998765432
Q ss_pred cc----cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-------------
Q 002331 830 FL----SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------- 891 (935)
Q Consensus 830 ~~----~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~------------- 891 (935)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 21 1123468899999999865 45789999999999999999999999876654332221100
Q ss_pred -----------ccccC-----CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 892 -----------NRRLE-----IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 892 -----------~~r~~-----ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..... +...++.++.++|.+||+.+ |.+||++.+++.|||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFD---PEERITVEQALQHPF 296 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCC---hhhCcCHHHHHhChh
Confidence 00111 11346889999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=317.41 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=208.4
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeC
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
|++.+.||+|+||.||+|+. +++.||+|++............+..|+.+++.++|+||+++++++...+.+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56778899999999999977 4789999998766433344556778999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCC
Q 002331 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (935)
Q Consensus 756 ~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s 835 (935)
+ ++|.+++.+....+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++............
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 7 5899999875457999999999999999999999998 999999999999999999999999998876543323333
Q ss_pred CCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-------------------ccc
Q 002331 836 TAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------------RRL 895 (935)
Q Consensus 836 ~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~-------------------~r~ 895 (935)
..++..|+|||.+.+. .++.++|||+|||++|+|++|+.||...+.......+.... ...
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 4567889999998776 78899999999999999999999998876554433321100 000
Q ss_pred --------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 --------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 --------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.....++..+.++|.+||..+ |.+||++.++++|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~---P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYN---PAKRISAKEALKHPY 281 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccC---cccCCCHHHHhhCcC
Confidence 001234778999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=322.62 Aligned_cols=251 Identities=28% Similarity=0.510 Sum_probs=208.9
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~----~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
..++|++.+.||+|+||.||+|.+ .+. .||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 446788999999999999999976 343 47888776443 233445688999999999999999999998754 4
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
.++++||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEcccccccccc
Confidence 67999999999999999876667899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 828 NTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 828 ~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
.... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.........+. .......+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTID 239 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHH
Confidence 3211 1223345678999999999999999999999999999997 899998877665554443 34445556678899
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+.++|.+||..+ |.+||++.++++.
T Consensus 240 ~~~li~~c~~~~---p~~Rp~~~~l~~~ 264 (303)
T cd05110 240 VYMVMVKCWMID---ADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 999999999999 9999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=312.85 Aligned_cols=235 Identities=23% Similarity=0.358 Sum_probs=193.2
Q ss_pred EEeeecCcEEEEEEEECCc------------eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 682 ERIGLGSYGEVYHADWNGT------------EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~g~------------~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
+.||+|+||.||+|.+.+. .|++|.+..... ....+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 3589999999999977432 377776654321 15678899999999999999999999888 7789
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC-------cEEEEeccc
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-------NVKVSDFGL 822 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-------~VKL~DFGl 822 (935)
+||||+++++|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999775557899999999999999999999998 99999999999999887 799999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCC
Q 002331 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 899 (935)
Q Consensus 823 A~~~~~~~~~~~s~~GT~~Y~APEvl~g~--~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~ 899 (935)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||............. .....+.
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~~~~ 227 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHRLPM 227 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCCCCC
Confidence 886543 2234567789999999876 78899999999999999999 588888776544433322 1222233
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 900 ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.....+.++|.+||..+ |.+||++.+|++.
T Consensus 228 ~~~~~~~~li~~~l~~~---p~~Rpt~~~il~~ 257 (259)
T cd05037 228 PDCAELANLINQCWTYD---PTKRPSFRAILRD 257 (259)
T ss_pred CCchHHHHHHHHHhccC---hhhCCCHHHHHHh
Confidence 33489999999999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.70 Aligned_cols=247 Identities=29% Similarity=0.428 Sum_probs=209.2
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
|...+.||+|+||+||+|++ .++.|+||++..... .......+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56677899999999999976 678999999875433 334456788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
+. ++|.+++......+++..++.++.||+.||.|||..| |+|+||+|+||+++.++.+||+|||++..... ..
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~ 175 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----AN 175 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC----CC
Confidence 96 5788877665567899999999999999999999998 99999999999999999999999998864322 23
Q ss_pred CCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHH
Q 002331 835 STAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 835 s~~GT~~Y~APEvl~---g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~q 911 (935)
...|+..|+|||++. +..++.++|||||||++|+|++|..||...+.......+.....+......++..+++||.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 457889999999984 45678899999999999999999999998877666655543333333334577889999999
Q ss_pred HHhhCCCCcCCCcCHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPSa~EILqHPF 934 (935)
||+.+ |.+||++.++++|||
T Consensus 256 ~l~~~---P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 256 CLQKI---PQERPASAELLRHDF 275 (313)
T ss_pred HccCC---hhhCcCHHHHhcCcc
Confidence 99999 999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=327.90 Aligned_cols=250 Identities=23% Similarity=0.384 Sum_probs=200.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC-----Cce
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 748 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~-----~~l 748 (935)
++|++.++||+|+||.||+|.+ +++.||||++.... .......+.+|+.+++.++|+||+++++++... ..+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 6899999999999999999976 67899999986432 223445677899999999999999999876543 358
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++||||+.+ +|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 999999965 88888865 36899999999999999999999999 99999999999999999999999999876543
Q ss_pred Ccc---cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--------------
Q 002331 829 TFL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------- 890 (935)
Q Consensus 829 ~~~---~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~-------------- 890 (935)
... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 211 1123568899999998754 5688999999999999999999999987654332221100
Q ss_pred ----------cccccC-----CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 891 ----------QNRRLE-----IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 891 ----------~~~r~~-----ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...... .....++++.+||.+||+.+ |.+||++.++++|||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d---P~~Rpt~~e~l~hp~ 294 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFN---PHKRITVEEALAHPY 294 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCC---hhhCcCHHHHhcCcc
Confidence 000000 11245778999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=318.05 Aligned_cols=243 Identities=24% Similarity=0.349 Sum_probs=199.4
Q ss_pred EeeecCcEEEEEEEE--CCceEEEEEeeccCCCHH-HHHHHHHHH---HHHHHcCCCceeeeecccccCCceEEEEeeCC
Q 002331 683 RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREV---KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~-~~~~f~~Ei---~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 756 (935)
.||+|+||.||++.+ .++.||||++........ ....+..|. .+++...||||+++++++...+.+++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999976 578999999876543321 112233333 34445579999999999999999999999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCC
Q 002331 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 836 (935)
Q Consensus 757 gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~ 836 (935)
+++|.+++.+. ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 155 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCc
Confidence 99999988653 46899999999999999999999998 999999999999999999999999998755332 22345
Q ss_pred CCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHhhccccccCCCCcCcHHHHHHHHHH
Q 002331 837 AGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (935)
Q Consensus 837 ~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~---~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qC 912 (935)
.|+..|+|||++.+. .++.++|||||||++|+|++|+.||.... ........ ......++..++..+.++|.+|
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGL 233 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHHHHHHHH
Confidence 789999999998754 68899999999999999999999998763 22222222 2345567777899999999999
Q ss_pred HhhCCCCcCCCc-----CHHHHHhCcCC
Q 002331 913 WQTGWSSLHIRT-----SQAQLSHKRFQ 935 (935)
Q Consensus 913 L~~D~ssP~kRP-----Sa~EILqHPFq 935 (935)
|..+ |.+|| ++.++++|||.
T Consensus 234 l~~~---p~~R~~~~~~~~~~ll~~~~~ 258 (278)
T cd05606 234 LQRD---VNRRLGCLGRGAQEVKEHPFF 258 (278)
T ss_pred hhcC---HHhccCCCCCCHHHHHhCccc
Confidence 9999 99999 99999999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=315.60 Aligned_cols=243 Identities=29% Similarity=0.481 Sum_probs=203.8
Q ss_pred EeeecCcEEEEEEEECC--------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 683 RIGLGSYGEVYHADWNG--------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~~g--------~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
.||+|+||.||+|++.. ..||||.+.... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999997632 569999876442 223456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC-----cEEEEecccc
Q 002331 755 LPRGSLFRILHRP------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-----NVKVSDFGLS 823 (935)
Q Consensus 755 ~~gGsL~dlL~~~------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-----~VKL~DFGlA 823 (935)
+++++|.+++.+. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999998642 234788999999999999999999998 99999999999999877 8999999998
Q ss_pred ccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCc
Q 002331 824 RLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (935)
Q Consensus 824 ~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ 900 (935)
........ ......++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+. .......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCccc
Confidence 75533211 1122345678999999999889999999999999999998 999998887777666553 3445566778
Q ss_pred CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 901 LDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 901 ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
++..+.++|.+||..+ |.+||++.+|++.
T Consensus 238 ~~~~~~~li~~~l~~~---p~~Rp~~~~i~~~ 266 (269)
T cd05044 238 CPDKIYQLMTNCWAQD---PSERPTFDRIQEI 266 (269)
T ss_pred chHHHHHHHHHHcCCC---cccCCCHHHHHHH
Confidence 8999999999999999 9999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=319.90 Aligned_cols=236 Identities=20% Similarity=0.324 Sum_probs=194.1
Q ss_pred EeeecCcEEEEEEEEC--------------------------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCcee
Q 002331 683 RIGLGSYGEVYHADWN--------------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~~--------------------------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIV 736 (935)
+||+|+||.||+|.+. ...|++|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 5999999999999641 1348888875432 23345678899999999999999
Q ss_pred eeecccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC---
Q 002331 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW--- 813 (935)
Q Consensus 737 kl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g--- 813 (935)
++++++......++||||+++++|..++.+....+++..+..++.||+.||+|||+.+ |+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999999766667899999999999999999999998 99999999999997643
Q ss_pred ----cEEEEeccccccccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHH-cCCCCCCCCChHHHHHH
Q 002331 814 ----NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGA 887 (935)
Q Consensus 814 ----~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELL-TG~~PF~~~~~~eil~~ 887 (935)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+.+....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999987644321 22457788999998875 56799999999999999985 78999988766554332
Q ss_pred hhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 888 VGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 888 I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
. .....++....+.+.++|.+||+.+ |.+||++.+||++
T Consensus 234 ~---~~~~~~~~~~~~~~~~li~~cl~~~---p~~Rps~~~il~~ 272 (274)
T cd05076 234 Y---EKKHRLPEPSCKELATLISQCLTYE---PTQRPSFRTILRD 272 (274)
T ss_pred H---HhccCCCCCCChHHHHHHHHHcccC---hhhCcCHHHHHHh
Confidence 2 1233455556788999999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.09 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=209.1
Q ss_pred CeeEEEEeeecCcEEEEEEEEC---CceEEEEEeeccC--------CCHHHHHHHHHHHHHHHH-cCCCceeeeeccccc
Q 002331 677 DLVLGERIGLGSYGEVYHADWN---GTEVAVKKFLDQD--------FSGAALLEFKREVKIMRR-LRHPNVVLFMGAVTR 744 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~~---g~~VAVK~i~~~~--------~~~~~~~~f~~Ei~iL~~-L~HPNIVkl~g~~~~ 744 (935)
.|++.+.||+|+||.||++.+. ++.+|||.+.... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778889999999999999873 5789999876432 223345567788888875 699999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHc---CCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 745 PPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~---~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
.+..++||||+++++|.+++. .....+++..++.++.|++.||.|||. .+ |+|+||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999998874 234568999999999999999999996 56 999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCc
Q 002331 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (935)
Q Consensus 821 GlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ 900 (935)
|++....... ......++..|++||.+.+..++.++||||||+++|+|++|+.||...+.......+......+.....
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence 9998765432 233456889999999999888999999999999999999999999888777666655433333222336
Q ss_pred CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 901 LDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 901 ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+++.+.++|.+||+.| |.+||++.++..+
T Consensus 238 ~~~~l~~li~~cl~~~---p~~Rp~~~e~~~~ 266 (269)
T cd08528 238 YSEDVTDVITSCLTPD---AEARPDIIQVSAM 266 (269)
T ss_pred CCHHHHHHHHHHCCCC---CccCCCHHHHHHH
Confidence 7899999999999999 9999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.09 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=207.8
Q ss_pred CeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCCC--HHHHHHHHHHHHHHHHc-CCCceeeeecccccCCce
Q 002331 677 DLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~--~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l 748 (935)
.|++.+.||+|+||.||+++. +|+.||+|++...... ....+.+.+|+.+++++ +|+||+++++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999975 5788999998754321 12345678899999999 699999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 9999999999999998764 46889999999999999999999998 99999999999999999999999999876543
Q ss_pred Cc-ccCCCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccccCCCCcC
Q 002331 829 TF-LSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKEL 901 (935)
Q Consensus 829 ~~-~~~~s~~GT~~Y~APEvl~g~--~~s~ksDIWSLG~ILyELLTG~~PF~~~~~----~eil~~I~~~~~r~~ip~~l 901 (935)
.. .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||..... ..+...+ ......++..+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQEM 235 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCccC
Confidence 21 112235688999999998753 467899999999999999999999974322 2233222 22344567788
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 902 DPLVARIIWECWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
++.+.++|.+||+.+ |.+|| ++++++.|||
T Consensus 236 ~~~~~~ll~~~l~~~---p~~R~~~~~~~~~~l~~~~~ 270 (290)
T cd05613 236 SALAKDIIQRLLMKD---PKKRLGCGPSDADEIKKHPF 270 (290)
T ss_pred CHHHHHHHHHHhcCC---HHHhcCCCCCCHHHHHcCcc
Confidence 999999999999999 99997 8999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=323.45 Aligned_cols=250 Identities=28% Similarity=0.414 Sum_probs=210.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
..|...+.||+|+||.||+|++ ++..||||.+..... .......+.+|+.+++.++|+||+++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4577788899999999999976 677899998865422 3344556788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+. ++|.+++......+++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9996 5788777554556899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||...+.......+.........+..++..+.+||
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence 2356888999999974 345788999999999999999999999887766655554333333333456889999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcCC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRFQ 935 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPFq 935 (935)
.+||+.+ |.+||++.++++|||.
T Consensus 248 ~~cl~~~---P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 248 DSCLQKI---PQDRPTSEVLLKHRFV 270 (308)
T ss_pred HHHhhCC---cccCCCHHHHhhCccc
Confidence 9999999 9999999999999994
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.94 Aligned_cols=236 Identities=20% Similarity=0.326 Sum_probs=196.6
Q ss_pred EeeecCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 683 RIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
.||+|+||.||+|.+. ...|++|.+.... ....+.+..|+.+++.+.||||+++++++..+...++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 5899999999999752 2347888764332 2344567889999999999999999999999899999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc--------EEEEecccccc
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--------VKVSDFGLSRL 825 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~--------VKL~DFGlA~~ 825 (935)
|+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +|++|||++..
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999876667899999999999999999999998 999999999999987654 69999998875
Q ss_pred ccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG-~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
.... ....++..|+|||++.+ ..++.++|||||||++|+|++| ..||...+........ ..+..+|.....
T Consensus 158 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY---EDRHQLPAPKWT 230 (258)
T ss_pred cCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH---HccccCCCCCcH
Confidence 4332 23567889999999986 4578999999999999999998 5677766665443322 234566777788
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+.+||.+||+.+ |.+||++++|++.
T Consensus 231 ~~~~li~~~l~~~---p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYE---PDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccC---hhhCCCHHHHHHh
Confidence 9999999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=327.28 Aligned_cols=247 Identities=26% Similarity=0.338 Sum_probs=199.3
Q ss_pred Eeeec--CcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCC
Q 002331 683 RIGLG--SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 683 ~LG~G--~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 758 (935)
.||+| +||+||++++ .++.||||++..........+.+.+|+.+++.++||||++++++|..++.+++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999987 7899999998766555556678899999999999999999999999999999999999999
Q ss_pred CHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc-----
Q 002331 759 SLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS----- 832 (935)
Q Consensus 759 sL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~----- 832 (935)
+|.+++.+.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++||+.+.........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999987532 35889999999999999999999998 999999999999999999999999865432211100
Q ss_pred --CCCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc----------------
Q 002331 833 --SKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---------------- 892 (935)
Q Consensus 833 --~~s~~GT~~Y~APEvl~g~--~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~---------------- 892 (935)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 1112345679999999764 47899999999999999999999998775544332221100
Q ss_pred -----------------------------cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 -----------------------------RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 -----------------------------~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.....+..+++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d---P~~Rpta~e~l~~~~ 310 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQD---PEKRPSASSLLSHAF 310 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCC---cccCCCHHHHhhCHH
Confidence 001112345678999999999999 999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.89 Aligned_cols=249 Identities=28% Similarity=0.488 Sum_probs=206.4
Q ss_pred eeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC------
Q 002331 678 LVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~------ 746 (935)
|.+.+.||+|+||.||+|.+ .+..||||++..........+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 56778899999999999975 3578999998776656666778899999999999999999999875432
Q ss_pred ceEEEEeeCCCCCHHHHHcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecc
Q 002331 747 NLSIITEFLPRGSLFRILHR-----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~-----~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFG 821 (935)
..++++||+.+++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 24789999999999887642 1234788899999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCC
Q 002331 822 LSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (935)
Q Consensus 822 lA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip 898 (935)
+++....... ......+++.|++||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCC
Confidence 9886543211 1122345678999999998889999999999999999999 899998887776665553 23344555
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
..++..+.+++.+||+.+ |.+||++.+++++
T Consensus 238 ~~~~~~~~~l~~~~l~~~---p~~Rps~~~~~~~ 268 (273)
T cd05074 238 PDCLEDVYELMCQCWSPE---PKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCHHHHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 678899999999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=325.51 Aligned_cols=249 Identities=23% Similarity=0.343 Sum_probs=206.0
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC------
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~------ 746 (935)
.++|++.+.||+|+||.||++.. .++.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 46799999999999999999976 6889999998654434444566889999999999999999999987654
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999999 6799988865 46899999999999999999999998 999999999999999999999999998765
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------- 894 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r----------- 894 (935)
... .....+++.|++||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+......
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 169 DSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred ccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 432 223467889999999876 45789999999999999999999999877654333222110000
Q ss_pred ------------------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 ------------------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ------------------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+...+++.+.++|.+||+.| |.+||++.+++.|||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d---P~~R~t~~~~l~~~~ 300 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLD---AESRITAAEALAHPY 300 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCC---hhhCCCHHHHhcCcc
Confidence 0122457888999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=327.73 Aligned_cols=252 Identities=20% Similarity=0.317 Sum_probs=204.1
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccC--CceE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP--PNLS 749 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~--~~l~ 749 (935)
.++|++.+.||+|+||.||+|.+ .++.||||++............+.+|+.+++++ +||||++++++|... ..+|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 36789999999999999999976 578899998865433333445677899999999 999999999988643 3589
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||++ ++|..++... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999997 5999988763 6788899999999999999999998 999999999999999999999999999865432
Q ss_pred cc-----cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc----------
Q 002331 830 FL-----SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---------- 893 (935)
Q Consensus 830 ~~-----~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~---------- 893 (935)
.. ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 11 1223468899999998765 4578899999999999999999999987655443332211100
Q ss_pred ----------------c---cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 ----------------R---LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 ----------------r---~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. ..+...++.++.++|.+||+.+ |.+||++.++++|||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~---P~~Rps~~~il~~~~ 297 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFN---PNKRLTAEEALEHPY 297 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCC---cccccCHHHHhhChh
Confidence 0 0111336889999999999999 999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.58 Aligned_cols=244 Identities=28% Similarity=0.429 Sum_probs=207.4
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 759 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGs 759 (935)
.+||+|+||.||++.. +++.||||++.... ......+.+|+.+++.++|+||+++++.+...+..++||||+++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 5699999999999976 67899999875432 2345668899999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCCC
Q 002331 760 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 839 (935)
Q Consensus 760 L~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT 839 (935)
|.+++.. ..+++..++.++.|++.||+|||+.| |+||||||+||++++++.++|+|||++..............++
T Consensus 104 L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 104 LTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence 9998865 35789999999999999999999998 9999999999999999999999999887654332223345688
Q ss_pred CCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCcCcHHHHHHHHHHHhhCCC
Q 002331 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWECWQTGWS 918 (935)
Q Consensus 840 ~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~-~~r~~ip~~ls~~L~dLI~qCL~~D~s 918 (935)
..|++||.+.+..++.++|+||||+++|+|++|..||.+.........+... .........+++.+.++|.+||+.+
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~-- 257 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD-- 257 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC--
Confidence 9999999998888899999999999999999999999987766555443211 1122233457899999999999999
Q ss_pred CcCCCcCHHHHHhCcC
Q 002331 919 SLHIRTSQAQLSHKRF 934 (935)
Q Consensus 919 sP~kRPSa~EILqHPF 934 (935)
|.+||++.++++|||
T Consensus 258 -P~~R~~~~~ll~~~~ 272 (292)
T cd06657 258 -PAQRATAAELLKHPF 272 (292)
T ss_pred -cccCcCHHHHhcChH
Confidence 999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=350.36 Aligned_cols=254 Identities=16% Similarity=0.215 Sum_probs=191.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEEC---CceEEEEE--------------eec-cCCCHHHHHHHHHHHHHHHHcCCCcee
Q 002331 675 WEDLVLGERIGLGSYGEVYHADWN---GTEVAVKK--------------FLD-QDFSGAALLEFKREVKIMRRLRHPNVV 736 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~~---g~~VAVK~--------------i~~-~~~~~~~~~~f~~Ei~iL~~L~HPNIV 736 (935)
.++|++++.||+|+||+||++... +..+++|. +.+ ..........+.+|+.+|++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998642 11222221 111 111223345678999999999999999
Q ss_pred eeecccccCCceEEEEeeCCCCCHHHHHcCCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC
Q 002331 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPH----CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812 (935)
Q Consensus 737 kl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~----~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~ 812 (935)
++++++...+..|+|+|++. ++|..++.... .......++.|+.||+.||.|||++| ||||||||+||||+.+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCD 303 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence 99999999999999999995 47777764321 22345667789999999999999998 9999999999999999
Q ss_pred CcEEEEeccccccccCCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC-CCCC--ChH-HHHHH
Q 002331 813 WNVKVSDFGLSRLKHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP-WIGM--NPM-QVVGA 887 (935)
Q Consensus 813 g~VKL~DFGlA~~~~~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~P-F~~~--~~~-eil~~ 887 (935)
+.+||+|||+++...... .......||..|+|||++.+..++.++|||||||+||||++|..+ |... ++. ++...
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 999999999998764432 222345799999999999999999999999999999999998764 4332 221 11111
Q ss_pred hhccc-ccc-----------------------CC-----CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 888 VGFQN-RRL-----------------------EI-----PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 888 I~~~~-~r~-----------------------~i-----p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+.... ... .+ ...++.++.++|.+||+.| |.+||++.|+|+|||
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~D---P~~Rpsa~elL~hp~ 456 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD---WHLRPGAAELLALPL 456 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccC---cccCcCHHHHhhChh
Confidence 11000 000 00 1235667888999999999 999999999999999
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.99 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=203.5
Q ss_pred CCee-EEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHH------------HHHHHHHHHHHHHHcCCCceeeeec
Q 002331 676 EDLV-LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA------------ALLEFKREVKIMRRLRHPNVVLFMG 740 (935)
Q Consensus 676 edy~-I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~------------~~~~f~~Ei~iL~~L~HPNIVkl~g 740 (935)
++|. +.+.||.|+||+||+|.+ .++.||||++........ ....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3443 567899999999999975 578999999865432210 0124678999999999999999999
Q ss_pred ccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
++..++..++||||+. ++|.+++... ..+++.....++.||+.||.|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCc
Confidence 9999999999999997 5899988653 46899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCC--------------cccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 002331 821 GLSRLKHNT--------------FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885 (935)
Q Consensus 821 GlA~~~~~~--------------~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil 885 (935)
|++...... ........++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998765411 1111223467889999998764 4689999999999999999999999988776655
Q ss_pred HHhhcccccc--------------------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 886 GAVGFQNRRL--------------------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 886 ~~I~~~~~r~--------------------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+......+ .+...++..+.++|.+||+.+ |.+||+++++|.|||
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLN---PLERISAKEALKHEY 315 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCC---chhccCHHHHhcCcc
Confidence 4332110000 011345788999999999999 999999999999999
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=311.49 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=202.7
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeecccccCCceEEEEee
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
|++.+.||.|+||.||+|.. .++.|+||++...... .......+|+..+++++ |+||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999987 5778999988654322 22233457899999998 99999999999999999999999
Q ss_pred CCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 755 LPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 755 ~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
+ +++|.+++.... ..+++..+..++.||+.+|.|||+++ |+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~ 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PY 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCC-Cc
Confidence 9 779998886643 46899999999999999999999998 9999999999999999999999999998665432 22
Q ss_pred CCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------------c
Q 002331 834 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-----------------L 895 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r-----------------~ 895 (935)
....++..|+|||++.+ ..++.++|+||||+++|+|++|++||...........+...... .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 33568889999998854 45789999999999999999999999877654443322110000 0
Q ss_pred -----------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 -----------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 -----------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
......+..+.++|.+||+.+ |.+||++.|++.|||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~---p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWD---PKKRPTASQALQHPY 282 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccC---cccCCCHHHHhhCCC
Confidence 001123678999999999999 999999999999999
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.40 Aligned_cols=257 Identities=23% Similarity=0.305 Sum_probs=209.5
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc-
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN- 747 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~- 747 (935)
+-|+-++|.|.+.||+|||.-||+++. +++.||+|++.... .+..+...+|++..++++|||+++++++...+..
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 457778999999999999999999975 78899999998775 3456778899999999999999999998754444
Q ss_pred ----eEEEEeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 748 ----LSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 748 ----l~LVmEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
.||++.|...|+|.+.+.+ .+..+++.+++.|+.+|++||++||...++++||||||.|||+.+.+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 9999999999999998864 455799999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcc---------cCCCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh
Q 002331 821 GLSRLKHNTFL---------SSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 888 (935)
Q Consensus 821 GlA~~~~~~~~---------~~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I 888 (935)
|.+....-... ......-|..|+|||.+.- ...++++|||||||+||+|+.|.-||...-...---+.
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 99876432110 1112345889999999974 44689999999999999999999999753221000011
Q ss_pred hccccccCCC--CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 889 GFQNRRLEIP--KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 889 ~~~~~r~~ip--~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
........+| ..++..+.+||++||+.| |.+||+..+++.+
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvd---P~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVD---PNQRPTIPELLSK 296 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCC---cccCCCHHHHHHH
Confidence 1122233333 448999999999999999 9999999999865
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=325.64 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=207.0
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc-----
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----- 747 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~----- 747 (935)
.++|++.+.||+|+||.||+|++ .+..||||++............+.+|+.+++.++|+||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 46899999999999999999987 57889999887553333344567789999999999999999998876654
Q ss_pred -eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 -LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 -l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
+++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 5699999875 46899999999999999999999998 999999999999999999999999998865
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc----------
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---------- 895 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~---------- 895 (935)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+......+
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred ccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 432 234567889999999865 357889999999999999999999998877655544332110000
Q ss_pred -------------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 -------------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 -------------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+...++..+.++|.+||+.+ |.+||++.+|++|||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~---P~~Rpt~~ell~h~~ 300 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLD---PDKRITAAEALAHPY 300 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCC---hhhCCCHHHHhcCCC
Confidence 011235789999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=325.17 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=201.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC------c
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------N 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~------~ 747 (935)
++|.+.+.||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 5799999999999999999976 5889999998765433334456789999999999999999999886543 4
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+++||||+.. +|..++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 6899999964 7777663 35889999999999999999999998 9999999999999999999999999987643
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-------------
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 893 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~------------- 893 (935)
.. .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 169 AE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred CC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 22 223567889999999876 4588999999999999999999999998775544433211000
Q ss_pred --------ccCC--------CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 --------RLEI--------PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 --------r~~i--------p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...+ ....++.+.+||.+||+.| |.+||++.+++.|||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d---P~~R~~~~e~l~h~~ 299 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELD---VDKRLTATEALEHPY 299 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCC---hhhCcCHHHHhcCcc
Confidence 0000 1246778999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=358.80 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=203.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.++||+|+||.||+|.+ .++.||||++..... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 6899999999999999999976 578999999875432 2344567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccc
Q 002331 753 EFLPRGSLFRILHRP----------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~----------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGl 822 (935)
||+++++|.+++... ....+...++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999988531 123456678889999999999999998 99999999999999999999999999
Q ss_pred cccccCC------------------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 002331 823 SRLKHNT------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884 (935)
Q Consensus 823 A~~~~~~------------------~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~ei 884 (935)
++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9865210 0111234699999999999999999999999999999999999999987655443
Q ss_pred HHHhhccccccCC--CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHH
Q 002331 885 VGAVGFQNRRLEI--PKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930 (935)
Q Consensus 885 l~~I~~~~~r~~i--p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EIL 930 (935)
..... ...+... ...+++.+.+++.+||+.| |.+|++..+.+
T Consensus 240 ~~~~~-i~~P~~~~p~~~iP~~L~~LI~rcL~~D---P~kR~ss~eeL 283 (932)
T PRK13184 240 SYRDV-ILSPIEVAPYREIPPFLSQIAMKALAVD---PAERYSSVQEL 283 (932)
T ss_pred hhhhh-ccChhhccccccCCHHHHHHHHHHccCC---hhhCcCHHHHH
Confidence 32211 1111111 2467889999999999999 99997665544
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=334.63 Aligned_cols=256 Identities=23% Similarity=0.287 Sum_probs=220.1
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEE--ECCceEEEEEeeccCCCHH-HHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~--~~g~~VAVK~i~~~~~~~~-~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
..+..+.|..-++||+|+||.||-++ .+|+-||+|++.+...... .......|..||.++..++||.+-.+|+..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 34566789999999999999999885 4799999998876655432 23345789999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
+++||..|.||+|.-+|...+ ..+++..++.++.+|+.||++||+.+ ||+|||||+|||||+.|+|+|.|+|+|..+
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999999998886533 46999999999999999999999998 999999999999999999999999999977
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccccCCCCcCc
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELD 902 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~----~eil~~I~~~~~r~~ip~~ls 902 (935)
.+. ......+||..|||||++.++.|+...|+|+|||+||||+.|+-||..... .++-..+ .....+++..++
T Consensus 338 ~~g-~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~--~~~~~ey~~kFS 414 (591)
T KOG0986|consen 338 PEG-KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT--LEDPEEYSDKFS 414 (591)
T ss_pred CCC-CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH--hcchhhcccccC
Confidence 654 233456899999999999999999999999999999999999999986432 2333333 445667889999
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 903 PLVARIIWECWQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPS-----a~EILqHPF 934 (935)
+++++|.+.+|++| |.+|.. ++++-+|||
T Consensus 415 ~eakslc~~LL~Kd---p~~RLGcrg~ga~evk~Hpf 448 (591)
T KOG0986|consen 415 EEAKSLCEGLLTKD---PEKRLGCRGEGAQEVKEHPF 448 (591)
T ss_pred HHHHHHHHHHHccC---HHHhccCCCcCcchhhhCcc
Confidence 99999999999999 999965 558999997
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=321.87 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=203.6
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC------
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------ 745 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~------ 745 (935)
..++|.+.+.||+|+||.||++.. +++.||||++............+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 347899999999999999999975 688999999876543333455678899999999999999999987533
Q ss_pred CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
...+++++++ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3478888887 7799988865 35899999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-----------
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----------- 893 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~----------- 893 (935)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 170 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 170 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 5332 233567899999999876 4678899999999999999999999987665443332211000
Q ss_pred ----------ccCC--------CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 ----------RLEI--------PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 ----------r~~i--------p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...+ ....++++.+||.+||+.| |.+||++.++++|||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---p~~R~t~~e~l~h~~ 302 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD---SDKRITAAQALAHAY 302 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCC---hhhcCCHHHHhcChh
Confidence 0001 1235788999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=341.40 Aligned_cols=255 Identities=27% Similarity=0.473 Sum_probs=224.6
Q ss_pred ccccCCCCCCeeEEEEeeecCcEEEEEEEE----CCc--eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecc
Q 002331 668 VCECEIPWEDLVLGERIGLGSYGEVYHADW----NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741 (935)
Q Consensus 668 ~~~~ei~~edy~I~e~LG~G~fG~Vyka~~----~g~--~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~ 741 (935)
...+++..+.+.+.+.||.|-||.||+|.+ .|+ .||||..+.... .+..+.|..|..+|++++|||||+++|+
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 345677778888899999999999999965 233 488887766543 3447889999999999999999999999
Q ss_pred cccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecc
Q 002331 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (935)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFG 821 (935)
+.+ ...|||||.++.|.|..|++.+...++......++.||+.||.|||+.. +|||||-.+||||.....|||+|||
T Consensus 460 ~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 460 CVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred eec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccc
Confidence 987 4689999999999999999998888999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcccCCCC-CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCC
Q 002331 822 LSRLKHNTFLSSKST-AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 899 (935)
Q Consensus 822 lA~~~~~~~~~~~s~-~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~ 899 (935)
+++.+.+..+...+. .-..-|||||-++-.+++.++|||.||+++||++. |.-||.+..+.+++..+. .+.+++.|.
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-nGeRlP~P~ 615 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-NGERLPCPP 615 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-CCCCCCCCC
Confidence 999987765543332 22457999999999999999999999999999875 889999999888887775 778889999
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHH
Q 002331 900 ELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~kRPSa~EIL 930 (935)
+||+.+..|+.+||..+ |.+||.+.+|.
T Consensus 616 nCPp~LYslmskcWaye---P~kRPrftei~ 643 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYE---PSKRPRFTEIK 643 (974)
T ss_pred CCChHHHHHHHHHhccC---cccCCcHHHHH
Confidence 99999999999999999 99999999875
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=311.69 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=206.5
Q ss_pred CeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCCC--HHHHHHHHHHHHHHHHc-CCCceeeeecccccCCce
Q 002331 677 DLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~--~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l 748 (935)
+|++.+.||+|+||.||++++ +++.||||++...... ......+..|+.++.++ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478999999999999999964 4678999998754321 22345678899999999 699999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++||||+++++|.+++.+. ..+++..+..++.|++.||.|||..+ ++||||||.||+++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 9999999999999998653 46889999999999999999999998 99999999999999999999999999876543
Q ss_pred Ccc-cCCCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccccCCCCcC
Q 002331 829 TFL-SSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKEL 901 (935)
Q Consensus 829 ~~~-~~~s~~GT~~Y~APEvl~g~~--~s~ksDIWSLG~ILyELLTG~~PF~~~~~----~eil~~I~~~~~r~~ip~~l 901 (935)
... ......|+..|++||.+.+.. .+.++||||||+++|+|++|..||..... ..+...+ .......+..+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPKTM 235 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCccc
Confidence 221 122346889999999987665 68899999999999999999999964322 2222222 22334567778
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcC---HHHHHhCcC
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTS---QAQLSHKRF 934 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPS---a~EILqHPF 934 (935)
+..+.++|.+||+.+ |++||+ +.++|+|||
T Consensus 236 ~~~l~~li~~~l~~~---p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 236 SAEARDFIQKLLEKD---PKKRLGANGADEIKNHPF 268 (288)
T ss_pred CHHHHHHHHHHhcCC---HhhccCcchHHHHhcCcc
Confidence 999999999999999 999998 577899998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=373.42 Aligned_cols=251 Identities=30% Similarity=0.451 Sum_probs=219.7
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|+-+.+||.|.||.||.|.. +|...|+|-++.+.........+.+|+.++..|+|||+|++||+-.+.+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 455677899999999999965 788899998887766555666788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc---
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--- 831 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~--- 831 (935)
|++|+|.+++.. ++..++.....+..|++.|+.|||++| ||||||||.||||+.+|.||++|||.|..+.....
T Consensus 1316 C~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred hccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 999999999976 345777777778899999999999999 99999999999999999999999999988765421
Q ss_pred -cCCCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccccccCCCCcCcHHHH
Q 002331 832 -SSKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 832 -~~~s~~GT~~Y~APEvl~g~~---~s~ksDIWSLG~ILyELLTG~~PF~~~~~-~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
.-....||+.|||||++.+.. ...+.|||||||++.||+||+.||...+. -+++.++. .+..+.+|..++.+-+
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-AGHKPQIPERLSSEGR 1471 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh-ccCCCCCchhhhHhHH
Confidence 123568999999999998654 56799999999999999999999987644 55566664 6778889999999999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++|.+||..| |++|.++.|||+|.|
T Consensus 1472 dFle~Cl~~d---P~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1472 DFLEHCLEQD---PKMRWTASQLLEHAF 1496 (1509)
T ss_pred HHHHHHHhcC---chhhhHHHHHHHhhc
Confidence 9999999999 999999999999987
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=322.10 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=201.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC--------
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-------- 745 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~-------- 745 (935)
.+|.+.+.||.|+||.||+|.. +++.||+|++..... .....+.+|+.+++.++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 6899999999999999999976 578999999876543 3345678899999999999999999876543
Q ss_pred ------CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec-CCCcEEEE
Q 002331 746 ------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVS 818 (935)
Q Consensus 746 ------~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~VKL~ 818 (935)
..+++||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+|||++ .++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 589888864 35889999999999999999999998 99999999999997 55679999
Q ss_pred eccccccccCCcc---cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc---
Q 002331 819 DFGLSRLKHNTFL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--- 891 (935)
Q Consensus 819 DFGlA~~~~~~~~---~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~--- 891 (935)
|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999876532211 1122357889999998754 55788999999999999999999999887665443332110
Q ss_pred --------------------cccc-----CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 892 --------------------NRRL-----EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 892 --------------------~~r~-----~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.... .+...++.++.+||.+||+.| |.+||++.++++|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~R~t~~ell~h~~ 302 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFN---PMDRLTAEEALMHPY 302 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCC---chhccCHHHHhCCCc
Confidence 0000 012357788999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=328.41 Aligned_cols=255 Identities=23% Similarity=0.367 Sum_probs=224.4
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEECC--ceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~g--~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~ 747 (935)
.|...+|.++.+||+|+||.|.++..+| +.||||++++... ..+..+--..|.++|... +-|.+++++..|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 5667899999999999999999997754 5699999887643 223344445678888877 67899999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+|+||||+.||+|...|++- +++-+..+..++.+|+-||-|||++| ||+||||.+||||+.+|+|||+|||+++.-.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999999999999774 46778888889999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
-......+++|||.|+|||++..++|+..+|+|++|++||||+.|++||.+.+..++...|. .....+|+.++.+...
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~--ehnvsyPKslSkEAv~ 579 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM--EHNVSYPKSLSKEAVA 579 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--HccCcCcccccHHHHH
Confidence 55566788999999999999999999999999999999999999999999999999988884 5567789999999999
Q ss_pred HHHHHHhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPS-----a~EILqHPF 934 (935)
+++..|.+. |.+|.. -++|-.|||
T Consensus 580 ickg~ltK~---P~kRLGcg~~ge~di~~H~F 608 (683)
T KOG0696|consen 580 ICKGLLTKH---PGKRLGCGPEGERDIREHPF 608 (683)
T ss_pred HHHHHhhcC---CccccCCCCccccchhhCcc
Confidence 999999999 999964 356778876
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.14 Aligned_cols=243 Identities=22% Similarity=0.373 Sum_probs=192.8
Q ss_pred EeeecCcEEEEEEEE-CCc---eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCC
Q 002331 683 RIGLGSYGEVYHADW-NGT---EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~-~g~---~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 758 (935)
.||+|+||.||+++. ++. .+++|.+.... .......+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 589999999999964 332 45566654432 2344667899999999999999999999999999999999999999
Q ss_pred CHHHHHcCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc--ccC
Q 002331 759 SLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSS 833 (935)
Q Consensus 759 sL~dlL~~~~---~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~--~~~ 833 (935)
+|.+++.+.. ...++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999997532 34567778889999999999999998 9999999999999999999999999986432211 112
Q ss_pred CCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc----cccCCCCcC
Q 002331 834 KSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN----RRLEIPKEL 901 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g-------~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~----~r~~ip~~l 901 (935)
....++..|+|||++.. ..++.++|||||||++|||++ |..||...+..+....+.... .++.++..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 34567889999999753 235779999999999999997 577898877766655443221 123344567
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
++.+.++|..|| .+ |.+||++++|++.
T Consensus 239 ~~~~~~l~~~c~-~~---P~~Rp~~~~i~~~ 265 (268)
T cd05086 239 SERWYEVLQFCW-LS---PEKRATAEEVHRL 265 (268)
T ss_pred cHHHHHHHHHHh-hC---cccCCCHHHHHHH
Confidence 889999999999 68 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.92 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=203.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc-CCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~-~~~l~LV 751 (935)
.++|++.+.||.|+||.||++.. +++.||||++............+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 46799999999999999999975 67889999886544333445567789999999999999999998865 5678999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||+|.|||++.++.+||+|||++......
T Consensus 89 ~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 89 TELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred eehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 9999 5689988865 35788888899999999999999999 999999999999999999999999998754322
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--------------------
Q 002331 832 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------------- 890 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~-------------------- 890 (935)
.....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 233467889999998766 5689999999999999999999999987665322211100
Q ss_pred ----cccccC-----CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 891 ----QNRRLE-----IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 891 ----~~~r~~-----ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...... ....+++.+.++|.+||+.+ |.+||++.+++.|||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~R~t~~ell~~~~ 290 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFD---PQKRISAAEALAHPY 290 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCC---hhhCCCHHHHhcCCc
Confidence 000011 11346789999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.53 Aligned_cols=251 Identities=23% Similarity=0.291 Sum_probs=199.8
Q ss_pred CeeEEEEeeecCcEEEEEEEEC----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeeccccc----CCc
Q 002331 677 DLVLGERIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----PPN 747 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~~----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~----~~~ 747 (935)
+|++.+.||+|+||.||++.+. +..||||++............+.+|+.+++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4889999999999999999874 56899998865432333455677899999999 59999999986432 245
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
++++|||+. ++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 789999986 589988865 346899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcc----cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-----------
Q 002331 828 NTFL----SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ----------- 891 (935)
Q Consensus 828 ~~~~----~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~----------- 891 (935)
.... ......|+..|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+...
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3211 1223568999999998765 56899999999999999999999999876543322211100
Q ss_pred ---------------cccc---CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 892 ---------------NRRL---EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 892 ---------------~~r~---~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.... .+...++..+.+||.+||+.+ |.+||++.+++.|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---P~~R~t~~~ll~~~~ 294 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFD---PTKRISVEEALEHPY 294 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCC---cccCCCHHHHhcChh
Confidence 0000 111345789999999999999 999999999999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=339.46 Aligned_cols=255 Identities=23% Similarity=0.351 Sum_probs=232.0
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEECCce--EEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~g~~--VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
....+++++..||-|+||.|=+++.++.. +|+|++++... .....+.+..|..||..++.|+||++|..|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 44567778888999999999999886665 89999887654 3345667889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
|.||-|-||.|+.++..+ +.|++.....++.-+++|++|||.+| ||+|||||+|+||+.+|-+||.|||+|+.+...
T Consensus 497 mLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999999764 57888888889999999999999999 999999999999999999999999999988766
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
.. .-++|||++|.|||++.++..+.++|.|+|||++|||++|.+||.+.+++..+..|......+.+|..++....+||
T Consensus 574 ~K-TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 574 RK-TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred Cc-eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 33 45699999999999999999999999999999999999999999999999999999888888899999999999999
Q ss_pred HHHHhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPS-----a~EILqHPF 934 (935)
++++..+ |.+|.. ..+|-+|.|
T Consensus 653 k~LCr~~---P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 653 KKLCRDN---PTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred HHHHhcC---cHhhhccccCChHHHHhhhh
Confidence 9999999 999976 788999988
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=336.82 Aligned_cols=247 Identities=27% Similarity=0.395 Sum_probs=215.7
Q ss_pred EEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCC
Q 002331 681 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 758 (935)
.++||.|.||+||-|++ +|+.||||+|.+-.+.......+..|+.||+++.||.||.+...|+..+.+++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 46699999999999965 7999999999998887777788999999999999999999999999999999999999776
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC---CCcEEEEeccccccccCCcccCCC
Q 002331 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKHNTFLSSKS 835 (935)
Q Consensus 759 sL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~VKL~DFGlA~~~~~~~~~~~s 835 (935)
-|.-+|....+++++.....++.||+.||.|||-++ |+|+||||+||||.. --++||||||+|+.+.+... ..+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-Rrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-RRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhh-hhh
Confidence 666677777788999999999999999999999999 999999999999964 35699999999999887643 467
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccccccCCCCcCcHHHHHHHHHHHh
Q 002331 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914 (935)
Q Consensus 836 ~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~-~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~ 914 (935)
.+||+.|+|||+++++.|...-|+||+|+|+|--+.|.+||...+. .+.+....+. .++.-.+.+++...+||..+|+
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM-yPp~PW~eis~~AidlIn~LLq 804 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM-YPPNPWSEISPEAIDLINNLLQ 804 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc-cCCCchhhcCHHHHHHHHHHHH
Confidence 8999999999999999999999999999999999999999986533 3333322222 2333346789999999999999
Q ss_pred hCCCCcCCCcCHHHHHhCcC
Q 002331 915 TGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 915 ~D~ssP~kRPSa~EILqHPF 934 (935)
.. -.+|.+.+..|.|||
T Consensus 805 Vk---m~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 805 VK---MRKRYSVDKSLSHPW 821 (888)
T ss_pred HH---HHHhcchHhhccchh
Confidence 99 999999999999999
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=348.17 Aligned_cols=147 Identities=28% Similarity=0.447 Sum_probs=133.1
Q ss_pred CCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
.++|.+.++||+|+||.||+|.+. ++.||||++..... .......+..|+.++..++||||+++++++...+.+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 478999999999999999999874 88999999876443 344556788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
|||+.+++|.+++... ..+++..++.|+.||+.||.|||.++ ||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999764 46889999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=319.25 Aligned_cols=244 Identities=25% Similarity=0.378 Sum_probs=203.9
Q ss_pred CCeeE-EEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeeccccc----CCc
Q 002331 676 EDLVL-GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----PPN 747 (935)
Q Consensus 676 edy~I-~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~----~~~ 747 (935)
++|.| -++||-|-.|.|..+.+ .++++|+|++.... ...+|+++.-.. .|||||.++++|++ ...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45655 36799999999999965 68899999876542 456788776655 79999999999854 355
Q ss_pred eEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec---CCCcEEEEecccc
Q 002331 748 LSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLS 823 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd---~~g~VKL~DFGlA 823 (935)
+.+|||.|+||.|+.-|+.. ...+++.++..|+.||..|+.|||..+ |.||||||+|+|.. .+..+||+|||+|
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccc
Confidence 88999999999999988653 456999999999999999999999999 99999999999996 4567999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccccCCC-
Q 002331 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIP- 898 (935)
Q Consensus 824 ~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~----~eil~~I~~~~~r~~ip- 898 (935)
+..... ....+.+-|+.|.|||++..++|+..+|+||||+++|-|++|.+||+...- ..+..+|.. +...+|
T Consensus 212 K~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~--gqy~FP~ 288 (400)
T KOG0604|consen 212 KETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT--GQYEFPE 288 (400)
T ss_pred cccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc--cCccCCC
Confidence 876543 334567889999999999999999999999999999999999999986543 234445533 333444
Q ss_pred ---CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 ---KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 ---~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++++.+++|+.+|+.+ |.+|.++++++.|||
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~---PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTE---PTERLTIEEVMDHPW 324 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCC---chhheeHHHhhcCch
Confidence 358899999999999999 999999999999999
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=309.48 Aligned_cols=253 Identities=17% Similarity=0.183 Sum_probs=187.7
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEECC-----ceEEEEEeeccCCCHH-HH--------HHHHHHHHHHHHcCCCceee
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGA-AL--------LEFKREVKIMRRLRHPNVVL 737 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~g-----~~VAVK~i~~~~~~~~-~~--------~~f~~Ei~iL~~L~HPNIVk 737 (935)
++...+|++.++||+|+||+||+|.+.+ ..+|+|+......... .. .....+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 4556789999999999999999998743 3566665432221110 00 01122334455668999999
Q ss_pred eecccccCC----ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC
Q 002331 738 FMGAVTRPP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 813 (935)
Q Consensus 738 l~g~~~~~~----~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g 813 (935)
+++.+.... ..++++|++.. ++.+++... ...++..++.|+.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNN 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCC
Confidence 998765443 24678888744 677766543 34678888999999999999999998 99999999999999999
Q ss_pred cEEEEeccccccccCCc-------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHH
Q 002331 814 NVKVSDFGLSRLKHNTF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVV 885 (935)
Q Consensus 814 ~VKL~DFGlA~~~~~~~-------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~-~eil 885 (935)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ....
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 99999999998653211 111234699999999999999999999999999999999999999987732 2221
Q ss_pred HHh-----hccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 886 GAV-----GFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 886 ~~I-----~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
... ............+++.+.+++..||+.+ |++||++.+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLS---YEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCC---CCCCCCHHHHHH
Confidence 111 0001111123457899999999999999 999999999986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=328.03 Aligned_cols=258 Identities=30% Similarity=0.471 Sum_probs=218.4
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEECC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
...+++.+.+.++++||+|-||.|.++...+ ..||||+++.... .....+|.+|+++|.+|+|||||+++|+|..++.
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 3457888899999999999999999998766 8999999876653 3446789999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~-lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
++||+||+++|+|.+|+.+...+ ..-.....|+.||+.||+||.+.+ ||||||.+.|||++.++++||+|||+++-+
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccccccc
Confidence 99999999999999999775333 355666779999999999999999 999999999999999999999999999854
Q ss_pred cCCccc--CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCChHHHHHHhhc------cccccC
Q 002331 827 HNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGMNPMQVVGAVGF------QNRRLE 896 (935)
Q Consensus 827 ~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT--G~~PF~~~~~~eil~~I~~------~~~r~~ 896 (935)
-...+. ....+-..+|||||.+...+++.++|+|+||+++||+++ ...||.....++++..... ....+.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence 332221 122334579999999999999999999999999999775 5789999988888765421 112235
Q ss_pred CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 897 IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 897 ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.|..++..+.++|.+||+.+ -.+||+|++|-.+
T Consensus 768 ~P~~cp~~lyelml~Cw~~e---s~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRE---SEQRPSFEQLHLF 800 (807)
T ss_pred CCCcCcHHHHHHHHHHhchh---hhcCCCHHHHHHH
Confidence 67889999999999999999 9999999998654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=345.20 Aligned_cols=255 Identities=31% Similarity=0.506 Sum_probs=229.0
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
-||......|.++||.|.||.||+|+. +...||||.++.. ..+....+|+.|+.||-++.||||++|.|++...
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 356778899999999999999999976 2346999988655 5667788999999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
...+||+|||++|.|..||.++.++|...++..+++.|+.||.||-+.+ +|||||-.+||||+.+...|+.|||+++.
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceee
Confidence 9999999999999999999998899999999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCcccCCCCC-C--CCCccCcccccCCCCCchhHHHHHHHHHHHHH-cCCCCCCCCChHHHHHHhhccccccCCCCcC
Q 002331 826 KHNTFLSSKSTA-G--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (935)
Q Consensus 826 ~~~~~~~~~s~~-G--T~~Y~APEvl~g~~~s~ksDIWSLG~ILyELL-TG~~PF~~~~~~eil~~I~~~~~r~~ip~~l 901 (935)
+.++.....+.. | ..+|.|||.+...+++.++||||+||+|||.+ .|..||.++.+.+++..|. ...+++-|-+|
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmDC 859 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMDC 859 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCCC
Confidence 866542222222 2 35899999999999999999999999999977 4899999999999999986 67888889999
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
|..|.+|+..||++| -.+||.|.||+.+
T Consensus 860 P~aL~qLMldCWqkd---R~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKD---RNRRPKFAQIVST 887 (996)
T ss_pred cHHHHHHHHHHHHHH---hhcCCCHHHHHHH
Confidence 999999999999999 9999999998753
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=314.42 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=204.1
Q ss_pred EEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEEeeCCC
Q 002331 681 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
.+.||+|+|+.|-.+.. ++..||||++.++. ......+.+|++++.+. .|+||++++++|+++..+|||||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 35699999999998854 89999999998773 45667788999999999 699999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC---cEEEEeccccccccCCc----
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRLKHNTF---- 830 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g---~VKL~DFGlA~~~~~~~---- 830 (935)
|.|...|.+. .-|++.++.++..+|+.||.|||.+| |.||||||+|||..... .||||||.++.......
T Consensus 161 GplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 161 GPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred chHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999998763 46999999999999999999999999 99999999999996544 48999999876543211
Q ss_pred ---ccCCCCCCCCCccCccccc---C--CCCCchhHHHHHHHHHHHHHcCCCCCCCC-------Ch---HHHHHHh---h
Q 002331 831 ---LSSKSTAGTPEWMAPEVLR---N--EPSNEKCDVYSFGVILWELATLKLPWIGM-------NP---MQVVGAV---G 889 (935)
Q Consensus 831 ---~~~~s~~GT~~Y~APEvl~---g--~~~s~ksDIWSLG~ILyELLTG~~PF~~~-------~~---~eil~~I---~ 889 (935)
-...+.+|+..|||||+.. + ..|+.++|.||||+|||-|+.|++||.+. +. -...... .
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 1123457889999999863 3 35899999999999999999999999863 11 1111111 1
Q ss_pred ccccccCCCC----cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 890 FQNRRLEIPK----ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 890 ~~~~r~~ip~----~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+.+..++|. +++.+.++||..+|..| +..|.++.++++|||
T Consensus 318 IQEGkYeFPdkdWahIS~eakdlisnLlvrd---a~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRD---AKQRLSAAQVLNHPW 363 (463)
T ss_pred HhccCCcCChhhhHHhhHHHHHHHHHHHhcc---HHhhhhhhhccCCcc
Confidence 2455666663 58899999999999999 999999999999999
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=294.66 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=214.6
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|.-.++||+|+||+||+++. .++.||+|.++..+-.+.......+|+-+|+.++|.|||++++....+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 344557899999999999975 577899999987766665666788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
|.. +|..++...++.++.+....++.|+++||.|+|.++ ++||||||.|+||+.+|.+||+|||+++..+-+.....
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 966 899999888888999999999999999999999999 99999999999999999999999999998877655555
Q ss_pred CCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccc------cC---CC-----
Q 002331 835 STAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRR------LE---IP----- 898 (935)
Q Consensus 835 s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r------~~---ip----- 898 (935)
..+.|.+|.+|.++.|.+ |+...|+||.|||+.|+.. |++.|.+.+..+.+.++-..-+. +. +|
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 567899999999999876 7889999999999999996 56668888777766665211111 10 11
Q ss_pred -------------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 -------------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 -------------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++..-++|++++|..+ |.+|.++++.++|||
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cn---p~qrisaeaalqhpy 285 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCN---PAQRISAEAALQHPY 285 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccC---cccccCHHHHhcCcc
Confidence 123344689999999999 999999999999998
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=328.47 Aligned_cols=254 Identities=34% Similarity=0.577 Sum_probs=225.2
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
.+|++...++.+..+||-|.||.||.|.|+ .-.||||.++... ..+++|..|..+|+.++|||+|+++|+|..+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 567888889999999999999999999884 5679999876543 45788999999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
.+|||+|||..|+|.+||.+.+ ..++...+++++.||..||+||..++ +|||||-.+|+||.++..||++|||++++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999998754 34677888899999999999999999 99999999999999999999999999999
Q ss_pred ccCCcccCC-CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 826 KHNTFLSSK-STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 826 ~~~~~~~~~-s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
+..+.+... ......-|.|||-+....++.|+|||+||++|||+.| |--||.+.+..+++.-+ ....+..-|..|++
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-EkgyRM~~PeGCPp 493 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-EKGYRMDGPEGCPP 493 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-hccccccCCCCCCH
Confidence 876544322 2223568999999999999999999999999999997 67899999988887765 47788999999999
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.+.+|+.+||+.. |..||+|.+|-+
T Consensus 494 kVYeLMraCW~Ws---PsDRPsFaeiHq 518 (1157)
T KOG4278|consen 494 KVYELMRACWNWS---PSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHHHHhcCC---cccCccHHHHHH
Confidence 9999999999999 999999999753
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=315.77 Aligned_cols=259 Identities=23% Similarity=0.335 Sum_probs=211.7
Q ss_pred ccccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeeccccc
Q 002331 668 VCECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR 744 (935)
Q Consensus 668 ~~~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~ 744 (935)
...+++..++++-+..||.|.||+|++..+ .|+..|||+|+.... +..+.++..|.+...+- ++||||++||+...
T Consensus 56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred ccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 344566667777788899999999999976 688999999988765 45566777777765544 89999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 745 PPNLSIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~----~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
++.+||.||+|+ .+|..+.+. ....++|+.+-.|..-.+.||.||...- .||||||||+||||+..|.||||||
T Consensus 135 EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 135 EGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred CCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecCCCEeeecc
Confidence 999999999995 477665532 3457899999999999999999998743 5999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccC-
Q 002331 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLE- 896 (935)
Q Consensus 821 GlA~~~~~~~~~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~-eil~~I~~~~~r~~- 896 (935)
|++-.+.+.. ..+...|...|||||.+.. ..|+.++|+||||++|||+.||.+||.+++.. +.+..+. .+.++.
T Consensus 213 GIcGqLv~Si-AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv-~gdpp~l 290 (361)
T KOG1006|consen 213 GICGQLVDSI-AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV-IGDPPIL 290 (361)
T ss_pred cchHhHHHHH-HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH-cCCCCee
Confidence 9998776653 3445689999999999974 45899999999999999999999999998662 2233332 222322
Q ss_pred -CCC---cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 897 -IPK---ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 897 -ip~---~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+. +.+..+..+|.-||.+| -..||.+.+++++||
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd---~~~Rpky~~Lk~~~f 329 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKD---RSDRPKYDDLKKFPF 329 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcc---cccCcchhhhhcCch
Confidence 222 37788999999999999 999999999999998
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=337.17 Aligned_cols=256 Identities=28% Similarity=0.445 Sum_probs=221.7
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEE--ECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccc-----
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVT----- 743 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~--~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~----- 743 (935)
..+.+.|+|.+.||.|.+|.||+++ ++++..|||++.... ...++++.|.+||+.+ .|||++.+||+|.
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3455779999999999999999995 478899999876543 2345677899999988 7999999999984
Q ss_pred cCCceEEEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccc
Q 002331 744 RPPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (935)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGl 822 (935)
.++.+|||||||.+|+.-++++. .+..+.|..+..|++.++.||.|||++. +||||||=.|||++.++.|||+|||.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeee
Confidence 35679999999999999999975 3567899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-cC
Q 002331 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNE-----PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-LE 896 (935)
Q Consensus 823 A~~~~~~~~~~~s~~GT~~Y~APEvl~g~-----~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r-~~ 896 (935)
+..+........+..||+.|||||++... .|+.++|+||||++..||.-|.+|+.++.++..+..|.....+ +.
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk 249 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 249 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence 99887777777889999999999999643 3678999999999999999999999999999888766422211 12
Q ss_pred CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcCC
Q 002331 897 IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRFQ 935 (935)
Q Consensus 897 ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPFq 935 (935)
-|+..+..+-++|..||.+| ..+||+..++|+|||+
T Consensus 250 rp~kWs~~FndFIs~cL~Kd---~e~RP~~~~ll~hpFi 285 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKD---YEQRPSTEELLKHPFI 285 (953)
T ss_pred chhhHHHHHHHHHHHHHhhc---cccCcchhhhccCCcc
Confidence 35677889999999999999 9999999999999996
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.45 Aligned_cols=226 Identities=20% Similarity=0.252 Sum_probs=190.2
Q ss_pred cCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCCHHHHH
Q 002331 687 GSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL 764 (935)
Q Consensus 687 G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL~dlL 764 (935)
|.||.||++.+ +++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999976 68899999986543 2234555555667999999999999999999999999999999998
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCCCCCccC
Q 002331 765 HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844 (935)
Q Consensus 765 ~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~A 844 (935)
.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+...... .....++..|+|
T Consensus 77 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~a 150 (237)
T cd05576 77 SKF-LNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCA 150 (237)
T ss_pred HHh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccC
Confidence 654 35899999999999999999999998 999999999999999999999999987655432 123456778999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCc
Q 002331 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRT 924 (935)
Q Consensus 845 PEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRP 924 (935)
||.+.+..++.++|||||||++|+|++|..||...... . .......+|..+++.++++|.+||+.| |.+||
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~li~~~l~~d---p~~R~ 221 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----NTHTTLNIPEWVSEEARSLLQQLLQFN---PTERL 221 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----ccccccCCcccCCHHHHHHHHHHccCC---HHHhc
Confidence 99998888899999999999999999999887643211 1 112234567788999999999999999 99999
Q ss_pred CH-----HHHHhCcC
Q 002331 925 SQ-----AQLSHKRF 934 (935)
Q Consensus 925 Sa-----~EILqHPF 934 (935)
++ +++++|||
T Consensus 222 ~~~~~~~~~~~~h~~ 236 (237)
T cd05576 222 GAGVAGVEDIKSHPF 236 (237)
T ss_pred CCCccchHHHHcCCC
Confidence 85 99999999
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=335.41 Aligned_cols=255 Identities=31% Similarity=0.526 Sum_probs=223.4
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC---Cc--eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN---GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~---g~--~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~ 743 (935)
.++-|.-+++.+.++||+|.||.|++|.|+ |+ .||||+++...... ....|.+|+.+|.+|+|+|++++||++.
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 346677788899999999999999999983 33 59999998765443 6789999999999999999999999998
Q ss_pred cCCceEEEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccc
Q 002331 744 RPPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (935)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGl 822 (935)
+ ..+.||||++++|+|.+.|++ ....|.....-.++.||+.||.||..++ +|||||-.+||||-....|||||||+
T Consensus 182 ~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 182 D-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred c-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccc
Confidence 8 678899999999999999977 4456777888899999999999999998 99999999999999999999999999
Q ss_pred cccccCCccc--CCC-CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCC
Q 002331 823 SRLKHNTFLS--SKS-TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (935)
Q Consensus 823 A~~~~~~~~~--~~s-~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip 898 (935)
.+.+...... ... ..--..|+|||.++...++.++|||++|++||||++ |..||.+....+++..+. .+.++.-|
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRP 337 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRP 337 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCC
Confidence 9977543221 111 112347999999999999999999999999999998 588999999999999997 88889999
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+.|+.++.+++.+||..+ |.+||+|..|..
T Consensus 338 k~csedIY~imk~cWah~---paDRptFsair~ 367 (1039)
T KOG0199|consen 338 KYCSEDIYQIMKNCWAHN---PADRPTFSAIRE 367 (1039)
T ss_pred CCChHHHHHHHHHhccCC---ccccccHHHHHH
Confidence 999999999999999999 999999999853
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=313.16 Aligned_cols=253 Identities=26% Similarity=0.356 Sum_probs=200.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE---C---CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc-CCce
Q 002331 676 EDLVLGERIGLGSYGEVYHADW---N---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNL 748 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~---~---g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~-~~~l 748 (935)
..|++...||+|+||.||+|.. + .+.||||+++.+.-....-....+|+.+++.++||||+.+..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 5788899999999999999943 1 3469999998662211222345689999999999999999999977 7789
Q ss_pred EEEEeeCCCCCHHHHHcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC----CcEEEEec
Q 002331 749 SIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN----WNVKVSDF 820 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~----~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~----g~VKL~DF 820 (935)
+|++||.+. +|..+|+- ....++..++..|++||+.|+.|||++- |+||||||.||||..+ |.|||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999977 89988852 2356899999999999999999999999 9999999999999866 99999999
Q ss_pred cccccccCCcc---cCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCh---------HHHHHH
Q 002331 821 GLSRLKHNTFL---SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNP---------MQVVGA 887 (935)
Q Consensus 821 GlA~~~~~~~~---~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~---------~eil~~ 887 (935)
|+++.+.++.. .....+.|.+|+|||.+.|.. |+.+.|||++|||+.||++-.+.|.+.+. .+.+.+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 99999876532 334456799999999999876 79999999999999999999888876422 111222
Q ss_pred hhccccc------c---CCC--------------------------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 888 VGFQNRR------L---EIP--------------------------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 888 I~~~~~r------~---~ip--------------------------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
|...-+. + .+| +.-++...+|+.+||+.| |.+|.++++.|+|
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yD---P~kRIta~qAleh 337 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYD---PIKRITAEQALEH 337 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccC---chhhccHHHHhcc
Confidence 2100000 0 011 123445789999999999 9999999999999
Q ss_pred cC
Q 002331 933 RF 934 (935)
Q Consensus 933 PF 934 (935)
+|
T Consensus 338 ~y 339 (438)
T KOG0666|consen 338 PY 339 (438)
T ss_pred cc
Confidence 97
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=348.41 Aligned_cols=248 Identities=28% Similarity=0.430 Sum_probs=200.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC--------
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-------- 745 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~-------- 745 (935)
.+|+.++.||+||||.||+++. +|+.||||+|.... .......+.+|+.+|.+|+|||||++|..|.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 5677888999999999999975 89999999998776 666777889999999999999999998654110
Q ss_pred --------------------------------------------------------------------------------
Q 002331 746 -------------------------------------------------------------------------------- 745 (935)
Q Consensus 746 -------------------------------------------------------------------------------- 745 (935)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 002331 746 -------------------------------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794 (935)
Q Consensus 746 -------------------------------~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g 794 (935)
-.+||=||||+..+|.+++.++...-.....|++++||++||.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 1268899999998888888876543368889999999999999999999
Q ss_pred CCEEeeCCCCCCeeecCCCcEEEEecccccccc------C------------CcccCCCCCCCCCccCcccccCCC---C
Q 002331 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH------N------------TFLSSKSTAGTPEWMAPEVLRNEP---S 853 (935)
Q Consensus 795 ~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~------~------------~~~~~~s~~GT~~Y~APEvl~g~~---~ 853 (935)
||||||||.||+|++++.|||+|||+++... + .....+..+||.-|+|||++.+.. |
T Consensus 718 --iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 718 --IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred --eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 9999999999999999999999999998611 0 011234568999999999998755 9
Q ss_pred CchhHHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhccccccCCC----CcCcHHHHHHHHHHHhhCCCCcCCCcCHHH
Q 002331 854 NEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIP----KELDPLVARIIWECWQTGWSSLHIRTSQAQ 928 (935)
Q Consensus 854 s~ksDIWSLG~ILyELLTG~~PF~~-~~~~eil~~I~~~~~r~~ip----~~ls~~L~dLI~qCL~~D~ssP~kRPSa~E 928 (935)
+.|+|+|||||+||||+. ||.. ++...++..+. ....+.+ ...-+.-..+|.+|++.| |.+|||+.|
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR--~g~iP~~~~f~~~~~~~e~slI~~Ll~hd---P~kRPtA~e 867 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR--KGSIPEPADFFDPEHPEEASLIRWLLSHD---PSKRPTATE 867 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc--cCCCCCCcccccccchHHHHHHHHHhcCC---CccCCCHHH
Confidence 999999999999999984 5653 34444555443 2222222 122345679999999999 999999999
Q ss_pred HHhCcC
Q 002331 929 LSHKRF 934 (935)
Q Consensus 929 ILqHPF 934 (935)
+|++-|
T Consensus 868 LL~s~l 873 (1351)
T KOG1035|consen 868 LLNSEL 873 (1351)
T ss_pred HhhccC
Confidence 999865
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=281.37 Aligned_cols=239 Identities=30% Similarity=0.482 Sum_probs=202.1
Q ss_pred CcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCCHHHHHc
Q 002331 688 SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH 765 (935)
Q Consensus 688 ~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL~dlL~ 765 (935)
+||.||+|.+ +++.|++|++........ ...+.+|++++++++|+||+++++.+......+++|||+++++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 5899999987 468999999876543322 5688899999999999999999999999899999999999999999987
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCCCCCccCc
Q 002331 766 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845 (935)
Q Consensus 766 ~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~AP 845 (935)
... .+++..++.++.+++.+|.|||+.+ |+|+||+|.||+++.++.++|+|||.+....... ......++..|++|
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 643 3889999999999999999999998 9999999999999999999999999998765432 23345688899999
Q ss_pred ccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhccccccCCCCc-CcHHHHHHHHHHHhhCCCCcCCC
Q 002331 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKE-LDPLVARIIWECWQTGWSSLHIR 923 (935)
Q Consensus 846 Evl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~-~~~~eil~~I~~~~~r~~ip~~-ls~~L~dLI~qCL~~D~ssP~kR 923 (935)
|.+.+..++.++|||+||+++|+|++|..||.. .+.......+............ ++..+.+++.+||..+ |.+|
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~---p~~R 232 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKD---PEKR 232 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCC---chhc
Confidence 999988889999999999999999999999988 5555444444322222111111 8899999999999999 9999
Q ss_pred cCHHHHHhCcC
Q 002331 924 TSQAQLSHKRF 934 (935)
Q Consensus 924 PSa~EILqHPF 934 (935)
|++.++++|||
T Consensus 233 p~~~~~~~~~~ 243 (244)
T smart00220 233 LTAEEALQHPF 243 (244)
T ss_pred cCHHHHhhCCC
Confidence 99999999998
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=328.68 Aligned_cols=240 Identities=22% Similarity=0.319 Sum_probs=204.9
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LV 751 (935)
.++|.+...+|.|+|+.|..+.+ ++..++||++..... ...+|+.++... .||||+++.+.+.+..+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 46677888899999999999965 678899999876621 223567666665 799999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee-cCCCcEEEEeccccccccCCc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-DKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL-d~~g~VKL~DFGlA~~~~~~~ 830 (935)
||++.++.+.+-+.... .....+..|+.+|+.|+.|||.+| ||||||||+|||+ +..++++|+|||.++.....
T Consensus 395 ~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred ehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999998887765532 233777789999999999999998 9999999999999 69999999999999877654
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~-eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
..+.+-|..|.|||++....|++++||||||++||+|++|+.||...... +++.++ ....+...++...++||
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~vS~~AKdLl 543 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSECVSDEAKDLL 543 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccccCHHHHHHH
Confidence 34457789999999999999999999999999999999999999876554 555554 34445588999999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||+.| |.+||++.+|+.|||
T Consensus 544 ~~LL~~d---P~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 544 QQLLQVD---PALRLGADEIGAHPW 565 (612)
T ss_pred HHhccCC---hhhCcChhhhccCcc
Confidence 9999999 999999999999999
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=323.00 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=215.8
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
.....-|..++.||-|+||.|.+++. ....||+|.+++.+. .......++.|.+||.....+-||+||..|++.+.+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 34456688899999999999999965 456799998877543 445566788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc-
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH- 827 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~- 827 (935)
|+||+|++||++..+|-+. +.|.|..++.++.++..|+++.|+.| +|||||||+|||||.+|+|||.||||+.-+.
T Consensus 705 YFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeecccccccee
Confidence 9999999999999988764 46888888888999999999999999 9999999999999999999999999986321
Q ss_pred --CCc---------------------------------------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHH
Q 002331 828 --NTF---------------------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 866 (935)
Q Consensus 828 --~~~---------------------------------------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~IL 866 (935)
+.. ......+||+.|+|||++....|+..+|+|+.|+||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 000 001134699999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHhhccccccCCC--CcCcHHHHHHHHHHHhhCCCCcCCCc---CHHHHHhCcC
Q 002331 867 WELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTGWSSLHIRT---SQAQLSHKRF 934 (935)
Q Consensus 867 yELLTG~~PF~~~~~~eil~~I~~~~~r~~ip--~~ls~~L~dLI~qCL~~D~ssP~kRP---Sa~EILqHPF 934 (935)
|||+.|++||....+.+...++......+.++ ..+++++.+||.++++- ++.|. ..++|-.|||
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~s----ad~RLGkng~d~vKaHpf 930 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCS----ADSRLGKNGADQVKAHPF 930 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcC----hhhhhcccchhhhhcCcc
Confidence 99999999999998888777776555555555 57899999999987643 56775 5677999998
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=331.16 Aligned_cols=255 Identities=33% Similarity=0.541 Sum_probs=221.3
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeee
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~ 739 (935)
.+++..+.+.+.+.||+|.||.|++|... ...||||.++..... .....+..|+++|+.+ +|+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 68888899999999999999999999642 346999998776554 6778899999999999 799999999
Q ss_pred cccccCCceEEEEeeCCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCC
Q 002331 740 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (935)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKP 804 (935)
|++...+.+++|+||+..|+|..++.+.+ ..+.....+.++.||+.|++||++.. +|||||-.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa 446 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA 446 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence 99999999999999999999999997755 34888999999999999999999998 99999999
Q ss_pred CCeeecCCCcEEEEeccccccccCCcccC-CCCCCCC--CccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 002331 805 PNLLVDKNWNVKVSDFGLSRLKHNTFLSS-KSTAGTP--EWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 880 (935)
Q Consensus 805 eNILLd~~g~VKL~DFGlA~~~~~~~~~~-~s~~GT~--~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~ 880 (935)
+||||.++..+||+|||+++...+..... ....++. .|||||.+....|+.++||||||++||||++ |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999655433222 2233333 5999999999999999999999999999998 688999866
Q ss_pred -hHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 881 -PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 881 -~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
..++... ...+.+...|..+++++.++++.||+.+ |++||+|.++.+
T Consensus 527 ~~~~l~~~-l~~G~r~~~P~~c~~eiY~iM~~CW~~~---p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 527 PTEELLEF-LKEGNRMEQPEHCSDEIYDLMKSCWNAD---PEDRPTFSECVE 574 (609)
T ss_pred cHHHHHHH-HhcCCCCCCCCCCCHHHHHHHHHHhCCC---cccCCCHHHHHH
Confidence 5555543 4578889999999999999999999999 999999999865
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=300.21 Aligned_cols=257 Identities=21% Similarity=0.340 Sum_probs=222.5
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHc-CCCceeeeecccccCC
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~ 746 (935)
+-+..++|.++++||+|+|.+|.++++ ..+.||+|++++.-+.+ ...+-++.|..+..+. +||.+|.++..|+.+.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 445678999999999999999999976 56789999998765433 3455567788888777 8999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+++|.||++||+|.-++++. ++++++.++.+..+|+.||.|||+.| ||+||||.+|||||..|++||.|+|+++.-
T Consensus 325 rlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred eEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999999999888764 57999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-------CChHHHHHHhhccccccCCCC
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-------MNPMQVVGAVGFQNRRLEIPK 899 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~-------~~~~eil~~I~~~~~r~~ip~ 899 (935)
..+.....+++|||.|+|||+++|..|...+|+|+||++++||+.|+.||.- .+..+.+..+ .......+|.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv-ilekqiripr 480 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV-ILEKQIRIPR 480 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH-Hhhhcccccc
Confidence 5555667789999999999999999999999999999999999999999973 2334444444 2556778899
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCCCc------CHHHHHhCcC
Q 002331 900 ELDPLVARIIWECWQTGWSSLHIRT------SQAQLSHKRF 934 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~kRP------Sa~EILqHPF 934 (935)
.++-....+++.-|++| |.+|. .+.++..|+|
T Consensus 481 slsvkas~vlkgflnkd---p~erlgc~~~~g~~dik~h~f 518 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKD---PKERLGCRPQTGFSDIKSHAF 518 (593)
T ss_pred eeehhhHHHHHHhhcCC---cHHhcCCCcccchhhhhcchh
Confidence 99999999999999999 99995 4677888876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=309.43 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=206.9
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeecc-CCCHH----HHHHHHHHHHHHHHcCCCceeeeeccccc-CC
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQ-DFSGA----ALLEFKREVKIMRRLRHPNVVLFMGAVTR-PP 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~-~~~~~----~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~-~~ 746 (935)
-++|-++.+||+|||+.||++.+ ..+.||||+-... ++.+. ..+...+|.+|.+.|.||.||++|++|.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 36788899999999999999965 5678899975433 22222 23346789999999999999999999964 45
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec---CCCcEEEEecccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLS 823 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd---~~g~VKL~DFGlA 823 (935)
.+|-|+|||+|.+|.-||+.. ..+++++++.|+.||+.||.||....++|||-||||.||||- ..|.|||.|||++
T Consensus 542 sFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred cceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 688999999999999999763 578999999999999999999999999999999999999994 5689999999999
Q ss_pred ccccCCccc-------CCCCCCCCCccCccccc-C---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhc-
Q 002331 824 RLKHNTFLS-------SKSTAGTPEWMAPEVLR-N---EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGF- 890 (935)
Q Consensus 824 ~~~~~~~~~-------~~s~~GT~~Y~APEvl~-g---~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~-~eil~~I~~- 890 (935)
+.+.+..+. .....||.||++||.|. + .+.+.++||||+|+|+|.++.|+-||..... .+++.....
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 987654332 23457999999999875 2 2368899999999999999999999987533 333332111
Q ss_pred cccccCCC--CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 891 QNRRLEIP--KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 891 ~~~r~~ip--~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
......+| ..++.+.+++|++||++. -+.|.+..++..|||
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYR---KeDR~DV~qLA~dpy 743 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYR---KEDRIDVQQLACDPY 743 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhh---hhhhhhHHHHccCcc
Confidence 11122233 458899999999999999 889999999999987
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=306.11 Aligned_cols=250 Identities=22% Similarity=0.274 Sum_probs=203.0
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-C-Cc----eeeeeccccc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H-PN----VVLFMGAVTR 744 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-H-PN----IVkl~g~~~~ 744 (935)
+...+|.+...+|+|+||.|..+.+ .+..||||+++.-. ...+..+-|+++|+++. + |+ +|++.+||+.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 3468899999999999999999965 46789999886542 33445667999999993 2 33 7899999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC------------
Q 002331 745 PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK------------ 811 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~------------ 811 (935)
.++.|||+|.+ |-++++++..+ -.+++...++.|++|++++++|||+.+ ++|.||||+|||+..
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCc
Confidence 99999999998 55999999874 456889999999999999999999999 999999999999931
Q ss_pred --------CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 002331 812 --------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883 (935)
Q Consensus 812 --------~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~e 883 (935)
+..|||+|||.|+...+.. ...+.|..|.|||++.+-.++.++||||+||||+||++|...|+..++.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3459999999998766543 45678999999999999999999999999999999999999999876544
Q ss_pred ---HHHHhhc----------------cccccCCC-------------------------CcCcHHHHHHHHHHHhhCCCC
Q 002331 884 ---VVGAVGF----------------QNRRLEIP-------------------------KELDPLVARIIWECWQTGWSS 919 (935)
Q Consensus 884 ---il~~I~~----------------~~~r~~ip-------------------------~~ls~~L~dLI~qCL~~D~ss 919 (935)
++.++.. ...++..+ ......|.+||++||..|
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD--- 393 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD--- 393 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC---
Confidence 3333210 00011101 011235899999999999
Q ss_pred cCCCcCHHHHHhCcC
Q 002331 920 LHIRTSQAQLSHKRF 934 (935)
Q Consensus 920 P~kRPSa~EILqHPF 934 (935)
|.+|+|+.|+|+|||
T Consensus 394 P~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 394 PARRITLREALSHPF 408 (415)
T ss_pred ccccccHHHHhcCHH
Confidence 999999999999998
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=318.06 Aligned_cols=198 Identities=30% Similarity=0.493 Sum_probs=171.5
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC------ceE
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------NLS 749 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~------~l~ 749 (935)
|...+.||+|+||.||++++ .|+.||||.+..... ....+...+|+++|++|+|+|||+++++-+... ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 44567799999999999975 799999999877542 234556789999999999999999999866544 467
Q ss_pred EEEeeCCCCCHHHHHcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec--CCC--cEEEEecccc
Q 002331 750 IITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNW--NVKVSDFGLS 823 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~--~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd--~~g--~VKL~DFGlA 823 (935)
+|||||.+|+|+.++.+ +...+++.+.+.++.++..||.|||++| ||||||||.||++- ++| ..||+|||.|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999986 3567999999999999999999999999 99999999999994 334 3799999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002331 824 RLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGM 879 (935)
Q Consensus 824 ~~~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~ 879 (935)
+-..+.. ...+.+||+.|++||++.. +.|+..+|.|||||++|+++||..||...
T Consensus 172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9887654 5677899999999999984 88899999999999999999999999754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-34 Score=296.65 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=204.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc--------C
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--------P 745 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~--------~ 745 (935)
..|+-..+||+|.||.||+|+. .|+.||+|++...+..+.......+|+++|..|+|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4566677899999999999965 57789998776544444444456789999999999999999998743 2
Q ss_pred CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
..+|+||.+|+. +|+-++.....+++...+.+++.+++.||.|+|+.. |+|||+|+.|+||+.+|.+||+|||+++.
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 348999999976 999999877778999999999999999999999998 99999999999999999999999999976
Q ss_pred ccCCcc----cCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------
Q 002331 826 KHNTFL----SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------ 894 (935)
Q Consensus 826 ~~~~~~----~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r------ 894 (935)
+..... ..+..+.|.+|++||.+.|. .|+++.|||+.|||+.||+++.+-|.+....+.+..|...-+.
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 532211 12234569999999998875 5899999999999999999999999988776665544211000
Q ss_pred c--------------CCCC-------------cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 L--------------EIPK-------------ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ~--------------~ip~-------------~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+ ++|+ .-+++..+|+.++|..| |.+|+++.++|.|.|
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~D---P~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLD---PTKRIDADQALNHDF 317 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccC---cccCcchHhhhchhh
Confidence 0 0111 12457889999999999 999999999999987
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=317.72 Aligned_cols=251 Identities=18% Similarity=0.224 Sum_probs=174.1
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--C----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecc----
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--N----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA---- 741 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~---- 741 (935)
.+..++|++.+.||+|+||.||+|++ + +..||||++......+ ....| .++...+.+++.++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----IWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH----HHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 34568999999999999999999987 3 6789999876433111 11111 1222223333333322
Q ss_pred --cccCCceEEEEeeCCCCCHHHHHcCCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhcCCCEEee
Q 002331 742 --VTRPPNLSIITEFLPRGSLFRILHRPHCQ-------------------VDEKRRIKMALDVARGMNCLHTSTPTIVHR 800 (935)
Q Consensus 742 --~~~~~~l~LVmEy~~gGsL~dlL~~~~~~-------------------lse~~il~Ia~QIa~AL~yLHs~g~~IIHr 800 (935)
...+..++|||||+.+++|.+++...... ..+..+..|+.||+.||.|||+++ |+||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHR 279 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHR 279 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 24556799999999999999998653211 123345679999999999999998 9999
Q ss_pred CCCCCCeeecC-CCcEEEEeccccccccCC-cccCCCCCCCCCccCcccccCCC----------------------CCch
Q 002331 801 DLKSPNLLVDK-NWNVKVSDFGLSRLKHNT-FLSSKSTAGTPEWMAPEVLRNEP----------------------SNEK 856 (935)
Q Consensus 801 DLKPeNILLd~-~g~VKL~DFGlA~~~~~~-~~~~~s~~GT~~Y~APEvl~g~~----------------------~s~k 856 (935)
||||+||||+. ++.+||+|||+++..... ........+++.|+|||++.... ++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999985 689999999999865322 22334568899999999764322 3446
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-------------c------cCCCCcCcHHHHHHHHHHHhhCC
Q 002331 857 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------------R------LEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 857 sDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~-------------r------~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
+|||||||+||||+++..++... .......+..... . ..+........++||.+||+.|
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d- 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK- 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC-
Confidence 79999999999999977665432 1111111110000 0 0111122344669999999999
Q ss_pred CCcCCCcCHHHHHhCcC
Q 002331 918 SSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 918 ssP~kRPSa~EILqHPF 934 (935)
|.+||++.++|+|||
T Consensus 438 --P~kR~ta~e~L~Hpf 452 (566)
T PLN03225 438 --GRQRISAKAALAHPY 452 (566)
T ss_pred --cccCCCHHHHhCCcC
Confidence 999999999999999
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=297.94 Aligned_cols=245 Identities=35% Similarity=0.630 Sum_probs=201.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHH--cCCCceeeeecccccCC----ceE
Q 002331 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTRPP----NLS 749 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~--L~HPNIVkl~g~~~~~~----~l~ 749 (935)
.++.+.+.||+|.||.||+|+|.|+.||||+|...+ ...+.+|.+|++. |+|+||+.|++.-..++ ++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 567899999999999999999999999999986654 3356788888875 49999999998765443 489
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCEEeeCCCCCCeeecCCCcEEEEecccc
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~------g~~IIHrDLKPeNILLd~~g~VKL~DFGlA 823 (935)
||++|.+.|+|+|||.+ ..++.+..++++..++.||+|||.. .|.|.|||||..||||.++|...|+|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999999999999988 4799999999999999999999972 256999999999999999999999999999
Q ss_pred ccccCC----cccCCCCCCCCCccCcccccCCCC------CchhHHHHHHHHHHHHHcC----------CCCCCCC----
Q 002331 824 RLKHNT----FLSSKSTAGTPEWMAPEVLRNEPS------NEKCDVYSFGVILWELATL----------KLPWIGM---- 879 (935)
Q Consensus 824 ~~~~~~----~~~~~s~~GT~~Y~APEvl~g~~~------s~ksDIWSLG~ILyELLTG----------~~PF~~~---- 879 (935)
...... ....+..+||.+|||||++...-. -..+||||||.++||++.. ++||.+.
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 875433 233456789999999999975421 2478999999999998862 5788764
Q ss_pred -ChHHHHHHhhccccccCCCCcCc-----HHHHHHHHHHHhhCCCCcCCCcCHHHHH
Q 002331 880 -NPMQVVGAVGFQNRRLEIPKELD-----PLVARIIWECWQTGWSSLHIRTSQAQLS 930 (935)
Q Consensus 880 -~~~eil~~I~~~~~r~~ip~~ls-----~~L~dLI~qCL~~D~ssP~kRPSa~EIL 930 (935)
+.+++.+-+..++.++.+|.... ..+.+||+.||..+ |.-|.++-.|-
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~N---p~aRltALriK 497 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYAN---PAARLTALRIK 497 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCC---chhhhHHHHHH
Confidence 33566666667778888875432 34788899999999 99999886653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=307.78 Aligned_cols=261 Identities=19% Similarity=0.189 Sum_probs=188.6
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE------------------CCceEEEEEeeccCCCH--H----------HHHHHH
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW------------------NGTEVAVKKFLDQDFSG--A----------ALLEFK 721 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~------------------~g~~VAVK~i~~~~~~~--~----------~~~~f~ 721 (935)
.+..++|.+.++||+|+||.||+|.+ .++.||||++....... . ..+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 45678999999999999999999953 34579999986432110 0 112234
Q ss_pred HHHHHHHHcCCCce-----eeeeccccc--------CCceEEEEeeCCCCCHHHHHcCCC--------------------
Q 002331 722 REVKIMRRLRHPNV-----VLFMGAVTR--------PPNLSIITEFLPRGSLFRILHRPH-------------------- 768 (935)
Q Consensus 722 ~Ei~iL~~L~HPNI-----Vkl~g~~~~--------~~~l~LVmEy~~gGsL~dlL~~~~-------------------- 768 (935)
.|+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57777888866554 667777643 356899999999999999886421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-cCCCCCCCCCccC
Q 002331 769 ---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-SSKSTAGTPEWMA 844 (935)
Q Consensus 769 ---~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~~s~~GT~~Y~A 844 (935)
..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........ ......+++.|+|
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 12356778889999999999999998 99999999999999999999999999975433211 1122345789999
Q ss_pred cccccCCC--------------------C--CchhHHHHHHHHHHHHHcCCC-CCCCCChHHH-----------HHHhhc
Q 002331 845 PEVLRNEP--------------------S--NEKCDVYSFGVILWELATLKL-PWIGMNPMQV-----------VGAVGF 890 (935)
Q Consensus 845 PEvl~g~~--------------------~--s~ksDIWSLG~ILyELLTG~~-PF~~~~~~ei-----------l~~I~~ 890 (935)
||++.... + ..+.||||+||++|+|++|.. ||........ ...+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99985432 1 124799999999999999975 7764321111 111111
Q ss_pred cccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 891 QNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 891 ~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...........++..++||.+||..+...|.+|+|++|+|+|||
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 12223334567899999999999987112378999999999999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=308.95 Aligned_cols=253 Identities=20% Similarity=0.240 Sum_probs=209.5
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC------CCceeeeeccc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR------HPNVVLFMGAV 742 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~------HPNIVkl~g~~ 742 (935)
.++.-.+|.+....|+|.|++|..|.+ .|..||||+|...... .+.=++|++||++|+ --|+++|+..|
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 455567899999999999999999976 5779999999877532 334468999999995 24899999999
Q ss_pred ccCCceEEEEeeCCCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC-CcEEEEe
Q 002331 743 TRPPNLSIITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSD 819 (935)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~dlL~~~~--~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~VKL~D 819 (935)
.+.+++|||||-+. .+|.++|++.+ -.+....+..++.|++.||..|.++| |+|.||||+||||++. ..+||||
T Consensus 504 ~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred hhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeecc
Confidence 99999999999984 59999998743 34778899999999999999999999 9999999999999865 5689999
Q ss_pred ccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC---
Q 002331 820 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--- 896 (935)
Q Consensus 820 FGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~--- 896 (935)
||.|....+... +.+..+..|.|||++.|.+|+...|+||+||+||||+||+..|.+..+.+++......++.++
T Consensus 581 fGSA~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 581 FGSASFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred Cccccccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 999988766533 235567899999999999999999999999999999999999999888777654322221111
Q ss_pred -------------------------------------CC-----------CcCc-------HHHHHHHHHHHhhCCCCcC
Q 002331 897 -------------------------------------IP-----------KELD-------PLVARIIWECWQTGWSSLH 921 (935)
Q Consensus 897 -------------------------------------ip-----------~~ls-------~~L~dLI~qCL~~D~ssP~ 921 (935)
.| ..++ ..|++|+.+||..| |.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld---P~ 735 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD---PE 735 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC---hh
Confidence 00 0111 24899999999999 99
Q ss_pred CCcCHHHHHhCcC
Q 002331 922 IRTSQAQLSHKRF 934 (935)
Q Consensus 922 kRPSa~EILqHPF 934 (935)
+|.+..++|.|||
T Consensus 736 KRit~nqAL~HpF 748 (752)
T KOG0670|consen 736 KRITVNQALKHPF 748 (752)
T ss_pred hcCCHHHHhcCCc
Confidence 9999999999999
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=297.18 Aligned_cols=244 Identities=32% Similarity=0.508 Sum_probs=198.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHH--cCCCceeeeecccccCC----ceE
Q 002331 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTRPP----NLS 749 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~--L~HPNIVkl~g~~~~~~----~l~ 749 (935)
..+++.+.||+|.||.||+|+.+++.||||++. .+....|+.|.+|+.. ++|+||++|+++-.... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 445677889999999999999999999999964 4456678888888875 48999999999876655 799
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCEEeeCCCCCCeeecCCCcEEEEeccc
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST-------PTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g-------~~IIHrDLKPeNILLd~~g~VKL~DFGl 822 (935)
||+||.+.|+|.+||+. ..++|....+|+..|++||+|||..- ++|+|||||..||||.++++..|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999999987 46999999999999999999999832 5699999999999999999999999999
Q ss_pred cccccCCc--ccCCCCCCCCCccCcccccCCCC------CchhHHHHHHHHHHHHHcCC------------CCCC-----
Q 002331 823 SRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPS------NEKCDVYSFGVILWELATLK------------LPWI----- 877 (935)
Q Consensus 823 A~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~------s~ksDIWSLG~ILyELLTG~------------~PF~----- 877 (935)
|..+.... ......+||.+|||||++.|... -.+.||||+|.+||||++.. .||+
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 98765321 12234689999999999987542 24789999999999999853 3343
Q ss_pred CCChHHHHHHhhccccccCCCCc-----CcHHHHHHHHHHHhhCCCCcCCCcCHHHH
Q 002331 878 GMNPMQVVGAVGFQNRRLEIPKE-----LDPLVARIIWECWQTGWSSLHIRTSQAQL 929 (935)
Q Consensus 878 ~~~~~eil~~I~~~~~r~~ip~~-----ls~~L~dLI~qCL~~D~ssP~kRPSa~EI 929 (935)
.....++...+...+.|+.+|.. -...+++.|+.||..| |+.|.|+.=+
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhD---aeARLTA~Cv 496 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHD---AEARLTAGCV 496 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCc---hhhhhhhHHH
Confidence 12335555555567778877753 2356899999999999 9999998643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=328.32 Aligned_cols=237 Identities=23% Similarity=0.339 Sum_probs=185.5
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
.|...+.||+|+||.||+|++ .+..||||++...... ...|++++++++|||||++++++.+++..|+||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 456667899999999999975 6889999988643321 12468889999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
+++|+|.+++++ +++..+..|+.||+.||+|||.. .++|+||||||+||+++.++..++. ||....... .
T Consensus 765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~ 835 (968)
T PLN00113 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----D 835 (968)
T ss_pred CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----C
Confidence 999999999963 78999999999999999999943 2349999999999999998888775 665543321 1
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHhhcccc------cc------C
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-----MQVVGAVGFQNR------RL------E 896 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~-----~eil~~I~~~~~------r~------~ 896 (935)
....+++.|+|||++.+..++.++|||||||++|||++|+.||..... .+..... .... .+ .
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 914 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC-YSDCHLDMWIDPSIRGDVS 914 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHh-cCccchhheeCccccCCCC
Confidence 234678999999999999999999999999999999999999854211 1111110 0000 01 1
Q ss_pred CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 897 IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 897 ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+.....++.+++.+||+.+ |++||++.++++.
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~---P~~RPt~~evl~~ 947 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATD---PTARPCANDVLKT 947 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCC---chhCcCHHHHHHH
Confidence 11122345788999999999 9999999999864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=306.40 Aligned_cols=246 Identities=28% Similarity=0.505 Sum_probs=213.7
Q ss_pred eeEEEEeeecCcEEEEEEEE--CC----ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 678 LVLGERIGLGSYGEVYHADW--NG----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g----~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
.+..++||.|+||+||+|.| .| -+||||++.... ..+.-.++..|+-+|.+|+|||++++++++.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 44568899999999999987 33 368999876543 3345667889999999999999999999998765 8899
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
++|++.|.|.+|++..+..+-.+..+.|..||++||.|||.+. ++||||-.+||||.+-.++||.|||+++.......
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999999888888999999999999999999999988 99999999999999999999999999998754432
Q ss_pred cC--CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHH
Q 002331 832 SS--KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 832 ~~--~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
.. ....--+.|||-|.+....|+.++||||||+++|||+| |..|+.+....++...+. ...++..|..++-++..+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-~geRLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-KGERLSQPPICTIDVYMV 932 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-ccccCCCCCCccHHHHHH
Confidence 22 22223467999999999999999999999999999997 899999998888876665 566689999999999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHh
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILq 931 (935)
+.+||..| +..||.|+++..
T Consensus 933 mvkCwmid---~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 933 MVKCWMID---ADSRPTFKELAE 952 (1177)
T ss_pred HHHHhccC---cccCccHHHHHH
Confidence 99999999 999999999753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=273.27 Aligned_cols=245 Identities=19% Similarity=0.337 Sum_probs=199.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEE--ECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeecccccCC--ceE
Q 002331 675 WEDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP--NLS 749 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~--~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~--~l~ 749 (935)
.++|++.+++|+|.|+.||.|. .+++.++||+++.. ..+.+.+|+.||+.|. ||||+++++...++. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 4789999999999999999997 47889999987543 4668899999999995 999999999998764 377
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC-CCcEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~VKL~DFGlA~~~~~ 828 (935)
||+||+.+.+...+.. .+....+..++.|++.||.|+|+.| |+|||+||.|++||. .-.++|+|||+|.+++.
T Consensus 112 LiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999999988877764 4778888899999999999999999 999999999999984 56799999999998876
Q ss_pred CcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhc-----------ccccc
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGF-----------QNRRL 895 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~-~~~~eil~~I~~-----------~~~r~ 895 (935)
... ....+.+..|..||.+.. +.|+..-|+|||||+|..|++.+.||.. .++.+.+-++.. .+...
T Consensus 186 ~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 186 GKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred Cce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 533 344567889999999876 4589999999999999999999988764 333222211100 00001
Q ss_pred C--------------------CC----CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 E--------------------IP----KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ~--------------------ip----~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. ++ .-.+++..+||.++|..| -++|+|+.|.+.|||
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYD---HqeRlTakEam~Hpy 324 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYD---HQERLTAKEAMAHPY 324 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhc---cccccchHHHhcCch
Confidence 1 11 124588999999999999 999999999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-29 Score=246.28 Aligned_cols=211 Identities=36% Similarity=0.600 Sum_probs=187.1
Q ss_pred eeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCCHH
Q 002331 684 IGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761 (935)
Q Consensus 684 LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL~ 761 (935)
||+|.+|.||++... ++.++||++....... ....+.+|+.+++.++|++|+++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999886 8999999987664332 3467889999999999999999999999989999999999999999
Q ss_pred HHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC-CCcEEEEeccccccccCCcccCCCCCCCC
Q 002331 762 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAGTP 840 (935)
Q Consensus 762 dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~VKL~DFGlA~~~~~~~~~~~s~~GT~ 840 (935)
+++......+++..++.++.+++.+|.+||..+ ++|+||+|.||+++. ++.++|+|||.+..............+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 999775456899999999999999999999998 999999999999999 89999999999986654422233456788
Q ss_pred CccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCC
Q 002331 841 EWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSS 919 (935)
Q Consensus 841 ~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ss 919 (935)
.|++||.+... .++.+.|+|+||+++++| ..+.+++.+||+.+
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~--- 201 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKD--- 201 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCC---
Confidence 99999999887 788999999999999999 68999999999999
Q ss_pred cCCCcCHHHHHhCc
Q 002331 920 LHIRTSQAQLSHKR 933 (935)
Q Consensus 920 P~kRPSa~EILqHP 933 (935)
|.+||++.++++|+
T Consensus 202 p~~R~~~~~l~~~~ 215 (215)
T cd00180 202 PEKRPSAKEILEHL 215 (215)
T ss_pred cccCcCHHHHhhCC
Confidence 99999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=310.38 Aligned_cols=241 Identities=27% Similarity=0.423 Sum_probs=191.7
Q ss_pred EEEeeecCcEE-EEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEEeeCCCC
Q 002331 681 GERIGLGSYGE-VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 681 ~e~LG~G~fG~-Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~~gG 758 (935)
.+.+|.|+-|+ ||+|...|+.||||++.... .....+|+..|+.- +|||||++|+.-.+...+||+.|.|..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 35589999986 79999999999999875442 34567999999988 799999999999999999999999965
Q ss_pred CHHHHHcCCCCCC---CHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC---C--CcEEEEeccccccccCC-
Q 002331 759 SLFRILHRPHCQV---DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---N--WNVKVSDFGLSRLKHNT- 829 (935)
Q Consensus 759 sL~dlL~~~~~~l---se~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~--g~VKL~DFGlA~~~~~~- 829 (935)
+|.++++...... .....+.+..|++.||+|||..+ ||||||||.||||+. + ..++|.|||+++.....
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999997731111 11334667899999999999998 999999999999975 3 56899999999976533
Q ss_pred --cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhccccc-cCCCCcCcHHH
Q 002331 830 --FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRR-LEIPKELDPLV 905 (935)
Q Consensus 830 --~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG-~~PF~~~~~~eil~~I~~~~~r-~~ip~~ls~~L 905 (935)
........||-.|+|||++.....+.++|||||||++|+.++| .+||...-..+. .|...... ..+....+.+.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchHHH
Confidence 2223456799999999999998888899999999999999987 899987644322 11111111 11222222389
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||.+|++.+ |..||++.++|.|||
T Consensus 744 ~dLI~~ml~~d---P~~RPsa~~VL~HPl 769 (903)
T KOG1027|consen 744 KDLISRMLNPD---PQLRPSATDVLNHPL 769 (903)
T ss_pred HHHHHHhcCCC---cccCCCHHHHhCCCc
Confidence 99999999999 999999999999997
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=277.35 Aligned_cols=248 Identities=23% Similarity=0.304 Sum_probs=202.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC------c
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------N 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~------~ 747 (935)
.+|.-++.+|.|.- .|..+-+ .+++||+|++..............+|..++..++|+||++++.+|.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777888999998 6666643 7899999988765333344556789999999999999999999986543 4
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
.|+|||+|.. +|...+. ..++-+.+..|+.|++.|+.|||+.| |+||||||+||+|..+..+||+|||+++...
T Consensus 96 ~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcccC
Confidence 8899999954 8888886 35788999999999999999999999 9999999999999999999999999998766
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-------------
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------- 894 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r------------- 894 (935)
.. ......+.|+.|.|||++.+-.+.+.+||||+||++.||++|+..|.+.+..+...++...-+.
T Consensus 170 ~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 170 TD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred cc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 55 4556678999999999999988999999999999999999999999987654433222100000
Q ss_pred ------------cC----CC-----------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 ------------LE----IP-----------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ------------~~----ip-----------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.. +| ..-...+++|+.+||-.+ |++|.+++++|+|||
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~---pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVID---PEKRISVDDALRHPY 312 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccC---hhhcccHHHHhcCCe
Confidence 00 11 112345899999999999 999999999999998
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=263.73 Aligned_cols=215 Identities=30% Similarity=0.459 Sum_probs=180.8
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~ 747 (935)
+++.-+++.-+..||+|+||.|-+.++ +|+..|+|.+..... .+...++.+|+++..+. .+|++|.|||.......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 566667777888999999999988866 899999999987643 45666778888887766 79999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 748 LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~---~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
.+|.||.|. .+|..+.. +.+..++|..+-+|+..++.||.|||++- .|||||+||.||||+..|+||+||||++-
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999995 48877653 34678999999999999999999999853 59999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhh
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLRN----EPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVG 889 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~g----~~~s~ksDIWSLG~ILyELLTG~~PF~~~-~~~eil~~I~ 889 (935)
.+.+... .....|.-.|||||.+.. ..|+-++||||||++++||.++++||..+ .+.+.+.++.
T Consensus 198 ~L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 198 YLVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred eehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 7766532 233568889999999864 36889999999999999999999999864 6666666663
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-31 Score=278.13 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=199.6
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC-----ceEEEEee
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLSIITEF 754 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~-----~l~LVmEy 754 (935)
+.||-|+||.||.+++ +|+.||+|++..-...-..-+.+.+|+++|..++|.|++..+++.+-.. .+|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 5699999999999976 7999999998765433445667889999999999999999888765432 37889999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-cC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-SS 833 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~ 833 (935)
|+. +|..+|-.. ..++...+.-+++||++||.|||+.+ |+||||||.|+||+.+..+||||||+++....... ..
T Consensus 139 mQS-DLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 139 MQS-DLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHh-hhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 965 888888654 46888888889999999999999999 99999999999999999999999999997643322 22
Q ss_pred CCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------------
Q 002331 834 KSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------------ 894 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r------------------ 894 (935)
+..+.|-.|.|||++.|.+ |+.++||||+|||+.||+..+..|...++.+.+..|...-+.
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L 294 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL 294 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence 3335678999999999865 899999999999999999999999998886665544211111
Q ss_pred ------cCCC--------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcCC
Q 002331 895 ------LEIP--------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRFQ 935 (935)
Q Consensus 895 ------~~ip--------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPFq 935 (935)
+.++ ..-..+...++.++|..| |.+|.+.++.+.|+|.
T Consensus 295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d---~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFD---PDKRISVEEALQHRYL 346 (449)
T ss_pred ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCC---CcccccHhhhcccccc
Confidence 1111 233456788999999999 9999999999999973
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=298.90 Aligned_cols=253 Identities=29% Similarity=0.471 Sum_probs=222.3
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
+.++|.++.++|.|+||.||++++ .++..|||+++...- ....-+.+|+-+++..+|||||.+++.+-..+.++|+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 457899999999999999999976 688999999876532 2344567899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
||||.+|+|.++.+-. +++.+.++..++++.+++|+|||..| =+|||||=.|||+++.|.+||.|||.+..+.....
T Consensus 91 MEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhhh
Confidence 9999999999987664 58999999999999999999999998 89999999999999999999999999988877767
Q ss_pred cCCCCCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc---CCCCcCcHHH
Q 002331 832 SSKSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---EIPKELDPLV 905 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl---~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~---~ip~~ls~~L 905 (935)
....+.||+.|||||+- +...|...+|||++|++..|+-.-++|.....+++.+.-+......+ +-+...++.+
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 77889999999999985 34568899999999999999999999999999888877654333332 2334577889
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
-+|++.||.++ |++||+++.+|+|||
T Consensus 248 h~fvK~altkn---pKkRptaeklL~h~f 273 (829)
T KOG0576|consen 248 HNFVKGALTKN---PKKRPTAEKLLQHPF 273 (829)
T ss_pred HHHHHHHhcCC---CccCCChhhheecee
Confidence 99999999999 999999999999998
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-27 Score=266.68 Aligned_cols=132 Identities=20% Similarity=0.295 Sum_probs=109.5
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-----C---Cceeeeeccc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----H---PNVVLFMGAV 742 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-----H---PNIVkl~g~~ 742 (935)
+...+|.+.++||.|-|++||++.+ ..+.||+|+.+... ...+....|+++|++++ | .+||+|++.|
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 3447899999999999999999965 67789999876432 33455678999999983 3 4699999999
Q ss_pred cc----CCceEEEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee
Q 002331 743 TR----PPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 809 (935)
Q Consensus 743 ~~----~~~l~LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL 809 (935)
.. +.++|||+|++ |.+|..+|.+ ....++...+.+|++||+.||.|||..- +|||.||||+|||+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 64 45799999999 6688888865 3456899999999999999999999843 49999999999998
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=268.30 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=216.7
Q ss_pred ccccccCCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeee
Q 002331 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738 (935)
Q Consensus 666 ~e~~~~ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl 738 (935)
....+..+...++++...+-+|+||.||.|.|. .+.|-||.++.. .++-....+..|..++..+.|||+..+
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 344556667778889999999999999999663 234666765544 345566778889999999999999999
Q ss_pred ecccc-cCCceEEEEeeCCCCCHHHHHcC-----C--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec
Q 002331 739 MGAVT-RPPNLSIITEFLPRGSLFRILHR-----P--HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810 (935)
Q Consensus 739 ~g~~~-~~~~l~LVmEy~~gGsL~dlL~~-----~--~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd 810 (935)
.++.. +....++++.++.-|+|..++.. . ...+...+...++.|++.|++|||+++ |||.||-.+|++|+
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID 430 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh
Confidence 99864 45668899999999999999972 1 234566778889999999999999999 99999999999999
Q ss_pred CCCcEEEEeccccccccCCcccCCC--CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 002331 811 KNWNVKVSDFGLSRLKHNTFLSSKS--TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 887 (935)
Q Consensus 811 ~~g~VKL~DFGlA~~~~~~~~~~~s--~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~ 887 (935)
+..+|||+|=.+++-.-...+.+-. ......||+||.+.+..|+.++|+||||++||||+| |+.|+...++.++...
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y 510 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY 510 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence 9999999999999865443333221 123458999999999999999999999999999998 7999999999999887
Q ss_pred hhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 888 VGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 888 I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
++ .+.+...|-+||+++..++.-||... |++||+++|+.+
T Consensus 511 lk-dGyRlaQP~NCPDeLf~vMacCWall---peeRPsf~Qlv~ 550 (563)
T KOG1024|consen 511 LK-DGYRLAQPFNCPDELFTVMACCWALL---PEERPSFSQLVI 550 (563)
T ss_pred Hh-ccceecCCCCCcHHHHHHHHHHHhcC---cccCCCHHHHHH
Confidence 75 78889999999999999999999999 999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=283.95 Aligned_cols=199 Identities=27% Similarity=0.411 Sum_probs=173.5
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHH------HHHHHHHHHHHHHHcC---CCceeeeecccc
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLR---HPNVVLFMGAVT 743 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~------~~~~f~~Ei~iL~~L~---HPNIVkl~g~~~ 743 (935)
+.+|...+.||.|+||.|++|.+ +...|+||.|.+...-.+ .+-.+-.|++||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 46799999999999999999976 566799998876543221 2223567999999997 999999999999
Q ss_pred cCCceEEEEeeC-CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccc
Q 002331 744 RPPNLSIITEFL-PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (935)
Q Consensus 744 ~~~~l~LVmEy~-~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGl 822 (935)
+++++||+||-. ++.+|+++|..+ ..++|.++..|++||+.|+++||++| |||||||-+||.|+.+|-+||+|||.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeeccc
Confidence 999999999974 567999999764 57999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 002331 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIG 878 (935)
Q Consensus 823 A~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~ 878 (935)
+........ ..++||..|.|||++.|.+| +..-|||+||++||.++....||+.
T Consensus 717 aa~~ksgpf--d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSGPF--DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCCCc--ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 987665432 45789999999999999887 7789999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-27 Score=241.10 Aligned_cols=209 Identities=34% Similarity=0.548 Sum_probs=178.0
Q ss_pred eeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeC
Q 002331 678 LVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
|.+.+.||.|++|.||++... ++.++||.+...... .....+.+|+..++.++|+||+++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 567889999999999999874 689999998765433 24567889999999999999999999999889999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc-ccCC
Q 002331 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-LSSK 834 (935)
Q Consensus 756 ~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~~~ 834 (935)
++++|.+++......+++..++.++.+++.+|.+||+++ ++|+||+|.||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999999764433889999999999999999999998 9999999999999999999999999988765432 1223
Q ss_pred CCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChH-HHHHHhh
Q 002331 835 STAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPM-QVVGAVG 889 (935)
Q Consensus 835 s~~GT~~Y~APEvl-~g~~~s~ksDIWSLG~ILyELLTG~~PF~~-~~~~-eil~~I~ 889 (935)
...++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. .++. .+...+.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 45678899999998 666778899999999999999999999987 4555 4555543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=289.28 Aligned_cols=198 Identities=19% Similarity=0.174 Sum_probs=147.0
Q ss_pred HHcCC-Cceeeeeccc-------ccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEe
Q 002331 728 RRLRH-PNVVLFMGAV-------TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799 (935)
Q Consensus 728 ~~L~H-PNIVkl~g~~-------~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIH 799 (935)
+.++| +||++++++| .....++++|||+ +++|.++|......+++..++.|+.||+.||.|||++| |||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 34445 5777888877 3334678889988 55999999876667999999999999999999999998 999
Q ss_pred eCCCCCCeeecCCC-------------------cEEEEeccccccccCCc----------------ccCCCCCCCCCccC
Q 002331 800 RDLKSPNLLVDKNW-------------------NVKVSDFGLSRLKHNTF----------------LSSKSTAGTPEWMA 844 (935)
Q Consensus 800 rDLKPeNILLd~~g-------------------~VKL~DFGlA~~~~~~~----------------~~~~s~~GT~~Y~A 844 (935)
|||||+||||+..+ .+||+|||+++...... .......||+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996544 45555666554321100 00112458899999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCc
Q 002331 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRT 924 (935)
Q Consensus 845 PEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRP 924 (935)
||++.+..++.++|||||||+||||++|.+||..... ....+.....+.... ...+...+++.+||+.+ |.+||
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~---P~~Rp 257 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPE---PSCRP 257 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCC---hhhCc
Confidence 9999999999999999999999999999888764322 111111111111111 12345678999999999 99999
Q ss_pred CHHHHHhCcC
Q 002331 925 SQAQLSHKRF 934 (935)
Q Consensus 925 Sa~EILqHPF 934 (935)
++.+||+|||
T Consensus 258 s~~eil~h~~ 267 (793)
T PLN00181 258 SMSELLQSEF 267 (793)
T ss_pred ChHHHhhchh
Confidence 9999999998
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-24 Score=222.48 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=206.8
Q ss_pred eeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHH-HHHHHHHHHHHHHHcCCC-ceeeeecccccCCceEEEEeeC
Q 002331 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHP-NVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~-~~~~f~~Ei~iL~~L~HP-NIVkl~g~~~~~~~l~LVmEy~ 755 (935)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++.+......+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 778899999999999999877 8899998877654443 577889999999999887 7999999997777789999999
Q ss_pred CCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC-cEEEEeccccccccCCcc-
Q 002331 756 PRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTFL- 831 (935)
Q Consensus 756 ~gGsL~dlL~~~~--~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~VKL~DFGlA~~~~~~~~- 831 (935)
.++.+.+++.... ..+.......++.|++.++.|+|..+ ++||||||+||+++..+ .++++|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999998876643 26889999999999999999999999 99999999999999988 799999999986544321
Q ss_pred -----cCCCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccc-c--C
Q 002331 832 -----SSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRR-L--E 896 (935)
Q Consensus 832 -----~~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~----~eil~~I~~~~~r-~--~ 896 (935)
......|+..|++||.+.+ ..+....|+|++|++++++++|..||..... ......+...... . .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2356789999999999988 5788999999999999999999999887763 4444444333222 1 1
Q ss_pred CCCcC----cHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 897 IPKEL----DPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 897 ip~~l----s~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..... ...+.+++..|+..+ |..|.+..+...++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~r~~~~~~~~~~~ 277 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKD---PKNRLSSSSDLSHDL 277 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcC---chhcCCHHHHhhchH
Confidence 22222 257999999999999 999999998877654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=225.53 Aligned_cols=159 Identities=22% Similarity=0.262 Sum_probs=129.2
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
|+|.+++...+..+++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||+++..... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----cCC
Confidence 6899999876667999999999999999999999976 999999999999999 9998865432 236
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcccccc-----CCCCcCcH--HHHHHH
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRL-----EIPKELDP--LVARII 909 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~-eil~~I~~~~~r~-----~ip~~ls~--~L~dLI 909 (935)
||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+....... ..+..+.. .+.++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999999999999999999999999999999999765432 2222221111111 11222333 699999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||..+ |.+||++.++++|+|
T Consensus 146 ~~cl~~~---p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 146 RVCASRL---PQRREAANHYLAHCR 167 (176)
T ss_pred HHHHhcc---cccccCHHHHHHHHH
Confidence 9999999 999999999999987
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=252.77 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=195.1
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCc
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~ 747 (935)
..+.|.+.++||+|.|++||++.+ .++.||+|.+..... ...+..|+++|..+ .+.||+++.+++..++.
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 346788999999999999999954 456899998866542 34578999999999 68999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec-CCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~VKL~DFGlA~~~ 826 (935)
..+||||++.....+++.. ++...+..+++.++.||.++|.+| ||||||||.|+|.+ ..+.-.|+|||++...
T Consensus 110 v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHH
Confidence 9999999999988888854 668888999999999999999999 99999999999998 5678999999998721
Q ss_pred cC---------------C-------------------cc----------cCCCCCCCCCccCcccccC-CCCCchhHHHH
Q 002331 827 HN---------------T-------------------FL----------SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYS 861 (935)
Q Consensus 827 ~~---------------~-------------------~~----------~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWS 861 (935)
.. . .+ ......||+.|.|||++.. ...+.++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 00 0 00 0012359999999999865 44688999999
Q ss_pred HHHHHHHHHcCCCCCCCCCh--------------HHHHHHhhcccc--------ccC-----------------------
Q 002331 862 FGVILWELATLKLPWIGMNP--------------MQVVGAVGFQNR--------RLE----------------------- 896 (935)
Q Consensus 862 LG~ILyELLTG~~PF~~~~~--------------~eil~~I~~~~~--------r~~----------------------- 896 (935)
.|+|+..++++++||..... .++.+.....+. .+.
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 99999999999999875322 111111000000 000
Q ss_pred -----CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 897 -----IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 897 -----ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.....+..+.+|+.+||..| |.+|.+++++|+|||
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~n---p~kRitAEeALkHpF 383 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELN---PQKRITAEDALKHPF 383 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCC---hhhcccHHHHhcCcC
Confidence 00123457899999999999 999999999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-26 Score=238.18 Aligned_cols=235 Identities=23% Similarity=0.390 Sum_probs=181.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeec-ccccCCceEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG-AVTRPPNLSII 751 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g-~~~~~~~l~LV 751 (935)
+.|.|.+.||+|.||.+.+++++ ++.+++|.+.... -.+.+|.+|...--.| .|.||+.-|+ +|+..+.++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 56899999999999999999884 5679999876553 2466788888665555 6899998776 47888889999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec--CCCcEEEEeccccccccCC
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd--~~g~VKL~DFGlA~~~~~~ 829 (935)
+||++.|+|..-+... .+-+....+++.|++.||.|+|+.+ +||||||.+||||- +..+|||||||+....+..
T Consensus 101 qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999988663 4888899999999999999999999 99999999999994 3457999999998866543
Q ss_pred cccCCCCCCCCCccCcccccC---CC--CCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHhh-ccccccCCCC--
Q 002331 830 FLSSKSTAGTPEWMAPEVLRN---EP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQ--VVGAVG-FQNRRLEIPK-- 899 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g---~~--~s~ksDIWSLG~ILyELLTG~~PF~~~~~~e--il~~I~-~~~~r~~ip~-- 899 (935)
... ..-+..|.+||+... +. ..+.+|+|.|||++|.+++|++||+.....+ ...... .......+|+
T Consensus 177 V~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 177 VKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred ehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 221 223557999998643 33 3678999999999999999999998532211 111111 1222234443
Q ss_pred -cCcHHHHHHHHHHHhhCCCCcCCC
Q 002331 900 -ELDPLVARIIWECWQTGWSSLHIR 923 (935)
Q Consensus 900 -~ls~~L~dLI~qCL~~D~ssP~kR 923 (935)
.+++.+.++.++-|..+ +++|
T Consensus 254 ~~fs~~a~r~Fkk~lt~~---~~dr 275 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPR---FKDR 275 (378)
T ss_pred cccCHHHHHHHHHhcCCc---cccc
Confidence 46788889999999999 8888
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=230.08 Aligned_cols=247 Identities=21% Similarity=0.243 Sum_probs=192.0
Q ss_pred CeeEEEEeeecCcEEEEEEEECC---ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC----CCceeeeeccc-ccCCce
Q 002331 677 DLVLGERIGLGSYGEVYHADWNG---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR----HPNVVLFMGAV-TRPPNL 748 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~~g---~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~----HPNIVkl~g~~-~~~~~l 748 (935)
+|.+.+.||+|+||.||++.... +.+|+|.......... ..+..|..++..+. ..++..+++.+ ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 89999999999999999998743 4688887655422111 15667888888886 26899999999 577788
Q ss_pred EEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC-----CcEEEEeccc
Q 002331 749 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-----WNVKVSDFGL 822 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-----g~VKL~DFGl 822 (935)
||||+.+ |.+|.++..... ..++....+.|+.|++.+|++||+.| +|||||||.|+++... ..+.|.|||+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 9999988 779999886544 78999999999999999999999999 9999999999999754 4699999999
Q ss_pred cc--cccCCc----c---c-CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc
Q 002331 823 SR--LKHNTF----L---S-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 892 (935)
Q Consensus 823 A~--~~~~~~----~---~-~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~ 892 (935)
++ ...... . . ...+.||..|+++.+..+...+.+.|+||++.++.+|+.|..||.+.........+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 321111 1 1 234569999999999999999999999999999999999999998776432222221111
Q ss_pred cccC---CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 893 RRLE---IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 893 ~r~~---ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.... .....+..+.++...+-..+ ...+|+...+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLD---YEDKPDYEKLAE 292 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccC---CcCCCCHHHHHH
Confidence 1111 23345677777777777778 889999888754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=224.48 Aligned_cols=244 Identities=17% Similarity=0.243 Sum_probs=201.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVm 752 (935)
-.|.++++||+|.||+++.|+. ++++||||.-.... ..-++..|.+.++.| ..++|...|.+...+.+-.|||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 4689999999999999999975 89999999643332 123567888899888 5799999999999988889999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC-----CCcEEEEecccccccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLSRLKH 827 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~-----~g~VKL~DFGlA~~~~ 827 (935)
|++ |.+|++++.-+++.|+.+.+..++.|++.-++|+|.+. +|+|||||+|+||.. ...|.|+|||+|+.+.
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 998 78999999888889999999999999999999999999 999999999999963 3458999999999876
Q ss_pred CCc-------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHhhccccccC-
Q 002331 828 NTF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM---NPMQVVGAVGFQNRRLE- 896 (935)
Q Consensus 828 ~~~-------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~---~~~eil~~I~~~~~r~~- 896 (935)
++. .......||.+||+-....|...+.+.|+-|||-++++++-|.+||.+. +..+-+.+|...+....
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 643 2234567999999999999999999999999999999999999999986 44555556643333322
Q ss_pred --CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHH
Q 002331 897 --IPKELDPLVARIIWECWQTGWSSLHIRTSQAQL 929 (935)
Q Consensus 897 --ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EI 929 (935)
+...+|.++..-+.-.-..+ ..+-|+.+-+
T Consensus 261 ~~Lc~g~P~efa~Yl~yvR~L~---F~E~PDYdyl 292 (449)
T KOG1165|consen 261 EVLCEGFPEEFATYLRYVRRLD---FFETPDYDYL 292 (449)
T ss_pred HHHHhcCHHHHHHHHHHHHhcC---cccCCCHHHH
Confidence 33567778877777777777 7777776543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-24 Score=253.90 Aligned_cols=249 Identities=23% Similarity=0.314 Sum_probs=195.3
Q ss_pred eEEEEeeecCcEEEEEEEE--CCceEEEEEee----ccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 679 VLGERIGLGSYGEVYHADW--NGTEVAVKKFL----DQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 679 ~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~----~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.....+|.|.+|.|+.+.. ..+.++.|.++ ...........+..|+-+-..|.|+||+..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467799999998887754 33344444433 12111222223667777778889999999998888877777779
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 831 (935)
|||++ +|+.++.+. .++....+-.++.|++.|+.|||..| |.||||||+|++++.+|.+||+|||.+.....+..
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 999999774 46888888899999999999999999 99999999999999999999999999987654322
Q ss_pred ---cCCCCCCCCCccCcccccCCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCChHHHH-HHh------hccccccCCCCc
Q 002331 832 ---SSKSTAGTPEWMAPEVLRNEPSNE-KCDVYSFGVILWELATLKLPWIGMNPMQVV-GAV------GFQNRRLEIPKE 900 (935)
Q Consensus 832 ---~~~s~~GT~~Y~APEvl~g~~~s~-ksDIWSLG~ILyELLTG~~PF~~~~~~eil-~~I------~~~~~r~~ip~~ 900 (935)
.....+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+.. ... .....+..+...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 245678999999999999999865 689999999999999999999865443221 111 111122234456
Q ss_pred CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 901 LDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 901 ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++...+.+|.+||+.+ |.+|.++++|++.+|
T Consensus 557 lp~~~~~~~~~~l~~~---P~~R~ti~~i~~d~W 587 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLD---PTKRITIEQILNDEW 587 (601)
T ss_pred chhhHHHHHHHHccCC---hhheecHHHHhhChH
Confidence 8889999999999999 999999999999999
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=208.71 Aligned_cols=248 Identities=20% Similarity=0.257 Sum_probs=201.1
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC-CceeeeecccccCCce
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNL 748 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~H-PNIVkl~g~~~~~~~l 748 (935)
.+....|.++++||.|+||.+|+|.. +|..||||+-....-. -.+..|..+++.|++ ..|..+..++.+..+-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 35567899999999999999999965 8999999986544322 245678999999965 7888888888888889
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec---CCCcEEEEecccccc
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRL 825 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd---~~g~VKL~DFGlA~~ 825 (935)
.+||+.+ |.+|.+++.-....++...++.++-|++.-++|+|.++ +|||||||+|+|.. ....+.|+|||+++.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhh
Confidence 9999998 78999998776778999999999999999999999999 99999999999996 456799999999997
Q ss_pred ccCC-------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHhhcccccc
Q 002331 826 KHNT-------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGFQNRRL 895 (935)
Q Consensus 826 ~~~~-------~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~e---il~~I~~~~~r~ 895 (935)
+.+. ........||.+|.+-....+...+.+.|+-|+|.+|..+.-|..||++..... ...+|...+-..
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 6432 122344579999999888888888999999999999999999999999976533 333342221111
Q ss_pred ---CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHH
Q 002331 896 ---EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQL 929 (935)
Q Consensus 896 ---~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EI 929 (935)
.+.+.+|.++.-.|..|-... .++-|+..-|
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~---F~E~Pdy~yl 277 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLG---FEEKPDYMYL 277 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcC---CCCCCcHHHH
Confidence 234678899999999998888 7778876543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=224.41 Aligned_cols=165 Identities=18% Similarity=0.167 Sum_probs=128.7
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE---CCceEEEEEeeccCC---CHHHHHHHHHHHHHHHHcCCCceee-eecccccC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVL-FMGAVTRP 745 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~---~g~~VAVK~i~~~~~---~~~~~~~f~~Ei~iL~~L~HPNIVk-l~g~~~~~ 745 (935)
...++|.+.+.||+|+||+||+|.+ .++.||||++..... .......+.+|+++|++++|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 3457899999999999999999976 466789998753311 2334566899999999999999985 5442
Q ss_pred CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCC-CCCCeeecCCCcEEEEeccccc
Q 002331 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL-KSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDL-KPeNILLd~~g~VKL~DFGlA~ 824 (935)
+..||||||+++++|... .. .. ...++.|++.||.|||++| |+|||| ||+|||++.++.+||+|||+++
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 457999999999999732 11 11 1457889999999999998 999999 9999999999999999999998
Q ss_pred cccCCccc--------CCCCCCCCCccCcccccCC
Q 002331 825 LKHNTFLS--------SKSTAGTPEWMAPEVLRNE 851 (935)
Q Consensus 825 ~~~~~~~~--------~~s~~GT~~Y~APEvl~g~ 851 (935)
........ -....+++.|+|||.+...
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 66433210 1234678889999998643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-23 Score=242.19 Aligned_cols=233 Identities=27% Similarity=0.396 Sum_probs=196.0
Q ss_pred eeecCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeecccccCCceEEEEeeCCC
Q 002331 684 IGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 684 LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+|+|.||.|++++. .+.-||+|+..+.............|..++..++ ||.+|++...|+.+..++++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999998843 5677999987765433222225567888999886 99999999999999999999999999
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCC
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~ 837 (935)
|.|+..+.... .+++.....+...++.|++++|+.+ |+|||+|++||+++.+|++|+.|||+++...+... .|
T Consensus 82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~c 154 (612)
T KOG0603|consen 82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----AC 154 (612)
T ss_pred chhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhh----cc
Confidence 99998886643 5666666777789999999999999 99999999999999999999999999987655433 28
Q ss_pred CCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCC
Q 002331 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGW 917 (935)
Q Consensus 838 GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ 917 (935)
||..|||||+++ ....++|+|+||+++|||++|..||.. ++...| ....+.+|..+...+++++.+++..+
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I--l~~~~~~p~~l~~~a~~~~~~l~~r~- 225 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI--LKAELEMPRELSAEARSLFRQLFKRN- 225 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH--hhhccCCchhhhHHHHHHHHHHHhhC-
Confidence 999999999998 567789999999999999999999999 444444 34466788999999999999999999
Q ss_pred CCcCCCcC-----HHHHHhCcC
Q 002331 918 SSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 918 ssP~kRPS-----a~EILqHPF 934 (935)
|..|.- ..+|++|+|
T Consensus 226 --p~nrLg~~~~~~~eik~h~f 245 (612)
T KOG0603|consen 226 --PENRLGAGPDGVDEIKQHEF 245 (612)
T ss_pred --HHHHhccCcchhHHHhccch
Confidence 999964 478888876
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-23 Score=216.54 Aligned_cols=250 Identities=28% Similarity=0.584 Sum_probs=212.0
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
|...++.+..+|.+.-.|..|+|+|.|..+++|++.........-..|..|.-.|+-+.||||+.++++|..+.++.++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 44566677788999999999999999999999998877776666678889998999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 753 EFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
.||+.|+|+.+++... -..+..++.+++.+|++|+.|||+..+-|..--|....|+||++.+.+|. .+-+++. .
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs----f 341 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS----F 341 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee----e
Confidence 9999999999998643 34677889999999999999999988545555788999999999887763 1111111 1
Q ss_pred cCCCCCCCCCccCcccccCCCCC---chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s---~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
......-.+.||+||.+...+.+ .++|+|||+++||||-|...||.+..+++.--++...+.+..+|..++..+..|
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHH
Confidence 12234457899999999876643 588999999999999999999999999998888888899999999999999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHH
Q 002331 909 IWECWQTGWSSLHIRTSQAQLS 930 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EIL 930 (935)
+.-|++.| |.+||.|+.|+
T Consensus 422 m~icmned---pgkrpkfdmiv 440 (448)
T KOG0195|consen 422 MNICMNED---PGKRPKFDMIV 440 (448)
T ss_pred HHHHhcCC---CCcCCCcceeh
Confidence 99999999 99999998764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=207.13 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=176.9
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEECC-------------------------------------ceEEEEEeeccCC-
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG-------------------------------------TEVAVKKFLDQDF- 712 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~g-------------------------------------~~VAVK~i~~~~~- 712 (935)
-.+..++|+|++.||+|.-..||.++... -+.|||.+..-+.
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 34667899999999999999999885310 0245665433211
Q ss_pred --CHHHHHHHHHHHH------H--------HH-------Hc-CCCceeeeecccccC-----------------------
Q 002331 713 --SGAALLEFKREVK------I--------MR-------RL-RHPNVVLFMGAVTRP----------------------- 745 (935)
Q Consensus 713 --~~~~~~~f~~Ei~------i--------L~-------~L-~HPNIVkl~g~~~~~----------------------- 745 (935)
....+..+-+|.- + .+ +| +|||||+++++|.+.
T Consensus 232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g 311 (598)
T KOG4158|consen 232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG 311 (598)
T ss_pred CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence 1122222222211 0 11 12 699999999987432
Q ss_pred ----CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec--CC--CcEEE
Q 002331 746 ----PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KN--WNVKV 817 (935)
Q Consensus 746 ----~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd--~~--g~VKL 817 (935)
..+|+||..++. +|.+|+-.+. .+......|+.|+++|+.|||++| |.|||+|.+||||. ++ -.+.|
T Consensus 312 ~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 312 AGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred cCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEE
Confidence 348999999866 8999997643 556666678889999999999999 99999999999993 33 45899
Q ss_pred EeccccccccCC-----cc-cCCCCCCCCCccCcccccCCC------CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 002331 818 SDFGLSRLKHNT-----FL-SSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885 (935)
Q Consensus 818 ~DFGlA~~~~~~-----~~-~~~s~~GT~~Y~APEvl~g~~------~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil 885 (935)
+|||++-.-... .. .....-|...-||||+.+..+ .-.++|.|+.|.+.||++....||+....+-+-
T Consensus 387 aDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~ 466 (598)
T KOG4158|consen 387 ADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD 466 (598)
T ss_pred cccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec
Confidence 999987532221 11 112335778899999987433 135899999999999999999999984332221
Q ss_pred HHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHH
Q 002331 886 GAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQA 927 (935)
Q Consensus 886 ~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~ 927 (935)
.+--.....+.+|+.+++.+++|+...|+.| |.+|++..
T Consensus 467 ~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~---pskRvsp~ 505 (598)
T KOG4158|consen 467 TRTYQESQLPALPSRVPPVARQLVFDLLKRD---PSKRVSPN 505 (598)
T ss_pred hhhhhhhhCCCCcccCChHHHHHHHHHhcCC---ccccCCcc
Confidence 1111233456788999999999999999999 99998865
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.4e-20 Score=195.32 Aligned_cols=175 Identities=13% Similarity=0.102 Sum_probs=136.3
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHH-HHHH------HHHHHHHHHHcCCCceeeeecccccC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA-ALLE------FKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~-~~~~------f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
+...+|.+.+.||.|+||.||++..++..+|||++.......+ .... +.+|+..+.++.|++|..+.+++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 3457899999999999999999877788999999976543332 2222 57899999999999999988886533
Q ss_pred --------CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEE
Q 002331 746 --------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 817 (935)
Q Consensus 746 --------~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL 817 (935)
...+|||||++|.+|.++.. +++. ...+|+.+|..||..| |+|||+||.||+++.+| ++|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~~----~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISED----VKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccHH----HHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EEE
Confidence 35789999999999988742 2332 3569999999999999 99999999999999988 999
Q ss_pred EeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc
Q 002331 818 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871 (935)
Q Consensus 818 ~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT 871 (935)
+|||........... ...+....++.+.|+|+||+++..+..
T Consensus 176 iDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 176 IDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999988654322110 013334456679999999999877653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-20 Score=222.54 Aligned_cols=214 Identities=29% Similarity=0.424 Sum_probs=162.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
.+|..++.|..|+||.||.++++ .+++|+| +.++.+ +.+ .|+.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilR--nilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILR--NILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhh--ccccccCCccee-----------------
Confidence 57888999999999999999775 7789995 333321 111 033333344443
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC----
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT---- 829 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~---- 829 (935)
|+-..+++..+ .++. +++.+++|||+.| |+|||+||+|+||+.-|++|+.|||+.+.....
T Consensus 136 ----gDc~tllk~~g-~lPv--------dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLKNIG-PLPV--------DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhcccCC-CCcc--------hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 33334443322 2332 3378999999999 999999999999999999999999998752110
Q ss_pred -----------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh-ccccccCC
Q 002331 830 -----------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-FQNRRLEI 897 (935)
Q Consensus 830 -----------~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~-~~~~r~~i 897 (935)
....+..+||+.|+|||++..+.|+..+|||++|+|+||++-|..||.+..++++...+. .....++-
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 122345689999999999999999999999999999999999999999999999887653 23333444
Q ss_pred CCcCcHHHHHHHHHHHhhCCCCcCCC---cCHHHHHhCcC
Q 002331 898 PKELDPLVARIIWECWQTGWSSLHIR---TSQAQLSHKRF 934 (935)
Q Consensus 898 p~~ls~~L~dLI~qCL~~D~ssP~kR---PSa~EILqHPF 934 (935)
...++++++++|.++|+.+ |..| ..+-++.+|.|
T Consensus 281 dea~p~Ea~dli~~LL~qn---p~~Rlgt~ga~evk~h~f 317 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQN---PLCRLGTGGALEVKQHGF 317 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhC---hHhhcccchhhhhhhccc
Confidence 5668899999999999999 9999 46677777776
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=226.17 Aligned_cols=245 Identities=18% Similarity=0.188 Sum_probs=181.3
Q ss_pred CeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCC--CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~--~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+|...+.||.+.|=+|.+|+++...|+||++.+++- .-....+...|++ ...++|||.+.+..+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 678889999999999999998777799999977652 2222333334444 5566999999999998888889999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc----
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF---- 830 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~---- 830 (935)
+.. +|++-+.. +..+...+..-|+.||+.||.-+|+.| |+|||||.+||||+.-+-+.|+||..-+..--+.
T Consensus 103 vkh-nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VKH-NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hhh-hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 955 88888865 345677777789999999999999999 9999999999999999999999998765421111
Q ss_pred ---ccCCCCCCCCCccCcccccCC----------C-CCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccc-
Q 002331 831 ---LSSKSTAGTPEWMAPEVLRNE----------P-SNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRR- 894 (935)
Q Consensus 831 ---~~~~s~~GT~~Y~APEvl~g~----------~-~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r- 894 (935)
+...+.....+|+|||.+... . .+++.||||+||+++||++ |++||.-. ++..........
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLAYRSGNADDP 255 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHhHhccCccCH
Confidence 111122345689999998531 1 4678999999999999987 57777421 111111000000
Q ss_pred -cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 895 -LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 895 -~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
..+.+--+..++.||..|++.| |.+|.++++.|+.
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rd---Ps~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRD---PSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccC---chhccCHHHHHHh
Confidence 0011222558999999999999 9999999999975
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.7e-20 Score=189.45 Aligned_cols=141 Identities=21% Similarity=0.233 Sum_probs=107.6
Q ss_pred EEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHH------------------------HHHHHHHHHHHHHcCCCce
Q 002331 681 GERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAA------------------------LLEFKREVKIMRRLRHPNV 735 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~------------------------~~~f~~Ei~iL~~L~HPNI 735 (935)
...||+|+||.||+|.. +|+.||||+++........ .....+|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35699999999999976 6899999998754221100 1223459999999987766
Q ss_pred eeeecccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCEEeeCCCCCCeeecCCCc
Q 002331 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL-HTSTPTIVHRDLKSPNLLVDKNWN 814 (935)
Q Consensus 736 Vkl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yL-Hs~g~~IIHrDLKPeNILLd~~g~ 814 (935)
.....+.. ...+|||||++++++...+.+ ...+++..+..++.||+.+|.+| |..| |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCc
Confidence 43322211 223899999998877655323 24688999999999999999999 6888 99999999999998 478
Q ss_pred EEEEecccccccc
Q 002331 815 VKVSDFGLSRLKH 827 (935)
Q Consensus 815 VKL~DFGlA~~~~ 827 (935)
++|+|||++....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-19 Score=186.30 Aligned_cols=186 Identities=16% Similarity=0.171 Sum_probs=142.2
Q ss_pred EEEEeeecCcEEEEEEEECCceEEEEEeeccCCCH--HHHHHHHHHHHHHHHcC-CCceeeeecccccCCceEEEEeeCC
Q 002331 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLP 756 (935)
Q Consensus 680 I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~--~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LVmEy~~ 756 (935)
+...|++|+||+||.+...+.+++.+.+....... -....+.+|+++|++|. |++|++++++ +..+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 45779999999999998888888888776544321 12235789999999995 5889999886 34699999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCC-CCCCeeecCCCcEEEEeccccccccCCccc---
Q 002331 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL-KSPNLLVDKNWNVKVSDFGLSRLKHNTFLS--- 832 (935)
Q Consensus 757 gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDL-KPeNILLd~~g~VKL~DFGlA~~~~~~~~~--- 832 (935)
|.+|.+.+.. . ...++.|++.+|.++|.+| |+|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~-----~---~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 82 GAAMYQRPPR-----G---DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred CccHHhhhhh-----h---hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9998765422 1 1346789999999999999 999999 799999999999999999999854432210
Q ss_pred ----------CCCCCCCCCccCcccccCC-CCC-chhHHHHHHHHHHHHHcCCCCCCCC
Q 002331 833 ----------SKSTAGTPEWMAPEVLRNE-PSN-EKCDVYSFGVILWELATLKLPWIGM 879 (935)
Q Consensus 833 ----------~~s~~GT~~Y~APEvl~g~-~~s-~ksDIWSLG~ILyELLTG~~PF~~~ 879 (935)
......++.|+.|+...-- ..+ .+.++++.|+-+|.++|+..++...
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0011257888888865432 223 5789999999999999999886544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=194.71 Aligned_cols=232 Identities=21% Similarity=0.261 Sum_probs=151.6
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCC----------Cceeeeecccc
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH----------PNVVLFMGAVT 743 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~H----------PNIVkl~g~~~ 743 (935)
.+..++.||.|+++.||.+++ +++.+|||++..... .....+.+++|......+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 467789999999999999998 568999998875542 23356667766654444322 12222222211
Q ss_pred ---------cC---C-----ceEEEEeeCCCCCHHHHHcC---C-C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEee
Q 002331 744 ---------RP---P-----NLSIITEFLPRGSLFRILHR---P-H--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHR 800 (935)
Q Consensus 744 ---------~~---~-----~l~LVmEy~~gGsL~dlL~~---~-~--~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHr 800 (935)
.. . +.+++|+-+. ++|.+++.- . . ..+....++.+..|+++.+++||..| |+|+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHg 169 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHG 169 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEES
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEec
Confidence 11 1 2467888774 588887531 1 1 12334555667799999999999999 9999
Q ss_pred CCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCC--------CCCchhHHHHHHHHHHHHHcC
Q 002331 801 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE--------PSNEKCDVYSFGVILWELATL 872 (935)
Q Consensus 801 DLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~--------~~s~ksDIWSLG~ILyELLTG 872 (935)
||+|+|+|++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|+++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999999987765543221 2345779999987442 468899999999999999999
Q ss_pred CCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCC
Q 002331 873 KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIR 923 (935)
Q Consensus 873 ~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kR 923 (935)
..||....+...... .+....++|+.++.||.++|+.+ |.+|
T Consensus 247 ~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~---~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRN---PEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SS---GGGS
T ss_pred cCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCC---cccC
Confidence 999987654322111 22223378899999999999999 9887
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.5e-19 Score=181.16 Aligned_cols=141 Identities=21% Similarity=0.245 Sum_probs=109.6
Q ss_pred EEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCH------------------------HHHHHHHHHHHHHHHcCCCce
Q 002331 681 GERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG------------------------AALLEFKREVKIMRRLRHPNV 735 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~------------------------~~~~~f~~Ei~iL~~L~HPNI 735 (935)
.+.||+|+||.||+|.+ +|+.||||++....... .....+.+|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999976 59999999987642110 012234678999999999887
Q ss_pred eeeecccccCCceEEEEeeCCCCCHHH-HHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCC
Q 002331 736 VLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW 813 (935)
Q Consensus 736 Vkl~g~~~~~~~l~LVmEy~~gGsL~d-lL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g 813 (935)
.....+... ..+|||||++++++.. .+.. ..++......++.|++.+|.+||. .| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CC
Confidence 443333222 2489999999875543 3433 457888899999999999999999 88 99999999999999 88
Q ss_pred cEEEEeccccccccC
Q 002331 814 NVKVSDFGLSRLKHN 828 (935)
Q Consensus 814 ~VKL~DFGlA~~~~~ 828 (935)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-18 Score=210.62 Aligned_cols=198 Identities=24% Similarity=0.307 Sum_probs=161.1
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC---CCceeeeeccccc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTR 744 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~---HPNIVkl~g~~~~ 744 (935)
..+++..+.|.|.+.||+|+||.||+|.. +|+.||||+-+.....+ |.--.+++.+|+ -+.|..+..++..
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34566778999999999999999999975 68899999876665432 222233444554 3556677777777
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec-------CCCcEEE
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-------KNWNVKV 817 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd-------~~g~VKL 817 (935)
.+..+||+||.+.|+|.+++.. .+..++.....|+.||+..+++||..+ |||+||||+|+||. ...-++|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CCcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEE
Confidence 8889999999999999999984 457899999999999999999999999 99999999999994 2345999
Q ss_pred Eecccccccc--CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 002331 818 SDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL 874 (935)
Q Consensus 818 ~DFGlA~~~~--~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~ 874 (935)
+|||.+.-+. .........++|-.+-.+|+..|+++++.+|.|.|+.+++-|++|++
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999986442 12233455678889999999999999999999999999999999963
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=169.97 Aligned_cols=136 Identities=23% Similarity=0.410 Sum_probs=115.1
Q ss_pred EEeeecCcEEEEEEEECCceEEEEEeeccCCCHH------HHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeC
Q 002331 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~------~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
+.||+|++|.||+|.+.+..|+||+......... ....+.+|+.++..+.|++|+....++...+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 4699999999999999999999998765433211 2345788999999999999877776666777889999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 756 ~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
+|++|.+++.... . ....++.+|+.+|.+||..+ |+|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986532 2 77889999999999999999 99999999999999 78999999998875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=168.37 Aligned_cols=133 Identities=22% Similarity=0.365 Sum_probs=108.8
Q ss_pred EeeecCcEEEEEEEECCceEEEEEeeccCCCH------HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCC
Q 002331 683 RIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG------AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~------~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 756 (935)
.||+|+||.||++.+.+..|+||+........ .....+.+|++++..++|+++....-++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 38999999999999999999999866543211 123567889999999988776544444455667799999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 757 gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
|++|.+++..... .++.+++.+|.+||+.| |+|||++|.|||++ ++.++++|||++...
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998855221 78899999999999999 99999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=173.17 Aligned_cols=134 Identities=19% Similarity=0.244 Sum_probs=103.8
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-----CCCceeeeecccccCC---ceE-EE
Q 002331 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-----RHPNVVLFMGAVTRPP---NLS-II 751 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-----~HPNIVkl~g~~~~~~---~l~-LV 751 (935)
.+.||+|+||.||.-...+.. +||++...... ....+.+|+.+++.+ .||||++++++++++. .++ +|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 356999999999973334444 68887654322 345689999999999 5799999999998874 333 78
Q ss_pred Eee--CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCEEeeCCCCCCeeecC----CCcEEEEecccc
Q 002331 752 TEF--LPRGSLFRILHRPHCQVDEKRRIKMALDVARGM-NCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDFGLS 823 (935)
Q Consensus 752 mEy--~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL-~yLHs~g~~IIHrDLKPeNILLd~----~g~VKL~DFGlA 823 (935)
||| +.+++|.+++++. .+++. ..++.|++.++ +|||+++ ||||||||+|||++. ++.++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 5579999999763 35555 35677888888 9999999 999999999999974 347999995433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-17 Score=192.77 Aligned_cols=200 Identities=33% Similarity=0.515 Sum_probs=160.9
Q ss_pred HHHcCCCceeeeecccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCC
Q 002331 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPN 806 (935)
Q Consensus 727 L~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeN 806 (935)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+......+++.....++++|+.||.|||.-.. ..|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeecccc
Confidence 456889999999999999999999999999999999998877789999999999999999999999652 2999999999
Q ss_pred eeecCCCcEEEEeccccccccCC--cccCCCCCCCCCccCcccccCCC-------CCchhHHHHHHHHHHHHHcCCCCCC
Q 002331 807 LLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEP-------SNEKCDVYSFGVILWELATLKLPWI 877 (935)
Q Consensus 807 ILLd~~g~VKL~DFGlA~~~~~~--~~~~~s~~GT~~Y~APEvl~g~~-------~s~ksDIWSLG~ILyELLTG~~PF~ 877 (935)
++++..+.+||.|||+....... ........-..-|.|||.+++.. .+.+.||||||++++|+++...||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999999999999998776421 01111122345799999998742 3567899999999999999999998
Q ss_pred CC----ChHHHHHHhhcccc---ccCCC--CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHH
Q 002331 878 GM----NPMQVVGAVGFQNR---RLEIP--KELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930 (935)
Q Consensus 878 ~~----~~~eil~~I~~~~~---r~~ip--~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EIL 930 (935)
.. .+.++...+..... ++.+. ..+++++..++++||..+ |..||++++|-
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~---P~~rPs~~~i~ 218 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEI---PEKRPSIEQIR 218 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccC---hhhCccHHHHH
Confidence 62 33455555543122 22222 145668999999999999 99999999874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.2e-17 Score=172.17 Aligned_cols=145 Identities=23% Similarity=0.227 Sum_probs=112.2
Q ss_pred CeeEEEEeeecCcEEEEEEE---ECCceEEEEEeeccCCCH----------------------HHHHHHHHHHHHHHHcC
Q 002331 677 DLVLGERIGLGSYGEVYHAD---WNGTEVAVKKFLDQDFSG----------------------AALLEFKREVKIMRRLR 731 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~---~~g~~VAVK~i~~~~~~~----------------------~~~~~f~~Ei~iL~~L~ 731 (935)
-|.+.+.||+|+||.||+|. .+|+.||||++....... .....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999997 378999999987543210 01234678999999996
Q ss_pred C--CceeeeecccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee
Q 002331 732 H--PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 809 (935)
Q Consensus 732 H--PNIVkl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL 809 (935)
+ ..+.+++++ ...+|||||+++.+|..++... ..+.......++.||+.+|.+||.+| +|+||||||+|||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEE
Confidence 5 334455543 2358999999998887655332 34566677889999999999999986 59999999999999
Q ss_pred cCCCcEEEEeccccccccC
Q 002331 810 DKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 810 d~~g~VKL~DFGlA~~~~~ 828 (935)
+ ++.++|+|||.+.....
T Consensus 183 ~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 183 H-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred E-CCCEEEEEChhhhccCC
Confidence 9 88999999999875443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=188.15 Aligned_cols=138 Identities=20% Similarity=0.331 Sum_probs=114.5
Q ss_pred CeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCH------HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG------AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~------~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
.|...+.||+|+||+||++.+.+..+++|+........ .....+.+|+++++.++|++|+..+.++......++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 34567889999999999999887777777544332211 123568899999999999999887777777777899
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
||||+++++|.+++. ....++.|++.+|.+||+.+ |+||||||+|||+ .++.++|+|||+++..
T Consensus 414 v~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 414 VMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999999999885 34678899999999999999 9999999999999 6789999999998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.2e-17 Score=184.79 Aligned_cols=178 Identities=21% Similarity=0.304 Sum_probs=137.1
Q ss_pred CceEEEEeeCCCCCHHHHHcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccc
Q 002331 746 PNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~--~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA 823 (935)
.++||.|++|...+|.++|.+ .....+....+.++.|++.|+.| ++ .+|+|+||.||++..+..+||+|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 358899999999999999964 34456778889999999999999 66 999999999999999999999999998
Q ss_pred ccccCCc------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccC
Q 002331 824 RLKHNTF------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLE 896 (935)
Q Consensus 824 ~~~~~~~------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ 896 (935)
....... .......||.+||+||++.+..|+.++|||+||+||+||+. -...|... .....+.....++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGIIPPE 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCCCChH
Confidence 7654332 23345689999999999999999999999999999999997 22222211 11112221222222
Q ss_pred CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcCC
Q 002331 897 IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRFQ 935 (935)
Q Consensus 897 ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPFq 935 (935)
+..+. +.-..|+.+++... |.+||++.+..-|.|+
T Consensus 481 ~~~d~-p~e~~ll~~lls~~---p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 481 FLQDY-PEEYTLLQQLLSPS---PEERPSAIEVALHEFL 515 (516)
T ss_pred HhhcC-cHHHHHHHHhcCCC---cccCchHHHHhhhhhc
Confidence 22333 34559999999999 9999988888888774
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.5e-16 Score=160.81 Aligned_cols=137 Identities=21% Similarity=0.230 Sum_probs=107.2
Q ss_pred eeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCH--------------------HHHHHHHHHHHHHHHcCCCc--
Q 002331 678 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG--------------------AALLEFKREVKIMRRLRHPN-- 734 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~--------------------~~~~~f~~Ei~iL~~L~HPN-- 734 (935)
|.+.+.||+|+||.||++.+ +|+.||||++....... .....+.+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 67788899999999999977 68999999876532100 01123677899999987763
Q ss_pred eeeeecccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc
Q 002331 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814 (935)
Q Consensus 735 IVkl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~ 814 (935)
++..++. ...++||||+++++|..+... .....++.+|+.++.++|..| |+||||||+||+|++++.
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCCc
Confidence 4444432 345899999999998776431 234568889999999999998 999999999999999999
Q ss_pred EEEEecccccccc
Q 002331 815 VKVSDFGLSRLKH 827 (935)
Q Consensus 815 VKL~DFGlA~~~~ 827 (935)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-17 Score=197.66 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=200.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE---CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeecccccCCceEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~---~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LV 751 (935)
..|.+.+.||+|+|+.|-.... ....+|+|.+............+..|..+-..+. |.|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4566677799999999988854 3345677766554433445556667888888885 99999999999999999999
Q ss_pred EeeCCCCCHHHHH-cCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCEEeeCCCCCCeeecCCC-cEEEEeccccccccC
Q 002331 752 TEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGMNCLH-TSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHN 828 (935)
Q Consensus 752 mEy~~gGsL~dlL-~~~~~~lse~~il~Ia~QIa~AL~yLH-s~g~~IIHrDLKPeNILLd~~g-~VKL~DFGlA~~~~~ 828 (935)
++|..++++++.+ +......+....-.++.|+..++.|+| ..+ +.||||||+|.+++..+ .+|+.|||++..+..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999988 443225566666778899999999999 888 99999999999999999 999999999987654
Q ss_pred -C--cccCCCCCC-CCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH-Hhhccccc--cCCCCc
Q 002331 829 -T--FLSSKSTAG-TPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG-AVGFQNRR--LEIPKE 900 (935)
Q Consensus 829 -~--~~~~~s~~G-T~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~-~I~~~~~r--~~ip~~ 900 (935)
. .......+| ++.|+|||.+.+. ...+..|+||.|+++..+++|..||.......... ........ ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 2 223345578 9999999999885 45788999999999999999999998655433211 11111111 334467
Q ss_pred CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 901 LDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 901 ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+.....+++.+++..+ |..|.+.+++-.++|
T Consensus 258 ~~~~~~~~l~k~l~~~---~~~r~s~~~~~~d~~ 288 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKEN---PSNRLSIEELKLDNW 288 (601)
T ss_pred CChhhhhcccccccCC---chhcccccccccccc
Confidence 8889999999999988 999999999999988
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.3e-15 Score=142.55 Aligned_cols=134 Identities=19% Similarity=0.186 Sum_probs=113.2
Q ss_pred EEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC--CceeeeecccccCCceEEEEeeCCC
Q 002331 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 680 I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~H--PNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.+.||.|.++.||++...+..++||.+..... ...+.+|+.+++.++| .++++++.++...+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 356799999999999998888999998765532 4567889999999976 5899999998888889999999988
Q ss_pred CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 758 GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST-PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 758 GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g-~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
+.+..+ +......++.+++.+|.+||... .+++|+||+|+|||+++.+.++++|||.+..
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 776543 45566778899999999999852 2499999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.7e-15 Score=151.46 Aligned_cols=137 Identities=23% Similarity=0.218 Sum_probs=97.3
Q ss_pred EEEeeecCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHH----------------------HHHHHHHHHHcCCC--ce
Q 002331 681 GERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLE----------------------FKREVKIMRRLRHP--NV 735 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~~----------------------f~~Ei~iL~~L~HP--NI 735 (935)
++.||+|+||+||+|.+. ++.||||++............ ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999874 889999998754322111111 13566666666433 24
Q ss_pred eeeecccccCCceEEEEeeCCCCCHHH-HHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCC
Q 002331 736 VLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW 813 (935)
Q Consensus 736 Vkl~g~~~~~~~l~LVmEy~~gGsL~d-lL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g 813 (935)
.++++. ...++||||++++.+.. .+.... . ......++.+++.++.++|. ++ |+||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CC
Confidence 444443 23589999999854321 121111 1 15667889999999999999 88 99999999999999 89
Q ss_pred cEEEEecccccccc
Q 002331 814 NVKVSDFGLSRLKH 827 (935)
Q Consensus 814 ~VKL~DFGlA~~~~ 827 (935)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1e-14 Score=155.76 Aligned_cols=136 Identities=16% Similarity=0.263 Sum_probs=106.4
Q ss_pred EEee-ecCcEEEEEEEECCceEEEEEeeccCC-----------CHHHHHHHHHHHHHHHHcCCCce--eeeecccccCCc
Q 002331 682 ERIG-LGSYGEVYHADWNGTEVAVKKFLDQDF-----------SGAALLEFKREVKIMRRLRHPNV--VLFMGAVTRPPN 747 (935)
Q Consensus 682 e~LG-~G~fG~Vyka~~~g~~VAVK~i~~~~~-----------~~~~~~~f~~Ei~iL~~L~HPNI--Vkl~g~~~~~~~ 747 (935)
..|| .|+.|+||+++..+..++||.+..... .......+.+|+.++..|.|++| ++.+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 888899999988899999998854321 11234567889999999988775 666666433222
Q ss_pred ----eEEEEeeCCC-CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccc
Q 002331 748 ----LSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822 (935)
Q Consensus 748 ----l~LVmEy~~g-GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGl 822 (935)
.++||||+++ .+|.+++... .+++.. +.+|+.+|.+||+.| |+||||||.|||++.++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA--PLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC--CCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECCC
Confidence 2599999997 6899988652 345443 568999999999999 99999999999999999999999998
Q ss_pred ccc
Q 002331 823 SRL 825 (935)
Q Consensus 823 A~~ 825 (935)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.4e-13 Score=159.79 Aligned_cols=248 Identities=22% Similarity=0.168 Sum_probs=191.6
Q ss_pred CCeeEEEEeee--cCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCce
Q 002331 676 EDLVLGERIGL--GSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 676 edy~I~e~LG~--G~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l 748 (935)
..+.+.+.+|. |.+|.||.++. .+..+|+|+-+...........=.+|+...+.+ .|+|.++.+..|+..+.+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34556677999 99999999965 466789886332221111112223566666666 599999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCEEeeCCCCCCeeecCC-CcEEEEecccc
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR----GMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLS 823 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~----AL~yLHs~g~~IIHrDLKPeNILLd~~-g~VKL~DFGlA 823 (935)
++-+|+|. .+|..+.+.....+++..++.++.+... ||.++|... |+|-|+||.||++..+ ...+++|||+.
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCccee
Confidence 99999995 6899998887767899999999999999 999999998 9999999999999999 88999999999
Q ss_pred ccccCCcccCCC-----CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHhhcccccc
Q 002331 824 RLKHNTFLSSKS-----TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM---NPMQVVGAVGFQNRRL 895 (935)
Q Consensus 824 ~~~~~~~~~~~s-----~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~---~~~eil~~I~~~~~r~ 895 (935)
..+.+....... ..|...|++||.+++. ++...|||+||.++.+..++..++... ...+. .....+.
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~----r~~~ip~ 345 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL----RQGYIPL 345 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccc----ccccCch
Confidence 887765433222 2688899999998665 568999999999999999986554432 11111 1112334
Q ss_pred CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++-...+..+..++.+|+..+ |..|++++.++.|+|
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~---~~~~~~~q~~~~l~~ 381 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDED---PRLRLTAQILTALNV 381 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcc---hhhhhHHHHHhcccc
Confidence 444556777888999999999 999999999998876
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.6e-13 Score=146.78 Aligned_cols=200 Identities=22% Similarity=0.303 Sum_probs=145.3
Q ss_pred HHHHcCCCceeeeecccccCC-----ceEEEEeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCE
Q 002331 726 IMRRLRHPNVVLFMGAVTRPP-----NLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797 (935)
Q Consensus 726 iL~~L~HPNIVkl~g~~~~~~-----~l~LVmEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~I 797 (935)
-|-++-|-|||+++.||.+.. ...++.|||..|+|..+|++ ++..+......+|+.||+.||.|||...|+|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 445667999999999996543 47899999999999999975 4556888888999999999999999999999
Q ss_pred EeeCCCCCCeeecCCCcEEEEeccccccccCCc-----ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC
Q 002331 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL 872 (935)
Q Consensus 798 IHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~-----~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG 872 (935)
+|+++..+-|++..+|-||++---... .+... .......+-+.|.+||.=.....+.++|||+||++..+|.-+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999989885322111 11110 111223466789999976655667799999999999999887
Q ss_pred CCC-CCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 873 KLP-WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 873 ~~P-F~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..- -...........+. ..+-..-+..-+.+|.+|++.. |..||++++++.||.
T Consensus 279 Eiq~tnseS~~~~ee~ia-----~~i~~len~lqr~~i~kcl~~e---P~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIA-----NVIIGLENGLQRGSITKCLEGE---PNGRPDARLLLFHPL 333 (458)
T ss_pred eeccCCCcceeehhhhhh-----hheeeccCccccCcCcccccCC---CCCCcchhhhhcCce
Confidence 543 22221111111110 0000111233467899999999 999999999999984
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.2e-12 Score=125.71 Aligned_cols=129 Identities=16% Similarity=0.117 Sum_probs=96.4
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce-eeeecccccCCceEEEEeeCCCCC
Q 002331 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFLPRGS 759 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNI-Vkl~g~~~~~~~l~LVmEy~~gGs 759 (935)
.+.|+.|.++.||+++..+..|+||+...... ....+.+|+.+++.+.+.++ .+++.... ...++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 35689999999999999999999998654321 12245788999998865444 34554433 34579999999987
Q ss_pred HHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC---CEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 760 LFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP---TIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 760 L~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~---~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
+.... .....++.+++.+|..||..+. .++|+|++|.||+++ ++.++|+|||.+.
T Consensus 78 l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 75430 1112356799999999999872 259999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=7.1e-12 Score=145.19 Aligned_cols=139 Identities=24% Similarity=0.275 Sum_probs=96.3
Q ss_pred EEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHH----------------------------H----------HHHHHH
Q 002331 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGA----------------------------A----------LLEFKR 722 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~----------------------------~----------~~~f~~ 722 (935)
+.||.|++|.||+|+. +|+.||||+.+......- . ...|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5699999999999987 799999998754321000 0 002445
Q ss_pred HHHHHHHc----C-CCcee--eeecccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 002331 723 EVKIMRRL----R-HPNVV--LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR-GMNCLHTST 794 (935)
Q Consensus 723 Ei~iL~~L----~-HPNIV--kl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~-AL~yLHs~g 794 (935)
|...+.++ + +++|. +++ +......+|||||++|++|.++........+ ...++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~--~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVY--WDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEe--hhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 55555555 2 33332 233 2223456899999999999887643211222 2345566665 467889988
Q ss_pred CCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 795 ~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
++|+|+||.||+++.++.++|+|||++....
T Consensus 278 --~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 --FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=6.6e-13 Score=161.02 Aligned_cols=258 Identities=21% Similarity=0.233 Sum_probs=199.5
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccC-CCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~-~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
+....+.+.+.+-+-+|.++.++.++- .+...++|+..... +..........+-.++...++|.++.....+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 566778899999999999999998854 34344444432211 111122333445555555567888888777777788
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
++|+++|+.+++|...++..+ ..+.+....++..+..++++||... ++|+|++|.|+|+..+|+.++.|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999999987754 5666666777789999999999987 8999999999999999999999998433211
Q ss_pred CC-------------------------------cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002331 828 NT-------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876 (935)
Q Consensus 828 ~~-------------------------------~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF 876 (935)
.. ........||+.|.+||.+.+......+|+|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 01122346899999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHhhcccccc-CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHH---HHHhCcC
Q 002331 877 IGMNPMQVVGAVGFQNRRL-EIPKELDPLVARIIWECWQTGWSSLHIRTSQA---QLSHKRF 934 (935)
Q Consensus 877 ~~~~~~eil~~I~~~~~r~-~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~---EILqHPF 934 (935)
....+.++...+......+ ..+...+...++++...+..+ |.+|..+. ++-.|+|
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~---~~qr~~a~~~~e~k~~~~ 1094 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEE---PTQRLGAKGAAEVKGHPF 1094 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccC---chhccCcccccccccCCc
Confidence 9999998887765444433 355678899999999999999 99998877 7777776
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.9e-11 Score=140.34 Aligned_cols=165 Identities=19% Similarity=0.239 Sum_probs=123.9
Q ss_pred ECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHH
Q 002331 697 WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR 776 (935)
Q Consensus 697 ~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~i 776 (935)
..+.+|.|..++...- .......+-++-|+.++||||+++++.++..+.+|||+|.+ ..|..++++. .....
T Consensus 35 ~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l----~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL----GKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh----HHHHH
Confidence 3677888887765543 33445677788899999999999999999999999999998 3677777663 25555
Q ss_pred HHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCch
Q 002331 777 IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856 (935)
Q Consensus 777 l~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~k 856 (935)
...+.||+.||.|||+.+ .++|++|.-..|+|++.|+.||++|-++..............---.|..|+.+.... -.
T Consensus 107 ~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cc
Confidence 667889999999998644 499999999999999999999999988764432211111111222456666554332 35
Q ss_pred hHHHHHHHHHHHHHcC
Q 002331 857 CDVYSFGVILWELATL 872 (935)
Q Consensus 857 sDIWSLG~ILyELLTG 872 (935)
.|.|.|||++++++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 7999999999999998
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=8e-11 Score=139.16 Aligned_cols=143 Identities=17% Similarity=0.183 Sum_probs=90.0
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE-C-CceEEEEEeeccCCC----------------------------H----HHHHH-
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW-N-GTEVAVKKFLDQDFS----------------------------G----AALLE- 719 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~-~-g~~VAVK~i~~~~~~----------------------------~----~~~~~- 719 (935)
+.+|.. +.||.|++|.||+|+. + |+.||||+++..... . +....
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345555 6899999999999987 3 899999998754210 0 01111
Q ss_pred -----HHHHHHHHHHcC----CCceeeeeccc-ccCCceEEEEeeCCCCCHHHH--HcCCCC---CCCHHHHHHHHHHHH
Q 002331 720 -----FKREVKIMRRLR----HPNVVLFMGAV-TRPPNLSIITEFLPRGSLFRI--LHRPHC---QVDEKRRIKMALDVA 784 (935)
Q Consensus 720 -----f~~Ei~iL~~L~----HPNIVkl~g~~-~~~~~l~LVmEy~~gGsL~dl--L~~~~~---~lse~~il~Ia~QIa 784 (935)
+.+|+..+.+++ +.+.+.+-.++ ......+|||||++|+.+.++ +...+. .+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 333443333331 32222222222 112346799999999999875 322221 133333344444443
Q ss_pred HHHHHHHhcCCCEEeeCCCCCCeeecCCC----cEEEEecccccccc
Q 002331 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLKH 827 (935)
Q Consensus 785 ~AL~yLHs~g~~IIHrDLKPeNILLd~~g----~VKL~DFGlA~~~~ 827 (935)
..| ++|+|+||.||+|+.+| .++++|||++....
T Consensus 278 -------~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 467 99999999999999888 99999999987553
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=7.6e-12 Score=145.54 Aligned_cols=247 Identities=21% Similarity=0.201 Sum_probs=184.0
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE---CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~---~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~ 747 (935)
-....+|..+..||.|.|+.|+.+.. .+..|++|.+.+..........-..|+.+...+ -|.++++++..|....+
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34567889999999999999999854 577899997766554433333335677777766 69999999999988888
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC-CcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~VKL~DFGlA~~~ 826 (935)
.|+-.|||.++++...+.- ...+++..++.+..|++.++.++|+.. ++|+|+||+||++..+ +.-+++|||++..+
T Consensus 341 ~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred ccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccccc
Confidence 9999999999887765522 235778888899999999999999998 9999999999999876 77899999998742
Q ss_pred cCCcccCCCCCCCCCcc--CcccccCCCCCchhHHHHHHHHHHHHHcCCC-CCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 827 HNTFLSSKSTAGTPEWM--APEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~--APEvl~g~~~s~ksDIWSLG~ILyELLTG~~-PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
.. ........-++. +++......+..+.|+++||..+.+.+++.. ++.+.....+ ..+..+..+ ....
T Consensus 418 ~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i-----~~~~~p~~~-~~~~ 488 (524)
T KOG0601|consen 418 AF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI-----RSGDTPNLP-GLKL 488 (524)
T ss_pred ce---ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceee-----ecccccCCC-chHH
Confidence 21 112222333444 4555556677889999999999999999864 3433332211 122223333 3348
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCc
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKR 933 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHP 933 (935)
++..+.+.++..+ +..||.+.++..|+
T Consensus 489 ~~q~~~kv~~~~~---~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 489 QLQVLLKVMINPD---RKRRPSAVELSLHS 515 (524)
T ss_pred hhhhhhhhhcCCc---cccchhhhhhcccc
Confidence 8899999999999 99999999987764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=2e-10 Score=119.91 Aligned_cols=138 Identities=20% Similarity=0.187 Sum_probs=98.3
Q ss_pred EEeeecCcEEEEEEEEC--------CceEEEEEeeccC--CC------------------HHHHHH----HHHHHHHHHH
Q 002331 682 ERIGLGSYGEVYHADWN--------GTEVAVKKFLDQD--FS------------------GAALLE----FKREVKIMRR 729 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~--------g~~VAVK~i~~~~--~~------------------~~~~~~----f~~Ei~iL~~ 729 (935)
..||.|.-+.||.|... +..+|||+.+... +. ...... .++|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 45899999999999643 3789999764211 10 011222 3489999998
Q ss_pred cCC--CceeeeecccccCCceEEEEeeCCCCCHHH-HHcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCEEeeCCCCC
Q 002331 730 LRH--PNVVLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCL-HTSTPTIVHRDLKSP 805 (935)
Q Consensus 730 L~H--PNIVkl~g~~~~~~~l~LVmEy~~gGsL~d-lL~~~~~~lse~~il~Ia~QIa~AL~yL-Hs~g~~IIHrDLKPe 805 (935)
+.. -++.+.+++ ..-+|||||+.++.+.. .++. ..+++.....+..+++.+|..| |+.| |||+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 842 455666654 34689999997654422 2222 2345556677889999999999 8888 999999999
Q ss_pred CeeecCCCcEEEEeccccccccC
Q 002331 806 NLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 806 NILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|||++ ++.++|+|||.+.....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCCC
Confidence 99997 46899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=5e-10 Score=114.89 Aligned_cols=141 Identities=21% Similarity=0.262 Sum_probs=107.3
Q ss_pred EEeeecCcEEEEEEEECC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC--CceeeeecccccC---CceEEEEeeC
Q 002331 682 ERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRP---PNLSIITEFL 755 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~H--PNIVkl~g~~~~~---~~l~LVmEy~ 755 (935)
+.|+.|.++.||+++..+ +.|+||+....... .....+..|+.+++.+.+ .++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998765 89999987554321 123467889999999965 3456677766553 3578999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 002331 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST----------------------------------------- 794 (935)
Q Consensus 756 ~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g----------------------------------------- 794 (935)
+|.++...+.. ..+++.....++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888765532 34677777788888888888888521
Q ss_pred -------------CCEEeeCCCCCCeeecC--CCcEEEEecccccc
Q 002331 795 -------------PTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRL 825 (935)
Q Consensus 795 -------------~~IIHrDLKPeNILLd~--~g~VKL~DFGlA~~ 825 (935)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23799999999999998 67789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=7e-10 Score=114.21 Aligned_cols=133 Identities=25% Similarity=0.363 Sum_probs=102.3
Q ss_pred EeeecCcEEEEEEEECCceEEEEEeeccCCCHH------HHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeCC
Q 002331 683 RIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~------~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 756 (935)
.+++|+-+.+|.+.+.|.++++|.-..+.+... ......+|+.++..++--.|.--+=++.+.+...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 578999999999999888888885444433322 23346789999998865555444444556667789999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 757 gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
|..|.+++... ...++..+=.-+.-||..| |||+||.++||++...+ +.++|||++...
T Consensus 83 G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 83 GELLKDALEEA--------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred ChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99999898764 2445667777778899999 99999999999997765 999999999743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.8e-09 Score=109.68 Aligned_cols=145 Identities=18% Similarity=0.247 Sum_probs=107.1
Q ss_pred EEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHH------HHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 680 I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~------~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
....|-+|+-+.|+++.+.|+.+.||.-....+... .....++|+++|.+++--.|.--.=+|.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 456789999999999999999999985443333222 23456789999998865455444444555566679999
Q ss_pred eCCC-CCHHHHHcCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC---cEEEEeccccccc
Q 002331 754 FLPR-GSLFRILHRPHCQ-VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRLK 826 (935)
Q Consensus 754 y~~g-GsL~dlL~~~~~~-lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g---~VKL~DFGlA~~~ 826 (935)
|+++ .++.+++...... ........++.+|-+.+.-||..+ |||+||..+||+|..++ .+.|+|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9977 4777777543222 333333678899999999999999 99999999999996443 4589999998654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.1e-08 Score=115.26 Aligned_cols=241 Identities=17% Similarity=0.235 Sum_probs=158.3
Q ss_pred EEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecc------ccc-CCceEEE
Q 002331 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA------VTR-PPNLSII 751 (935)
Q Consensus 680 I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~------~~~-~~~l~LV 751 (935)
.++.||+|+-+.+|..-.-+..|| |++...-...+. +.+.+|... .||-+-.-+.| .-+ ...+.+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~a-----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQA-----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhhchhh-eeecCCCchHHH-----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 456799999999998754344444 666544322111 123344444 56644331111 112 2226788
Q ss_pred EeeCCCCC-HHHHHc----C-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 752 TEFLPRGS-LFRILH----R-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 752 mEy~~gGs-L~dlL~----~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
|..+.+.. +..++. + .-...+|...++.++.|+.+.+.||.+| .+-+|+.++|+||.+++.|.|.|=..-..
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccceee
Confidence 88886652 233332 1 1234688999999999999999999999 99999999999999999999998654433
Q ss_pred ccCCcccCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcC-CCCCCCC-------ChHH--HHH-Hh-
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATL-KLPWIGM-------NPMQ--VVG-AV- 888 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLG~ILyELLTG-~~PF~~~-------~~~e--il~-~I- 888 (935)
- .........+|..+|.+||.-+ +..-+...|.|.||+++|+|+.| ++||.+. ++.+ +.. ..
T Consensus 167 ~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 167 N-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred c-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 2 2223334567899999999754 44456789999999999999987 9999874 2222 110 00
Q ss_pred -hcccccc------CCC-CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHH
Q 002331 889 -GFQNRRL------EIP-KELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930 (935)
Q Consensus 889 -~~~~~r~------~ip-~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EIL 930 (935)
....++. .+| ..+++.+..|..+|+... ..+.-||+++.++
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~-~~~~~RP~a~aW~ 294 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTES-GVATPRPTAKAWV 294 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhccc-CCCCCCCCHHHHH
Confidence 0011111 122 458899999999999875 2367899998765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.2e-08 Score=109.43 Aligned_cols=139 Identities=19% Similarity=0.123 Sum_probs=98.7
Q ss_pred eeecCcEEEEEEEECCceEEEEEeeccCCCHHH---------HHHHHHHHHHHHHcCCCce--eeeeccccc-----CCc
Q 002331 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAA---------LLEFKREVKIMRRLRHPNV--VLFMGAVTR-----PPN 747 (935)
Q Consensus 684 LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~---------~~~f~~Ei~iL~~L~HPNI--Vkl~g~~~~-----~~~ 747 (935)
+-......|+++.+.|+.|.||........+.. ...+.+|...+..|..-+| +..++++.. ...
T Consensus 30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 30 FRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred EecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 333333447788888999999976444321100 1136788888888743222 333333322 234
Q ss_pred eEEEEeeCCCC-CHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC-------CCcEEEE
Q 002331 748 LSIITEFLPRG-SLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-------NWNVKVS 818 (935)
Q Consensus 748 l~LVmEy~~gG-sL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~-------~g~VKL~ 818 (935)
.+||||++++. +|.+++... ....+......++.+++..+.-||..| |+|+|+++.||||+. ++.+.|+
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEE
Confidence 78999999876 799988531 234566777789999999999999999 999999999999975 4689999
Q ss_pred eccccc
Q 002331 819 DFGLSR 824 (935)
Q Consensus 819 DFGlA~ 824 (935)
||+.+.
T Consensus 188 Dl~r~~ 193 (268)
T PRK15123 188 DLHRAQ 193 (268)
T ss_pred ECCccc
Confidence 999775
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5.4e-08 Score=112.27 Aligned_cols=210 Identities=16% Similarity=0.195 Sum_probs=150.8
Q ss_pred cEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc----CCceEEEEeeCCC-CCHH
Q 002331 689 YGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSIITEFLPR-GSLF 761 (935)
Q Consensus 689 fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~----~~~l~LVmEy~~g-GsL~ 761 (935)
-.+.|++.. +|..|.+|++..... ........-+++|+++.|.|||+|.++|.. +..+++|++|.++ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 356788854 789999999832211 111122345778999999999999999863 3458999999875 4677
Q ss_pred HHHcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 762 RILHR--------------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 762 dlL~~--------------~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
++... .+...++..+|.++.|+..||.++|+.| +..+-|.|.+||++.+.+|+|...|+..+..
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 65421 2345778999999999999999999999 9999999999999999999998888776554
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCChHHH-HHHhhccccccCCCCcCcHHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP-WIGMNPMQV-VGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~P-F~~~~~~ei-l~~I~~~~~r~~ip~~ls~~L 905 (935)
.... |-+.+ -.+-|.=.||.+++.|.||..- |......+. +.. +...++.++
T Consensus 445 ~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---------I~~~yS~D~ 498 (655)
T KOG3741|consen 445 EDPT--------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---------ITTTYSTDL 498 (655)
T ss_pred CCCC--------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------hhhhhhHHH
Confidence 4320 11222 2467899999999999999643 333333333 222 235677889
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+++|.-..... +.+ -+..+++.+
T Consensus 499 rn~v~yl~s~~---~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 499 RNVVEYLESLN---FRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhcC---ccc-ccHHHHHHH
Confidence 99999888888 665 666666653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.7e-09 Score=124.30 Aligned_cols=150 Identities=17% Similarity=0.215 Sum_probs=114.7
Q ss_pred HHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC---------CCCCCCCCccCcccccCC
Q 002331 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---------KSTAGTPEWMAPEVLRNE 851 (935)
Q Consensus 781 ~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~---------~s~~GT~~Y~APEvl~g~ 851 (935)
.+++.||.|+|+.- ++||++|.|++|.++.++.+||+.|+++.......... ........|.|||.+.+.
T Consensus 106 ~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 35559999999964 79999999999999999999999999887554321111 111245689999999998
Q ss_pred CCCchhHHHHHHHHHHHHH-cCCCCCCCCChHHHHHH--hhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHH
Q 002331 852 PSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGA--VGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQ 928 (935)
Q Consensus 852 ~~s~ksDIWSLG~ILyELL-TG~~PF~~~~~~eil~~--I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~E 928 (935)
..+.++|+|||||++|.+. .|+.-+...+....... ....-........++.++++-|.+++..+ +..||++.+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~---~~~rp~~~~ 261 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGD---SAVRPTLDL 261 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCC---cccCcchhh
Confidence 8899999999999999999 45555554433322221 11222334456789999999999999999 999999999
Q ss_pred HHhCcC
Q 002331 929 LSHKRF 934 (935)
Q Consensus 929 ILqHPF 934 (935)
++..||
T Consensus 262 l~~~~f 267 (700)
T KOG2137|consen 262 LLSIPF 267 (700)
T ss_pred hhcccc
Confidence 998887
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.7e-08 Score=99.98 Aligned_cols=127 Identities=28% Similarity=0.310 Sum_probs=82.2
Q ss_pred EEEEEEE-CCceEEEEEeecc--CCC----------------------HHHHHHHHHHHHHHHHcCCC--ceeeeecccc
Q 002331 691 EVYHADW-NGTEVAVKKFLDQ--DFS----------------------GAALLEFKREVKIMRRLRHP--NVVLFMGAVT 743 (935)
Q Consensus 691 ~Vyka~~-~g~~VAVK~i~~~--~~~----------------------~~~~~~f~~Ei~iL~~L~HP--NIVkl~g~~~ 743 (935)
.||.|.. +|..+|||+.+.. .+. ........+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899976 7889999976532 111 11234567899999999654 456666543
Q ss_pred cCCceEEEEeeCC--CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 744 RPPNLSIITEFLP--RGSLFRILHRPHCQVDEKRRIKMALDVARGMNC-LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 744 ~~~~l~LVmEy~~--gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~y-LHs~g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|..| |||+||.+.|||++++ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEec
Confidence 3479999998 65665554331 1133345566777775555 57888 9999999999999887 9999999
Q ss_pred ccccccc
Q 002331 821 GLSRLKH 827 (935)
Q Consensus 821 GlA~~~~ 827 (935)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9887554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.6e-07 Score=98.36 Aligned_cols=127 Identities=27% Similarity=0.280 Sum_probs=90.1
Q ss_pred EECCceEEEEEeeccCCCH-----HHHHHHHHHHHHHHHcCCC--ceeeeecccccC----CceEEEEeeCCCC-CHHHH
Q 002331 696 DWNGTEVAVKKFLDQDFSG-----AALLEFKREVKIMRRLRHP--NVVLFMGAVTRP----PNLSIITEFLPRG-SLFRI 763 (935)
Q Consensus 696 ~~~g~~VAVK~i~~~~~~~-----~~~~~f~~Ei~iL~~L~HP--NIVkl~g~~~~~----~~l~LVmEy~~gG-sL~dl 763 (935)
...++.|-+|......... .......+|...+..|..- ...+.+++.... ...+||+|++++. +|.++
T Consensus 29 ~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~ 108 (206)
T PF06293_consen 29 DLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDL 108 (206)
T ss_pred cccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHH
Confidence 3455666666543221111 2234567888888777432 234444444332 2358999999874 79998
Q ss_pred HcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC---cEEEEecccccc
Q 002331 764 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRL 825 (935)
Q Consensus 764 L~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g---~VKL~DFGlA~~ 825 (935)
+.... ..+......++.+++..+.-||..| |+|+|+++.||||+.++ .+.|+||+-++.
T Consensus 109 ~~~~~-~~~~~~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 109 LQQWE-QLDPSQRRELLRALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHhhc-ccchhhHHHHHHHHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 87532 2666777889999999999999999 99999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.3e-07 Score=99.57 Aligned_cols=137 Identities=25% Similarity=0.301 Sum_probs=97.3
Q ss_pred eEEEEeeecCcEEEEEEEE-CCceEEEEEeeccC--C----------------C--HHHHHHHHHHHHHHHHcCCC--ce
Q 002331 679 VLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQD--F----------------S--GAALLEFKREVKIMRRLRHP--NV 735 (935)
Q Consensus 679 ~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~--~----------------~--~~~~~~f~~Ei~iL~~L~HP--NI 735 (935)
.++..||-|.-+.||.|.. .|.++|||.=+... + + .......++|.++|.+|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 5678899999999999976 69999999422110 0 0 12244578999999999544 66
Q ss_pred eeeecccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcE
Q 002331 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 815 (935)
Q Consensus 736 Vkl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~V 815 (935)
.+.+++ +...+||||++|..|...- ++....-.++..|++-+.-+-..| |||+|+.+-||||+++|.+
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCCE
Confidence 776664 4457999999997776542 122233334445555554444667 9999999999999999999
Q ss_pred EEEecccccccc
Q 002331 816 KVSDFGLSRLKH 827 (935)
Q Consensus 816 KL~DFGlA~~~~ 827 (935)
.++||-.+....
T Consensus 242 ~vIDwPQ~v~~~ 253 (304)
T COG0478 242 VVIDWPQAVPIS 253 (304)
T ss_pred EEEeCcccccCC
Confidence 999997765443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.4e-06 Score=87.79 Aligned_cols=140 Identities=18% Similarity=0.213 Sum_probs=83.2
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC--ceeeeeccc---ccCCceEEEEeeC
Q 002331 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGAV---TRPPNLSIITEFL 755 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HP--NIVkl~g~~---~~~~~l~LVmEy~ 755 (935)
++.|+.|..+.||++...+..+++|..... .....+.+|..+++.+... -+.+++... ......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999987789999986443 3455677888888888422 345555533 2223478999999
Q ss_pred CCCCHHH----------------HHc---CC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 002331 756 PRGSLFR----------------ILH---RP---HCQVDEKR---------RIKM------------ALDVAR-GMNCLH 791 (935)
Q Consensus 756 ~gGsL~d----------------lL~---~~---~~~lse~~---------il~I------------a~QIa~-AL~yLH 791 (935)
++..+.. ++. .. ...+.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987777 111 11 11111100 0000 011222 233333
Q ss_pred h-----cCCCEEeeCCCCCCeeec-CCCcEEEEeccccc
Q 002331 792 T-----STPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSR 824 (935)
Q Consensus 792 s-----~g~~IIHrDLKPeNILLd-~~g~VKL~DFGlA~ 824 (935)
. ....++|+|+.|.|||++ .++.|.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 122499999999999999 67778899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.7e-06 Score=88.28 Aligned_cols=139 Identities=17% Similarity=0.110 Sum_probs=101.8
Q ss_pred eecCcEEEEEEEECCceEEEEEeeccCC---C-HHHHHHHHHHHHHHHHcCC--Cceeeeeccc--ccC--CceEEEEee
Q 002331 685 GLGSYGEVYHADWNGTEVAVKKFLDQDF---S-GAALLEFKREVKIMRRLRH--PNVVLFMGAV--TRP--PNLSIITEF 754 (935)
Q Consensus 685 G~G~fG~Vyka~~~g~~VAVK~i~~~~~---~-~~~~~~f~~Ei~iL~~L~H--PNIVkl~g~~--~~~--~~l~LVmEy 754 (935)
|+||.+-|+.....|..|-||.-..... . ..-...|.+|+..|.+|.. -.+.+.+... ..+ -..+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 7799999999998888888886532111 0 1234578899999998843 2244444221 111 126799997
Q ss_pred CCC-CCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc--EEEEecccccc
Q 002331 755 LPR-GSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSRL 825 (935)
Q Consensus 755 ~~g-GsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~--VKL~DFGlA~~ 825 (935)
+.+ .+|.+++... -.+.+......++.+|+..|.-||..| +.|+|+-+.|||++.++. ++++||--++.
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 753 4888887542 235677888889999999999999999 999999999999986667 99999976553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.5e-06 Score=88.96 Aligned_cols=136 Identities=21% Similarity=0.192 Sum_probs=83.6
Q ss_pred EEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc--eeeeecccccCCceEEEEeeCCCCC
Q 002331 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGAVTRPPNLSIITEFLPRGS 759 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPN--IVkl~g~~~~~~~l~LVmEy~~gGs 759 (935)
..||.|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999985 35678888865432 1234578999998885433 4667777777777889999999863
Q ss_pred -HHHH---------------------HcCCC-CCCCHHH-HHHHHH----------HHHHH-HHHHH--hcCCCEEeeCC
Q 002331 760 -LFRI---------------------LHRPH-CQVDEKR-RIKMAL----------DVARG-MNCLH--TSTPTIVHRDL 802 (935)
Q Consensus 760 -L~dl---------------------L~~~~-~~lse~~-il~Ia~----------QIa~A-L~yLH--s~g~~IIHrDL 802 (935)
+... ++... ....... ...+.. .+... ..+|. ...+.++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 1111 11100 0111100 000100 01111 12222 22234899999
Q ss_pred CCCCeeecCCCcEEEEeccccc
Q 002331 803 KSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 803 KPeNILLd~~g~VKL~DFGlA~ 824 (935)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.28 E-value=8.3e-06 Score=86.90 Aligned_cols=140 Identities=16% Similarity=0.181 Sum_probs=94.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHH-HHHH------HHHHHHHHHHcCC---Cceeeeecc-
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA-ALLE------FKREVKIMRRLRH---PNVVLFMGA- 741 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~-~~~~------f~~Ei~iL~~L~H---PNIVkl~g~- 741 (935)
+...+|.+.+++-.....-|.+...+|+.+++|..+......+ .... ..+++..+..++. -.++.++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4456888999998888888999999999999998766442221 1111 2334444444422 222222222
Q ss_pred ----cccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEE
Q 002331 742 ----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 817 (935)
Q Consensus 742 ----~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL 817 (935)
+......+|+|||++|..|.++.. +++ .++..|.++|.-||..| +.|+|.+|.|++++.++ +++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i~i 175 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-IRI 175 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-EEE
Confidence 223344678999999988776542 222 24456778899999999 99999999999998654 999
Q ss_pred Eeccccc
Q 002331 818 SDFGLSR 824 (935)
Q Consensus 818 ~DFGlA~ 824 (935)
+||+..+
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.2e-06 Score=100.06 Aligned_cols=142 Identities=21% Similarity=0.217 Sum_probs=90.4
Q ss_pred EEeeecCcEEEEEEEEC-CceEEEEEeeccCCCH----------------------------HHHH----------HHHH
Q 002331 682 ERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSG----------------------------AALL----------EFKR 722 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~-g~~VAVK~i~~~~~~~----------------------------~~~~----------~f~~ 722 (935)
+.|+.++-|.||+|+.. |+.||||+.+..-... ...+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56999999999999885 9999999865432100 0001 1344
Q ss_pred HHHHHHHcC-----CCceeeeecccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCE
Q 002331 723 EVKIMRRLR-----HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797 (935)
Q Consensus 723 Ei~iL~~L~-----HPNIVkl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~I 797 (935)
|..-+.+++ .++|.--.=+++....-.|+|||++|..+.++..-....++.+.+.....++. +..+=..| +
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg--f 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG--F 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC--c
Confidence 555554442 34433222223334556799999999999887432223455444333222222 12222356 9
Q ss_pred EeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 798 IHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
.|.|.+|.||+++.+|++.+.|||+.....
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCC
Confidence 999999999999999999999999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.2e-05 Score=85.37 Aligned_cols=136 Identities=21% Similarity=0.224 Sum_probs=83.7
Q ss_pred eeecCc-EEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeecccccCCceEEEEeeCCCCCHH
Q 002331 684 IGLGSY-GEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761 (935)
Q Consensus 684 LG~G~f-G~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LVmEy~~gGsL~ 761 (935)
|-.|.. ..||+....+..+.||+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|..|.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 455555 7899997777788888764432 234567888888883 444567777777666789999999987765
Q ss_pred HHH-------------------cCC---CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh-----
Q 002331 762 RIL-------------------HRP---HCQVDEK--RRIKMAL--------------------DVARGMNCLHT----- 792 (935)
Q Consensus 762 dlL-------------------~~~---~~~lse~--~il~Ia~--------------------QIa~AL~yLHs----- 792 (935)
... +.. ...+... ....... .+...+..|-.
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 331 111 0011100 0000000 01111222211
Q ss_pred cCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 793 ~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12349999999999999998778999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=3.5e-07 Score=107.82 Aligned_cols=186 Identities=20% Similarity=0.197 Sum_probs=137.2
Q ss_pred CeeEEEEeeecCcEEEEEEEECCce-EEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc-eeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~~g~~-VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPN-IVkl~g~~~~~~~l~LVmEy 754 (935)
.+.....+++|+++.++|.+-..+. ...+.+... ....-++++|.+++||| .+..++-++-+...+++|++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3444556899999999999754332 224433322 34456788999999999 77778888888889999999
Q ss_pred CCCC-CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 755 LPRG-SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 755 ~~gG-sL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
+.++ +....+......+...+...+.+.-+++|++||+.. =+|+| ||+..+ +..|+.||+....+.... ..
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~ 387 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KP 387 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-cc
Confidence 9876 332222222233445556667777888999999864 48888 777765 689999999887766543 45
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~ 877 (935)
....+++.++|||+.....++...|.|++|.--.+|.-|-+|-.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 67889999999999999999999999999987777777766643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.9e-05 Score=82.19 Aligned_cols=139 Identities=21% Similarity=0.188 Sum_probs=92.4
Q ss_pred EEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHH----------------------HHHHHHHHHHHHHcC--CCcee
Q 002331 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAA----------------------LLEFKREVKIMRRLR--HPNVV 736 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~----------------------~~~f~~Ei~iL~~L~--HPNIV 736 (935)
..|..|.-..||+|.. .+..||||+++..-..... ..-..+|+.-|+++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3677888889999964 6889999988643211111 111345677777663 33444
Q ss_pred eeecccccCCceEEEEeeCCCCCHH-HHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCCc
Q 002331 737 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWN 814 (935)
Q Consensus 737 kl~g~~~~~~~l~LVmEy~~gGsL~-dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~ 814 (935)
+-+.+.. -.|||||+....+- =.|+. -.+.......+..++++.+.-|-. .+ +||+||..-|||+. ++.
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CCe
Confidence 5555443 36999999543110 01111 122333566677888888888877 66 99999999999999 889
Q ss_pred EEEEeccccccccCC
Q 002331 815 VKVSDFGLSRLKHNT 829 (935)
Q Consensus 815 VKL~DFGlA~~~~~~ 829 (935)
+.|+|||.+.....+
T Consensus 205 p~iID~~QaV~~~hp 219 (268)
T COG1718 205 PYIIDVSQAVTIDHP 219 (268)
T ss_pred EEEEECccccccCCC
Confidence 999999998765543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.99 E-value=8.2e-05 Score=78.49 Aligned_cols=127 Identities=28% Similarity=0.416 Sum_probs=92.4
Q ss_pred CCeeEEEEeeecCc-EEEEEEEECCceEEEEEeec---cC-------CCH---------HHHHHHHHHHHHHHHcC---C
Q 002331 676 EDLVLGERIGLGSY-GEVYHADWNGTEVAVKKFLD---QD-------FSG---------AALLEFKREVKIMRRLR---H 732 (935)
Q Consensus 676 edy~I~e~LG~G~f-G~Vyka~~~g~~VAVK~i~~---~~-------~~~---------~~~~~f~~Ei~iL~~L~---H 732 (935)
.+++.++.||.|.- |.||+++.+|+.||||++.. .. +.. ....-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68999999999999 99999999999999999432 11 000 11234778888888774 4
Q ss_pred Cce--eeeecccccC------------------CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 002331 733 PNV--VLFMGAVTRP------------------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792 (935)
Q Consensus 733 PNI--Vkl~g~~~~~------------------~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs 792 (935)
.++ |+++||..=. ....||.||++... .+... -+.+|.+-|..+|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHHH
Confidence 566 8999986211 12468888886532 12222 34577778888999
Q ss_pred cCCCEEeeCCCCCCeeecCCCcEEEEecccc
Q 002331 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (935)
Q Consensus 793 ~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA 823 (935)
.| |+-+|+++.|.. .-||+|||.+
T Consensus 183 ~g--I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LG--IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CC--eeeccCcccccc-----CCEEEecccC
Confidence 99 999999999987 3489999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=2.9e-05 Score=80.19 Aligned_cols=131 Identities=23% Similarity=0.249 Sum_probs=95.8
Q ss_pred eeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCcee-eeecccccCCceEEEEeeCC
Q 002331 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV-LFMGAVTRPPNLSIITEFLP 756 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIV-kl~g~~~~~~~l~LVmEy~~ 756 (935)
..+.+.|++|++|.||++.|.|..+|+|+-+... ....+..|+++|..+.-.++. ++|.|..+ ++.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence 3456779999999999999999999999754433 355788999999999776654 45554433 46699999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCC-CCCeeecCCCcEEEEeccccccc
Q 002331 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK-SPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 757 gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLK-PeNILLd~~g~VKL~DFGlA~~~ 826 (935)
|-.|.++-.. .+...+ ..++++-.-|...| |-|+.|. |..++|..++.+.|+||..|+..
T Consensus 96 G~~L~~~~~~----~~rk~l----~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 96 GRPLGKLEIG----GDRKHL----LRVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred Ccchhhhhhc----ccHHHH----HHHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 9888776542 123333 35555555566677 9999997 66666666679999999988744
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00013 Score=91.48 Aligned_cols=144 Identities=19% Similarity=0.279 Sum_probs=89.9
Q ss_pred EEEeeecCcEEEEEEEECC----ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCce--eeeecccccC---CceEE
Q 002331 681 GERIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNV--VLFMGAVTRP---PNLSI 750 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~g----~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNI--Vkl~g~~~~~---~~l~L 750 (935)
.+.|+.|.+..+|+.+..+ ..+++|+....... .....+.+|+++|+.+. |.+| .+++.++.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4668999999999987654 46788875433211 12346789999999995 6665 7778777664 46789
Q ss_pred EEeeCCCCCHHH--------------------HH---cCCC----------CCCC--HHHHHHHHH--------------
Q 002331 751 ITEFLPRGSLFR--------------------IL---HRPH----------CQVD--EKRRIKMAL-------------- 781 (935)
Q Consensus 751 VmEy~~gGsL~d--------------------lL---~~~~----------~~ls--e~~il~Ia~-------------- 781 (935)
||||++|..+.+ .+ +... .+.. ..++..|..
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 999998764211 11 1110 0000 112211111
Q ss_pred -HHHHHHHHHHhcCC---------CEEeeCCCCCCeeecC-CCc-EEEEecccccc
Q 002331 782 -DVARGMNCLHTSTP---------TIVHRDLKSPNLLVDK-NWN-VKVSDFGLSRL 825 (935)
Q Consensus 782 -QIa~AL~yLHs~g~---------~IIHrDLKPeNILLd~-~g~-VKL~DFGlA~~ 825 (935)
.+...+.+|..+-+ .+||+|+++.|||++. ++. +-|.||.++..
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 12334566644222 3999999999999985 334 57999998764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00026 Score=73.69 Aligned_cols=101 Identities=21% Similarity=0.271 Sum_probs=80.3
Q ss_pred HHHHHHHHHcCC-CceeeeecccccCCceEEEEeeCCCCCHHHH---HcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-
Q 002331 721 KREVKIMRRLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRI---LHRPHCQVDEKRRIKMALDVARGMNCLHTSTP- 795 (935)
Q Consensus 721 ~~Ei~iL~~L~H-PNIVkl~g~~~~~~~l~LVmEy~~gGsL~dl---L~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~- 795 (935)
..|.-+|+.+++ +++++++|+|-+ ++|+||...+.+... +.. -...+|..+.+|+.++++.+.+|+..-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 458888898966 699999999854 689999987655421 111 1246899999999999999999988321
Q ss_pred CEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 796 ~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+...|++++|+.|+++|++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 3899999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00011 Score=77.99 Aligned_cols=72 Identities=15% Similarity=0.165 Sum_probs=45.6
Q ss_pred EEeeecCcEE-EEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC---ceeeeecccccC---CceEEEEee
Q 002331 682 ERIGLGSYGE-VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP---NVVLFMGAVTRP---PNLSIITEF 754 (935)
Q Consensus 682 e~LG~G~fG~-Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HP---NIVkl~g~~~~~---~~l~LVmEy 754 (935)
+.|+.|+... ||+. +..+++|...... ....+.+|.++|..|... -+.++++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 4578777764 8986 3467778644321 234678899999887421 344455444332 235889999
Q ss_pred CCCCCH
Q 002331 755 LPRGSL 760 (935)
Q Consensus 755 ~~gGsL 760 (935)
++|.++
T Consensus 76 i~G~~l 81 (235)
T cd05155 76 LEGETA 81 (235)
T ss_pred ecCCCC
Confidence 988665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.79 E-value=7.7e-05 Score=93.44 Aligned_cols=232 Identities=16% Similarity=0.159 Sum_probs=155.1
Q ss_pred eeecCcEEEEEEEECC------ceEEEEEeec-cCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc----eEEEE
Q 002331 684 IGLGSYGEVYHADWNG------TEVAVKKFLD-QDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----LSIIT 752 (935)
Q Consensus 684 LG~G~fG~Vyka~~~g------~~VAVK~i~~-~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~----l~LVm 752 (935)
|..-.+|+++..+|.- .++-++.-.. .............|...+..+.|+|++.++.|...... +.+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 5666777777776521 1111111000 00111233445667778888899999999988654332 33556
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCC---CeeecCCCcEEEE--ecccccccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP---NLLVDKNWNVKVS--DFGLSRLKH 827 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPe---NILLd~~g~VKL~--DFGlA~~~~ 827 (935)
|+|...++...+..- ...+....+.+..++++||.|+|... ..|.-|... +--++..+.+.+. ||+..+...
T Consensus 266 ~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~ 342 (1351)
T KOG1035|consen 266 EICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLP 342 (1351)
T ss_pred hhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhcccccCC
Confidence 788888888888663 46788888889999999999999986 555544444 4444566777777 999887766
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCc--hhHHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhccccccCCCCcCcHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNE--KCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~--ksDIWSLG~ILyELLTG~~PF~~~-~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
+.... ....-...|.++|......++. ..|+|.+|.++..+..|..+-... .+.. .++......
T Consensus 343 d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~------------~l~~~~~~~ 409 (1351)
T KOG1035|consen 343 DNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPVS------------LLDVLSTSE 409 (1351)
T ss_pred Ccccc-hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchhh------------hhccccchh
Confidence 54322 2334456678888877666544 479999999999999876442211 1111 112222237
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+++.+|+..+ +++|++..+++.|+|
T Consensus 410 ~~d~~~~~~~~~---~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 410 LLDALPKCLDED---SEERLSALELLTHPF 436 (1351)
T ss_pred hhhhhhhhcchh---hhhccchhhhhhchh
Confidence 889999999999 999999999999998
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00011 Score=87.36 Aligned_cols=141 Identities=17% Similarity=0.156 Sum_probs=86.1
Q ss_pred EEeeecCcEEEEEEEE-CCceEEEEEeeccCCCH-----------------------------HHHH------HHHHHHH
Q 002331 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG-----------------------------AALL------EFKREVK 725 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~-----------------------------~~~~------~f~~Ei~ 725 (935)
+.||.-+.|.||+|+. +|+.||||+-+..-... +..+ .|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5699999999999976 78889999743321100 0000 1333433
Q ss_pred HHH----HcCCCc------eeeeecccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 002331 726 IMR----RLRHPN------VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795 (935)
Q Consensus 726 iL~----~L~HPN------IVkl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~ 795 (935)
-.. .++|-+ |.++|-.+ .....|+||||+|.-+.++-.-....++...+..-+.++..-+ |=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhcC-
Confidence 332 234444 33443322 2356899999999877654321123456554443333332222 12246
Q ss_pred CEEeeCCCCCCeeecC----CCcEEEEeccccccccC
Q 002331 796 TIVHRDLKSPNLLVDK----NWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 796 ~IIHrDLKPeNILLd~----~g~VKL~DFGlA~~~~~ 828 (935)
++|+|-+|.||++.. ++.+.+.|||+......
T Consensus 322 -ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 -FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred -CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999983 67899999999876543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00034 Score=73.64 Aligned_cols=73 Identities=18% Similarity=0.258 Sum_probs=48.0
Q ss_pred EEEeeecCcEEEEEEEEC---CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC-CceeeeecccccCCceEEEEeeCC
Q 002331 681 GERIGLGSYGEVYHADWN---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSIITEFLP 756 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~---g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~H-PNIVkl~g~~~~~~~l~LVmEy~~ 756 (935)
.+.|..|-...+|++... ++.|++|+...... ......+|+.+++.+.. .-.+++++.+.. .+||||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeC
Confidence 356888888999999765 57899997653211 11233578888888843 334455544332 38999998
Q ss_pred CCCH
Q 002331 757 RGSL 760 (935)
Q Consensus 757 gGsL 760 (935)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00056 Score=75.89 Aligned_cols=78 Identities=14% Similarity=-0.008 Sum_probs=56.0
Q ss_pred eEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC---Cceeeeeccccc---CCceEEEE
Q 002331 679 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH---PNVVLFMGAVTR---PPNLSIIT 752 (935)
Q Consensus 679 ~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~H---PNIVkl~g~~~~---~~~l~LVm 752 (935)
.-.+.||.|..+.||.....+..+.+|..+... ....+..|...|+.|.. -.+.++++++.. .+..+|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMARSFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEecccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 345679999999999998765567778743211 12467889999988842 357778876644 36689999
Q ss_pred eeCCCCCH
Q 002331 753 EFLPRGSL 760 (935)
Q Consensus 753 Ey~~gGsL 760 (935)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=1e-05 Score=102.49 Aligned_cols=250 Identities=14% Similarity=0.058 Sum_probs=157.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEECC---ceEEEEEeeccCC---CHHHHHHHHHHHHHHHHcCCCceeeeeccccc--CCc
Q 002331 676 EDLVLGERIGLGSYGEVYHADWNG---TEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPN 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~g---~~VAVK~i~~~~~---~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~--~~~ 747 (935)
+.+++.--+|-|.+ ++++|-+ ..+-+|+.+..++ .+...+....|.+.++...|+++...+.-... ...
T Consensus 1229 e~~EV~l~i~~~~~---~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFH---FRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhheeeeccccee---eccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 44555444555544 4555422 2344555544332 33334445566666677789999887765533 334
Q ss_pred eEEEEeeCCCCCHHHHHcCC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CCCEEeeCCCCCCeeecCCCcEEEEecc
Q 002331 748 LSIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTS---TPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~---~~~lse~~il~Ia~QIa~AL~yLHs~---g~~IIHrDLKPeNILLd~~g~VKL~DFG 821 (935)
.+.+++|+.+|.++..|-+. ...+++........+.+.+..-+|.. |...+|++||+-|.+|..+..+|++++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 78999999999999988542 22344444444444446666655542 3357999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcC
Q 002331 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (935)
Q Consensus 822 lA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~l 901 (935)
+.+.............+++.|+.|++...-.++.++|+|.+|+.+|++..|..+|.......+.. +.....-..++...
T Consensus 1386 LdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkg-iidn~tf~sIe~l~ 1464 (2724)
T KOG1826|consen 1386 LDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKG-IIDNHTFFSIEKLK 1464 (2724)
T ss_pred cccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcC-cccccccccccccC
Confidence 99955544444455678889999999988888889999999999999998887775443332222 21222233344443
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+.+.-.....+|-.. -..||.-..++..
T Consensus 1465 pgdaNve~~~~Ll~K---~~~rp~q~isls~ 1492 (2724)
T KOG1826|consen 1465 PGDANVEALHRLLWK---YMERPGQYISLSR 1492 (2724)
T ss_pred CCcccHHHHHHHHHH---hhhcchhhhhccc
Confidence 333333333333333 3477776665543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00095 Score=70.34 Aligned_cols=133 Identities=19% Similarity=0.267 Sum_probs=91.7
Q ss_pred EEeeecCcEEEEEEEECCceEEEEEeeccC--------------CCHHHHHHHHHHHHHHHHcC------CCceeeeecc
Q 002331 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQD--------------FSGAALLEFKREVKIMRRLR------HPNVVLFMGA 741 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~--------------~~~~~~~~f~~Ei~iL~~L~------HPNIVkl~g~ 741 (935)
..||+|+.=.||.--.+. ...||++.... .......+..+|+..+..+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~dp-~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPDDP-NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCCCC-CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 358999999999875433 34567765544 11122445667777666665 7889999999
Q ss_pred cccCCceEEEEeeCCC------CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC---
Q 002331 742 VTRPPNLSIITEFLPR------GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN--- 812 (935)
Q Consensus 742 ~~~~~~l~LVmEy~~g------GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~--- 812 (935)
.++...+.+|+|.+.. -+|.+++.+. .+++ .....+.++ ..||-.+. |+.+||+|.||++...
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~L~~f---~~~l~~~~--Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQALDEF---KRYLLDHH--IVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHHHHHH---HHHHHHcC--CeecCCCcccEEEEecCCC
Confidence 9999999999998642 3688888653 3555 333333333 45677777 9999999999999532
Q ss_pred C-cEEEEe-cccc
Q 002331 813 W-NVKVSD-FGLS 823 (935)
Q Consensus 813 g-~VKL~D-FGlA 823 (935)
. .+.|+| ||..
T Consensus 158 ~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 158 EFRLVLIDGLGEK 170 (199)
T ss_pred ceEEEEEeCCCCc
Confidence 2 588888 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0004 Score=74.63 Aligned_cols=135 Identities=16% Similarity=0.149 Sum_probs=77.8
Q ss_pred eeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce-eeeecccccCCceEEEEeeCCCCCHHH
Q 002331 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFLPRGSLFR 762 (935)
Q Consensus 684 LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNI-Vkl~g~~~~~~~l~LVmEy~~gGsL~d 762 (935)
+..|-...+|+....+..+++|....... .......+|..+++.+..-.+ .+++.... -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~--~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCK--ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccc--cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 56677889999988888899987543211 000134678888888853222 33443332 369999998865431
Q ss_pred --------------HH---cCC---CCCCCHH-HHHHHHHHH---------HHHHHHHHhc------CCCEEeeCCCCCC
Q 002331 763 --------------IL---HRP---HCQVDEK-RRIKMALDV---------ARGMNCLHTS------TPTIVHRDLKSPN 806 (935)
Q Consensus 763 --------------lL---~~~---~~~lse~-~il~Ia~QI---------a~AL~yLHs~------g~~IIHrDLKPeN 806 (935)
.+ +.. ...++.. .+..+..++ ...+..+-.. ...++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 11 111 1112221 111211111 1112222111 1248999999999
Q ss_pred eeecCCCcEEEEecccccc
Q 002331 807 LLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 807 ILLd~~g~VKL~DFGlA~~ 825 (935)
||+++++ ++|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00099 Score=72.76 Aligned_cols=140 Identities=19% Similarity=0.140 Sum_probs=84.5
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC--ceeeeecc------cccCCceEEEE
Q 002331 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGA------VTRPPNLSIIT 752 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HP--NIVkl~g~------~~~~~~l~LVm 752 (935)
.+.|..|....+|+....+..+++|+.... . ...+..|+.++..|.+. .+.+++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 456888888899999877778999987541 1 23456778888777432 24454432 12345678999
Q ss_pred eeCCCCCHHH-----------HH---cC--CC--C------CCCHHHHH----------HHHHHHHHHHHHHHh-----c
Q 002331 753 EFLPRGSLFR-----------IL---HR--PH--C------QVDEKRRI----------KMALDVARGMNCLHT-----S 793 (935)
Q Consensus 753 Ey~~gGsL~d-----------lL---~~--~~--~------~lse~~il----------~Ia~QIa~AL~yLHs-----~ 793 (935)
+|++|..+.. .+ +. .. . ...+.... .....+..++.++.. .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998865421 11 11 00 0 00111000 011122334444443 1
Q ss_pred CCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 794 g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
...++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 12499999999999999987789999997753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00032 Score=60.02 Aligned_cols=54 Identities=30% Similarity=0.248 Sum_probs=44.3
Q ss_pred cccccchhhHHHHHHhhhccCCCeeeecccCCC---------CCCCCceEEEEecCcceeeeec
Q 002331 262 INIGLSRHRALLFKVLADSIRLPCRLVKGSHYT---------GVEDDAVNIIKLEEEREFLVDL 316 (935)
Q Consensus 262 i~~G~~rhRalLfKvLaD~i~l~c~lv~G~~~~---------g~~~~a~~~v~~~~~~~~ivDl 316 (935)
-+.|.|.+.|.||+.|+-.+|||||+|.|.... ....++|++|.++ ++=+.+|-
T Consensus 4 ~~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~~-~~W~~~D~ 66 (68)
T smart00460 4 TKYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYLE-GGWVPVDP 66 (68)
T ss_pred ccceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEEC-CCeEEEeC
Confidence 368999999999999999999999999995432 2556889999985 66666663
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0026 Score=70.34 Aligned_cols=145 Identities=18% Similarity=0.152 Sum_probs=84.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC--ceeeeeccc------ccCCc
Q 002331 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGAV------TRPPN 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HP--NIVkl~g~~------~~~~~ 747 (935)
......+.|+.|....+|+++.++..+++|+..... . ...+..|..++..|... .+.+++... ...+.
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred CCceeccccCCccccceEEEEeCCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 334456678888888999997766688899765421 1 22344566777776321 234444321 22355
Q ss_pred eEEEEeeCCCCCHH-----------HHH---cC--CCC--------CC-CHHHHH------------HHHHHHHHHHHHH
Q 002331 748 LSIITEFLPRGSLF-----------RIL---HR--PHC--------QV-DEKRRI------------KMALDVARGMNCL 790 (935)
Q Consensus 748 l~LVmEy~~gGsL~-----------dlL---~~--~~~--------~l-se~~il------------~Ia~QIa~AL~yL 790 (935)
.+++|||++|..+. ..+ +. .+. .. .+.... .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999875431 111 11 000 00 000000 0011233345555
Q ss_pred Hh-----cCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 791 HT-----STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 791 Hs-----~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
.. ...+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 42 12359999999999999988877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0035 Score=69.42 Aligned_cols=140 Identities=14% Similarity=0.086 Sum_probs=76.6
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC--ceeeeecc------cccCCceEEEE
Q 002331 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGA------VTRPPNLSIIT 752 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HP--NIVkl~g~------~~~~~~l~LVm 752 (935)
.+.|+.|....+|+.+..+..+++|++. .... ..+..|+.++..|... .+.+++.. ....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE--RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec--cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 4557788888999998766689999875 2222 2233455555555211 12333321 12345678999
Q ss_pred eeCCCCCHH-----------HHHc---CC--CC--------CCCH-HHHHH------------HHHH-HHHHHHHHHh--
Q 002331 753 EFLPRGSLF-----------RILH---RP--HC--------QVDE-KRRIK------------MALD-VARGMNCLHT-- 792 (935)
Q Consensus 753 Ey~~gGsL~-----------dlL~---~~--~~--------~lse-~~il~------------Ia~Q-Ia~AL~yLHs-- 792 (935)
||++|..+. +.+. .. .. .+.+ ..... .+.+ +...+..+..
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 999886431 1111 10 00 0101 11110 1111 1112223321
Q ss_pred ---cCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 793 ---STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 793 ---~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
...++||+|+.|.|||++.+...-|+||+.+..
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 112599999999999998765568999998763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0027 Score=69.72 Aligned_cols=72 Identities=24% Similarity=0.366 Sum_probs=46.2
Q ss_pred EEeeecCcEEEEEEEEC--------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc-eeeeecccccCCceEEEE
Q 002331 682 ERIGLGSYGEVYHADWN--------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~--------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPN-IVkl~g~~~~~~~l~LVm 752 (935)
+.|..|-...||+++.. ++.|++|+..... .......+|..++..+...+ ..++++.+.. .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 45677777789998764 4789999865432 11234567888888884322 3355555532 3689
Q ss_pred eeCCCCCH
Q 002331 753 EFLPRGSL 760 (935)
Q Consensus 753 Ey~~gGsL 760 (935)
||++|..+
T Consensus 77 e~i~G~~l 84 (302)
T cd05156 77 EFIPSRTL 84 (302)
T ss_pred heeCCCcC
Confidence 99887665
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.013 Score=68.09 Aligned_cols=77 Identities=17% Similarity=0.050 Sum_probs=52.2
Q ss_pred EEEeeecCcEEEEEEEECC--ceEEEEEeecc-----CCCHHHHHHHHHHHHHHHHcC---CCceeeeecccccCCceEE
Q 002331 681 GERIGLGSYGEVYHADWNG--TEVAVKKFLDQ-----DFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~g--~~VAVK~i~~~-----~~~~~~~~~f~~Ei~iL~~L~---HPNIVkl~g~~~~~~~l~L 750 (935)
.+.||.|.+..||++...+ +.|+||.-... .........+..|.+.|+.+. ..++.+++.+- .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 3569999999999998754 38999974321 101123456677888888762 24566777663 355789
Q ss_pred EEeeCCCCC
Q 002331 751 ITEFLPRGS 759 (935)
Q Consensus 751 VmEy~~gGs 759 (935)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0013 Score=73.60 Aligned_cols=135 Identities=19% Similarity=0.222 Sum_probs=92.5
Q ss_pred eeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccC--C------------------CHHHHHHHHHHHHHHHHcC-CC-c
Q 002331 678 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQD--F------------------SGAALLEFKREVKIMRRLR-HP-N 734 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~--~------------------~~~~~~~f~~Ei~iL~~L~-HP-N 734 (935)
+.+++.||-|.-+.||.+-+ .|++.++|.=+... + -.-......+|...|+.|. |- -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 46788999999999999976 58888888321110 0 0111234567888888873 32 2
Q ss_pred eeeeecccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc
Q 002331 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814 (935)
Q Consensus 735 IVkl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~ 814 (935)
+.+.+++ +..++|||++.+-.|.+.-+- .+... +...+..-+--|..+| +||+|..-=||+|++++.
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLANHG--LIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHHHcC--ceecccchheeEEecCCC
Confidence 3444443 456899999998887765432 22233 3344445556677888 999999999999999999
Q ss_pred EEEEecccccc
Q 002331 815 VKVSDFGLSRL 825 (935)
Q Consensus 815 VKL~DFGlA~~ 825 (935)
++++||-....
T Consensus 241 i~vIDFPQmvS 251 (465)
T KOG2268|consen 241 IVVIDFPQMVS 251 (465)
T ss_pred EEEeechHhhc
Confidence 99999976543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.015 Score=65.52 Aligned_cols=147 Identities=18% Similarity=0.214 Sum_probs=83.6
Q ss_pred eeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC--CceeeeecccccCC--ceEEEEe
Q 002331 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPP--NLSIITE 753 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~H--PNIVkl~g~~~~~~--~l~LVmE 753 (935)
..+.+.+-.|.--.+|.....++++++. .......-.......+|+.+++.+.- --+...++.|.++. ..|.||+
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred CceeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3444555444444566665568888888 33222223345566788888888742 22345566665554 6799999
Q ss_pred eCCCCCHHH------------------HHc---C---CC----CC---CCHHHHHHHHH--------------HHHHHHH
Q 002331 754 FLPRGSLFR------------------ILH---R---PH----CQ---VDEKRRIKMAL--------------DVARGMN 788 (935)
Q Consensus 754 y~~gGsL~d------------------lL~---~---~~----~~---lse~~il~Ia~--------------QIa~AL~ 788 (935)
|++|..+.. +|. + .+ +. ....++..+.. .+..-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 998742221 111 0 00 00 00001111111 1122234
Q ss_pred HHHhcCC------CEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 789 CLHTSTP------TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 789 yLHs~g~------~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
+|+.+-+ .++|+|+.+.||+|+..+.+-++||+++.+
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 4444332 399999999999999988899999999875
|
|
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0013 Score=61.39 Aligned_cols=53 Identities=25% Similarity=0.270 Sum_probs=41.9
Q ss_pred ccccchhhHHHHHHhhhccCCCeeeecccCCC----------CCCCCceEEEEecCcceeeee
Q 002331 263 NIGLSRHRALLFKVLADSIRLPCRLVKGSHYT----------GVEDDAVNIIKLEEEREFLVD 315 (935)
Q Consensus 263 ~~G~~rhRalLfKvLaD~i~l~c~lv~G~~~~----------g~~~~a~~~v~~~~~~~~ivD 315 (935)
+.|.|..-|.||..|+-.+|||||+|.|.... +...++||+|.+.++.=+.+|
T Consensus 50 ~~G~C~~~a~l~~allr~~Gipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~~~~~W~~~D 112 (113)
T PF01841_consen 50 GRGDCEDYASLFVALLRALGIPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYLPGGGWIPLD 112 (113)
T ss_dssp EEESHHHHHHHHHHHHHHHT--EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEETTTEEEEEE
T ss_pred CCCccHHHHHHHHHHHhhCCCceEEEEEEcCCccccccccCCCCCCEEEEEEEEcCCcEEEcC
Confidence 45999999999999999999999999997642 344489999999666656655
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.0024 Score=74.38 Aligned_cols=54 Identities=28% Similarity=0.460 Sum_probs=46.4
Q ss_pred cccchhhHHHHHHhhhccCCCeeeecccCCCC-------CCCCceEEEEecCcceeeeeccc
Q 002331 264 IGLSRHRALLFKVLADSIRLPCRLVKGSHYTG-------VEDDAVNIIKLEEEREFLVDLMA 318 (935)
Q Consensus 264 ~G~~rhRalLfKvLaD~i~l~c~lv~G~~~~g-------~~~~a~~~v~~~~~~~~ivDlm~ 318 (935)
-++|--=|.|||.||-.+||||.+|+|.--.+ ..++|||+|+++| +=|+||.--
T Consensus 209 eavCtgYa~lfK~lcn~lgIp~~iIegf~k~~~~~~~~~~iNHaWN~VkiD~-~yy~VDtTw 269 (521)
T COG5279 209 EAVCTGYAELFKELCNALGIPCEIIEGFLKSPIYYTRDININHAWNIVKIDN-EYYLVDTTW 269 (521)
T ss_pred ccccchHHHHHHHHHHhcCCceEEEeecccccccccCCccccceeeEEEECC-eEEEEeeec
Confidence 47788889999999999999999999994444 4569999999977 889999754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.023 Score=64.44 Aligned_cols=142 Identities=17% Similarity=0.269 Sum_probs=80.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce-eeeecccccCCce
Q 002331 676 EDLVLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNL 748 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNI-Vkl~g~~~~~~~l 748 (935)
+.+.+. .|-.|-.-.+|++... ++.|++|+..... + ..-....|..+++.+..-++ .++++.+..+
T Consensus 37 ~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g--- 109 (344)
T PLN02236 37 EALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG--- 109 (344)
T ss_pred CcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--C-eeechHHHHHHHHHHHHcCCCCceEEEECCc---
Confidence 344444 4555888899999752 3578888765432 1 11223678888888843333 3555555332
Q ss_pred EEEEeeCCCCCHHHH-----------------HcCCC---CC-C-CHHHHHHHHHHH-----------------HHHHHH
Q 002331 749 SIITEFLPRGSLFRI-----------------LHRPH---CQ-V-DEKRRIKMALDV-----------------ARGMNC 789 (935)
Q Consensus 749 ~LVmEy~~gGsL~dl-----------------L~~~~---~~-l-se~~il~Ia~QI-----------------a~AL~y 789 (935)
.|+||+++.+|... ++... .. . .+..+.++..++ ...+..
T Consensus 110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 68999977665311 11111 01 1 122222332111 111222
Q ss_pred H----Hh--cCCCEEeeCCCCCCeeecC-CCcEEEEecccccc
Q 002331 790 L----HT--STPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRL 825 (935)
Q Consensus 790 L----Hs--~g~~IIHrDLKPeNILLd~-~g~VKL~DFGlA~~ 825 (935)
| .. ....++|+|+++.|||+++ ++.++|+||..+..
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2 11 1124899999999999986 57899999988764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.029 Score=61.84 Aligned_cols=30 Identities=23% Similarity=0.491 Sum_probs=25.2
Q ss_pred CEEeeCCCCCCeeecCCCc-EEEEecccccc
Q 002331 796 TIVHRDLKSPNLLVDKNWN-VKVSDFGLSRL 825 (935)
Q Consensus 796 ~IIHrDLKPeNILLd~~g~-VKL~DFGlA~~ 825 (935)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 46999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.025 Score=64.65 Aligned_cols=140 Identities=22% Similarity=0.266 Sum_probs=90.5
Q ss_pred EEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCC----------------------H--HHHHHHHHHHHHHHHcCCCc
Q 002331 680 LGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFS----------------------G--AALLEFKREVKIMRRLRHPN 734 (935)
Q Consensus 680 I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~----------------------~--~~~~~f~~Ei~iL~~L~HPN 734 (935)
|-..|..|.-..||.+.. +|..+|||+++..-+. . ....-..+|++-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345688999999999965 7889999976432110 0 11122456777787775443
Q ss_pred eeeeecccccCCceEEEEeeCCCCCHHH-HHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCC
Q 002331 735 VVLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKN 812 (935)
Q Consensus 735 IVkl~g~~~~~~~l~LVmEy~~gGsL~d-lL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~ 812 (935)
|...--+.. ....|||+|+....... .|+ .-.++...+..+-.|++.-|.-|-+ ++ +||.||.--|+|+. +
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE-C
Confidence 321111111 12469999995322211 122 2345666677777888888887755 55 99999999999995 5
Q ss_pred CcEEEEeccccccc
Q 002331 813 WNVKVSDFGLSRLK 826 (935)
Q Consensus 813 g~VKL~DFGlA~~~ 826 (935)
|.+.|+|.+.+.-.
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 68999999987643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.033 Score=62.01 Aligned_cols=75 Identities=21% Similarity=0.178 Sum_probs=48.7
Q ss_pred eEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC---CCceeeeecccccCCceEEEEeeC
Q 002331 679 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 679 ~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~---HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
+-.+.|+-|....+|+.+..++.+.||+-.... ...|..|..-|+.|. --.+.+.+++....+..+|||||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 345679999999999999889999999865322 235677888888773 345778888887777789999999
Q ss_pred CCC
Q 002331 756 PRG 758 (935)
Q Consensus 756 ~gG 758 (935)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.046 Score=63.72 Aligned_cols=75 Identities=15% Similarity=-0.008 Sum_probs=51.1
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccCC--C---HHHHHHHHHHHHHHHHcC---CCceeeeecccccCCceEEEE
Q 002331 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDF--S---GAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~--~---~~~~~~f~~Ei~iL~~L~---HPNIVkl~g~~~~~~~l~LVm 752 (935)
.+.||.|....||+....+..|+||.-..... . ......-..|...|+.+. ..++.+++.++.+ ..+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence 56789999999999987777899996542111 0 112333445666776653 2477788888773 467899
Q ss_pred eeCCC
Q 002331 753 EFLPR 757 (935)
Q Consensus 753 Ey~~g 757 (935)
||+++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.038 Score=62.28 Aligned_cols=142 Identities=18% Similarity=0.231 Sum_probs=79.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEECC-----ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce-eeeecccccCCceE
Q 002331 676 EDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLS 749 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~g-----~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNI-Vkl~g~~~~~~~l~ 749 (935)
+++++.. |..|-...+|++...+ ..|++|+..... + ......+|..+++.+..-++ .++++++..+
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G---- 86 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT--D-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG---- 86 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCc--C-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----
Confidence 3444444 4447778899986543 378888765421 1 12234578888888854444 3556555322
Q ss_pred EEEeeCCCCCHHH--------------HH---cCCC---C-CC-CHHHHHHHHHHH----------------------HH
Q 002331 750 IITEFLPRGSLFR--------------IL---HRPH---C-QV-DEKRRIKMALDV----------------------AR 785 (935)
Q Consensus 750 LVmEy~~gGsL~d--------------lL---~~~~---~-~l-se~~il~Ia~QI----------------------a~ 785 (935)
+|.+|+++..|.. .+ +... . .+ -+..+..+..++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5899987665421 11 1111 0 01 122222222111 11
Q ss_pred HHHHHH----hcC--CCEEeeCCCCCCeeecC-CCcEEEEecccccc
Q 002331 786 GMNCLH----TST--PTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRL 825 (935)
Q Consensus 786 AL~yLH----s~g--~~IIHrDLKPeNILLd~-~g~VKL~DFGlA~~ 825 (935)
-+..+. ..+ ..++|.|+.+.|||+++ ++.++|+||..+..
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 122111 112 23799999999999975 57899999998764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.047 Score=60.65 Aligned_cols=30 Identities=20% Similarity=0.307 Sum_probs=27.3
Q ss_pred CEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 796 ~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
+++|+|+.+.|||++.++.+.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 599999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.045 Score=60.02 Aligned_cols=28 Identities=29% Similarity=0.406 Sum_probs=25.0
Q ss_pred CEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 796 ~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 5999999999999987 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.022 Score=59.53 Aligned_cols=30 Identities=33% Similarity=0.572 Sum_probs=21.4
Q ss_pred CEEeeCCCCCCeee-cCCCcEEEEecccccc
Q 002331 796 TIVHRDLKSPNLLV-DKNWNVKVSDFGLSRL 825 (935)
Q Consensus 796 ~IIHrDLKPeNILL-d~~g~VKL~DFGlA~~ 825 (935)
.++|+|+.+.|||+ +.++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8899999999988763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.097 Score=60.01 Aligned_cols=113 Identities=18% Similarity=0.209 Sum_probs=74.3
Q ss_pred cCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccc
Q 002331 744 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (935)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA 823 (935)
...+.|++|++. |+.|..+ ......+...|+++.+..+.-+... .++=|||+...||||+ +|+|.|+||-++
T Consensus 297 e~~y~yl~~kdh-gt~is~i-----k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII-----KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecC-Cceeeee-----ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEEeeee
Confidence 334567888876 5555422 1245778888999988877777664 4799999999999999 999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCC
Q 002331 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK 873 (935)
Q Consensus 824 ~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~ 873 (935)
++...... ....+.--|-.+.|.. +..-+||-+ |--|+.|.
T Consensus 369 Rl~~~q~~-----isy~rldhp~lF~G~d-d~QFeIYrl---Mr~l~~g~ 409 (488)
T COG5072 369 RLSYSQGI-----ISYNRLDHPDLFNGVD-DYQFEIYRL---MRRLLKGR 409 (488)
T ss_pred ecccCCce-----eeccccCchhhhcCcc-ceeeeHHHH---HHHHhcCc
Confidence 96433221 1112233344555433 566677764 33344454
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.21 Score=56.79 Aligned_cols=136 Identities=18% Similarity=0.283 Sum_probs=79.3
Q ss_pred eeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc------eeeeec----ccccCCceEEEEe
Q 002331 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN------VVLFMG----AVTRPPNLSIITE 753 (935)
Q Consensus 684 LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPN------IVkl~g----~~~~~~~l~LVmE 753 (935)
|.. .-..||+....+..+++|+.... .. ..++..|...|..|.-.. |..+-| .+....+.+-+++
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~-~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPG-WT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCC-CC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 55678999887777788887665 33 234556777777763211 122212 1222236788999
Q ss_pred eCCCCCHHH------------HH---cC--CCC---------CCCHHH----H---------HHHHHHHHHHHHHHHhcC
Q 002331 754 FLPRGSLFR------------IL---HR--PHC---------QVDEKR----R---------IKMALDVARGMNCLHTST 794 (935)
Q Consensus 754 y~~gGsL~d------------lL---~~--~~~---------~lse~~----i---------l~Ia~QIa~AL~yLHs~g 794 (935)
|++|..+.. ++ +. .+. ...+.. . .....++...+..+...-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999887762 11 00 000 111210 0 012234444444444421
Q ss_pred ----C--C--EEeeCCCCCCeeecCCCc-EEEEeccccc
Q 002331 795 ----P--T--IVHRDLKSPNLLVDKNWN-VKVSDFGLSR 824 (935)
Q Consensus 795 ----~--~--IIHrDLKPeNILLd~~g~-VKL~DFGlA~ 824 (935)
+ + |||+|+.|.|||++.+.. +.++|||.+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 2 899999999999998875 8999999775
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.11 Score=59.71 Aligned_cols=74 Identities=19% Similarity=0.130 Sum_probs=45.9
Q ss_pred EeeecCcEEEEEEEECC--ceEEEEEeecc-----CCCHHHHHHHHHHHHHHHHcC--CCc-eeeeecccccCCceEEEE
Q 002331 683 RIGLGSYGEVYHADWNG--TEVAVKKFLDQ-----DFSGAALLEFKREVKIMRRLR--HPN-VVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~~g--~~VAVK~i~~~-----~~~~~~~~~f~~Ei~iL~~L~--HPN-IVkl~g~~~~~~~l~LVm 752 (935)
.||.|....||++...+ +.|+||.-... ........+...|...|+... .|. +.++|. | +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-F-DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-E-ccccceehH
Confidence 47999999999998754 57999954311 111223444556777887662 353 444443 2 344566999
Q ss_pred eeCCCC
Q 002331 753 EFLPRG 758 (935)
Q Consensus 753 Ey~~gG 758 (935)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.096 Score=60.91 Aligned_cols=75 Identities=19% Similarity=0.081 Sum_probs=49.0
Q ss_pred EEEeeecCcEEEEEEEEC--CceEEEEEeec----cCCCHHHHHHHHHHHHHHHHcC--CCc-eeeeecccccCCceEEE
Q 002331 681 GERIGLGSYGEVYHADWN--GTEVAVKKFLD----QDFSGAALLEFKREVKIMRRLR--HPN-VVLFMGAVTRPPNLSII 751 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~----~~~~~~~~~~f~~Ei~iL~~L~--HPN-IVkl~g~~~~~~~l~LV 751 (935)
.+.||-|.-.-||++... ++.|+||.-.. .....-...+...|..+|+.+. .|. +.++|.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 567899999999999864 66799995432 1111234555667888888763 354 4455543 34456789
Q ss_pred EeeCCC
Q 002331 752 TEFLPR 757 (935)
Q Consensus 752 mEy~~g 757 (935)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.042 Score=65.05 Aligned_cols=157 Identities=17% Similarity=0.171 Sum_probs=96.3
Q ss_pred HHHHHHHHHHHcCCCceeeeeccccc-CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCE
Q 002331 719 EFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797 (935)
Q Consensus 719 ~f~~Ei~iL~~L~HPNIVkl~g~~~~-~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~I 797 (935)
++.-...+++.+.|+|..+++++-.. .....+|||++ +.+|++++.... + ... ++. -++ +
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l---~~~----s~~-------~~~--~ 88 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--L---KDE----SLL-------AHG--V 88 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--c---chh----hhc-------ccc--c
Confidence 34456788999999999999887643 34478899999 569999886532 1 111 111 112 3
Q ss_pred EeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002331 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877 (935)
Q Consensus 798 IHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~ 877 (935)
.|- | .++.+| -+.. +. ... ..+|+|||++|.++.++.-|..-|.
T Consensus 89 ~~~-----~-------~~~~td-~~~t------~~-~~~----------------~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 89 LHL-----N-------IIYITD-HFLT------KY-PSP----------------IGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred cee-----h-------hhhccc-cccc------cC-CCC----------------CCcchhhhhHHHHHHHHHHhhHHHH
Confidence 332 1 233333 0000 00 001 1149999999999999999987777
Q ss_pred CCChHHHHHHhhc-ccccc---------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCc
Q 002331 878 GMNPMQVVGAVGF-QNRRL---------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKR 933 (935)
Q Consensus 878 ~~~~~eil~~I~~-~~~r~---------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHP 933 (935)
.....+....+.. ..... .+-..++..+.++..+|+-.. |..||.+.++.+++
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~---~~ir~l~~~~~k~~ 195 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLE---PIIRPLPMELSKRC 195 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccc---cccccchhHHhcCc
Confidence 6655444433311 00000 111345667888888998777 99999988888775
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.36 Score=52.55 Aligned_cols=76 Identities=20% Similarity=0.180 Sum_probs=56.7
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc---CCCceeeeecccccCCceEEEEeeCCC
Q 002331 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L---~HPNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
.+.+.-|..-..|...+...+|.||+-. ......|..|+.-|..| +--.+.+++.+....++.|+||||++-
T Consensus 21 r~~v~gG~inea~~v~dg~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~ 95 (286)
T COG3001 21 REEVSGGDINEAWRLRDGTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT 95 (286)
T ss_pred ccccCCccccceeEeecCCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence 4456677777778888888899999722 23345677787777776 345678899999999999999999987
Q ss_pred CCHH
Q 002331 758 GSLF 761 (935)
Q Consensus 758 GsL~ 761 (935)
+.+.
T Consensus 96 ~~~d 99 (286)
T COG3001 96 GPLD 99 (286)
T ss_pred CCCC
Confidence 5543
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.4 Score=55.59 Aligned_cols=77 Identities=18% Similarity=0.251 Sum_probs=45.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEECC---ce-----EEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce-eeeecccccCC
Q 002331 676 EDLVLGERIGLGSYGEVYHADWNG---TE-----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPP 746 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~g---~~-----VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNI-Vkl~g~~~~~~ 746 (935)
+++.+. .|..|-...+|++...+ .. |.++... ......-...+|+.+++.+...++ .++++.+..
T Consensus 51 ~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g---~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~-- 124 (383)
T PTZ00384 51 EFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS---TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD-- 124 (383)
T ss_pred ccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEecc---CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC--
Confidence 344444 55558888999996532 23 3333211 111112233578999999854444 566666653
Q ss_pred ceEEEEeeCCCCCH
Q 002331 747 NLSIITEFLPRGSL 760 (935)
Q Consensus 747 ~l~LVmEy~~gGsL 760 (935)
++|.||++|..|
T Consensus 125 --g~l~efIeGr~l 136 (383)
T PTZ00384 125 --FTIQEWVEGNTM 136 (383)
T ss_pred --EEEEEEeccccC
Confidence 599999988765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 935 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-95 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-94 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-37 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-37 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-37 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-37 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-36 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-36 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-36 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-36 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-36 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-35 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-35 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-35 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-35 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-35 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-34 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-33 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-32 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-32 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-32 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-32 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-32 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-32 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-32 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-32 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-32 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-32 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-32 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-32 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-32 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-32 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-32 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-32 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-32 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-32 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-32 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-31 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-31 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-31 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-31 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-31 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-29 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-29 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-29 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-28 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-28 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-28 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-28 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-28 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-28 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-28 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-28 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-28 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-28 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-28 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-28 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-28 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-28 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-28 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-28 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-28 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-28 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-27 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-27 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-27 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-27 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-27 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-27 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-27 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-27 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-27 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-27 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-27 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-27 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-27 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-27 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-27 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-27 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-27 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-27 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-27 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-27 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-27 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-27 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-27 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-27 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-27 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-27 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-27 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-26 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-26 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-26 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-26 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-26 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-26 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-26 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-26 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-26 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-26 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-26 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-26 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-26 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-26 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-25 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-25 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-25 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-25 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-25 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-25 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-25 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-25 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-25 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-25 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-25 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-25 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-25 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-25 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-25 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-25 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-25 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-25 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-25 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-24 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-24 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-24 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-24 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-24 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-24 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-24 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-24 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-24 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-24 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-24 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-24 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-24 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-24 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-24 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-24 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-24 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-24 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-24 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-24 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-24 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-24 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-24 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-24 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-24 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-24 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-24 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-24 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-24 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-24 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-24 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-24 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-24 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-23 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-23 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-23 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-23 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-23 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-23 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-23 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-23 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-23 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-23 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-23 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-23 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-23 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-23 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-23 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-23 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-23 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-23 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-23 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-23 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-23 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-23 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-23 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-23 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-23 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-23 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-23 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-22 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-22 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-22 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-22 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-22 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-22 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-22 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-22 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-22 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-22 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-22 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-22 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-22 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-22 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-21 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-21 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-21 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-21 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-21 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-21 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-21 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-21 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-21 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-21 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-21 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-21 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-21 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-21 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-20 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-20 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-20 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-20 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-20 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-20 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-20 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-20 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-20 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-20 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-20 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-19 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-19 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-19 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-19 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-19 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-19 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-19 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-19 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-19 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-19 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-19 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-19 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-19 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-19 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-19 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-19 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-19 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-19 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-19 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-19 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-17 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-17 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-17 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-17 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-17 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-17 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-17 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-17 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-17 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-16 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-15 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-14 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 7e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 455 bits (1173), Expect = e-154
Identities = 171/278 (61%), Positives = 209/278 (75%), Gaps = 3/278 (1%)
Query: 641 LKLRDLESPSSSVDSSTSKVDQIFD-DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG 699
+K P S D T++ D + +IPW DL + E+IG GS+G V+ A+W+G
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60
Query: 700 TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 759
++VAVK ++QDF + EF REV IM+RLRHPN+VLFMGAVT+PPNLSI+TE+L RGS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 760 LFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 817
L+R+LH+ Q+DE+RR+ MA DVA+GMN LH P IVHR+LKSPNLLVDK + VKV
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180
Query: 818 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877
DFGLSRLK +TFLSSKS AGTPEWMAPEVLR+EPSNEK DVYSFGVILWELATL+ PW
Sbjct: 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 878 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915
+NP QVV AVGF+ +RLEIP+ L+P VA II CW
Sbjct: 241 NLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTN 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 408 bits (1052), Expect = e-137
Identities = 74/250 (29%), Positives = 128/250 (51%), Gaps = 11/250 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I ++ L ++ GE++ W G ++ VK +D+S +F E +R
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 732 HPNVVLFMGAVTRPP--NLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMN 788
HPNV+ +GA PP + ++IT ++P GSL+ +LH VD+ + +K ALD+ARGM
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 848
LHT P I L S ++++D++ ++S + S P W+APE L
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAWVAPEAL 180
Query: 849 RNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
+ +P + D++SF V+LWEL T ++P+ ++ M++ V + R IP + P V
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240
Query: 906 ARIIWECWQT 915
++++ C
Sbjct: 241 SKLMKICMNE 250
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 406 bits (1045), Expect = e-136
Identities = 91/255 (35%), Positives = 138/255 (54%), Gaps = 15/255 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFL--DQDFSGAALLEFKREVKIMRR 729
EI + +L L E IG+G +G+VY A W G EVAVK + + ++E K+
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
L+HPN++ G + PNL ++ EF G L R+L ++ + A+ +ARGMN
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNY 120
Query: 790 LHTSTP-TIVHRDLKSPNLLVDK--------NWNVKVSDFGLSRLKHNTFLSSKSTAGTP 840
LH I+HRDLKS N+L+ + N +K++DFGL+R H T + S AG
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAY 178
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
WMAPEV+R ++ DV+S+GV+LWEL T ++P+ G++ + V V L IP
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238
Query: 901 LDPLVARIIWECWQT 915
A+++ +CW
Sbjct: 239 CPEPFAKLMEDCWNP 253
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 397 bits (1023), Expect = e-132
Identities = 94/259 (36%), Positives = 146/259 (56%), Gaps = 13/259 (5%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVK 725
D + EIP + +G+RIG GS+G VY W+G +VAVK + L FK EV
Sbjct: 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 785
++R+ RH N++LFMG T P L+I+T++ SL+ LH + + K+ I +A AR
Sbjct: 73 VLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWM 843
GM+ LH +I+HRDLKS N+ + ++ VK+ DFGL+ K S + G+ WM
Sbjct: 132 GMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 844 APEVLRNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRR---LE 896
APEV+R + SN + DVY+FG++L+EL T +LP+ +N Q++ VG + +
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249
Query: 897 IPKELDPLVARIIWECWQT 915
+ + R++ EC +
Sbjct: 250 VRSNCPKRMKRLMAECLKK 268
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 397 bits (1021), Expect = e-131
Identities = 84/286 (29%), Positives = 136/286 (47%), Gaps = 21/286 (7%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVA 703
+L S+ + IF E +IP+E L +GE IG G +G+VYH W+G EVA
Sbjct: 4 MNLSLLSARSFPRKASQTSIFLQ---EWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVA 59
Query: 704 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 763
++ + + L FKREV R+ RH NVVLFMGA PP+L+IIT +L+ +
Sbjct: 60 IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 764 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823
+ +D + ++A ++ +GM LH I+H+DLKS N+ D N V ++DFGL
Sbjct: 120 VRDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDFGLF 176
Query: 824 RLKHNTFLSSKST-----AGTPEWMAPEVLRN---------EPSNEKCDVYSFGVILWEL 869
+ + G +APE++R P ++ DV++ G I +EL
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
Query: 870 ATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915
+ P+ ++ +G + + ++ I+ CW
Sbjct: 237 HAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAF 282
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-128
Identities = 76/260 (29%), Positives = 127/260 (48%), Gaps = 21/260 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALL-----EFKREV 724
+ ++ ++IG G +G V+ + + VA+K + D G + EF+REV
Sbjct: 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
IM L HPN+V G + PP ++ EF+P G L+ L + ++++ LD+A
Sbjct: 75 FIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLSRLKHNTFLSSKSTAGT 839
G+ + P IVHRDL+SPN+ + KV+DFGLS+ ++ G
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGN 189
Query: 840 PEWMAPEVL--RNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRRL 895
+WMAPE + E EK D YSF +IL+ + T + P+ + ++ + + + R
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 896 EIPKELDPLVARIIWECWQT 915
IP++ P + +I CW
Sbjct: 250 TIPEDCPPRLRNVIELCWSG 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 381 bits (980), Expect = e-125
Identities = 79/261 (30%), Positives = 113/261 (43%), Gaps = 17/261 (6%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
DL+ GE +G G +G+ T + F F +EVK+MR
Sbjct: 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
L HPNV+ F+G + + L+ ITE++ G+L I+ Q +R+ A D+A GM
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--------------KHNTFLSSKS 835
LH+ I+HRDL S N LV +N NV V+DFGL+RL K +
Sbjct: 124 LHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRR 894
G P WMAPE++ +EK DV+SFG++L E+ P + +
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 895 LEIPKELDPLVARIIWECWQT 915
P P I C
Sbjct: 242 RYCPPNCPPSFFPITVRCCDL 262
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 374 bits (963), Expect = e-123
Identities = 74/249 (29%), Positives = 123/249 (49%), Gaps = 14/249 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I ++++ + E +G G++G V A W +VA+K+ + F E++ + R+
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERK----AFIVELRQLSRVN 59
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMNC 789
HPN+V GA P + ++ E+ GSL+ +LH P + L ++G+
Sbjct: 60 HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 790 LHTSTPT-IVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
LH+ P ++HRDLK PNLL+ V K+ DFG + ++K G+ WMAPEV
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEV 174
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVA 906
+EKCDV+S+G+ILWE+ T + P+ + P + R + K L +
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234
Query: 907 RIIWECWQT 915
++ CW
Sbjct: 235 SLMTRCWSK 243
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 342 bits (878), Expect = e-110
Identities = 88/321 (27%), Positives = 137/321 (42%), Gaps = 58/321 (18%)
Query: 637 MGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD 696
G +L+ +S SS S + Q + + + ++IG G YGEV+
Sbjct: 7 PGESLRDLIEQSQSSGSGSGLPLLVQ---------RTIAKQIQMVKQIGKGRYGEVWMGK 57
Query: 697 WNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHPNVVLFMGAVTRP----PNLSI 750
W G +VAVK F + + + RE +I +RH N++ F+ A + L +
Sbjct: 58 WRGEKVAVKVFFTTEEA-----SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112
Query: 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST------PTIVHRDLKS 804
IT++ GSL+ L +D K +K+A G+ LHT P I HRDLKS
Sbjct: 113 ITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170
Query: 805 PNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAGTPEWMAPEVL------RNEPSN 854
N+LV KN ++D GL+ + + + GT +M PEVL + S
Sbjct: 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230
Query: 855 EKCDVYSFGVILWELAT----------LKLPWIGMNPMQ-----VVGAVGFQNRRLEIPK 899
D+YSFG+ILWE+A +LP+ + P + V + R P
Sbjct: 231 IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN 290
Query: 900 -----ELDPLVARIIWECWQT 915
E + +++ ECW
Sbjct: 291 RWSSDECLRQMGKLMTECWAH 311
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 340 bits (873), Expect = e-110
Identities = 80/282 (28%), Positives = 125/282 (44%), Gaps = 49/282 (17%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHP 733
D+ L E +G G YGEV+ W G VAVK F +D + RE ++ LRH
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEK-----SWFRETELYNTVMLRHE 62
Query: 734 NVVLFMGAVTR----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
N++ F+ + L +IT + GSL+ L +D +++ L +A G+
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAH 120
Query: 790 LHT------STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF----LSSKSTAGT 839
LH P I HRDLKS N+LV KN ++D GL+ + + + + GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 840 PEWMAPEVLRNEP------SNEKCDVYSFGVILWELAT----------LKLPWIGMNP-- 881
+MAPEVL S ++ D+++FG++LWE+A K P+ + P
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 882 ---MQVVGAVGFQNRRLEIPKELD-----PLVARIIWECWQT 915
+ V +R IP +A+++ ECW
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQ 282
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-104
Identities = 94/320 (29%), Positives = 142/320 (44%), Gaps = 58/320 (18%)
Query: 638 GTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADW 697
GT LK + +S S + Q +VL E IG G +GEV+ W
Sbjct: 13 GTTLKDLIYDMTTSGSGSGLPLLVQ---------RTIARTIVLQESIGKGRFGEVWRGKW 63
Query: 698 NGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHPNVVLFMGAVTR----PPNLSII 751
G EVAVK F ++ + RE +I LRH N++ F+ A + L ++
Sbjct: 64 RGEEVAVKIFSSREER-----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118
Query: 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST------PTIVHRDLKSP 805
+++ GSLF L+R V + IK+AL A G+ LH P I HRDLKS
Sbjct: 119 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176
Query: 806 NLLVDKNWNVKVSDFGLSRLKHNT----FLSSKSTAGTPEWMAPEVLRNE------PSNE 855
N+LV KN ++D GL+ + ++ GT +MAPEVL + S +
Sbjct: 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 236
Query: 856 KCDVYSFGVILWELATL----------KLPWIGMNPM-----QVVGAVGFQNRRLEIPK- 899
+ D+Y+ G++ WE+A +LP+ + P ++ V Q R IP
Sbjct: 237 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR 296
Query: 900 ----ELDPLVARIIWECWQT 915
E ++A+I+ ECW
Sbjct: 297 WQSCEALRVMAKIMRECWYA 316
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = e-100
Identities = 79/308 (25%), Positives = 117/308 (37%), Gaps = 56/308 (18%)
Query: 647 ESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKK 706
SS VD T L L E G +G V+ A VAVK
Sbjct: 6 HHHSSGVDLGTE-----------NLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKI 54
Query: 707 FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----LSIITEFLPRGSLFR 762
F QD + + EV + ++H N++ F+GA R + L +IT F +GSL
Sbjct: 55 FPIQDKQS---WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD 111
Query: 763 ILHRPHCQVDEKRRIKMALDVARGMNCLHT--------STPTIVHRDLKSPNLLVDKNWN 814
L V +A +ARG+ LH P I HRD+KS N+L+ N
Sbjct: 112 FLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169
Query: 815 VKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEP-----SNEKCDVYSFGVILW 867
++DFGL+ + + GT +MAPEVL + + D+Y+ G++LW
Sbjct: 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229
Query: 868 ELATLKLPWIGMNP----------------MQVVGAVGFQNRRLEIPKELDP-----LVA 906
ELA+ G + V + +R + ++
Sbjct: 230 ELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLC 289
Query: 907 RIIWECWQ 914
I ECW
Sbjct: 290 ETIEECWD 297
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 302 bits (774), Expect = 4e-95
Identities = 80/299 (26%), Positives = 116/299 (38%), Gaps = 60/299 (20%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMR- 728
E + ++L L E IG G YG VY + VAVK F + F E I R
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ-----NFINEKNIYRV 61
Query: 729 -RLRHPNVVLFMGAVTRPP-----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
+ H N+ F+ R ++ E+ P GSL + L D ++A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHS 119
Query: 783 VARGMNCLHTST-------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL---- 831
V RG+ LHT P I HRDL S N+LV + +SDFGLS L
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 832 ----SSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELA---TLKLPWI 877
++ S GT +MAPEVL E + ++ D+Y+ G+I WE+ T P
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 878 GMNPMQV---------------VGAVGFQNRRLEIPKELDP------LVARIIWECWQT 915
+ Q+ V + +R + P+ + I +CW
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 4e-66
Identities = 75/243 (30%), Positives = 118/243 (48%), Gaps = 12/243 (4%)
Query: 680 LGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG GS+ VY D EVA + D+ + + FK E ++++ L+HPN+V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 738 FMGA----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
F + V + ++TE + G+L L R + K + +G+ LHT
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 794 TPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
TP I+HRDLK N+ + +VK+ D GL+ LK +F +K+ GTPE+MAPE+ +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEEK- 205
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV-GAVGFQNRRLEIPKELDPLVARIIWE 911
+E DVY+FG+ + E+AT + P+ + V + K P V II
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265
Query: 912 CWQ 914
C +
Sbjct: 266 CIR 268
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 3e-62
Identities = 77/250 (30%), Positives = 126/250 (50%), Gaps = 9/250 (3%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ + EDLVLGE+IG G++GEV+ T VAVK + +F +E +I+
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQEARIL 166
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
++ HPN+V +G T+ + I+ E + G L ++ K ++M D A GM
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAP 845
L + +HRDL + N LV + +K+SDFG+SR + + ++ P +W AP
Sbjct: 227 EYLESK--CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
E L + + DV+SFG++LWE +L P+ ++ Q V + RL P+
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDA 343
Query: 905 VARIIWECWQ 914
V R++ +CW
Sbjct: 344 VFRLMEQCWA 353
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-60
Identities = 71/283 (25%), Positives = 122/283 (43%), Gaps = 21/283 (7%)
Query: 650 SSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAV 704
+ + + + + I L+LG+ +G G +G V + +VAV
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAV 67
Query: 705 KKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-----PPNLSIITEFLPRGS 759
K + S + EF E M+ HPNV+ +G P +I F+ G
Sbjct: 68 KTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD 127
Query: 760 LFRIL--HRPHCQVDE---KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 814
L L R + +K +D+A GM L S +HRDL + N ++ +
Sbjct: 128 LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCMLRDDMT 185
Query: 815 VKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL 872
V V+DFGLS+ ++ + P +W+A E L + K DV++FGV +WE+AT
Sbjct: 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245
Query: 873 -KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
P+ G+ ++ + RL+ P++ + I++ CW+
Sbjct: 246 GMTPYPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWR 287
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-60
Identities = 73/246 (29%), Positives = 119/246 (48%), Gaps = 9/246 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
I +L + IG G +G V+ W +VA+K + + +F E ++M +L
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEE--DFIEEAEVMMKL 60
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
HP +V G + ++TEF+ G L L + + M LDV GM L
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 849
++HRDL + N LV +N +KVSDFG++R + +S + P +W +PEV
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 178
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ K DV+SFGV++WE+ + K+P+ + +VV + RL P+ V +I
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQI 237
Query: 909 IWECWQ 914
+ CW+
Sbjct: 238 MNHCWR 243
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-60
Identities = 82/264 (31%), Positives = 132/264 (50%), Gaps = 18/264 (6%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG 714
S + D+ + + ++L L + IG G +G+V D+ G +VAVK +
Sbjct: 3 GSVAAQDEFYRS---GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----D 55
Query: 715 AALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIITEFLPRGSLFRILH-RPHCQVD 772
A F E +M +LRH N+V +G + L I+TE++ +GSL L R +
Sbjct: 56 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG 115
Query: 773 EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832
+K +LDV M L VHRDL + N+LV ++ KVSDFGL++ +T +
Sbjct: 116 GDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173
Query: 833 SKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 890
K P +W APE LR + + K DV+SFG++LWE+ + ++P+ + VV V
Sbjct: 174 GK----LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE- 228
Query: 891 QNRRLEIPKELDPLVARIIWECWQ 914
+ +++ P P V ++ CW
Sbjct: 229 KGYKMDAPDGCPPAVYEVMKNCWH 252
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-59
Identities = 77/246 (31%), Positives = 118/246 (47%), Gaps = 9/246 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EI +DL + +G G +G V + W G +VA+K + + EF E K+M L
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSED--EFIEEAKVMMNL 76
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
H +V G T+ + IITE++ G L L + ++ ++M DV M L
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 849
+ +HRDL + N LV+ VKVSDFGLSR + +S + P W PEVL
Sbjct: 137 --ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 194
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ K D+++FGV++WE+ +L K+P+ + + Q RL P V I
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTI 253
Query: 909 IWECWQ 914
++ CW
Sbjct: 254 MYSCWH 259
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-59
Identities = 78/246 (31%), Positives = 126/246 (51%), Gaps = 9/246 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
E+ E++ L + +G G +G V W G +VAVK + + EF +E + M +L
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKM-IKEGSMSED--EFFQEAQTMMKL 60
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
HP +V F G ++ + I+TE++ G L L ++ + ++M DV GM L
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 849
+ +HRDL + N LVD++ VKVSDFG++R + S P +W APEV
Sbjct: 121 --ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ K DV++FG+++WE+ +L K+P+ +VV V Q RL P + +I
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQI 237
Query: 909 IWECWQ 914
++ CW
Sbjct: 238 MYSCWH 243
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 203 bits (520), Expect = 2e-59
Identities = 74/252 (29%), Positives = 113/252 (44%), Gaps = 12/252 (4%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREV 724
+ I ED+VL +G G +GEVY + VAVK +D + +F E
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKT-CKKDCTLDNKEKFMSEA 64
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
IM+ L HP++V +G + P II E P G L L R + + +L +
Sbjct: 65 VIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 843
+ M L + VHRD+ N+LV VK+ DFGLSR + S P +WM
Sbjct: 124 KAMAYL--ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
+PE + DV+ F V +WE+ + K P+ + V+G + + RL P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCP 240
Query: 903 PLVARIIWECWQ 914
P++ ++ CW
Sbjct: 241 PVLYTLMTRCWD 252
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-59
Identities = 72/264 (27%), Positives = 120/264 (45%), Gaps = 22/264 (8%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREV 724
+ IP + LG +G G +G V A +VAVK + + + EF RE
Sbjct: 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 725 KIMRRLRHPNVVLFMGAVTR------PPNLSIITEFLPRGSLFRIL--HRPH---CQVDE 773
M+ HP+V +G R P +I F+ G L L R +
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 774 KRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833
+ ++ +D+A GM L S+ +HRDL + N ++ ++ V V+DFGLSR ++
Sbjct: 137 QTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 834 KSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 890
+ A P +W+A E L + DV++FGV +WE+ T + P+ G+ ++ +
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI- 253
Query: 891 QNRRLEIPKELDPLVARIIWECWQ 914
RL+ P E V ++++CW
Sbjct: 254 GGNRLKQPPECMEEVYDLMYQCWS 277
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 5e-59
Identities = 66/253 (26%), Positives = 114/253 (45%), Gaps = 14/253 (5%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREV 724
+ + + +G G++G VY W VA+K+ L + S A E E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEA 68
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+M + +P+V +G + +IT+ +P G L + + + + + +A
Sbjct: 69 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-EW 842
+GMN L +VHRDL + N+LV +VK++DFGL++ L P +W
Sbjct: 128 KGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
MA E + + + DV+S+GV +WEL T P+ G+ ++ + + RL P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244
Query: 902 DPLVARIIWECWQ 914
V I+ +CW
Sbjct: 245 TIDVYMIMRKCWM 257
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 5e-59
Identities = 78/261 (29%), Positives = 125/261 (47%), Gaps = 17/261 (6%)
Query: 667 DVCECEIP--WEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLE 719
+V + IP IG G +G VYH ++ + A+K L + +
Sbjct: 10 EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS-LSRITEMQQVEA 68
Query: 720 FKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
F RE +MR L HPNV+ +G + P ++ ++ G L + + P K I
Sbjct: 69 FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS 128
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKST 836
L VARGM L + VHRDL + N ++D+++ VKV+DFGL+R + + +
Sbjct: 129 FGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 837 AGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR 893
P +W A E L+ K DV+SFGV+LWEL T P+ ++P + + Q R
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGR 245
Query: 894 RLEIPKELDPLVARIIWECWQ 914
RL P+ + +++ +CW+
Sbjct: 246 RLPQPEYCPDSLYQVMQQCWE 266
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 6e-59
Identities = 82/256 (32%), Positives = 135/256 (52%), Gaps = 14/256 (5%)
Query: 663 IFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFK 721
++D E E+P E L L ER+G G +GEV+ +NG T+VAVK L Q F
Sbjct: 3 WWED---EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPD--AFL 56
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMA 780
E +M++L+H +V VT+ P IITE++ GSL L ++ + + MA
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 840
+A GM + +HRDL++ N+LV + K++DFGL+RL + +++ A P
Sbjct: 116 AQIAEGMAFI--EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 841 -EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIP 898
+W APE + K DV+SFG++L E+ T ++P+ GM +V+ + + R+ P
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRP 232
Query: 899 KELDPLVARIIWECWQ 914
+ +++ CW+
Sbjct: 233 DNCPEELYQLMRLCWK 248
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 9e-59
Identities = 82/274 (29%), Positives = 129/274 (47%), Gaps = 30/274 (10%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALL 718
+ I D+VL +G G++G+V+ A+ VAVK +D + AA
Sbjct: 5 SGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARK 62
Query: 719 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR 776
+F+RE +++ L+H ++V F G L ++ E++ G L + L H P + +
Sbjct: 63 DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 777 -------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823
+ +A +A GM L ++ VHRDL + N LV N VK+ DFG+S
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 824 RLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMN 880
R ++T P WM PE + + DV+SFGVILWE+ T K PW ++
Sbjct: 181 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240
Query: 881 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+V+ + Q R LE P+ V ++ CWQ
Sbjct: 241 NTEVIECIT-QGRVLERPRVCPKEVYDVMLGCWQ 273
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-58
Identities = 80/262 (30%), Positives = 130/262 (49%), Gaps = 23/262 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+ E + + +G GS+G VY G T VA+K +++ S +EF E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEA 79
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPHCQVDEKRR------ 776
+M+ +VV +G V++ +I E + RG L + RP +
Sbjct: 80 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 777 -IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835
I+MA ++A GM L + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 140 MIQMAGEIADGMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 836 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
G P WM+PE L++ DV+SFGV+LWE+ATL + P+ G++ QV+ V +
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEG 256
Query: 893 RRLEIPKELDPLVARIIWECWQ 914
L+ P ++ ++ CWQ
Sbjct: 257 GLLDKPDNCPDMLFELMRMCWQ 278
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-58
Identities = 81/255 (31%), Positives = 118/255 (46%), Gaps = 13/255 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALL-EFKRE 723
C I +DL L E++G GS+G V +W+ VAVK S + +F RE
Sbjct: 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783
V M L H N++ G V PP + ++TE P GSL L + + A+ V
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P- 840
A GM L + +HRDL + NLL+ VK+ DFGL R P
Sbjct: 131 AEGMGYL--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK 899
W APE L+ + D + FGV LWE+ T + PWIG+N Q++ + + RL P+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248
Query: 900 ELDPLVARIIWECWQ 914
+ + ++ +CW
Sbjct: 249 DCPQDIYNVMVQCWA 263
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-57
Identities = 88/251 (35%), Positives = 131/251 (52%), Gaps = 13/251 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ E+ D+ + ++G G YGEVY W VAVK L +D EF +E +M
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVE--EFLKEAAVM 63
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVAR 785
+ ++HPN+V +G TR P IITEF+ G+L L +V + MA ++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISS 122
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMA 844
M L +HRDL + N LV +N VKV+DFGLSRL ++ + A P +W A
Sbjct: 123 AMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
PE L + K DV++FGV+LWE+AT P+ G++ QV + ++ R+E P+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 239
Query: 904 LVARIIWECWQ 914
V ++ CWQ
Sbjct: 240 KVYELMRACWQ 250
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 3e-57
Identities = 78/268 (29%), Positives = 115/268 (42%), Gaps = 29/268 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
EI + E +G +G+VY G VA+K L G EF+ E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT-LKDKAEGPLREEFRHEA 63
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR------ 776
+ RL+HPNVV +G VT+ LS+I + G L L PH V
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 777 -------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829
+ + +A GM L S+ +VH+DL + N+LV NVK+SD GL R +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 830 FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVG 886
P WMAPE + + D++S+GV+LWE+ + P+ G + VV
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241
Query: 887 AVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + L P + V ++ ECW
Sbjct: 242 MIR-NRQVLPCPDDCPAWVYALMIECWN 268
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-57
Identities = 74/252 (29%), Positives = 114/252 (45%), Gaps = 12/252 (4%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREV 724
+ EI E + LG IG G +G+V+ + VA+K S + +F +E
Sbjct: 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEA 67
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
MR+ HP++V +G +T P II E G L L +D I A ++
Sbjct: 68 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 843
+ L + VHRD+ + N+LV N VK+ DFGLSR ++ S P +WM
Sbjct: 127 TALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
APE + DV+ FGV +WE+ P+ G+ V+G + RL +P
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 243
Query: 903 PLVARIIWECWQ 914
P + ++ +CW
Sbjct: 244 PTLYSLMTKCWA 255
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 4e-57
Identities = 74/262 (28%), Positives = 117/262 (44%), Gaps = 23/262 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+P +++ L +G G++GEVY +G +VAVK L + S L+F E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEA 84
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDE----KRRIK 778
I+ + H N+V +G + I+ E + G L L RP +
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSKS 835
+A D+A G L +HRD+ + N L+ K+ DFG++R + K
Sbjct: 145 VARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 836 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
P +WM PE K D +SFGV+LWE+ +L +P+ + +V+ V
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 261
Query: 893 RRLEIPKELDPLVARIIWECWQ 914
R++ PK V RI+ +CWQ
Sbjct: 262 GRMDPPKNCPGPVYRIMTQCWQ 283
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 4e-57
Identities = 77/273 (28%), Positives = 122/273 (44%), Gaps = 15/273 (5%)
Query: 653 VDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKF 707
+D S + + + E IG G +G VYH AVK
Sbjct: 2 IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS- 60
Query: 708 LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSLFRILHR 766
L++ + +F E IM+ HPNV+ +G R + ++ ++ G L +
Sbjct: 61 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 767 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
K I L VA+GM L ++ VHRDL + N ++D+ + VKV+DFGL+R
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178
Query: 827 HNT--FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNP 881
++ + T P +WMA E L+ + K DV+SFGV+LWEL T P+ +N
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238
Query: 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + Q RRL P+ + ++ +CW
Sbjct: 239 FDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWH 270
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 6e-57
Identities = 92/303 (30%), Positives = 141/303 (46%), Gaps = 30/303 (9%)
Query: 636 FMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA 695
MG+ L E S + + Q F D C I D+VL +G G++G+V+ A
Sbjct: 2 AMGSGSSLSPTEGKGSGLQGHIIENPQYFSDA-CVHHIKRRDIVLKWELGEGAFGKVFLA 60
Query: 696 DWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748
+ + VAVK ++ S +A +F+RE +++ L+H ++V F G T L
Sbjct: 61 ECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118
Query: 749 SIITEFLPRGSLFRIL--HRPHCQVDEKRR------------IKMALDVARGMNCLHTST 794
++ E++ G L R L H P ++ + +A VA GM L +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AG 176
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEP 852
VHRDL + N LV + VK+ DFG+SR ++T P WM PE +
Sbjct: 177 LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 236
Query: 853 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
+ DV+SFGV+LWE+ T K PW ++ + + + Q R LE P+ P V I+
Sbjct: 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRG 295
Query: 912 CWQ 914
CWQ
Sbjct: 296 CWQ 298
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-56
Identities = 59/253 (23%), Positives = 110/253 (43%), Gaps = 14/253 (5%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREV 724
+L + +G G +G V+ W V +K ++ + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDHM 66
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+ L H ++V +G L ++T++LP GSL + + + + + + +A
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EW 842
+GM L +VHR+L + N+L+ V+V+DFG++ L + TP +W
Sbjct: 126 KGMYYL--EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
MA E + + DV+S+GV +WEL T P+ G+ +V + + RL P+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQIC 242
Query: 902 DPLVARIIWECWQ 914
V ++ +CW
Sbjct: 243 TIDVYMVMVKCWM 255
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 3e-56
Identities = 81/251 (32%), Positives = 128/251 (50%), Gaps = 19/251 (7%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVK--KFLDQDFSGAALLEFKREVKIM 727
+ ++L L + IG G +G+V D+ G +VAVK K + A F E +M
Sbjct: 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK------NDATAQAFLAEASVM 240
Query: 728 RRLRHPNVVLFMGAVTR-PPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVAR 785
+LRH N+V +G + L I+TE++ +GSL L R + +K +LDV
Sbjct: 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMA 844
M L VHRDL + N+LV ++ KVSDFGL++ +T + K P +W A
Sbjct: 301 AMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTA 354
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
PE LR + + K DV+SFG++LWE+ + ++P+ + VV V + +++ P P
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPP 413
Query: 904 LVARIIWECWQ 914
V ++ CW
Sbjct: 414 AVYDVMKNCWH 424
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 4e-56
Identities = 74/262 (28%), Positives = 117/262 (44%), Gaps = 23/262 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+P +++ L +G G++GEVY +G +VAVK L + S L+F E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEA 125
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDE----KRRIK 778
I+ + H N+V +G + I+ E + G L L RP +
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSKS 835
+A D+A G L +HRD+ + N L+ K+ DFG++R + K
Sbjct: 186 VARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243
Query: 836 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
P +WM PE K D +SFGV+LWE+ +L +P+ + +V+ V
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 302
Query: 893 RRLEIPKELDPLVARIIWECWQ 914
R++ PK V RI+ +CWQ
Sbjct: 303 GRMDPPKNCPGPVYRIMTQCWQ 324
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-56
Identities = 75/289 (25%), Positives = 121/289 (41%), Gaps = 37/289 (12%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQD 711
++ + + + E P ++ IG G++G V+ A G T VAVK L ++
Sbjct: 30 RMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEE 88
Query: 712 FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHC 769
S +F+RE +M +PN+V +G + ++ E++ G L L PH
Sbjct: 89 ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHT 148
Query: 770 QVDEKRR---------------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 808
+ +A VA GM L S VHRDL + N L
Sbjct: 149 VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCL 206
Query: 809 VDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVIL 866
V +N VK++DFGLSR ++ P WM PE + + DV+++GV+L
Sbjct: 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266
Query: 867 WELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
WE+ + P+ GM +V+ V L P+ + ++ CW
Sbjct: 267 WEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWS 314
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 6e-56
Identities = 81/271 (29%), Positives = 138/271 (50%), Gaps = 32/271 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 722
E P + L LG+ +G G++G+V A+ G VAVK L D + L +
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLVS 89
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHC---------- 769
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L RP
Sbjct: 90 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 770 ---QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
Q+ K + +ARGM L ++ +HRDL + N+LV +N +K++DFGL+R
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 827 HNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
+N K+T G P +WMAPE L + + DV+SFGV++WE+ TL P+ G+ +
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + + R++ P + ++ +CW
Sbjct: 268 LFKLLK-EGHRMDKPANCTNELYMMMRDCWH 297
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 6e-56
Identities = 77/278 (27%), Positives = 123/278 (44%), Gaps = 15/278 (5%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEV 702
+ + +D S + + + E IG G +G VYH
Sbjct: 61 ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 120
Query: 703 AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSLF 761
AVK L++ + +F E IM+ HPNV+ +G R + ++ ++ G L
Sbjct: 121 AVKS-LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 762 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
+ K I L VA+GM L ++ VHRDL + N ++D+ + VKV+DFG
Sbjct: 180 NFIRNETHNPTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFG 237
Query: 822 LSRLKHNT--FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPW 876
L+R ++ T P +WMA E L+ + K DV+SFGV+LWEL T P+
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297
Query: 877 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+N + + Q RRL P+ + ++ +CW
Sbjct: 298 PDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWH 334
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 9e-56
Identities = 66/253 (26%), Positives = 114/253 (45%), Gaps = 14/253 (5%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREV 724
+ + + +G G++G VY W VA+K+ L + S A E E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEA 68
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+M + +P+V +G + +IT+ +P G L + + + + + +A
Sbjct: 69 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-EW 842
+GMN L +VHRDL + N+LV +VK++DFGL++ L P +W
Sbjct: 128 KGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
MA E + + + DV+S+GV +WEL T P+ G+ ++ + + RL P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244
Query: 902 DPLVARIIWECWQ 914
V I+ +CW
Sbjct: 245 TIDVYMIMVKCWM 257
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 9e-56
Identities = 83/250 (33%), Positives = 131/250 (52%), Gaps = 13/250 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMR 728
EIP E L L ++G G +GEV+ WNG T VA+K L + F +E ++M+
Sbjct: 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTM--SPEAFLQEAQVMK 234
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARG 786
+LRH +V V+ P I+TE++ +GSL L + + + MA +A G
Sbjct: 235 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASG 292
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAP 845
M + VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W AP
Sbjct: 293 MAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
E K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 409
Query: 905 VARIIWECWQ 914
+ ++ +CW+
Sbjct: 410 LHDLMCQCWR 419
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-55
Identities = 78/249 (31%), Positives = 131/249 (52%), Gaps = 11/249 (4%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMR 728
EIP E L L +++G G +GEV+ A +N T+VAVK ++ F E +M+
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVMK 238
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGM 787
L+H +V VT+ P IITEF+ +GSL L + + I + +A GM
Sbjct: 239 TLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPE 846
+ +HRDL++ N+LV + K++DFGL+R+ + +++ A P +W APE
Sbjct: 298 AFI--EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 355
Query: 847 VLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
+ K DV+SFG++L E+ T ++P+ GM+ +V+ A+ + R+ P+ +
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEEL 414
Query: 906 ARIIWECWQ 914
I+ CW+
Sbjct: 415 YNIMMRCWK 423
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-55
Identities = 67/254 (26%), Positives = 115/254 (45%), Gaps = 14/254 (5%)
Query: 670 ECEIPWEDLVLGER-IGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREV 724
E + + L L ++ +G G++G V + VAVK ++ A E E
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+M++L +P +V +G + ++ E G L + L + + V +K I++ V+
Sbjct: 70 NVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVS 127
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-E 841
GM L VHRDL + N+L+ K+SDFGLS+ K+ P +
Sbjct: 128 MGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
W APE + + K DV+SFGV++WE + + P+ GM +V + + R+ P
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 244
Query: 901 LDPLVARIIWECWQ 914
+ ++ CW
Sbjct: 245 CPREMYDLMNLCWT 258
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-55
Identities = 84/271 (30%), Positives = 143/271 (52%), Gaps = 32/271 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 722
E+P + LVLG+ +G G++G+V A+ G T+VAVK L D + L +
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLIS 123
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILHR 766
E+++M+ + +H N++ +GA T+ L +I E+ +G+L + H
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 767 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
P Q+ K + A VARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 827 HNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
H+ K+T G P +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ +
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + + R++ P + ++ +CW
Sbjct: 302 LFKLLK-EGHRMDKPSNCTNELYMMMRDCWH 331
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-55
Identities = 74/253 (29%), Positives = 126/253 (49%), Gaps = 14/253 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVK 725
EI + + IG G +GEVY VA+K L ++ ++F E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAG 98
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 785
IM + H N++ G +++ + IITE++ G+L + L + + + M +A
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EW 842
GM L + VHRDL + N+LV+ N KVSDFGLSR+ + ++ +T+G P W
Sbjct: 159 GMKYL--ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901
APE + DV+SFG+++WE+ T + P+ ++ +V+ A+ RL P +
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 275
Query: 902 DPLVARIIWECWQ 914
+ +++ +CWQ
Sbjct: 276 PSAIYQLMMQCWQ 288
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 3e-55
Identities = 85/251 (33%), Positives = 130/251 (51%), Gaps = 13/251 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ E+ D+ + ++G G YGEVY W VAVK L +D EF +E +M
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVE--EFLKEAAVM 270
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVAR 785
+ ++HPN+V +G TR P IITEF+ G+L L +V + MA ++
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISS 329
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMA 844
M L +HR+L + N LV +N VKV+DFGLSR + +T+ + +W A
Sbjct: 330 AMEYLEKK--NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 387
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
PE L + K DV++FGV+LWE+AT P+ G++ QV + ++ R+E P+
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 446
Query: 904 LVARIIWECWQ 914
V ++ CWQ
Sbjct: 447 KVYELMRACWQ 457
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-55
Identities = 80/252 (31%), Positives = 119/252 (47%), Gaps = 13/252 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKI 726
EI + + + IG G GEV + VA+K L ++ +F E I
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA-LKAGYTERQRRDFLSEASI 103
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
M + HPN++ G VTR I+TE++ GSL L Q + + M V G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EWM 843
M L S VHRDL + N+LVD N KVSDFGLSR+ + ++ +T G P W
Sbjct: 164 MRYL--SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
APE + + DV+SFGV++WE+ + P+ M V+ +V + RL P
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGCP 280
Query: 903 PLVARIIWECWQ 914
+ +++ +CW
Sbjct: 281 HALHQLMLDCWH 292
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 4e-55
Identities = 82/276 (29%), Positives = 132/276 (47%), Gaps = 37/276 (13%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P ++LVLG+ +G G +G+V A T VAVK L ++ S + L + E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-LKENASPSELRDLLSEF 77
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR------ 776
+++++ HP+V+ GA ++ L +I E+ GSL L R
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 777 ---------------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
I A +++GM L + +VHRDL + N+LV + +K+SDFG
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 822 LSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG 878
LSR + K + G P +WMA E L + + DV+SFGV+LWE+ TL P+ G
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 879 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ P ++ + R+E P + R++ +CW+
Sbjct: 256 IPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWK 290
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 5e-55
Identities = 87/311 (27%), Positives = 149/311 (47%), Gaps = 40/311 (12%)
Query: 637 MGTNLKLRDLESPSSSVDS-----STSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGE 691
M +N L + + SS S+ + D E P + L LG+ +G G +G+
Sbjct: 40 MNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKW---EFPRDKLTLGKPLGEGCFGQ 96
Query: 692 VYHADWNG---------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741
V A+ G VAVK L D + L + E+++M+ + +H N++ +GA
Sbjct: 97 VVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155
Query: 742 VTRPPNLSIITEFLPRGSL--FRILHRPHC-------------QVDEKRRIKMALDVARG 786
T+ L +I E+ +G+L + RP Q+ K + +ARG
Sbjct: 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMA 844
M L ++ +HRDL + N+LV +N +K++DFGL+R +N K+T G P +WMA
Sbjct: 216 MEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 273
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
PE L + + DV+SFGV++WE+ TL P+ G+ ++ + + R++ P
Sbjct: 274 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTN 332
Query: 904 LVARIIWECWQ 914
+ ++ +CW
Sbjct: 333 ELYMMMRDCWH 343
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 8e-55
Identities = 80/266 (30%), Positives = 126/266 (47%), Gaps = 30/266 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ W D+ + IG G++G+V A + A+K+ + + S +F E++++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVL 79
Query: 728 RRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR-------- 776
+L HPN++ +GA L + E+ P G+L L R
Sbjct: 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 777 -----IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831
+ A DVARGM+ L S +HRDL + N+LV +N+ K++DFGLSR +
Sbjct: 140 SSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-- 195
Query: 832 SSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV 888
K T G P WMA E L DV+S+GV+LWE+ +L P+ GM ++ +
Sbjct: 196 -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
Query: 889 GFQNRRLEIPKELDPLVARIIWECWQ 914
Q RLE P D V ++ +CW+
Sbjct: 255 P-QGYRLEKPLNCDDEVYDLMRQCWR 279
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 8e-55
Identities = 75/269 (27%), Positives = 120/269 (44%), Gaps = 30/269 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVK 725
L +G G +G+V + G +VAVK L + G + + K+E++
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIE 75
Query: 726 IMRRLRHPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783
I+R L H N+V + G T + +I EFLP GSL L + +++ K+++K A+ +
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P- 840
+GM+ L + VHRDL + N+LV+ VK+ DFGL++ P
Sbjct: 136 CKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV 193
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL---------------KLPWIGMNPMQVV 885
W APE L DV+SFGV L EL T M ++V
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253
Query: 886 GAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + +RL P V +++ +CW+
Sbjct: 254 NTLK-EGKRLPCPPNCPDEVYQLMRKCWE 281
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 9e-55
Identities = 74/272 (27%), Positives = 121/272 (44%), Gaps = 32/272 (11%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 723
+ L +++G G++G V ++ VAVKK L + L +F+RE
Sbjct: 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHS-TEEHLRDFERE 61
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLS--IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
++I++ L+H N+V + G + +I E+LP GSL L + ++D + ++
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG-T 839
+ +GM L T +HRDL + N+LV+ VK+ DFGL++ L + G +
Sbjct: 122 QICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 840 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL----------------KLPWIGMNPM 882
P W APE L + DV+SFGV+L+EL T M
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 883 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
++ + N RL P + I+ ECW
Sbjct: 240 HLIELLK-NNGRLPRPDGCPDEIYMIMTECWN 270
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-54
Identities = 75/270 (27%), Positives = 121/270 (44%), Gaps = 32/270 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVK 725
+ L +++G G++G V ++ VAVKK Q + L +F+RE++
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 94
Query: 726 IMRRLRHPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783
I++ L+H N+V + G L +I E+LP GSL L + ++D + ++ +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG-TP- 840
+GM L T +HRDL + N+LV+ VK+ DFGL++ L + G +P
Sbjct: 155 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 212
Query: 841 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL----------------KLPWIGMNPMQV 884
W APE L + DV+SFGV+L+EL T M +
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272
Query: 885 VGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + N RL P + I+ ECW
Sbjct: 273 IELLK-NNGRLPRPDGCPDEIYMIMTECWN 301
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-54
Identities = 65/252 (25%), Positives = 117/252 (46%), Gaps = 14/252 (5%)
Query: 672 EIPWEDLVLGE-RIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVKI 726
+ ++L++ + +G G++G V + +VA+K L Q A E RE +I
Sbjct: 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQI 63
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
M +L +P +V +G + ++ E G L + L ++ ++ V+ G
Sbjct: 64 MHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 122
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EWM 843
M L VHRDL + N+L+ K+SDFGLS+ + + P +W
Sbjct: 123 MKYL--EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P E
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECP 239
Query: 903 PLVARIIWECWQ 914
P + ++ +CW
Sbjct: 240 PELYALMSDCWI 251
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 5e-54
Identities = 74/252 (29%), Positives = 125/252 (49%), Gaps = 13/252 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKI 726
E+ ++ + + +G G +GEV VA+K L ++ +F E I
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT-LKVGYTEKQRRDFLGEASI 99
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
M + HPN++ G VT+ + I+TE++ GSL L + Q + + M +A G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EWM 843
M L S VHRDL + N+L++ N KVSDFGL R+ + ++ +T G P W
Sbjct: 160 MKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
+PE + DV+S+G++LWE+ + + P+ M+ V+ AV + RL P +
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCP 276
Query: 903 PLVARIIWECWQ 914
+ +++ +CWQ
Sbjct: 277 AALYQLMLDCWQ 288
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 7e-54
Identities = 81/306 (26%), Positives = 132/306 (43%), Gaps = 37/306 (12%)
Query: 642 KLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-- 699
+L+ ++ SS + + ++ D+ + E P E+L G+ +G G++G+V +A G
Sbjct: 12 QLQMVQVTGSSDNEYFYVDFREYEYDL-KWEFPRENLEFGKVLGSGAFGKVMNATAYGIS 70
Query: 700 -----TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITE 753
+VAVK L + + E+K+M +L H N+V +GA T + +I E
Sbjct: 71 KTGVSIQVAVKM-LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129
Query: 754 FLPRGSLFRIL--HRPHCQVDEKRR--------------------IKMALDVARGMNCLH 791
+ G L L R DE + A VA+GM L
Sbjct: 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL- 188
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLR 849
+ VHRDL + N+LV VK+ DFGL+R + P +WMAPE L
Sbjct: 189 -EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
K DV+S+G++LWE+ +L P+ G+ + +++ P + I
Sbjct: 248 EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYII 307
Query: 909 IWECWQ 914
+ CW
Sbjct: 308 MQSCWA 313
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 9e-54
Identities = 78/271 (28%), Positives = 127/271 (46%), Gaps = 32/271 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P + L LG+ +G G++G+V AD G VAVK L + + + E+
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALMSEL 81
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRIL--HRPHC----------- 769
KI+ + H NVV +GA T+P L +I EF G+L L R
Sbjct: 82 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 770 --QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827
+ + I + VA+GM L ++ +HRDL + N+L+ + VK+ DFGL+R +
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 828 NTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM-NPMQ 883
+ P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+ +
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + R+ P P + + + +CW
Sbjct: 260 FCRRLK-EGTRMRAPDYTTPEMYQTMLDCWH 289
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 9e-54
Identities = 74/250 (29%), Positives = 113/250 (45%), Gaps = 12/250 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKI 726
EI E + LG IG G +G+V+ + VA+K S + +F +E
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEALT 444
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
MR+ HP++V +G +T P II E G L L +D I A ++
Sbjct: 445 MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAP 845
+ L + VHRD+ + N+LV N VK+ DFGLSR ++ S P +WMAP
Sbjct: 504 LAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
E + DV+ FGV +WE+ P+ G+ V+G + RL +P P
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPT 620
Query: 905 VARIIWECWQ 914
+ ++ +CW
Sbjct: 621 LYSLMTKCWA 630
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-53
Identities = 59/263 (22%), Positives = 111/263 (42%), Gaps = 32/263 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 722
+I EDL+ E +G G++ +++ TEV +K LD+ F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKV-LDKA-HRNYSESFFE 61
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
+M +L H ++VL G ++ EF+ GSL L + ++ ++++A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--------VKVSDFGLSRLKHNTFLSSK 834
+A M+ L T++H ++ + N+L+ + + +K+SD G+S + K
Sbjct: 122 LAAAMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----VLPK 174
Query: 835 STAGTP-EWMAPEVLRNEPS-NEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 891
W+ PE + N + N D +SFG LWE+ + P ++ + +
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-D 233
Query: 892 NRRLEIPKELDPLVARIIWECWQ 914
+L PK +A +I C
Sbjct: 234 RHQLPAPK--AAELANLINNCMD 254
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-53
Identities = 74/271 (27%), Positives = 113/271 (41%), Gaps = 31/271 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P L G+ +G G++G+V A G VAVK L E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSEL 77
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPH------------- 768
K++ L H N+V +GA T +ITE+ G L L R
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 769 --CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
+D + + + VA+GM L ++ +HRDL + N+L+ K+ DFGL+R
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 827 HNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
N P +WMAPE + N + DV+S+G+ LWEL +L P+ GM
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + R+ P+ + I+ CW
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWD 286
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-53
Identities = 83/250 (33%), Positives = 131/250 (52%), Gaps = 13/250 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMR 728
EIP E L L ++G G +GEV+ WNG T VA+K L + F +E ++M+
Sbjct: 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTM--SPEAFLQEAQVMK 317
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARG 786
+LRH +V V+ P I+TE++ +GSL L + + + MA +A G
Sbjct: 318 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASG 375
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAP 845
M + VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W AP
Sbjct: 376 MAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 433
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
E K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 492
Query: 905 VARIIWECWQ 914
+ ++ +CW+
Sbjct: 493 LHDLMCQCWR 502
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 3e-53
Identities = 68/271 (25%), Positives = 113/271 (41%), Gaps = 32/271 (11%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 723
L +G G +G+V ++ VAVK L D +K+E
Sbjct: 25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA-LKADAGPQHRSGWKQE 83
Query: 724 VKIMRRLRHPNVVLFMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
+ I+R L H +++ + G +L ++ E++P GSL L R + + + A
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQ 141
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG-T 839
+ GM LH +HRDL + N+L+D + VK+ DFGL++ + G +
Sbjct: 142 QICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 840 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL---------------KLPWIGMNPMQ 883
P W APE L+ DV+SFGV L+EL T + M ++
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + + RL P + V ++ CW+
Sbjct: 260 LTELLE-RGERLPRPDKCPAEVYHLMKNCWE 289
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 7e-53
Identities = 71/268 (26%), Positives = 115/268 (42%), Gaps = 29/268 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P +L G+ +G G++G+V A G +VAVK L E+
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM-LKSTAHADEKEALMSEL 100
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR----- 776
KIM L +H N+V +GA T + +ITE+ G L L + D
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 777 ------IKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830
+ + VA+GM L ++ +HRD+ + N+L+ K+ DFGL+R N
Sbjct: 161 ASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 831 LSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG-MNPMQVVG 886
P +WMAPE + + + DV+S+G++LWE+ +L P+ G + +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278
Query: 887 AVGFQNRRLEIPKELDPLVARIIWECWQ 914
V ++ P + I+ CW
Sbjct: 279 LVK-DGYQMAQPAFAPKNIYSIMQACWA 305
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 8e-51
Identities = 68/270 (25%), Positives = 116/270 (42%), Gaps = 29/270 (10%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 723
L ++G G++G V ++ VAVK+ Q +F+RE
Sbjct: 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQRE 74
Query: 724 VKIMRRLRHPNVVLFMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
++I++ L +V + G P +L ++ E+LP G L L R ++D R + +
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS 134
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGT 839
+ +GM L + VHRDL + N+LV+ +VK++DFGL++L + + +
Sbjct: 135 QICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 840 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF------- 890
P W APE L + + + DV+SFGV+L+EL T +
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 891 ------QNRRLEIPKELDPLVARIIWECWQ 914
+ +RL P V ++ CW
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELMKLCWA 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-48
Identities = 59/218 (27%), Positives = 109/218 (50%), Gaps = 10/218 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRH 732
+ + ++IG G + EVY A +G VA+KK + A + +E+ ++++L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARGMNC 789
PNV+ + + L+I+ E G L R++ + + E+ K + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
+H+ ++HRD+K N+ + VK+ D GL R + ++ S GTP +M+PE +
Sbjct: 152 MHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVV 885
N K D++S G +L+E+A L+ P+ G MN +
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 247
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-48
Identities = 67/280 (23%), Positives = 112/280 (40%), Gaps = 19/280 (6%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA-DW-NGTE 701
+ + D+ + + E + R+G GS+GEV+ D G +
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761
AVKK + F E+ L P +V GAV P ++I E L GSL
Sbjct: 86 CAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138
Query: 762 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDF 820
+++ + + E R + G+ LHT I+H D+K+ N+L+ + + DF
Sbjct: 139 QLI-KQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDF 195
Query: 821 GLSR-----LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 875
G + + L+ GT MAPEV+ +P + K D++S ++ + P
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
Query: 876 WIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQ 914
W + + + EIP PL A+ I E +
Sbjct: 256 WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLR 295
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-48
Identities = 57/242 (23%), Positives = 122/242 (50%), Gaps = 6/242 (2%)
Query: 676 EDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
E V ++IG GS+G+ +G + +K+ S E +REV ++ ++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGMNCLHT 792
N+V + + +L I+ ++ G LF+ + + E + + + + + +H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
I+HRD+KS N+ + K+ V++ DFG++R+ ++T +++ GTP +++PE+ N+P
Sbjct: 144 RK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
N K D+++ G +L+EL TLK + + +V + + + ++ +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQL 260
Query: 913 WQ 914
++
Sbjct: 261 FK 262
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 7e-48
Identities = 64/254 (25%), Positives = 118/254 (46%), Gaps = 14/254 (5%)
Query: 670 ECEIPWEDLVLGE-RIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREV 724
+ + ++L++ + +G G++G V + +VA+K L Q A E RE
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREA 387
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+IM +L +P +V +G + ++ E G L + L ++ ++ V+
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-E 841
GM L VHR+L + N+L+ K+SDFGLS+ + + P +
Sbjct: 447 MGMKYL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
W APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P E
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 563
Query: 901 LDPLVARIIWECWQ 914
P + ++ +CW
Sbjct: 564 CPPELYALMSDCWI 577
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-47
Identities = 67/249 (26%), Positives = 116/249 (46%), Gaps = 11/249 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
ED + IG GSYG +G + K+ + A EV ++R L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 734 NVVLFMGAVTRPPN--LSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARGMN 788
N+V + + N L I+ E+ G L ++ + +DE+ +++ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 789 CLH---TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
H T++HRDLK N+ +D NVK+ DFGL+R+ ++ +K+ GTP +M+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
E + NEK D++S G +L+EL L P+ + ++ G + + + IP +
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDEL 244
Query: 906 ARIIWECWQ 914
II
Sbjct: 245 NEIITRMLN 253
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 7e-47
Identities = 71/269 (26%), Positives = 132/269 (49%), Gaps = 14/269 (5%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDF 712
S S + + D+ E + +++ +G G+YG VY D N +A+K+ ++D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 713 SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH--CQ 770
+ L E+ + + L+H N+V ++G+ + + I E +P GSL +L +
Sbjct: 61 RYSQPLH--EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118
Query: 771 VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNT 829
+E+ + G+ LH + IVHRD+K N+L++ + +K+SDFG S+
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176
Query: 830 FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFG-VILWELATLKLPWIGM-NPMQVV 885
+++ GT ++MAPE++ P + D++S G I+ E+AT K P+ + P +
Sbjct: 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQAAM 235
Query: 886 GAVGFQNRRLEIPKELDPLVARIIWECWQ 914
VG EIP+ + I +C++
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFE 264
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 61/258 (23%), Positives = 109/258 (42%), Gaps = 39/258 (15%)
Query: 676 EDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
D +G G++G+V A + A+KK + L EV ++ L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQ 62
Query: 734 NVVLFMGAVTRPPNLS-------------IITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
VV + A N I E+ G+L+ ++H + ++
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--- 837
+ ++ +H+ I+HRDLK N+ +D++ NVK+ DFGL++ H + K +
Sbjct: 123 RQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 838 -----------GTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885
GT ++A EVL NEK D+YS G+I +E+ + GM + ++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFSTGMERVNIL 238
Query: 886 GAVGFQNRRLEIPKELDP 903
+ ++ +E P + D
Sbjct: 239 KKL--RSVSIEFPPDFDD 254
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-45
Identities = 63/202 (31%), Positives = 112/202 (55%), Gaps = 14/202 (6%)
Query: 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
++G G +G+VY +G +VA+K+ + S + EF+ E++ + RHP+
Sbjct: 43 HKFLIGH----GVFGKVYKGVLRDGAKVALKR-RTPE-SSQGIEEFETEIETLSFCRHPH 96
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLH 791
+V +G + +I +++ G+L R L+ P + ++R+++ + ARG++ LH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVLR 849
T I+HRD+KS N+L+D+N+ K++DFG+S+ + ST GT ++ PE
Sbjct: 157 T--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFI 214
Query: 850 NEPSNEKCDVYSFGVILWELAT 871
EK DVYSFGV+L+E+
Sbjct: 215 KGRLTEKSDVYSFGVVLFEVLC 236
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 9e-45
Identities = 65/195 (33%), Positives = 108/195 (55%), Gaps = 9/195 (4%)
Query: 684 IGLGSYGEVYHAD-WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742
+G G +G+VY +GT VAVK+ L ++ + L+F+ EV+++ H N++ G
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 743 TRPPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLH-TSTPTIV 798
P ++ ++ GS+ L +D +R ++AL ARG+ LH P I+
Sbjct: 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 799 HRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856
HRD+K+ N+L+D+ + V DFGL++L +T +++ GT +APE L S+EK
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKSSEK 215
Query: 857 CDVYSFGVILWELAT 871
DV+ +GV+L EL T
Sbjct: 216 TDVFGYGVMLLELIT 230
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 50/250 (20%), Positives = 102/250 (40%), Gaps = 22/250 (8%)
Query: 680 LGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VV 736
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + ++
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ ++ E L L + +D R ++ ++ +H
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH--G 147
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPS- 853
IVH DLK N L+ +K+ DFG++ T + S GT +M PE +++ S
Sbjct: 148 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 854 ----------NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELD 902
+ K DV+S G IL+ + K P+ + N + + A+ N +E P +
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 266
Query: 903 PLVARIIWEC 912
+ ++ C
Sbjct: 267 KDLQDVLKCC 276
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-44
Identities = 50/250 (20%), Positives = 102/250 (40%), Gaps = 22/250 (8%)
Query: 680 LGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VV 736
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + ++
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ ++ E L L + +D R ++ ++ +H
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH--G 128
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPS- 853
IVH DLK N L+ +K+ DFG++ T + S GT +M PE +++ S
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 854 ----------NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELD 902
+ K DV+S G IL+ + K P+ + N + + A+ N +E P +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 247
Query: 903 PLVARIIWEC 912
+ ++ C
Sbjct: 248 KDLQDVLKCC 257
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+L + +G G+ V+ G A+K F + + RE +++++L H N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 737 -LFMGAV---TRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCL 790
LF A+ T + +I EF P GSL+ +L P + E + + DV GMN L
Sbjct: 71 KLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 791 HTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 845
+ IVHR++K N++ D K++DFG +R L+ + S GT E++ P
Sbjct: 129 REN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHP 184
Query: 846 EVLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883
++ + D++S GV + AT LP+ +
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 54/221 (24%), Positives = 106/221 (47%), Gaps = 32/221 (14%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRH 732
D E IG G +G+V+ A +G +K+ + + + +REVK + +L H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-------KAEREVKALAKLDH 63
Query: 733 PNVVLFMGA----------------VTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKR 775
N+V + G ++ L I EF +G+L + + R ++D+
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 776 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSK 834
+++ + +G++ +H+ +++RDLK N+ + VK+ DFGL LK++
Sbjct: 124 ALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 875
+ GT +M+PE + ++ ++ D+Y+ G+IL EL +
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 66/219 (30%), Positives = 119/219 (54%), Gaps = 19/219 (8%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
P E E+IG GS+GEV+ + VA+K +D + + + + ++E+ ++ +
Sbjct: 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCD 78
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
P V + G+ + L II E+L GS +L +DE + + ++ +G++ LH
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLH 136
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAP 845
+ +HRD+K+ N+L+ ++ VK++DFG++ ++K NTF GTP WMAP
Sbjct: 137 SEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF------VGTPFWMAP 188
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884
EV++ + K D++S G+ ELA + P ++PM+V
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV 227
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-43
Identities = 61/262 (23%), Positives = 117/262 (44%), Gaps = 8/262 (3%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTE 701
+ LE + +++ E+ +D +G G+ G V+ +G
Sbjct: 2 KKLEELELD-EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761
+A K + + A + RE++++ P +V F GA +SI E + GSL
Sbjct: 61 MARKL-IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119
Query: 762 RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
++L + ++ E+ K+++ V +G+ L I+HRD+K N+LV+ +K+ DFG
Sbjct: 120 QVLKKAG-RIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 881
+S ++ + S GT +M+PE L+ + + D++S G+ L E+A + P +
Sbjct: 178 VSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
Query: 882 MQVVGAVGFQNRRLEIPKELDP 903
++ G Q P
Sbjct: 236 KELELMFGCQVEGDAAETPPRP 257
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 3e-43
Identities = 49/250 (19%), Positives = 101/250 (40%), Gaps = 22/250 (8%)
Query: 680 LGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VV 736
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + ++
Sbjct: 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ ++ E L L + +D R ++ ++ +H
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH--G 175
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
IVH DLK N L+ +K+ DFG++ T + S G +M PE +++ S+
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 855 -----------EKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELD 902
K DV+S G IL+ + K P+ + N + + A+ N +E P +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 294
Query: 903 PLVARIIWEC 912
+ ++ C
Sbjct: 295 KDLQDVLKCC 304
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 6e-43
Identities = 49/221 (22%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 680 LGERIGLGSYGEVYHADWNGTEVAVK---------------KFLDQDFSGAALLEFKREV 724
+ + G + ++ + + A+K D+ + +FK E+
Sbjct: 35 IIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+I+ +++ + G +T + II E++ S+ + +D+ + + V
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIPIQVI 153
Query: 785 R--------GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 836
+ + +H + I HRD+K N+L+DKN VK+SDFG S + + K +
Sbjct: 154 KCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KGS 210
Query: 837 AGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLP 875
GT E+M PE NE + K D++S G+ L+ + +P
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 6e-43
Identities = 60/271 (22%), Positives = 109/271 (40%), Gaps = 22/271 (8%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+ ER+G G +G V G +VA+K+ Q+ S + E++IM++L HPNVV
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 737 -LF-----MGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMN 788
+ + + E+ G L + L++ C + E + D++ +
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMA 844
LH + I+HRDLK N+++ K+ D G ++ L GT +++A
Sbjct: 136 YLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLA 191
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
PE+L + D +SFG + +E T P++ + + E D L
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK-VREKSNEHIVVYDDL 250
Query: 905 VARIIWECWQTGWSSLHIRTSQAQLSHKRFQ 935
+ + + H+ A + Q
Sbjct: 251 TGAVKFSSVLPTPN--HLSGILAGKLERWLQ 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-43
Identities = 61/280 (21%), Positives = 96/280 (34%), Gaps = 24/280 (8%)
Query: 609 NSKDENPKNVE--DHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDD 666
+ + V+ + + + R L+SP S Q F
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQ- 60
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDFSGAALLEFKREV 724
R+G GSYGEV+ +G AVK+ + EV
Sbjct: 61 -------------RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV 107
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783
++ +HP V A L + TE SL + + E + D
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDT 166
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 843
+ LH+ +VH D+K N+ + K+ DFGL + T + + G P +M
Sbjct: 167 LLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGDPRYM 223
Query: 844 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883
APE+L DV+S G+ + E+A G Q
Sbjct: 224 APELL-QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQ 262
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 67/228 (29%), Positives = 116/228 (50%), Gaps = 22/228 (9%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGAALLEFKR 722
D+ + P E + E++G GSYG VY A G VA+K+ ++ D E +
Sbjct: 19 DEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-----EIIK 73
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E+ IM++ P+VV + G+ + +L I+ E+ GS+ I+ + + E +
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 783 VARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKST 836
+G+ LH +HRD+K+ N+L++ + K++DFG++ K NT +
Sbjct: 134 TLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI----- 186
Query: 837 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884
GTP WMAPEV++ N D++S G+ E+A K P+ ++PM+
Sbjct: 187 -GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-42
Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 28/225 (12%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV- 736
L + +G G+ V+ G A+K F + + RE +++++L H N+V
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 737 LFMGAV---TRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLH 791
LF A+ T + +I EF P GSL+ +L P + E + + DV GMN L
Sbjct: 72 LF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 792 TSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 846
+ IVHR++K N++ D K++DFG +R L+ + S GT E++ P+
Sbjct: 130 EN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPD 185
Query: 847 VLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883
+ + D++S GV + AT LP+ +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-42
Identities = 69/199 (34%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 679 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRHPNVV 736
+GE G +G VY N T VAVKK + +F +E+K+M + +H N+V
Sbjct: 38 KMGE----GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDVARGMNCLHTST 794
+G + +L ++ ++P GSL L R K+A A G+N LH
Sbjct: 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE-- 151
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVLRNEP 852
+HRD+KS N+L+D+ + K+SDFGL+R + ++ GT +MAPE LR E
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE- 210
Query: 853 SNEKCDVYSFGVILWELAT 871
K D+YSFGV+L E+ T
Sbjct: 211 ITPKSDIYSFGVVLLEIIT 229
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-41
Identities = 45/221 (20%), Positives = 86/221 (38%), Gaps = 25/221 (11%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ + +++G G + V +G A+K+ L + E +RE + R HP
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ--DREEAQREADMHRLFNHP 86
Query: 734 NVVLFMGAVTRPPN----LSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARG 786
N++ + R ++ F RG+L+ + + E + + + L + RG
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--------- 837
+ +H HRDLK N+L+ + D G S+
Sbjct: 147 LEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 838 GTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLP 875
T + APE+ + +E+ DV+S G +L+ + + P
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-41
Identities = 67/255 (26%), Positives = 113/255 (44%), Gaps = 30/255 (11%)
Query: 645 DLESPSSSVDSSTSKV--DQIFD--DDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWN 698
++ + ++ + V +Q V + P L +IG GS G V A +
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS 69
Query: 699 GTEVAVKKF---LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755
G +VAVK Q EV IMR +H NVV + L ++ EFL
Sbjct: 70 GRQVAVKMMDLRKQQRRE-----LLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124
Query: 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 815
G+L I+ +++E++ + V + + LH ++HRD+KS ++L+ + V
Sbjct: 125 QGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRV 180
Query: 816 KVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 869
K+SDFG K + GTP WMAPEV+ + D++S G+++ E+
Sbjct: 181 KLSDFGFCAQISKDVPKRKSL------VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234
Query: 870 ATLKLPWIGMNPMQV 884
+ P+ +P+Q
Sbjct: 235 VDGEPPYFSDSPVQA 249
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 61/237 (25%), Positives = 108/237 (45%), Gaps = 10/237 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
ED +G +G G +G VY A + +A+K A + +REV+I LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
PN++ G + +I E+ P G+++R L + + DE+R ++A ++ H+
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHS 127
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
++HRD+K NLL+ +K++DFG S H GT +++ PE++
Sbjct: 128 KR--VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
+EK D++S GV+ +E K P+ + + P + +I
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLI 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 62/227 (27%), Positives = 113/227 (49%), Gaps = 22/227 (9%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKRE 723
+ P + E+IG G+ G VY A G EVA+++ L Q E
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINE 67
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783
+ +MR ++PN+V ++ + L ++ E+L GSL ++ +DE + + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCREC 125
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTA 837
+ + LH++ ++HRD+KS N+L+ + +VK++DFG + K +T
Sbjct: 126 LQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------V 177
Query: 838 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884
GTP WMAPEV+ + K D++S G++ E+ + P++ NP++
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-41
Identities = 57/244 (23%), Positives = 97/244 (39%), Gaps = 22/244 (9%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD-WNGTEVAVKKFLDQDFS 713
SS S D++ + + +G G+ G + + ++ +VAVK+ L + FS
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS 62
Query: 714 GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVD 772
A REV+++R HPNV+ + I E +L + +
Sbjct: 63 FA-----DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHL 116
Query: 773 EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-----DKNWNVKVSDFGLSRL-- 825
I + G+ LH+ IVHRDLK N+L+ +SDFGL +
Sbjct: 117 GLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 826 -KHNTFLSSKSTAGTPEWMAPEVLRNEPS---NEKCDVYSFGVILWELATL-KLPWIGMN 880
++F GT W+APE+L + D++S G + + + + P+
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 881 PMQV 884
Q
Sbjct: 235 QRQA 238
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 60/237 (25%), Positives = 111/237 (46%), Gaps = 10/237 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
+D +G +G G +G VY A N +A+K + +RE++I LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
PN++ + ++ EF PRG L++ L + H + DE+R ++A ++ H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHE 132
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
++HRD+K NLL+ +K++DFG S + ++ GT +++ PE++ +
Sbjct: 133 RK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTMCGTLDYLPPEMIEGKT 188
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
+EK D++ GV+ +E P+ + + + N L+ P L +I
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI--VNVDLKFPPFLSDGSKDLI 243
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 66/233 (28%), Positives = 113/233 (48%), Gaps = 30/233 (12%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
I +D L E IG G+ V A +VA+K+ ++ + ++ E +E++ M +
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKR-INLEKCQTSMDELLKEIQAMSQC 70
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR------IKMAL-DV 783
HPN+V + + L ++ + L GS+ I+ + + K I L +V
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-----------RLKHNTFLS 832
G+ LH + +HRD+K+ N+L+ ++ +V+++DFG+S TF
Sbjct: 131 LEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF-- 186
Query: 833 SKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884
GTP WMAPEV+ + + K D++SFG+ ELAT P+ PM+V
Sbjct: 187 ----VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-40
Identities = 67/246 (27%), Positives = 105/246 (42%), Gaps = 17/246 (6%)
Query: 647 ESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAV 704
+ ++ + P + IG GS+G VY A N VA+
Sbjct: 25 AMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAI 84
Query: 705 KKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 763
KK S + +EV+ +++LRHPN + + G R ++ E+ GS +
Sbjct: 85 KKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDL 143
Query: 764 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823
L + E + +G+ LH+ ++HRD+K+ N+L+ + VK+ DFG +
Sbjct: 144 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA 201
Query: 824 --RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS---NEKCDVYSFGVILWELATLKLPWIG 878
N+F GTP WMAPEV+ + K DV+S G+ ELA K P
Sbjct: 202 SIMAPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
Query: 879 MNPMQV 884
MN M
Sbjct: 256 MNAMSA 261
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-40
Identities = 68/232 (29%), Positives = 116/232 (50%), Gaps = 23/232 (9%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKRE 723
+ V P E + +G G++G+VY A G A K ++ S L ++ E
Sbjct: 9 EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKV-IETK-SEEELEDYIVE 66
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDV 783
++I+ HP +V +GA L I+ EF P G++ I+ + E + + +
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM 126
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTA 837
+N LH+ I+HRDLK+ N+L+ +++++DFG+S K ++F+
Sbjct: 127 LEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------ 178
Query: 838 GTPEWMAPEVLRNEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQV 884
GTP WMAPEV+ E + K D++S G+ L E+A ++ P +NPM+V
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 58/235 (24%), Positives = 96/235 (40%), Gaps = 29/235 (12%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVV 736
+ + G + VY A +G E A+K+ L + +EV M++L HPN+V
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE--KNRAIIQEVCFMKKLSGHPNIV 89
Query: 737 LFMGAVTRPPNLS-------IITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGM 787
F A + S ++ L +G L L + +K+ R +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---------- 837
+H P I+HRDLK NLL+ +K+ DFG + + S S
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 838 --GTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 887
TP + PE++ N P EK D+++ G IL+ L + P+ +++V
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 67/258 (25%), Positives = 114/258 (44%), Gaps = 43/258 (16%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVK-----KFLDQDFSGAALLEF----------- 720
L + IG GSYG V A + + T A+K K + Q
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 721 --------KREVKIMRRLRHPNVV-LF--MGAVTRPPNLSIITEFLPRGSLFRILHRPHC 769
+E+ I+++L HPNVV L + +L ++ E + +G + +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTLKPL 134
Query: 770 QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KH 827
D+ R D+ +G+ LH I+HRD+K NLLV ++ ++K++DFG+S
Sbjct: 135 SEDQARFY--FQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 828 NTFLSSKSTAGTPEWMAPEVLRNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPMQV 884
+ L +T GTP +MAPE L + DV++ GV L+ + P++ M +
Sbjct: 191 DALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 885 VGAVGFQNRRLEIPKELD 902
+ +++ LE P + D
Sbjct: 249 HSKI--KSQALEFPDQPD 264
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 51/259 (19%), Positives = 92/259 (35%), Gaps = 38/259 (14%)
Query: 681 GERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVV 736
E+IG G +G V+ +G A+K+ REV L +H +VV
Sbjct: 16 LEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+ A ++ I E+ GSL + +R E + L V RG+ +H+
Sbjct: 75 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134
Query: 794 TPTIVHRDLKSPNLLVDKN-------------------WNVKVSDFGLSRLKHNTFLSSK 834
+ +VH D+K N+ + + K+ D G + +
Sbjct: 135 S--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----Q 188
Query: 835 STAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 893
G ++A EVL+ N K D+++ + + A + + + Q R
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI----RQGR 244
Query: 894 RLEIPKELDPLVARIIWEC 912
IP+ L ++
Sbjct: 245 LPRIPQVLSQEFTELLKVM 263
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-39
Identities = 69/251 (27%), Positives = 116/251 (46%), Gaps = 32/251 (12%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDF 712
+S S + + D+ P L E +G G+YG+VY G A+K D
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV---MDV 59
Query: 713 SGAALLEFKREVKIMRRL-RHPNVVLFMGA------VTRPPNLSIITEFLPRGSLFRILH 765
+G E K+E+ ++++ H N+ + GA L ++ EF GS+ ++
Sbjct: 60 TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 766 RPHCQVDEKRRIKMAL-DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS- 823
++ I ++ RG++ LH ++HRD+K N+L+ +N VK+ DFG+S
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 824 -----RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-----NEKCDVYSFGVILWELATLK 873
+ NTF GTP WMAPEV+ + + + K D++S G+ E+A
Sbjct: 178 QLDRTVGRRNTF------IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
Query: 874 LPWIGMNPMQV 884
P M+PM+
Sbjct: 232 PPLCDMHPMRA 242
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 68/219 (31%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
W+ L + +G G+YGEV A VAVK +D + K+E+ I + L
Sbjct: 8 DWD---LVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLN 63
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVAR----- 785
H NVV F G + E+ G LF RI I M A+
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQ 113
Query: 786 ---GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAG 838
G+ LH I HRD+K NLL+D+ N+K+SDFGL+ + L G
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCG 169
Query: 839 TPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPW 876
T ++APE+L+ E DV+S G++L + +LPW
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-39
Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 31/224 (13%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
D + +G G +G V+ A + A+K+ + A + REVK + +L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHP 63
Query: 734 NVVLFMGA------------VTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKM 779
+V + A + L I + + +L ++ + + + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 780 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-- 837
L +A + LH+ ++HRDLK N+ + VKV DFGL
Sbjct: 124 FLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 838 ----------GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
GT +M+PE + + K D++S G+IL+EL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-38
Identities = 51/257 (19%), Positives = 95/257 (36%), Gaps = 25/257 (9%)
Query: 661 DQIFDDDVCECEIPWEDLVLGERIGLG--SYGEVYHA--DWNGTEVAVKKFLDQDFSGAA 716
+ ++ + L IG G V A G V V++ + S
Sbjct: 10 ENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM 69
Query: 717 LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR 776
+ + E+ + + HPN+V + L ++T F+ GS ++ +
Sbjct: 70 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA 129
Query: 777 IKMAL-DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNT 829
I L V + ++ +H VHR +K+ ++L+ + V +S + +
Sbjct: 130 IAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
Query: 830 -FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 886
K + W++PEVL+ + K D+YS G+ ELA +P+ M Q++
Sbjct: 188 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML- 246
Query: 887 AVGFQNRRLEIPKELDP 903
LE P
Sbjct: 247 --------LEKLNGTVP 255
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 24/208 (11%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNV 735
G +G G + + + A K + + E+ I R L H +V
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQHV 77
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GM 787
V F G + ++ E R SL + KRR + AR G
Sbjct: 78 VGFHGFFEDNDFVFVVLELCRRRSLLELH---------KRRKALTEPEARYYLRQIVLGC 128
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
LH + ++HRDLK NL ++++ VK+ DFGL+ K GTP ++APEV
Sbjct: 129 QYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 186
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLP 875
L + + + DV+S G I++ L K P
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ E +G G++ V T E A K + S + +RE +I R+L+HPN+V
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
++ ++ + + G LF I+ R E + + H++
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSN--G 125
Query: 797 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
IVHR+LK NLL+ K VK++DFGL+ + + AGTP +++PEVL+ +P
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDP 183
Query: 853 SNEKCDVYSFGVIL 866
++ D+++ GVIL
Sbjct: 184 YSKPVDIWACGVIL 197
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKI-MR 728
+ EDL IG G+YG V +G +AVK+ + + ++ + MR
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR-IRSTVDEKEQKQLLMDLDVVMR 76
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ----VDEKRRIKMALDVA 784
P +V F GA+ R + I E + S + + + E+ K+ L
Sbjct: 77 SSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844
+ +N L I+HRD+K N+L+D++ N+K+ DFG+S ++ ++ AG +MA
Sbjct: 136 KALNHLK-ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMA 193
Query: 845 PEVLRNEPSNE----KCDVYSFGVILWELATLKLPWIGMNPM 882
PE + S + + DV+S G+ L+ELAT + P+ N +
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-38
Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 14/193 (7%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
E +G G++ EV+ T A+K + LE E+ ++++++H N+V
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHENIVT 70
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ ++ + + G LF RIL R EK + V + LH +
Sbjct: 71 LEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENG-- 126
Query: 797 IVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
IVHRDLK NLL ++N + ++DFGLS+++ N + + GTP ++APEVL +P
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGTPGYVAPEVLAQKPY 184
Query: 854 NEKCDVYSFGVIL 866
++ D +S GVI
Sbjct: 185 SKAVDCWSIGVIT 197
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 25/233 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKI-MR 728
E+ +DL +G G+YG V +G +AVK+ + + ++ I MR
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISMR 61
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDVAR 785
+ P V F GA+ R ++ I E + SL + + + + E K+A+ + +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----LKHNTFLSSKSTAGTP 840
+ LH S +++HRD+K N+L++ VK+ DFG+S + + AG
Sbjct: 121 ALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID------AGCK 173
Query: 841 EWMAPEVLRNEPS----NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAV 888
+MAPE + E + + K D++S G+ + ELA L+ P+ P Q + V
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
+GE +G G + V G E A K + G + E +REV I+R++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
NV+ ++ +I E + G LF + + + E+ + G+N LHT
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT 133
Query: 793 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 847
I H DLK N+++ ++K+ DFGL+ ++ K+ GTPE++APE+
Sbjct: 134 KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEI 189
Query: 848 LRNEPSNEKCDVYSFGVIL 866
+ EP + D++S GVI
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 68/219 (31%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
W+ L + +G G+YGEV A VAVK +D + K+E+ I + L
Sbjct: 8 DWD---LVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLN 63
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVAR----- 785
H NVV F G + E+ G LF RI I M A+
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----------PDIGMPEPDAQRFFHQ 113
Query: 786 ---GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAG 838
G+ LH I HRD+K NLL+D+ N+K+SDFGL+ + L G
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCG 169
Query: 839 TPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPW 876
T ++APE+L+ E DV+S G++L + +LPW
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 65/194 (33%), Positives = 97/194 (50%), Gaps = 14/194 (7%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G GS+GEV T E AVK REV+++++L HPN++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ + I+ E G LF I+ R E ++ V G+ +H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH--N 141
Query: 797 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
IVHRDLK N+L+ +K+ ++K+ DFGLS + NT + + GT ++APEVLR
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-GT 198
Query: 853 SNEKCDVYSFGVIL 866
+EKCDV+S GVIL
Sbjct: 199 YDEKCDVWSAGVIL 212
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 5/199 (2%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVV 736
+G +G GS+ VY A G EVA+K + A +++ + EVKI +L+HP+++
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ ++ E G + R L E + GM LH+
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 856
I+HRDL NLL+ +N N+K++DFGL+ + GTP +++PE+ +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 857 CDVYSFGVILWELATLKLP 875
DV+S G + + L + P
Sbjct: 193 SDVWSLGCMFYTLLIGRPP 211
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
+GE +G G + V G E A K + L G + E +REV I+R +RHP
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
N++ ++ +I E + G LF + + + E + + G++ LH+
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHS 126
Query: 793 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 847
I H DLK N+++ N +K+ DFG++ ++ K+ GTPE++APE+
Sbjct: 127 KR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEI 182
Query: 848 LRNEPSNEKCDVYSFGVIL 866
+ EP + D++S GVI
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 24/208 (11%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNV 735
G +G G + + + A K + + E+ I R L H +V
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQHV 103
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR--------GM 787
V F G + ++ E R SL + KRR + AR G
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELH---------KRRKALTEPEARYYLRQIVLGC 154
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
LH + ++HRDLK NL ++++ VK+ DFGL+ K GTP ++APEV
Sbjct: 155 QYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 212
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLP 875
L + + + DV+S G I++ L K P
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-37
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ E +G G++ V T E A K + S + +RE +I R+L+HPN+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
++ ++ + + G LF I+ R E + + H++
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSN--G 148
Query: 797 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
IVHR+LK NLL+ K VK++DFGL+ + + AGTP +++PEVL+ +P
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDP 206
Query: 853 SNEKCDVYSFGVIL 866
++ D+++ GVIL
Sbjct: 207 YSKPVDIWACGVIL 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
GE +G G + V G + A K + G + + +REV I++ ++HP
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
NV+ ++ +I E + G LF + + + E+ + + G+ LH+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHS 132
Query: 793 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 847
I H DLK N+++ +K+ DFGL+ + K+ GTPE++APE+
Sbjct: 133 LQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 188
Query: 848 LRNEPSNEKCDVYSFGVIL 866
+ EP + D++S GVI
Sbjct: 189 VNYEPLGLEADMWSIGVIT 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-37
Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 10/193 (5%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
L E +G G++ V E A + S + +RE +I R L+HPN+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+++ + +I + + G LF I+ R + E + + H
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQM--G 130
Query: 797 IVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
+VHR+LK NLL+ K VK++DFGL+ + AGTP +++PEVLR +P
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 854 NEKCDVYSFGVIL 866
+ D+++ GVIL
Sbjct: 191 GKPVDLWACGVIL 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-36
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
+GE +G G + V G E A K + G E +REV I+R++ HP
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
N++ ++ +I E + G LF + + + E+ + G+N LHT
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT 133
Query: 793 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 847
I H DLK N+++ ++K+ DFGL+ ++ K+ GTPE++APE+
Sbjct: 134 KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEI 189
Query: 848 LRNEPSNEKCDVYSFGVIL 866
+ EP + D++S GVI
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 69/240 (28%), Positives = 121/240 (50%), Gaps = 22/240 (9%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVV 736
LG+ +G+G++G+V G +VAVK Q ++ KRE++ ++ RHP+++
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGMNCLH 791
++ P + ++ E++ G LF I + E RR I A+D H
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD------YCH 128
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRN 850
+VHRDLK N+L+D + N K++DFGLS + FL +++ G+P + APEV+
Sbjct: 129 RHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVISG 184
Query: 851 EP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
+ + D++S GVIL+ L LP+ + + + + IP+ L+ VA ++
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLNRSVATLL 242
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 50/239 (20%), Positives = 98/239 (41%), Gaps = 13/239 (5%)
Query: 652 SVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLD 709
S SS + + + DL +G G+ G+V+ G +AVK+ +
Sbjct: 2 SSGSSGKQTGYLTIGGQ-RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ-MR 59
Query: 710 QDFSGAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH 768
+ + ++ + ++ P +V G ++ I E + +
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG 119
Query: 769 CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828
+ E+ KM + + + + L ++HRD+K N+L+D+ +K+ DFG+S +
Sbjct: 120 P-IPERILGKMTVAIVKALYYLK-EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177
Query: 829 TFLSSKSTAGTPEWMAPEVLRNEPSNE-----KCDVYSFGVILWELATLKLPWIGMNPM 882
+ +AG +MAPE + + + DV+S G+ L ELAT + P+
Sbjct: 178 D-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-36
Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 23/252 (9%)
Query: 625 YHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERI 684
+H + NL + + S ++S T+ + + D + + + +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 685 GLGSYGEVYHADWNGT--EVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
G G+ VY GT A+K K +D+ + E+ ++ RL HPN++
Sbjct: 62 GRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-------IVRTEIGVLLRLSHPNIIKLK 114
Query: 740 GAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIV 798
P +S++ E + G LF RI+ + + E+ + + LH + IV
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENG--IV 170
Query: 799 HRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
HRDLK NLL + +K++DFGLS+ ++H + K+ GTP + APE+LR
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYG 228
Query: 855 EKCDVYSFGVIL 866
+ D++S G+I
Sbjct: 229 PEVDMWSVGIIT 240
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-36
Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 13/235 (5%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
L + IG G++ +V A G EVA+K + +L + REV+IM+ L HPN+V
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ L +I E+ G +F ++ + E R + + H
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK--FRQIVSAVQYCHQKR-- 134
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSN- 854
IVHRDLK+ NLL+D + N+K++DFG S L + G P + APE+ + + +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELFQGKKYDG 192
Query: 855 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
+ DV+S GVIL+ L + LP+ G N ++ V + IP + ++
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMSTDCENLL 245
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 56/256 (21%), Positives = 107/256 (41%), Gaps = 44/256 (17%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRHP 733
++G+ +G GSYG+V AVK L + K+E++++RRLRH
Sbjct: 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 734 NVV-LF--MGAVTRPPNLSIITEFLPRGS--LF-RILHRPHCQVDEKRRIKMALDVAR-- 785
NV+ L + + ++ E+ G + + + + + A
Sbjct: 67 NVIQLVDVLYNEE-KQKMYMVMEYCVCGMQEMLDSVPEK-----------RFPVCQAHGY 114
Query: 786 ------GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKS 835
G+ LH+ IVH+D+K NLL+ +K+S G++ + ++
Sbjct: 115 FCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC--RT 170
Query: 836 TAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 893
+ G+P + PE+ S K D++S GV L+ + T P+ G N ++ +
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--GKG 228
Query: 894 RLEIPKELDPLVARII 909
IP + P ++ ++
Sbjct: 229 SYAIPGDCGPPLSDLL 244
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPN 734
L E IG G + V G + AVK G + + KRE I L+HP+
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVD--EKRRIKMALDVARGMNCLH 791
+V + + L ++ EF+ L I+ R E + + H
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 792 TSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 848
+ I+HRD+K +L+ + + VK+ FG++ + L + GTP +MAPEV+
Sbjct: 148 DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 849 RNEPSNEKCDVYSFGVIL 866
+ EP + DV+ GVIL
Sbjct: 206 KREPYGKPVDVWGCGVIL 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 24/205 (11%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK-------KFLDQDFSGAALLEFKREVKIMRRL 730
E +G G V E AVK + +EV I+R++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 731 -RHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMN 788
HPN++ ++ + + +G LF + + + EK K+ + +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVIC 138
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 847
LH IVHRDLK N+L+D + N+K++DFG S L L + GTP ++APE+
Sbjct: 139 ALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEI 194
Query: 848 LRNEPS------NEKCDVYSFGVIL 866
+ + ++ D++S GVI+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 12/196 (6%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNV 735
+ + +G G + V G E A K + E E+ ++ + P V
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+ + +I E+ G +F L V E I++ + G+ LH +
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 795 PTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRN 850
IVH DLK N+L+ ++K+ DFG+SR + H L + GTPE++APE+L
Sbjct: 152 --IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILNY 207
Query: 851 EPSNEKCDVYSFGVIL 866
+P D+++ G+I
Sbjct: 208 DPITTATDMWNIGIIA 223
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 16/194 (8%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
L IG GS+GEV A A KK K+E++IM+ L HPN++
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF--KQEIEIMKSLDHPNIIR 70
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
++ ++ E G LF R++H+ E ++ DV + H
Sbjct: 71 LYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKL--N 126
Query: 797 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+ HRDLK N L + +K+ DFGL+ K + ++ GTP +++P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLEG-L 183
Query: 853 SNEKCDVYSFGVIL 866
+CD +S GV++
Sbjct: 184 YGPECDEWSAGVMM 197
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLE------FKREVKIMRRLR 731
+ + +G G+ GEV A +VA+K + F+ + E + E++I+++L
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 790
HP ++ + I+ E + G LF +++ + + + + L
Sbjct: 74 HPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY--FYQMLLAVQYL 130
Query: 791 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 846
H + I+HRDLK N+L+ +++ +K++DFG S+ L + + ++ GTP ++APE
Sbjct: 131 HEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAPE 186
Query: 847 VLRNEPS---NEKCDVYSFGVIL 866
VL + + N D +S GVIL
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-35
Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVK-----KFLDQDFSGAALLEFKREVKIMRRLRH 732
+ E +G G++G V+ T K LD+ K E+ IM +L H
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-------TVKNEISIMNQLHH 107
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLH 791
P ++ A + +I EFL G LF RI + ++ E I G+ +H
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMH 166
Query: 792 TSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVL 848
+ IVH D+K N++ K +VK+ DFGL+ L + + K T T E+ APE++
Sbjct: 167 EHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIV 222
Query: 849 RNEPSNEKCDVYSFGVIL 866
EP D+++ GV+
Sbjct: 223 DREPVGFYTDMWAIGVLG 240
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
+ + +GLG G+V G + A+K D + ++EV + P++
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHI 84
Query: 736 VLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 790
V + L II E + G LF RI R E+ ++ D+ + L
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 791 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
H+ I HRD+K NLL +K+ +K++DFG ++ L ++ TP ++APEV
Sbjct: 145 HSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QTPCYTPYYVAPEV 200
Query: 848 LRNEPSNEKCDVYSFGVIL 866
L E ++ CD++S GVI+
Sbjct: 201 LGPEKYDKSCDMWSLGVIM 219
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 45/197 (22%), Positives = 86/197 (43%), Gaps = 22/197 (11%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ E +G G +G V+ + K K DQ K+E+ I+ RH
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-------LVKKEISILNIARHR 61
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
N++ + L +I EF+ +F RI +++E+ + V + LH+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS 120
Query: 793 STPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLR 849
I H D++ N++ ++ +K+ +FG +R LK + PE+ APEV +
Sbjct: 121 HN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQ 176
Query: 850 NEPSNEKCDVYSFGVIL 866
++ + D++S G ++
Sbjct: 177 HDVVSTATDMWSLGTLV 193
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-34
Identities = 71/248 (28%), Positives = 116/248 (46%), Gaps = 28/248 (11%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVK 705
+P + S + +++ +++G G+YGEV T E A+K
Sbjct: 23 TPGMFITSKKGHLSEMYQ--------------RVKKLGSGAYGEVLLCRDKVTHVERAIK 68
Query: 706 KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RIL 764
S ++ + EV +++ L HPN++ N ++ E G LF I+
Sbjct: 69 IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII 128
Query: 765 HRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFG 821
HR +E + V G+ LH IVHRDLK NLL+ +K+ +K+ DFG
Sbjct: 129 HRMK--FNEVDAAVIIKQVLSGVTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 822 LSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 880
LS + ++ + + GT ++APEVLR + +EKCDV+S GVIL+ L P+ G
Sbjct: 185 LSAVFENQKKMKER--LGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241
Query: 881 PMQVVGAV 888
+++ V
Sbjct: 242 DQEILRKV 249
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-34
Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLE------FKREVKIMRRLR 731
+ + +G G+ GEV A +VA++ + F+ + E + E++I+++L
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 790
HP ++ + I+ E + G LF +++ + E + + L
Sbjct: 199 HPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYL 255
Query: 791 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 846
H + I+HRDLK N+L+ +++ +K++DFG S+ L + + ++ GTP ++APE
Sbjct: 256 HEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAPE 311
Query: 847 VLRNEPS---NEKCDVYSFGVIL 866
VL + + N D +S GVIL
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLR 731
+ IG G V G E AVK + L + +RE I+R++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 732 -HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNC 789
HP+++ + + + ++ + + +G LF + + + EK + + ++
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSF 215
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVL 848
LH + IVHRDLK N+L+D N +++SDFG S L+ L + GTP ++APE+L
Sbjct: 216 LHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEIL 271
Query: 849 RNEPS------NEKCDVYSFGVIL 866
+ ++ D+++ GVIL
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVIL 295
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGT--EVAVK-----KFLDQDFSGAALLEFKREVKIMRR 729
+ E +G G +G+V+ + T ++A K D++ E K E+ +M +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-------EVKNEISVMNQ 142
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMN 788
L H N++ A ++ ++ E++ G LF RI+ + + E I + G+
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIR 201
Query: 789 CLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 845
+H I+H DLK N+L +K+ DFGL+R K L K GTPE++AP
Sbjct: 202 HMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLAP 257
Query: 846 EVLRNEPSNEKCDVYSFGVIL 866
EV+ + + D++S GVI
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIA 278
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 18/210 (8%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVK-----KFL-DQDFSGAALLEFKREVKIMRRL 730
+G G++G V+ A EV VK K L D L + E+ I+ R+
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGS-LF-RILHRPHCQVDEKRRIKMALDVARGMN 788
H N++ + ++ E G LF I P I + +
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI--FRQLVSAVG 144
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEV 847
L I+HRD+K N+++ +++ +K+ DFG + + + GT E+ APEV
Sbjct: 145 YLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYCAPEV 200
Query: 848 LRNEP-SNEKCDVYSFGVILWELATLKLPW 876
L P + +++S GV L+ L + P+
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPF 230
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-34
Identities = 55/229 (24%), Positives = 90/229 (39%), Gaps = 40/229 (17%)
Query: 679 VLGERIGLGSYGEVYHAD-WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVV 736
V + +G GS G V + G VAVK+ L A E+K++ HPNV+
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA-----LMEIKLLTESDDHPNVI 72
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLF-RILHR-----PHCQVDEKRRIKMALDVARGMNCL 790
+ + T L I E +L + + E I + +A G+ L
Sbjct: 73 RYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 791 HTSTPTIVHRDLKSPNLLVD-------------KNWNVKVSDFGLSRL----KHNTFLSS 833
H+ I+HRDLK N+LV +N + +SDFGL + + + +
Sbjct: 132 HSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 834 KSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELATLKLP 875
+ +GT W APE+L D++S G + + + +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 61/259 (23%), Positives = 97/259 (37%), Gaps = 50/259 (19%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPN 734
L IG GSYG V A A+K K + + + K EV++M++L HPN
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+ + ++ E G L ++ + + + C +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 794 TPT------------------------------------IVHRDLKSPNLLV--DKNWNV 815
I HRD+K N L +K++ +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI 209
Query: 816 KVSDFGLSRL----KHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWEL 869
K+ DFGLS+ + + + AGTP ++APEVL NE KCD +S GV+L L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 870 ATLKLPWIGMNPMQVVGAV 888
+P+ G+N + V
Sbjct: 270 LMGAVPFPGVNDADTISQV 288
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 8e-34
Identities = 41/240 (17%), Positives = 85/240 (35%), Gaps = 38/240 (15%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKR 722
E ++ + + + +G G++ +VY A N + +K A EF
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ-----KPANPWEFYI 113
Query: 723 EVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR----PHCQVDEKR 775
++M RL+ + F A ++ E G+L ++ P + +
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173
Query: 776 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-----------DKNWNVKVSDFGLSR 824
I A+ + + +H I+H D+K N ++ D + + + D G S
Sbjct: 174 VISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 825 ----LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 880
T ++K T + E+L N+P N + D + ++ + +
Sbjct: 232 DMKLFPKGTIFTAK--CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+ ++G G++G+V+ + +G E +K +++D S + + + E+++++ L HPN++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIK-TINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQV--DEKRRIKMALDVARGMNCLHTS 793
N+ I+ E G L RI+ E ++ + + H+
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 794 TPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLR 849
+VH+DLK N+L + +K+ DFGL+ K + + AGT +MAPEV +
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVFK 199
Query: 850 NEPSNEKCDVYSFGVIL 866
KCD++S GV++
Sbjct: 200 -RDVTFKCDIWSAGVVM 215
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 28/209 (13%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNV 735
+ IG G++G VAVK ++++ A ++ +RE+ R LRHPN+
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVK-YIERG----AAIDENVQREIINHRSLRHPNI 78
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGMNCL 790
V F + P +L+II E+ G L+ RI + DE R + + M
Sbjct: 79 VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ-- 136
Query: 791 HTSTPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEV 847
I HRDLK N L+D + +K+ DFG S+ ++ KST GTP ++APEV
Sbjct: 137 ------ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEV 188
Query: 848 LRNEPSN-EKCDVYSFGVILWELATLKLP 875
L + + + DV+S GV L+ + P
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 58/240 (24%), Positives = 109/240 (45%), Gaps = 16/240 (6%)
Query: 680 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLRHPNV 735
+ +++G G VY A D +VA+K + L F+REV +L H N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
V + ++ E++ +L + H + I + G+ H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
IVHRD+K N+L+D N +K+ DFG+++ L + + GT ++ +PE + E ++
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 855 EKCDVYSFGVILWELATLKLPWIGMNPMQVV-----GAVGFQNRRL--EIPKELDPLVAR 907
E D+YS G++L+E+ + P+ G + + +V + +IP+ L ++ R
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILR 250
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-33
Identities = 65/197 (32%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G GS+GEV E AVK REV+++++L HPN++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ + I+ E G LF I+ R E ++ V G+ +H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH--N 141
Query: 797 IVHRDLKSPNLLV---DKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEP 852
IVHRDLK N+L+ +K+ ++K+ DFGLS + NT + + GT ++APEVLR
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-GT 198
Query: 853 SNEKCDVYSFGVILWEL 869
+EKCDV+S GVIL+ L
Sbjct: 199 YDEKCDVWSAGVILYIL 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 72/244 (29%), Positives = 118/244 (48%), Gaps = 31/244 (12%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVK-----KFLDQDFSGAALLEFKREVKIMRRLRH 732
+ E +G GS+G+V A +VA+K D +RE+ ++ LRH
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM----RVEREISYLKLLRH 68
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGM 787
P+++ +T P ++ ++ E+ G LF I+ + DE RR I A++
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIE----- 122
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPE 846
H IVHRDLK NLL+D N NVK++DFGLS + FL K++ G+P + APE
Sbjct: 123 -YCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPE 177
Query: 847 VLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
V+ + + + DV+S G++L+ + +LP+ + V + +P L P
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGA 235
Query: 906 ARII 909
+I
Sbjct: 236 QSLI 239
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-33
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
V + +GLG G+V + A+K D + +REV++ R + P++
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHI 117
Query: 736 VLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 790
V + L I+ E L G LF RI R E+ ++ + + L
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 791 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 846
H+ I HRD+K NLL N +K++DFG ++ + L + TP ++APE
Sbjct: 178 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAPE 233
Query: 847 VLRNEPSNEKCDVYSFGVIL 866
VL E ++ CD++S GVI+
Sbjct: 234 VLGPEKYDKSCDMWSLGVIM 253
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 7e-33
Identities = 43/275 (15%), Positives = 88/275 (32%), Gaps = 45/275 (16%)
Query: 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRL 730
LV G +G A G V + A+ + K EV +R L
Sbjct: 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 731 R----------------------HPNVVLFMGAVTRPPNLSIITEFLPR-------GSLF 761
R P + ++ +++ F +
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 762 RILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 818
+L H + R+++ L V R + LH +VH L+ ++++D+ V ++
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLT 253
Query: 819 DFGLSRLKHNTFLSSKSTA-GTPEWMAPEVLRNEPSNEK-----CDVYSFGVILWELATL 872
F + +S PE A +L + D ++ G+ ++ +
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 873 KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
LP + + F++ + IP+ + L+
Sbjct: 314 DLPNTDDAALGGSEWI-FRSCK-NIPQPVRALLEG 346
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-33
Identities = 66/279 (23%), Positives = 110/279 (39%), Gaps = 37/279 (13%)
Query: 599 GPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTS 658
P L + + + + E G R K T + + V+
Sbjct: 94 CEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD 153
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVK-----KFLDQD 711
V +D + E +G G++G V+ T A K D++
Sbjct: 154 HVLDHYD--------------IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 712 FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQ 770
++E++ M LRHP +V A + +I EF+ G LF ++ H +
Sbjct: 200 -------TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNK 251
Query: 771 VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL-VDKNWN-VKVSDFGLSR-LKH 827
+ E ++ V +G+ +H + VH DLK N++ K N +K+ DFGL+ L
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309
Query: 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 866
+ K T GT E+ APEV +P D++S GV+
Sbjct: 310 KQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-33
Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 16/195 (8%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNV 735
+ + +G GS+ + AVK + + ++E+ ++ HPN+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT-----QKEITALKLCEGHPNI 68
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
V + ++ E L G LF RI + H E + + ++ +H
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVG 126
Query: 795 PTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
+VHRDLK NLL + N +K+ DFG +RLK K+ T + APE+L
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 852 PSNEKCDVYSFGVIL 866
+E CD++S GVIL
Sbjct: 185 GYDESCDLWSLGVIL 199
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-33
Identities = 73/249 (29%), Positives = 111/249 (44%), Gaps = 29/249 (11%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVK 705
+P V ST+ + +G GS+GEV G E AVK
Sbjct: 12 TPGMFVQHSTAIFSDRYK--------------GQRVLGKGSFGEVILCKDKITGQECAVK 57
Query: 706 KFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RI 763
+ E REV+++++L HPN++ ++ E G LF I
Sbjct: 58 VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI 117
Query: 764 LHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDF 820
+ R E ++ V G+ +H + IVHRDLK NLL+ K+ N+++ DF
Sbjct: 118 ISRKR--FSEVDAARIIRQVLSGITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDF 173
Query: 821 GLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 879
GLS + + + K GT ++APEVL +EKCDV+S GVIL+ L + P+ G
Sbjct: 174 GLSTHFEASKKMKDK--IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGA 230
Query: 880 NPMQVVGAV 888
N ++ V
Sbjct: 231 NEYDILKKV 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-33
Identities = 67/241 (27%), Positives = 123/241 (51%), Gaps = 24/241 (9%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNV 735
LG+ +G+G++G+V + G +VAVK L++ S + + +RE++ ++ RHP++
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDVARGMNCL 790
+ ++ P ++ ++ E++ G LF I E RR I +D
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD------YC 132
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLR 849
H +VHRDLK N+L+D + N K++DFGLS + FL +++ G+P + APEV+
Sbjct: 133 HRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVIS 188
Query: 850 NEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ + D++S GVIL+ L LP+ + + + + P+ L+P V +
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNPSVISL 246
Query: 909 I 909
+
Sbjct: 247 L 247
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-32
Identities = 66/240 (27%), Positives = 103/240 (42%), Gaps = 39/240 (16%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVK 705
+P V K+ + + ++G G+YGEV E A+K
Sbjct: 22 NPGMYVRKKEGKIGESYF--------------KVRKLGSGAYGEVLLCKEKNGHSEKAIK 67
Query: 706 -----------KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754
D E E+ +++ L HPN++ ++TEF
Sbjct: 68 VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF 127
Query: 755 LPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---D 810
G LF +I++R DE + + G+ LH IVHRD+K N+L+ +
Sbjct: 128 YEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKH--NIVHRDIKPENILLENKN 183
Query: 811 KNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 869
N+K+ DFGLS + L + GT ++APEVL+ + NEKCDV+S GVI++ L
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKLRDR--LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYIL 240
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 22/197 (11%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVV 736
+ E IG+GSY E AVK + + E++I+ R +HPN++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHPNII 79
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+ ++TE + G L +IL + E+ + + + + LH
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQG- 136
Query: 796 TIVHRDLKSPNLLV----DKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLR 849
+VHRDLK N+L ++++ DFG ++ N L + T ++APEVL
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLE 193
Query: 850 NEPSNEKCDVYSFGVIL 866
+ + CD++S GV+L
Sbjct: 194 RQGYDAACDIWSLGVLL 210
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 73/322 (22%), Positives = 122/322 (37%), Gaps = 74/322 (22%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEF 720
D + E P + L LG+ +G G++G+V AD G K L + + +
Sbjct: 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 72
Query: 721 KREVKIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRP----------- 767
E+KI+ + H NVV +GA T+P L +I EF G+L L
Sbjct: 73 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG 132
Query: 768 -----------HCQVDEKRRIKM-----------ALDVARGMNCLHTSTPTIVHRDLKSP 805
VD KRR+ ++ + P +++D +
Sbjct: 133 ARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTL 192
Query: 806 NLLVDKNWNV------------------------------KVSDFGLSR-LKHNTFLSSK 834
L+ ++ V K+ DFGL+R + + K
Sbjct: 193 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 835 STAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
A P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+ + +
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
Query: 893 RRLEIPKELDPLVARIIWECWQ 914
R+ P P + + + +CW
Sbjct: 313 TRMRAPDYTTPEMYQTMLDCWH 334
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 72/251 (28%), Positives = 120/251 (47%), Gaps = 33/251 (13%)
Query: 680 LGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLRHPNV 735
LGE +G G EV+ A +VAVK L D + + L F+RE + L HP +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 736 VLFMGAV--------TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
V AV P I+ E++ +L I+H + KR I++ D + +
Sbjct: 75 V----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQAL 129
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPEWMA 844
N H + I+HRD+K N+++ VKV DFG++R ++ S TA GT ++++
Sbjct: 130 NFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV--------VGAVGFQNRRLE 896
PE R + + + DVYS G +L+E+ T + P+ G +P+ V ++
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE--G 245
Query: 897 IPKELDPLVAR 907
+ +LD +V +
Sbjct: 246 LSADLDAVVLK 256
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 9e-32
Identities = 32/244 (13%), Positives = 63/244 (25%), Gaps = 43/244 (17%)
Query: 677 DLVLGERIGLGSYGEVYHA-DWN-GTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHP 733
L L E + +G V+ D + A+K F + + S + L RL
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 734 NVVLFMG--------AVTRPPNLSIITEFLPRGSLFRILHR----PHCQVD--------- 772
+ + + P + + + P VD
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 773 ----------EKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822
+ + R L + +VH NL + + + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 823 SRLKHNTFLSSKSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGM 879
+ P AP + + G+ ++ + L LP+ +
Sbjct: 241 LWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 880 NPMQ 883
P
Sbjct: 297 TPGI 300
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 38/234 (16%)
Query: 652 SVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLD 709
S DS + + + ++ + + +G G++ V E AVK
Sbjct: 2 STDSFSGRFEDVYQ-------------LQEDVLGEGAHARVQTCINLITSQEYAVKIIEK 48
Query: 710 QDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRP 767
Q + REV+++ + + H NV+ + ++ E + GS+ I R
Sbjct: 49 QPGHIRS--RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR 106
Query: 768 HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR 824
H +E + DVA ++ LH I HRDLK N+L ++ VK+ DF L
Sbjct: 107 H--FNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162
Query: 825 -LKHNTFLSSKST------AGTPEWMAPEVLRNEPS-----NEKCDVYSFGVIL 866
+K N S ST G+ E+MAPEV+ +++CD++S GVIL
Sbjct: 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 18/210 (8%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRH 732
+G +G G +G VY + VA+K + EV +++++
Sbjct: 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 733 --PNVVLFMGAVTRPPNLSIITEF-LPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMN 788
V+ + RP + +I E P LF I R Q + R V +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF--FWQVLEAVR 163
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
H ++HRD+K N+L+D N +K+ DFG L +T GT + PE
Sbjct: 164 HCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEW 219
Query: 848 LRNEP-SNEKCDVYSFGVILWELATLKLPW 876
+R V+S G++L+++ +P+
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 30/246 (12%)
Query: 680 LGERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLRH 732
L +G G G+VY A + VA+K + + S +RE + RL+
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRER---IVALK-LMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 733 PNVVLFMGAV----TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 788
P+VV + L + + L +L R + R + + + ++
Sbjct: 94 PHVV----PIHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALD 148
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-GTPEWMAPEV 847
H + HRD+K N+LV + + DFG++ + L+ GT +MAPE
Sbjct: 149 AAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------NRRLEIPKEL 901
+ + D+Y+ +L+E T P+ G + + V+GA Q R IP
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVAF 265
Query: 902 DPLVAR 907
D ++AR
Sbjct: 266 DAVIAR 271
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 46/212 (21%), Positives = 83/212 (39%), Gaps = 20/212 (9%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLR- 731
LG +G G +G V+ + +VA+K + + + EV ++ ++
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 732 ---HPNVVLFMGAVTRPPNLSIITEF-LPRGSLF-RILHRPHCQVDEKRRIKMALDVARG 786
HP V+ + ++ E LP LF I + R V
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF--FGQVVAA 151
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
+ H+ +VHRD+K N+L+D + K+ DFG L H+ GT + P
Sbjct: 152 IQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDGTRVYSPP 207
Query: 846 EVLRNEP-SNEKCDVYSFGVILWELATLKLPW 876
E + V+S G++L+++ +P+
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPF 239
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 41/278 (14%), Positives = 85/278 (30%), Gaps = 54/278 (19%)
Query: 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLR-- 731
LV G +G A G V + A+ + K EV +R LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 732 -----------------------HPNVVLFMGAVTRPPNLSI-ITEFLPRGSLFRILH-- 765
++ LS + +L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 766 ----RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
H + R+++ L V R + LH +VH L+ ++++D+ V ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 822 LSRLKHNTFLSSKSTAGTPEWMAPEVL-----------RNEPSNEKCDVYSFGVILWELA 870
+ ++ + + PE+ R D ++ G++++ +
Sbjct: 252 HLV-RDGAR---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 871 TLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
LP + + F++ + IP+ + L+
Sbjct: 308 CADLPITKDAALGGSEWI-FRSCK-NIPQPVRALLEGF 343
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-29
Identities = 52/239 (21%), Positives = 91/239 (38%), Gaps = 30/239 (12%)
Query: 680 LGERIGLGSYGEVYHA-DW--NGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHP 733
+ I G G +Y A D NG V +K + D + E + + + HP
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM----AMAERQFLAEVVHP 139
Query: 734 NVVL-----FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 788
++V P I+ E++ SL R + + I L++ ++
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALS 196
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 848
LH+ +V+ DLK N+++ + +K+ D G S GTP + APE++
Sbjct: 197 YLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGYLYGTPGFQAPEIV 249
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
R P+ D+Y+ G L L G + V + + L+ L+ R
Sbjct: 250 RTGPT-VATDIYTVGRTLAALTLDLPTRNG----RYVDGLPEDDPVLKTYDSYGRLLRR 303
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 53/247 (21%), Positives = 104/247 (42%), Gaps = 38/247 (15%)
Query: 676 EDLVLGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFK------REVKI 726
ED G+ +G GS+ V E A+K +++ RE +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELA-TSREYAIKIL-----EKRHIIKENKVPYVTRERDV 83
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKMAL 781
M RL HP V L + G L + + + + R I AL
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GT 839
+ LH I+HRDLK N+L++++ +++++DFG +++ +++ + GT
Sbjct: 144 E------YLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLE 896
++++PE+L + + + D+++ G I+++L P+ N + FQ +
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEYD 250
Query: 897 IPKELDP 903
P++ P
Sbjct: 251 FPEKFFP 257
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 44/234 (18%), Positives = 85/234 (36%), Gaps = 25/234 (10%)
Query: 693 YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752
+ + + + + S + + +++ M N V + + L I
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 753 EFLPRGSLF-RILHRPHCQVDEKRRI-KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810
+ + +L + R + E + + +A + LH+ ++HRDLK N+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT 198
Query: 811 KNWNVKVSDFGLSRLKHNTFLSSKSTA------------GTPEWMAPEVLRNEPSNEKCD 858
+ VKV DFGL GT +M+PE + + K D
Sbjct: 199 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258
Query: 859 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD---PLVARII 909
++S G+IL+EL M ++++ V R L+ P P ++
Sbjct: 259 IFSLGLILFELLYSFST--QMERVRIITDV----RNLKFPLLFTQKYPQEHMMV 306
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 17/63 (26%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
D + +G G +G V+ A + A+K+ + A + REVK + +L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHP 64
Query: 734 NVV 736
+V
Sbjct: 65 GIV 67
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 50/199 (25%), Positives = 79/199 (39%), Gaps = 42/199 (21%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
V + +GLG G+V + A+K D + +REV++ R + P++
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHI 73
Query: 736 VLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDVARGMNCL 790
V + L I+ E L G LF RI R E+ ++ + + L
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 791 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
H+ I HRD+K NLL N +K++DFG A E
Sbjct: 134 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AKET 170
Query: 848 LRNEPSNEKCDVYSFGVIL 866
E ++ CD++S GVI+
Sbjct: 171 TG-EKYDKSCDMWSLGVIM 188
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 51/241 (21%), Positives = 107/241 (44%), Gaps = 33/241 (13%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE------FKREVKIMRRLRHPNV 735
IG G++GEV + A+K + +L+ F+ E ++ +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKIL-----NKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR------RIKMALDVARGMNC 789
A NL ++ ++ G L +L + ++ E+ + +A+D
Sbjct: 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID------S 190
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVL 848
+H VHRD+K N+L+D N +++++DFG +L + + S GTP++++PE+L
Sbjct: 191 VHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 849 RNEPSNEK-----CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
+ + CD +S GV ++E+ + P+ + ++ G + R + P ++
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308
Query: 904 L 904
+
Sbjct: 309 V 309
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
+IG GSYG V+ G VA+KKF +D AL RE++++++L+HPN+
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL----REIRMLKQLKHPNL 64
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHT 792
V + R L ++ E+ ++ L R V E K L + +N H
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCHK 120
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 847
+HRD+K N+L+ K+ +K+ DFG +RL L+ S E W +PE+
Sbjct: 121 HN--CIHRDVKPENILITKHSVIKLCDFGFARL-----LTGPSDYYDDEVATRWYRSPEL 173
Query: 848 LRNEPS-NEKCDVYSFGVILWELATLK 873
L + DV++ G + EL +
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
E+IG G+YG V+ A VA+K+ LD D G AL RE+ +++ L+H N+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKELKHKNI 63
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHT 792
V + L+++ EF + L + + +D K + L +G+ H+
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHS 119
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 847
++HRDLK NLL+++N +K+++FGL+R + E W P+V
Sbjct: 120 RN--VLHRDLKPQNLLINRNGELKLANFGLARAF-----GIPVRCYSAEVVTLWYRPPDV 172
Query: 848 LRNEPS-NEKCDVYSFGVILWELATLKLP 875
L + D++S G I ELA P
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 48/238 (20%), Positives = 103/238 (43%), Gaps = 25/238 (10%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE------FKREVKIMRRLRHPNV 735
IG G++ EV T A+K + +L+ F+ E ++ +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIM-----NKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTST 794
A L ++ E+ G L +L + ++ + R +A ++ ++ +H
Sbjct: 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLG 182
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
VHRD+K N+L+D+ +++++DFG +L+ + + S GTP++++PE+L+
Sbjct: 183 --YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 854 NEK-------CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
CD ++ GV +E+ + P+ + + G + L +P + +
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 29/206 (14%)
Query: 682 ERIGLGSYGEVYHA-DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNVV 736
E++G G+YG VY A D G VA+K+ LD + G A+ RE+ +++ L HPN+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI----REISLLKELHHPNIV 82
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHTS 793
+ + L+++ EF+ + L ++L + + K + L RG+ H
Sbjct: 83 SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQH 138
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 848
I+HRDLK NLL++ + +K++DFGL+R + T E W AP+VL
Sbjct: 139 R--ILHRDLKPQNLLINSDGALKLADFGLARAF-----GIPVRSYTHEVVTLWYRAPDVL 191
Query: 849 RNEPS-NEKCDVYSFGVILWELATLK 873
+ D++S G I E+ T K
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 682 ERIGLGSYGEVYHA-DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNVV 736
E+IG G+YG VY A + G A+KK L+++ G + RE+ I++ L+H N+V
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI----REISILKELKHSNIV 63
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHTS 793
+ L ++ E L + L ++L ++ K + L G+ H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHDR 119
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 848
++HRDLK NLL+++ +K++DFGL+R T E W AP+VL
Sbjct: 120 R--VLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIVTLWYRAPDVL 172
Query: 849 RNEPS-NEKCDVYSFGVILWELATLK 873
+ D++S G I E+
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 30/207 (14%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
+G GSYG V G VA+KKF D A+ RE+K++++LRH N+
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM----REIKLLKQLRHENL 86
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHT 792
V + + ++ EF+ ++ L +D ++ + + G+ H+
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII---NGIGFCHS 142
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 847
I+HRD+K N+LV ++ VK+ DFG +R L++ E W APE+
Sbjct: 143 HN--IIHRDIKPENILVSQSGVVKLCDFGFART-----LAAPGEVYDDEVATRWYRAPEL 195
Query: 848 LRNEPS-NEKCDVYSFGVILWELATLK 873
L + + DV++ G ++ E+ +
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 59/233 (25%), Positives = 103/233 (44%), Gaps = 24/233 (10%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFMG 740
IG G++GEV T A+K + + F E IM P VV
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR------RIKMALDVARGMNCLHTST 794
A L ++ E++P G L ++ V EK + +ALD +H+
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALD------AIHSMG 188
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
+HRD+K N+L+DK+ ++K++DFG ++ + + GTP++++PEVL+++
Sbjct: 189 --FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 854 NEK----CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902
+ CD +S GV L+E+ P+ + + + L P + D
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 58/289 (20%), Positives = 122/289 (42%), Gaps = 49/289 (16%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPW----------EDLVLGERIGLGSYGEVYHADW 697
+ ++ S V + + W + + +G GS+G V
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 698 NGTE--VAVKKFLDQDFSGAALLEFKR------EVKIMRRLRHPNVVLFMGAVTRPPNLS 749
+ A+K +++ K+ E +I++ + P +V + NL
Sbjct: 63 KESGNHYAMKIL-----DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 750 IITEFLPRGSLFRILHRPHCQVDEKRR-----IKMALDVARGMNCLHTSTPTIVHRDLKS 804
++ E++ G +F L R + R I + + LH+ +++RDLK
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------YLHSLD--LIYRDLKP 169
Query: 805 PNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFG 863
NLL+D+ ++V+DFG + R+K T+ + GTPE +APE++ ++ N+ D ++ G
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEALAPEIILSKGYNKAVDWWALG 225
Query: 864 VILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDPLVARII 909
V+++E+A P+ P+Q+ ++ ++ P + ++
Sbjct: 226 VLIYEMAAGYPPFFADQPIQI-----YEKIVSGKVRFPSHFSSDLKDLL 269
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQD--FSGAALLEFKREVKIMRRLRHPNVV 736
+++G G+Y VY T+ VA+K+ L+ + A+ REV +++ L+H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLKHANIV 63
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNCLHTS 793
+ +L+++ E+L + L + L ++ K + L RG+ H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---RGLAYCHR- 118
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 848
++HRDLK NLL+++ +K++DFGL+R K S + E W P++L
Sbjct: 119 -QKVLHRDLKPQNLLINERGELKLADFGLARAK-----SIPTKTYDNEVVTLWYRPPDIL 172
Query: 849 RNEPS-NEKCDVYSFGVILWELATLK 873
+ + D++ G I +E+AT +
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQD--FSGAALLEFKREVKIMRRLRHPNVV 736
E++G G+Y VY G VA+K+ LD + A+ RE+ +M+ L+H N+V
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI----REISLMKELKHENIV 66
Query: 737 LFMGAVTRPPNLSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
+ L+++ EF+ R K L +G+
Sbjct: 67 RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL---QGLAF 123
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-A 844
H + I+HRDLK NLL++K +K+ DFGL+R + E W A
Sbjct: 124 CHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAF-----GIPVNTFSSEVVTLWYRA 176
Query: 845 PEVLRNEPS-NEKCDVYSFGVILWELATLK 873
P+VL + + D++S G IL E+ T K
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGA---ALLEFKREVKIMRRLRH 732
+ +G G + VY A VA+KK + G AL RE+K+++ L H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL----REIKLLQELSH 71
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDVARGMNC 789
PN++ + A N+S++ +F+ L I+ + K + M L +G+
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL---QGLEY 127
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-A 844
LH I+HRDLK NLL+D+N +K++DFGL++ S + A T + W A
Sbjct: 128 LHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF-----GSPNRAYTHQVVTRWYRA 180
Query: 845 PEVLRNEPS-NEKCDVYSFGVILWELATLK 873
PE+L D+++ G IL EL
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 44/209 (21%), Positives = 84/209 (40%), Gaps = 22/209 (10%)
Query: 682 ERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFK---------REVKIMRRLR 731
I GSYG V D G VA+K+ + G + RE++++
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 732 HPNVVLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 785
HPN++ + ++TE + L +++H + + +
Sbjct: 88 HPNILGLR-DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILL 145
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
G++ LH + +VHRDL N+L+ N ++ + DF L+R + + AP
Sbjct: 146 GLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT-HRWYRAP 202
Query: 846 EVLRNEPS-NEKCDVYSFGVILWELATLK 873
E++ + D++S G ++ E+ K
Sbjct: 203 ELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
+IG G++GEV+ A G +VA+KK ++ + G AL RE+KI++ L+H NV
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL----REIKILQLLKHENV 78
Query: 736 VLFMGAVT--------RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
V + ++ ++ +F L +L + ++ + G+
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM 843
+H + I+HRD+K+ N+L+ ++ +K++DFGL+R + +S+ T W
Sbjct: 138 YYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARA-FSLAKNSQPNRYTNRVVTLWY 194
Query: 844 -APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
PE+L E D++ G I+ E+ T
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 44/215 (20%)
Query: 682 ERIGLGSYGEVYHADWNGT-EVAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+ IG GS+G V+ A + EVA+KK D+ F RE++IMR ++HPNVV
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-------RELQIMRIVKHPNVVDLK 98
Query: 740 GAVTRPPN------LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD--------VAR 785
+ L+++ E++P +++R K + M + + R
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY-----AKLKQTMPMLLIKLYMYQLLR 152
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPE--- 841
+ +H+ I HRD+K NLL+D +K+ DFG ++ ++ +
Sbjct: 153 SLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAK----ILIAGEPN--VSYICS 204
Query: 842 -WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
+ APE++ + D++S G ++ EL +
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G G +GEV T A KK + AL E K+ I+ ++ VV
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE-KQ---ILEKVNSRFVV 247
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDVARGMNCLHTSTP 795
A L ++ + G L ++ E R + A ++ G+ LH
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER- 306
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST-AGTPEWMAPEVLRNEPSN 854
IV+RDLK N+L+D + ++++SD GL+ H + GT +MAPEV++NE
Sbjct: 307 -IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 855 EKCDVYSFGVILWELATLKLPWIGMN 880
D ++ G +L+E+ + P+
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRK 389
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 31/208 (14%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+ IG G+ G V A VA+KK F +Q + A RE+ +M+ + H N+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNI 86
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVAR 785
+ + T +L I+ E + +L +++ + +
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-------LLYQMLC 138
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
G+ LH++ I+HRDLK N++V + +K+ DFGL+R +F+ + T + AP
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAP 195
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLK 873
EV+ E D++S G I+ E+
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 34/211 (16%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
++G G+YGEVY A VA+K+ L+ + G A+ REV +++ L+H N+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI----REVSLLKELQHRNI 95
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+ + L +I E+ L + + + K + + G+N H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI---NGVNFCH-- 149
Query: 794 TPTIVHRDLKSPNLLVDKNW-----NVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM- 843
+ +HRDLK NLL+ + +K+ DFGL+R T E W
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-----GIPIRQFTHEIITLWYR 204
Query: 844 APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
PE+L + D++S I E+
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-22
Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 42/215 (19%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G G+YG V A G VA+KK F F+ L RE+KI++ +H N++
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKHENII 72
Query: 737 LFMGAVTRPPNLS------IITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVAR 785
+ RP + II E + L R++ H Q R
Sbjct: 73 TIF-NIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY-------FIYQTLR 123
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-- 843
+ LH S ++HRDLK NLL++ N ++KV DFGL+R+ + + G M
Sbjct: 124 AVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 844 --------APEVLRNEPS-NEKCDVYSFGVILWEL 869
APEV+ + DV+S G IL EL
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 4e-22
Identities = 52/219 (23%), Positives = 94/219 (42%), Gaps = 33/219 (15%)
Query: 679 VLGERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
G ++G G+YG VY A + + A+K+ S +A RE+ ++R L+HPN
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPN 79
Query: 735 VVLFMGAVTRPPNLSI--ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA-------- 784
V+ + + + ++ L+ I+ K+ +++ +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWN----VKVSDFGLSRLKHNTFLSSKSTAGTP 840
G++ LH + ++HRDLK N+LV VK++D G +RL ++ P
Sbjct: 139 DGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP--LKPLADLDP 194
Query: 841 E----WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
W APE+L + D+++ G I EL T +
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 7e-22
Identities = 58/254 (22%), Positives = 116/254 (45%), Gaps = 45/254 (17%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTE--VAVK---KFLDQDFSGAALLEFKR------EV 724
+D + +G GS+G V+ A+K K ++ K+ E
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK--------EIVVRLKQVEHTNDER 57
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKM 779
++ + HP ++ G + +I +++ G LF +L + + + + +
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 780 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAG 838
AL+ LH+ I++RDLK N+L+DKN ++K++DFG + + T+ + G
Sbjct: 118 ALE------YLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY----TLCG 165
Query: 839 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRL 895
TP+++APEV+ +P N+ D +SFG++++E+ P+ N M+ ++ L
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAEL 220
Query: 896 EIPKELDPLVARII 909
P + V ++
Sbjct: 221 RFPPFFNEDVKDLL 234
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 7e-22
Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 20/233 (8%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G G +GEV+ T A KK + A++E K+ I+ ++ +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE-KK---ILAKVHSRFIV 248
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV---DEKRRIKMALDVARGMNCLHTS 793
A +L ++ + G + ++ E R I + G+ LH
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
I++RDLK N+L+D + NV++SD GL+ +K AGTP +MAPE+L E
Sbjct: 309 N--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 854 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDP 903
+ D ++ GV L+E+ + P+ + Q + + P + P
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-KQRVLEQAVTYPDKFSP 418
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 57/229 (24%), Positives = 104/229 (45%), Gaps = 19/229 (8%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G++G+V T + K+ + A E ++++ RHP +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSRHPFLTA 212
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+ L + E+ G LF L R E R ++ ++ LH S +
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALDYLH-SEKNV 270
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 857
V+RDLK NL++DK+ ++K++DFGL + + K+ GTPE++APEVL +
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 330
Query: 858 DVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDP 903
D + GV+++E+ +LP+ + ++ F+ + P+ L P
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDHEKL-----FELILMEEIRFPRTLGP 374
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 47/220 (21%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLR---HPNV 735
G G++G V G VA+KK D F RE++IM+ L HPN+
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVLHHPNI 81
Query: 736 V----LFMGAVTRPPN---LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD------ 782
V F R L+++ E++P +L R + +R++
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY-----RRQVAPPPILIKVFL 135
Query: 783 --VARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAGT 839
+ R + CLH + + HRD+K N+LV++ + +K+ DFG ++ S S
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK------KLSPSEPNV 189
Query: 840 PEWM-----APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
APE++ D++S G I E+ +
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 42/217 (19%)
Query: 682 ERIGLGSYGEVYHA-DWNGTE--VAVKKF-LDQDFSGA---ALLEFKREVKIMRRLR--- 731
IG G+YG+V+ A D VA+K+ + G + REV ++R L
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRHLETFE 72
Query: 732 HPNVV-----LFMGAVTRPPNLSIITEFLPR--GSLFRILHRPHCQVDE-KRRIKMALDV 783
HPNVV + R L+++ E + + + + P + K + L
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL-- 130
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN--TFLSSKSTAGTPE 841
RG++ LH+ +VHRDLK N+LV + +K++DFGL+R+ T
Sbjct: 131 -RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--------TSV 179
Query: 842 ----WM-APEVLRNEPSNEKCDVYSFGVILWELATLK 873
W APEVL D++S G I E+ K
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-21
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 41/214 (19%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+ IG GS+G VY A +G VA+KK D+ F RE++IMR+L H N+V
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRL 112
Query: 739 MGAVTRPPN------LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD--------VA 784
L+++ +++P +++R+ + + + + +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHY-----SRAKQTLPVIYVKLYMYQLF 166
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSR-LKHNTFLSSK-STAGTPE 841
R + +H+ I HRD+K NLL+D + +K+ DFG ++ L S +
Sbjct: 167 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS----R 220
Query: 842 WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
+ APE++ DV+S G +L EL +
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 5e-21
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 31/208 (14%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+ IG G+ G V A VA+KK F +Q + A RE+ +M+ + H N+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNI 123
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVAR 785
+ + T L ++ E + +L +++ + +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-------LLYQMLC 175
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
G+ LH++ I+HRDLK N++V + +K+ DFGL+R +F+ + T + AP
Sbjct: 176 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAP 232
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLK 873
EV+ E D++S G I+ E+ K
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-21
Identities = 53/240 (22%), Positives = 113/240 (47%), Gaps = 25/240 (10%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG GS+G+V N T+ A+K K ++++ + +E++IM+ L HP +V
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN----EVRNVFKELQIMQGLEHPFLV 78
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ ++ ++ + L G L L + +E ++ + ++ ++ L
Sbjct: 79 NLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQR-- 135
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-- 853
I+HRD+K N+L+D++ +V ++DF ++ L T +++ + GT +MAPE+ +
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMFSSRKGAG 193
Query: 854 -NEKCDVYSFGVILWELATLKLPWIGM---NPMQVVGAVGFQNRRLEIPKELDPLVARII 909
+ D +S GV +EL + P+ + ++V F+ + P + ++
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--FETTVVTYPSAWSQEMVSLL 251
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 5e-21
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG G +GEVY T A+K + AL E + + ++ P +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 255
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
A P LS I + + G L L + H E A ++ G+ +H
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRF-- 312
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL-RNEPSNE 855
+V+RDLK N+L+D++ +V++SD GL+ + ++ GT +MAPEVL + +
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 856 KCDVYSFGVILWELATLKLPWIGMNP 881
D +S G +L++L P+
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKT 396
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-21
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 44/214 (20%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+G G+YG V A +G +VA+KK F + F+ A RE+ +++ ++H NV
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHENV 85
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDVAR 785
+ + T +L ++ F+ L +I+ Q + + +
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY-------LVYQMLK 137
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-- 843
G+ +H++ +VHRDLK NL V+++ +K+ DFGL+R T +
Sbjct: 138 GLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTR 187
Query: 844 ---APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
APEV+ + N+ D++S G I+ E+ T K
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-21
Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 26/233 (11%)
Query: 684 IGLGSYGEVY---HADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+G GS+G+V+ + V K L + K E I+ + HP
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR----DRVRTKMERDILVEVNHPF 87
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCLHTS 793
+V A L +I +FL G LF L + E+ + +A ++A ++ LH+
Sbjct: 88 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-FTEEDVKFYLA-ELALALDHLHSL 145
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
I++RDLK N+L+D+ ++K++DFGLS+ + + S GT E+MAPEV+
Sbjct: 146 G--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 854 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDP 903
+ D +SFGV+++E+ T LP+ G + + +L +P+ L P
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQGKDRKET-----MTMILKAKLGMPQFLSP 251
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFK--REVKIMRRLR---HP 733
IG+G+YG VY A +G VA+K + G L REV ++RRL HP
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 734 NVV----LFMG-AVTRPPNLSIITEFLPR--GSLFRILHRPHCQVDE-KRRIKMALDVAR 785
NVV + R ++++ E + + + P + K ++ L R
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL---R 131
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPE-- 841
G++ LH + IVHRDLK N+LV VK++DFGL+R+ TP
Sbjct: 132 GLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--------TPVVV 181
Query: 842 --WM-APEVLRNEPSNEKCDVYSFGVILWELATLK 873
W APEVL D++S G I E+ K
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 57/235 (24%), Positives = 103/235 (43%), Gaps = 32/235 (13%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G++G+V T + K+ + A E ++++ RHP +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPFLTA 69
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
A L + E+ G LF L R E+R ++ + LH+ +
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSRD--V 126
Query: 798 VHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRNE 851
V+RD+K NL++DK+ ++K++DFGL + TF GTPE++APEVL +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF------CGTPEYLAPEVLEDN 180
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDP 903
D + GV+++E+ +LP+ + ++ F+ + P+ L P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELILMEEIRFPRTLSP 230
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 33/241 (13%), Positives = 67/241 (27%), Gaps = 46/241 (19%)
Query: 680 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAA--LLEFKREVKIMRRLRHPNV 735
L G + + A D +VA+ F+D L E + R+ P V
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP 795
+ V ++ E++ GSL + I+ +A + H +
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 855
+ + V + +V ++ +N
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYPATMP---------------------------DANP 181
Query: 856 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---------NRRLEIPKELDPLVA 906
+ D+ G L+ L + P + + +IP ++ + A
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241
Query: 907 R 907
R
Sbjct: 242 R 242
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 4e-20
Identities = 60/242 (24%), Positives = 103/242 (42%), Gaps = 42/242 (17%)
Query: 684 IGLGSYGEVY---HADWNGTEV--AVKKFLDQDFSGAALLEFKREV-------KIMRRLR 731
+G G YG+V+ T A+K A ++ ++ I+ ++
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVL-----KKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNCL 790
HP +V + A L +I E+L G LF L R E +A +++ + L
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLA-EISMALGHL 137
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMA 844
H I++RDLK N++++ +VK++DFGL + +TF GT E+MA
Sbjct: 138 HQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC------GTIEYMA 189
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKEL 901
PE+L N D +S G +++++ T P+ G N + +L +P L
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-----IDKILKCKLNLPPYL 244
Query: 902 DP 903
Sbjct: 245 TQ 246
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 56/229 (24%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
IG GSYG VY A VA+KK F D L RE+ I+ RL+ +
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL----REITILNRLKSDYI 87
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDV 783
+ + P +L I+ E L ++ P H + + ++
Sbjct: 88 IRLY-DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-------ILYNL 138
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR------------LKHNTFL 831
G N +H S I+HRDLK N L++++ +VKV DFGL+R
Sbjct: 139 LLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 832 SSKSTAGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWEL 869
+ + APE++ + + + D++S G I EL
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 37/211 (17%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+ +G G+YG V A G +VA+KK F + F+ A RE+++++ +RH NV
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMRHENV 86
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMN 788
+ + T L ++ F+ L +++ + + RI+ + + +G+
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK---HEKLGEDRIQFLVYQMLKGLR 142
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM- 843
+H + I+HRDLK NL V+++ +K+ DFGL+R + T W
Sbjct: 143 YIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR--------QADSEMTGYVVTRWYR 192
Query: 844 APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
APEV+ N + D++S G I+ E+ T K
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-20
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+G G+YG V A G VAVKK F + RE+++++ ++H NV
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENV 90
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMN 788
+ + T +L ++T + L I+ CQ ++ + + RG+
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK---CQKLTDDHVQFLIYQILRGLK 146
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW-MAPEV 847
+H++ I+HRDLK NL V+++ +K+ DFGL+R + +T W APE+
Sbjct: 147 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT----RWYRAPEI 200
Query: 848 LRNEPS-NEKCDVYSFGVILWELATLK 873
+ N N+ D++S G I+ EL T +
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 65/243 (26%), Positives = 111/243 (45%), Gaps = 35/243 (14%)
Query: 684 IGLGSYGEVYHADWNGTEV-----AVKKFLDQDFSGAALLEFKREVKIM--RR-----LR 731
+G GS+G+V+ A++ T A+KK +L M +R
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKK--------DVVLMDDDVECTMVEKRVLSLAWE 76
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HP + NL + E+L G L + H D R A ++ G+ LH
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 135
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLR 849
+ IV+RDLK N+L+DK+ ++K++DFG+ K N +K+ GTP+++APE+L
Sbjct: 136 SKG--IVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILL 191
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVA 906
+ N D +SFGV+L+E+ + P+ G + ++ F P+ L+
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----FHSIRMDNPFYPRWLEKEAK 246
Query: 907 RII 909
++
Sbjct: 247 DLL 249
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 41/213 (19%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG G+YG V A + N VA+KK F Q + L RE+KI+ R RH N++
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 739 MGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DVARGMNCLH 791
+ R P + I+ + + L+++L Q I L + RG+ +H
Sbjct: 91 N-DIIRAPTIEQMKDVYIVQDLME-TDLYKLLK---TQHLSNDHICYFLYQILRGLKYIH 145
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-------- 843
++ ++HRDLK NLL++ ++K+ DFGL+R + ++
Sbjct: 146 SAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVATRW 196
Query: 844 --APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
APE++ N + D++S G IL E+ + +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 47/217 (21%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 673 IPWE---DLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ W D L ++G G Y EV+ A N +V VK + KRE+KI+
Sbjct: 30 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKIL 84
Query: 728 RRLR-HPNVVLFMGAVTRPP---NLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMA 780
LR PN++ + + P +++ E + ++ + +
Sbjct: 85 ENLRGGPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR----FYMYEI 139
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGT 839
L + ++ H+ I+HRD+K N+++D ++ +++ D+GL+ H + A +
Sbjct: 140 L---KALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA-S 193
Query: 840 PEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLP 875
+ PE+L + + D++S G +L + K P
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 3e-19
Identities = 58/234 (24%), Positives = 92/234 (39%), Gaps = 61/234 (26%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
IG GSYG V A VA+KK F D L RE+ I+ RL H +V
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----REIAILNRLNHDHV 114
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDV 783
V + + P ++ ++ E ++ P H + + ++
Sbjct: 115 VKVL-DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-------LLYNL 165
Query: 784 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----------------LK 826
G+ +H++ I+HRDLK N LV+++ +VKV DFGL+R
Sbjct: 166 LVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 827 HNTFLSSKSTAGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWEL 869
++ T + APE++ + + E DV+S G I EL
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-19
Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 25/232 (10%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG GS+G+V A EV AVK L + + E R V +++ ++HP +V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE--RNV-LLKNVKHPFLV 102
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ L + +++ G LF L R C E R A ++A + LH+
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERC-FLEPRARFYAAEIASALGYLHSLN-- 159
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPSN 854
IV+RDLK N+L+D ++ ++DFGL K N +S ++ GTPE++APEVL +P +
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 855 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDP 903
D + G +L+E+ P+ N ++ + N + L++ +
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----YDNILNKPLQLKPNITN 264
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 6e-19
Identities = 78/442 (17%), Positives = 164/442 (37%), Gaps = 33/442 (7%)
Query: 480 KTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKIN 539
T + ++ + V R ++ + + ++ K + K
Sbjct: 153 GTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQK 212
Query: 540 REPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQ--L 597
+ + + I D SR+ GS S + +
Sbjct: 213 TKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGV 272
Query: 598 NGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSST 657
+G + P E E R+K + + + + S +
Sbjct: 273 DGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN 332
Query: 658 SKVDQIFDDDVCECEIPWEDL-VLGERIGLGSYGEVYHADWNGTE------VAVKKFLDQ 710
D++ D + L VLG+ GS+G+V ++ GT+ + K + Q
Sbjct: 333 GNRDRMKLTD-------FNFLMVLGK----GSFGKVMLSERKGTDELYAVKILKKDVVIQ 381
Query: 711 DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ 770
D + KR + + + P + L + E++ G L + + +
Sbjct: 382 DDDVECTMVEKRVLALPGK--PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-R 438
Query: 771 VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830
E + A ++A G+ L + I++RDLK N+++D ++K++DFG+ +
Sbjct: 439 FKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496
Query: 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF 890
+++K+ GTP+++APE++ +P + D ++FGV+L+E+ + P+ G + ++ F
Sbjct: 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----F 551
Query: 891 Q---NRRLEIPKELDPLVARII 909
Q + PK + I
Sbjct: 552 QSIMEHNVAYPKSMSKEAVAIC 573
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 49/220 (22%), Positives = 89/220 (40%), Gaps = 42/220 (19%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G G G V+ A + VA+KK D AL RE+KI+RRL H N+V
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----REIKIIRRLDHDNIVK 72
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRI----------LHRP-HCQVDEKRRIKMAL-DVAR 785
+ P + + L + L + ++ + + R
Sbjct: 73 VF-EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM- 843
G+ +H++ ++HRDLK NL ++ ++ +K+ DFGL+R +
Sbjct: 132 GLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLAR-------IMDPHYSHKGHLS 182
Query: 844 ---------APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
+P +L + + + D+++ G I E+ T K
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 52/229 (22%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLR-HPN 734
+++G G+YG V+ + G VAVKK F + + RE+ I+ L H N
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILTELSGHEN 70
Query: 735 VVLFMGAVTRPPNLS---IITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVARG 786
+V + V R N ++ +++ L ++ H Q + + +
Sbjct: 71 IVNLL-NVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQY-------VVYQLIKV 121
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----------LKHNTFLSSKS 835
+ LH+ ++HRD+K N+L++ +VKV+DFGLSR + + ++++
Sbjct: 122 IKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 836 TAGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWELATLK 873
+ APE+L + D++S G IL E+ K
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 59/238 (24%), Positives = 98/238 (41%), Gaps = 25/238 (10%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G GS+G+V A T AVK L D + E + + + HP +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE--KRI-LSLARNHPFLT 87
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
P L + EF+ G L + + DE R A ++ + LH
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLHDKG-- 144
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPSN 854
I++RDLK N+L+D + K++DFG+ K + GTP+++APE+L+
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 855 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARII 909
D ++ GV+L+E+ P+ N + F+ N + P L I+
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDL-----FEAILNDEVVYPTWLHEDATGIL 255
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 9e-18
Identities = 53/248 (21%), Positives = 92/248 (37%), Gaps = 77/248 (31%)
Query: 682 ERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFK-REVKIMRRLRHPNVV-- 736
+ +G GS+G V G A+KK L QD +K RE+ IM+ L H N++
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVL-QDPR------YKNRELDIMKVLDHVNIIKL 65
Query: 737 ------------------------------LFMGAVTRPPN------LSIITEFLPRGSL 760
+ + N L++I E++P +L
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTL 124
Query: 761 FRILHRPHCQVDEKRRIKMALD--------VARGMNCLHTSTPTIVHRDLKSPNLLVD-K 811
++L + + ++ + R + +H+ I HRD+K NLLV+ K
Sbjct: 125 HKVLKSFI-----RSGRSIPMNLISIYIYQLFRAVGFIHSL--GICHRDIKPQNLLVNSK 177
Query: 812 NWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVLRNEPS-NEKCDVYSFGVI 865
+ +K+ DFG ++ S + APE++ D++S G +
Sbjct: 178 DNTLKLCDFGSAK------KLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 866 LWELATLK 873
EL K
Sbjct: 232 FGELILGK 239
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 57/246 (23%), Positives = 105/246 (42%), Gaps = 32/246 (13%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG GSY +V T+ A+K D + E + V + HP +V
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE--KHV-FEQASNHPFLV 73
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
L + E++ G L + R + E+ + +++ +N LH
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERG-- 130
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRN 850
I++RDLK N+L+D ++K++D+G+ + +TF GTP ++APE+LR
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRG 184
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG----FQ---NRRLEIPKELDP 903
E D ++ GV+++E+ + P+ + FQ +++ IP+ L
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 244
Query: 904 LVARII 909
A ++
Sbjct: 245 KAASVL 250
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 56/242 (23%), Positives = 107/242 (44%), Gaps = 34/242 (14%)
Query: 684 IGLGSYGEVY---HADWNGTEV--AVKKFLDQDFSGAALLEFKREV-------KIMRRLR 731
+G G+YG+V+ + T A+K A +++ + +++ +R
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVL-----KKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 732 H-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDVARGMNC 789
P +V A L +I +++ G LF L + + E +I + ++ +
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVG-EIVLALEH 174
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPEWMAPE 846
LH I++RD+K N+L+D N +V ++DFGLS K ++ GT E+MAP+
Sbjct: 175 LHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS--KEFVADETERAYDFCGTIEYMAPD 230
Query: 847 VLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKEL 901
++R S ++ D +S GV+++EL T P+ + + P+E+
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKSEPPYPQEM 289
Query: 902 DP 903
Sbjct: 290 SA 291
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-17
Identities = 54/242 (22%), Positives = 108/242 (44%), Gaps = 33/242 (13%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRR-LRHPNVV 736
+G GS+G+V ++ GT+ + K + QD E +++ + P +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT---MVEKRVLALPGKPPFLT 84
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
L + E++ G L + + + E + A ++A G+ L +
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG-- 141
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRN 850
I++RDLK N+++D ++K++DFG+ + TF GTP+++APE++
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF------CGTPDYIAPEIIAY 195
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVAR 907
+P + D ++FGV+L+E+ + P+ G + ++ FQ + PK +
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----FQSIMEHNVAYPKSMSKEAVA 250
Query: 908 II 909
I
Sbjct: 251 IC 252
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-17
Identities = 58/246 (23%), Positives = 105/246 (42%), Gaps = 32/246 (13%)
Query: 684 IGLGSYGEVYHADWNGTEV-----AVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG GSY +V T+ VKK D + E + V + HP +V
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE--KHV-FEQASNHPFLV 116
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
L + E++ G L + R + E+ + +++ +N LH
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERG-- 173
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRN 850
I++RDLK N+L+D ++K++D+G+ + +TF GTP ++APE+LR
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRG 227
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG----FQ---NRRLEIPKELDP 903
E D ++ GV+++E+ + P+ + FQ +++ IP+ L
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 287
Query: 904 LVARII 909
A ++
Sbjct: 288 KAASVL 293
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.7 bits (172), Expect = 4e-13
Identities = 35/197 (17%), Positives = 55/197 (27%), Gaps = 48/197 (24%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKK------FLDQDFSGAALLEFKREVKI 726
+P E L E+IG G +GEV+ + T VA+K L E E+ I
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 727 MRRL---------RHPNVVLFMGA------------------------------VTRPPN 747
+ L R + +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNL 807
L I+ EF G + + + I + + S HRDL N+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSI--LHQLTASLAVAEAS-LRFEHRDLHWGNV 193
Query: 808 LVDKNWNVKVSDFGLSR 824
L+ K K+ +
Sbjct: 194 LLKKTSLKKLHYTLNGK 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 43/220 (19%), Positives = 93/220 (42%), Gaps = 44/220 (20%)
Query: 682 ERIGLGSYGEVYHA-D-WNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLR-- 731
++G G + V+ A D N T VA+K + + + E+K+++R+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA---------EDEIKLLQRVNDA 75
Query: 732 ---------HPNVVLFMGAVT-RPPNLS---IITEFLPRGSLFRILHRPHCQVDEKRRIK 778
+++ + + PN ++ E L +L ++ + + +K
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134
Query: 779 -MALDVARGMNCLHTSTPTIVHRDLKSPNLLVD------KNWNVKVSDFGLSRLKHNTFL 831
++ + G++ +H I+H D+K N+L++ +K++D G + +
Sbjct: 135 QISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
+S T E+ +PEVL P D++S +++EL T
Sbjct: 194 NSIQT---REYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 60/233 (25%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 733
LG +IG GS+G++Y G EVA+K + + L E KI + ++ P
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQL--HIESKIYKMMQGGVGIP 68
Query: 734 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
+ V+ M G P+L LF R K +K
Sbjct: 69 TIRWCGAEGDYNVMVMELLG-----PSLE---------DLFNFCSR-------KFSLKTV 107
Query: 781 LDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRL-------K 826
L +A M +H+ +HRD+K N L+ V + DFGL++ +
Sbjct: 108 LLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
Query: 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 879
H + +K+ GT + + + + D+ S G +L LPW G+
Sbjct: 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 36/210 (17%)
Query: 682 ERIGLGSYGEVYHADW--NGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRHP 733
IG GS+G+V A VA+K FL+Q A +E V+++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ-----AQIE----VRLLELMNKH 110
Query: 734 ------NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARG 786
+V +L ++ E L +L+ +L + + + A +
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 787 MNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHN---TFLSSKSTAGTPE 841
+ L T +I+H DLK N+L+ K +K+ DFG S ++ S+
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------ 223
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
+ +PEVL P + D++S G IL E+ T
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 38/210 (18%)
Query: 682 ERIGLGSYGEVYHA-D-WNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH- 732
+ IG GS+G+V A D VA+K +F Q A E ++I+ LR
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ-----AAEE----IRILEHLRKQ 153
Query: 733 -----PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARG 786
NV+ + T ++ + E L +L+ ++ + Q ++ A + +
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 787 MNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHN---TFLSSKSTAGTPE 841
++ LH + I+H DLK N+L+ +KV DFG S +H T++ S+
Sbjct: 213 LDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF------ 264
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
+ APEV+ D++S G IL EL T
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 46/236 (19%), Positives = 86/236 (36%), Gaps = 62/236 (26%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 733
+G++IG G++GE+ + VA+ K L E + ++L P
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAI-KLEPMKSRAPQL---HLEYRFYKQLGSGDGIP 68
Query: 734 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
V + + G P+L LF + R +K
Sbjct: 69 QVYYFGPCGKYNAMVLELLG-----PSLE---------DLFDLCDR-------TFSLKTV 107
Query: 781 LDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLSRL------ 825
L +A + +H+ +++RD+K N L+ + N + + DF L++
Sbjct: 108 LMIAIQLISRMEYVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165
Query: 826 -KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 880
KH + KS GT +M+ + + + D+ + G + LPW G+
Sbjct: 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 55/236 (23%), Positives = 91/236 (38%), Gaps = 62/236 (26%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 733
+G RIG GS+G ++ N +VA+K + S A L + E + + L P
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQL--RDEYRTYKLLAGCTGIP 69
Query: 734 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
NV VL + G P+L L + R K +K
Sbjct: 70 NVYYFGQEGLHNVLVIDLLG-----PSLE---------DLLDLCGR-------KFSVKTV 108
Query: 781 LDVARGM----NCLHTSTPTIVHRDLKSPNLLV----DKNWN-VKVSDFGLSRL------ 825
A+ M +H ++V+RD+K N L+ KN N + V DFG+ +
Sbjct: 109 AMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166
Query: 826 -KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 880
+H + K+ +GT +M+ + + D+ + G + LPW G+
Sbjct: 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 60/234 (25%), Positives = 90/234 (38%), Gaps = 60/234 (25%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 733
LG +IG GS+GE+Y EVA+K + + L E KI R L+ P
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQL--LYESKIYRILQGGTGIP 66
Query: 734 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
NV VL M G P+L LF R K +K
Sbjct: 67 NVRWFGVEGDYNVLVMDLLG-----PSLE---------DLFNFCSR-------KLSLKTV 105
Query: 781 LDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRL-------K 826
L +A M +H+ + +HRD+K N L+ V + DFGL++ +
Sbjct: 106 LMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
Query: 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 880
H + +K+ GT + + + + D+ S G +L LPW G+
Sbjct: 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 2e-08
Identities = 63/412 (15%), Positives = 115/412 (27%), Gaps = 134/412 (32%)
Query: 596 QLNGPPLVEDLSSNSKDENPKNV----E-DHEIGYHDRRKCTHDRFMGTNLKLRDLESPS 650
+ V++ + PK++ E DH I D T R T L
Sbjct: 23 SVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT-LRLFWT---LLS--KQE 76
Query: 651 SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERI---------GLGSYGEVYHADWNGTE 701
V Q F ++V + L I Y E +N +
Sbjct: 77 EMV--------QKFVEEVLRINYKF----LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMR------RLR-HPNVVLF-MG---------AVTR 744
V K + R ++ LR NV++ + V
Sbjct: 125 VFAKYNV------------SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL 172
Query: 745 PPNLSIITEFLPRGSL---FRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRD 801
+ + + + + P ++ +++ +D H+S +
Sbjct: 173 --SYKVQCKM-DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 802 LKS-----------PN-LLV-DKNWNVKVSD-FGL-------SRLKHNT-FLSSKSTAGT 839
+++ N LLV N K + F L +R K T FLS+ +T
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT--- 286
Query: 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 899
+ + + E+ +L L ++ P ++P+
Sbjct: 287 ---------THISLDHHSMTLTPD----EVKSLLLKYLDCRPQ-------------DLPR 320
Query: 900 E---LDPLVARII----------WECW-QTGWSSLH--IRTSQAQLSHKRFQ 935
E +P II W+ W L I +S L ++
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 3e-07
Identities = 49/332 (14%), Positives = 94/332 (28%), Gaps = 59/332 (17%)
Query: 16 SNRTNETLASTTSCATDHNRTSSSSSNAAP-----PSPSASAATAASS--PAPVVS---- 64
+ T +R + + A P A PA V
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158
Query: 65 SGSRTDYMTSE--EEFQVQLAMA-----ISASSSN-PEDFSEKDQIRAATLLSLNNRRSD 116
GS ++ + ++VQ M ++ + N PE E Q + RSD
Sbjct: 159 LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218
Query: 117 LG---RDKADVAAEVLSR--QYWEYN----VLD--YEERVVDGFYDIYG---LST--DPS 160
+ + L R + Y VL + + F ++ L T
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF-NL-SCKILLTTRFKQ 276
Query: 161 TQGKLPSLA--HLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQ 218
L + H+ + + T D L++ C DLP + ++
Sbjct: 277 VTDFLSAATTTHISLDHHSMTL-------TPDEVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 219 LADLVNGHMGGPVKDANIMLARWMERSTE-LRRSLQTSVLPIGSINIGLSRHRALLFKVL 277
L+ ++ ++D W + + L +++S + + R V
Sbjct: 330 LS-II----AESIRDGLATWDNWKHVNCDKLTTIIESS---LNVLEPAEYRKMFDRLSVF 381
Query: 278 ADSIRLP----CRLVKGSHYTGVEDDAVNIIK 305
S +P + + V + K
Sbjct: 382 PPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 5e-06
Identities = 91/652 (13%), Positives = 163/652 (25%), Gaps = 223/652 (34%)
Query: 296 VEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDS 355
V+D +I+ EE +D I+ +KD + L + +
Sbjct: 38 VQDMPKSILSKEE-----ID-----------HIIMSKDAVSGTL--RL--FWTLLSKQEE 77
Query: 356 GAVYSKPKPLHAEGSSQNSTVDGSLPLNGG--STSEKAESL-PSFPSPSYEPGAASSGIS 412
V+ L +N + K E PS + Y I
Sbjct: 78 MV---------------QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY--------IE 114
Query: 413 SR-VTPNQSDYLSS---------STIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQED 462
R N + + + +L + R NV+ G
Sbjct: 115 QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE-----------LRPAKNVLIDGV----- 158
Query: 463 SKSLFADLNPFQIKGAGKTSL------------------------HKNPTESKVEEFQS- 497
G+GKT + + N E+ +E Q
Sbjct: 159 -------------LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL 205
Query: 498 -HRINPVSGRPPIPMMRKNQHPYNEVPRKKEY----SYMEGIL-------PKINREPNNN 545
++I+P ++ + Y +L K N +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS 265
Query: 546 ---LSTSASTSSTSENFNPHSFKPS-NDANISSKDSESRSALSGSGPSLASSTSQLNGPP 601
L T+ T + S + +++ E +S L L+ P
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL----------KYLDCRP 315
Query: 602 LVEDLSSNSKDENP-------KNVEDHEIGYHDRRKCTHDRFMGTNL-KLRDLESPSSSV 653
+DL NP +++ D T D + N KL SS+
Sbjct: 316 --QDLPREVLTTNPRRLSIIAESIRDG--------LATWDNWKHVNCDKLT--TIIESSL 363
Query: 654 DSSTSKVDQ-------IFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKK 706
+ + +F IP +L + W +
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPSA---HIPTI--LL----------SLI---WFDVIKSDVM 405
Query: 707 FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 766
+ +L+E K+ + + SI E + LHR
Sbjct: 406 VVVNKLHKYSLVE-KQPKESTISI-P----------------SIYLELKVKLENEYALHR 447
Query: 767 -------PHCQVDEKRRIKMALD------VARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 813
D I LD + H R + +D +
Sbjct: 448 SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-----HLKNIEHPERMTLFRMVFLDFRF 502
Query: 814 -NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK--CDVYSF 862
K+ + N S +T ++ P + N+P E+ + F
Sbjct: 503 LEQKIRHDSTAW---NASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 47/235 (20%), Positives = 81/235 (34%), Gaps = 44/235 (18%)
Query: 680 LGERIGLGSYGEVYHAD-WNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G IG G +G +Y AD + V + + S L E+K +R P +
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT--ELKFYQRAAKPEQI 96
Query: 737 LFMGAVTRPPNLSIIT-----EFLPRGSLFRIL-----------HRPHCQVDEKRR--IK 778
+ L + G +R + +R K
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEAN----AKRFSRK 152
Query: 779 MALDVARGM----NCLHTSTPTIVHRDLKSPNLLVD-KNWN-VKVSDFGLSRL------- 825
L ++ + +H VH D+K+ NLL++ KN + V + D+GL+
Sbjct: 153 TVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 826 KHNTFLSSKSTAGTPEWMAPEV-LRNEPSNEKCDVYSFGVILWELATLKLPWIGM 879
K + GT E+ + + PS + D+ G + + T LPW
Sbjct: 211 KAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 47/236 (19%), Positives = 80/236 (33%), Gaps = 47/236 (19%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
VLG++IG G +G +Y A + A + ++ L E+K +R+ + +
Sbjct: 40 VLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLF--SELKFYQRVAKKDCI 96
Query: 737 LFMGAVTRPPNLSIIT-----EFLPRGSLFRILHRPHCQV------------DEKRR--I 777
+ L I +G +R + V +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFM------VMERLGIDLQKISGQNGTFKK 150
Query: 778 KMALDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWNVKV--SDFGLSRL------ 825
L + M +H + VH D+K+ NLL+ +V +D+GLS
Sbjct: 151 STVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 826 -KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGM 879
K K GT E+ + + + S + DV G + KLPW
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQN 263
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 47/253 (18%), Positives = 89/253 (35%), Gaps = 74/253 (29%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLR-----HPN- 734
+G G + V+ + VA+K + ++ A E+++++ +R PN
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA----LDEIRLLKSVRNSDPNDPNR 100
Query: 735 --VVLFMGAVT-RPPN---LSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDVARGM 787
VV + N + ++ E L L + + + + Q +K + V +G+
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 788 NCLHTSTPTIVHRDLKSPNLLV-------------------------------------- 809
+ LHT I+H D+K N+L+
Sbjct: 160 DYLHTKC-RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 810 -----------DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 858
+ VK++D G + H F T ++ + EVL N D
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT---RQYRSLEVLIGSGYNTPAD 275
Query: 859 VYSFGVILWELAT 871
++S + +ELAT
Sbjct: 276 IWSTACMAFELAT 288
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 53/235 (22%), Positives = 86/235 (36%), Gaps = 70/235 (29%)
Query: 682 ERIGLGSYGEVYHA---DWNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH 732
+ +G G++G+V G VAVK ++ + A E ++++ L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA-----ARSE----IQVLEHLNT 70
Query: 733 P------NVVLFMGAVTRPPNLSIITEFLPRGSL--------FRILHRPHCQVDEKRRIK 778
V + ++ I+ E L S F H + K
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIR-------K 122
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPN-LLVD------------------KNWNVKVSD 819
MA + + +N LH++ + H DLK N L V N ++KV D
Sbjct: 123 MAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 820 FG---LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
FG H+T +S++ APEV+ ++ CDV+S G IL E
Sbjct: 181 FGSATYDDEHHSTLVSTRHYR------APEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 49/234 (20%), Positives = 88/234 (37%), Gaps = 68/234 (29%)
Query: 682 ERIGLGSYGEVYHA---DWNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH 732
+G G++G+V ++VA+K K+ + A LE + ++++++
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA-----ARLE----INVLKKIKE 75
Query: 733 P------NVVLFMGAVTRPPNLSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKM 779
VL ++ I E L + + F+ PH + M
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR-------HM 128
Query: 780 ALDVARGMNCLHTSTPTIVHRDLKSPN-LLVD------------------KNWNVKVSDF 820
A + + LH + + H DLK N L V+ KN +++V+DF
Sbjct: 129 AYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 821 G---LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
G H T ++++ PEV+ + CDV+S G IL+E
Sbjct: 187 GSATFDHEHHTTIVATRHY------RPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 48/239 (20%), Positives = 89/239 (37%), Gaps = 74/239 (30%)
Query: 682 ERIGLGSYGEVYHADW---NGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH 732
++G G++G V N AVK K+ A +E I++++++
Sbjct: 41 RKMGDGTFGRVLLC-QHIDNKKYYAVKVVRNIKKYTRS-----AKIE----ADILKKIQN 90
Query: 733 -----PNVVLFMGAVTRPPNLSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKMA 780
N+V + G ++ +I E L + + H +
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK-------LYC 143
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPN-LLVD------------------------KNWNV 815
+++ + +N L + + H DLK N LL D K+ +
Sbjct: 144 IEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 816 KVSDFG---LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 871
K+ DFG H + ++++ + APEV+ N + D++SFG +L EL T
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQ------YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 43/236 (18%), Positives = 76/236 (32%), Gaps = 44/236 (18%)
Query: 679 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKR-----EVKIMRRLRHP 733
L + G +Y A T Q F + L+ K E +R P
Sbjct: 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKF--SLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 734 NVVLFMGAVTRPPNLSI--ITEFLPRGSLFRIL-----------HRPHCQVDEKRR---I 777
V + P L+I F +R L +
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP----KHVLSE 158
Query: 778 KMALDVARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWNVKV--SDFGLSRL-----K 826
+ L VA + LH + VH ++ + N+ VD +V + +G + K
Sbjct: 159 RSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 827 HNTFLSSKSTA--GTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGM 879
H ++ + G E+++ ++ + PS + D+ S G + + LPW
Sbjct: 217 HVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNC 271
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 29/162 (17%), Positives = 56/162 (34%), Gaps = 38/162 (23%)
Query: 680 LGERIGLGSYGEVYHA-DWNGTEVAVKKF----------------LDQDFSGAALLEFKR 722
+G+ +G G V++ E VK D FS A+ +
Sbjct: 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 153
Query: 723 EVKIMRRLRH---PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM 779
E + +++L+ P V + G ++ E I + +V + ++
Sbjct: 154 EFRALQKLQGLAVPKVYAWEGNA-------VLMEL--------IDAKELYRVRVENPDEV 198
Query: 780 ALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
+ + + IVH DL N+LV + + + DF
Sbjct: 199 LDMILEEVAKFYHR--GIVHGDLSQYNVLVSEE-GIWIIDFP 237
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 935 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.05 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.06 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.05 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.67 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.53 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.31 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.26 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.21 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.19 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.15 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.89 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.75 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.6 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.58 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.56 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.55 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 96.4 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.8 | |
| 3kd4_A | 506 | Putative protease; structural genomics, joint cent | 95.1 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 94.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.93 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.12 | |
| 1x3z_A | 335 | Peptide: N-glycanase; hydrolase-hydrolase inhibito | 92.42 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.17 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.35 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-56 Score=493.34 Aligned_cols=255 Identities=24% Similarity=0.422 Sum_probs=226.5
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
..++|++++.||+|+||+||+|++ +|+.||||++............+.+|+.+|++|+|||||+++++|++++.+|||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999987 588999999988877777788899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 752 TEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 752 mEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||+||+|.++|.. ....+++..++.|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||+++......
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999999964 3456799999999999999999999999 9999999999999999999999999998775443
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
......+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++.++.. ...+.++..+++++++||.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~ 258 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-GSFPPVSLHYSYDLRSLVS 258 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-CCCCCCCccCCHHHHHHHH
Confidence 333456899999999999999999999999999999999999999999999888887753 3345677889999999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||+.| |.+||+++|||+|||
T Consensus 259 ~~L~~d---P~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 259 QLFKRN---PRDRPSVNSILEKGF 279 (350)
T ss_dssp HHTCSS---GGGSCCHHHHHTSHH
T ss_pred HHccCC---hhHCcCHHHHhcCHH
Confidence 999999 999999999999998
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=480.46 Aligned_cols=251 Identities=28% Similarity=0.399 Sum_probs=225.4
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.+.|++.++||+|+||+||+|++ +|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35799999999999999999987 58899999997654322 345789999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
|||++|+|.+++.+ ..+++..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+++........
T Consensus 151 Ey~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 151 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp CCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred eCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999999976 46999999999999999999999999 999999999999999999999999999987665455
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccCCCCcCcHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~-~r~~ip~~ls~~L~dLI~q 911 (935)
..+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++..+.... .....+..+++++++||.+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 567899999999999999999999999999999999999999999999988887765322 1233446789999999999
Q ss_pred HHhhCCCCcCCCcCHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPSa~EILqHPF 934 (935)
||+.| |.+||+++|||+|||
T Consensus 307 ~L~~d---P~~R~ta~e~l~Hp~ 326 (346)
T 4fih_A 307 LLVRD---PAQRATAAELLKHPF 326 (346)
T ss_dssp HSCSS---TTTSCCHHHHTTCGG
T ss_pred HcCCC---hhHCcCHHHHhcCHh
Confidence 99999 999999999999999
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=476.10 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=226.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++++.||+|+||+||+|++ +++.||||++.+.... ......+.+|+++|++|+|||||+++++|++++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6799999999999999999987 6889999999765321 223567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC--c
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--F 830 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~--~ 830 (935)
|||+||+|++++.+. +.+++..++.|+.||+.||+|||+++ ||||||||+||||+.+|++||+|||+++..... .
T Consensus 112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 999999999999763 47999999999999999999999999 999999999999999999999999999976432 2
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
....+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..++...+. .....+|..+++++++||.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli~ 266 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII--KLEYDFPEKFFPKARDLVE 266 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTCCHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCcccCHHHHHHHH
Confidence 23456799999999999999999999999999999999999999999999988888875 3456788999999999999
Q ss_pred HHHhhCCCCcCCCcCHHH------HHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQ------LSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~E------ILqHPF 934 (935)
+||+.| |.+||+++| |++|||
T Consensus 267 ~lL~~d---p~~R~t~~e~~~~~~i~~Hp~ 293 (311)
T 4aw0_A 267 KLLVLD---ATKRLGCEEMEGYGPLKAHPF 293 (311)
T ss_dssp HHSCSS---GGGSTTSGGGTCHHHHHTSGG
T ss_pred HHccCC---HhHCcChHHHcCCHHHHCCCC
Confidence 999999 999999987 689998
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=464.53 Aligned_cols=250 Identities=31% Similarity=0.471 Sum_probs=219.9
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc----CCceEEE
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSII 751 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~----~~~l~LV 751 (935)
|++.++||+|+||+||+|.+ ++..||||++............|.+|+.+|++|+|||||+++++|.+ +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 57888999999999999987 57789999998877777778889999999999999999999999865 3558999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec-CCCcEEEEeccccccccCCc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||++|+|.+++.+. ..+++..++.|+.||+.||+|||+++++||||||||+||||+ .+|.+||+|||+|+.....
T Consensus 108 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 9999999999999763 479999999999999999999999887899999999999998 4899999999999865433
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~-~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
...+.+||+.|||||++.+ .|+.++|||||||+||||++|++||.+... ..+...+.....+..++..+++++++||
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 263 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHH
Confidence 2345789999999999976 589999999999999999999999987544 4555555544455567778899999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||+.| |.+|||++|||+|||
T Consensus 264 ~~~L~~d---P~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 264 EGCIRQN---KDERYSIKDLLNHAF 285 (290)
T ss_dssp HHHSCSS---GGGSCCHHHHHTSGG
T ss_pred HHHccCC---hhHCcCHHHHhcCcc
Confidence 9999999 999999999999999
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-55 Score=476.31 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=220.5
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
+..++|++++.||+|+||+||+|++ .++.||||++............+.+|+.+|++++|||||+++++|++++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 3457899999999999999999976 36789999997654333233467889999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+|||||||+||+|.+++.+. ..+++..+..|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+...
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999999764 47999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..++...+. .....+|..+++++++
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~ 255 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQS 255 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH--cCCCCCCCcCCHHHHH
Confidence 54445567899999999999999999999999999999999999999999999998888774 3456788999999999
Q ss_pred HHHHHHhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPS-----a~EILqHPF 934 (935)
||.+||+.| |.+||+ ++||++|||
T Consensus 256 li~~~L~~d---P~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 256 LLRMLFKRN---PANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp HHHHHTCSS---GGGSTTCSTTTHHHHHTSGG
T ss_pred HHHHHcccC---HHHCCCCCcCCHHHHHcCcc
Confidence 999999999 999998 689999998
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=459.53 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=209.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++++.||+|+||+||+|++ +|+.||||++....... .....+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999986 68899999998765433 34567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||| +|+|.+++.+. ..+++..+..|+.||+.||+|||++| ||||||||+||||+.++++||+|||+|+..... ..
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~ 167 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NF 167 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCC-Cc
Confidence 999 67999998764 47999999999999999999999999 999999999999999999999999999876543 23
Q ss_pred CCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~q 911 (935)
..+.+||+.|||||++.+..+ +.++|||||||++|+|++|++||.+.+..++...+. .....+|..+++++++||.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 245 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFLSPGAAGLIKR 245 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHH
Confidence 345789999999999998876 689999999999999999999999998888877774 34567788999999999999
Q ss_pred HHhhCCCCcCCCcCHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPSa~EILqHPF 934 (935)
||+.| |.+|||++|+|+|||
T Consensus 246 ~L~~d---P~~R~s~~eil~hpw 265 (275)
T 3hyh_A 246 MLIVN---PLNRISIHEIMQDDW 265 (275)
T ss_dssp HSCSS---GGGSCCHHHHHHCHH
T ss_pred HccCC---hhHCcCHHHHHcCcc
Confidence 99999 999999999999998
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=482.88 Aligned_cols=252 Identities=29% Similarity=0.408 Sum_probs=226.7
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
+.+.|+++++||+|+||.||+|++ +|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+++.+|||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 346799999999999999999987 5889999999765432 234578999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
||||+||+|.+++.. ..+++..+..|+.||+.||+|||++| ||||||||+||||+.+|+|||+|||+++.......
T Consensus 227 mEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 227 MEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999999975 35999999999999999999999999 99999999999999999999999999998765545
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccCCCCcCcHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIW 910 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~-~r~~ip~~ls~~L~dLI~ 910 (935)
...+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++..+.... .....+..+++++++||.
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 382 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 382 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence 5567899999999999999999999999999999999999999999999988887775332 233455679999999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||+.| |.+||++.|||+|||
T Consensus 383 ~~L~~d---P~~R~ta~ell~Hp~ 403 (423)
T 4fie_A 383 RLLVRD---PAQRATAAELLKHPF 403 (423)
T ss_dssp HHSCSS---TTTSCCHHHHTTCGG
T ss_pred HHcCCC---hhHCcCHHHHhcCHH
Confidence 999999 999999999999999
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=460.30 Aligned_cols=255 Identities=33% Similarity=0.560 Sum_probs=217.8
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
..|+|+.++|+++++||+|+||+||+|++++ .||||+++.........+.|.+|+.+|++++|||||++++++.+ +.+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 4578999999999999999999999998765 59999998776677778899999999999999999999998865 568
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|||||||++|+|.++|......+++..++.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999999877778999999999999999999999998 99999999999999999999999999987643
Q ss_pred C--cccCCCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cc---cCCCC
Q 002331 829 T--FLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RR---LEIPK 899 (935)
Q Consensus 829 ~--~~~~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~-~r---~~ip~ 899 (935)
. .......+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.+....+..+.... .. ..++.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence 2 122345689999999999964 358999999999999999999999999877655444332222 22 24567
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHH
Q 002331 900 ELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~kRPSa~EIL 930 (935)
.+++.+.+||.+||+.| |.+||++.+|+
T Consensus 265 ~~~~~l~~li~~cl~~d---P~~RPs~~ei~ 292 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKV---KEERPLFPQIL 292 (307)
T ss_dssp TSCHHHHHHHHHHTCSS---STTSCCHHHHH
T ss_pred cchHHHHHHHHHHcCCC---HhHCcCHHHHH
Confidence 89999999999999999 99999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=464.89 Aligned_cols=244 Identities=27% Similarity=0.362 Sum_probs=213.7
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
..++|++.++||+|+||+||+|++ +|+.||||++...... .+|+.+|+.|+|||||+++++|.+++.+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 446799999999999999999987 5889999999865432 4699999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC-cEEEEeccccccccCCc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~VKL~DFGlA~~~~~~~ 830 (935)
||||++|+|.++|++. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.+| ++||+|||+++......
T Consensus 129 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp ECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999999764 47999999999999999999999999 99999999999999987 69999999998765321
Q ss_pred -----ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-cCCCCcCcHH
Q 002331 831 -----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-LEIPKELDPL 904 (935)
Q Consensus 831 -----~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r-~~ip~~ls~~ 904 (935)
......+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..++...+.....+ ..+|..+++.
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence 1223468999999999999999999999999999999999999999988777666666543333 3578899999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHH
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLS 930 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EIL 930 (935)
+.+||.+||+.| |.+|||+.||+
T Consensus 286 ~~~li~~~L~~d---P~~R~sa~el~ 308 (336)
T 4g3f_A 286 TAQAIQEGLRKE---PVHRASAMELR 308 (336)
T ss_dssp HHHHHHHHTCSS---GGGSCCHHHHH
T ss_pred HHHHHHHHccCC---HhHCcCHHHHH
Confidence 999999999999 99999999984
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=457.27 Aligned_cols=254 Identities=33% Similarity=0.516 Sum_probs=219.4
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~ 743 (935)
.++..++|.+.++||+|+||+||+|++. ++.||||++... .....+.|.+|+++|++|+|||||+++++|.
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3456688999999999999999999863 678999998654 3556778999999999999999999999999
Q ss_pred cCCceEEEEeeCCCCCHHHHHcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee
Q 002331 744 RPPNLSIITEFLPRGSLFRILHRPH--------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 809 (935)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~~~~--------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL 809 (935)
+.+.+|||||||++|+|.+++++.. .++++..++.|+.||+.||.|||+++ ||||||||+||||
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl 191 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLV 191 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEE
Confidence 9999999999999999999997532 45899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 002331 810 DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVG 886 (935)
Q Consensus 810 d~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~ 886 (935)
+.++.+||+|||+++...... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+++.
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999998764332 22334679999999999999999999999999999999999 899999999988887
Q ss_pred HhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 887 AVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 887 ~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+. ...++.+|..+++++.+||.+||+.| |.+||++.+|+++
T Consensus 272 ~i~-~g~~~~~p~~~~~~~~~li~~cl~~d---P~~RPs~~ei~~~ 313 (329)
T 4aoj_A 272 CIT-QGRELERPRACPPEVYAIMRGCWQRE---PQQRHSIKDVHAR 313 (329)
T ss_dssp HHH-HTCCCCCCTTCCHHHHHHHHHHCCSS---TTTSCCHHHHHHH
T ss_pred HHH-cCCCCCCcccccHHHHHHHHHHcCcC---hhHCcCHHHHHHH
Confidence 775 44577889999999999999999999 9999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=455.66 Aligned_cols=252 Identities=31% Similarity=0.537 Sum_probs=222.5
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
+|..++|.+.+.||+|+||+||+|++ +++.||||++... .....+.|.+|+++|++|+|||||+++++|.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 46678999999999999999999986 3668999998754 35567789999999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC
Q 002331 745 PPNLSIITEFLPRGSLFRILHRP------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~------------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~ 812 (935)
++.+|||||||++|+|.++|++. ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.+
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC
Confidence 99999999999999999999642 246899999999999999999999998 9999999999999999
Q ss_pred CcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhh
Q 002331 813 WNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 889 (935)
Q Consensus 813 g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~ 889 (935)
+.+||+|||+++....... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999986544322 2233468999999999999999999999999999999998 899999999998888775
Q ss_pred ccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 890 FQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 890 ~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
...++.+|..+++++.+||.+||+.| |.+||++.+|++
T Consensus 245 -~~~~~~~p~~~~~~~~~li~~cl~~d---P~~RPs~~~i~~ 282 (299)
T 4asz_A 245 -QGRVLQRPRTCPQEVYELMLGCWQRE---PHMRKNIKGIHT 282 (299)
T ss_dssp -HTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred -cCCCCCCCccchHHHHHHHHHHcCCC---hhHCcCHHHHHH
Confidence 44567789999999999999999999 999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=454.57 Aligned_cols=254 Identities=29% Similarity=0.485 Sum_probs=224.4
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
++...++++.++||+|+||+||+|++ +++.||||++.... .....+.|.+|+.+|++++|||||+++|+|.+
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 56778899999999999999999986 35789999987543 33445679999999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee
Q 002331 745 PPNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV 809 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~---------------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL 809 (935)
++.++||||||++|+|.++|... ...+++..++.|+.||+.||+|||+++ ||||||||+||||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLV 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEE
Confidence 99999999999999999999642 235899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 002331 810 DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVG 886 (935)
Q Consensus 810 d~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~ 886 (935)
++++.+||+|||+++...... ......+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..++..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998764332 22345679999999999999999999999999999999998 899999999998888
Q ss_pred HhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 887 AVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 887 ~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+. ...++++|..+++++.+||.+||+.| |.+||++.+|+++
T Consensus 259 ~i~-~~~~~~~p~~~~~~~~~li~~C~~~d---P~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIR-NRQVLPCPDDCPAWVYALMIECWNEF---PSRRPRFKDIHSR 300 (308)
T ss_dssp HHH-TTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHH-cCCCCCCcccchHHHHHHHHHHcCCC---hhHCcCHHHHHHH
Confidence 775 45567789999999999999999999 9999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=455.15 Aligned_cols=260 Identities=30% Similarity=0.471 Sum_probs=225.1
Q ss_pred cccccCCCCCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC-Cceeee
Q 002331 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLF 738 (935)
Q Consensus 667 e~~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g-------~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~H-PNIVkl 738 (935)
+..+|+|+.++|++++.||+|+||+||+|++.+ +.||||++.... .......|.+|+.+|.+++| ||||++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 445689999999999999999999999998743 579999987553 34456789999999999965 999999
Q ss_pred ecccccC-CceEEEEeeCCCCCHHHHHcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCC
Q 002331 739 MGAVTRP-PNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 802 (935)
Q Consensus 739 ~g~~~~~-~~l~LVmEy~~gGsL~dlL~~~---------------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDL 802 (935)
+++|.+. +.++||||||++|+|.++|++. ...+++..++.|+.||+.||+|||+++ ||||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDL 211 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 211 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCcc
Confidence 9998664 5689999999999999999642 235899999999999999999999999 999999
Q ss_pred CCCCeeecCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002331 803 KSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 879 (935)
Q Consensus 803 KPeNILLd~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~ 879 (935)
||+||||++++.+||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998764322 22344578999999999999999999999999999999998 89999987
Q ss_pred ChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 880 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 880 ~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+..+.+..+.....++.+|..+++++.+||.+||+.| |.+||++.+|++|
T Consensus 292 ~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~d---P~~RPt~~eil~~ 341 (353)
T 4ase_A 292 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE---PSQRPTFSELVEH 341 (353)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcC---hhHCcCHHHHHHH
Confidence 7555444444456778899999999999999999999 9999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=451.08 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=216.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccc------cCCc
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT------RPPN 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~------~~~~ 747 (935)
++|++++.||+|+||+||+|++ +|+.||||++............+.+|+.+|+.|+|||||++++++. +.+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999987 5889999999877666666778899999999999999999999865 3467
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+|||||||+ |+|.+++.+. ..+++..+..|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||+++...
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 999999996 6899999764 57999999999999999999999999 9999999999999999999999999998654
Q ss_pred CC----cccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC------
Q 002331 828 NT----FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE------ 896 (935)
Q Consensus 828 ~~----~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~------ 896 (935)
.. .....+.+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+......+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 32 2234567899999999998875 569999999999999999999999999988777766532211110
Q ss_pred -----------------------CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 897 -----------------------IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 897 -----------------------ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+...+++++.+||.+||+.| |.+|||++|+|+|||
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~d---P~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFE---PSARISAAAALRHPF 347 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSS---TTTSCCHHHHTTSGG
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCC---hhHCcCHHHHhcCHh
Confidence 11346889999999999999 999999999999999
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=439.36 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=197.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC-------
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------- 746 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~------- 746 (935)
++|++++.||+|+||+||+|++ +|+.||||++.... .+...+.+.+|+.+|++|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4699999999999999999987 58899999987654 3455677899999999999999999999987544
Q ss_pred -----ceEEEEeeCCCCCHHHHHcCCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEe
Q 002331 747 -----NLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 819 (935)
Q Consensus 747 -----~l~LVmEy~~gGsL~dlL~~~~~--~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~D 819 (935)
.+|||||||++|+|.+++..... ..++..++.|+.||+.||+|||++| ||||||||+||||+.++.+||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999976432 3456778899999999999999999 99999999999999999999999
Q ss_pred ccccccccCCcc------------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHH
Q 002331 820 FGLSRLKHNTFL------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVG 886 (935)
Q Consensus 820 FGlA~~~~~~~~------------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~-~eil~ 886 (935)
||+|+....... .....+||+.|||||++.+..|+.++|||||||+||||++ ||..... ...+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 999987643211 1234579999999999999999999999999999999996 7865422 22222
Q ss_pred HhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 887 AVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 887 ~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+.. ...+......++.+.+||.+||+.| |.+||++.|||+|||
T Consensus 239 ~~~~-~~~p~~~~~~~~~~~~li~~~L~~d---P~~Rps~~eil~h~~ 282 (299)
T 4g31_A 239 DVRN-LKFPPLFTQKYPCEYVMVQDMLSPS---PMERPEAINIIENAV 282 (299)
T ss_dssp HHHT-TCCCHHHHHHCHHHHHHHHHHTCSS---GGGSCCHHHHHTSGG
T ss_pred HHhc-CCCCCCCcccCHHHHHHHHHHcCCC---hhHCcCHHHHhcCHh
Confidence 3321 1112222345677889999999999 999999999999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=458.46 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=225.6
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++++.||+|+||+||+|++ +|+.||||++.... ......+.+|+.+|+.|+|||||+++++|.+.+.+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 36899999999999999999987 68899999987654 334567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC--CCcEEEEeccccccccCCc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~--~g~VKL~DFGlA~~~~~~~ 830 (935)
|||+||+|+++|.+....+++..+..|+.||+.||.|||+++ |+||||||+||||+. .+.+||+|||+++.....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 999999999999776678999999999999999999999999 999999999999985 489999999999977543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCcCcHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 908 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--~ip~~ls~~L~dL 908 (935)
......+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+.+..+......+ ..+..+++++++|
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 22345689999999999999999999999999999999999999999999998888875443322 2335789999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||+.| |.+||++.|+|+|||
T Consensus 391 i~~~L~~d---p~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 391 IRKLLLAD---PNTRMTIHQALEHPW 413 (573)
T ss_dssp HHTTSCSS---GGGSCCHHHHHHSTT
T ss_pred HHHHccCC---hhHCcCHHHHhcCcC
Confidence 99999999 999999999999999
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=430.11 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=203.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~ 749 (935)
++|+++++||+|+||+||+|++ .++.||||++..... ...+.+|+++|+.+ +|||||+++++|.+.+++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 6799999999999999999975 357899999866532 34577899999998 6999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC-CcEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~VKL~DFGlA~~~~~ 828 (935)
||||||++|+|.+++. .+++..+..|+.||+.||+|||++| ||||||||+||||+.+ +.+||+|||+|+...+
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999999994 4899999999999999999999999 9999999999999876 8999999999986543
Q ss_pred Cc----------------------------ccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002331 829 TF----------------------------LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGM 879 (935)
Q Consensus 829 ~~----------------------------~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~ 879 (935)
.. ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 21 012345799999999999876 4899999999999999999999999654
Q ss_pred C-hHHHHHHhhcc----------------------------------------------------ccccCCCCcCcHHHH
Q 002331 880 N-PMQVVGAVGFQ----------------------------------------------------NRRLEIPKELDPLVA 906 (935)
Q Consensus 880 ~-~~eil~~I~~~----------------------------------------------------~~r~~ip~~ls~~L~ 906 (935)
+ ..+.+..+... .........++++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 3 33332222100 000011245788999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||.+||+.| |.+|||++|+|+|||
T Consensus 331 DLl~~lL~~d---P~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 331 DLLDKLLDLN---PASRITAEEALLHPF 355 (361)
T ss_dssp HHHHHHTCSC---TTTSCCHHHHHTSGG
T ss_pred HHHHHHCcCC---hhHCcCHHHHhcCcc
Confidence 9999999999 999999999999999
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=423.13 Aligned_cols=249 Identities=33% Similarity=0.525 Sum_probs=199.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC----ceEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NLSII 751 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~----~l~LV 751 (935)
++|.+.++||+|+||+||+|+++|+.||||++.... .....++.|+.++.+++|||||++++++.+++ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 468999999999999999999999999999986543 22223345666677889999999999997654 47999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~------g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
||||++|+|.+++++ ..+++..+++|+.|++.||+|||.+ .++||||||||+||||+.++.+||+|||+++.
T Consensus 80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999976 3589999999999999999999986 22499999999999999999999999999987
Q ss_pred ccCCcc----cCCCCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHcCCCCCCC----------C-----C
Q 002331 826 KHNTFL----SSKSTAGTPEWMAPEVLRNE------PSNEKCDVYSFGVILWELATLKLPWIG----------M-----N 880 (935)
Q Consensus 826 ~~~~~~----~~~s~~GT~~Y~APEvl~g~------~~s~ksDIWSLG~ILyELLTG~~PF~~----------~-----~ 880 (935)
...... .....+||+.|||||++.+. .++.++|||||||+||||+||..||.. . .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 644321 12345799999999999765 357799999999999999999766532 1 2
Q ss_pred hHHHHHHhhccccccCCCCc-----CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 881 PMQVVGAVGFQNRRLEIPKE-----LDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 881 ~~eil~~I~~~~~r~~ip~~-----ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
...+...+.....++.+|.. ++..+.+||.+||+.| |.+|||+.||++.
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~d---P~~RPt~~ei~~~ 291 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN---GAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccC---HhHCcCHHHHHHH
Confidence 23444444445556666643 3457899999999999 9999999999863
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=456.21 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=217.5
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC----HHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS----GAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~----~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
..+..++|+++++||+|+||+||+|++ +|+.||||++.+.... .........++.+++.++|||||+++++|++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 356678999999999999999999987 6889999999754321 1222223344566677799999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
.+.+|||||||+||+|+++|.+. +.+++..++.|+.||+.||+|||++| ||||||||+||||+.+|+|||+|||+|+
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999999999764 47999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHhhccccccCCCCc
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQNRRLEIPKE 900 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~-g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~---~~eil~~I~~~~~r~~ip~~ 900 (935)
..... ...+.+||+.|||||++. +..|+.++|||||||+||||++|++||.+.+ ..++...+ ......+|..
T Consensus 341 ~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p~~ 416 (689)
T 3v5w_A 341 DFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDS 416 (689)
T ss_dssp ECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCCTT
T ss_pred ecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCCcc
Confidence 76543 235679999999999996 5679999999999999999999999998643 33344333 3455678899
Q ss_pred CcHHHHHHHHHHHhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 901 LDPLVARIIWECWQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 901 ls~~L~dLI~qCL~~D~ssP~kRPS-----a~EILqHPF 934 (935)
+++++++||.+||+.| |.+|++ +++|++|||
T Consensus 417 ~S~~a~dLI~~lL~~d---P~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 417 FSPELRSLLEGLLQRD---VNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp SCHHHHHHHHHHTCSC---GGGCTTCSSSTHHHHTTSGG
T ss_pred CCHHHHHHHHHHccCC---HhHCCCCCCCCHHHHhcCcc
Confidence 9999999999999999 999998 799999998
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=403.36 Aligned_cols=262 Identities=65% Similarity=1.076 Sum_probs=226.9
Q ss_pred cccccCCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 667 e~~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
....+++.+++|++.+.||+|+||+||+|+++++.||||++............+.+|+.+|++++||||+++++++.+.+
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 34456788899999999999999999999999999999999888777777888999999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~--~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
.+++||||+++++|.+++.+... .+++..++.++.||+.||.|||++|++|+||||||+||||+.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999986432 3899999999999999999999987779999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....+..++..+++.
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T 3p86_A 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred cccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence 76554444456789999999999999999999999999999999999999999999988888877677788899999999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+.+||.+||+.| |.+||++.+|++
T Consensus 268 l~~li~~~l~~d---P~~Rps~~~ll~ 291 (309)
T 3p86_A 268 VAAIIEGCWTNE---PWKRPSFATIMD 291 (309)
T ss_dssp HHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHccCC---hhhCcCHHHHHH
Confidence 999999999999 999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=408.37 Aligned_cols=252 Identities=28% Similarity=0.426 Sum_probs=228.6
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
..++|++.+.||+|+||.||+|++ +|+.||||++............+.+|+.+|+.++||||+++++++...+.+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 347899999999999999999987 688999999988777777778899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++...... .
T Consensus 93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-G 168 (328)
T ss_dssp ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-C
T ss_pred EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-C
Confidence 9999999999998653 46899999999999999999999999 999999999999999999999999999866543 2
Q ss_pred cCCCCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSN-EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s-~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..++...+. .....+|..+++++.+||.
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 246 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL--RGKYRIPFYMSTDCENLLK 246 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHH
Confidence 23457899999999999988874 89999999999999999999999999888887764 3455678889999999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||+.| |.+||++++|++|||
T Consensus 247 ~~L~~d---P~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 247 RFLVLN---PIKRGTLEQIMKDRW 267 (328)
T ss_dssp HHCCSS---TTTSCCHHHHTTCTT
T ss_pred HHCCCC---hhHCcCHHHHhcCHh
Confidence 999999 999999999999999
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=395.11 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=223.5
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
..++|++.+.||+|+||+||+|.+ +++.||||++....... ...+.+|+.+++.++||||++++++|...+.+++|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 346899999999999999999975 68899999987654332 34678999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+++++|.+++.+. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999999763 5899999999999999999999999 99999999999999999999999999987765544
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc-cccccCCCCcCcHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~-~~~r~~ip~~ls~~L~dLI~ 910 (935)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.. .......+..+++.+.+||.
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence 45567899999999999999999999999999999999999999999888766655432 22344556789999999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||+.| |.+||++.++|+|||
T Consensus 252 ~~l~~d---p~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 252 RCLEMD---VEKRGSAKELLQHQF 272 (297)
T ss_dssp HHSCSS---TTTSCCHHHHTTCGG
T ss_pred HHccCC---hhHCcCHHHHhhChh
Confidence 999999 999999999999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=407.51 Aligned_cols=254 Identities=23% Similarity=0.406 Sum_probs=225.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
+..++|++++.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 4557899999999999999999987 588999999875422 1123456789999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||+++|+|..++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++.....
T Consensus 82 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999999999753 46899999999999999999999999 999999999999999999999999999865443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+.. ....+|..+++++++||
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li 236 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 3444567899999999999999999999999999999999999999999988887777643 45567888999999999
Q ss_pred HHHHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
.+||+.| |.+|| ++++|++|||
T Consensus 237 ~~lL~~d---P~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 237 AGLLKKD---PKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp HHHTCSS---TTTSTTCSTTTHHHHHTSGG
T ss_pred HHHhhcC---HHHhcCCCCCCHHHHHcCCC
Confidence 9999999 99999 9999999998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=390.85 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=215.1
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH------------------------HHHHHHHHHHHHH
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG------------------------AALLEFKREVKIM 727 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~------------------------~~~~~f~~Ei~iL 727 (935)
..++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 347899999999999999999976 57899999987654221 1235688999999
Q ss_pred HHcCCCceeeeeccccc--CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCC
Q 002331 728 RRLRHPNVVLFMGAVTR--PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 805 (935)
Q Consensus 728 ~~L~HPNIVkl~g~~~~--~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPe 805 (935)
++++||||+++++++.+ ...+++||||+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence 99999999999999976 5679999999999999887654 46999999999999999999999999 999999999
Q ss_pred CeeecCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 002331 806 NLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNPM 882 (935)
Q Consensus 806 NILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~---~s~ksDIWSLG~ILyELLTG~~PF~~~~~~ 882 (935)
||||+.++.+||+|||+++.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 99999999999999999987654433334568999999999998765 378999999999999999999999998887
Q ss_pred HHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 883 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 883 eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.....+............+++.+.+||.+||+.| |.+||++.+|++|||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d---p~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKN---PESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSC---TTTSCCHHHHTTCHH
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcC---hhhCCCHHHHhcCcc
Confidence 7776665444344444678999999999999999 999999999999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=409.87 Aligned_cols=255 Identities=23% Similarity=0.351 Sum_probs=220.0
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~ 747 (935)
.+..++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|..+ +||||++++++|.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 35568999999999999999999987 578999999876432 222345678899999998 79999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+||||||+++|+|..++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999999763 46999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+. .....+|..+++.+.+
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ 253 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLHEDATG 253 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHH
Confidence 44344556789999999999999999999999999999999999999999999988888774 3455678889999999
Q ss_pred HHHHHHhhCCCCcCCCcCH------HHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTSQ------AQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa------~EILqHPF 934 (935)
||.+||+.| |.+||++ ++|++|||
T Consensus 254 li~~lL~~d---P~~R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 254 ILKSFMTKN---PTMRLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp HHHHHTCSS---GGGSTTSGGGTCTHHHHTSGG
T ss_pred HHHHHhhhC---HHHccCCcccCCHHHHhhCCc
Confidence 999999999 9999999 99999998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=392.53 Aligned_cols=257 Identities=23% Similarity=0.301 Sum_probs=215.1
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
+-..++|++++.||+|+||+||+|++ +++.||||++............+.+|+.++++++||||+++++++.++..+++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34458899999999999999999987 68899999987665444456678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||+++ +|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9999975 888888776677999999999999999999999999 9999999999999999999999999998765544
Q ss_pred ccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--------------
Q 002331 831 LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-------------- 895 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~-------------- 895 (935)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+......+
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 44455678999999999977 568999999999999999999999999876655544432110000
Q ss_pred --------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 --------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 --------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+...+++++.+||.+||+.| |.+||+++++|+|||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFD---PNKRISARDAMNHPY 303 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSC---TTTSCCHHHHHTSGG
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCC---hhHCCCHHHHhcCcc
Confidence 012346789999999999999 999999999999998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=385.61 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=215.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|+||+||+|++ +++.||||++............+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999987 57889999998776666666778899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
|+++ +|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9976 666666554567999999999999999999999999 9999999999999999999999999998776554445
Q ss_pred CCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCC-CCCCChHHHHHHhhcccc------------------
Q 002331 834 KSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLP-WIGMNPMQVVGAVGFQNR------------------ 893 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~P-F~~~~~~eil~~I~~~~~------------------ 893 (935)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+....+.....
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 5668899999999998766 79999999999999999998777 555555555444321100
Q ss_pred ---------ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 ---------RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 ---------r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...+...+++.+++||.+||+.| |.+||+++|+|+|||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCN---PVQRISAEEALQHPY 285 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSS---GGGSCCHHHHHTSGG
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccC---hhhCCCHHHHhcCcc
Confidence 01122357899999999999999 999999999999998
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=395.75 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=215.0
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCCC--HHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~--~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
++..++|++.+.||+|+||.||++++ .++.||||++...... ......+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 45568999999999999999999976 5789999999765432 2334567889999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
.+.+|+||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999999753 46899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+. .....+|..+++.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~ 247 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL--KCKLNLPPYLTQE 247 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HTCCCCCTTSCHH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHH
Confidence 65443333455689999999999999999999999999999999999999999998888777664 3455678889999
Q ss_pred HHHHHHHHHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 905 VARIIWECWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
+.+||.+||+.| |.+|| ++.++++|||
T Consensus 248 ~~~li~~~L~~d---p~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 248 ARDLLKKLLKRN---AASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp HHHHHHHHSCSC---GGGSTTSSTTTHHHHHHSGG
T ss_pred HHHHHHHHHhcC---HhhccCCCCCCHHHHHcCCc
Confidence 999999999999 99999 8999999998
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=387.85 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=213.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
++|++++.||+|+||.||+|++ .++.||||++............+.+|+.+++.++||||+++++++...+.+++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 6899999999999999999987 488999999876543333345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
+++ +|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 975 999999876678999999999999999999999999 99999999999999999999999999987654333334
Q ss_pred CCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-------------------
Q 002331 835 STAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------------- 894 (935)
Q Consensus 835 s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r------------------- 894 (935)
...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 56789999999999764 5899999999999999999999999998776655543211000
Q ss_pred --------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 --------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 --------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+...+++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLD---PNQRITAKQALEHAY 283 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSS---TTTSCCHHHHHTSGG
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCC---cccCCCHHHHhcCcc
Confidence 0122457899999999999999 999999999999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=399.68 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=223.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 5799999999999999999987 58899999998877777777789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC---CcEEEEeccccccccCCc
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~---g~VKL~DFGlA~~~~~~~ 830 (935)
|+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.+ +.+||+|||++.......
T Consensus 109 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 109 LVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 99999999999764 46899999999999999999999999 9999999999999864 459999999998765432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CcCcHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARI 908 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip--~~ls~~L~dL 908 (935)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+.........+ ..+++.+++|
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 186 -AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264 (362)
T ss_dssp -SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred -ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 2345689999999999999999999999999999999999999999998888777765433332222 4689999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||+.| |.+||++.++|+|||
T Consensus 265 i~~~L~~d---P~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 265 IDSMLTVN---PKKRITADQALKVPW 287 (362)
T ss_dssp HHHHSCSS---GGGSCCHHHHTTSHH
T ss_pred HHHHcCCC---hhhCcCHHHHhcCcc
Confidence 99999999 999999999999998
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=400.79 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=221.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
++|++++.||+|+||.||+|++ +|+.||||++....... .....+.+|+.+|++++||||++++++|.+...++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 6799999999999999999987 58899999998654322 13457889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC----cEEEEecccccc
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 825 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g----~VKL~DFGlA~~ 825 (935)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++ .+||+|||+++.
T Consensus 92 lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 92 LILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 999999999999999763 47999999999999999999999999 99999999999998776 799999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCcCcH
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDP 903 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--~ip~~ls~ 903 (935)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... ..+..+++
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 247 (361)
T 2yab_A 169 IEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247 (361)
T ss_dssp CCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 6543 22345679999999999999999999999999999999999999999998888877764332221 12356889
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+++||.+||..| |.+||++.++|+|||
T Consensus 248 ~~~~li~~~L~~d---P~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 248 LAKDFIRKLLVKE---TRKRLTIQEALRHPW 275 (361)
T ss_dssp HHHHHHHHHSCSS---TTTSCCHHHHHTSTT
T ss_pred HHHHHHHHHCCCC---hhHCcCHHHHhcCcC
Confidence 9999999999999 999999999999999
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=397.59 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=221.7
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCce
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l 748 (935)
+..++|++++.||+|+||.||+|++ +++.||||++..... .......+.+|+.++.++ +||||++++++|.+.+.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 4457899999999999999999987 478999999987654 345566788999999988 899999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999999999753 46899999999999999999999999 99999999999999999999999999986543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---------ChHHHHHHhhccccccCCCC
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM---------NPMQVVGAVGFQNRRLEIPK 899 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~---------~~~eil~~I~~~~~r~~ip~ 899 (935)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+...+ ......+|.
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~ 240 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPR 240 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--HHCCCCCCT
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--HcCCCCCCC
Confidence 333445678999999999999999999999999999999999999999752 222333333 234566788
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCCCcCH------HHHHhCcC
Q 002331 900 ELDPLVARIIWECWQTGWSSLHIRTSQ------AQLSHKRF 934 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~kRPSa------~EILqHPF 934 (935)
.++..+++||.+||+.| |.+||++ .+|++|||
T Consensus 241 ~~s~~~~~li~~lL~~d---P~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKD---PKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp TSCHHHHHHHHHHTCSS---TTTSTTCCTTTHHHHHHTSGG
T ss_pred CCCHHHHHHHHHHhcCC---HhHCCCCCCcCCHHHHhcCCc
Confidence 99999999999999999 9999984 89999998
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=403.97 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=224.0
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~ 747 (935)
.+..++|++.+.||+|+||.||+|++ +++.||||++..... .......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999987 578999999876421 112344577899999877 99999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+|+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 99999999999999999753 46899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....+|..+++++++
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~ 247 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAKD 247 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCCCCCcccCHHHHH
Confidence 333344567899999999999999999999999999999999999999999998888877743 345678889999999
Q ss_pred HHHHHHhhCCCCcCCCcCHH-HHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTSQA-QLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~-EILqHPF 934 (935)
||.+||+.| |.+||++. +|++|||
T Consensus 248 li~~lL~~d---p~~R~~~~~~i~~hp~ 272 (345)
T 1xjd_A 248 LLVKLFVRE---PEKRLGVRGDIRQHPL 272 (345)
T ss_dssp HHHHHSCSS---GGGSBTTBSCGGGSGG
T ss_pred HHHHHhcCC---HhHcCCChHHHHcCcc
Confidence 999999999 99999998 9999998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=411.44 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=225.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++++.||+|+||.||+|.+ .++.||+|++............+.+|+.+|+.++|||||++++++.+.+..|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 6799999999999999999976 68899999998877666667789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec---CCCcEEEEeccccccccCCc
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd---~~g~VKL~DFGlA~~~~~~~ 830 (935)
|+++|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+||||+ .++.+||+|||++.......
T Consensus 91 ~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 91 LVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred eCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 99999999988764 46999999999999999999999999 99999999999998 46889999999998776544
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CcCcHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARI 908 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip--~~ls~~L~dL 908 (935)
.......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..++...+.........+ ..+++.+++|
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 247 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 44456789999999999999999999999999999999999999999999888887775444333322 4689999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||+.| |.+||++.++|+|||
T Consensus 248 i~~~L~~d---P~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 248 INKMLTIN---PSKRITAAEALKHPW 270 (444)
T ss_dssp HHHHSCSS---TTTSCCHHHHHHSCT
T ss_pred HHHHcCCC---hhHCCCHHHHhcCcc
Confidence 99999999 999999999999999
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=394.72 Aligned_cols=251 Identities=24% Similarity=0.421 Sum_probs=223.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
+..++|++.+.||+|+||.||+|+. +++.||||++....... .....+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 3457899999999999999999987 58899999987543211 23456788999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999999763 46899999999999999999999999 999999999999999999999999999876543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.. ....+|..+++++.+||
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li 234 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLL 234 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHH
Confidence 2356899999999999999999999999999999999999999999988887777643 34567888999999999
Q ss_pred HHHHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
.+||+.| |.+|| ++++|++|||
T Consensus 235 ~~lL~~d---p~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 235 SRLITRD---LSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp HHHTCSC---TTTCTTSSTTTTHHHHTSGG
T ss_pred HHHhccC---HHHcCCCcCCCHHHHhcCcc
Confidence 9999999 99999 9999999998
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=403.20 Aligned_cols=256 Identities=20% Similarity=0.338 Sum_probs=223.9
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCC
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~ 746 (935)
..+..++|++++.||+|+||.||+|++. ++.||||++..... .......+..|..+|..+ +||||++++++|.+.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 4466789999999999999999999884 57899999876432 112345677899999888 8999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+||||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++..
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999999999753 46899999999999999999999999 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHH
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+.. ....+|..+++++.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~ 249 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAV 249 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHH
Confidence 4333445567899999999999999999999999999999999999999999998888877743 45667889999999
Q ss_pred HHHHHHHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 907 RIIWECWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
+||.+||+.| |.+|| ++++|++|||
T Consensus 250 ~li~~lL~~d---P~~R~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 250 AICKGLMTKH---PGKRLGCGPEGERDIKEHAF 279 (353)
T ss_dssp HHHHHHTCSC---TTSCTTCSTTHHHHHHTSGG
T ss_pred HHHHHHhhcC---HHHcCCCCCCCHHHHhcCcc
Confidence 9999999999 99999 5799999998
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=393.75 Aligned_cols=251 Identities=18% Similarity=0.300 Sum_probs=221.4
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++++.||+|+||.||+|.+ +++.||+|++.... .....+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 47899999999999999999987 57889999986442 34556889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC--CCcEEEEeccccccccCCc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~--~g~VKL~DFGlA~~~~~~~ 830 (935)
||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 999999999999876667999999999999999999999999 999999999999987 7899999999998765432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC--CCCcCcHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVARI 908 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~--ip~~ls~~L~dL 908 (935)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........ ....+++++.+|
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 22345789999999999998899999999999999999999999999988888777653332221 124689999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||..| |.+||++.++|+|||
T Consensus 238 i~~~L~~d---p~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 238 VDRLLVKE---RKSRMTASEALQHPW 260 (321)
T ss_dssp HHTTSCSS---GGGSCCHHHHHHSHH
T ss_pred HHHHcCCC---hhHCcCHHHHhcChh
Confidence 99999999 999999999999998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=374.60 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=224.4
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 47899999999999999999987 5789999999887777777788999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc---EEEEeccccccccCC
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNT 829 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~---VKL~DFGlA~~~~~~ 829 (935)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 999999999888653 46899999999999999999999999 999999999999986655 999999999876543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC--CCCcCcHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVAR 907 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~--ip~~ls~~L~d 907 (935)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+........ ....+++.+.+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 162 E-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp C-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred c-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 2 23446799999999999999999999999999999999999999999988887776654333332 22578999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
||.+||+.| |.+||++.++|+|||
T Consensus 241 li~~~l~~d---p~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 241 LIDSMLTVN---PKKRITADQALKVPW 264 (284)
T ss_dssp HHHHHSCSS---TTTSCCHHHHTTSHH
T ss_pred HHHHHcccC---hhhCCCHHHHhcCcc
Confidence 999999999 999999999999998
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=405.41 Aligned_cols=255 Identities=21% Similarity=0.348 Sum_probs=220.1
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHc-CCCceeeeecccccCCc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~ 747 (935)
.+..++|+++++||+|+||.||+|++ +++.||||++.+..... .....+.+|..+|.++ +|||||+++++|.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45668999999999999999999987 57789999998764432 3345678899999887 89999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+||||||+++|+|..++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999999999763 46999999999999999999999999 9999999999999999999999999998644
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---------hHHHHHHhhccccccCCC
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---------PMQVVGAVGFQNRRLEIP 898 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~---------~~eil~~I~~~~~r~~ip 898 (935)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ......+|
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p 282 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIP 282 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCCCC
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccCCC
Confidence 44344566789999999999999999999999999999999999999997432 12233333 34566788
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcC------HHHHHhCcC
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTS------QAQLSHKRF 934 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPS------a~EILqHPF 934 (935)
..+++++++||.+||+.| |.+||+ +++|++|||
T Consensus 283 ~~~s~~~~~li~~lL~~d---P~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 283 RSLSVKAASVLKSFLNKD---PKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp TTSCHHHHHHHHHHTCSC---TTTSTTCSTTTHHHHHHHSTT
T ss_pred CcCCHHHHHHHHHHhcCC---HhHcCCCCCCCCHHHHhcCcc
Confidence 899999999999999999 999998 489999999
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=372.05 Aligned_cols=254 Identities=29% Similarity=0.558 Sum_probs=228.1
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC--Cce
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 748 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l 748 (935)
.++..++|++.+.||+|+||.||+|+++++.||||++............+.+|+.++++++||||+++++++.+. ..+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 456778999999999999999999999999999999988777777778899999999999999999999999877 778
Q ss_pred EEEEeeCCCCCHHHHHcCCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 749 SIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~-~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
++||||+++++|.+++.+... .+++..++.|+.||+.||.|||+++.+|+||||||+|||++.++.+||+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999987543 5899999999999999999999987779999999999999999999999999876532
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCc---hhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~---ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
. ....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+.......+.....++.++..+++.
T Consensus 165 ~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 165 S-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp C-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred c-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2 3356899999999998765544 8999999999999999999999999888877776677778888999999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+.+||.+||+.| |.+||++.+|++.
T Consensus 240 ~~~li~~~l~~~---p~~Rps~~~il~~ 264 (271)
T 3kmu_A 240 VSKLMKICMNED---PAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 999999999999 9999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=388.02 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=219.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
++|.+.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|+.++||||+++++++.+...++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5699999999999999999987 58899999987654321 13567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC----cEEEEecccccc
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 825 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g----~VKL~DFGlA~~ 825 (935)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||+++.
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 999999999999999763 57999999999999999999999999 99999999999998877 899999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCcCcH
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDP 903 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--~ip~~ls~ 903 (935)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....... ..+..+++
T Consensus 168 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 168 IDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp CCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence 65332 2344679999999999999999999999999999999999999999988877776654322221 12256889
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+.+||.+||+.| |.+||++.++|+|||
T Consensus 247 ~~~~li~~~L~~d---P~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 247 LAKDFIRRLLVKD---PKKRMTIQDSLQHPW 274 (326)
T ss_dssp HHHHHHHHHSCSS---GGGSCCHHHHHHSTT
T ss_pred HHHHHHHHHccCC---hhhCCCHHHHhcCCC
Confidence 9999999999999 999999999999999
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=394.78 Aligned_cols=259 Identities=21% Similarity=0.273 Sum_probs=217.8
Q ss_pred cCCCCCCeeEEEEeeec--CcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 671 CEIPWEDLVLGERIGLG--SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G--~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
+....++|++++.||+| +||.||+|++ +++.||||++............+.+|+.+++.++|||||+++++|.+.+
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 33455789999999999 9999999987 5889999999887777777788999999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
.+|+||||+++++|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||++..
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999999998653 356899999999999999999999999 99999999999999999999999998865
Q ss_pred ccCCc-------ccCCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc---
Q 002331 826 KHNTF-------LSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--- 893 (935)
Q Consensus 826 ~~~~~-------~~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~--- 893 (935)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 42211 11233478999999999987 5789999999999999999999999988665544433211100
Q ss_pred -----------------------------------------ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 894 -----------------------------------------RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 894 -----------------------------------------r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
...++..+++.+.+||.+||+.| |.+||++.++|+|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d---P~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN---PDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSC---TTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcC---cccCCCHHHHhcC
Confidence 11234567899999999999999 9999999999999
Q ss_pred cC
Q 002331 933 RF 934 (935)
Q Consensus 933 PF 934 (935)
||
T Consensus 335 p~ 336 (389)
T 3gni_B 335 SF 336 (389)
T ss_dssp GG
T ss_pred HH
Confidence 98
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=412.95 Aligned_cols=260 Identities=20% Similarity=0.344 Sum_probs=225.4
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
...+..++|+++++||+|+||+||+|++ .++.||||++....... .....+.+|+.++..++||||++++++|.+.+
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 4567778999999999999999999987 46889999987532111 11223788999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+|||||||++|+|.+++.+....+++..++.++.||+.||.|||+++ ||||||||+||||+.++++||+|||+++..
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 999999999999999999876678999999999999999999999999 999999999999999999999999999765
Q ss_pred cCCc-ccCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCC-
Q 002331 827 HNTF-LSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK- 899 (935)
Q Consensus 827 ~~~~-~~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~- 899 (935)
.... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+....+........+|.
T Consensus 226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 305 (437)
T 4aw2_A 226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQ 305 (437)
T ss_dssp CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSS
T ss_pred ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcc
Confidence 4432 2234568999999999997 45689999999999999999999999999999888887754444445554
Q ss_pred --cCcHHHHHHHHHHHhhCCCCcCC--CcCHHHHHhCcC
Q 002331 900 --ELDPLVARIIWECWQTGWSSLHI--RTSQAQLSHKRF 934 (935)
Q Consensus 900 --~ls~~L~dLI~qCL~~D~ssP~k--RPSa~EILqHPF 934 (935)
.+++++++||++||+.+ |.+ |+++++|++|||
T Consensus 306 ~~~~s~~~~dLi~~lL~~~---~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSR---EHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCG---GGCTTTTTTHHHHTSGG
T ss_pred cccCCHHHHHHHHHHhccc---ccccCCCCHHHHhCCCc
Confidence 48999999999999888 888 999999999998
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=378.79 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=197.9
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
.++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36899999999999999999986 68899999986543211 1245688999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 9999999999999876678999999999999999999999999 99999999999999999999999999987654333
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~q 911 (935)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. .....+|..++..+.+||.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--SSCCCCCTTSCHHHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--hcccCCccccCHHHHHHHHH
Confidence 3345678999999999999889999999999999999999999999876665554442 23345677899999999999
Q ss_pred HHhhCCCCcCCCcCHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPSa~EILqHPF 934 (935)
||+.| |.+||++.++++|||
T Consensus 246 ~l~~d---p~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 246 LLRRN---PADRLSLSSVLDHPF 265 (278)
T ss_dssp HSCSS---GGGSCCHHHHTTSTT
T ss_pred HcccC---HhhCCCHHHHhcCcc
Confidence 99999 999999999999999
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=397.25 Aligned_cols=251 Identities=22% Similarity=0.385 Sum_probs=224.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
...++|++++.||+|+||.||+|++ +++.||||++...... ......+.+|+.+|+.++||||+++++++.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 4457899999999999999999987 5889999998754321 123456789999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
|||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999999763 46899999999999999999999999 999999999999999999999999999876543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+.. ....+|..+++.+.+||
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTCCHHHHHHH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 2346799999999999999999999999999999999999999999998888877743 35667888999999999
Q ss_pred HHHHhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPS-----a~EILqHPF 934 (935)
.+||+.| |.+||+ +++|++|||
T Consensus 270 ~~lL~~d---p~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 270 RNLLQVD---LTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp HHHSCSC---TTTCTTSSTTTTHHHHTSGG
T ss_pred HHHhhcC---HHhccCCccCCHHHHHhCcC
Confidence 9999999 999998 999999998
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.10 Aligned_cols=254 Identities=30% Similarity=0.508 Sum_probs=225.8
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
.+.+..++|++.+.||+|+||.||+|.+ +++.||||++....... ..+.+|+.++++++||||+++++++.+...+
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 3567778999999999999999999988 67789999998665443 4688999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999999999999877777999999999999999999999999 99999999999999999999999999986644
Q ss_pred Cc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHH
Q 002331 829 TF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 829 ~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
.. .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+. .......+..+++.+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVY 237 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHHH
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCcCCHHHH
Confidence 32 22334557788999999999999999999999999999999 999999999888877764 3345667788899999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+||.+||+.| |.+||++.++++|
T Consensus 238 ~li~~~l~~~---p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 238 QIMNHCWRER---PEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHccCC---cccCcCHHHHHHH
Confidence 9999999999 9999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=409.93 Aligned_cols=254 Identities=23% Similarity=0.407 Sum_probs=215.4
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
+..++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|+.++||||++++++|...+.++
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 4457899999999999999999987 578999999876432 2334556788999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|||||+++++|.+++.+. ..+++..++.++.||+.||.|||+ +| ||||||||+||||+.++.+||+|||+++....
T Consensus 225 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999999763 468999999999999999999998 88 99999999999999999999999999986544
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHH
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+.. ....+|..+++.+.+|
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~l 379 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLGPEAKSL 379 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHH
Confidence 43444567899999999999999999999999999999999999999999998888777643 3456788899999999
Q ss_pred HHHHHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
|.+||+.| |.+|| ++++|++|||
T Consensus 380 i~~~L~~d---P~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 380 LSGLLKKD---PKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp HHHHTCSS---TTTSTTCSTTTHHHHHTSGG
T ss_pred HHHHcccC---HHHhCCCCCCCHHHHHhCcc
Confidence 99999999 99999 9999999998
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=379.77 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=212.1
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++++.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++...+.+++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36899999999999999999987 4889999999877666666778889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.........
T Consensus 82 e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999999999988653 46899999999999999999999999 999999999999999999999999999876644344
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-------------------
Q 002331 833 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------------- 892 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~------------------- 892 (935)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 445678999999999986 567999999999999999999999999987766554332110
Q ss_pred cccCC----------CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 RRLEI----------PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 ~r~~i----------p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..... ...+++.+.+||.+||+.| |.+||++++||+|||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMD---PTERLTCEQLLHHPY 287 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSS---TTTSCCHHHHHTSGG
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCC---hhhcCCHHHHhcChH
Confidence 00000 1357888999999999999 999999999999998
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=394.12 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=213.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC---CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~---~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
++|++.+.||+|+||.||+|.+ +++.||||++..... .......+.+|+.+++.++||||+++++++.+.+.+||
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5799999999999999999987 588999999864321 11124578899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc---EEEEeccccc
Q 002331 751 ITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSR 824 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~---VKL~DFGlA~ 824 (935)
|||||++++|.+++.+ .+..+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||++.
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999887753 2345899999999999999999999999 999999999999986554 9999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCcCc
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELD 902 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--~ip~~ls 902 (935)
............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ......+....... .....++
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s 260 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS 260 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSC
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCC
Confidence 77655444456689999999999999999999999999999999999999998864 33444432222111 1124688
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+.+++||.+||+.| |.+||++.++|+|||
T Consensus 261 ~~~~~li~~~L~~d---P~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 261 ESAKDLVRRMLMLD---PAERITVYEALNHPW 289 (351)
T ss_dssp HHHHHHHHHHTCSS---TTTSCCHHHHHTSHH
T ss_pred HHHHHHHHHHCCCC---hhHCcCHHHHhcChh
Confidence 99999999999999 999999999999998
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=409.56 Aligned_cols=258 Identities=23% Similarity=0.377 Sum_probs=223.8
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
..++..++|++++.||+|+||+||+|++ +++.||||++...... ......+.+|+.+++.++|||||+++++|.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 4567778999999999999999999987 5788999998653211 111234778999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+||||||+++|+|.+++.+ ..+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++..
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 99999999999999999975 35899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--C
Q 002331 827 HNTF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--K 899 (935)
Q Consensus 827 ~~~~-~~~~s~~GT~~Y~APEvl~g~~----~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip--~ 899 (935)
.... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+........+| .
T Consensus 219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 298 (410)
T 3v8s_A 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298 (410)
T ss_dssp CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTC
T ss_pred ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcc
Confidence 5432 2334678999999999998765 7889999999999999999999999999988888776444344444 4
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCC--CcCHHHHHhCcC
Q 002331 900 ELDPLVARIIWECWQTGWSSLHI--RTSQAQLSHKRF 934 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~k--RPSa~EILqHPF 934 (935)
.+++++++||.+||+.+ |.+ ||++++|++|||
T Consensus 299 ~~s~~~~~li~~lL~~~---~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 299 DISKEAKNLICAFLTDR---EVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp CCCHHHHHHHHHHSSCG---GGCTTSSCHHHHHTSGG
T ss_pred cccHHHHHHHHHHccCh---hhhCCCCCHHHHhcCcc
Confidence 68999999999999988 888 999999999998
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=387.37 Aligned_cols=253 Identities=25% Similarity=0.306 Sum_probs=200.8
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++++.||+|+||.||+|.+ +++.||||++..... ......+.+|+.++++++||||+++++++..++.+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 36799999999999999999976 588999999875532 222346778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 753 EFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~-----~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
||++ ++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9998 5999988532 245899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-------------
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 893 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~------------- 893 (935)
..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 443334456789999999999874 689999999999999999999999999887766654421100
Q ss_pred -------------------ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 -------------------RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 -------------------r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
....+..++..+.+||.+||+.| |.+||++.++|+|||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d---P~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN---PDMRLSAKQALHHPW 296 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSS---GGGSCCHHHHTTSGG
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCC---cccCCCHHHHhCChh
Confidence 01122357889999999999999 999999999999998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=399.95 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=216.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHH-HHHcCCCceeeeecccccCCce
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~i-L~~L~HPNIVkl~g~~~~~~~l 748 (935)
+..++|++++.||+|+||.||+|++ +++.||||++...... ......+.+|..+ ++.++||||++++++|.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 3457899999999999999999987 5778999999876543 2334456677776 4678999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
||||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999999763 46889999999999999999999999 99999999999999999999999999986544
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHH
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....++..+++.+++|
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~l 269 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSARHL 269 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--SCCCCCSSSCHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cccCCCCCCCHHHHHH
Confidence 43445567899999999999999999999999999999999999999999998888877743 3556778899999999
Q ss_pred HHHHHhhCCCCcCCCcCH----HHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQ----AQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa----~EILqHPF 934 (935)
|.+||+.| |.+||++ .+|++|||
T Consensus 270 i~~lL~~d---p~~R~~~~~~~~~i~~h~~ 296 (373)
T 2r5t_A 270 LEGLLQKD---RTKRLGAKDDFMEIKSHVF 296 (373)
T ss_dssp HHHHTCSS---GGGSTTTTTTHHHHHTSGG
T ss_pred HHHHcccC---HHhCCCCCCCHHHHhCCcc
Confidence 99999999 9999986 79999998
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=391.96 Aligned_cols=255 Identities=29% Similarity=0.507 Sum_probs=222.5
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeec
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 740 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g 740 (935)
+++..++|++++.||+|+||.||+|++. +..||||++... ........+.+|+.+|+.+ +||||+++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4566789999999999999999999752 346999998755 3455677899999999999 8999999999
Q ss_pred ccccCCceEEEEeeCCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCC
Q 002331 741 AVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 805 (935)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPe 805 (935)
++.+.+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~ 232 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAAR 232 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchh
Confidence 9999999999999999999999997532 34789999999999999999999999 999999999
Q ss_pred CeeecCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 002331 806 NLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPM 882 (935)
Q Consensus 806 NILLd~~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~ 882 (935)
||||+.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999986654322 2233457789999999999999999999999999999999 99999998887
Q ss_pred HHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 883 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 883 eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
++...+. ...+..++..+++++.+||.+||+.| |.+||++.+|+++
T Consensus 313 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~d---P~~Rpt~~ell~~ 358 (370)
T 2psq_A 313 ELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVED 358 (370)
T ss_dssp GHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 7776554 44566788899999999999999999 9999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=369.94 Aligned_cols=254 Identities=37% Similarity=0.645 Sum_probs=214.6
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCC--HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~--~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
++..++|++.+.||+|+||.||+|.+.++.||||++...... ......+.+|+.+++.++||||+++++++.+.+.++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 567789999999999999999999999999999998754322 233567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CEEeeCCCCCCeeecC--------CCcEEEEec
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP-TIVHRDLKSPNLLVDK--------NWNVKVSDF 820 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~-~IIHrDLKPeNILLd~--------~g~VKL~DF 820 (935)
+||||+++++|.+++.. ..+++..++.++.||+.||.|||+++. +|+||||||+||||+. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999965 468999999999999999999999874 4889999999999986 788999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCc
Q 002331 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (935)
Q Consensus 821 GlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ 900 (935)
|++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+........++..
T Consensus 161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 9998655432 22457899999999999999999999999999999999999999999888887777666677788899
Q ss_pred CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 901 LDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 901 ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+++.+.+||.+||+.| |.+||++.+++++
T Consensus 239 ~~~~~~~li~~~l~~~---p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPD---PHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCC---cccCcCHHHHHHH
Confidence 9999999999999999 9999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=386.62 Aligned_cols=253 Identities=27% Similarity=0.342 Sum_probs=213.0
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++++.||+|+||.||+|.+ +++.||||++...... .....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 47899999999999999999987 5889999998755432 23456889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC--c
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--F 830 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~--~ 830 (935)
||+++++|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..... .
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999999764 46999999999999999999999999 999999999999999999999999999865422 1
Q ss_pred ccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccCCCCcCcHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~-eil~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ..................+++.+.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 22345689999999999988775 77999999999999999999999876553 22222222222333346789999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||+.| |.+||++.||++|||
T Consensus 242 i~~~L~~d---P~~R~t~~eil~h~~ 264 (323)
T 3tki_A 242 LHKILVEN---PSARITIPDIKKDRW 264 (323)
T ss_dssp HHHHSCSS---TTTSCCHHHHTTCTT
T ss_pred HHHHccCC---hhhCcCHHHHhhChh
Confidence 99999999 999999999999999
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=407.83 Aligned_cols=259 Identities=19% Similarity=0.316 Sum_probs=223.1
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
+.++..++|++.+.||+|+||.||+|++ +++.||||++.+.... ......+.+|+.++..++||||++++++|.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 4567778999999999999999999987 5889999998754321 112334788999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+||||||+++|+|.+++.+.+..+++..++.++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+++..
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheec
Confidence 999999999999999999765557999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCccccc-------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC
Q 002331 827 HNTFL-SSKSTAGTPEWMAPEVLR-------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (935)
Q Consensus 827 ~~~~~-~~~s~~GT~~Y~APEvl~-------g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip 898 (935)
..... .....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+....+........+|
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence 54322 234568999999999997 3568999999999999999999999999999888877765433333333
Q ss_pred ---CcCcHHHHHHHHHHHhhCCCCcCCC---cCHHHHHhCcC
Q 002331 899 ---KELDPLVARIIWECWQTGWSSLHIR---TSQAQLSHKRF 934 (935)
Q Consensus 899 ---~~ls~~L~dLI~qCL~~D~ssP~kR---PSa~EILqHPF 934 (935)
..+++++++||.+||+ + |.+| |++++|++|||
T Consensus 293 ~~~~~~s~~~~dli~~lL~-~---p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLC-P---PETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-C---GGGCTTTTTHHHHHTSGG
T ss_pred ccccCCCHHHHHHHHHHcC-C---hhhcCCCCCHHHHhcCCC
Confidence 6799999999999998 9 9998 59999999998
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=375.63 Aligned_cols=253 Identities=24% Similarity=0.437 Sum_probs=219.7
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
++..++|++++.||+|+||.||+|.+ .+..||||++....... .....+.+|+.++++++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 45668999999999999999999987 46689999986543221 1245688999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999999998653 46899999999999999999999998 99999999999999999999999999865443
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHH
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
. ......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....+|..+++.+.+|
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDL 237 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHH
T ss_pred c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCCCCCcCCHHHHHH
Confidence 2 2234578999999999999999999999999999999999999999998887776663 34556778899999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||+.| |.+||++.+||+|||
T Consensus 238 i~~~l~~~---p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 238 ISRLLKHN---PSQRPMLREVLEHPW 260 (279)
T ss_dssp HHHHCCSS---GGGSCCHHHHHHCHH
T ss_pred HHHHhccC---hhhCCCHHHHhhCcc
Confidence 99999999 999999999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=381.29 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=219.3
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
.|...+.||+|+||.||+|++ +|+.||||++...... ....+.+|+.+++.++||||+++++++...+.+++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 478888999999999999987 5889999998765432 245678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
+++++|.+++.+ ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++...........
T Consensus 124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 999999999975 36899999999999999999999998 99999999999999999999999999987655433445
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCcCcHHHHHHHHHHH
Q 002331 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECW 913 (935)
Q Consensus 835 s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~-r~~ip~~ls~~L~dLI~qCL 913 (935)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..... ....+..+++.+.+||.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 66899999999999999999999999999999999999999999888777766543222 12233568899999999999
Q ss_pred hhCCCCcCCCcCHHHHHhCcC
Q 002331 914 QTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 914 ~~D~ssP~kRPSa~EILqHPF 934 (935)
+.| |.+||++.++++|||
T Consensus 280 ~~d---p~~Rps~~ell~hp~ 297 (321)
T 2c30_A 280 VRD---PQERATAQELLDHPF 297 (321)
T ss_dssp CSS---TTTSCCHHHHHTSGG
T ss_pred cCC---hhhCcCHHHHhcChh
Confidence 999 999999999999998
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=373.63 Aligned_cols=257 Identities=25% Similarity=0.359 Sum_probs=202.9
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
+++..++|++.+.||+|+||.||+|++ +++.||||++............+..+..+++.++||||+++++++.+.+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 356778999999999999999999987 788999999876654444444455566667788999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 749 SIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
++||||+++ +|.+++.. ....+++..++.|+.||+.||.|||++ | |+||||||+||||+.++.+||+|||+++
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999999975 88777643 356799999999999999999999998 8 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhccccccCCCC
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVL----RNEPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPK 899 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl----~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~-~~~eil~~I~~~~~r~~ip~ 899 (935)
...... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||... ..................+.
T Consensus 159 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 159 YLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred cccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 765432 23345799999999996 5567899999999999999999999999863 44444443333333333445
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 900 ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+++.+.+||.+||+.| |.+||++.++++|||
T Consensus 238 ~~~~~~~~li~~~l~~~---p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKN---SKERPTYPELMQHPF 269 (290)
T ss_dssp TSCHHHHHHHHHHTCSS---GGGSCCHHHHTTSHH
T ss_pred cCCHHHHHHHHHHhhcC---hhhCcCHHHHHhCcc
Confidence 78999999999999999 999999999999998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=372.78 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=225.6
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
..++|.+++.||+|+||.||++.+ .++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 447899999999999999999987 477899999876543 44566778999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999999998653 46899999999999999999999999 9999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+. .....++..+++.+.+||.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 247 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQ 247 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHHHH
Confidence 34445679999999999999889999999999999999999999999988877666553 3445678889999999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||+.| |.+||+++++++|||
T Consensus 248 ~~l~~~---p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 248 KMLQTD---PTARPTINELLNDEF 268 (294)
T ss_dssp HHTCSS---GGGSCCGGGGGGSHH
T ss_pred HHcccC---hhhCcCHHHHhhChh
Confidence 999999 999999999999997
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=392.26 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=204.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeecccccCC--ceE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP--NLS 749 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~--~l~ 749 (935)
.++|++++.||+|+||.||+|.+ +++.||||++............+.+|+.+|+.+. ||||+++++++...+ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 36899999999999999999976 5889999998766555666777889999999996 999999999997544 689
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+|||||+ ++|..++.. ..+++..+..++.||+.||.|||+.| |+||||||+||||+.++.+||+|||+++.....
T Consensus 88 lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 9999997 589999876 36899999999999999999999999 999999999999999999999999999865321
Q ss_pred ---------------------cccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 002331 830 ---------------------FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 887 (935)
Q Consensus 830 ---------------------~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~ 887 (935)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111234579999999999987 6789999999999999999999999999887766655
Q ss_pred hhcccccc---------------------------------------------CCCCcCcHHHHHHHHHHHhhCCCCcCC
Q 002331 888 VGFQNRRL---------------------------------------------EIPKELDPLVARIIWECWQTGWSSLHI 922 (935)
Q Consensus 888 I~~~~~r~---------------------------------------------~ip~~ls~~L~dLI~qCL~~D~ssP~k 922 (935)
+......+ ..+..+++++.+||.+||+.| |.+
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d---P~~ 319 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN---PNK 319 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS---GGG
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC---ccc
Confidence 43111100 011267889999999999999 999
Q ss_pred CcCHHHHHhCcC
Q 002331 923 RTSQAQLSHKRF 934 (935)
Q Consensus 923 RPSa~EILqHPF 934 (935)
||+++|+|+|||
T Consensus 320 R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 320 RISANDALKHPF 331 (388)
T ss_dssp SCCHHHHTTSTT
T ss_pred CCCHHHHhCCHH
Confidence 999999999999
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=371.70 Aligned_cols=256 Identities=31% Similarity=0.458 Sum_probs=220.1
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc----C
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----P 745 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~----~ 745 (935)
......|.+.+.||+|+||.||+|.+ .+..||+|++............+.+|+.+++.++||||+++++++.. .
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 34456799999999999999999987 56789999998877777778889999999999999999999998764 3
Q ss_pred CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec-CCCcEEEEeccccc
Q 002331 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSR 824 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~VKL~DFGlA~ 824 (935)
..+++||||+++++|.+++.+. ..+++..++.|+.||+.||.|||+.+.+|+||||||+||||+ .++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 5589999999999999999753 468999999999999999999999876799999999999998 78999999999997
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccccccCCCCcCcH
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~-~eil~~I~~~~~r~~ip~~ls~ 903 (935)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ......+........++...++
T Consensus 181 ~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 181 LKRASF--AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp GCCTTS--BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred cccccc--cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 654432 234578999999999875 488999999999999999999999988544 4444444434444556677889
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+.+||.+||+.| |.+||++.+||+|||
T Consensus 258 ~l~~li~~~l~~d---p~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 258 EVKEIIEGCIRQN---KDERYSIKDLLNHAF 285 (290)
T ss_dssp HHHHHHHHHSCSS---GGGSCCHHHHHTSGG
T ss_pred HHHHHHHHHccCC---hhhCCCHHHHhhCcc
Confidence 9999999999999 999999999999998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=386.61 Aligned_cols=260 Identities=29% Similarity=0.470 Sum_probs=223.0
Q ss_pred cccccCCCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeee
Q 002331 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (935)
Q Consensus 667 e~~~~ei~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl 738 (935)
....+++..++|++++.||+|+||.||+|++ .++.||||++.... .......+.+|+.++.++ +||||+++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4456788899999999999999999999974 34789999987543 344567789999999999 79999999
Q ss_pred ecccccCCc-eEEEEeeCCCCCHHHHHcCCCC------------------------------------------------
Q 002331 739 MGAVTRPPN-LSIITEFLPRGSLFRILHRPHC------------------------------------------------ 769 (935)
Q Consensus 739 ~g~~~~~~~-l~LVmEy~~gGsL~dlL~~~~~------------------------------------------------ 769 (935)
++++...+. +++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999877554 8999999999999999976432
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc--
Q 002331 770 -----------------QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 830 (935)
Q Consensus 770 -----------------~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~-- 830 (935)
.+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 1889999999999999999999999 9999999999999999999999999998653321
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+...................+..+++.+.+||
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 329 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM 329 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 22334567889999999999999999999999999999998 99999987765555444445566778888999999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+||+.| |.+||++.+|++|
T Consensus 330 ~~~l~~d---P~~Rps~~ell~~ 349 (359)
T 3vhe_A 330 LDCWHGE---PSQRPTFSELVEH 349 (359)
T ss_dssp HHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHccCC---hhhCCCHHHHHHH
Confidence 9999999 9999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=385.17 Aligned_cols=255 Identities=20% Similarity=0.291 Sum_probs=216.4
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC--CceeeeecccccCCce
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPPNL 748 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~H--PNIVkl~g~~~~~~~l 748 (935)
.+..++|++.+.||+|+||.||++.+ +++.||||++............+.+|+.+|+.++| +||+++++++.....+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 45668899999999999999999976 57789999998877777777889999999999976 9999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
+||||+ .+++|.+++.+. ..+++..++.|+.||+.||.|||+++ |+||||||+||||+ ++.+||+|||+++....
T Consensus 85 ~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 999995 578999999764 47899999999999999999999999 99999999999997 67899999999987643
Q ss_pred Ccc--cCCCCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccccc
Q 002331 829 TFL--SSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRR 894 (935)
Q Consensus 829 ~~~--~~~s~~GT~~Y~APEvl~g-----------~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~-~eil~~I~~~~~r 894 (935)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 322 2335679999999999865 6688999999999999999999999987533 3444444445556
Q ss_pred cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++...+..+.+||.+||+.| |.+||++.++|+|||
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~d---p~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRD---PKQRISIPELLAHPY 276 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSS---TTTSCCHHHHHTSHH
T ss_pred cCCcccCCHHHHHHHHHHcCCC---hhHCCCHHHHHhCcc
Confidence 6778888999999999999999 999999999999998
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=397.26 Aligned_cols=255 Identities=20% Similarity=0.329 Sum_probs=220.7
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
.++..++|++++.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 356678999999999999999999987 577899999875432 11234568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+|+||||+.+|+|..++.+. ..+++..++.|+.||+.||.|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999999999864 46999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHhhccccccCCCCcC
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQNRRLEIPKEL 901 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLG~ILyELLTG~~PF~~~~---~~eil~~I~~~~~r~~ip~~l 901 (935)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ...+...+ ......+|..+
T Consensus 167 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~~ 243 (384)
T 4fr4_A 167 RE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAW 243 (384)
T ss_dssp TT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTTS
T ss_pred CC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCcC
Confidence 43 23456789999999999974 458899999999999999999999998543 33333333 34456678889
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcC-HHHHHhCcC
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTS-QAQLSHKRF 934 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPS-a~EILqHPF 934 (935)
++.+.+||.+||+.| |.+||+ +++|++|||
T Consensus 244 s~~~~~li~~lL~~d---P~~R~s~~~~l~~hp~ 274 (384)
T 4fr4_A 244 SQEMVSLLKKLLEPN---PDQRFSQLSDVQNFPY 274 (384)
T ss_dssp CHHHHHHHHHHSCSS---GGGSCCSHHHHHTSGG
T ss_pred CHHHHHHHHHHhcCC---HhHhcccHHHHHcChh
Confidence 999999999999999 999998 999999998
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=367.93 Aligned_cols=253 Identities=32% Similarity=0.537 Sum_probs=222.7
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
+++..++|++.+.||+|+||.||+|++. +..||||++....... ..+.+|+.++++++||||+++++++.+....+
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 4567789999999999999999999875 4579999987665443 45789999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||+++++|.+++......+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999999775556999999999999999999999999 999999999999999999999999999866443
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 830 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 830 ~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
. .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+. .......+..+++.+.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHH
Confidence 2 22234456778999999999889999999999999999999 999999998887776664 34455667788999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
||.+||+.| |.+||++.+|+++
T Consensus 237 li~~~l~~~---p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 237 IMYSCWHEL---PEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHTTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHcCCC---hhhCcCHHHHHHH
Confidence 999999999 9999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=371.58 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=221.5
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccc--ccCCceEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV--TRPPNLSI 750 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~--~~~~~l~L 750 (935)
.++|++.+.||+|+||.||++++ +++.||||++............+.+|+.++++++||||+++++++ .....+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 36899999999999999999987 588999999988777777778899999999999999999999987 44667999
Q ss_pred EEeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---CCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 751 ITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTST---PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g---~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ .+|+||||||+||||+.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999999864 2345899999999999999999999986 249999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
.............|++.|+|||++.+..++.++|||||||++|+|++|..||...+..++...+.. .....++..+++.
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-cccccCCcccCHH
Confidence 665432222334689999999999999999999999999999999999999999988777766643 3345677889999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhCcCC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHKRFQ 935 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqHPFq 935 (935)
+.+||.+||+.| |.+||++.+||+|+|.
T Consensus 244 l~~li~~~l~~~---p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 244 LNEIITRMLNLK---DYHRPSVEEILENPLI 271 (279)
T ss_dssp HHHHHHHHTCSS---GGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHcCCC---cccCCCHHHHHhChhh
Confidence 999999999999 9999999999999984
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=381.52 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=221.9
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
.++..++|++.+.||+|+||.||+|++ .+..||||++.... .......+.+|+.+|++++||||+++++++.+.
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 356678999999999999999999987 34469999987543 455667899999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
+.++|||||+++++|.+++......+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 9999999999999999999876678999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcC
Q 002331 826 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (935)
Q Consensus 826 ~~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~l 901 (935)
...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. .......+..+
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 279 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGC 279 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCCCc
Confidence 654321 2223346778999999999999999999999999999999 999999999888877765 34566677889
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
++.+.+||.+||..| |.+||++.+|++
T Consensus 280 ~~~l~~li~~~l~~d---p~~Rps~~eil~ 306 (325)
T 3kul_A 280 PHALHQLMLDCWHKD---RAQRPRFSQIVS 306 (325)
T ss_dssp CHHHHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCC---hhhCcCHHHHHH
Confidence 999999999999999 999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=395.98 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=216.8
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
.++|.+.+.||+|+||.||+|.+ +++.||||++....... .....+.+|+.+++.++||||+++++++.....+++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999987 68899999987542211 1234678999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+ +|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.......
T Consensus 88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 9999 67899888653 46999999999999999999999999 9999999999999999999999999998765442
Q ss_pred cCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+ ......+|..+++.+.+||.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHHH
Confidence 2345689999999999998876 78999999999999999999999887655443333 33445678889999999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||+.| |.+||++++|++|||
T Consensus 241 ~~L~~d---P~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 241 RMIVAD---PMQRITIQEIRRDPW 261 (336)
T ss_dssp TTSCSS---GGGSCCHHHHTTCHH
T ss_pred HHcCCC---hhHCcCHHHHHhChh
Confidence 999999 999999999999998
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=370.62 Aligned_cols=255 Identities=31% Similarity=0.493 Sum_probs=222.3
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
..+++..++|++.+.||+|+||.||++++. +..||||++....... ..+.+|+.++++++||||+++++++.+.+.
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 346678899999999999999999999885 5579999998665443 457899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999999999876667999999999999999999999999 9999999999999999999999999998664
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHH
Q 002331 828 NTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 828 ~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+. .......+..+++.+
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 250 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKV 250 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCCHHH
Confidence 432 22233456788999999999999999999999999999998 999999998888777664 344556678889999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+||.+||+.| |.+||++.+|++|
T Consensus 251 ~~li~~~l~~~---p~~Rps~~~ll~~ 274 (283)
T 3gen_A 251 YTIMYSCWHEK---ADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHTTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHccCC---hhHCcCHHHHHHH
Confidence 99999999999 9999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=393.17 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=221.1
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++.+.||+|+||.||+|.+ +++.||+|++.... ......+.+|+.+|+.++||||+++++++.+...+++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 36799999999999999999987 57889999987553 234457889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC--CCcEEEEeccccccccCCc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~--~g~VKL~DFGlA~~~~~~~ 830 (935)
||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+. .+.+||+|||+++......
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 999999999999876667999999999999999999999999 999999999999974 5789999999998765432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cCCCCcCcHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDPLVARI 908 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r--~~ip~~ls~~L~dL 908 (935)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...... ......+++++.+|
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 284 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 223357999999999999999999999999999999999999999999887777766433222 23345789999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||+.| |.+||++.++|+|||
T Consensus 285 i~~~L~~d---P~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 285 IKNLLQKE---PRKRLTVHDALEHPW 307 (387)
T ss_dssp HHTTSCSS---GGGSCCHHHHHTSTT
T ss_pred HHHHcCCC---hhHCcCHHHHhhCcc
Confidence 99999999 999999999999998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=385.99 Aligned_cols=253 Identities=21% Similarity=0.238 Sum_probs=204.4
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++.+.||+|+||+||+|.+ +++.||||++............+.+|+.+|++++||||+++++++.+.+.++|||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 46899999999999999999976 6889999999776555555667789999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee-----cCCCcEEEEecccccccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-----DKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL-----d~~g~VKL~DFGlA~~~~ 827 (935)
||+++ +|.+++.+. ..+++..++.|+.||+.||.|||+++ |+||||||+|||| +..+.+||+|||+++...
T Consensus 113 e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99975 999998764 36899999999999999999999999 9999999999999 455669999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC----------
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE---------- 896 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~---------- 896 (935)
..........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.+..+......+.
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 443444556789999999999875 489999999999999999999999999887766655432111100
Q ss_pred ------------------CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 897 ------------------IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 897 ------------------ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++..+++++.+||.+||+.| |.+||+++|+|+|||
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMD---PVKRISAKNALEHPY 321 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSS---GGGSCCHHHHHTSGG
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCC---hhhCCCHHHHhCCcc
Confidence 11226789999999999999 999999999999998
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=382.17 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=225.5
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
..++|.+++.||+|+||.||++++ .++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 346899999999999999999987 477899999876543 44566778999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.......
T Consensus 119 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 99999999999998653 46899999999999999999999999 9999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+. .....++..+++.+.+||.
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 273 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQ 273 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--cCCCCCCccCCHHHHHHHH
Confidence 44455679999999999999999999999999999999999999999988777666553 3345677889999999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||+.| |.+||++.+||+|||
T Consensus 274 ~~l~~d---p~~Rps~~ell~~~~ 294 (335)
T 2owb_A 274 KMLQTD---PTARPTINELLNDEF 294 (335)
T ss_dssp HHTCSS---GGGSCCGGGGGGSHH
T ss_pred HHccCC---hhHCcCHHHHhcCcc
Confidence 999999 999999999999998
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=366.61 Aligned_cols=246 Identities=21% Similarity=0.289 Sum_probs=213.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.++..+ +||||+++++++.+.+.+++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999987 588999999987655556667888999999999 9999999999999999999999
Q ss_pred eeCCCCCHHHHHcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC-----------------
Q 002331 753 EFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN----------------- 812 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~---~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~----------------- 812 (935)
||+++++|.+++.+. ...+++..++.|+.||+.||.|||+++ |+||||||+||||+.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999999653 246899999999999999999999999 9999999999999844
Q ss_pred --CcEEEEeccccccccCCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh
Q 002331 813 --WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG 889 (935)
Q Consensus 813 --g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~ 889 (935)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+..........
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~--- 241 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR--- 241 (289)
T ss_dssp -CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHH---
T ss_pred CceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHH---
Confidence 47999999999876543 234689999999999876 56789999999999999999998876554332221
Q ss_pred ccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 890 FQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 890 ~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
......++..+++.+.+||.+||+.| |.+||++.++++|||
T Consensus 242 -~~~~~~~~~~~~~~~~~li~~~l~~d---p~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 242 -QGRLPRIPQVLSQEFTELLKVMIHPD---PERRPSAMALVKHSV 282 (289)
T ss_dssp -TTCCCCCSSCCCHHHHHHHHHHTCSS---GGGSCCHHHHHTCTT
T ss_pred -cCCCCCCCcccCHHHHHHHHHHhCCC---cccCCCHHHHhhChH
Confidence 33455678889999999999999999 999999999999999
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=378.63 Aligned_cols=248 Identities=23% Similarity=0.242 Sum_probs=208.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.++||+|+||+||+|++ +++.||||++............+..|+..+..+ +||||++++++|.+.+.+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6799999999999999999987 588999999877655555555666666666665 9999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+ +++|.+++...+..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....... .
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 212 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-A 212 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccCC-C
Confidence 999 66999988766667999999999999999999999998 9999999999999999999999999988765432 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qC 912 (935)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||.+..... .+.....+..++..+++.+.+||.+|
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQGYLPPEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhccCCCcccccCCCHHHHHHHHHH
Confidence 344579999999999987 68999999999999999999977766543322 22222333445567899999999999
Q ss_pred HhhCCCCcCCCcCHHHHHhCcC
Q 002331 913 WQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 913 L~~D~ssP~kRPSa~EILqHPF 934 (935)
|+.| |.+||++.+||+|||
T Consensus 289 L~~d---P~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 289 LEPD---PKLRATAEALLALPV 307 (311)
T ss_dssp SCSS---TTTSCCHHHHHTSGG
T ss_pred cCCC---hhhCcCHHHHHhCcc
Confidence 9999 999999999999999
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=385.46 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=206.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++++.||+|+||.||+|++ +++.||||++..... ......+.+|+.+|+.++||||+++++++...+.+++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 6899999999999999999987 578899999865432 1122234579999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
|++ ++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 997 5899988776667999999999999999999999999 9999999999999999999999999998765443444
Q ss_pred CCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-----------------
Q 002331 834 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----------------- 895 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~----------------- 895 (935)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 45678999999999887 568999999999999999999999999988877665543211110
Q ss_pred -----------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 -----------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 -----------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.....+++++.+||.+||+.| |.+||+++|+|+|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFE---GRNRISAEDAMKHPF 284 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSS---GGGSCCHHHHTTSGG
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcC---cccCCCHHHHhcChh
Confidence 012357889999999999999 999999999999999
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=380.10 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=223.4
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~g-------~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~ 742 (935)
.+++..++|++++.||+|+||.||+|++.+ +.||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456777899999999999999999998753 789999987553 445567899999999999999999999999
Q ss_pred ccCCceEEEEeeCCCCCHHHHHcCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEe
Q 002331 743 TRPPNLSIITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799 (935)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~dlL~~~~-----------------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIH 799 (935)
.+.+.+++||||+++++|.+++.... ..+++..++.|+.||+.||.|||+++ |+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH 197 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 197 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 99999999999999999999996531 56899999999999999999999999 999
Q ss_pred eCCCCCCeeecCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 002331 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPW 876 (935)
Q Consensus 800 rDLKPeNILLd~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF 876 (935)
|||||+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999999999999999999998654322 12234567889999999999999999999999999999999 99999
Q ss_pred CCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 877 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 877 ~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+....++...+. ......++..+++.+.+||.+||+.| |.+||++.+|+++
T Consensus 278 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~---p~~Rps~~~~~~~ 329 (343)
T 1luf_A 278 YGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKL---PADRPSFCSIHRI 329 (343)
T ss_dssp TTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred CCCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccC---cccCCCHHHHHHH
Confidence 9998888777664 34455678889999999999999999 9999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=376.66 Aligned_cols=255 Identities=27% Similarity=0.363 Sum_probs=209.3
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC---HHHHHHHHHHHHHHHHc---CCCceeeeeccccc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRL---RHPNVVLFMGAVTR 744 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~---~~~~~~f~~Ei~iL~~L---~HPNIVkl~g~~~~ 744 (935)
+..++|++.+.||+|+||+||+|++ +++.||||++...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3457899999999999999999985 6889999998754321 11123455677777666 59999999999876
Q ss_pred CC-----ceEEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEE
Q 002331 745 PP-----NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 818 (935)
Q Consensus 745 ~~-----~l~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~ 818 (935)
.. .+++||||+. ++|.+++.+.. ..+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEe
Confidence 55 4899999997 59999997643 34899999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc---
Q 002331 819 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--- 895 (935)
Q Consensus 819 DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--- 895 (935)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+......+
T Consensus 163 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99999866543 22345678999999999999999999999999999999999999999988877766553211100
Q ss_pred ----------------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 ----------------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ----------------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+...+++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~R~t~~e~l~h~~ 299 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFN---PHKRISAFRALQHSY 299 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSS---TTTSCCHHHHHTSTT
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCC---CccCCCHHHHhcCcc
Confidence 012357899999999999999 999999999999999
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=377.97 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=220.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.++++++||||+++++++.+...++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 5799999999999999999987 58899999987654322 13567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC----cEEEEecccccc
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 825 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g----~VKL~DFGlA~~ 825 (935)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++ .+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 999999999999999763 46899999999999999999999999 99999999999999887 799999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCcCcH
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDP 903 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--~ip~~ls~ 903 (935)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....... .++..+++
T Consensus 169 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (321)
T 2a2a_A 169 IEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247 (321)
T ss_dssp CCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred cCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence 65432 2344679999999999999999999999999999999999999999988887776664322211 12356889
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+.+||.+||+.| |.+||++.++|+|||
T Consensus 248 ~~~~li~~~l~~d---p~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 248 LAKDFIRKLLVKE---TRKRLTIQEALRHPW 275 (321)
T ss_dssp HHHHHHHTTSCSS---TTTSCCHHHHHHSTT
T ss_pred HHHHHHHHHcCCC---hhhCcCHHHHhcCcc
Confidence 9999999999999 999999999999999
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=371.89 Aligned_cols=254 Identities=24% Similarity=0.418 Sum_probs=222.7
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
..+..++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 345668999999999999999999987 46789999986543211 123568899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+++||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999999999753 36899999999999999999999998 9999999999999999999999999987654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
.. ......|++.|+|||++.+..++.++|||||||++|+|++|..||......+....+. .....++..++..+.+
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 241 (284)
T 2vgo_A 166 SL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSKD 241 (284)
T ss_dssp SS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHH
T ss_pred cc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHHH
Confidence 32 2344678999999999999999999999999999999999999999988877766653 3445677889999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
||.+||+.| |.+||++.+|++|||
T Consensus 242 li~~~l~~~---p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 242 LISKLLRYH---PPQRLPLKGVMEHPW 265 (284)
T ss_dssp HHHHHSCSS---GGGSCCHHHHHTCHH
T ss_pred HHHHHhhcC---HhhCCCHHHHhhCHH
Confidence 999999999 999999999999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=388.05 Aligned_cols=252 Identities=26% Similarity=0.353 Sum_probs=203.9
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
...++|++.+.||+|+||+||++++ +++.||||++....... ..+.+|+.+++.++||||+++++++.+...+++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 4457899999999999999999987 68899999997654322 357799999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc--EEEEeccccccccC
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSRLKHN 828 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~--VKL~DFGlA~~~~~ 828 (935)
||||+++|+|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+||||+.++. +||+|||+++....
T Consensus 94 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 94 IMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999999998653 46999999999999999999999999 999999999999987665 99999999975432
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccccCCCCcCcH
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEK-CDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~s~k-sDIWSLG~ILyELLTG~~PF~~~~~----~eil~~I~~~~~r~~ip~~ls~ 903 (935)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+... ......+............+++
T Consensus 171 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 171 H-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred c-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 2 22344679999999999988887655 8999999999999999999987543 3344444323333333346899
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+++||.+||+.| |.+||++.+|++|||
T Consensus 250 ~~~~li~~~L~~d---P~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 250 ECCHLISRIFVAD---PATRISIPEIKTHSW 277 (361)
T ss_dssp HHHHHHHHHSCSC---TTTSCCHHHHHTSHH
T ss_pred HHHHHHHHHccCC---hhHCcCHHHHHhCcc
Confidence 9999999999999 999999999999998
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=376.58 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=203.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC-------
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------- 746 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~------- 746 (935)
++|++++.||+|+||.||+|++ +++.||||++.... .......+.+|+.+|++++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 5799999999999999999987 58899999997654 3345567899999999999999999999885543
Q ss_pred --------------------------------------------------ceEEEEeeCCCCCHHHHHcCCC--CCCCHH
Q 002331 747 --------------------------------------------------NLSIITEFLPRGSLFRILHRPH--CQVDEK 774 (935)
Q Consensus 747 --------------------------------------------------~l~LVmEy~~gGsL~dlL~~~~--~~lse~ 774 (935)
.+++|||||++++|.+++.+.. ....+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 2799999999999999997643 235566
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc------------ccCCCCCCCCCc
Q 002331 775 RRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF------------LSSKSTAGTPEW 842 (935)
Q Consensus 775 ~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~------------~~~~s~~GT~~Y 842 (935)
.++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...... .......||+.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 78999999999999999999 9999999999999999999999999998765431 122345799999
Q ss_pred cCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCC
Q 002331 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHI 922 (935)
Q Consensus 843 ~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~k 922 (935)
+|||++.+..++.++|||||||++|+|++|..|+... ......+. ....+......++.+.+||.+||+.| |.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~---p~~ 316 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPS---PTE 316 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSS---GGG
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhh-ccCCCcccccCChhHHHHHHHHccCC---CCc
Confidence 9999999999999999999999999999987765321 12222221 11112222445678899999999999 999
Q ss_pred CcCHHHHHhCcC
Q 002331 923 RTSQAQLSHKRF 934 (935)
Q Consensus 923 RPSa~EILqHPF 934 (935)
||++.++|+|||
T Consensus 317 Rps~~~~l~~~~ 328 (332)
T 3qd2_B 317 RPEATDIIENAI 328 (332)
T ss_dssp SCCHHHHHHSTT
T ss_pred CCCHHHHhhchh
Confidence 999999999999
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=371.09 Aligned_cols=250 Identities=26% Similarity=0.471 Sum_probs=224.0
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
+.|++.+.||+|+||.||+|.+ .++.||||++...... .....+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 5699999999999999999986 5789999998765432 235678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
|+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++..........
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 9999999999975 46899999999999999999999999 9999999999999999999999999998766544444
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 913 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL 913 (935)
....|++.|+|||++.+..++.++|||||||++|+|++|..||...........+. ......++..++..+.+||.+||
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCCHHHHHHHHHHC
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccCHHHHHHHHHHc
Confidence 56679999999999999999999999999999999999999999988877766553 34455677889999999999999
Q ss_pred hhCCCCcCCCcCHHHHHhCcC
Q 002331 914 QTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 914 ~~D~ssP~kRPSa~EILqHPF 934 (935)
+.| |.+||++.+|++|||
T Consensus 256 ~~d---p~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 256 NKE---PSFRPTAKELLKHKF 273 (303)
T ss_dssp CSS---GGGSCCHHHHTTCHH
T ss_pred CCC---hhhCcCHHHHhhChh
Confidence 999 999999999999998
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=381.92 Aligned_cols=254 Identities=27% Similarity=0.388 Sum_probs=212.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccC---CCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~---~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
++|++.+.||+|+||.||+|.+ +++.||||++.... ........+.+|+.++++++||||+++++++.+.+.+++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5799999999999999999987 57789999987542 223456678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 002331 751 ITEFLPRGSLFRILHRP---------------------------------------HCQVDEKRRIKMALDVARGMNCLH 791 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~---------------------------------------~~~lse~~il~Ia~QIa~AL~yLH 791 (935)
||||+++|+|.+++... ...+++..++.|+.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998520 112467788899999999999999
Q ss_pred hcCCCEEeeCCCCCCeeecCCC--cEEEEeccccccccCCc----ccCCCCCCCCCccCcccccC--CCCCchhHHHHHH
Q 002331 792 TSTPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRLKHNTF----LSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFG 863 (935)
Q Consensus 792 s~g~~IIHrDLKPeNILLd~~g--~VKL~DFGlA~~~~~~~----~~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLG 863 (935)
+++ |+||||||+||||+.++ .+||+|||+++...... .......||+.|+|||++.+ ..++.++||||||
T Consensus 186 ~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 186 NQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 999 99999999999998766 89999999998653321 12345679999999999975 6789999999999
Q ss_pred HHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 864 VILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 864 ~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip--~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|++|+|++|+.||.+.+..+....+.........+ ..+++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~---p~~Rps~~~~l~hp~ 333 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN---VDERFDAMRALQHPW 333 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSC---TTTSCCHHHHHHSHH
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCC---hhHCCCHHHHhcChh
Confidence 99999999999999998888777765444333333 347899999999999999 999999999999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=385.64 Aligned_cols=249 Identities=28% Similarity=0.417 Sum_probs=219.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
+.|.+.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.+|++++||||+++++++...+.+++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4699999999999999999986 6889999999765433 345567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+. |+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 9997 5888888654567999999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
....||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+.......+.....+...+..+++.+.+||
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 3467999999999985 567899999999999999999999999998887777666544444455677899999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||+.| |.+||++++||+|||
T Consensus 287 ~~~l~~d---P~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 287 DSCLQKI---PQDRPTSEVLLKHRF 308 (348)
T ss_dssp HHHTCSS---GGGSCCHHHHTTCHH
T ss_pred HHHcccC---hhhCcCHHHHhhChh
Confidence 9999999 999999999999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=366.47 Aligned_cols=247 Identities=24% Similarity=0.369 Sum_probs=216.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|+||.||+|.+ .+..||+|++....... ...+.+|+.++++++||||+++++++.+...+++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 5799999999999999999987 45689999987654332 4568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee---cCCCcEEEEeccccccccCCc
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL---d~~g~VKL~DFGlA~~~~~~~ 830 (935)
|+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||| +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 87 LCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp CCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred ccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 99999999988653 46899999999999999999999999 9999999999999 78899999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC----CcCcHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP----KELDPLVA 906 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip----~~ls~~L~ 906 (935)
.......||+.|+|||++.+. ++.++|||||||++|+|++|+.||......+....+... ...++ ..+++.+.
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--TFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCHHHHTTSCHHHH
T ss_pred cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCchhhhcCCHHHH
Confidence 233456799999999998765 889999999999999999999999999888877766433 22333 26889999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||.+||+.| |.+||++.++|+|||
T Consensus 240 ~li~~~l~~d---p~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 240 SLIRRLLTKS---PKQRITSLQALEHEW 264 (277)
T ss_dssp HHHHHHTCSS---TTTSCCHHHHTTSHH
T ss_pred HHHHHHccCC---hhhCcCHHHHhcCHH
Confidence 9999999999 999999999999998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=380.72 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=214.8
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-----CCceeeeecc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----HPNVVLFMGA 741 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-----HPNIVkl~g~ 741 (935)
....+..++|++.++||+|+||.||+|++ +++.||||++... ......+..|+.+++.+. ||||++++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 44455668999999999999999999988 6889999998642 344556788999999996 9999999999
Q ss_pred cccCCceEEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC---------
Q 002331 742 VTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--------- 811 (935)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~--------- 811 (935)
+...+.+++||||+ +++|.+++.+.. ..+++..++.|+.||+.||.|||++| |+||||||+||||+.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccc
Confidence 99999999999999 889999987543 45899999999999999999999999 999999999999975
Q ss_pred ----------------CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC
Q 002331 812 ----------------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 875 (935)
Q Consensus 812 ----------------~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~P 875 (935)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 789999999999865432 2356789999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHhhcccccc------------------------CCC--------------------CcCcHHHHHHHHH
Q 002331 876 WIGMNPMQVVGAVGFQNRRL------------------------EIP--------------------KELDPLVARIIWE 911 (935)
Q Consensus 876 F~~~~~~eil~~I~~~~~r~------------------------~ip--------------------~~ls~~L~dLI~q 911 (935)
|...+..+....+....... ..| ...++.+.+||.+
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 99888766655442211110 011 1123778899999
Q ss_pred HHhhCCCCcCCCcCHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPSa~EILqHPF 934 (935)
||+.| |.+||++.++|+|||
T Consensus 339 ~L~~d---P~~Rpta~elL~hp~ 358 (360)
T 3llt_A 339 ILQID---PTLRPSPAELLKHKF 358 (360)
T ss_dssp HCCSS---GGGSCCHHHHTTSGG
T ss_pred HhcCC---hhhCCCHHHHhcCcc
Confidence 99999 999999999999999
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=379.08 Aligned_cols=259 Identities=28% Similarity=0.402 Sum_probs=220.6
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeec
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 740 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g 740 (935)
..+++..++|.+++.||+|+||.||+|++ .+..||||++.... .......+.+|+.+|+++ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 45778889999999999999999999986 34579999987543 233456788999999999 8999999999
Q ss_pred ccccCCceEEEEeeCCCCCHHHHHcCCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCEE
Q 002331 741 AVTRPPNLSIITEFLPRGSLFRILHRPHC----------------------QVDEKRRIKMALDVARGMNCLHTSTPTIV 798 (935)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~~~~~----------------------~lse~~il~Ia~QIa~AL~yLHs~g~~II 798 (935)
++...+.+++||||+++|+|.+++..... .+++..++.++.||+.||.|||++| |+
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 194 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 194 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 99999999999999999999999976432 3789999999999999999999999 99
Q ss_pred eeCCCCCCeeecCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 002331 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLP 875 (935)
Q Consensus 799 HrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~P 875 (935)
||||||+||||+.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999986543321 1223456788999999999999999999999999999998 9999
Q ss_pred CCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCc
Q 002331 876 WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKR 933 (935)
Q Consensus 876 F~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHP 933 (935)
|.+.........+.........+..+++.+.+||.+||..| |.+||++.+|+++.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~~l~~~l 329 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD---SRKRPSFPNLTSFL 329 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHHHH
T ss_pred cccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCC---chhCcCHHHHHHHH
Confidence 99877655554444455566778889999999999999999 99999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=384.27 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=201.0
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
...++|++.+.||+|+||.||+|++ .++.||||++.... ....+.+|+.+|++++||||+++++++...+.+++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3457899999999999999999988 46789999987543 23467789999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC---CCcEEEEecccccccc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKH 827 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~VKL~DFGlA~~~~ 827 (935)
||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||+++...
T Consensus 126 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999999764 46899999999999999999999999 999999999999975 8999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhcccccc--CCCCcCcHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRL--EIPKELDPL 904 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~e-il~~I~~~~~r~--~ip~~ls~~ 904 (935)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+ ....+....... .....++..
T Consensus 203 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 203 HQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred ccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 432 2344679999999999999999999999999999999999999998776554 344443222221 233568999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+.+||.+||+.| |.+||++.++|+|||
T Consensus 282 ~~~li~~~L~~d---P~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 282 AKDLVRKLIVLD---PKKRLTTFQALQHPW 308 (349)
T ss_dssp HHHHHHTTSCSS---GGGSCCHHHHHHSTT
T ss_pred HHHHHHHHccCC---hhhCcCHHHHhcCcc
Confidence 999999999999 999999999999999
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=381.71 Aligned_cols=255 Identities=23% Similarity=0.247 Sum_probs=211.1
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH---HHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG---AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~---~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
..++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.+++.++||||+++++++.+...+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 347899999999999999999987 47899999987543222 1234678999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++||||+++ +|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 999999986 899999876677899999999999999999999999 99999999999999999999999999987755
Q ss_pred CcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------------
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------------ 895 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~------------ 895 (935)
.........||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+......+
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 44444567899999999999764 58999999999999999999999999988877665543211110
Q ss_pred ---------C-----CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 ---------E-----IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ---------~-----ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. +...+++.+.+||.+||+.| |.+||++.|+|+|||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN---PCARITATQALKMKY 294 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSS---TTTSCCHHHHHTSGG
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccC---hhhCCCHHHHhcChh
Confidence 0 11456789999999999999 999999999999998
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=362.43 Aligned_cols=253 Identities=31% Similarity=0.515 Sum_probs=223.7
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
+.+..++|++.+.||+|+||.||++.+ +++.||||++....... ..+.+|+.++++++||||+++++++.+.+.++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 567778999999999999999999987 67789999998765443 46889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999999999876667899999999999999999999999 999999999999999999999999999866432
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 830 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 830 ~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
. .......+++.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+. ...+...+..++..+.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~ 236 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQ 236 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-cCCcCCCCccCcHHHHH
Confidence 1 12234567789999999999999999999999999999999 899999998888777664 33455667788999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
||.+||+.| |.+||++.+++++
T Consensus 237 li~~~l~~~---p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 237 IMNHCWRER---PEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHccCC---hhhCcCHHHHHHH
Confidence 999999999 9999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=384.74 Aligned_cols=257 Identities=30% Similarity=0.508 Sum_probs=225.6
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeee
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl 738 (935)
..+++..++|.+++.||+|+||.||+|++. +..||||++... ........+.+|+.+++++ +|||||++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 446778899999999999999999999852 257999998765 3455667889999999999 99999999
Q ss_pred ecccccCCceEEEEeeCCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCC
Q 002331 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 803 (935)
Q Consensus 739 ~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLK 803 (935)
++++...+.+++||||+++++|.+++.... ..+++..++.|+.||+.||.|||+++ |+|||||
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 218 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA 218 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCC
Confidence 999999999999999999999999996532 35899999999999999999999998 9999999
Q ss_pred CCCeeecCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 002331 804 SPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 880 (935)
Q Consensus 804 PeNILLd~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~ 880 (935)
|+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998765432 22233457789999999999999999999999999999999 999999998
Q ss_pred hHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 881 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 881 ~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
..++...+. ...+...+..+++.+.+||.+||+.| |.+||++.+|+++
T Consensus 299 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~d---P~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAV---PSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 888777664 44566778889999999999999999 9999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=390.42 Aligned_cols=255 Identities=30% Similarity=0.509 Sum_probs=224.2
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
.+++..++|++++.||+|+||.||+|++ +++.||||++... ........+.+|+.+|++++||||+++++++...+.
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 4677888999999999999999999988 5889999998754 344556678899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
++|||||+++|+|.+++...+..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999999765567899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccCC--CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 828 NTFLSSK--STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 828 ~~~~~~~--s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
....... ...+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...+...|..+++.
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 343 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDA 343 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 4322211 1234668999999998889999999999999999998 999999998887776654 45567788889999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+.+||.+||+.| |.+||++.+|++
T Consensus 344 l~~li~~cl~~d---P~~Rps~~~i~~ 367 (377)
T 3cbl_A 344 VFRLMEQCWAYE---PGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHcCCC---chhCcCHHHHHH
Confidence 999999999999 999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=377.42 Aligned_cols=260 Identities=27% Similarity=0.457 Sum_probs=206.9
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEECC-----ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g-----~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~ 743 (935)
..+.+..++|++++.||+|+||.||+|++.. ..||||++............+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 4456778899999999999999999997632 27999999876555566788999999999999999999999998
Q ss_pred cCCce------EEEEeeCCCCCHHHHHcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC
Q 002331 744 RPPNL------SIITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812 (935)
Q Consensus 744 ~~~~l------~LVmEy~~gGsL~dlL~~~-----~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~ 812 (935)
..... ++||||+++++|.+++... ...+++..++.|+.||+.||.|||++| |+||||||+||||+.+
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED 173 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC
Confidence 77655 9999999999999998531 225899999999999999999999999 9999999999999999
Q ss_pred CcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhh
Q 002331 813 WNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 889 (935)
Q Consensus 813 g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~ 889 (935)
+.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 9999999999986543321 1223456788999999999999999999999999999999 899999988887776664
Q ss_pred ccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcC-------HHHHHhCcC
Q 002331 890 FQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTS-------QAQLSHKRF 934 (935)
Q Consensus 890 ~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPS-------a~EILqHPF 934 (935)
.......+..+++.+.+||.+||+.| |.+||+ ++++++|+|
T Consensus 254 -~~~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 254 -GGNRLKQPPECMEEVYDLMYQCWSAD---PKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHTTCSS---GGGSCCHHHHHHHHHHHHHC--
T ss_pred -cCCCCCCCCccCHHHHHHHHHHccCC---hhhCcCHHHHHHHHHHHHHHhh
Confidence 34456677889999999999999999 999999 777888887
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=389.85 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=212.2
Q ss_pred eeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeC
Q 002331 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
|...+.||+|+||.||+|++ +++.||||++.... ......+.+|+.+|++++||||+++++++...+.++|||||+
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 34477899999999999987 58899999987654 244567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee--cCCCcEEEEeccccccccCCcccC
Q 002331 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 756 ~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL--d~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++...... ..
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~ 245 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KL 245 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cc
Confidence 999999988765567999999999999999999999999 9999999999999 567899999999998765432 23
Q ss_pred CCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCcCcHHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARIIWE 911 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--~ip~~ls~~L~dLI~q 911 (935)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+....... .....+++++++||.+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 34579999999999999999999999999999999999999999998887777664332222 1225689999999999
Q ss_pred HHhhCCCCcCCCcCHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPSa~EILqHPF 934 (935)
||+.| |.+||++.++|+|||
T Consensus 326 ~L~~d---p~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 326 LLIKE---KSWRISASEALKHPW 345 (373)
T ss_dssp TSCSS---GGGSCCHHHHHHSHH
T ss_pred HcCCC---hhhCCCHHHHhcCcC
Confidence 99999 999999999999998
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=371.41 Aligned_cols=257 Identities=31% Similarity=0.513 Sum_probs=223.9
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~ 741 (935)
..+++..++|.+++.||+|+||.||+|++ .++.||||++.... .......+.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 45677889999999999999999999975 24789999987543 45566788999999999999999999999
Q ss_pred cccCCceEEEEeeCCCCCHHHHHcCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEE
Q 002331 742 VTRPPNLSIITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIV 798 (935)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~~~~-----------------------~~lse~~il~Ia~QIa~AL~yLHs~g~~II 798 (935)
+.+.+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iv 172 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LV 172 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cc
Confidence 999999999999999999999996532 24889999999999999999999999 99
Q ss_pred eeCCCCCCeeecCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 002331 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLP 875 (935)
Q Consensus 799 HrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~P 875 (935)
||||||+||||+.++.+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998664322 12234457788999999999889999999999999999999 9999
Q ss_pred CCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 876 WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 876 F~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
|.+.....+...+. .......+..+++.+.+||.+||+.| |.+||++.+|+++
T Consensus 253 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~d---p~~Rps~~~l~~~ 305 (314)
T 2ivs_A 253 YPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQE---PDKRPVFADISKD 305 (314)
T ss_dssp STTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCC---hhhCcCHHHHHHH
Confidence 99988877766554 34456677889999999999999999 9999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=385.93 Aligned_cols=247 Identities=22% Similarity=0.375 Sum_probs=212.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||+|.+ +++.||||++...... ..+|++++.++ +||||+++++++.+.+.+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 6799999999999999999987 5789999999765432 34688888887 7999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC----CcEEEEeccccccccC
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN----WNVKVSDFGLSRLKHN 828 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~----g~VKL~DFGlA~~~~~ 828 (935)
||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||+... +.+||+|||+++....
T Consensus 96 E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999764 46999999999999999999999999 9999999999998432 3599999999987655
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC---CChHHHHHHhhcccccc--CCCCcCcH
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG---MNPMQVVGAVGFQNRRL--EIPKELDP 903 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~---~~~~eil~~I~~~~~r~--~ip~~ls~ 903 (935)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+ ....++...+....... ..+..+++
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH
Confidence 43444567899999999999988889999999999999999999999986 34555666554332222 23357899
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+++||.+||+.| |.+||++.++++|||
T Consensus 253 ~~~~li~~~L~~d---P~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 253 TAKDLVSKMLHVD---PHQRLTAALVLRHPW 280 (342)
T ss_dssp HHHHHHHHHTCSS---TTTSCCHHHHTTSHH
T ss_pred HHHHHHHHHCCCC---hhHCcCHHHHhcCCe
Confidence 9999999999999 999999999999998
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=400.50 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=207.1
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC------
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~------ 746 (935)
.++|++++.||+|+||+||+|.+ +++.||||++............+.+|+.+|+.++|||||+++++|....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999976 5889999999876556666778899999999999999999999986553
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+||||||+++ +|.+++.. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 46999999976 57777754 4899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-----------
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----------- 895 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~----------- 895 (935)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+....+.+
T Consensus 215 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 215 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp --C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred CCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 543 23345789999999999999999999999999999999999999999988766655442211100
Q ss_pred ---------C---------CCCc-----------CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 ---------E---------IPKE-----------LDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ---------~---------ip~~-----------ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. ++.. .++++++||.+||+.| |.+||+++|+|+|||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~d---P~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID---PAKRISVDDALQHPY 358 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSS---TTTSCCHHHHHTSTT
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCC---hhhCCCHHHHhcChh
Confidence 0 0111 1567999999999999 999999999999999
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=380.82 Aligned_cols=255 Identities=25% Similarity=0.328 Sum_probs=214.0
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
..++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 347899999999999999999987 488999999987766666677788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++........
T Consensus 103 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999999998887653 46999999999999999999999999 99999999999999999999999999987654434
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc----------------
Q 002331 832 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---------------- 894 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r---------------- 894 (935)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+......
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 44556799999999999875 6899999999999999999999999988776655443211000
Q ss_pred -cC------------CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 -LE------------IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 -~~------------ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.. ....+++.+.+||.+||+.| |.+||++.+||+|||
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d---P~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHID---PDKRPFCAELLHHDF 309 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSS---GGGSCCGGGGGGSHH
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccC---cccCCCHHHHhcCch
Confidence 00 11357899999999999999 999999999999998
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=381.48 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=212.8
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc-------
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------- 744 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~------- 744 (935)
..++|++++.||+|+||.||+|++ +++.||||++............+.+|+.+|+.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 347899999999999999999987 58899999987665444445567799999999999999999999876
Q ss_pred -CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccc
Q 002331 745 -PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (935)
Q Consensus 745 -~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA 823 (935)
.+.+++||||+++ +|.+++......+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 3468999999975 788887776667999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCC----cccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--C
Q 002331 824 RLKHNT----FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--E 896 (935)
Q Consensus 824 ~~~~~~----~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--~ 896 (935)
+..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+....... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 865421 122244578999999999986 457999999999999999999999999988776665543211111 1
Q ss_pred CCCc----------------------------CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 897 IPKE----------------------------LDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 897 ip~~----------------------------ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.... .++.+.+||.+||+.| |.+||+++|+|+|||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD---PAQRIDSDDALNHDF 314 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSS---GGGSCCHHHHHTSGG
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCC---hhhCCCHHHHhCCCC
Confidence 1000 2678999999999999 999999999999998
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=375.89 Aligned_cols=252 Identities=33% Similarity=0.487 Sum_probs=212.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
+..++|++++.||+|+||+||+|.+ +++.||||++... .......+.+|+.++++++||||+++++++.+++.+++
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 4457899999999999999999987 4889999987543 45667789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||+++++|.+++......+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999876678999999999999999999999999 9999999999999999999999999998754332
Q ss_pred cc--------------CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh-hcccccc
Q 002331 831 LS--------------SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRRL 895 (935)
Q Consensus 831 ~~--------------~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I-~~~~~r~ 895 (935)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||............ .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 11 11457999999999999999999999999999999999999998764332110000 0001122
Q ss_pred CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 896 EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 896 ~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
..+..+++.+.+||.+||+.| |.+||++.+|++
T Consensus 243 ~~~~~~~~~l~~li~~~l~~d---P~~Rps~~~l~~ 275 (310)
T 3s95_A 243 YCPPNCPPSFFPITVRCCDLD---PEKRPSFVKLEH 275 (310)
T ss_dssp TCCTTCCTTHHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred cCCCCCCHHHHHHHHHHccCC---hhhCcCHHHHHH
Confidence 346778899999999999999 999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=389.42 Aligned_cols=254 Identities=19% Similarity=0.291 Sum_probs=216.0
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC--CCceeeeecccccCCceE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~--HPNIVkl~g~~~~~~~l~ 749 (935)
+...+|++++.||+|+||.||++.+ .++.||||++............+.+|+.+|+.++ ||||+++++++...+.+|
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3446799999999999999999976 4788999999877667777888999999999996 599999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
|||| +.+++|.+++.+. ..+++..++.|+.||+.||.|||+++ |+||||||+||||+ ++.+||+|||+++.....
T Consensus 133 lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999 5678999999764 37889999999999999999999999 99999999999995 589999999999876433
Q ss_pred c--ccCCCCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhcccccc
Q 002331 830 F--LSSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRL 895 (935)
Q Consensus 830 ~--~~~~s~~GT~~Y~APEvl~g-----------~~~s~ksDIWSLG~ILyELLTG~~PF~~~~-~~eil~~I~~~~~r~ 895 (935)
. ......+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.... ....+..+.......
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 2 12345679999999999875 368899999999999999999999998753 334444554445556
Q ss_pred CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.++...+..+.+||.+||+.| |.+||++.+||+|||
T Consensus 288 ~~~~~~~~~~~~li~~~L~~d---P~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRD---PKQRISIPELLAHPY 323 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSS---TTTSCCHHHHHTSHH
T ss_pred CCCccchHHHHHHHHHHcccC---hhhCCCHHHHhhCcC
Confidence 677888999999999999999 999999999999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=404.32 Aligned_cols=254 Identities=25% Similarity=0.493 Sum_probs=224.6
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
.+..++|.+++.||+|+||.||+|++ +|+.||||++....... .....+.+|+.+|+.++||||+++++++...+.+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34558899999999999999999987 58899999987543211 2345788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|+||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999999763 57999999999999999999999999 99999999999999999999999999987654
Q ss_pred CcccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+...+. ......|..+++.+.+
T Consensus 169 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~ 245 (476)
T 2y94_A 169 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQYLNPSVIS 245 (476)
T ss_dssp TC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH--TTCCCCCTTCCHHHHH
T ss_pred cc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCcCCCccCCHHHHH
Confidence 32 2345689999999999998775 789999999999999999999999988887777764 3345677889999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
||.+||+.| |.+||++.+|++|||
T Consensus 246 Li~~~L~~d---P~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 246 LLKHMLQVD---PMKRATIKDIREHEW 269 (476)
T ss_dssp HHHHHTCSS---TTTSCCHHHHHTCHH
T ss_pred HHHHHcCCC---chhCcCHHHHHhCHH
Confidence 999999999 999999999999998
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=373.44 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=213.3
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeeccccc--
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR-- 744 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~-- 744 (935)
.+....++|++.+.||+|+||.||+|++ +++.||||++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3445568999999999999999999988 7889999998765432 34678999999999 89999999999876
Q ss_pred ----CCceEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEe
Q 002331 745 ----PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 819 (935)
Q Consensus 745 ----~~~l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~D 819 (935)
.+.+++||||+++++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEee
Confidence 46789999999999999999753 346899999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCcccCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc
Q 002331 820 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR 894 (935)
Q Consensus 820 FGlA~~~~~~~~~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r 894 (935)
||++..............|++.|+|||++. +..++.++|||||||++|+|++|..||.+.+.......+.....+
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 252 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence 999987654333334567999999999987 566889999999999999999999999998887766655444444
Q ss_pred cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...+..++..+.+||.+||..| |.+||++.+|++|||
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~~ll~hp~ 289 (326)
T 2x7f_A 253 RLKSKKWSKKFQSFIESCLVKN---HSQRPATEQLMKHPF 289 (326)
T ss_dssp CCSCSCSCHHHHHHHHHHCCSS---GGGSCCHHHHHTSHH
T ss_pred cCCccccCHHHHHHHHHHhccC---hhhCCCHHHHhhChH
Confidence 4455678999999999999999 999999999999998
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=368.48 Aligned_cols=255 Identities=29% Similarity=0.481 Sum_probs=211.1
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
.+++..++|++++.||+|+||.||+|.+. +..||||++.... .......+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 45677789999999999999999999763 3469999876543 4456677899999999999999999999985
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
++..++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccccc
Confidence 46789999999999999999876667999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCc
Q 002331 825 LKHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902 (935)
Q Consensus 825 ~~~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls 902 (935)
....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. ...+..++..++
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~ 243 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 243 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 7654322 2233456788999999999999999999999999999996 999999988877776664 334566788899
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+.+.+||.+||+.| |.+||++.+|+++
T Consensus 244 ~~l~~li~~~l~~~---p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 244 PTLYSLMTKCWAYD---PSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCC---hhhCcCHHHHHHH
Confidence 99999999999999 9999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=367.07 Aligned_cols=254 Identities=26% Similarity=0.478 Sum_probs=214.0
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
.+..++|++++.||+|+||.||+|++ +++.||||++...... ......+.+|+.+++.++||||+++++++...+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 34568999999999999999999987 5889999998654321 12345688999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999999653 46899999999999999999999999 99999999999999999999999999987654
Q ss_pred CcccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
.. ......|++.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+. .....+|..++..+.+
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEYLNRSVAT 240 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCcccCchhcCHHHHH
Confidence 32 2234578999999999988765 689999999999999999999999988877776663 3345567889999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
||.+||+.| |.+||++.+|++|||
T Consensus 241 li~~~l~~~---p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 241 LLMHMLQVD---PLKRATIKDIREHEW 264 (276)
T ss_dssp HHHHHTCSS---GGGSCCHHHHHHSHH
T ss_pred HHHHHccCC---hhhCCCHHHHHhChh
Confidence 999999999 999999999999998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=370.73 Aligned_cols=251 Identities=24% Similarity=0.428 Sum_probs=211.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|.+.+.||+|+||.||++++ .+..||||++...... .....+.+|+++|++++||||+++++++.+...+++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 5799999999999999999987 5789999998765422 235678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee---cCCCcEEEEecccccccc
Q 002331 754 FLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 754 y~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL---d~~g~VKL~DFGlA~~~~ 827 (935)
|+++++|.+++.. ....+++..++.|+.||+.||.|||++| |+||||||+|||| +.++.+||+|||++....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998853 2357999999999999999999999999 9999999999999 456889999999998655
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCC-CCcCcHHHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI-PKELDPLVA 906 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~i-p~~ls~~L~ 906 (935)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+......... ...+++.+.
T Consensus 179 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T 3is5_A 179 SD-EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256 (285)
T ss_dssp ---------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred Cc-ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence 43 22345678999999999864 5789999999999999999999999999888777665433333222 234789999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||.+||+.| |.+||++.+||+|||
T Consensus 257 ~li~~~L~~d---P~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 257 DLLKQMLTKD---PERRPSAAQVLHHEW 281 (285)
T ss_dssp HHHHHHTCSC---TTTSCCHHHHHTSGG
T ss_pred HHHHHHccCC---hhhCcCHHHHhcCHH
Confidence 9999999999 999999999999998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=370.74 Aligned_cols=258 Identities=28% Similarity=0.411 Sum_probs=222.2
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeec
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 740 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g 740 (935)
..+++..++|++++.||+|+||.||+|++ .++.||||++.... .......+.+|+.+++++ +||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 34678889999999999999999999975 35789999987553 334567789999999999 9999999999
Q ss_pred ccccCCceEEEEeeCCCCCHHHHHcCCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCC
Q 002331 741 AVTRPPNLSIITEFLPRGSLFRILHRPHC-----------------QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 803 (935)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~~~~~-----------------~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLK 803 (935)
++...+..++||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+|||||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlk 172 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA 172 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCc
Confidence 99999999999999999999999975432 4899999999999999999999999 9999999
Q ss_pred CCCeeecCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 002331 804 SPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 880 (935)
Q Consensus 804 PeNILLd~~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~ 880 (935)
|+||||+.++.+||+|||++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999987654321 1233456788999999999999999999999999999998 999999876
Q ss_pred hHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 881 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 881 ~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.............+...+..++..+.+||.+||+.| |.+||++.+|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDAD---PLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCC---chhCcCHHHHHHH
Confidence 655444443344555667889999999999999999 9999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=370.50 Aligned_cols=253 Identities=28% Similarity=0.450 Sum_probs=215.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
...++|++.+.||+|+||.||+|.+ +++.||||++..... ...+.+|+.+++.++||||+++++++...+.+++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4567899999999999999999987 488999999876542 3467889999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999999754567999999999999999999999999 9999999999999999999999999998766544
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCcCcHHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARII 909 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~-~~r~~ip~~ls~~L~dLI 909 (935)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+... ......+..++..+.+||
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHH
Confidence 4445567999999999999999999999999999999999999999988876665544322 122334567899999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||..| |.+||++.++++|||
T Consensus 260 ~~~l~~d---p~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 260 KQCLVKS---PEQRATATQLLQHPF 281 (314)
T ss_dssp HHHTCSC---TTTSCCHHHHTTSHH
T ss_pred HHHccCC---hhhCcCHHHHHhCHH
Confidence 9999999 999999999999998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=401.03 Aligned_cols=251 Identities=29% Similarity=0.413 Sum_probs=214.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++++.||+|+||+||+|++ .+..||||++............+.+|+.+|+.++|||||+++++|.+...+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4799999999999999999987 57889999998765444445678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC---CCcEEEEeccccccccCCc
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~VKL~DFGlA~~~~~~~ 830 (935)
||++|+|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+||||+. ++.+||+|||++.......
T Consensus 117 ~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 117 CYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 99999999988653 46899999999999999999999999 999999999999975 4559999999998765442
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CcCcHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARI 908 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip--~~ls~~L~dL 908 (935)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....++...+.........+ ..+++.+++|
T Consensus 194 -~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 194 -KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp -CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred -cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 3345679999999999874 58999999999999999999999999999988888775444433322 4689999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||+.| |.+||++.++|+|||
T Consensus 272 i~~~L~~d---p~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 272 IKQMLQFD---SQRRISAQQALEHPW 294 (494)
T ss_dssp HHHHTCSS---TTTSCCHHHHHTCHH
T ss_pred HHHHCCCC---hhhCccHHHHhcCcc
Confidence 99999999 999999999999998
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=394.25 Aligned_cols=252 Identities=25% Similarity=0.284 Sum_probs=193.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccc-----cCCce
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT-----RPPNL 748 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~-----~~~~l 748 (935)
++|++++.||+|+||+||+|.+ +++.||||++............+.+|+.+|+.++|||||++++++. ....+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 6899999999999999999976 5889999999776556666778999999999999999999999984 33569
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|+||||+. ++|.+++... ..+++..++.|+.||+.||.|||++| ||||||||+||||+.++.+||+|||+++....
T Consensus 133 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 99999984 6999999764 46999999999999999999999999 99999999999999999999999999987542
Q ss_pred Cc---------------------------ccCCCCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHc---------
Q 002331 829 TF---------------------------LSSKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELAT--------- 871 (935)
Q Consensus 829 ~~---------------------------~~~~s~~GT~~Y~APEvl-~g~~~s~ksDIWSLG~ILyELLT--------- 871 (935)
.. ......+||+.|+|||++ .+..++.++||||||||||||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 21 112345789999999986 56679999999999999999999
Q ss_pred --CCCCCCCCCh--------------------HHHHHHhhc------------------------ccc-----ccCCCCc
Q 002331 872 --LKLPWIGMNP--------------------MQVVGAVGF------------------------QNR-----RLEIPKE 900 (935)
Q Consensus 872 --G~~PF~~~~~--------------------~eil~~I~~------------------------~~~-----r~~ip~~ 900 (935)
|+++|.+... ...+..+.. ... .......
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 6777766431 111111100 000 0011234
Q ss_pred CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 901 LDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 901 ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+++++.+||.+||..| |.+||+++|+|+|||
T Consensus 369 ~s~~~~dLl~~mL~~d---P~~R~t~~e~L~Hp~ 399 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFN---PNKRITINECLAHPF 399 (458)
T ss_dssp SCHHHHHHHHHHSCSS---TTTSCCHHHHHHSGG
T ss_pred CCHHHHHHHHHHhccC---ccccCCHHHHhcCHh
Confidence 6899999999999999 999999999999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=401.79 Aligned_cols=251 Identities=28% Similarity=0.462 Sum_probs=218.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|+||+||+|++ +++.||||++............+.+|+.+|++++|||||++++++.+...+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 5799999999999999999987 58899999987543322335678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec---CCCcEEEEeccccccccCCc
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd---~~g~VKL~DFGlA~~~~~~~ 830 (935)
|+.+++|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||+++......
T Consensus 102 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 99999999988653 46899999999999999999999999 99999999999995 56679999999998765432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CcCcHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARI 908 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip--~~ls~~L~dL 908 (935)
.....+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.+..++...+.........+ ..+++.+++|
T Consensus 179 -~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 179 -KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp ----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred -ccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 23456799999999999874 8999999999999999999999999999988888776554444433 4689999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||+.| |.+||++.++|+|||
T Consensus 257 i~~~L~~d---p~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 257 IRKMLTFH---PSLRITATQCLEHPW 279 (486)
T ss_dssp HHHHTCSS---TTTSCCHHHHHHCHH
T ss_pred HHHHcCCC---hhhCcCHHHHhcCHh
Confidence 99999999 999999999999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=384.20 Aligned_cols=249 Identities=23% Similarity=0.343 Sum_probs=209.5
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC------
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~------ 746 (935)
.++|++.+.||+|+||.||+|.+ +|+.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 36899999999999999999987 5889999998766556666778899999999999999999999987653
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 7899999976 46899999999999999999999999 999999999999999999999999999875
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------ 893 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~------------ 893 (935)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 179 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 179 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 432 334678999999999987 6789999999999999999999999999887665544321110
Q ss_pred -----------------ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 -----------------RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 -----------------r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...+...+++.+.+||.+||+.| |.+||+++++|+|||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~d---P~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD---AEQRVTAGEALAHPY 310 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSS---TTTSCCHHHHHHSGG
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCC---hhHCCCHHHHhcChH
Confidence 01233567899999999999999 999999999999998
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=418.78 Aligned_cols=257 Identities=20% Similarity=0.338 Sum_probs=225.7
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHc-CCCceeeeecccccC
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 745 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~ 745 (935)
...+..++|++++.||+|+||.||+|++ +++.||||++..... .......+..|..+|..+ +||||++++++|.+.
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 3456678999999999999999999987 567899999875421 112345677899999987 799999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
+.+||||||+++|+|.+++.+. ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|++||+|||+++.
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred CEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999999999764 46999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHH
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
...........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..++...+. .....+|..+++++
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~ 569 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEA 569 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--SSCCCCCTTSCHHH
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHH
Confidence 5444444566789999999999999999999999999999999999999999999988888875 34567888999999
Q ss_pred HHHHHHHHhhCCCCcCCCcCH-----HHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQ-----AQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa-----~EILqHPF 934 (935)
.+||.+||+.| |.+||++ ++|++|||
T Consensus 570 ~~li~~lL~~d---P~~R~~~~~~~~~ei~~h~f 600 (674)
T 3pfq_A 570 VAICKGLMTKH---PGKRLGCGPEGERDIKEHAF 600 (674)
T ss_dssp HHHHHHHSCSS---STTCTTCSTTHHHHHHSSGG
T ss_pred HHHHHHHccCC---HHHCCCCCCCcHHHHhcCcc
Confidence 99999999999 9999997 99999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=376.59 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=216.3
Q ss_pred CCeeEE-EEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEE
Q 002331 676 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 676 edy~I~-e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LV 751 (935)
++|.+. +.||+|+||.||+|.+ +++.||||++............+.+|+.+++.+ .||||+++++++.+.+.+++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 467776 8999999999999987 488999999987655444456788999999999 569999999999999999999
Q ss_pred EeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC---CCcEEEEecccccccc
Q 002331 752 TEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKH 827 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~VKL~DFGlA~~~~ 827 (935)
|||+++++|.+++... ...+++..++.|+.||+.||.|||++| |+||||||+||||+. ++.+||+|||+++...
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 9999999999998643 457899999999999999999999999 999999999999987 7899999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc--cccCCCCcCcHHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--RRLEIPKELDPLV 905 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~--~r~~ip~~ls~~L 905 (935)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.... ........+++.+
T Consensus 186 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 264 (327)
T 3lm5_A 186 HAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA 264 (327)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred Ccc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHH
Confidence 432 2334679999999999999999999999999999999999999999988877766554322 2233446789999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||.+||+.| |.+||++++||+|||
T Consensus 265 ~~li~~~L~~d---P~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 265 TDFIQSLLVKN---PEKRPTAEICLSHSW 290 (327)
T ss_dssp HHHHHHHSCSS---GGGSCCHHHHTTCGG
T ss_pred HHHHHHHcCCC---hhhCcCHHHHhCCHh
Confidence 99999999999 999999999999998
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=371.93 Aligned_cols=254 Identities=29% Similarity=0.462 Sum_probs=214.3
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
..++|++.+.||+|+||.||+|++ +++.||+|++..... .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 347899999999999999999988 478899999865432 2345788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 9999999999998765567999999999999999999999998 99999999999999999999999999765433222
Q ss_pred cCCCCCCCCCccCcccc-----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCcCcHHH
Q 002331 832 SSKSTAGTPEWMAPEVL-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLV 905 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl-----~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~-r~~ip~~ls~~L 905 (935)
......|++.|+|||++ .+..++.++|||||||++|+|++|..||...+.......+..... ....+..++..+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHH
Confidence 23446789999999998 466788999999999999999999999999888776665543222 223456789999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||.+||+.| |.+||++.+|++|||
T Consensus 253 ~~li~~~l~~d---p~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 253 RDFLKIALDKN---PETRPSAAQLLEHPF 278 (302)
T ss_dssp HHHHHHHSCSC---TTTSCCHHHHTTSTT
T ss_pred HHHHHHHcccC---hhhCCCHHHHhcChH
Confidence 99999999999 999999999999999
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=364.33 Aligned_cols=252 Identities=31% Similarity=0.555 Sum_probs=215.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHH--HH---HHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA--AL---LEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~--~~---~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
+..++|++.+.||+|+||.||+|++ +++.||||++........ .. ..+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 4568999999999999999999987 688999999876543221 11 5788999999999999999999999765
Q ss_pred CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc-----EEEEec
Q 002331 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDF 820 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~-----VKL~DF 820 (935)
. ++||||+++++|.+++.+....+++..++.++.||+.||.|||+++.+|+||||||+||||+.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 799999999999999877777899999999999999999999998767999999999999988776 999999
Q ss_pred cccccccCCcccCCCCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH--HHHhhccccccC
Q 002331 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV--VGAVGFQNRRLE 896 (935)
Q Consensus 821 GlA~~~~~~~~~~~s~~GT~~Y~APEvl~--g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~ei--l~~I~~~~~r~~ 896 (935)
|+++..... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||........ ...+.....+..
T Consensus 174 g~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 174 GLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp TTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred Ccccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 999855432 23467999999999994 45578999999999999999999999987654433 444444566677
Q ss_pred CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 897 IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 897 ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
++..+++.+.+||.+||+.| |.+||++.+|++.
T Consensus 251 ~~~~~~~~l~~li~~~l~~d---p~~Rps~~~ll~~ 283 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGD---PKKRPHFSYIVKE 283 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCC---hhhCcCHHHHHHH
Confidence 88899999999999999999 9999999999863
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=365.90 Aligned_cols=252 Identities=26% Similarity=0.420 Sum_probs=215.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.++++++||||+++++++.+...++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 5699999999999999999987 48899999987654322 13567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC----cEEEEecccccc
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 825 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g----~VKL~DFGlA~~ 825 (935)
+||||+++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 999999999999999653 46899999999999999999999998 99999999999998777 899999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCcCcH
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDP 903 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--~ip~~ls~ 903 (935)
..... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....... ..+..+++
T Consensus 162 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 162 IEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp CC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 65432 2234578999999999999999999999999999999999999999988877776654322211 22356789
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+.+||.+||+.| |.+||++.++++|||
T Consensus 241 ~~~~li~~~l~~d---p~~Rps~~~~l~h~~ 268 (283)
T 3bhy_A 241 LAKDFIRRLLVKD---PKRRMTIAQSLEHSW 268 (283)
T ss_dssp HHHHHHHTTSCSS---GGGSCCHHHHHHCHH
T ss_pred HHHHHHHHHccCC---HhHCcCHHHHHhCHH
Confidence 9999999999999 999999999999998
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=380.70 Aligned_cols=240 Identities=22% Similarity=0.366 Sum_probs=187.7
Q ss_pred EEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeecccccCCceEEEEeeCCCC
Q 002331 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LVmEy~~gG 758 (935)
+.||+|+||.||+|.+ +++.||||++.... ...+.+|+.+++.+. ||||+++++++.+....|+||||++++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 6799999999999987 57899999986542 346778999999996 999999999999999999999999999
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC---cEEEEeccccccccCCcccCCC
Q 002331 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRLKHNTFLSSKS 835 (935)
Q Consensus 759 sL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g---~VKL~DFGlA~~~~~~~~~~~s 835 (935)
+|.+++.+. ..+++..++.|+.||+.||.|||+++ |+||||||+||||+.++ .+||+|||+++...........
T Consensus 92 ~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 168 (325)
T 3kn6_A 92 ELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168 (325)
T ss_dssp BHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccc
Confidence 999999764 47999999999999999999999999 99999999999997665 8999999999876554444455
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-------HHHHHHhhccccccCCC----CcCcHH
Q 002331 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGAVGFQNRRLEIP----KELDPL 904 (935)
Q Consensus 836 ~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~-------~eil~~I~~~~~r~~ip----~~ls~~ 904 (935)
.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+. .++...+.. ....++ ..++++
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~ 246 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--GDFSFEGEAWKNVSQE 246 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT--TCCCCCSHHHHTSCHH
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc--CCCCCCcccccCCCHH
Confidence 6789999999999999999999999999999999999999987543 444555432 222222 357899
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+++||.+||+.| |.+||++.++++|||
T Consensus 247 ~~~li~~~L~~d---P~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 247 AKDLIQGLLTVD---PNKRLKMSGLRYNEW 273 (325)
T ss_dssp HHHHHHHHHCCC---TTTCCCTTTSTTCGG
T ss_pred HHHHHHHHCCCC---hhHCCCHHHHhcChh
Confidence 999999999999 999999999999999
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=387.41 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=221.4
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
++..++|++++.||+|+||.||+|++ .++.||||++... ........+.+|+.++++++|||||++++++.+
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 45678999999999999999999985 3557999998643 344556678899999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC---cE
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NV 815 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g---~V 815 (935)
....++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||++| |+||||||+||||+.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999996422 45899999999999999999999999 99999999999999555 59
Q ss_pred EEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc
Q 002331 816 KVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 892 (935)
Q Consensus 816 KL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~ 892 (935)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. ..
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 999999998643221 22233567899999999999999999999999999999998 999999999888877765 44
Q ss_pred cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 ~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+...+..+++.+.+||.+||+.| |.+||++.+|+++.+
T Consensus 303 ~~~~~~~~~~~~l~~li~~~l~~d---P~~Rps~~eil~~l~ 341 (367)
T 3l9p_A 303 GRMDPPKNCPGPVYRIMTQCWQHQ---PEDRPNFAIILERIE 341 (367)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCC---HhHCcCHHHHHHHHH
Confidence 456678889999999999999999 999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=400.58 Aligned_cols=252 Identities=29% Similarity=0.427 Sum_probs=221.7
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
.++|++.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36799999999999999999987 6889999999765432 23456788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee---cCCCcEEEEeccccccccC
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL---d~~g~VKL~DFGlA~~~~~ 828 (935)
|||+.+++|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+|||| +.++.+||+|||+++....
T Consensus 105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999998764 46999999999999999999999999 9999999999999 5678999999999986654
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CcCcHHHH
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVA 906 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip--~~ls~~L~ 906 (935)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..++...+.........+ ..+++.++
T Consensus 182 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 182 SK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred cc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 32 2234579999999999987 58999999999999999999999999999988888876554444433 46899999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||.+||+.| |.+||++.++|+|||
T Consensus 260 ~li~~~L~~d---p~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 260 DLIRKMLTYV---PSMRISARDALDHEW 284 (484)
T ss_dssp HHHHHHTCSS---GGGSCCHHHHHTSHH
T ss_pred HHHHHHCCCC---hhHCcCHHHHhhChh
Confidence 9999999999 999999999999998
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=365.30 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=222.8
Q ss_pred cCCCCCCeeEEE-EeeecCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 671 CEIPWEDLVLGE-RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 671 ~ei~~edy~I~e-~LG~G~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
+.+..++|.+.+ .||+|+||.||+|.+ .+..||||++.... .......+.+|+.++++++||||+++++++ ..
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 456667888877 999999999999975 56789999987653 445677889999999999999999999999 45
Q ss_pred CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
+.+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceee
Confidence 6799999999999999999876677999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcC
Q 002331 826 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (935)
Q Consensus 826 ~~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~l 901 (935)
...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......++...+. ...+..++..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~ 238 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC 238 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTC
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCCCCc
Confidence 643211 1223456889999999998889999999999999999998 999999988877776664 34556778899
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++.+.+||.+||+.| |.+||++.+|+++.+
T Consensus 239 ~~~l~~li~~~l~~~---p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 239 PPELYALMSDCWIYK---WEDRPDFLTVEQRMR 268 (287)
T ss_dssp CHHHHHHHHHTTCSS---GGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCC---hhhCcCHHHHHHHHH
Confidence 999999999999999 999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=366.03 Aligned_cols=257 Identities=35% Similarity=0.604 Sum_probs=207.7
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
...++..++|++.+.||+|+||.||+|++.+ .||||++............+.+|+.+|++++||||+++++++ ....+
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 3467888999999999999999999998765 599999987776777778899999999999999999999965 45678
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999999999999877778999999999999999999999999 99999999999999999999999999976542
Q ss_pred C--cccCCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH-Hhhccccc---cCCCC
Q 002331 829 T--FLSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG-AVGFQNRR---LEIPK 899 (935)
Q Consensus 829 ~--~~~~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~-~I~~~~~r---~~ip~ 899 (935)
. ........||+.|+|||++. +..++.++|||||||++|+|++|+.||.+........ .+...... ..+..
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence 1 12223457899999999987 5668889999999999999999999998865544433 33222222 23445
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 900 ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+++.+.+||.+||+.| |.+||++.+|++.
T Consensus 253 ~~~~~l~~li~~~l~~~---p~~Rps~~ell~~ 282 (289)
T 3og7_A 253 NCPKRMKRLMAECLKKK---RDERPSFPRILAE 282 (289)
T ss_dssp TSCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHccCC---hhhCCCHHHHHHH
Confidence 78999999999999999 9999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=361.50 Aligned_cols=252 Identities=27% Similarity=0.348 Sum_probs=214.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|+||.||+|.+ +++.||||++...... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 5799999999999999999987 5889999998765432 345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc--c
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--L 831 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~--~ 831 (935)
|+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++....... .
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999999999763 46899999999999999999999999 9999999999999999999999999998654221 2
Q ss_pred cCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~-eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
......|++.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+............+++.+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 2344678999999999988765 77999999999999999999999876543 222222222222233356899999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||+.| |.+||++.+|++|||
T Consensus 243 ~~~l~~~---p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 243 HKILVEN---PSARITIPDIKKDRW 264 (276)
T ss_dssp HHHSCSS---TTTSCCHHHHTTCTT
T ss_pred HHHCCCC---chhCCCHHHHhcCcc
Confidence 9999999 999999999999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=363.63 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=219.0
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC---C----HHHHHHHHHHHHHHHHcC-CCceeeeeccccc
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---S----GAALLEFKREVKIMRRLR-HPNVVLFMGAVTR 744 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~---~----~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~ 744 (935)
.++|++.+.||+|+||.||+|.+ +++.||||++..... . ......+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 47899999999999999999987 578999999876531 1 123456789999999995 9999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999999999753 46899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLR------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~------g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip 898 (935)
..... .......|++.|+|||++. ...++.++|||||||++|+|++|..||...+.......+.........+
T Consensus 173 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 173 QLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp ECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred hcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 76543 2234467899999999985 4567899999999999999999999999988877776664433333322
Q ss_pred --CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 --KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 --~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++..+.+||.+||+.| |.+||++.++|+|||
T Consensus 252 ~~~~~~~~l~~li~~~l~~d---p~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 252 EWDDYSDTVKDLVSRFLVVQ---PQKRYTAEEALAHPF 286 (298)
T ss_dssp TGGGSCHHHHHHHHHHCCSS---GGGSCCHHHHTTSGG
T ss_pred cccccCHHHHHHHHHHccCC---cccCCCHHHHHhChH
Confidence 468899999999999999 999999999999998
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=379.69 Aligned_cols=256 Identities=24% Similarity=0.315 Sum_probs=217.7
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
..++..++|++.+.||+|+||.||+|++. ++.||+|++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 34566789999999999999999999884 8899999987653 45566788999999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
+++||||+++++|.+++.+. ..+++..++.++.||+.||.|||.. | |+||||||+||||+.++.+||+|||++...
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 99999999999999999763 3689999999999999999999985 8 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh------------------
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV------------------ 888 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I------------------ 888 (935)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+
T Consensus 183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 183 IDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 432 223467999999999999999999999999999999999999999887665433221
Q ss_pred ------------------------hccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 889 ------------------------GFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 889 ------------------------~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.........+..++.++.+||.+||+.| |.+||+++++|+|||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN---PAERADLKQLMVHAF 327 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSS---TTTSCCHHHHHTSHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcC---hhhCCCHHHHhhChH
Confidence 1111111122457899999999999999 999999999999998
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=389.30 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=199.1
Q ss_pred CCeeEE-EEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHH-cCCCceeeeeccccc----CCc
Q 002331 676 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR-LRHPNVVLFMGAVTR----PPN 747 (935)
Q Consensus 676 edy~I~-e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~-L~HPNIVkl~g~~~~----~~~ 747 (935)
++|.+. +.||+|+||+||++.+ +++.||||++... ..+.+|+.++.+ ++||||++++++|.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 567776 7899999999999987 5788999998643 245678888754 489999999998865 567
Q ss_pred eEEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC---CCcEEEEecccc
Q 002331 748 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLS 823 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~VKL~DFGlA 823 (935)
+|||||||++|+|.+++.... ..+++..++.|+.||+.||.|||++| |+||||||+||||+. ++.+||+|||++
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 899999999999999997643 46999999999999999999999999 999999999999987 789999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH----HHHHhhccccccC--C
Q 002331 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ----VVGAVGFQNRRLE--I 897 (935)
Q Consensus 824 ~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~e----il~~I~~~~~r~~--i 897 (935)
+..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+... ....+........ .
T Consensus 212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 212 KETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp EECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred cccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 865433 22345688999999999999999999999999999999999999998764322 2223322222222 2
Q ss_pred CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 898 PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 898 p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...+++++.+||.+||+.| |.+||++.+|++|||
T Consensus 291 ~~~~s~~~~~li~~~L~~d---P~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTE---PTQRMTITEFMNHPW 324 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSS---GGGSCCHHHHHHSHH
T ss_pred cccCCHHHHHHHHHHCCCC---hhHCcCHHHHhcCcc
Confidence 2568999999999999999 999999999999998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=385.93 Aligned_cols=253 Identities=24% Similarity=0.296 Sum_probs=204.4
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC-----Cc
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PN 747 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~-----~~ 747 (935)
.++|++++.||+|+||.||+|.+ +++.||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 47899999999999999999987 578899999987655566677899999999999999999999998766 56
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+|+||||++ ++|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 999999996 5999999764 46999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCcc----------------------cCCCCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHcC-----------C
Q 002331 828 NTFL----------------------SSKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATL-----------K 873 (935)
Q Consensus 828 ~~~~----------------------~~~s~~GT~~Y~APEvl-~g~~~s~ksDIWSLG~ILyELLTG-----------~ 873 (935)
.... .....+||++|+|||++ .+..++.++|||||||++|||++| .
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 3211 12456899999999986 566699999999999999999984 4
Q ss_pred CCCCCCCh-----------------HHHH------------------------HHhhccccccCC-----CCcCcHHHHH
Q 002331 874 LPWIGMNP-----------------MQVV------------------------GAVGFQNRRLEI-----PKELDPLVAR 907 (935)
Q Consensus 874 ~PF~~~~~-----------------~eil------------------------~~I~~~~~r~~i-----p~~ls~~L~d 907 (935)
++|.+.+. ...+ ..+......... ...+++.+.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 44444321 1111 111100111111 1457899999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
||.+||+.| |.+||+++|+|+|||
T Consensus 341 Ll~~mL~~d---P~~R~ta~e~L~Hp~ 364 (432)
T 3n9x_A 341 LLESMLKFN---PNKRITIDQALDHPY 364 (432)
T ss_dssp HHHHHSCSS---TTTSCCHHHHHTCGG
T ss_pred HHHHHhcCC---cccCCCHHHHhcChh
Confidence 999999999 999999999999998
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=369.92 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=210.7
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
..++|++.+.||+|+||.||+|++ .++.||||++..... .......+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 347899999999999999999986 578999999866433 44566789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||+++++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 89 v~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999999764 46899999999999999999999999 9999999999999999999999999998765432
Q ss_pred -ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---cCCCCcCcHHHH
Q 002331 831 -LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---LEIPKELDPLVA 906 (935)
Q Consensus 831 -~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r---~~ip~~ls~~L~ 906 (935)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.............+ ..++..+++.+.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 2233457999999999999999999999999999999999999999998877665444322211 234567899999
Q ss_pred HHHHHHHhhCCCCcCCCc-CHHHHH
Q 002331 907 RIIWECWQTGWSSLHIRT-SQAQLS 930 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRP-Sa~EIL 930 (935)
++|.+||..| |.+|| ++++++
T Consensus 246 ~li~~~l~~d---p~~R~~~~~~l~ 267 (294)
T 4eqm_A 246 NVILRATEKD---KANRYKTIQEMK 267 (294)
T ss_dssp HHHHHHSCSS---GGGSCSSHHHHH
T ss_pred HHHHHHhcCC---HhHccccHHHHH
Confidence 9999999999 99999 555544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=405.30 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=222.6
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
.+..++|.+.+.||+|+||.||+|++ +|+.||||++....... .....+.+|+.+|+.++||||++++++|.+...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 35568899999999999999999987 58899999987543211 2245678999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 749 SIITEFLPRGSLFRILHRP---HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~---~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
||||||+++|+|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+||||+.+|++||+|||+++.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999999998653 346899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhccccccCCCCcC
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQNRRLEIPKEL 901 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~----~~eil~~I~~~~~r~~ip~~l 901 (935)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..++...+. .....+|..+
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~~ 416 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKF 416 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTTS
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCccc
Confidence 6554333445689999999999999999999999999999999999999998753 344544443 3455678889
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPS-----a~EILqHPF 934 (935)
++.+++||.+||+.| |.+||+ +++|++|||
T Consensus 417 s~~~~~li~~lL~~d---P~~R~~~~~~~a~ei~~Hpf 451 (543)
T 3c4z_A 417 SPASKDFCEALLQKD---PEKRLGFRDGSCDGLRTHPL 451 (543)
T ss_dssp CHHHHHHHHHHSCSS---GGGSCCCBTTBSHHHHTSGG
T ss_pred CHHHHHHHHHhccCC---HhHCCCCcccCHHHHHcCcc
Confidence 999999999999999 999995 589999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=392.21 Aligned_cols=250 Identities=32% Similarity=0.555 Sum_probs=219.8
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC-c
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-N 747 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~-~ 747 (935)
..+++..++|++.+.||+|+||.||+|+++++.||||+++... ....+.+|+.+|++++|||||++++++.... .
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 4577888999999999999999999999999999999987654 2456889999999999999999999976655 7
Q ss_pred eEEEEeeCCCCCHHHHHcCCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~-~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
++|||||+++|+|.+++.+.+. .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999976433 4789999999999999999999999 999999999999999999999999999854
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHH
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. ...+...|..+++.+
T Consensus 340 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 340 SST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 415 (450)
T ss_dssp C---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHH
Confidence 332 223467889999999999999999999999999999998 999999988777776664 445677889999999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.+||.+||+.| |.+||++.+|++
T Consensus 416 ~~li~~cl~~d---p~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLD---AATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHcCCC---hhHCcCHHHHHH
Confidence 99999999999 999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=397.82 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=216.1
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-----------HHHHHHHHHHHHHHHcCCCceeeeecc
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-----------AALLEFKREVKIMRRLRHPNVVLFMGA 741 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-----------~~~~~f~~Ei~iL~~L~HPNIVkl~g~ 741 (935)
.++|.++++||+|+||+||+|++ .++.||||++....... .....+.+|+.+|++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 36899999999999999999987 57889999987654322 234578899999999999999999999
Q ss_pred cccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC---cEEEE
Q 002331 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVS 818 (935)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g---~VKL~ 818 (935)
+.+...+|||||||++|+|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+||||+.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEE
Confidence 99999999999999999999988653 46999999999999999999999999 99999999999998776 69999
Q ss_pred eccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCC-
Q 002331 819 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI- 897 (935)
Q Consensus 819 DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~i- 897 (935)
|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+.........
T Consensus 192 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 192 DFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred ECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 99999876543 23345679999999999875 5889999999999999999999999999998888877544333222
Q ss_pred -CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 898 -PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 898 -p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...+++.+++||.+||+.| |.+||+++++|+|||
T Consensus 270 ~~~~~s~~~~~li~~~L~~d---p~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYD---YNKRCTAEEALNSRW 304 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSS---TTTSCCHHHHHTSHH
T ss_pred ccCCCCHHHHHHHHHHcCCC---hhHCCCHHHHhcCHh
Confidence 2568999999999999999 999999999999998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=367.63 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=215.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|.+.+.||+|+||.||++++ +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 5799999999999999999987 588999999876432 223467899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee---cCCCcEEEEeccccccccCCc
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL---d~~g~VKL~DFGlA~~~~~~~ 830 (935)
|+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 99999999998653 46899999999999999999999999 9999999999999 78899999999999765432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cCCCCcCcHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDPLVARI 908 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r--~~ip~~ls~~L~dL 908 (935)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+...... ...+..+++.+.+|
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 241 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 122346899999999999999999999999999999999999999998888777766433322 23446789999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||+.| |.+||++.++|+|||
T Consensus 242 i~~~l~~d---p~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 242 ICHLLEKD---PNERYTCEKALSHPW 264 (304)
T ss_dssp HHHHHCSS---TTTSCCHHHHHTSHH
T ss_pred HHHHcCCC---hhHCcCHHHHhcCcc
Confidence 99999999 999999999999998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=366.93 Aligned_cols=253 Identities=30% Similarity=0.495 Sum_probs=210.5
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc-
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR- 744 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~- 744 (935)
++..++|++++.||+|+||.||+|++ .++.||||++... .......+.+|+.+|++++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 45568899999999999999999984 5788999998754 34556778999999999999999999998854
Q ss_pred -CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccc
Q 002331 745 -PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (935)
Q Consensus 745 -~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA 823 (935)
...+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 45689999999999999999876667999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH----------------HH
Q 002331 824 RLKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----------------QV 884 (935)
Q Consensus 824 ~~~~~~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~----------------ei 884 (935)
....... .......++..|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 8764332 1122345677899999999999999999999999999999999998754221 11
Q ss_pred HHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 885 VGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 885 l~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
...+ ....+...+..+++.+.+||.+||+.| |.+||++.+|++.
T Consensus 242 ~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~el~~~ 285 (295)
T 3ugc_A 242 IELL-KNNGRLPRPDGCPDEIYMIMTECWNNN---VNQRPSFRDLALR 285 (295)
T ss_dssp HHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSS---GGGSCCHHHHHHH
T ss_pred HHHH-hccCcCCCCcCcCHHHHHHHHHHcCCC---hhhCCCHHHHHHH
Confidence 1122 234556678889999999999999999 9999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=372.67 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=208.6
Q ss_pred CCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC--ceEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLSI 750 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~--~l~L 750 (935)
.++|++.+.||+|+||+||+|++. ++.||||++...... .....+.+|+.+|++++||||+++++++.... .+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 468999999999999999999884 889999998754322 22456779999999999999999999987655 7899
Q ss_pred EEeeCCCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee----cCCCcEEEEeccccc
Q 002331 751 ITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR 824 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~--~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL----d~~g~VKL~DFGlA~ 824 (935)
||||+++++|.+++.... ..+++..++.|+.||+.||.|||++| |+||||||+|||| +.++.+||+|||+++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999997643 23899999999999999999999999 9999999999999 788889999999998
Q ss_pred cccCCcccCCCCCCCCCccCccccc--------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccc
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQN 892 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~--------g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~----~eil~~I~~~~ 892 (935)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||..... .++...+....
T Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred ecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 765442 234467999999999986 56789999999999999999999999975332 33333332111
Q ss_pred c-----------------------ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCc
Q 002331 893 R-----------------------RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKR 933 (935)
Q Consensus 893 ~-----------------------r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHP 933 (935)
. ...++..++..+.+||.+||+.| |.+||+++|+|+||
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d---P~~R~s~~ell~h~ 304 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD---QEKCWGFDQFFAET 304 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCC---TTTSCCHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCC---hhhhccHHHhhhcc
Confidence 1 01233456778999999999999 99999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=377.06 Aligned_cols=256 Identities=29% Similarity=0.390 Sum_probs=210.1
Q ss_pred cccccCCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 667 e~~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
...++.+..++|++++.||+|+||.||+|++.++.||||++.... .....+.+|+.+|++++|||||++++++....
T Consensus 15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp CCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 344566778899999999999999999999999999999986543 33445667999999999999999999998754
Q ss_pred c----eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCEEeeCCCCCCeeecCC
Q 002331 747 N----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS----------TPTIVHRDLKSPNLLVDKN 812 (935)
Q Consensus 747 ~----l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~----------g~~IIHrDLKPeNILLd~~ 812 (935)
. +++||||+++|+|.+++.+ ..+++..++.|+.||+.||.|||+. + |+||||||+||||+.+
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNN 167 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTT
T ss_pred CCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCC
Confidence 3 6999999999999999976 3589999999999999999999998 7 9999999999999999
Q ss_pred CcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCC-----
Q 002331 813 WNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNE-----PSNEKCDVYSFGVILWELATLKLPWIGMN----- 880 (935)
Q Consensus 813 g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~-----~~s~ksDIWSLG~ILyELLTG~~PF~~~~----- 880 (935)
+.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 9999999999987654322 23345799999999999874 34668899999999999999999997642
Q ss_pred -----------hHHHHHHhhccccccCCCC-----cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 881 -----------PMQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 881 -----------~~eil~~I~~~~~r~~ip~-----~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
...+...+.....++.++. ..++.+.+||.+||+.| |.+||++.+|++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d---P~~Rps~~ell~~ 312 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD---AEARLSAGCVGER 312 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCC---hhhCcCHHHHHHH
Confidence 2233333333333333332 23456999999999999 9999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=370.77 Aligned_cols=258 Identities=29% Similarity=0.499 Sum_probs=223.9
Q ss_pred ccccCCCCCCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceee
Q 002331 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 737 (935)
Q Consensus 668 ~~~~ei~~edy~I~e~LG~G~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVk 737 (935)
...+++..++|++++.||+|+||.||+|++. +..||||++.... .......+.+|+.+++++ +||||++
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 3456778899999999999999999999863 4679999987543 445667889999999999 8999999
Q ss_pred eecccccCCceEEEEeeCCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCC
Q 002331 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 802 (935)
Q Consensus 738 l~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDL 802 (935)
+++++...+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dl 183 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDL 183 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCC
Confidence 9999999999999999999999999997643 24889999999999999999999999 999999
Q ss_pred CCCCeeecCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002331 803 KSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 879 (935)
Q Consensus 803 KPeNILLd~~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~ 879 (935)
||+||||+.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 184 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999999999987654321 2233456788999999999889999999999999999999 99999999
Q ss_pred ChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 880 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 880 ~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
...++...+. ...+..++..++..+.+||.+||+.| |.+||++.+|+++
T Consensus 264 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~ell~~ 312 (334)
T 2pvf_A 264 PVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAV---PSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred CHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCC---hhhCcCHHHHHHH
Confidence 8887776654 34456677889999999999999999 9999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=378.29 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=218.9
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCH---------------HHHHHHHHHHHHHHHcCCCcee
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG---------------AALLEFKREVKIMRRLRHPNVV 736 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~---------------~~~~~f~~Ei~iL~~L~HPNIV 736 (935)
.+..++|++++.||+|+||.||+|+++++.||||++....... .....+.+|+.++++++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 3456899999999999999999999999999999987543211 1126788999999999999999
Q ss_pred eeecccccCCceEEEEeeCCCCCHHHH------HcCC-CCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCee
Q 002331 737 LFMGAVTRPPNLSIITEFLPRGSLFRI------LHRP-HCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLL 808 (935)
Q Consensus 737 kl~g~~~~~~~l~LVmEy~~gGsL~dl------L~~~-~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNIL 808 (935)
++++++.+.+.+++||||+++++|.++ +.+. ...+++..++.++.||+.||.|||+ +| |+||||||+|||
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEE
Confidence 999999999999999999999999998 5542 4679999999999999999999999 88 999999999999
Q ss_pred ecCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCC-CCCc-hhHHHHHHHHHHHHHcCCCCCCCCCh-HHHH
Q 002331 809 VDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNE-KCDVYSFGVILWELATLKLPWIGMNP-MQVV 885 (935)
Q Consensus 809 Ld~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~-~~s~-ksDIWSLG~ILyELLTG~~PF~~~~~-~eil 885 (935)
|+.++.+||+|||++...... ......|++.|+|||++.+. .++. ++|||||||++|+|++|..||..... .+..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999999999876443 23456789999999999887 5665 99999999999999999999998776 6666
Q ss_pred HHhhccccccCCC-------------------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 886 GAVGFQNRRLEIP-------------------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 886 ~~I~~~~~r~~ip-------------------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+... ...++ ..+++.+.+||.+||+.| |.+||++.++++|||
T Consensus 263 ~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d---P~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 263 NNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN---PAERITSEDALKHEW 325 (348)
T ss_dssp HHHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSS---GGGSCCHHHHHTSGG
T ss_pred HHHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCC---hhhCCCHHHHhcCcc
Confidence 555322 33333 568999999999999999 999999999999998
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=381.73 Aligned_cols=244 Identities=22% Similarity=0.333 Sum_probs=212.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHH------HHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~------~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
++|++.+.||+|+||.||+|.+ +++.||||++........ ....+.+|+.+|++++||||++++++|.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 6899999999999999999976 688999999986543221 33456789999999999999999999999999
Q ss_pred eEEEEeeCCCC-CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRG-SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gG-sL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
+++||||+.+| +|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999776 999999764 46999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHH
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
.... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .......+..+++.+
T Consensus 181 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~l 251 (335)
T 3dls_A 181 ERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------VEAAIHPPYLVSKEL 251 (335)
T ss_dssp CTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------TTTCCCCSSCCCHHH
T ss_pred CCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------HhhccCCCcccCHHH
Confidence 5432 2334679999999999998876 88999999999999999999999864321 223344566789999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||.+||+.| |.+||++.+|++|||
T Consensus 252 ~~li~~~L~~d---P~~Rps~~ell~hp~ 277 (335)
T 3dls_A 252 MSLVSGLLQPV---PERRTTLEKLVTDPW 277 (335)
T ss_dssp HHHHHHHTCSS---GGGSCCHHHHHHCTT
T ss_pred HHHHHHHccCC---hhhCcCHHHHhcCcc
Confidence 99999999999 999999999999999
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=375.44 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=211.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCce---
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL--- 748 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l--- 748 (935)
.++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999986 688999999977543 345566789999999999999999999998766543
Q ss_pred -EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 749 -SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 749 -~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 9999999999999999753 46899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCcCc
Q 002331 828 NTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELD 902 (935)
Q Consensus 828 ~~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--~ip~~ls 902 (935)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+................. .....++
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 321 12234568999999999999999999999999999999999999999988877665543222211 1235689
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+++.+||.+||+.| |.+||+..+++.|+|
T Consensus 248 ~~l~~li~~~l~~d---P~~R~~~~~~l~~~l 276 (311)
T 3ork_A 248 ADLDAVVLKALAKN---PENRYQTAAEMRADL 276 (311)
T ss_dssp HHHHHHHHHHTCSS---GGGSCSSHHHHHHHH
T ss_pred HHHHHHHHHHHhcC---HhhChhhHHHHHHHH
Confidence 99999999999999 999999999999887
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=365.28 Aligned_cols=255 Identities=26% Similarity=0.439 Sum_probs=212.5
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
+..++|.....||+|+||.||+|++ +++.||||++.... ......+.+|+.+++.++||||+++++++...+.+++
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 4445566666899999999999987 57789999987653 2345678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC-CCcEEEEecccccccc
Q 002331 751 ITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKH 827 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~--~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~VKL~DFGlA~~~~ 827 (935)
||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+. ++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 999999999999997542 34678999999999999999999998 999999999999987 8999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccCCCCcCcHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~--~s~ksDIWSLG~ILyELLTG~~PF~~~~~~-eil~~I~~~~~r~~ip~~ls~~ 904 (935)
..........|++.|+|||++.+.. ++.++|||||||++|+|++|+.||...... ..............++..+++.
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAE 254 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHH
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHH
Confidence 4333334567999999999997643 789999999999999999999999865432 2222222334556778889999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+.+||.+||+.| |.+||++.++|+|||
T Consensus 255 ~~~li~~~l~~d---p~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 255 AKAFILKCFEPD---PDKRACANDLLVDEF 281 (295)
T ss_dssp HHHHHHHTTCSS---TTTSCCHHHHHTSGG
T ss_pred HHHHHHHHccCC---hhhCCCHHHHhcChh
Confidence 999999999999 999999999999998
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=383.82 Aligned_cols=253 Identities=28% Similarity=0.495 Sum_probs=210.8
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
++..++|.+.+.||+|+||.||+|++ .+..||||++.... .......+.+|+.+|++++||||+++++++.+.+
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 45667899999999999999999975 35679999986543 4556678999999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+++||||+++++|.+++.+....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999999887778999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCc
Q 002331 827 HNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902 (935)
Q Consensus 827 ~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls 902 (935)
..... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......++...+. ...+...+..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 276 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCP 276 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTTCB
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccc
Confidence 54321 1122345778999999999999999999999999999998 999999998888777664 334555677899
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
..+.+||.+||+.| |.+||++.+|++
T Consensus 277 ~~l~~li~~cl~~d---p~~RPs~~~i~~ 302 (373)
T 2qol_A 277 AALYQLMLDCWQKD---RNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCcC---hhhCcCHHHHHH
Confidence 99999999999999 999999999886
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=368.14 Aligned_cols=260 Identities=29% Similarity=0.474 Sum_probs=220.7
Q ss_pred cccccCCCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeee
Q 002331 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (935)
Q Consensus 667 e~~~~ei~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl 738 (935)
....+++..++|++++.||+|+||.||+|++ .++.||||++.... .......+.+|+.++.++ +||||+++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 3345677889999999999999999999974 34789999987553 445566789999999999 79999999
Q ss_pred ecccccCC-ceEEEEeeCCCCCHHHHHcCCCCC---------------CCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCC
Q 002331 739 MGAVTRPP-NLSIITEFLPRGSLFRILHRPHCQ---------------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 802 (935)
Q Consensus 739 ~g~~~~~~-~l~LVmEy~~gGsL~dlL~~~~~~---------------lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDL 802 (935)
++++...+ .+++||||+++++|.+++...... +++..++.++.||+.||.|||+++ |+||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~di 174 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 174 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccC
Confidence 99987654 489999999999999999764332 889999999999999999999999 999999
Q ss_pred CCCCeeecCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 002331 803 KSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 879 (935)
Q Consensus 803 KPeNILLd~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~ 879 (935)
||+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999999998654321 12233457889999999999999999999999999999998 99999887
Q ss_pred ChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 880 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 880 ~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
..................+..+++.+.++|.+||+.| |.+||++.+|++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~ell~~ 304 (316)
T 2xir_A 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE---PSQRPTFSELVEH 304 (316)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred chhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 6544443333344556777889999999999999999 9999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=379.46 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=204.2
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC------
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~------ 746 (935)
.++|++++.||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47899999999999999999976 5889999999876556666778899999999999999999999987665
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+|+||||+++ +|.+++.. .+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 68999999975 78888864 4889999999999999999999999 999999999999999999999999999866
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------ 894 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r------------ 894 (935)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 178 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 178 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred ccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 543 2234467999999999999999999999999999999999999999998877665554321110
Q ss_pred --------cC--------------CCC------cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 --------LE--------------IPK------ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 --------~~--------------ip~------~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+. +|. ..+..+++||.+||+.| |.+|||++++|+|||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d---P~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID---ASKRISVDEALQHPY 321 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSS---GGGSCCHHHHHHSHH
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCC---hhhCCCHHHHhCCcc
Confidence 00 010 12578999999999999 999999999999998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=369.44 Aligned_cols=257 Identities=30% Similarity=0.494 Sum_probs=222.6
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~ 741 (935)
..+++..++|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 346677789999999999999999999753 5789999987543 34455678899999999999999999999
Q ss_pred cccCCceEEEEeeCCCCCHHHHHcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC
Q 002331 742 VTRPPNLSIITEFLPRGSLFRILHRP---------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812 (935)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~~~---------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~ 812 (935)
+.+.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.+
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED 174 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC
Confidence 99999999999999999999998642 135789999999999999999999999 9999999999999999
Q ss_pred CcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhh
Q 002331 813 WNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 889 (935)
Q Consensus 813 g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~ 889 (935)
+.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 9999999999986543321 1233456889999999999999999999999999999999 899999998887777664
Q ss_pred ccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 890 FQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 890 ~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.......+..+++.+.+||.+||+.| |.+||++.+++++
T Consensus 255 -~~~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 -EGGLLDKPDNCPDMLFELMRMCWQYN---PKMRPSFLEIISS 293 (322)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCC---cccCcCHHHHHHH
Confidence 33445667889999999999999999 9999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=368.76 Aligned_cols=259 Identities=28% Similarity=0.430 Sum_probs=198.4
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
.+.+..++|++.+.||+|+||.||+|.+ +++.||||++..... ......+.+|+.++++++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 3567789999999999999999999976 688999998865432 2335567899999999999999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 748 LSIITEFLPRGSLFRILHR-------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~-------~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEec
Confidence 9999999999999999863 3456899999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCc-----ccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-
Q 002331 821 GLSRLKHNTF-----LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR- 893 (935)
Q Consensus 821 GlA~~~~~~~-----~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~- 893 (935)
|++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9987654321 11234578999999999876 5689999999999999999999999998776655443321111
Q ss_pred -------ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 -------RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 -------r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.......++..+.+||.+||+.| |.+||++.+|++|||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~d---p~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKD---PEKRPTAAELLRHKF 290 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSS---GGGSCCHHHHHTSTT
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCC---hhhCcCHHHHhhChh
Confidence 11233567899999999999999 999999999999998
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=405.92 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=221.4
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCce
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 748 (935)
.+..++|++.+.||+|+||.||+|++ +|+.||||++...... ......+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 45668899999999999999999987 5889999998754321 12244578999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 749 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
||||||+++|+|.+++.... ..+++..++.++.||+.||.|||++| ||||||||+||||+.+|++||+|||+++...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999987643 35899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhccccccCCCCcCcH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~----~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ...+...+ ...+..++..+++
T Consensus 338 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~~~~~~p~~~s~ 414 (576)
T 2acx_A 338 EGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KEVPEEYSERFSP 414 (576)
T ss_dssp TTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HHCCCCCCTTSCH
T ss_pred cCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hcccccCCccCCH
Confidence 432 2234689999999999999999999999999999999999999998753 33444443 2345567788999
Q ss_pred HHHHHHHHHHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
++++||.+||+.| |.+|| ++++|++|||
T Consensus 415 ~~~dLI~~lL~~d---P~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 415 QARSLCSQLLCKD---PAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp HHHHHHHHHTCSS---GGGSTTCSSSHHHHHHTSGG
T ss_pred HHHHHHHHhccCC---HHHcCCCCCCCHHHHHhChh
Confidence 9999999999999 99999 8999999998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=379.41 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=206.6
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc-----
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----- 744 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~----- 744 (935)
+...++|++++.||+|+||+||+|++ +++.||||++...... ..+|+.+|+.++|||||+++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 34567899999999999999999987 6889999998754321 2379999999999999999999843
Q ss_pred ---------------------------------CCceEEEEeeCCCCCHHHHHc---CCCCCCCHHHHHHHHHHHHHHHH
Q 002331 745 ---------------------------------PPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMN 788 (935)
Q Consensus 745 ---------------------------------~~~l~LVmEy~~gGsL~dlL~---~~~~~lse~~il~Ia~QIa~AL~ 788 (935)
...+++||||+++ +|.+++. +....+++..++.|+.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3348899999985 7777664 23457999999999999999999
Q ss_pred HHHhcCCCEEeeCCCCCCeeec-CCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHH
Q 002331 789 CLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVIL 866 (935)
Q Consensus 789 yLHs~g~~IIHrDLKPeNILLd-~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~IL 866 (935)
|||++| |+||||||+||||+ .++.+||+|||+++..... .......+|+.|+|||++.+.. ++.++|||||||++
T Consensus 156 ~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999999 99999999999998 6899999999999876443 2334567899999999988754 89999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHhhcccc---------------------------ccCCCCcCcHHHHHHHHHHHhhCCCC
Q 002331 867 WELATLKLPWIGMNPMQVVGAVGFQNR---------------------------RLEIPKELDPLVARIIWECWQTGWSS 919 (935)
Q Consensus 867 yELLTG~~PF~~~~~~eil~~I~~~~~---------------------------r~~ip~~ls~~L~dLI~qCL~~D~ss 919 (935)
|+|++|+.||.+.+..+.+..+..... ...++..+++++.+||.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d--- 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE--- 309 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS---
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC---
Confidence 999999999999887766554421100 11145668899999999999999
Q ss_pred cCCCcCHHHHHhCcC
Q 002331 920 LHIRTSQAQLSHKRF 934 (935)
Q Consensus 920 P~kRPSa~EILqHPF 934 (935)
|.+||++.|+|+|||
T Consensus 310 P~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 310 PDLRINPYEAMAHPF 324 (383)
T ss_dssp GGGSCCHHHHHTSGG
T ss_pred hhhCCCHHHHhcCHH
Confidence 999999999999998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=366.02 Aligned_cols=252 Identities=23% Similarity=0.396 Sum_probs=213.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC--HHHHHHHHHHHHHHHHcCCCceeeeeccc--ccCCce
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAV--TRPPNL 748 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~--~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~--~~~~~l 748 (935)
.++|++++.||+|+||.||++.+ +++.||||++...... ......+.+|+.+++.++||||+++++++ .+...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36899999999999999999987 5779999998754321 23456789999999999999999999998 455679
Q ss_pred EEEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 749 SIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
++||||++++ |.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 9999999876 6666643 3457899999999999999999999999 9999999999999999999999999998654
Q ss_pred CC--cccCCCCCCCCCccCcccccCCCC--CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 828 NT--FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 828 ~~--~~~~~s~~GT~~Y~APEvl~g~~~--s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
.. ........||+.|+|||++.+... +.++|||||||++|+|++|..||.+.+..+....+. .....++..+++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~--~~~~~~~~~~~~ 238 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG--KGSYAIPGDCGP 238 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HCCCCCCSSSCH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh--cCCCCCCCccCH
Confidence 32 122234568999999999987543 789999999999999999999999988887777664 335567788999
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+.+||.+||+.| |.+||++.++++|||
T Consensus 239 ~l~~li~~~l~~d---p~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 239 PLSDLLKGMLEYE---PAKRFSIRQIRQHSW 266 (305)
T ss_dssp HHHHHHHHHTCSS---TTTSCCHHHHHHSHH
T ss_pred HHHHHHHHHccCC---hhhCCCHHHHhcCcc
Confidence 9999999999999 999999999999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=356.45 Aligned_cols=253 Identities=31% Similarity=0.538 Sum_probs=219.5
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
.++++..++|++.+.||+|+||.||+|.+. +..||||++...... ...+.+|+.+++.++||||+++++++.. +.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence 356788899999999999999999999875 558999998765433 3568899999999999999999999874 56
Q ss_pred eEEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++...
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 899999999999999997532 26899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 827 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 827 ~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
..... ......++..|+|||++.+..++.++|||||||++|+|++ |+.||.+....+....+. .......+..+++.
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCcccccHH
Confidence 54322 2233457889999999998889999999999999999999 999999988887776664 33455667889999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+.+||.+||..| |.+||++.+|++
T Consensus 239 l~~li~~~l~~~---p~~Rps~~~l~~ 262 (279)
T 1qpc_A 239 LYQLMRLCWKER---PEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHhccC---hhhCCCHHHHHH
Confidence 999999999999 999999999876
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=365.53 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=214.4
Q ss_pred cccccCCCCCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecc
Q 002331 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741 (935)
Q Consensus 667 e~~~~ei~~edy~I~e~LG~G~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~ 741 (935)
....+.+..++|.+++.||+|+||.||+|++. +..||||++............+.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 44566778899999999999999999999752 3479999998776666777889999999999999999999999
Q ss_pred cccCC-----ceEEEEeeCCCCCHHHHHc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC
Q 002331 742 VTRPP-----NLSIITEFLPRGSLFRILH-----RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 811 (935)
Q Consensus 742 ~~~~~-----~l~LVmEy~~gGsL~dlL~-----~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~ 811 (935)
+.... ..++||||+++++|.+++. .....+++..++.|+.||+.||.|||+++ |+||||||+||||+.
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~ 182 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRD 182 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECT
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcC
Confidence 87654 3599999999999999983 23356899999999999999999999998 999999999999999
Q ss_pred CCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHh
Q 002331 812 NWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAV 888 (935)
Q Consensus 812 ~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I 888 (935)
++.+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 262 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 9999999999998654332 11233457789999999999999999999999999999999 89999998887776655
Q ss_pred hccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 889 GFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 889 ~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
. ...+...+..+++.+.+||.+||..| |.+||++.+|+++
T Consensus 263 ~-~~~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~~l~~~ 302 (313)
T 3brb_A 263 L-HGHRLKQPEDCLDELYEIMYSCWRTD---PLDRPTFSVLRLQ 302 (313)
T ss_dssp H-TTCCCCCBTTCCHHHHHHHHHTTCSS---GGGSCCHHHHHHH
T ss_pred H-cCCCCCCCccccHHHHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 4 34456677889999999999999999 9999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=370.14 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=204.0
Q ss_pred CCeeEE-EEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEE
Q 002331 676 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 676 edy~I~-e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LV 751 (935)
++|++. +.||+|+||.||+|++ +++.||||++...... ....+.+|+.++.++ +||||+++++++.+.+.+++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 568884 7899999999999976 6889999998765322 345678999999985 799999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc---EEEEeccccccccC
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHN 828 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~---VKL~DFGlA~~~~~ 828 (935)
|||+++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++. +||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 9999999999999763 46899999999999999999999999 999999999999987766 99999999876532
Q ss_pred Cc-------ccCCCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---------------
Q 002331 829 TF-------LSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNP--------------- 881 (935)
Q Consensus 829 ~~-------~~~~s~~GT~~Y~APEvl~g-----~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~--------------- 881 (935)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 11 11223469999999999975 4578899999999999999999999987542
Q ss_pred HHHHHHhhccccccCCC----CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 882 MQVVGAVGFQNRRLEIP----KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 882 ~eil~~I~~~~~r~~ip----~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+...+. .....++ ..+++.+++||.+||+.| |.+||++.++|+|||
T Consensus 247 ~~~~~~i~--~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 247 NMLFESIQ--EGKYEFPDKDWAHISCAAKDLISKLLVRD---AKQRLSAAQVLQHPW 298 (316)
T ss_dssp HHHHHHHH--HCCCCCCHHHHTTSCHHHHHHHHHHSCSS---TTTSCCHHHHHHSTT
T ss_pred HHHHHHHh--ccCcccCchhcccCCHHHHHHHHHHhhCC---hhhCCCHHHHhcChh
Confidence 22333332 2223333 458899999999999999 999999999999999
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=370.00 Aligned_cols=255 Identities=28% Similarity=0.469 Sum_probs=216.8
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEEC------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
.++..++|.+.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.++++++||||+++++++.+
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 4677789999999999999999999763 2359999987543 44556678999999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
.+.++|||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999999999999876678999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCc
Q 002331 825 LKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (935)
Q Consensus 825 ~~~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ 900 (935)
....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......++...+. ...+...+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 274 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD 274 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCCCccc
Confidence 7643221 1222346788999999999999999999999999999999 999999998888777664 3345566788
Q ss_pred CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 901 LDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 901 ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+++.+.+||.+||+.| |.+||++.+|+++
T Consensus 275 ~~~~l~~li~~~l~~~---p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 275 CPSAIYQLMMQCWQQE---RARRPKFADIVSI 303 (333)
T ss_dssp CBHHHHHHHHHHTCSS---TTTSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 9999999999999999 9999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=360.58 Aligned_cols=255 Identities=29% Similarity=0.460 Sum_probs=216.7
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
.+.+..++|++.+.||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 34567789999999999999999999763 2359999887653 34556788999999999999999999999875
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
+..++||||+++++|.+++.+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCc
Confidence 4578999999999999999776667999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCc
Q 002331 825 LKHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902 (935)
Q Consensus 825 ~~~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls 902 (935)
....... ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...........+. .......+..++
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 240 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCP 240 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTCC
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCCC
Confidence 7654321 2233457789999999999999999999999999999998 999999877776665553 334556778899
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+.+.+||.+||..| |.+||++.+|+++
T Consensus 241 ~~l~~li~~~l~~~---p~~Rps~~ell~~ 267 (281)
T 3cc6_A 241 PVLYTLMTRCWDYD---PSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCC---chhCcCHHHHHHH
Confidence 99999999999999 9999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=375.98 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=217.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC--CH----HHHHHHHHHHHHHHHc-CCCceeeeecccccCC
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF--SG----AALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~--~~----~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~ 746 (935)
++|.+.+.||+|+||.||+|++ +|+.||||++..... .. .....+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999987 588999999876532 21 2345678999999999 8999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 999999999999999999753 46899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRN------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-- 898 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g------~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip-- 898 (935)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.........+
T Consensus 251 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 251 EPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 543 22345689999999999864 357889999999999999999999999988877776664333332222
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++..+.+||.+||+.| |.+||++.++|+|||
T Consensus 330 ~~~~~~~~~li~~~L~~d---P~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVD---PEARLTAEQALQHPF 362 (365)
T ss_dssp SSSCHHHHHHHHHHSCSS---TTTSCCHHHHHHSGG
T ss_pred ccCCHHHHHHHHHHcCCC---hhHCcCHHHHhcCcc
Confidence 467889999999999999 999999999999998
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=369.73 Aligned_cols=257 Identities=27% Similarity=0.427 Sum_probs=220.8
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~g-------~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~ 741 (935)
.+++..++|++++.||+|+||.||+|.+.+ ..||||++.... .......+.+|+.+++.+ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 467888999999999999999999998732 379999987553 344567789999999999 89999999999
Q ss_pred cccCCceEEEEeeCCCCCHHHHHcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCee
Q 002331 742 VTRPPNLSIITEFLPRGSLFRILHRP-------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLL 808 (935)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~~~-------------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNIL 808 (935)
+.+.+.+++||||+++|+|.+++.+. ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl 196 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVL 196 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEE
Confidence 99999999999999999999998642 245799999999999999999999998 999999999999
Q ss_pred ecCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 002331 809 VDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVV 885 (935)
Q Consensus 809 Ld~~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil 885 (935)
|+.++.+||+|||++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999986543221 1233456788999999999999999999999999999998 89999987665555
Q ss_pred HHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 886 GAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 886 ~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
..+.........+..+++.+.+||.+||+.| |.+||++.+|+++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~---p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALE---PTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccC---hhhCcCHHHHHHH
Confidence 4444445556677888999999999999999 9999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=367.10 Aligned_cols=252 Identities=28% Similarity=0.380 Sum_probs=210.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE---CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc---CCCceeeeecccc-----c
Q 002331 676 EDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVT-----R 744 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~---~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L---~HPNIVkl~g~~~-----~ 744 (935)
++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 6899999999999999999987 467899999875443222223455777777766 8999999999986 5
Q ss_pred CCceEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA 823 (935)
...+++||||++ ++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCccc
Confidence 667999999997 5999998653 345899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc----------
Q 002331 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---------- 893 (935)
Q Consensus 824 ~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~---------- 893 (935)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 168 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 168 RIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 8665332 23456789999999999999999999999999999999999999999887766554421100
Q ss_pred ---------------ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 ---------------RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 ---------------r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...+...++..+++||.+||+.| |.+||++.++|+|||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN---PAKRISAYSALSHPY 299 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS---TTTSCCHHHHHTSGG
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCC---cccCCCHHHHhcCcc
Confidence 01233568899999999999999 999999999999998
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=376.66 Aligned_cols=248 Identities=19% Similarity=0.219 Sum_probs=203.5
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC--------CCceeeeecccc-
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--------HPNVVLFMGAVT- 743 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~--------HPNIVkl~g~~~- 743 (935)
.++|++.++||+|+||+||+|++ .++.||||++... ......+.+|+.+|+.++ |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47899999999999999999976 5789999998643 345567889999999985 788999999987
Q ss_pred ---cCCceEEEEeeCCCCCHHHHH-cCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCEEeeCCCCCCeeecCCC-----
Q 002331 744 ---RPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNW----- 813 (935)
Q Consensus 744 ---~~~~l~LVmEy~~gGsL~dlL-~~~~~~lse~~il~Ia~QIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g----- 813 (935)
....++|||||+.+ +|.+++ ......+++..++.|+.||+.||.|||++ | |+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHH
T ss_pred cCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhh
Confidence 56679999999954 555554 44446799999999999999999999998 8 99999999999998775
Q ss_pred --------------------------------------------cEEEEeccccccccCCcccCCCCCCCCCccCccccc
Q 002331 814 --------------------------------------------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849 (935)
Q Consensus 814 --------------------------------------------~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~ 849 (935)
.+||+|||+++..... .....||+.|+|||++.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhc
Confidence 7999999999876543 23467899999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh------HHHHHHhhcc-c------------------------------
Q 002331 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNP------MQVVGAVGFQ-N------------------------------ 892 (935)
Q Consensus 850 g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~------~eil~~I~~~-~------------------------------ 892 (935)
+..++.++|||||||+||+|++|+.||.+.+. ......+... .
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 99999999999999999999999999986542 1111111000 0
Q ss_pred ---------cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 ---------RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 ---------~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.....+...++.+.+||.+||+.| |.+||++.+||+|||
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELI---PEKRATAAECLRHPW 394 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSS---GGGSCCHHHHHTSGG
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccC---hhhcCCHHHHhhCcc
Confidence 001123445678999999999999 999999999999999
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=361.64 Aligned_cols=255 Identities=34% Similarity=0.572 Sum_probs=223.3
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
..+++..++|++.+.||+|+||.||+|.+. +..||||++.... .....+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 356778899999999999999999999884 7889999987543 24567889999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 747 NLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
.+++||||+++++|.+++.+ ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++..
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999999975 3356899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 826 KHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 826 ~~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+. ...+...+..+++
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 239 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCCH
Confidence 654321 2233456788999999999999999999999999999999 999999988877766554 3455667788999
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+.+||.+||+.| |.+||++.+|++.
T Consensus 240 ~l~~li~~~l~~d---p~~Rps~~~~~~~ 265 (288)
T 3kfa_A 240 KVYELMRACWQWN---PSDRPSFAEIHQA 265 (288)
T ss_dssp HHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHHHhCCC---hhhCcCHHHHHHH
Confidence 9999999999999 9999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=367.95 Aligned_cols=245 Identities=20% Similarity=0.319 Sum_probs=204.6
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeeccccc--CCceE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTR--PPNLS 749 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~--~~~l~ 749 (935)
.++|++++.||+|+||.||+|.+ +++.||||++.... ...+.+|+.+|++++ ||||+++++++.+ ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 36899999999999999999976 68899999986443 356889999999996 9999999999987 66789
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC-cEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~VKL~DFGlA~~~~~ 828 (935)
+||||+++++|.+++.. +++..++.++.||+.||.|||++| |+||||||+||||+.++ .+||+|||+++....
T Consensus 110 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999999999853 889999999999999999999999 99999999999999776 899999999987654
Q ss_pred CcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhc-------------cc-
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGF-------------QN- 892 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~-~~~eil~~I~~-------------~~- 892 (935)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||... ...+.+..+.. ..
T Consensus 184 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 184 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 32 2345678999999999987 66899999999999999999999999643 22222211100 00
Q ss_pred ---------------------cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 ---------------------RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 ---------------------~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.....+..+++.+.+||.+||+.| |.+||+++++|+|||
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD---HQSRLTAREAMEHPY 322 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSS---GGGSCCHHHHHTSGG
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCC---cccCCCHHHHhcCcc
Confidence 001112337899999999999999 999999999999998
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.09 Aligned_cols=247 Identities=32% Similarity=0.564 Sum_probs=202.0
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHH--cCCCceeeeeccccc----CCc
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTR----PPN 747 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~--L~HPNIVkl~g~~~~----~~~ 747 (935)
..++|++.+.||+|+||+||+|+++++.||||++.... ...+.+|.+++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 34689999999999999999999999999999986542 3345567777776 799999999998643 345
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCEEeeCCCCCCeeecCCCcEEEEe
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH--------TSTPTIVHRDLKSPNLLVDKNWNVKVSD 819 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLH--------s~g~~IIHrDLKPeNILLd~~g~VKL~D 819 (935)
+++||||+++|+|.++++. ..+++..++.|+.||+.||.||| +++ |+||||||+||||+.++.+||+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECC
T ss_pred eEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEEee
Confidence 8999999999999999965 46999999999999999999999 777 99999999999999999999999
Q ss_pred ccccccccCCcc----cCCCCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHcC----------CCCCCCC
Q 002331 820 FGLSRLKHNTFL----SSKSTAGTPEWMAPEVLRNE------PSNEKCDVYSFGVILWELATL----------KLPWIGM 879 (935)
Q Consensus 820 FGlA~~~~~~~~----~~~s~~GT~~Y~APEvl~g~------~~s~ksDIWSLG~ILyELLTG----------~~PF~~~ 879 (935)
||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 999976543321 12345799999999999876 345799999999999999999 8888653
Q ss_pred C-----hHHHHHHhhccccccCCCC-----cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 880 N-----PMQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 880 ~-----~~eil~~I~~~~~r~~ip~-----~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
. ...+...+.....+..++. .+++.+.+||.+||+.| |.+||++.+|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d---P~~Rps~~~i~~~ 296 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN---PSARLTALRIKKT 296 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSS---GGGSCCHHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcC---hhhCCCHHHHHHH
Confidence 2 2333333333344444443 35688999999999999 9999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.86 Aligned_cols=257 Identities=19% Similarity=0.286 Sum_probs=207.3
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCC---------CHHHHHHHHHHHHHHHHcCCCceeeeec
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDF---------SGAALLEFKREVKIMRRLRHPNVVLFMG 740 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~---------~~~~~~~f~~Ei~iL~~L~HPNIVkl~g 740 (935)
.....++|++++.||+|+||.||+|.+ .++.||||++..... .......+.+|+.+|++++||||+++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 334568899999999999999999976 688999999865322 2234567899999999999999999999
Q ss_pred ccc-----cCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcE
Q 002331 741 AVT-----RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 815 (935)
Q Consensus 741 ~~~-----~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~V 815 (935)
++. ....+|+||||++ |+|.+++......+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~ 173 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDI 173 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCCE
Confidence 983 3346899999997 5888888776678999999999999999999999999 9999999999999999999
Q ss_pred EEEeccccccccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc
Q 002331 816 KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR 894 (935)
Q Consensus 816 KL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r 894 (935)
||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+......
T Consensus 174 kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 174 TICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp EECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999999755433 22344678999999999987 67899999999999999999999999998876665544211110
Q ss_pred ------------------------------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 ------------------------------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ------------------------------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++..+++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFN---PQRRISTEQALRHPY 319 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSS---GGGSCCHHHHHTSGG
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCC---hhhCCCHHHHHcCch
Confidence 0122456889999999999999 999999999999998
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=375.37 Aligned_cols=247 Identities=25% Similarity=0.360 Sum_probs=210.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCce-----
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL----- 748 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l----- 748 (935)
++|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 6899999999999999999986 588999999987766666778889999999999999999999999877665
Q ss_pred -EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 749 -SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 749 -~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
++||||+. ++|.+++.. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 122 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 589888854 4899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------ 894 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r------------ 894 (935)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 196 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 196 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred cC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 33 234678999999999987 67899999999999999999999999998876665544211100
Q ss_pred -----------------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 -----------------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 -----------------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++..+++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELD---VDKRLTAAQALTHPF 326 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSC---TTTSCCHHHHHTSGG
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCC---hhhcCCHHHHhcCcc
Confidence 0122457899999999999999 999999999999998
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=389.06 Aligned_cols=253 Identities=30% Similarity=0.534 Sum_probs=221.9
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
..+++..++|++.+.||+|+||.||+|+++ +..||||++...... .+.+.+|+.+|++++|||||++++++. .+.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 457788899999999999999999999884 678999998765432 557889999999999999999999987 567
Q ss_pred eEEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
++|||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 899999999999999997532 35888999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 827 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 827 ~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
..... ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+....++...+. ...+...|..+++.
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 413 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEE 413 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCHH
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 54322 1233456788999999999999999999999999999999 999999999888877764 44566678899999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+.+||.+||+.| |.+||++++|++
T Consensus 414 l~~li~~cl~~d---p~~RPt~~~i~~ 437 (454)
T 1qcf_A 414 LYNIMMRCWKNR---PEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHccCC---hhHCcCHHHHHH
Confidence 999999999999 999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=358.77 Aligned_cols=250 Identities=18% Similarity=0.241 Sum_probs=211.4
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~ 749 (935)
+..++|++++.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.+ +|+||+++++++......+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 3457899999999999999999985 7889999998755322 2467899999999 8999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc-----EEEEeccccc
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLSR 824 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~-----VKL~DFGlA~ 824 (935)
+||||+ +++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|||+++
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999999 89999999876667999999999999999999999998 999999999999987766 9999999998
Q ss_pred cccCCcc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHhhccc--
Q 002331 825 LKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQN-- 892 (935)
Q Consensus 825 ~~~~~~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~---~~eil~~I~~~~-- 892 (935)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ..+....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 7654321 2345579999999999999999999999999999999999999998843 333333332221
Q ss_pred -cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 893 -RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 893 -~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
....+...+++.+.+||.+||+.| |.+||++++|++.
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~d---p~~RP~~~~l~~~ 277 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLA---FDATPDYDYLQGL 277 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCC---TTCCCCHHHHHHH
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCC---cccCCCHHHHHHH
Confidence 112234578999999999999999 9999999998763
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=380.80 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=195.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC------Cc
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------PN 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~------~~ 747 (935)
++|++++.||+|+||.||+|.+ +|+.||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 7899999999999999999976 688999999877655556677888999999999999999999998654 56
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 89999999 6799998875 46999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------ 894 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r------------ 894 (935)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 184 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred cc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 32 234679999999999987 67899999999999999999999999998876655543211100
Q ss_pred ---------cC--------CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 ---------LE--------IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ---------~~--------ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.. +...+++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~d---P~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD---SDKRITAAQALAHAY 314 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSS---GGGSCCHHHHHTSGG
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCC---cccCcCHHHHhcChh
Confidence 00 11346789999999999999 999999999999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=364.75 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=210.6
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEEC--C-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWN--G-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~--g-------~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~ 742 (935)
++..++|++.+.||+|+||.||+|.+. + ..||+|++.... ......+.+|+.++++++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 355689999999999999999999763 2 469999986543 23356788999999999999999999999
Q ss_pred ccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc--------
Q 002331 743 TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-------- 814 (935)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~-------- 814 (935)
.+.+..++||||+++++|.+++.+....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999999876656999999999999999999999999 999999999999998877
Q ss_pred EEEEeccccccccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhccc
Q 002331 815 VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892 (935)
Q Consensus 815 VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG-~~PF~~~~~~eil~~I~~~~ 892 (935)
+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||...+........ .
T Consensus 160 ~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~---~ 232 (289)
T 4fvq_A 160 IKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY---E 232 (289)
T ss_dssp EEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---H
T ss_pred eeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh---h
Confidence 999999998765432 12357889999999987 6789999999999999999995 5566666655544433 2
Q ss_pred cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 893 RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 893 ~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
....++...++.+.+||.+||+.| |.+||++.+|+++
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~~ll~~ 269 (289)
T 4fvq_A 233 DRHQLPAPKAAELANLINNCMDYE---PDHRPSFRAIIRD 269 (289)
T ss_dssp TTCCCCCCSSCTTHHHHHHHSCSS---GGGSCCHHHHHHH
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCC---hhHCcCHHHHHHH
Confidence 345566777889999999999999 9999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=361.53 Aligned_cols=254 Identities=30% Similarity=0.453 Sum_probs=211.7
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
.+..++|++.+.||+|+||.||+|++ .++.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 34557799999999999999999984 67899999987543 222346788999999999999999999999876
Q ss_pred --CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccc
Q 002331 746 --PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (935)
Q Consensus 746 --~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA 823 (935)
..+++||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECccccc
Confidence 6689999999999999999765667999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC--------------ChHHHHH
Q 002331 824 RLKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM--------------NPMQVVG 886 (935)
Q Consensus 824 ~~~~~~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~--------------~~~eil~ 886 (935)
....... .......||..|+|||++.+..++.++|||||||++|+|++|..||... .......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 8765432 2233456888899999999999999999999999999999999876432 1111222
Q ss_pred HhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 887 AVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 887 ~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.......+...+..+++.+.+||.+||+.| |.+||++.+|++
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQ---PSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSS---GGGSCCHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCCC---CCCCCCHHHHHH
Confidence 222344566678889999999999999999 999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=371.75 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=210.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~----~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
+..++|++.+.||+|+||.||+|++ +++ +||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence 3447899999999999999999986 343 35777765432 233456788999999999999999999999875
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
..++||||+.+|+|.+++.+....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 478999999999999999876678999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 827 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 827 ~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. .......+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 43322 2233456789999999999999999999999999999999 999999988777666554 4445667788999
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+.+||.+||+.| |.+||++.+|+++
T Consensus 247 ~~~~li~~~l~~~---p~~Rps~~ell~~ 272 (327)
T 3poz_A 247 DVYMIMVKCWMID---ADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHTCSC---GGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCC---hhhCCCHHHHHHH
Confidence 9999999999999 9999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=360.57 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=216.3
Q ss_pred ccCCCCCCeeEEE-EeeecCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 670 ECEIPWEDLVLGE-RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 670 ~~ei~~edy~I~e-~LG~G~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
++.+..++|.+.+ .||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3456678899998 999999999999954 357899999977655555677899999999999999999999999 5
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
.+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 56789999999999999999763 46899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCc
Q 002331 825 LKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (935)
Q Consensus 825 ~~~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ 900 (935)
....... ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+....++...+. ...+..++..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 244 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 244 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence 7643321 1222346788999999998889999999999999999999 999999998887776664 3455677888
Q ss_pred CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 901 LDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 901 ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+++.+.+||.+||+.| |.+||++.+|++
T Consensus 245 ~~~~l~~li~~~l~~d---p~~Rps~~~l~~ 272 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYD---VENRPGFAAVEL 272 (291)
T ss_dssp CCHHHHHHHHHHTCSS---TTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCC---hhhCcCHHHHHH
Confidence 9999999999999999 999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=373.02 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=210.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC-----Cce
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 748 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~-----~~l 748 (935)
.+|++++.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+|++++||||+++++++... ..+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 6899999999999999999986 57889999987543 344557788999999999999999999998654 368
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|+||||+. ++|.+++.. ..+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99999997 499999875 35899999999999999999999999 99999999999999999999999999987653
Q ss_pred Ccc---cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc----------
Q 002331 829 TFL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---------- 894 (935)
Q Consensus 829 ~~~---~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r---------- 894 (935)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 321 1234579999999998754 55899999999999999999999999988766555443211000
Q ss_pred -------------------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 -------------------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 -------------------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+...+++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN---PHKRIEVEQALAHPY 316 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSS---TTTSCCHHHHHTSGG
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCC---hhhCCCHHHHhcCcc
Confidence 0112457899999999999999 999999999999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=363.38 Aligned_cols=251 Identities=28% Similarity=0.456 Sum_probs=217.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++.....+++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 6799999999999999999987 58899999997655444445678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC---CcEEEEeccccccccCCc
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~---g~VKL~DFGlA~~~~~~~ 830 (935)
|+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.+ +.+||+|||++.......
T Consensus 102 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99999999988653 36899999999999999999999999 9999999999999754 479999999998664432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC--CcCcHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARI 908 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip--~~ls~~L~dL 908 (935)
......|++.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..++...+.........+ ..+++.+.+|
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 179 -KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp -SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred -ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 22334578899999998765 8899999999999999999999999998888777765444333333 5689999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||+.| |.+||++.++|+|||
T Consensus 257 i~~~l~~d---p~~Rps~~ell~hp~ 279 (287)
T 2wei_A 257 IRKMLTFH---PSLRITATQCLEHPW 279 (287)
T ss_dssp HHHHTCSS---GGGSCCHHHHHHSHH
T ss_pred HHHHcccC---hhhCcCHHHHhcCHH
Confidence 99999999 999999999999998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=364.15 Aligned_cols=258 Identities=22% Similarity=0.341 Sum_probs=199.6
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
..+.+..++|++.+.||+|+||.||+|++ +++.||||++............+..+..+++.++||||+++++++...+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 34556678999999999999999999987 5889999999876544444445555666788889999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
.+++||||+ ++.+..++.+....+++..++.++.||+.||.|||+. | |+||||||+||||+.++.+||+|||++..
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999999 5567766655456799999999999999999999995 8 99999999999999999999999999976
Q ss_pred ccCCcccCCCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhccccccCCC-
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIP- 898 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLG~ILyELLTG~~PF~~~-~~~eil~~I~~~~~r~~ip- 898 (935)
..... ......|++.|+|||++. +..++.++|||||||++|+|++|+.||... ...+....+. ...+..++
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 252 (318)
T 2dyl_A 175 LVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QEEPPLLPG 252 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HSCCCCCCS
T ss_pred ccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-ccCCCCCCc
Confidence 54432 223457899999999994 456789999999999999999999999874 4444444432 22333333
Q ss_pred -CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 -KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 -~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+++.+.+||.+||+.| |.+||++.+|++|||
T Consensus 253 ~~~~~~~l~~li~~~l~~d---p~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKD---HRKRPKYNKLLEHSF 286 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSC---TTTSCCHHHHTTSHH
T ss_pred cCCCCHHHHHHHHHHccCC---hhHCcCHHHHhhCHH
Confidence 458999999999999999 999999999999998
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=379.84 Aligned_cols=254 Identities=23% Similarity=0.361 Sum_probs=213.0
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCC--CHHHHHHHHHHHHHHHHc-CCCceeeeeccccc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR 744 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~--~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~ 744 (935)
+..++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 3457899999999999999999987 688999999865321 111233466799999999 69999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
.+.++|||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999999753 46899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCC-cccCCCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhccccccCC
Q 002331 825 LKHNT-FLSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQNRRLEI 897 (935)
Q Consensus 825 ~~~~~-~~~~~s~~GT~~Y~APEvl~g~--~~s~ksDIWSLG~ILyELLTG~~PF~~~~----~~eil~~I~~~~~r~~i 897 (935)
..... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... ...+...+ ......+
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~ 285 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPY 285 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCCCCC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--hccCCCC
Confidence 65432 1223345799999999999863 47899999999999999999999997532 23333333 2345567
Q ss_pred CCcCcHHHHHHHHHHHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 898 PKELDPLVARIIWECWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 898 p~~ls~~L~dLI~qCL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
+..++..+.+||.+||..| |.+|| +++++++|||
T Consensus 286 ~~~~~~~~~~li~~~L~~d---P~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKD---PKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSS---GGGSTTSSTTTHHHHHTSGG
T ss_pred CcccCHHHHHHHHHHhhhC---HHHhcCCCCCCHHHHHcCcc
Confidence 7889999999999999999 99999 9999999998
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=372.89 Aligned_cols=252 Identities=25% Similarity=0.434 Sum_probs=213.2
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCce----EEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~----VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
+..++|++.+.||+|+||.||+|++ +++. ||+|++..... ......+.+|+.++++++||||+++++++. +.
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 4557899999999999999999987 3443 77787654321 122335678999999999999999999886 46
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
..++||||+++|+|.+++......+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCccccc
Confidence 789999999999999999876668999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 827 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 827 ~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
..... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. ...+...+..++.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICTI 244 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTBCT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcCcH
Confidence 43321 2234567889999999999999999999999999999999 999999988777766654 4456667788999
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+.+||.+||+.| |.+||++.+|+++
T Consensus 245 ~~~~li~~~l~~d---p~~Rps~~el~~~ 270 (325)
T 3kex_A 245 DVYMVMVKCWMID---ENIRPTFKELANE 270 (325)
T ss_dssp TTTHHHHHHTCSC---TTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 9999999999999 9999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=387.02 Aligned_cols=247 Identities=15% Similarity=0.136 Sum_probs=198.8
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHH---HHHHcCCCceeeee------
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVK---IMRRLRHPNVVLFM------ 739 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~---iL~~L~HPNIVkl~------ 739 (935)
....++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+. +|++++|||||+++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 34457899999999999999999985 588999999975432 3345677889995 45555899999998
Q ss_pred -cccccCC-----------------ceEEEEeeCCCCCHHHHHcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 002331 740 -GAVTRPP-----------------NLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMALDVARGMNCLHTSTP 795 (935)
Q Consensus 740 -g~~~~~~-----------------~l~LVmEy~~gGsL~dlL~~~~------~~lse~~il~Ia~QIa~AL~yLHs~g~ 795 (935)
+++...+ ..||||||+ +|+|.+++.+.. ..+++..++.|+.||+.||.|||++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 226 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 226 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4444432 378999999 579999997532 12335888889999999999999999
Q ss_pred CEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCC-----------CCCchhHHHHHHH
Q 002331 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-----------PSNEKCDVYSFGV 864 (935)
Q Consensus 796 ~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~-----------~~s~ksDIWSLG~ 864 (935)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++.+. .++.++|||||||
T Consensus 227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTCE---EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred -eecCCCCHHHEEEcCCCCEEEEechhheecCCc---ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999999864432 234567 999999999887 8999999999999
Q ss_pred HHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 865 ILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 865 ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++|||++|+.||.+.+.......+ ...+..+++.+.+||.+||+.| |.+||++.++++|||
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~d---p~~Rpt~~e~l~hp~ 362 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYP---KEDRLLPLQAMETPE 362 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSS---GGGCCCHHHHHTSHH
T ss_pred HHHHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCC---chhCCCHHHHhhChH
Confidence 999999999999876654332222 2233678999999999999999 999999999999998
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=366.12 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=208.8
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC-----Cc
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PN 747 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~-----~~ 747 (935)
.++|++.+.||+|+||.||+|++ +++.||||++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 47899999999999999999987 48899999986433 344566788999999999999999999987654 67
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
.++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 899999997 589999876 36899999999999999999999999 9999999999999999999999999998754
Q ss_pred CCcc----------cCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-
Q 002331 828 NTFL----------SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL- 895 (935)
Q Consensus 828 ~~~~----------~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~- 895 (935)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 3211 1223578999999998765 678999999999999999999999999887655443321100000
Q ss_pred -----------------------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 -----------------------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 -----------------------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.....+++.+.+||.+||+.| |.+||++.+||+|||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rpt~~ell~hp~ 308 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD---PAKRITAKEALEHPY 308 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSS---GGGSCCHHHHHTSGG
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcC---cccCCCHHHHhcCcc
Confidence 112467899999999999999 999999999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=368.59 Aligned_cols=247 Identities=24% Similarity=0.355 Sum_probs=209.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc------
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN------ 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~------ 747 (935)
++|.+.+.||+|+||.||+|.+ +|+.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 6899999999999999999987 58899999998766666667788999999999999999999999987654
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999997 588887753 4899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc--------------
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------- 892 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~-------------- 892 (935)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 178 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 178 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred CC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 32 234578999999999987 678999999999999999999999999988766554432110
Q ss_pred ---------------cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 ---------------RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 ---------------~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
....+...+++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---p~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELD---VDKRLTAAQALTHPF 308 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSC---TTTSCCHHHHHTSGG
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCC---cccCCCHHHHhcCcc
Confidence 011233567899999999999999 999999999999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=367.14 Aligned_cols=252 Identities=31% Similarity=0.563 Sum_probs=214.7
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCce--EEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~--VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~ 747 (935)
+.+++|++.+.||+|+||.||+|++ ++.. ||||++.... .......+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 5568999999999999999999975 5554 4899886432 233455688999999999 89999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC
Q 002331 748 LSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN 812 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~ 812 (935)
+++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||++| |+||||||+||||+.+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCC
Confidence 999999999999999997643 46899999999999999999999999 9999999999999999
Q ss_pred CcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q 002331 813 WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 891 (935)
Q Consensus 813 g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~ 891 (935)
+.+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+. .
T Consensus 179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~ 256 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 256 (327)
T ss_dssp GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-G
T ss_pred CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-c
Confidence 99999999998754322 22233457889999999999889999999999999999998 999999998888777664 3
Q ss_pred ccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 892 NRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 892 ~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
..+...+..+++.+.+||.+||+.| |.+||++.+++++
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~ell~~ 294 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREK---PYERPSFAQILVS 294 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCC---hhhCcCHHHHHHH
Confidence 3455677889999999999999999 9999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=359.95 Aligned_cols=249 Identities=32% Similarity=0.564 Sum_probs=210.6
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc-CCce
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNL 748 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~-~~~l 748 (935)
.+.+..++|++.+.||+|+||.||+++++++.||||++.... ....+.+|+.++++++||||+++++++.. .+.+
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 456778999999999999999999999999999999987543 34568899999999999999999998654 4579
Q ss_pred EEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 749 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999999997532 23789999999999999999999999 9999999999999999999999999988654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
.. .....+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+. ...+...+..+++.+.
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 169 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVY 244 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHH
T ss_pred cc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCHHHH
Confidence 33 223467889999999999999999999999999999998 999999988777776654 3445667888999999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
++|.+||+.| |.+||++.+|++
T Consensus 245 ~li~~~l~~~---p~~Rps~~~l~~ 266 (278)
T 1byg_A 245 EVMKNCWHLD---AAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHhcCC---hhhCCCHHHHHH
Confidence 9999999999 999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=357.46 Aligned_cols=250 Identities=30% Similarity=0.463 Sum_probs=212.0
Q ss_pred CCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccc-ccCCce
Q 002331 675 WEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV-TRPPNL 748 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~-~~~~~l 748 (935)
..+|++.+.||+|+||.||+|++. ...||||++... ........+.+|+.++++++||||+++++++ ..++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 357999999999999999999762 225888987653 2445567789999999999999999999985 556678
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
++||||+++++|.+++......+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999999877777899999999999999999999999 99999999999999999999999999986643
Q ss_pred Cc----ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 829 TF----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 829 ~~----~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
.. .......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+. ...+...+..+++
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 259 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPD 259 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCCH
Confidence 32 12233457789999999999999999999999999999999 677787777666655553 3445566788999
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.+.+||.+||+.| |.+||++.+|++
T Consensus 260 ~l~~li~~~l~~~---p~~Rps~~ell~ 284 (298)
T 3f66_A 260 PLYEVMLKCWHPK---AEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCC---hhhCcCHHHHHH
Confidence 9999999999999 999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=362.27 Aligned_cols=250 Identities=20% Similarity=0.253 Sum_probs=210.2
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE---CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC------ceeeeecccc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP------NVVLFMGAVT 743 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~---~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HP------NIVkl~g~~~ 743 (935)
+..++|++.+.||+|+||.||+|.+ +++.||||++... ......+.+|+.+++.++|+ +|+++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 3457899999999999999999976 5788999998643 34456788999999988655 5999999999
Q ss_pred cCCceEEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC-----------
Q 002331 744 RPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK----------- 811 (935)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~----------- 811 (935)
..+.+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC---
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999999 789999886543 46899999999999999999999999 999999999999987
Q ss_pred --------CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Q 002331 812 --------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883 (935)
Q Consensus 812 --------~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~e 883 (935)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999865432 234678999999999999999999999999999999999999999887765
Q ss_pred HHHHhhccccc------------------------------------------cCCCCcCcHHHHHHHHHHHhhCCCCcC
Q 002331 884 VVGAVGFQNRR------------------------------------------LEIPKELDPLVARIIWECWQTGWSSLH 921 (935)
Q Consensus 884 il~~I~~~~~r------------------------------------------~~ip~~ls~~L~dLI~qCL~~D~ssP~ 921 (935)
....+...... ...+...++.+.+||.+||+.| |.
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d---P~ 318 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD---PA 318 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS---TT
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC---cc
Confidence 54433111000 0112334678999999999999 99
Q ss_pred CCcCHHHHHhCcC
Q 002331 922 IRTSQAQLSHKRF 934 (935)
Q Consensus 922 kRPSa~EILqHPF 934 (935)
+||++.|||+|||
T Consensus 319 ~Rpt~~ell~hp~ 331 (339)
T 1z57_A 319 KRITLREALKHPF 331 (339)
T ss_dssp TSCCHHHHTTSGG
T ss_pred cccCHHHHhcCHH
Confidence 9999999999998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=386.32 Aligned_cols=252 Identities=22% Similarity=0.349 Sum_probs=200.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC------HHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~------~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
.++|.+.+.||+|+||.||+|.+ +++.||||++...... ......+.+|+.+|++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 36899999999999999999987 5789999998765321 1223357899999999999999999999865 4
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC---CcEEEEecccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLS 823 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~---g~VKL~DFGlA 823 (935)
.+++||||+++++|.+++.+. ..+++..++.|+.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred ceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccc
Confidence 589999999999999998764 47999999999999999999999999 9999999999999754 45999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhcccc--ccCC
Q 002331 824 RLKHNTFLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNR--RLEI 897 (935)
Q Consensus 824 ~~~~~~~~~~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~e-il~~I~~~~~--r~~i 897 (935)
+...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... +...+..... .+..
T Consensus 290 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 290 KILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp TSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred eecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 8765432 2345679999999999864 567889999999999999999999998754322 2222221111 1112
Q ss_pred CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 898 PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 898 p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...+++.+.+||.+||+.| |.+||+++++|+|||
T Consensus 369 ~~~~~~~~~~li~~~L~~d---P~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVD---PKARFTTEEALRHPW 402 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSS---TTTSCCHHHHHHSGG
T ss_pred hcccCHHHHHHHHHHccCC---hhHCcCHHHHhCCcc
Confidence 2568899999999999999 999999999999999
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=392.03 Aligned_cols=254 Identities=34% Similarity=0.572 Sum_probs=224.0
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
..+++..++|++.+.||+|+||.||+|.+. +..||||++...... ...|.+|+.+|++++|||||++++++....
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 456788899999999999999999999884 788999998765432 457889999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
.++|||||+++|+|.+++.+. ...+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeeccccee
Confidence 999999999999999999753 356899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 826 KHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 826 ~~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
...... ......++..|+|||++.+..++.++|||||||+||||++ |..||.+.+..++...+. ...+...|..+++
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 446 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 446 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 654322 2233456778999999999899999999999999999999 999999988877766653 4556677889999
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.+.+||.+||+.| |.+||++.+|++
T Consensus 447 ~l~~li~~cl~~d---P~~RPs~~el~~ 471 (495)
T 1opk_A 447 KVYELMRACWQWN---PSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHHcCcC---hhHCcCHHHHHH
Confidence 9999999999999 999999999976
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=383.16 Aligned_cols=251 Identities=13% Similarity=0.062 Sum_probs=192.1
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHc--CCCceeeeeccc-------
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL--RHPNVVLFMGAV------- 742 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L--~HPNIVkl~g~~------- 742 (935)
..+|++.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.+++.| +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 35699999999999999999986 5889999999887653 34556677886655555 699988866433
Q ss_pred ccC-----------------CceEEEEeeCCCCCHHHHHcCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCEEe
Q 002331 743 TRP-----------------PNLSIITEFLPRGSLFRILHRPHCQVDEKRR------IKMALDVARGMNCLHTSTPTIVH 799 (935)
Q Consensus 743 ~~~-----------------~~l~LVmEy~~gGsL~dlL~~~~~~lse~~i------l~Ia~QIa~AL~yLHs~g~~IIH 799 (935)
... ..+||||||++ ++|.+++...+..+.+..+ +.++.||+.||.|||++| |+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 221 33899999998 7999999764444555555 678899999999999999 999
Q ss_pred eCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002331 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWI 877 (935)
Q Consensus 800 rDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLG~ILyELLTG~~PF~ 877 (935)
|||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998765432 13456799999999987 678999999999999999999999998
Q ss_pred CCChHHHHH--H---hhcccccc--CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 878 GMNPMQVVG--A---VGFQNRRL--EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 878 ~~~~~eil~--~---I~~~~~r~--~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+..+..... . ........ ..+..+++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD---RRRRLLPLEAMETPE 355 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSS---TTTCCCHHHHTTSHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCC---hhhCCCHHHHhcCHH
Confidence 874431110 0 00011122 223578999999999999999 999999999999998
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=359.57 Aligned_cols=254 Identities=24% Similarity=0.435 Sum_probs=204.3
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
..++|++.+.||+|+||.||+|.+ +++.||||++..... .......+.+|+.+++.++||||+++++++...+.+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 446899999999999999999986 688999999976433 44566788999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 751 ITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
||||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999863 3456899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC--ChHHHHHHhhccccccCCCCcCcHHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM--NPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~--~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
..........|++.|+|||++.+..++.++|||||||++|+|++|+.||.+. +.......+.....+...+..+++.+
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 4433334567899999999999999999999999999999999999999764 33444444433333333346789999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+||.+||..| |.+||++.+|+++
T Consensus 268 ~~li~~~l~~d---p~~Rps~~~il~~ 291 (310)
T 2wqm_A 268 RQLVNMCINPD---PEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHcCCC---hhhCCCHHHHHHH
Confidence 99999999999 9999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=369.33 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=217.3
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
++..++|++++.||+|+||.||+|++ .++.||||++... ........+.+|+.++++++||||+++++++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 45668999999999999999999973 4567999998644 344556678899999999999999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC---CCcE
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNV 815 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~V 815 (935)
....|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+. +..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999997533 35889999999999999999999999 999999999999984 4569
Q ss_pred EEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc
Q 002331 816 KVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 892 (935)
Q Consensus 816 KL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~ 892 (935)
||+|||++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+. ..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-cC
Confidence 9999999976533221 1223467889999999999999999999999999999998 999999988877776664 34
Q ss_pred cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 ~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.....+..+++.+.+||.+||+.| |.+||++.+|+++.|
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQ---PEDRPNFAIILERIE 300 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCC---hhhCcCHHHHHHHHH
Confidence 456677889999999999999999 999999999999865
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=368.83 Aligned_cols=251 Identities=23% Similarity=0.360 Sum_probs=203.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC------HHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~------~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
++|++.+.||+|+||.||+|.+ +++.||||++...... ......+.+|+.+|+.++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999987 5789999998764321 122345789999999999999999999987654
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc---EEEEeccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSR 824 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~---VKL~DFGlA~ 824 (935)
+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|||+++
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 89999999999999998763 57899999999999999999999999 999999999999987654 9999999998
Q ss_pred cccCCcccCCCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcccc--ccCCC
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNR--RLEIP 898 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~-eil~~I~~~~~--r~~ip 898 (935)
....... .....||+.|+|||++. +..++.++|||||||++|+|++|..||...... .+...+..... ....+
T Consensus 166 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 166 ILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp ECCCCHH-HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred ecccccc-cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 7654321 12346899999999974 466889999999999999999999999865432 22222211111 11223
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 245 ~~~~~~~~~li~~~l~~d---P~~Rps~~~~l~h~~ 277 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVD---PKARFTTEEALRHPW 277 (322)
T ss_dssp TTSCHHHHHHHHHHSCSS---TTTSCCHHHHHTSGG
T ss_pred hhcCHHHHHHHHHHcccC---HhhCCCHHHHhhCcC
Confidence 567899999999999999 999999999999998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=362.70 Aligned_cols=256 Identities=20% Similarity=0.284 Sum_probs=214.8
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC--CCceeeeecccccCCc
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRPPN 747 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~--HPNIVkl~g~~~~~~~ 747 (935)
+.+..++|++.+.||+|+||.||++.+ +++.||||++............+.+|+.++++++ |+||+++++++...+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 456668899999999999999999976 5778999999877667777888999999999996 5999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+++||| +.+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||++ +.+||+|||++....
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999999 5578999999764 47899999999999999999999998 999999999999964 899999999998764
Q ss_pred CCcc--cCCCCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcccc
Q 002331 828 NTFL--SSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNR 893 (935)
Q Consensus 828 ~~~~--~~~s~~GT~~Y~APEvl~g-----------~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~-~eil~~I~~~~~ 893 (935)
.... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+.....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 3321 1234578999999999876 4678899999999999999999999987543 333444444445
Q ss_pred ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...++...+..+.+||.+||+.| |.+||++.++|+|||
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~ell~h~~ 295 (313)
T 3cek_A 258 EIEFPDIPEKDLQDVLKCCLKRD---PKQRISIPELLAHPY 295 (313)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSS---TTTSCCHHHHHTSHH
T ss_pred ccCCcccchHHHHHHHHHHccCC---cccCcCHHHHhcCcc
Confidence 56677888999999999999999 999999999999998
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=354.78 Aligned_cols=249 Identities=31% Similarity=0.532 Sum_probs=212.8
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CC---ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCce-EE
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NG---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL-SI 750 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g---~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l-~L 750 (935)
.|.+.++||+|+||.||+|++ ++ ..||||++.... .......+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 466789999999999999976 22 269999886533 445667889999999999999999999999876665 99
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||+.+++|.+++......+++..++.|+.||+.||.|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99999999999999887778999999999999999999999999 9999999999999999999999999998654321
Q ss_pred ----ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhccccccCCCCcCcHHH
Q 002331 831 ----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 831 ----~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG-~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
.......+++.|+|||++.+..++.++|||||||++|+|++| .+||...+..+....+. .......+..+++.+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccchHHH
Confidence 222345678899999999999999999999999999999995 55666777666665553 444566778899999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+||.+||+.| |.+||++.++++.
T Consensus 258 ~~li~~~l~~~---p~~Rps~~~ll~~ 281 (298)
T 3pls_A 258 YQVMQQCWEAD---PAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHccCC---hhhCcCHHHHHHH
Confidence 99999999999 9999999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=367.61 Aligned_cols=246 Identities=17% Similarity=0.251 Sum_probs=207.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LV 751 (935)
.++|++.+.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 47899999999999999999985 6889999998765432 2477899999999 999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc-----EEEEeccccccc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLSRLK 826 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~-----VKL~DFGlA~~~ 826 (935)
|||+ +++|.+++......+++..++.|+.||+.||.|||+++ |+||||||+||||+.++. +||+|||+++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9999 89999999865668999999999999999999999999 999999999999998887 999999999876
Q ss_pred cCCcc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhccccccC
Q 002331 827 HNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLE 896 (935)
Q Consensus 827 ~~~~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~---~eil~~I~~~~~r~~ 896 (935)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .+....+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 44321 12456899999999999999999999999999999999999999998543 333333321111111
Q ss_pred ---CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 897 ---IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 897 ---ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+...++ .+.+||.+||..| |.+||++++|++
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~---p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLD---FFEKPDYDYLRK 274 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCC---TTCCCCHHHHHH
T ss_pred HHHHhccCh-HHHHHHHHHHhCC---CCCCCCHHHHHH
Confidence 123355 9999999999999 999999999876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=359.67 Aligned_cols=255 Identities=32% Similarity=0.519 Sum_probs=211.7
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEEC---Cc--eEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWN---GT--EVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~---g~--~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
.+..++|++.+.||+|+||.||+|++. ++ .||||++..... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 345578999999999999999999852 22 589998876543 234567889999999999999999999999876
Q ss_pred CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
. .++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEcccccccc
Confidence 5 89999999999999999765567999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcC
Q 002331 826 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (935)
Q Consensus 826 ~~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~l 901 (935)
...... ......++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+.....+...+..+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc
Confidence 643321 1233457788999999999889999999999999999999 999999999888888776666666777889
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+..+.++|.+||..| |.+||++.+|+++
T Consensus 251 ~~~l~~li~~~l~~~---p~~Rps~~~l~~~ 278 (291)
T 1u46_A 251 PQDIYNVMVQCWAHK---PEDRPTFVALRDF 278 (291)
T ss_dssp CHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCC---cccCcCHHHHHHH
Confidence 999999999999999 9999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=361.44 Aligned_cols=245 Identities=29% Similarity=0.590 Sum_probs=204.2
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
+..++|++.+.||+|+||.||++++.++.||||++... .....+.+|+.+|++++||||+++++++.+ ..++||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 45678999999999999999999999999999998543 245678899999999999999999999874 489999
Q ss_pred eeCCCCCHHHHHcCCCC--CCCHHHHHHHHHHHHHHHHHHHh---cCCCEEeeCCCCCCeeecCCCc-EEEEeccccccc
Q 002331 753 EFLPRGSLFRILHRPHC--QVDEKRRIKMALDVARGMNCLHT---STPTIVHRDLKSPNLLVDKNWN-VKVSDFGLSRLK 826 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~--~lse~~il~Ia~QIa~AL~yLHs---~g~~IIHrDLKPeNILLd~~g~-VKL~DFGlA~~~ 826 (935)
||+++++|.+++..... .+++..++.++.||+.||.|||+ ++ |+||||||+||||+.++. +||+|||++...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999999976432 47889999999999999999999 66 999999999999998886 799999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHhhccccccCCCCcCcHH
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~--~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+ ....+..++..+++.
T Consensus 157 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (307)
T 2eva_A 157 QTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-HNGTRPPLIKNLPKP 232 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-HTTCCCCCBTTCCHH
T ss_pred ccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-hcCCCCCcccccCHH
Confidence 432 2234689999999999999999999999999999999999999986533 2233333 234456667889999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+.+||.+||+.| |.+||++.+|+++
T Consensus 233 l~~li~~~l~~d---p~~Rps~~ell~~ 257 (307)
T 2eva_A 233 IESLMTRCWSKD---PSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCC---hhhCcCHHHHHHH
Confidence 999999999999 9999999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=359.89 Aligned_cols=250 Identities=21% Similarity=0.311 Sum_probs=203.5
Q ss_pred CCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccc---------
Q 002331 675 WEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--------- 743 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~--------- 743 (935)
.++|++++.||+|+||.||+|.+. ++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 378999999999999999999874 8899999987543 455677899999999999999999998863
Q ss_pred -----cCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec-CCCcEEE
Q 002331 744 -----RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKV 817 (935)
Q Consensus 744 -----~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~VKL 817 (935)
+...+++||||++ ++|.+++.+ ..+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999997 599999975 46899999999999999999999999 99999999999997 5779999
Q ss_pred EeccccccccCCc---ccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc
Q 002331 818 SDFGLSRLKHNTF---LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 893 (935)
Q Consensus 818 ~DFGlA~~~~~~~---~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~ 893 (935)
+|||+++...... .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998754321 11233467999999998865 6789999999999999999999999999887665554421110
Q ss_pred c----------------------------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 R----------------------------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 r----------------------------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. ..++..++..+.+||.+||+.| |.+||++.++|+|||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFS---PMDRLTAEEALSHPY 308 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSS---GGGSCCHHHHHTSHH
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCC---ccccCCHHHHhCCcc
Confidence 0 0122467899999999999999 999999999999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.90 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=202.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc---------
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--------- 744 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~--------- 744 (935)
++|++++.||+|+||.||+|++ +++.||||++... ......+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4799999999999999999986 6889999998643 3456778899999999999999999998754
Q ss_pred ----CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 745 ----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 745 ----~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
...+++||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEeeC
Confidence 45689999999999999999866667889999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCc--------------ccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC-ChHHH
Q 002331 821 GLSRLKHNTF--------------LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGM-NPMQV 884 (935)
Q Consensus 821 GlA~~~~~~~--------------~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~-~~~ei 884 (935)
|++....... .......|++.|+|||++.+. .++.++|||||||++|+|++ ||... +....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9998654221 122345689999999999865 68999999999999999998 55533 33333
Q ss_pred HHHhhcc--ccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 885 VGAVGFQ--NRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 885 l~~I~~~--~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
...+... ..+..++...++.+.+||.+||+.| |.+||++.++++|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d---p~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHD---PNKRPGARTLLNSGW 286 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSS---GGGSCCHHHHHHSSC
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcC---cccCcCHHHHhCCCC
Confidence 4333221 2233455667888999999999999 999999999999999
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=380.92 Aligned_cols=246 Identities=23% Similarity=0.295 Sum_probs=202.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc------CCc
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PPN 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~------~~~ 747 (935)
.+|++++.||+|+||.||+|++ +++.||||++..... .+.+|+++|+.++|||||+++++|.. ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4699999999999999999988 588999999865421 23479999999999999999998843 223
Q ss_pred eEEEEeeCCCCCHHHHHc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC-CcEEEEecccc
Q 002331 748 LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLS 823 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~---~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~VKL~DFGlA 823 (935)
+++||||+++ +|.+++. +....+++..++.|+.||+.||.|||++| |+||||||+||||+.+ +.+||+|||++
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 7799999976 6666553 23457999999999999999999999999 9999999999999955 67899999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc----------
Q 002331 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---------- 892 (935)
Q Consensus 824 ~~~~~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~---------- 892 (935)
+..... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.+..+.+..+....
T Consensus 205 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 205 KQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp EECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 876443 223456789999999999765 68999999999999999999999999987665544332110
Q ss_pred -----cccC------------CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 -----RRLE------------IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 -----~r~~------------ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.... ++..+++++.+||.+||..| |.+||++.|+|+|||
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~d---P~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT---PTARLTPLEACAHSF 339 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSS---GGGSCCHHHHHTSGG
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCC---hhHCCCHHHHhCCHh
Confidence 0111 23467899999999999999 999999999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=378.99 Aligned_cols=248 Identities=23% Similarity=0.261 Sum_probs=209.6
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc------CCCceeeeecccccCC
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL------RHPNVVLFMGAVTRPP 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L------~HPNIVkl~g~~~~~~ 746 (935)
..+|++++.||+|+||.||+|.+ .++.||||++... ......+.+|+.+++.+ +|+||+++++++...+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 36799999999999999999977 5789999998653 33455677888888877 5779999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc--EEEEecccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGLS 823 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~--VKL~DFGlA 823 (935)
.+++||||+. ++|.+++.... ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.++. +||+|||++
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999999996 58998886543 45899999999999999999999999 999999999999999887 999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--------
Q 002331 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-------- 895 (935)
Q Consensus 824 ~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~-------- 895 (935)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+......+
T Consensus 250 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 250 CYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp EETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred eecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 765433 234679999999999999999999999999999999999999999988766554432110000
Q ss_pred -------------------------------------------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCH
Q 002331 896 -------------------------------------------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQ 926 (935)
Q Consensus 896 -------------------------------------------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa 926 (935)
.++...++.+.+||.+||+.| |.+|||+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d---P~~Rpta 403 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD---PAVRMTP 403 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS---TTTSCCH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC---hhhCCCH
Confidence 011234788999999999999 9999999
Q ss_pred HHHHhCcC
Q 002331 927 AQLSHKRF 934 (935)
Q Consensus 927 ~EILqHPF 934 (935)
.|+|+|||
T Consensus 404 ~e~L~Hpw 411 (429)
T 3kvw_A 404 GQALRHPW 411 (429)
T ss_dssp HHHHTSTT
T ss_pred HHHhCChh
Confidence 99999999
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=366.05 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=191.6
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHH-HHHHcCCCceeeeecccccC
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVK-IMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~-iL~~L~HPNIVkl~g~~~~~ 745 (935)
..+++..++|++.+.||+|+||.||+|.+ +++.||||++..... ......+.+|+. +++.++||||+++++++...
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 45678889999999999999999999987 488999999976543 334445556665 66677999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHcC----CCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 746 PNLSIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~----~~~~lse~~il~Ia~QIa~AL~yLHs~-g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
+..++||||+++ +|.+++.. ....+++..++.++.|++.||.|||+. | |+||||||+||||+.++.+||+||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCC
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccC
Confidence 999999999975 78777652 345789999999999999999999998 8 999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcccccc
Q 002331 821 GLSRLKHNTFLSSKSTAGTPEWMAPEVL----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRL 895 (935)
Q Consensus 821 GlA~~~~~~~~~~~s~~GT~~Y~APEvl----~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~-eil~~I~~~~~r~ 895 (935)
|+++...... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...... +....+ ......
T Consensus 171 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~ 248 (327)
T 3aln_A 171 GISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDPP 248 (327)
T ss_dssp SSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-CCSCCC
T ss_pred CCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-hcCCCC
Confidence 9998765432 22334789999999998 4566899999999999999999999999876432 222222 122222
Q ss_pred CCC----CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 EIP----KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ~ip----~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.++ ..+++.+.+||.+||+.| |.+||++.+|++|||
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~ell~hp~ 288 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKD---ESKRPKYKELLKHPF 288 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSS---GGGSCCHHHHTTSHH
T ss_pred CCCCcccccCCHHHHHHHHHHhhCC---hhhCcCHHHHHhChH
Confidence 222 468899999999999999 999999999999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=365.95 Aligned_cols=253 Identities=27% Similarity=0.435 Sum_probs=214.6
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccc--c
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--R 744 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~--~ 744 (935)
+..++|++.+.||+|+||.||+|++ .++.||||++.... ......+.+|+.++++++||||+++++++. .
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 4457899999999999999999984 57789999987553 445667899999999999999999999876 4
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
...+++||||+++++|.+++......+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccce
Confidence 55689999999999999999765557999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH--------------HHHHH
Q 002331 825 LKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--------------QVVGA 887 (935)
Q Consensus 825 ~~~~~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~--------------eil~~ 887 (935)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||...... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 764322 1233456788899999999998999999999999999999999998754332 11222
Q ss_pred hhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 888 VGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 888 I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
......+...+..+++.+.+||.+||+.| |.+||++.+|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~d---P~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPS---PQDRPSFSALGPQ 297 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 22344556678889999999999999999 9999999999764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=384.05 Aligned_cols=253 Identities=32% Similarity=0.546 Sum_probs=216.7
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEECC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
..+++..++|++.+.||+|+||.||+|.+.+ ..||||++...... .+.+.+|+.+|++++||||+++++++.+ +.
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 4467888999999999999999999999864 57999998765433 3568899999999999999999999876 67
Q ss_pred eEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
++|||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 89999999999999999642 345899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 827 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 827 ~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+. ...+...|..+++.
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 409 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 409 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 54322 1223456788999999999999999999999999999999 999999999888877764 44566778899999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+.+||.+||+.| |.+||++++|++
T Consensus 410 l~~li~~cl~~d---P~~Rpt~~~l~~ 433 (452)
T 1fmk_A 410 LHDLMCQCWRKE---PEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHccCC---hhhCcCHHHHHH
Confidence 999999999999 999999999876
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=367.80 Aligned_cols=252 Identities=27% Similarity=0.471 Sum_probs=209.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCce----EEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~----VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
+..++|++.+.||+|+||.||+|.+ +++. ||+|.+.... .......+.+|+.++++++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 4457899999999999999999987 4444 5777665432 2234567889999999999999999999998754
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.++||||+.+++|.+++......+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 88999999999999999876678999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcH
Q 002331 827 HNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 827 ~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
.... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. .......+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 4322 12233456788999999999999999999999999999999 999999988877766554 4455667788999
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+.+||.+||+.| |.+||++.+|++.
T Consensus 247 ~l~~li~~~l~~d---p~~Rps~~ell~~ 272 (327)
T 3lzb_A 247 DVYMIMRKCWMID---ADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCC---hhHCcCHHHHHHH
Confidence 9999999999999 9999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=375.91 Aligned_cols=248 Identities=23% Similarity=0.259 Sum_probs=202.6
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC------c
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------N 747 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~------~ 747 (935)
..+|.+.+.||+|+||.||+|++ .+..||+|++...... ..+|+.+|+.++||||++++++|.... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 35799999999999999999987 4566999988654321 236999999999999999999985433 3
Q ss_pred eEEEEeeCCCCCHHHHHc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec-CCCcEEEEeccccc
Q 002331 748 LSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSR 824 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~--~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~VKL~DFGlA~ 824 (935)
+++||||++++.+..+.. .....+++..++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||+++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 889999998754433321 23457899999999999999999999999 99999999999999 79999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc----------
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---------- 893 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~---------- 893 (935)
..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 191 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 191 ILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp ECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 76443 223456789999999999775 489999999999999999999999999887665544321100
Q ss_pred -----c------------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 -----R------------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 -----r------------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. ..++..+++++.+||.+||+.| |.+||++.++++|||
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYT---PSARLTAIEALCHPF 324 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS---GGGSCCHHHHHTSGG
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCC---hhhCCCHHHHhcChh
Confidence 0 0133458899999999999999 999999999999998
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=368.07 Aligned_cols=255 Identities=28% Similarity=0.419 Sum_probs=210.7
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
+...++|++.+.||+|+||.||+|++ +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34557899999999999999999987 478999998766533 345678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 751 ITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~---~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999996532 35899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH---H----Hhhc--------
Q 002331 828 NTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV---G----AVGF-------- 890 (935)
Q Consensus 828 ~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil---~----~I~~-------- 890 (935)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+.+.. . ....
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 321 1223346899999999999989999999999999999999999999865432211 0 0000
Q ss_pred cccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCc
Q 002331 891 QNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKR 933 (935)
Q Consensus 891 ~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHP 933 (935)
......++..++..+.++|.+||+.| |.+||++.+++++.
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~d---P~~Rps~~ell~~L 310 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALS---SEDRPSMGDVLWKL 310 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSS---GGGSCCHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCC---cccCcCHHHHHHHH
Confidence 00111233445678999999999999 99999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=365.86 Aligned_cols=251 Identities=19% Similarity=0.238 Sum_probs=194.4
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc----
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN---- 747 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~---- 747 (935)
..++|++.+.||+|+||.||+|++ +++.||||++...... ...+.+|++.+..++||||++++++|.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 347899999999999999999987 4889999988654322 1234567788888999999999999865433
Q ss_pred ---eEEEEeeCCCCCHHHHHc---CCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCEEeeCCCCCCeeecC-CCcEEEE
Q 002331 748 ---LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMNCLH--TSTPTIVHRDLKSPNLLVDK-NWNVKVS 818 (935)
Q Consensus 748 ---l~LVmEy~~gGsL~dlL~---~~~~~lse~~il~Ia~QIa~AL~yLH--s~g~~IIHrDLKPeNILLd~-~g~VKL~ 818 (935)
+++||||+++ +|.+.+. .....+++..++.++.||+.||.||| ++| |+||||||+||||+. ++.+||+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEEC
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEe
Confidence 8899999987 5544332 34567899999999999999999999 777 999999999999996 8999999
Q ss_pred eccccccccCCcccCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc----
Q 002331 819 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---- 893 (935)
Q Consensus 819 DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~---- 893 (935)
|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 175 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 175 DFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 999998765432 234567899999999987654 89999999999999999999999999887766655421100
Q ss_pred --------------------------ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 894 --------------------------RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 894 --------------------------r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
....+..+++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL---PEERMKPYEALCHPY 317 (360)
T ss_dssp HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSS---GGGSCCHHHHTTSGG
T ss_pred HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccC---ccccCCHHHHhcCcc
Confidence 01122336789999999999999 999999999999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=366.70 Aligned_cols=259 Identities=32% Similarity=0.526 Sum_probs=218.1
Q ss_pred cccccCCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 667 e~~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
....+++..++|++++.||+|+||.||+|++.+ .||||++............+.+|+.++++++||||+++++++.+.+
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 345678889999999999999999999998866 5999998765433333445778999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+ ++.+||+|||++...
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999999876667999999999999999999999999 99999999999998 679999999998754
Q ss_pred cCC-----cccCCCCCCCCCccCcccccC---------CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc
Q 002331 827 HNT-----FLSSKSTAGTPEWMAPEVLRN---------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 892 (935)
Q Consensus 827 ~~~-----~~~~~s~~GT~~Y~APEvl~g---------~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~ 892 (935)
... ........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 321 112233468899999999874 457889999999999999999999999998888777765444
Q ss_pred cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 893 RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 893 ~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.....+..++..+.+||.+||..| |.+||++.+|++.
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~---p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFE---QEERPTFTKLMDM 296 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSS---TTTSCCHHHHHHH
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCC---hhhCcCHHHHHHH
Confidence 444444578899999999999999 9999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=359.31 Aligned_cols=246 Identities=32% Similarity=0.558 Sum_probs=200.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc--CCCceeeeecccccC----Cce
Q 002331 675 WEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL--RHPNVVLFMGAVTRP----PNL 748 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L--~HPNIVkl~g~~~~~----~~l 748 (935)
.++|++.+.||+|+||.||+|+++++.||||++.... ...+.+|.+++..+ +||||+++++++... ..+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3689999999999999999999999999999986542 22344555555544 999999999998776 679
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS--------TPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~--------g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
++||||+++++|.++++.. .+++..++.++.||+.||.|||.+ + |+||||||+||||+.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEEEeC
Confidence 9999999999999999763 689999999999999999999998 7 999999999999999999999999
Q ss_pred cccccccCCccc----CCCCCCCCCccCcccccCCCCCch------hHHHHHHHHHHHHHcC----------CCCCCCCC
Q 002331 821 GLSRLKHNTFLS----SKSTAGTPEWMAPEVLRNEPSNEK------CDVYSFGVILWELATL----------KLPWIGMN 880 (935)
Q Consensus 821 GlA~~~~~~~~~----~~s~~GT~~Y~APEvl~g~~~s~k------sDIWSLG~ILyELLTG----------~~PF~~~~ 880 (935)
|+++........ .....||+.|+|||++.+..+... +|||||||++|||++| ..||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 999765432211 234579999999999988766554 9999999999999999 77776532
Q ss_pred -----hHHHHHHhhccccccCCCC-----cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 881 -----PMQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 881 -----~~eil~~I~~~~~r~~ip~-----~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.......+.....+..++. .+++.+.+||.+||+.| |.+||++.+|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d---P~~Rps~~ell~~ 325 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN---PASRLTALRVKKT 325 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSS---GGGSCCHHHHHHH
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhC---hhhCCCHHHHHHH
Confidence 2233333333344444443 56788999999999999 9999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=358.97 Aligned_cols=249 Identities=20% Similarity=0.263 Sum_probs=206.1
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc------eeeeeccccc
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN------VVLFMGAVTR 744 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPN------IVkl~g~~~~ 744 (935)
..++|++.+.||+|+||.||+|.+ .+ +.||||++... ......+.+|+.+++.++|++ |+.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 357899999999999999999987 33 68999998643 344567888999999987655 8999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee--------------
Q 002331 745 PPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV-------------- 809 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL-------------- 809 (935)
.+.++|||||+ +++|.+++.. ....+++..++.|+.||+.||.|||++| |+||||||+||||
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccccc
Confidence 99999999999 5566666543 3357999999999999999999999998 9999999999999
Q ss_pred -----cCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHH
Q 002331 810 -----DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884 (935)
Q Consensus 810 -----d~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~ei 884 (935)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56889999999999865433 2346799999999999999999999999999999999999999998877655
Q ss_pred HHHhhcccccc------------------------------------------CCCCcCcHHHHHHHHHHHhhCCCCcCC
Q 002331 885 VGAVGFQNRRL------------------------------------------EIPKELDPLVARIIWECWQTGWSSLHI 922 (935)
Q Consensus 885 l~~I~~~~~r~------------------------------------------~ip~~ls~~L~dLI~qCL~~D~ssP~k 922 (935)
...+....... ......+..+.+||.+||+.| |.+
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d---P~~ 324 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD---PAQ 324 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS---TTT
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC---hhh
Confidence 44332111000 011223568999999999999 999
Q ss_pred CcCHHHHHhCcC
Q 002331 923 RTSQAQLSHKRF 934 (935)
Q Consensus 923 RPSa~EILqHPF 934 (935)
||++.++|+|||
T Consensus 325 Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 325 RITLAEALLHPF 336 (355)
T ss_dssp SCCHHHHTTSGG
T ss_pred CcCHHHHhcChh
Confidence 999999999998
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=370.60 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=210.0
Q ss_pred ccccCCCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 668 VCECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 668 ~~~~ei~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
..++++..++|++.+.||+|+||.||+|++ +++.||||++...... .....+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 345567778999999999999999999976 5889999998754321 12225789999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 747 NLSIITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDVARGMNCLHTS---TPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~---~~lse~~il~Ia~QIa~AL~yLHs~---g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
..++||||+++++|.+++.... ..+++..++.|+.||+.||.|||++ + |+||||||+||||+.++.+||+||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECCC
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEeccC
Confidence 9999999999999999997632 3489999999999999999999998 8 999999999999999999999999
Q ss_pred cccccccCCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----Ch---HHHHHHhhc-
Q 002331 821 GLSRLKHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-----NP---MQVVGAVGF- 890 (935)
Q Consensus 821 GlA~~~~~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~-----~~---~eil~~I~~- 890 (935)
|+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||... .. .........
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence 9998764322 2233456999999999999888999999999999999999999999521 11 111111100
Q ss_pred --------cccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCc
Q 002331 891 --------QNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKR 933 (935)
Q Consensus 891 --------~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHP 933 (935)
......++...+..+.+||.+||+.| |.+||++.+|++|-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d---P~~Rps~~ell~~L 306 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS---PMERPKMSEVVRML 306 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSC---GGGSCCHHHHHHHH
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcC---CccCCCHHHHHHHh
Confidence 00111223344578999999999999 99999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=372.67 Aligned_cols=253 Identities=18% Similarity=0.190 Sum_probs=201.5
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHH---------HHHHHHHHHHHHHcCCCce
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAA---------LLEFKREVKIMRRLRHPNV 735 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~---------~~~f~~Ei~iL~~L~HPNI 735 (935)
++..++|++++.||+|+||.||+|.+. ++.||||++......... ...+..|+..+..++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 355679999999999999999999873 468999998765311100 0123345666777889999
Q ss_pred eeeecccccC----CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec-
Q 002331 736 VLFMGAVTRP----PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD- 810 (935)
Q Consensus 736 Vkl~g~~~~~----~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd- 810 (935)
+++++++... ..++|||||+ +++|.+++......+++..++.|+.||+.||.|||+++ |+||||||+||||+
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY 187 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEES
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEec
Confidence 9999998765 4489999999 99999999876678999999999999999999999998 99999999999999
Q ss_pred -CCCcEEEEeccccccccCCcc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH
Q 002331 811 -KNWNVKVSDFGLSRLKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 882 (935)
Q Consensus 811 -~~g~VKL~DFGlA~~~~~~~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~ 882 (935)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999986543211 113345999999999999999999999999999999999999999864322
Q ss_pred -HHHHHhhcccccc---------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 883 -QVVGAVGFQNRRL---------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 883 -eil~~I~~~~~r~---------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
....... ..... ..+..+++++.+||.+||..+ |.+||++.+|++
T Consensus 268 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~---p~~RP~~~~l~~ 322 (364)
T 3op5_A 268 PKYVRDSK-IRYRENIASLMDKCFPAANAPGEIAKYMETVKLLD---YTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHH-HHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCC---TTCCCCHHHHHH
T ss_pred HHHHHHHH-HHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCC---CCCCCCHHHHHH
Confidence 2111110 00001 112567899999999999999 999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=362.51 Aligned_cols=249 Identities=29% Similarity=0.436 Sum_probs=195.8
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHH--HHHcCCCceeeeeccc-----c
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHPNVVLFMGAV-----T 743 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~i--L~~L~HPNIVkl~g~~-----~ 743 (935)
..+..++|++++.||+|+||.||+|+++++.||||++.... ...+..|..+ +..++||||+++++.+ .
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 45677999999999999999999999999999999986543 2233334444 4458999999999743 3
Q ss_pred cCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCEEeeCCCCCCeeecCCCc
Q 002331 744 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS---------TPTIVHRDLKSPNLLVDKNWN 814 (935)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~---------g~~IIHrDLKPeNILLd~~g~ 814 (935)
....+++||||+++|+|.+++... ..++..++.|+.||+.||.|||+. + |+||||||+||||+.++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSC
T ss_pred CCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCc
Confidence 334578999999999999999763 458899999999999999999998 8 999999999999999999
Q ss_pred EEEEeccccccccCCc--------ccCCCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 002331 815 VKVSDFGLSRLKHNTF--------LSSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELATLKLPWIGM 879 (935)
Q Consensus 815 VKL~DFGlA~~~~~~~--------~~~~s~~GT~~Y~APEvl~g-------~~~s~ksDIWSLG~ILyELLTG~~PF~~~ 879 (935)
+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999998654321 11234579999999999987 34567899999999999999997776432
Q ss_pred Ch------------------HHHHHHhhccccccCCCCc------CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 880 NP------------------MQVVGAVGFQNRRLEIPKE------LDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 880 ~~------------------~eil~~I~~~~~r~~ip~~------ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.. ......+.....+..++.. +++.+.+||.+||+.| |.+||++.+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d---P~~Rps~~e~l~ 311 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD---AEARLTAQXAEE 311 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSS---GGGSCCHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCC---hhhCcchHHHHH
Confidence 11 1222222223344445543 4568999999999999 999999999964
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=389.48 Aligned_cols=254 Identities=32% Similarity=0.540 Sum_probs=222.5
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEECC-ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
..+++..++|++.++||+|+||.||+|++.+ ..||||++...... .+.|.+|+.+|++++|||||++++++.+ +.
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 4577888999999999999999999999864 67999999765433 3568899999999999999999999876 67
Q ss_pred eEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
+||||||+++|+|.+++... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 89999999999999999642 345899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 827 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 827 ~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
..... ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+....++...+. ...+...+..++..
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 492 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 492 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 54321 1233456788999999999999999999999999999999 899999999888877764 44566778899999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+.+||.+||+.| |.+||++++|++.
T Consensus 493 l~~li~~cl~~d---P~~RPt~~~l~~~ 517 (535)
T 2h8h_A 493 LHDLMCQCWRKE---PEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCC---hhHCcCHHHHHHH
Confidence 999999999999 9999999998763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=358.27 Aligned_cols=248 Identities=27% Similarity=0.406 Sum_probs=209.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC--Cc
Q 002331 676 EDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PN 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~--~~ 747 (935)
+.|++++.||+|+||+||++.+ +++.||||++... ........+.+|+.+|++++||||+++++++.+. ..
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 4469999999999999999865 5788999998765 3445667789999999999999999999999774 56
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+++||||+++++|.+++.+. .+++..++.|+.||+.||.|||+.| |+||||||+||||+.++.+||+|||++....
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 89999999999999999764 4899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH--------------HHHHhhc
Q 002331 828 NTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ--------------VVGAVGF 890 (935)
Q Consensus 828 ~~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~e--------------il~~I~~ 890 (935)
... .......+++.|+|||++.+..++.++|||||||++|+|++|..||....... .......
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 432 12234567888999999999889999999999999999999999997643211 1112222
Q ss_pred cccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 891 QNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 891 ~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.......+..+++.+.+||.+||+.| |.+||++.+|++
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~d---P~~Rps~~ell~ 303 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETE---ASFRPTFENLIP 303 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCC---cccCcCHHHHHH
Confidence 44556677889999999999999999 999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=358.01 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=192.6
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeeccc----
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAV---- 742 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~---- 742 (935)
.+++...+|++.+.||+|+||.||+|++ +++.||||++.... ......+.+|+.+++++. ||||+++++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 3455667899999999999999999988 78899999886543 445667889999999995 99999999988
Q ss_pred ----ccCCceEEEEeeCCCCCHHHHHcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEE
Q 002331 743 ----TRPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 816 (935)
Q Consensus 743 ----~~~~~l~LVmEy~~gGsL~dlL~~--~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VK 816 (935)
.....+++||||+. |+|.+++.+ ....+++..++.|+.||+.||.|||+++++|+||||||+||||+.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 34445899999996 689888854 34579999999999999999999999877799999999999999999999
Q ss_pred EEeccccccccCCcc------------cCCCCCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 002331 817 VSDFGLSRLKHNTFL------------SSKSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 881 (935)
Q Consensus 817 L~DFGlA~~~~~~~~------------~~~s~~GT~~Y~APEvl---~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~ 881 (935)
|+|||+++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 999999987643211 11134689999999998 566789999999999999999999999987665
Q ss_pred HHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCc
Q 002331 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKR 933 (935)
Q Consensus 882 ~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHP 933 (935)
..+... ......+..++..+.+||.+||+.| |.+||++.+++++.
T Consensus 259 ~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~---p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 259 LRIVNG----KYSIPPHDTQYTVFHSLIRAMLQVN---PEERLSIAEVVHQL 303 (337)
T ss_dssp -----------CCCCTTCCSSGGGHHHHHHHSCSS---GGGSCCHHHHHHHH
T ss_pred HHhhcC----cccCCcccccchHHHHHHHHHccCC---hhhCcCHHHHHHHH
Confidence 544332 2233445667788999999999999 99999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=373.66 Aligned_cols=250 Identities=30% Similarity=0.496 Sum_probs=204.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--C-C--ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccc-cCCceE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--N-G--TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT-RPPNLS 749 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~-g--~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~-~~~~l~ 749 (935)
..|.+.+.||+|+||.||+|++ . + ..||||.+.... .......+.+|+.++++++||||+++++++. .++..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 4588899999999999999976 2 2 358999876532 3355678999999999999999999999864 456789
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
+||||+++++|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999999887777899999999999999999999999 999999999999999999999999999865432
Q ss_pred cc----cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 830 FL----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 830 ~~----~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
.. ......+++.|+|||++.+..++.++|||||||++|||++ |.+||...+..+....+. ...+...|..+++.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~~~~ 324 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTCCHH
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 21 1233457788999999999999999999999999999999 688888877666655543 34456677889999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+.+||.+||+.| |.+||++.+|+++
T Consensus 325 l~~li~~cl~~d---p~~RPs~~ell~~ 349 (373)
T 3c1x_A 325 LYEVMLKCWHPK---AEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCC---hhhCcCHHHHHHH
Confidence 999999999999 9999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=366.13 Aligned_cols=252 Identities=23% Similarity=0.245 Sum_probs=207.8
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CC-----ceeeeeccccc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HP-----NVVLFMGAVTR 744 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HP-----NIVkl~g~~~~ 744 (935)
...++|++.+.||+|+||+||+|.+ +++.||||++... ......+.+|+.+++.++ |+ +|+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3458999999999999999999987 5788999998643 344566788999988884 55 49999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec--CCCcEEEEecc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFG 821 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd--~~g~VKL~DFG 821 (935)
.+.++|||||+++ +|.+++.... ..+++..++.++.||+.||.|||.+..+||||||||+||||+ .++.+||+|||
T Consensus 128 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 128 RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 9999999999964 9999886543 468999999999999999999995333499999999999995 57889999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-----
Q 002331 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE----- 896 (935)
Q Consensus 822 lA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~----- 896 (935)
+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......+.
T Consensus 207 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 207 SSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred Cceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99876543 2346799999999999999999999999999999999999999999887766655432111000
Q ss_pred -----------CCC----------------------------------------------cCcHHHHHHHHHHHhhCCCC
Q 002331 897 -----------IPK----------------------------------------------ELDPLVARIIWECWQTGWSS 919 (935)
Q Consensus 897 -----------ip~----------------------------------------------~ls~~L~dLI~qCL~~D~ss 919 (935)
++. ...+.+.+||.+||+.|
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d--- 360 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD--- 360 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC---
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC---
Confidence 000 01147899999999999
Q ss_pred cCCCcCHHHHHhCcC
Q 002331 920 LHIRTSQAQLSHKRF 934 (935)
Q Consensus 920 P~kRPSa~EILqHPF 934 (935)
|.+|||+.|+|+|||
T Consensus 361 P~~Rpta~e~L~hp~ 375 (382)
T 2vx3_A 361 PKTRIQPYYALQHSF 375 (382)
T ss_dssp TTTSCCHHHHTTSGG
T ss_pred hhhCCCHHHHhcCcc
Confidence 999999999999998
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=393.01 Aligned_cols=253 Identities=25% Similarity=0.444 Sum_probs=215.9
Q ss_pred cCCCCCCeeEEE-EeeecCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 671 CEIPWEDLVLGE-RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 671 ~ei~~edy~I~e-~LG~G~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
+.+..+++.+.+ .||+|+||.||+|.+ .+..||||+++... .......+.+|+++|++++|||||++++++..
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 445667777776 899999999999976 34579999987653 22345678999999999999999999999976
Q ss_pred CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
+.++|||||+++|+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 5699999999999999999876677999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcC
Q 002331 826 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (935)
Q Consensus 826 ~~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~l 901 (935)
...... ......+++.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..++...+. ...+..+|..+
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~ 564 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC 564 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCCTTC
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcC
Confidence 643211 1122345689999999999999999999999999999998 999999998888877765 45567788899
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
++.+.+||.+||+.| |.+||++.+|++
T Consensus 565 ~~~l~~li~~cl~~d---P~~RPs~~~l~~ 591 (613)
T 2ozo_A 565 PPELYALMSDCWIYK---WEDRPDFLTVEQ 591 (613)
T ss_dssp CHHHHHHHHHTTCSS---TTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCC---hhHCcCHHHHHH
Confidence 999999999999999 999999999865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=356.92 Aligned_cols=252 Identities=20% Similarity=0.258 Sum_probs=205.4
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
..++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++...+.+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 357899999999999999999986 588999999876533 34456778999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||+++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999999999753 46899999999999999999999999 9999999999999999999999999998664432
Q ss_pred -ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc-ccCCCCcCcHHHHHH
Q 002331 831 -LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARI 908 (935)
Q Consensus 831 -~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~-r~~ip~~ls~~L~dL 908 (935)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+..... ...++..+++.+.+|
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 122345789999999999999999999999999999999999999998876655444432221 224567789999999
Q ss_pred HHHHHhhCCCCcCCCc-CHHHHHh
Q 002331 909 IWECWQTGWSSLHIRT-SQAQLSH 931 (935)
Q Consensus 909 I~qCL~~D~ssP~kRP-Sa~EILq 931 (935)
|.+||+.| |.+|| +++++++
T Consensus 269 i~~~l~~d---P~~Rp~s~~~l~~ 289 (309)
T 2h34_A 269 IARGMAKN---PEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHTCSS---GGGSCSSHHHHHH
T ss_pred HHHhccCC---HHHHHHhHHHHHH
Confidence 99999999 99999 8888875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=367.70 Aligned_cols=252 Identities=21% Similarity=0.236 Sum_probs=199.7
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCCCHH---------HHHHHHHHHHHHHHcCCCceee
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGA---------ALLEFKREVKIMRRLRHPNVVL 737 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~~~~---------~~~~f~~Ei~iL~~L~HPNIVk 737 (935)
++..++|++++.||+|+||.||+|.+ .+..||||++........ ....+.+|+.+++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 34568899999999999999999987 457899999876532111 1123567888999999999999
Q ss_pred eeccccc----CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC
Q 002331 738 FMGAVTR----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 813 (935)
Q Consensus 738 l~g~~~~----~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g 813 (935)
+++++.. ...+|+||||+ +++|.+++.... .+++..++.|+.||+.||.|||+++ |+||||||+||||+.++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSS
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCC
Confidence 9999877 67899999999 999999997644 7999999999999999999999998 99999999999998877
Q ss_pred --cEEEEeccccccccCCcc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC--ChH
Q 002331 814 --NVKVSDFGLSRLKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM--NPM 882 (935)
Q Consensus 814 --~VKL~DFGlA~~~~~~~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~--~~~ 882 (935)
.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. +..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999986543211 113457999999999999999999999999999999999999999652 322
Q ss_pred HHHHHhhccccccCCC---------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 883 QVVGAVGFQNRRLEIP---------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 883 eil~~I~~~~~r~~ip---------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
...... ......++ ..+++.+.+||.+||..| |.+||++++|++.
T Consensus 269 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~~l~~~ 322 (345)
T 2v62_A 269 AVQTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLA---YDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCC---TTCCCCHHHHHHH
T ss_pred HHHHHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcC---cccCCCHHHHHHH
Confidence 222111 11112222 278899999999999999 9999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=347.72 Aligned_cols=247 Identities=21% Similarity=0.258 Sum_probs=204.2
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccc-ccCCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV-TRPPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~-~~~~~l~LV 751 (935)
.++|++.+.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++|++++..+.++ ......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 36899999999999999999985 6889999998765433 2477899999999987766655554 566778999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee---cCCCcEEEEeccccccccC
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL---d~~g~VKL~DFGlA~~~~~ 828 (935)
|||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||++.....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 9999 88999999855567999999999999999999999999 9999999999999 4889999999999987654
Q ss_pred Ccc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhc---ccccc
Q 002331 829 TFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGF---QNRRL 895 (935)
Q Consensus 829 ~~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~---~eil~~I~~---~~~r~ 895 (935)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... .+....+.. .....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 322 12456799999999999999999999999999999999999999987432 122222211 11112
Q ss_pred CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 896 EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 896 ~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.++..+++.+.+||.+||+.| |.+||++.+|++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~d---p~~Rps~~~l~~ 273 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLR---FDDKPDYSYLRQ 273 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSC---TTCCCCHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcC---cCcCCCHHHHHH
Confidence 234678999999999999999 999999999876
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=372.40 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=186.0
Q ss_pred CeeE-EEEeeecCcEEEEEEEEC----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccc--ccCCceE
Q 002331 677 DLVL-GERIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV--TRPPNLS 749 (935)
Q Consensus 677 dy~I-~e~LG~G~fG~Vyka~~~----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~--~~~~~l~ 749 (935)
.|.+ +++||+|+||.||+|++. ++.||||++....... .+.+|+.+|+.++|||||+++++| .....+|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH----HHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH----HHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 4555 567999999999999863 6789999987665433 567899999999999999999999 4567899
Q ss_pred EEEeeCCCCCHHHHHcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee----cCCCcEEE
Q 002331 750 IITEFLPRGSLFRILHR--------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKV 817 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~--------~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL----d~~g~VKL 817 (935)
|||||+.+ +|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 99999965 88877742 1235899999999999999999999999 9999999999999 67899999
Q ss_pred EeccccccccCCc---ccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChH---------HH
Q 002331 818 SDFGLSRLKHNTF---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM---------QV 884 (935)
Q Consensus 818 ~DFGlA~~~~~~~---~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~---------ei 884 (935)
+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.... +.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 9999998765321 223446799999999999874 4899999999999999999999999865431 22
Q ss_pred HHHhhcccccc------------------------------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHH
Q 002331 885 VGAVGFQNRRL------------------------------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQ 928 (935)
Q Consensus 885 l~~I~~~~~r~------------------------------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~E 928 (935)
+..+......+ ......++.+.+||.+||+.| |.+|||++|
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~d---P~~R~ta~e 330 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD---PIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSS---GGGSCCHHH
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCC---cccCCCHHH
Confidence 22211000000 001122678899999999999 999999999
Q ss_pred HHhCcC
Q 002331 929 LSHKRF 934 (935)
Q Consensus 929 ILqHPF 934 (935)
+|+|||
T Consensus 331 ~L~hp~ 336 (405)
T 3rgf_A 331 AMQDPY 336 (405)
T ss_dssp HHTSGG
T ss_pred HhcChh
Confidence 999999
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.90 Aligned_cols=250 Identities=18% Similarity=0.279 Sum_probs=203.9
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-----------CCceeeee
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----------HPNVVLFM 739 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-----------HPNIVkl~ 739 (935)
+..++|++.+.||+|+||.||+|++ +++.||||++... ......+.+|+.++++++ ||||++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 3457899999999999999999986 6889999998643 334566788999998885 89999999
Q ss_pred cccccCC----ceEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhc-CCCEEeeCCCCCCeeec---
Q 002331 740 GAVTRPP----NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTS-TPTIVHRDLKSPNLLVD--- 810 (935)
Q Consensus 740 g~~~~~~----~l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~-g~~IIHrDLKPeNILLd--- 810 (935)
+++...+ .+++||||+ +++|.+++.+. ...+++..++.|+.||+.||.|||++ | |+||||||+||||+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccC
Confidence 9987654 689999999 88999998653 34589999999999999999999998 8 99999999999994
Q ss_pred ---CCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh------
Q 002331 811 ---KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP------ 881 (935)
Q Consensus 811 ---~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~------ 881 (935)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999876543 2345789999999999999999999999999999999999999986542
Q ss_pred HHHHHHhhc----------------------------------------cccccCCCCcCcHHHHHHHHHHHhhCCCCcC
Q 002331 882 MQVVGAVGF----------------------------------------QNRRLEIPKELDPLVARIIWECWQTGWSSLH 921 (935)
Q Consensus 882 ~eil~~I~~----------------------------------------~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~ 921 (935)
...+..+.. ......++..++..+.+||.+||+.| |.
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~ 323 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD---PR 323 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS---TT
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC---cc
Confidence 111111100 00112344566788999999999999 99
Q ss_pred CCcCHHHHHhCcC
Q 002331 922 IRTSQAQLSHKRF 934 (935)
Q Consensus 922 kRPSa~EILqHPF 934 (935)
+||++.+||+|||
T Consensus 324 ~Rpt~~ell~hp~ 336 (373)
T 1q8y_A 324 KRADAGGLVNHPW 336 (373)
T ss_dssp TCBCHHHHHTCGG
T ss_pred ccCCHHHHhhChh
Confidence 9999999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=357.57 Aligned_cols=247 Identities=22% Similarity=0.377 Sum_probs=202.8
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHc----CCCceeeeecc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRL----RHPNVVLFMGA 741 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~iL~~L----~HPNIVkl~g~ 741 (935)
+...++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34457899999999999999999977 67899999987654322 1233456799999998 89999999999
Q ss_pred cccCCceEEEEee-CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec-CCCcEEEEe
Q 002331 742 VTRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSD 819 (935)
Q Consensus 742 ~~~~~~l~LVmEy-~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~VKL~D 819 (935)
+...+..++|||| +.+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999999 7899999999763 46899999999999999999999999 99999999999999 899999999
Q ss_pred ccccccccCCcccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCC
Q 002331 820 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898 (935)
Q Consensus 820 FGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip 898 (935)
||++....... .....|++.|+|||++.+..+ +.++|||||||++|+|++|+.||..... .. .....++
T Consensus 184 fg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~------~~~~~~~ 253 (312)
T 2iwi_A 184 FGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--IL------EAELHFP 253 (312)
T ss_dssp CSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HH------HTCCCCC
T ss_pred cchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--Hh------hhccCCc
Confidence 99998765432 234678999999999987666 4589999999999999999999976421 11 2344567
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..++..+.+||.+||+.| |.+||++.++++|||
T Consensus 254 ~~~~~~~~~li~~~l~~~---p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 254 AHVSPDCCALIRRCLAPK---PSSRPSLEEILLDPW 286 (312)
T ss_dssp TTSCHHHHHHHHHHTCSS---TTTSCCHHHHHHSTT
T ss_pred ccCCHHHHHHHHHHccCC---hhhCcCHHHHhcChh
Confidence 889999999999999999 999999999999999
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.70 Aligned_cols=241 Identities=23% Similarity=0.362 Sum_probs=206.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc---------
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--------- 744 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~--------- 744 (935)
.+|++.+.||+|+||.||+|++ +++.||||++.... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 5799999999999999999988 48899999987653 246789999999999999999998754
Q ss_pred -------CCceEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEE
Q 002331 745 -------PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 816 (935)
Q Consensus 745 -------~~~l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VK 816 (935)
...+++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCEE
Confidence 44589999999999999999643 356899999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC
Q 002331 817 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE 896 (935)
Q Consensus 817 L~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ 896 (935)
|+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.... .....+. ...
T Consensus 163 l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~----~~~ 235 (284)
T 2a19_B 163 IGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR----DGI 235 (284)
T ss_dssp ECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH----TTC
T ss_pred ECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh----ccc
Confidence 99999998765432 2344579999999999999999999999999999999999998875321 2222221 233
Q ss_pred CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 897 IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 897 ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
++..++..+.+||.+||+.| |.+||++.+++++.+
T Consensus 236 ~~~~~~~~~~~li~~~l~~d---p~~Rps~~e~l~~l~ 270 (284)
T 2a19_B 236 ISDIFDKKEKTLLQKLLSKK---PEDRPNTSEILRTLT 270 (284)
T ss_dssp CCTTSCHHHHHHHHHHTCSS---GGGSCCHHHHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCC---hhhCcCHHHHHHHHH
Confidence 56778999999999999999 999999999999865
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=356.39 Aligned_cols=245 Identities=35% Similarity=0.602 Sum_probs=205.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHH--cCCCceeeeecccccCC----ceE
Q 002331 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTRPP----NLS 749 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~--L~HPNIVkl~g~~~~~~----~l~ 749 (935)
++|++.+.||+|+||.||+|+++++.||||++.... ...+.+|++++.. ++||||+++++++.... .++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 679999999999999999999999999999986442 3456788899888 69999999999998776 799
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCEEeeCCCCCCeeecCCCcEEEEecc
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH--------TSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLH--------s~g~~IIHrDLKPeNILLd~~g~VKL~DFG 821 (935)
+||||+++++|.+++.+ ..+++..++.++.||+.||.||| +.+ |+||||||+||||+.++.+||+|||
T Consensus 117 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEEEECC
Confidence 99999999999999976 35899999999999999999999 777 9999999999999999999999999
Q ss_pred ccccccCCcc----cCCCCCCCCCccCcccccCCC------CCchhHHHHHHHHHHHHHcC----------CCCCCCCC-
Q 002331 822 LSRLKHNTFL----SSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATL----------KLPWIGMN- 880 (935)
Q Consensus 822 lA~~~~~~~~----~~~s~~GT~~Y~APEvl~g~~------~s~ksDIWSLG~ILyELLTG----------~~PF~~~~- 880 (935)
++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++| ..||....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 9987654321 234557999999999998763 23689999999999999999 78987652
Q ss_pred ----hHHHHHHhhccccccCCCC-----cCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 881 ----PMQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 881 ----~~eil~~I~~~~~r~~ip~-----~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
...+...+.....++.++. .++..+.+||.+||+.| |.+||++.+|++|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d---p~~Rps~~~i~~~ 330 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN---GAARLTALRIKKT 330 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSS---GGGSCCHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccC---hhhCCCHHHHHHH
Confidence 2344444433444455553 34578999999999999 9999999999976
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=346.92 Aligned_cols=246 Identities=21% Similarity=0.266 Sum_probs=200.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccc-ccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV-TRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~-~~~~~l~LVm 752 (935)
++|++.+.||+|+||.||+|++ .++.||||++...... ..+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 6899999999999999999985 6889999987654322 2477899999999887766666554 6667789999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee---cCCCcEEEEeccccccccCC
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL---d~~g~VKL~DFGlA~~~~~~ 829 (935)
||+ +++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 999 88999999865567999999999999999999999999 9999999999999 78999999999999876543
Q ss_pred cc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhc---cccccC
Q 002331 830 FL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGF---QNRRLE 896 (935)
Q Consensus 830 ~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~---eil~~I~~---~~~r~~ 896 (935)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... .....+.. ......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 21 223567999999999999999999999999999999999999999875332 12222111 111112
Q ss_pred CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 897 IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 897 ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+...+++.+.+||.+||+.| |.+||++.+|++
T Consensus 242 ~~~~~~~~l~~li~~~l~~~---p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLR---FDDKPDYSYLRQ 273 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSC---TTCCCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHHhcC---CCCCCCHHHHHH
Confidence 33667899999999999999 999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.91 Aligned_cols=249 Identities=29% Similarity=0.439 Sum_probs=205.8
Q ss_pred eeEEEEeeecCcEEEEEEEECCceEEEEEeeccC--CCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEeeC
Q 002331 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~--~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 755 (935)
|..++.||+|+||.||+|.++++.||||++.... ........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 4456889999999999999999999999987542 23345667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc--c
Q 002331 756 PRGSLFRILHRP--HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--L 831 (935)
Q Consensus 756 ~gGsL~dlL~~~--~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~--~ 831 (935)
++++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++....... .
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999998642 346899999999999999999999999 9999999999999999999999999998654321 1
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHH----HHHHhhc---------cccccCCC
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ----VVGAVGF---------QNRRLEIP 898 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~e----il~~I~~---------~~~r~~ip 898 (935)
......||+.|+|||++.+. ++.++|||||||++|+|++|..||....... +...+.. .......+
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD 269 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred cccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 22345789999999998764 7889999999999999999999998754322 1111110 01112233
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
..++..+.++|.+||+.| |.+||++.+|+++
T Consensus 270 ~~~~~~l~~li~~cl~~~---p~~Rps~~~l~~~ 300 (307)
T 2nru_A 270 STSVEAMYSVASQCLHEK---KNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHHHHHHHHHHTCSS---TTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHHHHcCCC---cccCcCHHHHHHH
Confidence 456678999999999999 9999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.33 Aligned_cols=254 Identities=20% Similarity=0.283 Sum_probs=206.2
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccc----c
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT----R 744 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~----~ 744 (935)
+.+..++|++.+.||+|+||.||++++ +++.||||++... .......+.+|+.+++.++||||+++++++. .
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 345668899999999999999999986 6889999988654 3455677899999999999999999999986 3
Q ss_pred CCceEEEEeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecc
Q 002331 745 PPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFG 821 (935)
...+++||||+++++|.+++.+ ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCS
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecC
Confidence 4568999999999999998864 3567999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCccc---------CCCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHH
Q 002331 822 LSRLKHNTFLS---------SKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGA 887 (935)
Q Consensus 822 lA~~~~~~~~~---------~~s~~GT~~Y~APEvl~g~~---~s~ksDIWSLG~ILyELLTG~~PF~~~~~--~eil~~ 887 (935)
++......... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... ......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 98764321100 11235799999999997654 68899999999999999999999964211 111111
Q ss_pred hhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 888 VGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 888 I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+. .......+..+++.+.+||.+||+.| |.+||++.+|+++
T Consensus 260 ~~-~~~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 VQ-NQLSIPQSPRHSSALWQLLNSMMTVD---PHQRPHIPLLLSQ 300 (317)
T ss_dssp HH-CC--CCCCTTSCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred hh-ccCCCCccccCCHHHHHHHHHHhhcC---hhhCCCHHHHHHH
Confidence 21 22334445678999999999999999 9999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=362.69 Aligned_cols=247 Identities=20% Similarity=0.344 Sum_probs=210.5
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcC--CCceeeeecccc
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLR--HPNVVLFMGAVT 743 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~iL~~L~--HPNIVkl~g~~~ 743 (935)
+...++|++++.||+|+||.||+|.+ +++.||||++....... .....+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999987 68899999987654322 12234667999999996 599999999999
Q ss_pred cCCceEEEEeeCCC-CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec-CCCcEEEEecc
Q 002331 744 RPPNLSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFG 821 (935)
Q Consensus 744 ~~~~l~LVmEy~~g-GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~VKL~DFG 821 (935)
..+.+++||||+.+ ++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999976 8999998753 46899999999999999999999999 99999999999999 78999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCc
Q 002331 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (935)
Q Consensus 822 lA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ 900 (935)
+++...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... .. .....++..
T Consensus 196 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~------~~~~~~~~~ 265 (320)
T 3a99_A 196 SGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--II------RGQVFFRQR 265 (320)
T ss_dssp TCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HH------HCCCCCSSC
T ss_pred ccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--hh------ccccccccc
Confidence 998765432 234679999999999987665 6889999999999999999999976431 11 223456678
Q ss_pred CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 901 LDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 901 ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+++.+.+||.+||+.| |.+||++++|++|||
T Consensus 266 ~~~~~~~li~~~l~~d---p~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 266 VSSECQHLIRWCLALR---PSDRPTFEEIQNHPW 296 (320)
T ss_dssp CCHHHHHHHHHHTCSS---GGGSCCHHHHHTSGG
T ss_pred CCHHHHHHHHHHccCC---hhhCcCHHHHhcCHh
Confidence 8999999999999999 999999999999998
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=354.99 Aligned_cols=252 Identities=30% Similarity=0.491 Sum_probs=211.7
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
.+..++|++++.||+|+||.||++++ .++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 45567899999999999999999984 57889999987642 34566789999999999999999999988665
Q ss_pred C--ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccc
Q 002331 746 P--NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 823 (935)
Q Consensus 746 ~--~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA 823 (935)
+ .+++||||+++++|.+++.+....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcch
Confidence 4 789999999999999999876667999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH----------------HH
Q 002331 824 RLKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----------------QV 884 (935)
Q Consensus 824 ~~~~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~----------------ei 884 (935)
........ ......++..|+|||++.+..++.++|||||||++|+|++|..||...... .+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 87654321 123345777899999999988999999999999999999999998643111 11
Q ss_pred HHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 885 VGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 885 l~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
...+ ....+...+..+++.+.+||.+||+.| |.+||++.+|++
T Consensus 273 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~d---P~~Rps~~el~~ 315 (326)
T 2w1i_A 273 IELL-KNNGRLPRPDGCPDEIYMIMTECWNNN---VNQRPSFRDLAL 315 (326)
T ss_dssp HHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSS---GGGSCCHHHHHH
T ss_pred HHHh-hcCCCCCCCCcccHHHHHHHHHHcCCC---hhhCcCHHHHHH
Confidence 1111 233455677889999999999999999 999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=390.58 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=214.1
Q ss_pred CCCCCCeeEE-EEeeecCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 672 EIPWEDLVLG-ERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 672 ei~~edy~I~-e~LG~G~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
.+....+.+. +.||+|+||.||+|.+ .++.||||+++...........+.+|+.+|++++|||||++++++.. +
T Consensus 364 ~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~ 442 (635)
T 4fl3_A 364 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E 442 (635)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred cccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 3444555554 4899999999999965 35789999998765555556789999999999999999999999965 5
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.++|||||+++|+|.+++... ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred CEEEEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 689999999999999999753 46899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCc
Q 002331 827 HNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902 (935)
Q Consensus 827 ~~~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls 902 (935)
.... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..++...+. ...+..+|..++
T Consensus 520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~ 598 (635)
T 4fl3_A 520 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCP 598 (635)
T ss_dssp TC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred ccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 4322 11223356788999999999999999999999999999998 999999999888777664 455677888999
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+++.+||.+||+.| |.+||++.+|++
T Consensus 599 ~~l~~li~~cl~~d---P~~RPs~~~l~~ 624 (635)
T 4fl3_A 599 REMYDLMNLCWTYD---VENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHHTCSS---TTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCC---HhHCcCHHHHHH
Confidence 99999999999999 999999999976
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=361.56 Aligned_cols=246 Identities=16% Similarity=0.165 Sum_probs=202.1
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEE-------ECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC---CCceeee
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHAD-------WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLF 738 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~-------~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~---HPNIVkl 738 (935)
..+++..++|.+.+.||+|+||+||+|. ..++.||||++.... ...+.+|+.+++.++ |+||+++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 3456677899999999999999999993 267899999986543 345778888888886 8999999
Q ss_pred ecccccCCceEEEEeeCCCCCHHHHHcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC---
Q 002331 739 MGAVTRPPNLSIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--- 811 (935)
Q Consensus 739 ~g~~~~~~~l~LVmEy~~gGsL~dlL~~----~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~--- 811 (935)
++++...+..||||||+++|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGT
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEeccccc
Confidence 9999999999999999999999999963 3457999999999999999999999998 999999999999998
Q ss_pred --------CCcEEEEeccccccccC--CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 002331 812 --------NWNVKVSDFGLSRLKHN--TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 881 (935)
Q Consensus 812 --------~g~VKL~DFGlA~~~~~--~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~ 881 (935)
++.+||+|||+++.... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999975431 22233456899999999999999999999999999999999999999975433
Q ss_pred HHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHH
Q 002331 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930 (935)
Q Consensus 882 ~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EIL 930 (935)
... ...........++.+.+++..||+.+ |.+|+...+.+
T Consensus 291 ~~~------~~~~~~~~~~~~~~~~~~~~~~l~~~---p~~r~~~~~~l 330 (365)
T 3e7e_A 291 GEC------KPEGLFRRLPHLDMWNEFFHVMLNIP---DCHHLPSLDLL 330 (365)
T ss_dssp TEE------EECSCCTTCSSHHHHHHHHHHHHCCC---CTTCCCCHHHH
T ss_pred Cce------eechhccccCcHHHHHHHHHHHcCCC---CCCcchHHHHH
Confidence 210 00011111134788999999999999 99995443333
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=358.35 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=177.9
Q ss_pred CCeeEE-EEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc----CCce
Q 002331 676 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNL 748 (935)
Q Consensus 676 edy~I~-e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~----~~~l 748 (935)
++|.+. +.||+|+||.||+|.+ +++.||||++.... .. .......++.++||||+++++++.. ...+
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 678885 4699999999999987 48899999986532 11 1222334566799999999999875 4458
Q ss_pred EEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC---CCcEEEEeccccc
Q 002331 749 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSR 824 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~VKL~DFGlA~ 824 (935)
++||||+++|+|.+++.+.. ..+++..++.|+.||+.||.|||++| |+||||||+||||+. ++.+||+|||+++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999999999999997643 46999999999999999999999999 999999999999975 4569999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH----Hhhccc--cccCCC
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG----AVGFQN--RRLEIP 898 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~----~I~~~~--~r~~ip 898 (935)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .+.... .+....
T Consensus 180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T 3fhr_A 180 ETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257 (336)
T ss_dssp EC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred ecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence 65433 2234578999999999988889999999999999999999999998766544321 111111 112223
Q ss_pred CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 ~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 258 ~~~~~~~~~li~~~L~~d---P~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTD---PTERLTITQFMNHPW 290 (336)
T ss_dssp TTCCHHHHHHHHHHSCSS---GGGSCCHHHHHHSHH
T ss_pred ccCCHHHHHHHHHHCCCC---hhHCcCHHHHhcCcc
Confidence 578999999999999999 999999999999998
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=367.07 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=205.7
Q ss_pred CCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC--ceEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLSI 750 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~--~l~L 750 (935)
.++|++.+.||+|+||.||+|++. ++.||||++...... .....+.+|+.+|++++||||+++++++.... .+++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 468999999999999999999874 889999998754322 22456779999999999999999999987655 6899
Q ss_pred EEeeCCCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee----cCCCcEEEEeccccc
Q 002331 751 ITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR 824 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~--~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL----d~~g~VKL~DFGlA~ 824 (935)
||||+++++|.+++.+.. ..+++..++.|+.||+.||.|||++| |+||||||+|||| +.++.+||+|||+++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999997632 23899999999999999999999999 9999999999999 788889999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccC--------CCCCchhHHHHHHHHHHHHHcCCCCCCCC----ChHHHHHHhhccc
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLRN--------EPSNEKCDVYSFGVILWELATLKLPWIGM----NPMQVVGAVGFQN 892 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~g--------~~~s~ksDIWSLG~ILyELLTG~~PF~~~----~~~eil~~I~~~~ 892 (935)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ...++...+....
T Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp ECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred EccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 765442 2345679999999999875 45678999999999999999999999753 2233443332111
Q ss_pred cc-----------------------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 893 RR-----------------------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 893 ~r-----------------------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.. ..++..++..+.++|.+||+.| |.+||++.+++++
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~d---P~~R~s~~e~l~~ 303 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD---QEKCWGFDQFFAE 303 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCC---TTTSCCHHHHHHH
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccC---hhhhccHHHHHHH
Confidence 10 1122446678999999999999 9999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=358.04 Aligned_cols=246 Identities=15% Similarity=0.162 Sum_probs=201.3
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEEC----------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceee-----
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWN----------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL----- 737 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~----------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVk----- 737 (935)
...++|++.+.||+|+||.||+|++. ++.||||++... ..+.+|+.++++++||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhh
Confidence 34578999999999999999999873 678999998755 25778999999999999998
Q ss_pred ----------eeccccc-CCceEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCC
Q 002331 738 ----------FMGAVTR-PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSP 805 (935)
Q Consensus 738 ----------l~g~~~~-~~~l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPe 805 (935)
+++++.. ...+++||||+ +++|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~ 188 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAE 188 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGG
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHH
Confidence 4445544 67789999999 99999999764 357999999999999999999999998 999999999
Q ss_pred CeeecCCC--cEEEEeccccccccCCcc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 002331 806 NLLVDKNW--NVKVSDFGLSRLKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 876 (935)
Q Consensus 806 NILLd~~g--~VKL~DFGlA~~~~~~~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF 876 (935)
||||+.++ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 999999999986543211 123447999999999999999999999999999999999999999
Q ss_pred CCCC--hHHHHHHhh-ccccccCCC------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 877 IGMN--PMQVVGAVG-FQNRRLEIP------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 877 ~~~~--~~eil~~I~-~~~~r~~ip------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.... ...+..... .......++ ..+++.+.+||.+||+.| |.+||++.+|++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d---p~~Rps~~~l~~ 329 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALT---YEEKPPYAMLRN 329 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCC---TTCCCCHHHHHH
T ss_pred ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCC---hhhCCCHHHHHH
Confidence 8764 333322221 111122221 256899999999999999 999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=371.08 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=201.4
Q ss_pred cCCCCCCeeEEEEeeecCcEE-EEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCce
Q 002331 671 CEIPWEDLVLGERIGLGSYGE-VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~-Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l 748 (935)
+.+...+|.+.+.||+|+||+ ||++..+++.||||++...... .+.+|+.+|+.+ +|||||++++++.+...+
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 445566899999999999998 5556678999999998654322 246899999999 899999999999999999
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC-----CCcEEEEecccc
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLS 823 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~-----~g~VKL~DFGlA 823 (935)
|||||||. |+|.+++......+.+..++.|+.||+.||.|||+++ |+||||||+||||+. ...+||+|||++
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99999996 5999999876656666677889999999999999999 999999999999953 346889999999
Q ss_pred ccccCCc---ccCCCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccc-c
Q 002331 824 RLKHNTF---LSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRR-L 895 (935)
Q Consensus 824 ~~~~~~~---~~~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r-~ 895 (935)
+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+...... .
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence 8764321 22344679999999999974 557889999999999999999 89999776555443333211111 1
Q ss_pred CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+...+..+.+||.+||+.| |.+||++.+|++|||
T Consensus 251 ~~~~~~~~~~~~li~~~L~~d---P~~Rps~~evl~hp~ 286 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMD---PQKRPSAKHVLKHPF 286 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSS---GGGSCCHHHHHTSTT
T ss_pred CccccccHHHHHHHHHHHhCC---HhhCCCHHHHHhCcc
Confidence 122345677999999999999 999999999999998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=383.21 Aligned_cols=255 Identities=29% Similarity=0.483 Sum_probs=218.3
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
.+++..++|++++.||+|+||.||+|.+. +..||||++.... .......+.+|+.+|++++||||+++++++.+
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 34566789999999999999999999873 3469999876532 44556788999999999999999999999854
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
+.+++||||+++|+|.+++......+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 5789999999999999999866667999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCc
Q 002331 825 LKHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902 (935)
Q Consensus 825 ~~~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls 902 (935)
....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...+..++..++
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~ 618 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 618 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCTTCC
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCcccc
Confidence 7654322 2223456789999999999999999999999999999997 999999998888877764 345566788999
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+.+.+||.+||..| |.+||++.+|++.
T Consensus 619 ~~l~~li~~~l~~d---P~~RPs~~el~~~ 645 (656)
T 2j0j_A 619 PTLYSLMTKCWAYD---PSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCC---hhHCcCHHHHHHH
Confidence 99999999999999 9999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=361.41 Aligned_cols=246 Identities=24% Similarity=0.328 Sum_probs=191.1
Q ss_pred CCeeEEEEeeecCcEEEEEE-EECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka-~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
+.|.+.+.||+|+||+||.+ ..+|+.||||++.... ...+.+|+.+|+.+ +|||||++++++.+...+|||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 45667899999999999655 5589999999986542 34567899999876 89999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCC------CHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC-------------Cc
Q 002331 754 FLPRGSLFRILHRPHCQV------DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-------------WN 814 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~l------se~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-------------g~ 814 (935)
||. |+|.+++....... .+..++.|+.||+.||.|||+++ |+||||||+||||+.+ +.
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence 996 59999997643211 22345679999999999999999 9999999999999754 48
Q ss_pred EEEEeccccccccCCcc----cCCCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChH
Q 002331 815 VKVSDFGLSRLKHNTFL----SSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPM 882 (935)
Q Consensus 815 VKL~DFGlA~~~~~~~~----~~~s~~GT~~Y~APEvl~g-------~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~ 882 (935)
+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999987654321 1234579999999999976 568999999999999999999 89999876544
Q ss_pred HHHHHhhcccccc-C----CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 883 QVVGAVGFQNRRL-E----IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 883 eil~~I~~~~~r~-~----ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
... +....... . .+..+++++.+||.+||+.| |.+||++.+|++|||
T Consensus 247 ~~~--i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d---P~~Rps~~eil~hp~ 298 (434)
T 2rio_A 247 ESN--IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD---PLKRPTAMKVLRHPL 298 (434)
T ss_dssp HHH--HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSS---GGGSCCHHHHHTSGG
T ss_pred HHH--HhcCCCCcccccccccccchHHHHHHHHHHhhCC---hhhCCCHHHHHhCCc
Confidence 321 11111111 1 12245688999999999999 999999999999998
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=366.77 Aligned_cols=247 Identities=21% Similarity=0.269 Sum_probs=205.9
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC-CceeeeecccccCCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~H-PNIVkl~g~~~~~~~l~LV 751 (935)
.++|+++++||+|+||.||+|++ +++.||||++....... .+.+|+++++.|+| ++|..+..++...+..+||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 47899999999999999999986 58899999887654322 46789999999976 6666666677778889999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeee---cCCCcEEEEeccccccccC
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILL---d~~g~VKL~DFGlA~~~~~ 828 (935)
|||+ +++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+|||| +.++.+||+|||+++....
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9999 88999999865668999999999999999999999999 9999999999999 6889999999999987654
Q ss_pred Ccc-------cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhcc---cccc
Q 002331 829 TFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQ---NRRL 895 (935)
Q Consensus 829 ~~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~---~eil~~I~~~---~~r~ 895 (935)
... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+... .+.+..+... ....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 321 12356799999999999999999999999999999999999999987544 2223222111 1112
Q ss_pred CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 896 EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 896 ~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.++..+++++.+||.+||+.+ |.+||++.+|++
T Consensus 239 ~l~~~~p~~l~~li~~cl~~d---P~~RPs~~el~~ 271 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLR---FDDKPDYSYLKR 271 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCC---TTCCCCHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCC---hhhCcCHHHHHH
Confidence 233678899999999999999 999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=336.49 Aligned_cols=225 Identities=24% Similarity=0.387 Sum_probs=184.4
Q ss_pred CCeeEE-EEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHH-HHcCCCceeeeeccccc----CCc
Q 002331 676 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIM-RRLRHPNVVLFMGAVTR----PPN 747 (935)
Q Consensus 676 edy~I~-e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL-~~L~HPNIVkl~g~~~~----~~~ 747 (935)
++|.+. +.||+|+||.||++.+ +++.||||++... ..+.+|+.++ +.++||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 567776 8899999999999987 6789999998643 2456788888 55599999999999876 677
Q ss_pred eEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC---CCcEEEEecccc
Q 002331 748 LSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLS 823 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~VKL~DFGlA 823 (935)
+++||||+++++|.+++.+. ...+++..++.++.||+.||.|||+++ |+||||||+||||+. ++.+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999999754 346999999999999999999999999 999999999999997 789999999998
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--cccccCCC---
Q 002331 824 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIP--- 898 (935)
Q Consensus 824 ~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~--~~~r~~ip--- 898 (935)
.... +..++.++|||||||++|+|++|+.||.+.........+.. ......++
T Consensus 168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 6432 23467899999999999999999999988765543322211 11122233
Q ss_pred -CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 -KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 -~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+++.+.+||.+||+.| |.+||++.++|+|||
T Consensus 226 ~~~~~~~~~~li~~~l~~d---P~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTE---PTQRMTITEFMNHPW 259 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSS---TTTSCCHHHHHTSHH
T ss_pred cccCCHHHHHHHHHHcccC---hhhCCCHHHHhcChh
Confidence 568999999999999999 999999999999998
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.96 Aligned_cols=244 Identities=18% Similarity=0.176 Sum_probs=194.2
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCC------CHHHHHHHHHHHHHHHHcC---------------
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF------SGAALLEFKREVKIMRRLR--------------- 731 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~------~~~~~~~f~~Ei~iL~~L~--------------- 731 (935)
+..++|++++.||+|+||+||+|+++++.||||++..... .......+.+|+.+|+.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 3457899999999999999999999999999999986542 1223467888999998886
Q ss_pred -----------CCceeeeeccccc-------------CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHH
Q 002331 732 -----------HPNVVLFMGAVTR-------------PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787 (935)
Q Consensus 732 -----------HPNIVkl~g~~~~-------------~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL 787 (935)
||||++++++|.+ .+.+||||||+++|++.+.+.+ ..+++..++.|+.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 5666666666654 7789999999999977666644 4689999999999999999
Q ss_pred HHHH-hcCCCEEeeCCCCCCeeecCCC--------------------cEEEEeccccccccCCcccCCCCCCCCCccCcc
Q 002331 788 NCLH-TSTPTIVHRDLKSPNLLVDKNW--------------------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 846 (935)
Q Consensus 788 ~yLH-s~g~~IIHrDLKPeNILLd~~g--------------------~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APE 846 (935)
.||| +++ |+||||||+||||+.++ .+||+|||+++..... ..+||+.|+|||
T Consensus 175 ~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred HHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence 9999 898 99999999999999887 8999999999876543 347999999999
Q ss_pred cccCCCCCchhHHHHHHHH-HHHHHcCCCCCCCCCh-HHHHHHhhcc-ccc----cCCCCcCcHHHHHHHHHHHhhCCCC
Q 002331 847 VLRNEPSNEKCDVYSFGVI-LWELATLKLPWIGMNP-MQVVGAVGFQ-NRR----LEIPKELDPLVARIIWECWQTGWSS 919 (935)
Q Consensus 847 vl~g~~~s~ksDIWSLG~I-LyELLTG~~PF~~~~~-~eil~~I~~~-~~r----~~ip~~ls~~L~dLI~qCL~~D~ss 919 (935)
++.+.. +.++|||||+++ .++++.|..||.+... ......+... ... ..++..+++++++||.+||+.|
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 999877 899999998777 7888999999865322 1111121100 111 1122457889999999999865
Q ss_pred cCCCcCHHHHH-hCcC
Q 002331 920 LHIRTSQAQLS-HKRF 934 (935)
Q Consensus 920 P~kRPSa~EIL-qHPF 934 (935)
|++|+| +|||
T Consensus 324 -----sa~e~l~~Hp~ 334 (336)
T 2vuw_A 324 -----SATDLLCQHSL 334 (336)
T ss_dssp -----SHHHHHHHCGG
T ss_pred -----CHHHHHhcCCC
Confidence 999999 9998
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=356.69 Aligned_cols=246 Identities=17% Similarity=0.131 Sum_probs=193.6
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCC-Cceeee----------
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH-PNVVLF---------- 738 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~H-PNIVkl---------- 738 (935)
.....|.+++.||+|+||+||+|++. |+.||||++..... .....+.+.+|+.+++.++| +|+..+
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 44567899999999999999999974 89999999874332 22345678899999999977 322111
Q ss_pred -----------eccccc-----CCceEEEEeeCCCCCHHHHHc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 002331 739 -----------MGAVTR-----PPNLSIITEFLPRGSLFRILH------RPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796 (935)
Q Consensus 739 -----------~g~~~~-----~~~l~LVmEy~~gGsL~dlL~------~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~ 796 (935)
+.++.. ...++++|+++ +++|.+++. ..+..+++..++.|+.||+.||.|||+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 111111 22467777766 679999884 33445788899999999999999999999
Q ss_pred EEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccc----------cCCCCCchhHHHHHHHHH
Q 002331 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL----------RNEPSNEKCDVYSFGVIL 866 (935)
Q Consensus 797 IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl----------~g~~~s~ksDIWSLG~IL 866 (935)
||||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999999876543 334577 999999999 555688899999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 867 WELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 867 yELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|+|++|+.||...+.......+ ......+++.+.+||.+||+.| |.+||++.++++|||
T Consensus 308 ~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~d---P~~Rpt~~~~l~~~~ 366 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYP---KEDRLLPLQAMETPE 366 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSS---GGGSCCHHHHTTSHH
T ss_pred HHHHHCCCCCCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCC---hhhCcCHHHHHhCHH
Confidence 9999999999887655433222 1222467899999999999999 999999999999997
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=372.11 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=205.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc------CC
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PP 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~------~~ 746 (935)
.++|++.+.||+|+||.||+|.+ +++.||||++... ........+.+|+.++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 37899999999999999999976 6889999988654 345567788999999999999999999998765 67
Q ss_pred ceEEEEeeCCCCCHHHHHcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCc---EEEEecc
Q 002331 747 NLSIITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFG 821 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~--~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~---VKL~DFG 821 (935)
..++||||+++++|.+++.... ..+++..++.|+.||+.||.|||+.| |+||||||+||||+.++. +||+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7899999999999999997633 35889999999999999999999999 999999999999987665 9999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH---------Hhh---
Q 002331 822 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG---------AVG--- 889 (935)
Q Consensus 822 lA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~---------~I~--- 889 (935)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+........ .+.
T Consensus 170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 998765442 2345689999999999999999999999999999999999999997653321100 000
Q ss_pred ccc----------cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 890 FQN----------RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 890 ~~~----------~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
... .+..++..+++.+.+||.+||..| |.+||++.++++|||
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~D---P~kRPTa~elL~hp~ 300 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWH---QRQRGTDPQNPNVGC 300 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSS---CC---CCTTCCCCTT
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCC---HhhCcCHHHHhcCHH
Confidence 000 011233457889999999999999 999999999999998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=366.49 Aligned_cols=238 Identities=21% Similarity=0.246 Sum_probs=197.6
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE---CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc--
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-- 747 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~---~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~-- 747 (935)
+..++|++.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.+|++++|||||+++++|...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 3457899999999999999999987 47899999886543 34556678899999999999999999999987666
Q ss_pred ---eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 748 ---LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 748 ---l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
+||||||+++++|.+++.. .+++..++.|+.||+.||.|||++| ||||||||+||||+.+ .+||+|||+++
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp CEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999988765 6899999999999999999999999 9999999999999885 99999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCC-CCcCcH
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI-PKELDP 903 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~i-p~~ls~ 903 (935)
..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+..... ..... ....++
T Consensus 230 ~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~~~~~~~~~~~~ 295 (681)
T 2pzi_A 230 RINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------LPEDDPVLKTYD 295 (681)
T ss_dssp ETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------CCTTCHHHHHCH
T ss_pred hcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------ccccccccccCH
Confidence 76543 3467999999999998764 889999999999999999999887532110 00000 012457
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+.+||.+||+.| |.+||+..+.+.|+|
T Consensus 296 ~l~~li~~~l~~d---P~~R~~~~~~l~~~l 323 (681)
T 2pzi_A 296 SYGRLLRRAIDPD---PRQRFTTAEEMSAQL 323 (681)
T ss_dssp HHHHHHHHHTCSS---GGGSCSSHHHHHHHH
T ss_pred HHHHHHhhhccCC---hhhCCCHHHHHHHHH
Confidence 8999999999999 999998888887765
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=323.15 Aligned_cols=223 Identities=15% Similarity=0.099 Sum_probs=186.4
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEEC--CceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~~--g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
..++|++.+.||+|+||.||+|++. ++.||||++...... ......+.+|+.++.+++||||+++++++.+.+.+|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3468999999999999999999884 889999999876443 4566788999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
||||+++++|.+++++. .....+..|+.||+.||.|||++| |+||||||+||||+.+|.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc---------
Confidence 99999999999999652 456678889999999999999999 9999999999999999999998543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh-hccccc----cCCCCcCcHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRR----LEIPKELDPLV 905 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I-~~~~~r----~~ip~~ls~~L 905 (935)
|++ .++.++|||||||++|+|++|+.||.+.+....+... ...... ..++..+++.+
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 233 3689999999999999999999999987654321100 000111 12346789999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+||.+||+.| |.+| ++.++++.
T Consensus 237 ~~li~~~l~~d---P~~R-s~~el~~~ 259 (286)
T 3uqc_A 237 SAVAARSVQGD---GGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHCTT---SSCC-CHHHHHHH
T ss_pred HHHHHHHcccC---CccC-CHHHHHHH
Confidence 99999999999 9999 99999863
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=307.30 Aligned_cols=185 Identities=16% Similarity=0.092 Sum_probs=133.4
Q ss_pred EeeecCcEEEEEEEE--CCceEEEEEeeccCC--------CHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEE
Q 002331 683 RIGLGSYGEVYHADW--NGTEVAVKKFLDQDF--------SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 683 ~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~--------~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LV 751 (935)
.++.|++|.+..++. -|+.||||++..... .+...++|.+|+++|+++ .|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 467888887777643 689999999976532 123456799999999999 799999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||++|++|.++|.+. .++++. +|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+++.......
T Consensus 321 MEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 9999999999999874 456664 47899999999999999 99999999999999999999999999987765544
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL 874 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~ 874 (935)
...+.+||+.|+|||++.+. +..++|+|++|+++++|.++..
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 45567899999999999875 5578999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.2e-27 Score=273.40 Aligned_cols=185 Identities=15% Similarity=0.221 Sum_probs=148.6
Q ss_pred EEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHH------HHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 680 I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~------~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
..+.||+|+||.||++++.++.+++|++........ ..+.+.+|+++|++++||||+++..++...+..|||||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 356899999999999998999999998765443321 23458999999999999999966555556777899999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc-
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS- 832 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~- 832 (935)
|+++++|.+++.+ ++.|+.||+.||.|||+++ |+||||||+||||+. .+||+|||+++........
T Consensus 420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999975 5579999999999999999 999999999999998 9999999999977543211
Q ss_pred ------CCCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002331 833 ------SKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWI 877 (935)
Q Consensus 833 ------~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLG~ILyELLTG~~PF~ 877 (935)
.....||+.|+|||++.+ ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 135679999999999987 567788999999999988887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=217.42 Aligned_cols=145 Identities=19% Similarity=0.170 Sum_probs=116.5
Q ss_pred CeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCH----------------HHHHHHHHHHHHHHHcCCCceeeee
Q 002331 677 DLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG----------------AALLEFKREVKIMRRLRHPNVVLFM 739 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~----------------~~~~~f~~Ei~iL~~L~HPNIVkl~ 739 (935)
.|.+++.||+|+||.||+|.+ +|+.||||++....... .....+.+|+.+|++++ | ++++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 455679999999999999988 58899999986432111 24567889999999998 5 6666
Q ss_pred cccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEe
Q 002331 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 819 (935)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~D 819 (935)
+++.. +..|+||||+++++|.+ +.. .....++.||+.||.|||++| |+||||||+||||+ ++.+||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEEE
Confidence 65543 56799999999999998 422 123468999999999999999 99999999999999 99999999
Q ss_pred ccccccccCCcccCCCCCCCCCccCccccc
Q 002331 820 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849 (935)
Q Consensus 820 FGlA~~~~~~~~~~~s~~GT~~Y~APEvl~ 849 (935)
||+++. +..|.|||.+.
T Consensus 236 FG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE-------------TTSTTHHHHHH
T ss_pred CCCCeE-------------CCCCCHHHHHH
Confidence 999863 33578899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=6.9e-19 Score=186.23 Aligned_cols=138 Identities=20% Similarity=0.232 Sum_probs=107.5
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCce--EEEEEeeccCCC----------------------HHHHHHHHHHHHHHHHc
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTE--VAVKKFLDQDFS----------------------GAALLEFKREVKIMRRL 730 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~--VAVK~i~~~~~~----------------------~~~~~~f~~Ei~iL~~L 730 (935)
-|.+.+.||+|+||.||+|.+ +|+. ||||+++..... ......+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999987 8888 999987543211 11223678999999999
Q ss_pred CCCce--eeeecccccCCceEEEEeeCCC-C----CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCEEeeCC
Q 002331 731 RHPNV--VLFMGAVTRPPNLSIITEFLPR-G----SLFRILHRPHCQVDEKRRIKMALDVARGMNCLH-TSTPTIVHRDL 802 (935)
Q Consensus 731 ~HPNI--Vkl~g~~~~~~~l~LVmEy~~g-G----sL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLH-s~g~~IIHrDL 802 (935)
.|++| ..+++. ...+|||||+.+ | .|.++... .++..+..++.||+.||.||| .+| ||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE--LVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCC
Confidence 87754 344432 357899999942 3 77776532 234566789999999999999 888 999999
Q ss_pred CCCCeeecCCCcEEEEeccccccc
Q 002331 803 KSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 803 KPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
||+||||+. .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.5e-16 Score=179.68 Aligned_cols=136 Identities=15% Similarity=0.164 Sum_probs=97.4
Q ss_pred eeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCC---------------CHH-----HHHHHHHHHHHHHHcCCCcee
Q 002331 678 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDF---------------SGA-----ALLEFKREVKIMRRLRHPNVV 736 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~---------------~~~-----~~~~f~~Ei~iL~~L~HPNIV 736 (935)
|.+++.||.|+||.||+|.. +|+.||||+++.... ... ......+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 89999999999999999976 789999998753211 000 011123455556655433321
Q ss_pred --eeecccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC-
Q 002331 737 --LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW- 813 (935)
Q Consensus 737 --kl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g- 813 (935)
..++. ...+|||||++|+.|.++... .....++.||+.+|.+||++| ||||||||.||||++++
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEEC
T ss_pred CCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCC
Confidence 12211 124799999999888765432 123457889999999999999 99999999999998776
Q ss_pred ---------cEEEEeccccccc
Q 002331 814 ---------NVKVSDFGLSRLK 826 (935)
Q Consensus 814 ---------~VKL~DFGlA~~~ 826 (935)
.+.|+||+.+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 3899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=6.9e-12 Score=131.01 Aligned_cols=141 Identities=16% Similarity=0.037 Sum_probs=111.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCCceEEEEee
Q 002331 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
..|.+...++.|+++.||++...++.+++|+....... ....+.+|+.+++.+ .+..+.++++++.+.+..|+||||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 46888888999999999999888899999987653211 122478899999998 467788899998888889999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST---------------------------------------- 794 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g---------------------------------------- 794 (935)
++|.+|.+.+.. ......++.+++.+|..||...
T Consensus 92 i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 999999876421 1123367789999999999810
Q ss_pred -----------------CCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 795 -----------------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 795 -----------------~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
+.++|+|++|.|||++.++.+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 239999999999999876566799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=1.9e-10 Score=118.40 Aligned_cols=135 Identities=19% Similarity=0.135 Sum_probs=99.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc--eeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPN--IVkl~g~~~~~~~l~LVm 752 (935)
..|.+....+.|..+.||++.. +|+.|+||+..... ...+.+|+.+++.+.+.+ +.++++++...+..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 4556655445666799999976 36779999865442 134678999999885434 556888888878899999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST-------------------------------------- 794 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g-------------------------------------- 794 (935)
||++|.+|. ... .+. ..++.+++..|..||...
T Consensus 95 e~i~G~~l~--~~~----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 95 GEVPGQDLL--SSH----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp ECCSSEETT--TSC----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EecCCcccC--cCc----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 999998874 221 122 246677888888888743
Q ss_pred ------------------CCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 795 ------------------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 795 ------------------~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
..++|+|++|.|||++.++.++|+|||.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999877667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.05 E-value=3.9e-10 Score=123.82 Aligned_cols=142 Identities=19% Similarity=0.206 Sum_probs=106.9
Q ss_pred EEEEeeecCcEEEEEEEECCceEEEEEee--ccCCCHHHHHHHHHHHHHHHHcC--CCceeeeecccccC---CceEEEE
Q 002331 680 LGERIGLGSYGEVYHADWNGTEVAVKKFL--DQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRP---PNLSIIT 752 (935)
Q Consensus 680 I~e~LG~G~fG~Vyka~~~g~~VAVK~i~--~~~~~~~~~~~f~~Ei~iL~~L~--HPNIVkl~g~~~~~---~~l~LVm 752 (935)
..+.|+.|.++.||+++..+..+++|+.. .... ......+.+|+.+++.|. +..+.+++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45779999999999998888889999765 3221 112346788999999996 45578888887766 4589999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS--------------------------------------- 793 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~--------------------------------------- 793 (935)
||++|..+.+.. ...++......++.+++..|..||..
T Consensus 121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999987764321 12467888888999999999999983
Q ss_pred -----------------CCCEEeeCCCCCCeeecCCCc--EEEEecccccc
Q 002331 794 -----------------TPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSRL 825 (935)
Q Consensus 794 -----------------g~~IIHrDLKPeNILLd~~g~--VKL~DFGlA~~ 825 (935)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 135999999999999997653 69999998874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=2.1e-09 Score=115.39 Aligned_cols=185 Identities=19% Similarity=0.184 Sum_probs=121.9
Q ss_pred EEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCc--eeeeecccccCC---ceEEEEeeC
Q 002331 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPN--VVLFMGAVTRPP---NLSIITEFL 755 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPN--IVkl~g~~~~~~---~l~LVmEy~ 755 (935)
+.++.|....||++. ..++||+.... .....+.+|+.+|+.+ .+.. +.+++......+ ..|+||||+
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 458999999999974 67889975422 3456788999999888 3332 344554443333 358999999
Q ss_pred CCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 002331 756 PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST----------------------------------------- 794 (935)
Q Consensus 756 ~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g----------------------------------------- 794 (935)
+|..|..... ..++......++.+++..|..||...
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988865332 23667777788888888888888611
Q ss_pred ---------------CCEEeeCCCCCCeeecC--CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccC-----CC
Q 002331 795 ---------------PTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-----EP 852 (935)
Q Consensus 795 ---------------~~IIHrDLKPeNILLd~--~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g-----~~ 852 (935)
+.++|+|++|.|||++. .+.+.|+||+.+..-... ...........-..|+.+.. ..
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 24899999999999998 556889999988653221 10000000000023332211 11
Q ss_pred C---------CchhHHHHHHHHHHHHHcCCCCCC
Q 002331 853 S---------NEKCDVYSFGVILWELATLKLPWI 877 (935)
Q Consensus 853 ~---------s~ksDIWSLG~ILyELLTG~~PF~ 877 (935)
. ....+.|+++.++|.+.+|..+|.
T Consensus 255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 123689999999999999987753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=3e-06 Score=91.63 Aligned_cols=135 Identities=18% Similarity=0.150 Sum_probs=94.5
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCC---ceeeeecccc-cCCceEEEEeeCC
Q 002331 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP---NVVLFMGAVT-RPPNLSIITEFLP 756 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HP---NIVkl~g~~~-~~~~l~LVmEy~~ 756 (935)
.+.++.|....||+. +..++||+-. .......+.+|+.+|+.|.+. .+.+++.++. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 355899999999998 6789999742 223456788999999999642 2455555553 4456789999999
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 002331 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST------------------------------------------ 794 (935)
Q Consensus 757 gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g------------------------------------------ 794 (935)
|..|....-. .++......++.++...|..||...
T Consensus 97 G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 97 GQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp SEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9888763211 2344455555555655555555422
Q ss_pred ----------------CCEEeeCCCCCCeeecC---CCcE-EEEecccccc
Q 002331 795 ----------------PTIVHRDLKSPNLLVDK---NWNV-KVSDFGLSRL 825 (935)
Q Consensus 795 ----------------~~IIHrDLKPeNILLd~---~g~V-KL~DFGlA~~ 825 (935)
+.++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 23799999999999987 4554 8999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.5e-06 Score=90.87 Aligned_cols=132 Identities=18% Similarity=0.219 Sum_probs=94.2
Q ss_pred EeeecCcE-EEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeecccccCCceEEEEeeCCCC
Q 002331 683 RIGLGSYG-EVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 683 ~LG~G~fG-~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LVmEy~~gG 758 (935)
.+..|..| .||+... .+..++||+-... ....+.+|..+|+.|. +--+.++++++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34555554 6898764 4567899975432 3456788999999884 333667888888888899999999998
Q ss_pred CHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------
Q 002331 759 SLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP------------------------------------------- 795 (935)
Q Consensus 759 sL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~------------------------------------------- 795 (935)
++.+..... ......++.++...|..||....
T Consensus 106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 887765321 11223455666667777775320
Q ss_pred -------------CEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 796 -------------TIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 796 -------------~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 17999999999999987777899999775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=2e-06 Score=93.86 Aligned_cols=84 Identities=6% Similarity=-0.031 Sum_probs=55.1
Q ss_pred eeEEEEe-eecCcEEEEEEEEC--------CceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcC-C--Cceeeeeccccc
Q 002331 678 LVLGERI-GLGSYGEVYHADWN--------GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-H--PNVVLFMGAVTR 744 (935)
Q Consensus 678 y~I~e~L-G~G~fG~Vyka~~~--------g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~-H--PNIVkl~g~~~~ 744 (935)
....+.| +.|....+|+.... +..+++|+...... .......+.+|+.+|+.|. + -.+.+++.++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445778 88999999998764 67899997643220 0000124567888888773 2 346677777655
Q ss_pred C---CceEEEEeeCCCCCHH
Q 002331 745 P---PNLSIITEFLPRGSLF 761 (935)
Q Consensus 745 ~---~~l~LVmEy~~gGsL~ 761 (935)
. +..++||||++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3568999999886543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.05 E-value=2.5e-05 Score=83.69 Aligned_cols=139 Identities=15% Similarity=0.083 Sum_probs=79.8
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC--CCceeeeecc------cccCCceEEEE
Q 002331 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGA------VTRPPNLSIIT 752 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~--HPNIVkl~g~------~~~~~~l~LVm 752 (935)
.+.|+.|..+.||++...+..+++|+.... . ..+..|+.+++.|. .-.+.+++.. ....+..+++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 456777788999999887777999987652 1 22334555555552 1123333331 12456688999
Q ss_pred eeCCCCCHH-----------HHH---cC--CCC--C---------CCHHH------------------------------
Q 002331 753 EFLPRGSLF-----------RIL---HR--PHC--Q---------VDEKR------------------------------ 775 (935)
Q Consensus 753 Ey~~gGsL~-----------dlL---~~--~~~--~---------lse~~------------------------------ 775 (935)
||++|..+. +.+ +. ... + ..+..
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986431 111 11 000 0 11111
Q ss_pred -HHHHHHHHHHHHHHHHh-----------cCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 776 -RIKMALDVARGMNCLHT-----------STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 776 -il~Ia~QIa~AL~yLHs-----------~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
...+..++..++.+|+. ....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 01111223445666653 223599999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=3e-05 Score=86.17 Aligned_cols=77 Identities=17% Similarity=0.131 Sum_probs=48.9
Q ss_pred EEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC--CH---HHHHHHHHHHHHHHHcC-C-Cc-eeeeecccccCCceE
Q 002331 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF--SG---AALLEFKREVKIMRRLR-H-PN-VVLFMGAVTRPPNLS 749 (935)
Q Consensus 680 I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~--~~---~~~~~f~~Ei~iL~~L~-H-PN-IVkl~g~~~~~~~l~ 749 (935)
-.+.||.|.++.||+++. .++.|+||....... .. .....+..|..+|+.+. + +. +.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 356799999999999954 567899997653211 00 11234567888888873 2 33 3455543 344568
Q ss_pred EEEeeCCCC
Q 002331 750 IITEFLPRG 758 (935)
Q Consensus 750 LVmEy~~gG 758 (935)
+||||+++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00015 Score=79.35 Aligned_cols=76 Identities=20% Similarity=0.126 Sum_probs=60.7
Q ss_pred EEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC---CCceeeeecccccCCceEEEEeeCC
Q 002331 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEFLP 756 (935)
Q Consensus 680 I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~---HPNIVkl~g~~~~~~~l~LVmEy~~ 756 (935)
-.+.|+.|.+..+|+....+..++||+.... ....+..|...|+.|. ...+.+++.+....+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 4577999999999999888889999986543 2456788999998883 3567788888877788999999999
Q ss_pred CCCH
Q 002331 757 RGSL 760 (935)
Q Consensus 757 gGsL 760 (935)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00019 Score=80.63 Aligned_cols=76 Identities=17% Similarity=0.160 Sum_probs=45.8
Q ss_pred CCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCCCCC--CCCccCcccccCC---CCCchhHHHHHHHHHHHH
Q 002331 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG--TPEWMAPEVLRNE---PSNEKCDVYSFGVILWEL 869 (935)
Q Consensus 795 ~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s~~G--T~~Y~APEvl~g~---~~s~ksDIWSLG~ILyEL 869 (935)
+.++|+|++|.|||++.++ ++|+||+.+..-...... ..... ...|++|+..... ......++..+...+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 3599999999999998876 999999988743211000 00000 1235666554321 112234555777777777
Q ss_pred HcC
Q 002331 870 ATL 872 (935)
Q Consensus 870 LTG 872 (935)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00088 Score=70.23 Aligned_cols=140 Identities=16% Similarity=0.141 Sum_probs=95.0
Q ss_pred CCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCCC
Q 002331 757 RGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH-TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835 (935)
Q Consensus 757 gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLH-s~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~s 835 (935)
..+|.++|...+.+++++++|.++.|.+.+|.-+- ... -..+=+.|..|+|..+|.|-+.+ +.+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-----------
Confidence 44899999888889999999999999999987662 111 11233457899999999998763 1110
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhh
Q 002331 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 915 (935)
Q Consensus 836 ~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~ 915 (935)
.....+.+||.+. ...+.+.=|||||++||.-+--. .+...+..+++.|.+||..|...
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg-------------------L~e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG-------------------LKENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTT-------------------CCTTEEECCCHHHHHHHHHHTTC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC-------------------CCcccchhhCHHHHHHHHHHHhc
Confidence 1233567888763 34568899999999999988522 22233456899999999999866
Q ss_pred C-----------------C-----CCcCCCcCHHHHHh
Q 002331 916 G-----------------W-----SSLHIRTSQAQLSH 931 (935)
Q Consensus 916 D-----------------~-----ssP~kRPSa~EILq 931 (935)
. | ..+..|+++++|++
T Consensus 157 ~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 157 VEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp CC--------------------CCSCCCCCCSHHHHHH
T ss_pred ccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 2 1 12468899999986
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00086 Score=71.78 Aligned_cols=145 Identities=12% Similarity=0.085 Sum_probs=81.4
Q ss_pred CeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc--eeeeeccc------ccCCce
Q 002331 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGAV------TRPPNL 748 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPN--IVkl~g~~------~~~~~l 748 (935)
+..-.+.|+.|....+|++...+..+++|+..... ....+..|+.+++.|...+ +.+++... ...+..
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred cceEeeccCCCcccceEEEEeCCccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 34456778889999999998776689999876521 1224456777777663212 23333221 123457
Q ss_pred EEEEeeCCCCCHH-----------HH---HcC--C--CCC----CC---HHHHHH------------HHHHHHHHHHHHH
Q 002331 749 SIITEFLPRGSLF-----------RI---LHR--P--HCQ----VD---EKRRIK------------MALDVARGMNCLH 791 (935)
Q Consensus 749 ~LVmEy~~gGsL~-----------dl---L~~--~--~~~----ls---e~~il~------------Ia~QIa~AL~yLH 791 (935)
+++|+|++|..+. +. ++. . ... .. +...+. +...+...+.+|+
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999999875431 11 111 0 000 11 111000 0011344555555
Q ss_pred hc-----CCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 792 TS-----TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 792 s~-----g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
.. ...++|+|+++.|||++.++.+.|+||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 32 12499999999999998876668999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00077 Score=72.87 Aligned_cols=137 Identities=14% Similarity=0.100 Sum_probs=70.4
Q ss_pred EEeeecCcEE-EEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-C-CceeeeecccccCCceEEEEeeCCC
Q 002331 682 ERIGLGSYGE-VYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H-PNVVLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 682 e~LG~G~fG~-Vyka~~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-H-PNIVkl~g~~~~~~~l~LVmEy~~g 757 (935)
+.|+.|.... +|+.... +..+++|....... ..+..|+.+++.|. + -.+.+++.+.... -+++||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCC
Confidence 3465555544 6677764 77787776433210 22345667776663 2 2344566543332 2789999977
Q ss_pred CCHHHHHcC---------------------C----CCCCCHHHHH-------HHH-------------HHHHHHHHHHH-
Q 002331 758 GSLFRILHR---------------------P----HCQVDEKRRI-------KMA-------------LDVARGMNCLH- 791 (935)
Q Consensus 758 GsL~dlL~~---------------------~----~~~lse~~il-------~Ia-------------~QIa~AL~yLH- 791 (935)
..+.+++.. . ...++..... .+. ..+...+..|.
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 666543321 0 0112221110 000 01111222221
Q ss_pred ---hcCCCEEeeCCCCCCeeecCC----CcEEEEecccccc
Q 002331 792 ---TSTPTIVHRDLKSPNLLVDKN----WNVKVSDFGLSRL 825 (935)
Q Consensus 792 ---s~g~~IIHrDLKPeNILLd~~----g~VKL~DFGlA~~ 825 (935)
.....++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 112359999999999999874 6899999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00071 Score=72.32 Aligned_cols=135 Identities=15% Similarity=0.098 Sum_probs=74.2
Q ss_pred EEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce-eeeecccccCCceEEEEeeC-CCC
Q 002331 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFL-PRG 758 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNI-Vkl~g~~~~~~~l~LVmEy~-~gG 758 (935)
.+.|+.|....+|++ ..+++|+..... .......+|+.+++.+...++ .++++.+. +.-++|+||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCc
Confidence 577999999999999 678889765421 111123467777777632222 45555433 3346899999 654
Q ss_pred CHHH---------------H---HcCCCCC----CCH-HHHHHHHH--------------HHHHHHH----HHH--hcCC
Q 002331 759 SLFR---------------I---LHRPHCQ----VDE-KRRIKMAL--------------DVARGMN----CLH--TSTP 795 (935)
Q Consensus 759 sL~d---------------l---L~~~~~~----lse-~~il~Ia~--------------QIa~AL~----yLH--s~g~ 795 (935)
.|.. . ++..... ++. ..+..+.. .+...+. .|. ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4321 0 1111111 111 11111111 0111111 111 1122
Q ss_pred CEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 796 ~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
.++|+|+.+.||| ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5667789999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0016 Score=69.05 Aligned_cols=78 Identities=17% Similarity=0.158 Sum_probs=54.4
Q ss_pred CCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-C--CceeeeecccccCCceEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H--PNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-H--PNIVkl~g~~~~~~~l~LV 751 (935)
.++.-.+.+|.|..+.||+.+. +|+.|+||+....... ....|..|+..|+.|. . --+.+++++. .-++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 4556678899999999999987 6889999976543221 1234678999998883 2 2244555542 24799
Q ss_pred EeeCCCCC
Q 002331 752 TEFLPRGS 759 (935)
Q Consensus 752 mEy~~gGs 759 (935)
|||++++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99998664
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.002 Score=73.18 Aligned_cols=70 Identities=14% Similarity=0.229 Sum_probs=47.6
Q ss_pred EEEeeecCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc-eeeeecccccCCceEE
Q 002331 681 GERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSI 750 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPN-IVkl~g~~~~~~~l~L 750 (935)
.+.|+.|-...||++... +..|++|+..... . ...+.+|..+++.|...+ ..++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 466888999999999864 4689999874321 1 123447888888884223 3566766543 38
Q ss_pred EEeeCCCC
Q 002331 751 ITEFLPRG 758 (935)
Q Consensus 751 VmEy~~gG 758 (935)
||||++|.
T Consensus 150 v~e~l~G~ 157 (429)
T 1nw1_A 150 LEEYIPSR 157 (429)
T ss_dssp EECCCCEE
T ss_pred EEEEeCCc
Confidence 99999863
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0067 Score=66.39 Aligned_cols=30 Identities=23% Similarity=0.426 Sum_probs=27.2
Q ss_pred CEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 796 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 796 ~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
.++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 599999999999999888899999987764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0059 Score=70.23 Aligned_cols=73 Identities=18% Similarity=0.100 Sum_probs=47.4
Q ss_pred EEEeeecCcEEEEEEEECC--ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce-eeeecccccCCceEEEEeeCCC
Q 002331 681 GERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFLPR 757 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~g--~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNI-Vkl~g~~~~~~~l~LVmEy~~g 757 (935)
.+.|+.|-...+|++...+ ..|++|+....... .....+|..+++.|...+| .++++.+.. .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 4568889999999998866 78999986432100 1112578899998854444 567776632 359999986
Q ss_pred CCH
Q 002331 758 GSL 760 (935)
Q Consensus 758 GsL 760 (935)
..|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0043 Score=69.69 Aligned_cols=137 Identities=13% Similarity=0.160 Sum_probs=80.2
Q ss_pred EEeeecCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeecccccCCceEEE
Q 002331 682 ERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LV 751 (935)
+.|..|-...+|++... ++.|++|+.... . .....+.+|..+++.|. +.-..++++.+.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L--QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 45777888889999763 368889875321 1 12345568999998883 3333566766654 299
Q ss_pred EeeCCCCCHH--------------HHH---cCC----CCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 002331 752 TEFLPRGSLF--------------RIL---HRP----HCQVD--EKRRIKMALDVAR-------------------GMNC 789 (935)
Q Consensus 752 mEy~~gGsL~--------------dlL---~~~----~~~ls--e~~il~Ia~QIa~-------------------AL~y 789 (935)
|||++|..|. +.| +.. ..... +.++.++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 9999875442 111 121 11122 3444445443321 2333
Q ss_pred HH----hcC--CCEEeeCCCCCCeeecCC----CcEEEEecccccc
Q 002331 790 LH----TST--PTIVHRDLKSPNLLVDKN----WNVKVSDFGLSRL 825 (935)
Q Consensus 790 LH----s~g--~~IIHrDLKPeNILLd~~----g~VKL~DFGlA~~ 825 (935)
|. ..+ ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 222 259999999999999876 7899999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.56 E-value=0.015 Score=62.29 Aligned_cols=138 Identities=13% Similarity=0.085 Sum_probs=77.7
Q ss_pred EEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC--Cceeeeecc-----cccCCceEEEEe
Q 002331 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGA-----VTRPPNLSIITE 753 (935)
Q Consensus 682 e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~H--PNIVkl~g~-----~~~~~~l~LVmE 753 (935)
+.|+ |....||++.. +|+.+++|+....... ...+..|..+++.|.. -.+++++.. ....+..+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 3466 88889999876 4568999988644332 2345667788777732 124444443 112345678999
Q ss_pred eCCCCCHH-----------HHH---c----CC----CCCCCHHHH----HHH---------------HHHHHHHHHHHHh
Q 002331 754 FLPRGSLF-----------RIL---H----RP----HCQVDEKRR----IKM---------------ALDVARGMNCLHT 792 (935)
Q Consensus 754 y~~gGsL~-----------dlL---~----~~----~~~lse~~i----l~I---------------a~QIa~AL~yLHs 792 (935)
|++|..+. +.+ + .. ....+.... ..+ ...+-..+..+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99875321 111 1 00 011221111 001 0011112223322
Q ss_pred -----cCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 793 -----STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 793 -----~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 223489999999999999 4 899999988754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0029 Score=69.47 Aligned_cols=72 Identities=13% Similarity=0.156 Sum_probs=42.8
Q ss_pred EEEeeecCcEEEEEEEECC----------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc-eeeeecccccCCceE
Q 002331 681 GERIGLGSYGEVYHADWNG----------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLS 749 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~g----------~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPN-IVkl~g~~~~~~~l~ 749 (935)
.+.|+.|....+|++...+ ..|++|+..... ........|..+++.|...+ ..++++.+. -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence 4568888889999998754 678888764321 11112357888888774223 346665442 36
Q ss_pred EEEeeCCCCC
Q 002331 750 IITEFLPRGS 759 (935)
Q Consensus 750 LVmEy~~gGs 759 (935)
+||||++|..
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998753
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0038 Score=68.00 Aligned_cols=101 Identities=15% Similarity=0.099 Sum_probs=67.1
Q ss_pred HHHHHHHHHhcCCCCchHHHHHHHHHHHHhhcCCCCCChhHHHHhHHHHHHHHHHhhCCceeEeeecccccchhhHHHHH
Q 002331 196 LVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFK 275 (935)
Q Consensus 196 L~~~a~~~~~~l~~~~~~~~~~~LA~lV~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~s~v~plg~i~~G~~rhRalLfK 275 (935)
|.++|..+..+ .....+.++.|...|.+.+. ........... ...-|+ -+.|+|++-|.||.
T Consensus 128 i~~~A~~~~~~--~~~~~~~~~ai~~~v~~~~~-Y~~~~~~~~~~---a~~~l~------------~~~G~C~d~A~l~v 189 (293)
T 3isr_A 128 LQKLAYKEFGK--IENVYSKVLAITDWIYNNVE-YISGSTNSQTS---AFDTIT------------ERAGVCRDFAHLGI 189 (293)
T ss_dssp SHHHHHHHHTT--CCSHHHHHHHHHHHHHHHSE-ECTTSCCTTCC---HHHHHH------------HCEECHHHHHHHHH
T ss_pred HHHHHHHHhcc--CCCHHHHHHHHHHHHHhhcE-EeccCCCCCCC---HHHhhc------------CCcEehHHHHHHHH
Confidence 55667776655 34556788999999988654 21111100001 111222 35899999999999
Q ss_pred HhhhccCCCeeeecccCCCC--CCCCceEEEEecCcceeeee
Q 002331 276 VLADSIRLPCRLVKGSHYTG--VEDDAVNIIKLEEEREFLVD 315 (935)
Q Consensus 276 vLaD~i~l~c~lv~G~~~~g--~~~~a~~~v~~~~~~~~ivD 315 (935)
.||-.+|||||+|.|..... .+.+||++|.+.+ .=+.+|
T Consensus 190 al~Ra~GIPAR~VsGy~~~~~~~~~HAW~Evyl~g-gWv~~D 230 (293)
T 3isr_A 190 ALCRALSIPARYFTGYAFKLNPPDFHACFEAYIGG-NWIIFD 230 (293)
T ss_dssp HHHHHTTCCEEEEEEEETTCSSCCEEEEEEEEETT-EEEEEC
T ss_pred HHHHHCCCCEEEEEEECCCCCCCCeEEEEEEEECC-cEEEEE
Confidence 99999999999999976432 3448999999965 444444
|
| >3kd4_A Putative protease; structural genomics, joint center for STR genomics, JCSG, protein structure initiative, PSI-2, hydrol; HET: MSE; 2.00A {Parabacteroides distasonis atcc 8503} | Back alignment and structure |
|---|
Probab=95.10 E-value=0.065 Score=62.35 Aligned_cols=106 Identities=11% Similarity=0.055 Sum_probs=66.1
Q ss_pred HHHHHHHHHhcCCCCchHHHHHHHHHHHHhhcCCCCCChhHHHHhHHHHHHHHHHhhCCceeEeeecccccchhhHHHHH
Q 002331 196 LVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFK 275 (935)
Q Consensus 196 L~~~a~~~~~~l~~~~~~~~~~~LA~lV~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~s~v~plg~i~~G~~rhRalLfK 275 (935)
+.++|..+..+ ..+..+.++.|-.+|.+.+.=.....+..-..-.....-|+.. .|.|+-.|+||.
T Consensus 230 i~~~a~~l~~~--~~~~~ek~~~iy~~V~~~i~y~~~~~~~~g~~~~~a~~vl~~~------------~G~C~d~a~Ll~ 295 (506)
T 3kd4_A 230 SKTFAQFLTDK--SGNEQEKVNIIRDHILNNLSTCPIPMAMTGYTVRDIDTVLRSA------------YGTPLEIAQLLN 295 (506)
T ss_dssp HHHHHHHHHSS--CSSHHHHHHHHHHHHHHHCEECCCCGGGGTTCCCCHHHHHHHT------------EECHHHHHHHHH
T ss_pred HHHHHHHHHhc--CCCHHHHHHHHHHHHHhccEecceecccCCCCCCCHHHHHHhC------------CcchHHHHHHHH
Confidence 44455555555 4455566777777777666311000000000000112233333 699999999999
Q ss_pred HhhhccCCCeeeecccCC--------CCCCCCceEEEEecCcceeeeec
Q 002331 276 VLADSIRLPCRLVKGSHY--------TGVEDDAVNIIKLEEEREFLVDL 316 (935)
Q Consensus 276 vLaD~i~l~c~lv~G~~~--------~g~~~~a~~~v~~~~~~~~ivDl 316 (935)
.|+-..||||++|-+.-. -...+++|..|.+ +|+.|++|-
T Consensus 296 AllRa~GIpA~~v~~~t~~~~~~~~~lp~~nh~i~~v~~-~g~~y~lDa 343 (506)
T 3kd4_A 296 VMLNAAGIPSEVLAVYPGHLDTDACGLAAIQTLAVKATV-DGKDQYLSA 343 (506)
T ss_dssp HHHHHTTCCEEEEEEEETTSCGGGCCSTTCCEEEEEEEE-TTEEEEESS
T ss_pred HHHHHCCCCcEEEEEEcCCCCCccCCCCCCCEEEEEEEE-CCEEEEEec
Confidence 999999999999987732 1123678988886 789999997
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=94.77 E-value=0.022 Score=61.99 Aligned_cols=49 Identities=16% Similarity=0.138 Sum_probs=41.4
Q ss_pred cccccchhhHHHHHHhhhccCCCeeeecccCCCCCCCCceEEEEecC-cceeeee
Q 002331 262 INIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEE-EREFLVD 315 (935)
Q Consensus 262 i~~G~~rhRalLfKvLaD~i~l~c~lv~G~~~~g~~~~a~~~v~~~~-~~~~ivD 315 (935)
-+.|+|++-|.||-+||-.+|||||+|-|. +++||++|.+.. ..=+-||
T Consensus 138 ~r~G~C~d~A~lf~al~Ra~GIpAR~V~Gy-----~~HaW~Evy~~g~~gWv~~D 187 (295)
T 2f4m_A 138 TRCGRCGEWANCFTLCCRALGFEARYVWDY-----TDHVWTEVYSPSQQRWLHCD 187 (295)
T ss_dssp HCEESHHHHHHHHHHHHHHTTCCEEEEEET-----TTEEEEEEEETTTTEEEEEE
T ss_pred cCCEeeHHHHHHHHHHHHHCCCCEEEEcCC-----CCEEEEEEEECCCCeEEEEe
Confidence 368999999999999999999999999997 578999999975 3333444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.93 E-value=0.074 Score=60.61 Aligned_cols=72 Identities=13% Similarity=0.130 Sum_probs=47.0
Q ss_pred EEEeeecCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeecccccCCceEE
Q 002331 681 GERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~L 750 (935)
.+.|..|-...+|++... +..|++|+..... .......+|..+++.|. +.-..++++.+. -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 456777888899999875 6789999854321 11112357888888773 322345555432 278
Q ss_pred EEeeCCCCC
Q 002331 751 ITEFLPRGS 759 (935)
Q Consensus 751 VmEy~~gGs 759 (935)
||||++|..
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 999998865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.12 E-value=0.25 Score=55.25 Aligned_cols=29 Identities=24% Similarity=0.425 Sum_probs=25.3
Q ss_pred EEeeCCCCCCeee------cCCCcEEEEecccccc
Q 002331 797 IVHRDLKSPNLLV------DKNWNVKVSDFGLSRL 825 (935)
Q Consensus 797 IIHrDLKPeNILL------d~~g~VKL~DFGlA~~ 825 (935)
++|+|+.+.|||+ +++..++++||-.+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999998874
|
| >1x3z_A Peptide: N-glycanase; hydrolase-hydrolase inhibitor complex; HET: SUC; 2.80A {Saccharomyces cerevisiae} SCOP: d.3.1.4 PDB: 1x3w_A* 3esw_A* | Back alignment and structure |
|---|
Probab=92.42 E-value=0.095 Score=57.79 Aligned_cols=48 Identities=23% Similarity=0.166 Sum_probs=40.3
Q ss_pred ccccchhhHHHHHHhhhccCCCeeeecccCCCCCCCCceEEEEecCccee-eee
Q 002331 263 NIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEEEREF-LVD 315 (935)
Q Consensus 263 ~~G~~rhRalLfKvLaD~i~l~c~lv~G~~~~g~~~~a~~~v~~~~~~~~-ivD 315 (935)
+.|.|.|=|.||=.|+=.+|||||+|-|. .+++|++|.+.....+ =||
T Consensus 180 r~G~C~e~A~lF~~llRalGi~aR~V~~~-----~~H~W~EV~~~~~~rWv~vD 228 (335)
T 1x3z_A 180 RKGRCGEWCNLFTLILKSFGLDVRYVWNR-----EDHVWCEYFSNFLNRWVHVD 228 (335)
T ss_dssp CEECHHHHHHHHHHHHHTTTCCEEEEEET-----TTEEEEEEEETTTTEEEEEE
T ss_pred CCcChHHHHHHHHHHHHHCCCCeEEEecC-----CCcEEEEEEECCCCCEEEEC
Confidence 47999999999999999999999999873 5889999998764333 345
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.17 E-value=2.3 Score=44.23 Aligned_cols=116 Identities=11% Similarity=0.096 Sum_probs=77.3
Q ss_pred CCCceeeeecccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec
Q 002331 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD 810 (935)
Q Consensus 731 ~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd 810 (935)
.||+++.. .+-.+++.+.|.++.-+.+.=+..++ ..+...+++++.+|+....+++. =+|--|+|+||+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEEc
Confidence 58888866 45555666666666544332222233 36788999999999988765544 37889999999999
Q ss_pred CCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 002331 811 KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 877 (935)
Q Consensus 811 ~~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~ 877 (935)
.++.+++.=-|+-.. ++|. ..+...=+-.+=|++..+++++..|.
T Consensus 114 ~~~~p~i~~RGik~~-----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 114 RDGLPIAKTRGLQNV-----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TTSCEEESCCEETTT-----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCCCEEEEEccCccC-----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999976664321 1222 12222333457788889999888774
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.35 E-value=0.097 Score=60.13 Aligned_cols=60 Identities=13% Similarity=0.090 Sum_probs=16.3
Q ss_pred EEEEeeecCcEEEEEEEECC--ceEEE------EEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccc
Q 002331 680 LGERIGLGSYGEVYHADWNG--TEVAV------KKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (935)
Q Consensus 680 I~e~LG~G~fG~Vyka~~~g--~~VAV------K~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~ 742 (935)
+.+.|| ||.||++.+.+ .+||| |..............+.+|..+++.++|||+++.+++.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 344566 99999998864 47888 76655555555566788899999999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 935 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-73 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-63 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-59 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-51 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-44 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (617), Expect = 1e-73
Identities = 87/252 (34%), Positives = 141/252 (55%), Gaps = 13/252 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
EIP + +G+RIG GS+G VY W+G VAVK + L FK EV ++R+ R
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
H N++LFMG T P L+I+T++ SL+ LH + + + I +A A+GM+ LH
Sbjct: 63 HVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVLR 849
+I+HRDLKS N+ + ++ VK+ DFGL+ +K S + +G+ WMAPEV+R
Sbjct: 122 A--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 850 NE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----EIPKELD 902
+ P + + DVY+FG++L+EL T +LP+ +N + + + ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 903 PLVARIIWECWQ 914
+ R++ EC +
Sbjct: 240 KAMKRLMAECLK 251
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 3e-68
Identities = 78/246 (31%), Positives = 125/246 (50%), Gaps = 13/246 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
+ ++L L + IG G +G+V D+ G +VAVK + A F E +M +LR
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 58
Query: 732 HPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNC 789
H N+V +G + L I+TE++ +GSL L R + +K +LDV M
Sbjct: 59 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
L VHRDL + N+LV ++ KVSDFGL++ +T + +W APE LR
Sbjct: 119 LEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALR 173
Query: 850 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908
+ + K DV+SFG++LWE+ + ++P+ + VV V + +++ P P V +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEV 232
Query: 909 IWECWQ 914
+ CW
Sbjct: 233 MKNCWH 238
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 5e-66
Identities = 76/245 (31%), Positives = 117/245 (47%), Gaps = 9/245 (3%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I +DL + +G G +G V + W +VA+K + S EF E K+M L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
H +V G T+ + IITE++ G L L + ++ ++M DV M L
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRN 850
+ +HRDL + N LV+ VKVSDFGLSR + + + SS + W PEVL
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 851 EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
+ K D+++FGV++WE+ +L K+P+ + + Q RL P V I+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIM 234
Query: 910 WECWQ 914
+ CW
Sbjct: 235 YSCWH 239
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 7e-66
Identities = 67/249 (26%), Positives = 116/249 (46%), Gaps = 11/249 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
ED + IG GSYG +G + K+ + A EV ++R L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 734 NVVLFMGAVTRPPN--LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDVARGMN 788
N+V + + N L I+ E+ G L ++ + +DE+ +++ + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 789 CLH---TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 845
H T++HRDLK N+ +D NVK+ DFGL+R+ ++ +K+ GTP +M+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905
E + NEK D++S G +L+EL L P+ + ++ G + + + IP +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDEL 242
Query: 906 ARIIWECWQ 914
II
Sbjct: 243 NEIITRMLN 251
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 6e-65
Identities = 75/245 (30%), Positives = 120/245 (48%), Gaps = 9/245 (3%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I +L + IG G +G V+ W N +VA+K + S +F E ++M +L
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HP +V G + ++ EF+ G L L + + M LDV GM L
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRN 850
++HRDL + N LV +N +KVSDFG++R + + + SS T +W +PEV
Sbjct: 119 --EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 851 EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
+ K DV+SFGV++WE+ + K+P+ + +VV + RL P+ V +I+
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIM 235
Query: 910 WECWQ 914
CW+
Sbjct: 236 NHCWK 240
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 7e-64
Identities = 78/256 (30%), Positives = 134/256 (52%), Gaps = 14/256 (5%)
Query: 663 IFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFK 721
++D+ E+P E L L ER+G G +GEV+ +N T+VAVK S F
Sbjct: 3 WWEDEW---EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFL 56
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMA 780
E +M++L+H +V VT+ P + IITE++ GSL L P ++ + + MA
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 781 LDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 839
+A GM + +HRDL++ N+LV + K++DFGL+R ++ N + + +
Sbjct: 116 AQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 840 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIP 898
+W APE + K DV+SFG++L E+ T ++P+ GM +V+ + + R+ P
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRP 232
Query: 899 KELDPLVARIIWECWQ 914
+ +++ CW+
Sbjct: 233 DNCPEELYQLMRLCWK 248
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (548), Expect = 8e-64
Identities = 79/254 (31%), Positives = 121/254 (47%), Gaps = 15/254 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKI 726
EI + + + IG G +GEV VA+K L ++ +F E I
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASI 80
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
M + HPNV+ G VT+ + IITEF+ GSL L + Q + + M +A G
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTPE 841
M L VHRDL + N+LV+ N KVSDFGLSR T+ S+
Sbjct: 141 MKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
W APE ++ DV+S+G+++WE+ + + P+ M V+ A+ Q+ RL P +
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMD 257
Query: 901 LDPLVARIIWECWQ 914
+ +++ +CWQ
Sbjct: 258 CPSALHQLMLDCWQ 271
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-63
Identities = 76/243 (31%), Positives = 117/243 (48%), Gaps = 12/243 (4%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG GS+ VY EVA + D+ + + FK E ++++ L+HPN+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 738 FMGA----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
F + V + ++TE + G+L L R + K + +G+ LHT
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 794 TPTIVHRDLKSPN-LLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
TP I+HRDLK N + +VK+ D GL+ LK +F +K+ GTPE+MAPE+ +
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEEKY 189
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
E DVY+FG+ + E+AT + P+ N Q+ V + K P V II
Sbjct: 190 D-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248
Query: 912 CWQ 914
C +
Sbjct: 249 CIR 251
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 1e-63
Identities = 80/254 (31%), Positives = 121/254 (47%), Gaps = 13/254 (5%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLE-FKREV 724
C I +DL L E++G GS+G V +W+ VAVK S ++ F REV
Sbjct: 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
M L H N++ G V PP + ++TE P GSL L + + A+ VA
Sbjct: 63 NAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPE 841
GM L + +HRDL + NLL+ VK+ DFGL R + ++ +
Sbjct: 122 EGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
W APE L+ + D + FGV LWE+ T + PWIG+N Q++ + + RL P++
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 901 LDPLVARIIWECWQ 914
+ ++ +CW
Sbjct: 240 CPQDIYNVMVQCWA 253
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 9e-63
Identities = 66/254 (25%), Positives = 121/254 (47%), Gaps = 14/254 (5%)
Query: 670 ECEIPWEDLVLGER-IGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREV 724
+ + ++L++ + +G G++G V + +VA+K L Q A E RE
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREA 60
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+IM +L +P +V +G V + L ++ E G L + L ++ ++ V+
Sbjct: 61 QIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPE 841
GM L VHRDL + N+L+ K+SDFGLS+ + + + + +
Sbjct: 120 MGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 842 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 900
W APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P E
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 236
Query: 901 LDPLVARIIWECWQ 914
P + ++ +CW
Sbjct: 237 CPPELYALMSDCWI 250
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-62
Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 12/250 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-----VAVKKFLDQDFSGAALLEFKREVKI 726
EI E + LG IG G +G+V+ + E VA+K S + +F +E
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEALT 61
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARG 786
MR+ HP++V +G +T + II E G L L +D I A ++
Sbjct: 62 MRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 787 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 845
+ L + VHRD+ + N+LV N VK+ DFGLSR ++ +T+ + +WMAP
Sbjct: 121 LAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904
E + DV+ FGV +WE+ P+ G+ V+G + RL +P P
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPT 237
Query: 905 VARIIWECWQ 914
+ ++ +CW
Sbjct: 238 LYSLMTKCWA 247
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 3e-62
Identities = 82/247 (33%), Positives = 130/247 (52%), Gaps = 11/247 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L ++G G +GEV+ WNGT VA+K S F +E ++M++L
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKL 69
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNC 789
RH +V V+ P + I+TE++ +GSL L + + + MA +A GM
Sbjct: 70 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVL 848
+ VHRDL++ N+LV +N KV+DFGL+RL + N + + + +W APE
Sbjct: 129 VER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E +
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHD 245
Query: 908 IIWECWQ 914
++ +CW+
Sbjct: 246 LMCQCWR 252
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 9e-62
Identities = 62/262 (23%), Positives = 116/262 (44%), Gaps = 9/262 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E+ +D +G G+ G V+ +G +A K + + A + RE++++
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHE 60
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
P +V F GA +SI E + GSL ++L + ++ E+ K+++ V +G+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
L I+HRD+K N+LV+ +K+ DFG+S ++ + S GT +M+PE L+
Sbjct: 120 LREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ 176
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
+ + D++S G+ L E+A + P + ++ + F + E P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGDAAETPPRPRTPG 234
Query: 910 WECWQTGWSSLHIRTSQAQLSH 931
G S L +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDY 256
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 3e-61
Identities = 67/249 (26%), Positives = 115/249 (46%), Gaps = 12/249 (4%)
Query: 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
P + + +G G++G+VY A A K + ++ E+ I+
Sbjct: 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE--DYMVEIDILASCD 67
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HPN+V + A NL I+ EF G++ ++ + E + + +N LH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL--- 848
+ I+HRDLK+ N+L + ++K++DFG+S T S GTP WMAPEV+
Sbjct: 128 DN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 849 --RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLV 905
++ P + K DV+S G+ L E+A ++ P +NPM+V+ + L P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 906 ARIIWECWQ 914
+ +C +
Sbjct: 246 KDFLKKCLE 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 3e-61
Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 36/276 (13%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-------EVAVKKFLDQDFSGAALLEFKREV 724
E P E+L G+ +G G++G+V +A G +VAVK L + + E+
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALMSEL 91
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ------------- 770
K+M +L H N+V +GA T + +I E+ G L L +
Sbjct: 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 771 ---------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
+ + + A VA+GM L + VHRDL + N+LV VK+ DFG
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 822 LSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG 878
L+R + ++ + +WMAPE L K DV+S+G++LWE+ +L P+ G
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 879 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + +++ P + I+ CW
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWA 305
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (528), Expect = 3e-61
Identities = 81/247 (32%), Positives = 123/247 (49%), Gaps = 9/247 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E+ D+ + ++G G YGEVY W VAVK + EF +E +M+
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 69
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMN 788
++HPN+V +G TR P IITEF+ G+L L +V + MA ++ M
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 847
L +HRDL + N LV +N VKV+DFGLSR + +T+ + +W APE
Sbjct: 130 YLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
L + K DV++FGV+LWE+AT + + V + ++ R+E P+ V
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 908 IIWECWQ 914
++ CWQ
Sbjct: 248 LMRACWQ 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 5e-61
Identities = 66/251 (26%), Positives = 116/251 (46%), Gaps = 14/251 (5%)
Query: 673 IPWEDLVLGER-IGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ + L L ++ +G G++G V + VAVK ++ A E E +M
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
++L +P +V +G + + ++ E G L + L + + V +K I++ V+ GM
Sbjct: 63 QQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGM 120
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMA 844
L S VHRDL + N+L+ K+SDFGLS+ N + + +W A
Sbjct: 121 KYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 903
PE + + K DV+SFGV++WE + + P+ GM +V + + R+ P
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPR 237
Query: 904 LVARIIWECWQ 914
+ ++ CW
Sbjct: 238 EMYDLMNLCWT 248
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 6e-61
Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 26/264 (9%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT----EVAVKKFLDQDFSGAALLEFKREVKIM 727
+ W D+ + IG G++G+V A + A+K+ + + S +F E++++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVL 64
Query: 728 RRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---------------V 771
+L HPN++ +GA L + E+ P G+L L + +
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 772 DEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831
++ + A DVARGM+ L +HRDL + N+LV +N+ K++DFGLSR ++
Sbjct: 125 SSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYV 181
Query: 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 890
WMA E L DV+S+GV+LWE+ +L P+ GM ++ +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240
Query: 891 QNRRLEIPKELDPLVARIIWECWQ 914
Q RLE P D V ++ +CW+
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWR 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-60
Identities = 60/242 (24%), Positives = 110/242 (45%), Gaps = 10/242 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
ED +G +G G +G VY A + +A+K A + +REV+I LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
PN++ G + +I E+ P G+++R L + DE+R ++A ++ H+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS 124
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
++HRD+K NLL+ +K++DFG S ++ + GT +++ PE++
Sbjct: 125 KR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRM 180
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
+EK D++S GV+ +E K P+ + + P + +I
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRL 238
Query: 913 WQ 914
+
Sbjct: 239 LK 240
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (515), Expect = 3e-59
Identities = 72/276 (26%), Positives = 118/276 (42%), Gaps = 37/276 (13%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREV 724
E P ++ IG G++G V+ A T VAVK L ++ S +F+RE
Sbjct: 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQREA 67
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-------------- 770
+M +PN+V +G + ++ E++ G L L
Sbjct: 68 ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 771 ---------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 821
+ ++ +A VA GM L VHRDL + N LV +N VK++DFG
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 822 LSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIG 878
LSR + + + + + A WM PE + + DV+++GV+LWE+ + L P+ G
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 879 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
M +V+ V L P+ + ++ CW
Sbjct: 246 MAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWS 280
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-59
Identities = 71/253 (28%), Positives = 121/253 (47%), Gaps = 14/253 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT------EVAVKKFLDQDFSGAALLEFKREVK 725
EI + + IG G +GEVY + VA+K L ++ ++F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAG 61
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVAR 785
IM + H N++ G +++ + IITE++ G+L + L + + + M +A
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 786 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPEW 842
GM L VHRDL + N+LV+ N KVSDFGLSR+ + ++ +T+ W
Sbjct: 122 GMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 843 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQVVGAVGFQNRRLEIPKEL 901
APE + DV+SFG+++WE+ T ++ +V+ A+ RL P +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 238
Query: 902 DPLVARIIWECWQ 914
+ +++ +CWQ
Sbjct: 239 PSAIYQLMMQCWQ 251
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 7e-59
Identities = 63/251 (25%), Positives = 119/251 (47%), Gaps = 9/251 (3%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREV 724
+ P + E+IG G+ G VY A G EVA+++ Q E+
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE--LIINEI 68
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
+MR ++PN+V ++ + L ++ E+L GSL ++ DE + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECL 126
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844
+ + LH++ ++HRD+KS N+L+ + +VK++DFG + GTP WMA
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDP 903
PEV+ + K D++S G++ E+ + P++ NP++ + + L+ P++L
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 904 LVARIIWECWQ 914
+ + C
Sbjct: 245 IFRDFLNRCLD 255
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-58
Identities = 77/262 (29%), Positives = 128/262 (48%), Gaps = 23/262 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKREV 724
E+ E + + +G GS+G VY D T VA+K +++ S +EF E
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEA 74
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV---------DEKR 775
+M+ +VV +G V++ +I E + RG L L + +
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 776 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 835
I+MA ++A GM L+ + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 135 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 836 TA--GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 892
WM+PE L++ DV+SFGV+LWE+ATL + P+ G++ QV+ V +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEG 251
Query: 893 RRLEIPKELDPLVARIIWECWQ 914
L+ P ++ ++ CWQ
Sbjct: 252 GLLDKPDNCPDMLFELMRMCWQ 273
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 1e-58
Identities = 77/261 (29%), Positives = 119/261 (45%), Gaps = 17/261 (6%)
Query: 667 DVCECEIPWEDLVL--GERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALLE 719
V I L++ E IG G +G VYH D AVK L++ + +
Sbjct: 16 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ 74
Query: 720 FKREVKIMRRLRHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
F E IM+ HPNV+ +G R ++ ++ G L + K I
Sbjct: 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134
Query: 779 MALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH----NTFLSSK 834
L VA+GM L + VHRDL + N ++D+ + VKV+DFGL+R + ++ +
Sbjct: 135 FGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192
Query: 835 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR 893
+WMA E L+ + K DV+SFGV+LWEL T P+ +N + + Q R
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGR 251
Query: 894 RLEIPKELDPLVARIIWECWQ 914
RL P+ + ++ +CW
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWH 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (508), Expect = 4e-58
Identities = 68/260 (26%), Positives = 107/260 (41%), Gaps = 19/260 (7%)
Query: 661 DQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAAL 717
+ F DD P + IG GS+G VY A N VA+KK S
Sbjct: 6 ELFFKDD------PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 718 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 777
+ +EV+ +++LRHPN + + G R ++ E+ + + + E
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIA 118
Query: 778 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 837
+ +G+ LH+ ++HRD+K+ N+L+ + VK+ DFG + + S
Sbjct: 119 AVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFV 172
Query: 838 GTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR 894
GTP WMAPEV+ + K DV+S G+ ELA K P MN M + +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
Query: 895 LEIPKELDPLVARIIWECWQ 914
+ C Q
Sbjct: 233 ALQSGHWSEYFRNFVDSCLQ 252
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 6e-57
Identities = 83/279 (29%), Positives = 123/279 (44%), Gaps = 45/279 (16%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+VL E IG G +GEV+ W G EVAVK F ++ + E+ LRH N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENI 59
Query: 736 VLFMGAVTRP----PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
+ F+ A + L +++++ GSLF L+R V + IK+AL A G+ LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH 117
Query: 792 T------STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAGTPE 841
P I HRDLKS N+LV KN ++D GL+ ++ GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 842 WMAPEVLRNE------PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ------------ 883
+MAPEVL + S ++ D+Y+ G++ WE+A Q
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 884 ---VVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQ 914
+ V Q R IP E ++A+I+ ECW
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 8e-57
Identities = 70/271 (25%), Positives = 111/271 (40%), Gaps = 31/271 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREV 724
E P L G+ +G G++G+V A VAVK L E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSEL 77
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR----------------- 766
K++ L H N+V +GA T +ITE+ G L L R
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 767 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL- 825
+D + + + VA+GM L + +HRDL + N+L+ K+ DFGL+R
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 826 -KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQ 883
+ ++ + +WMAPE + N + DV+S+G+ LWEL +L GM
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + R+ P+ + I+ CW
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWD 286
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 6e-56
Identities = 53/269 (19%), Positives = 108/269 (40%), Gaps = 14/269 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRH 732
ED G+ +G GS+ V A E A+K + RE +M RL H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
P V L + G L + + + DE ++ + LH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG 126
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRN 850
I+HRDLK N+L++++ +++++DFG +++ + + S GT ++++PE+L
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910
+ + + D+++ G I+++L P+ N + + + P++ P ++
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVE 242
Query: 911 ECWQTG----WSSLHIRTSQAQLSHKRFQ 935
+ + +H F+
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 8e-56
Identities = 65/247 (26%), Positives = 114/247 (46%), Gaps = 12/247 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRL 730
+ + +G G++G VY W G +V + K L + S A E E +M +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCL 790
+P+V +G + +IT+ +P G L + + + + + +A+GMN L
Sbjct: 69 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVL 848
+VHRDL + N+LV +VK++DFGL++L ++ +WMA E +
Sbjct: 128 ED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 849 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907
+ + DV+S+GV +WEL T P+ G+ ++ + + RL P V
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVYM 244
Query: 908 IIWECWQ 914
I+ +CW
Sbjct: 245 IMVKCWM 251
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 2e-55
Identities = 69/245 (28%), Positives = 108/245 (44%), Gaps = 10/245 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
ED L + +G G+YGEV A VAVK +D + K+E+ I + L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHE 63
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
NVV F G + E+ G LF + + E + + G+ LH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNE 851
I HRD+K NLL+D+ N+K+SDFGL+ + +N GT ++APE+L+
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 852 P-SNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVARII 909
E DV+S G++L + +LPW + Q + L K++D ++
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 910 WECWQ 914
+
Sbjct: 241 HKILV 245
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-55
Identities = 79/271 (29%), Positives = 138/271 (50%), Gaps = 32/271 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKR 722
E+P + LVLG+ +G G++G+V A+ T+VAVK L D + L +
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLIS 67
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH---------------R 766
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 767 PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826
P Q+ K + A VARGM L + +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 827 H--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 883
H + + + + +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ +
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 884 VVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + + R++ P + ++ +CW
Sbjct: 246 LFKLLK-EGHRMDKPSNCTNELYMMMRDCWH 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 188 bits (479), Expect = 1e-53
Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 11/245 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ + E +G G++G V+ G A K + S ++E++ M LRHP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE--TVRKEIQTMSVLRHP 83
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+V A + +I EF+ G LF + H ++ E ++ V +G+ +H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 794 TPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
VH DLK N++ ++ +K+ DFGL+ + S K T GT E+ APEV +
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARII 909
P D++S GV+ + L + P+ G N + + V N + I
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260
Query: 910 WECWQ 914
+
Sbjct: 261 RKLLL 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 6e-53
Identities = 77/275 (28%), Positives = 125/275 (45%), Gaps = 30/275 (10%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLE 719
D + E P + L LG+ +G G++G+V AD VAVK L + + +
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRA 62
Query: 720 FKREVKIMRR-LRHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRPHCQ------- 770
E+KI+ H NVV +GA T+P L +I EF G+L L +
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 771 --------VDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 822
+ + I + VA+GM L + +HRDL + N+L+ + VK+ DFGL
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGL 180
Query: 823 SRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 879
+R K ++ +WMAPE + + + DV+SFGV+LWE+ +L P+ G+
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240
Query: 880 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 914
+ + R+ P P + + + +CW
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-52
Identities = 61/243 (25%), Positives = 118/243 (48%), Gaps = 9/243 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRR-LR 731
ED +L + +G GS+G+V+ A++ A+K +E E +++
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
HP + NL + E+L G L + H + D R A ++ G+ LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH 120
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
+ IV+RDLK N+L+DK+ ++K++DFG+ + + + GTP+++APE+L +
Sbjct: 121 S--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911
N D +SFGV+L+E+ + P+ G + ++ ++ + P+ L+ ++ +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVK 236
Query: 912 CWQ 914
+
Sbjct: 237 LFV 239
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-52
Identities = 46/246 (18%), Positives = 102/246 (41%), Gaps = 12/246 (4%)
Query: 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
+E ++ E +G G +G V+ + K G + K+E+ I+ RH
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARH 60
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
N++ + L +I EF+ +F ++ +++E+ + V + LH
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH- 119
Query: 793 STPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
+ I H D++ N++ ++ +K+ +FG +R + + PE+ APEV ++
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQH 177
Query: 851 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 908
+ + D++S G +++ L + P++ Q++ + E KE+
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 909 IWECWQ 914
+
Sbjct: 238 VDRLLV 243
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 182 bits (462), Expect = 9e-52
Identities = 58/242 (23%), Positives = 110/242 (45%), Gaps = 11/242 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
+D + +G GS+G V+ NG A+K + +E E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
P ++ G + +I +++ G L R + A +V + LH+
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
I++RDLK N+L+DKN ++K++DFG ++ + + GTP+++APEV+ +P
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKP 177
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
N+ D +SFG++++E+ P+ N M+ + N L P + V ++
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVKDLLSRL 235
Query: 913 WQ 914
Sbjct: 236 IT 237
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 182 bits (464), Expect = 1e-51
Identities = 57/245 (23%), Positives = 102/245 (41%), Gaps = 11/245 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ + E +G G++G V+ G K K E+ IM +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHP 86
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
++ A + +I EFL G LF + ++ E I G+ +H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 794 TPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
+IVH D+K N++ + K +VK+ DFGL+ + + +T T E+ APE++ E
Sbjct: 147 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDRE 203
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARII 909
P D+++ GV+ + L + P+ G + ++ + V + + + P I
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 910 WECWQ 914
Q
Sbjct: 264 KNLLQ 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (457), Expect = 3e-51
Identities = 59/242 (24%), Positives = 108/242 (44%), Gaps = 12/242 (4%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G G++ EV A+ VA+K + + + E+ ++ +++HPN+V
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKC-IAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+L +I + + G LF + E+ ++ V + LH I
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHD--LGI 128
Query: 798 VHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 854
VHRDLK NLL D++ + +SDFGLS+++ + S + GTP ++APEVL +P +
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVAPEVLAQKPYS 187
Query: 855 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWEC 912
+ D +S GVI + L P+ N ++ + + P ++ I
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 247
Query: 913 WQ 914
+
Sbjct: 248 ME 249
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 5e-50
Identities = 58/266 (21%), Positives = 116/266 (43%), Gaps = 11/266 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRH 732
D + +G G++G+V G A+K + + + E ++++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
P + A L + E+ G LF L R E+R ++ + LH+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS 123
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+V+RD+K NL++DK+ ++K++DFGL + + + K+ GTPE++APEVL +
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
D + GV+++E+ +LP+ + ++ + + P+ L P ++
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGL 239
Query: 913 WQTGWS---SLHIRTSQAQLSHKRFQ 935
+ ++ + H+ F
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 173 bits (439), Expect = 4e-49
Identities = 59/258 (22%), Positives = 104/258 (40%), Gaps = 22/258 (8%)
Query: 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-------FKREVK 725
+E+ E +G G V E AVK + E +EV
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 726 IMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
I+R++ HPN++ ++ + + +G LF L + EK K+ +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALL 120
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844
+ LH IVHRDLK N+L+D + N+K++DFG S + GTP ++A
Sbjct: 121 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLA 177
Query: 845 PEVLRNEPS------NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 898
PE++ + ++ D++S GVI++ L P+ M ++ + N + P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 899 --KELDPLVARIIWECWQ 914
+ V ++
Sbjct: 238 EWDDYSDTVKDLVSRFLV 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 170 bits (432), Expect = 3e-48
Identities = 64/251 (25%), Positives = 113/251 (45%), Gaps = 15/251 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRH 732
+ LGE +G G EV+ A +VAVK D + L F+RE + L H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 733 PNVVLFMGAVTRPPNLS----IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMN 788
P +V I+ E++ +L I+H + KR I++ D + +N
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALN 125
Query: 789 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMAP 845
H I+HRD+K N+++ VKV DFG++R N+ + + GT ++++P
Sbjct: 126 FSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDP 903
E R + + + DVYS G +L+E+ T + P+ G +P+ V ++ + L
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243
Query: 904 LVARIIWECWQ 914
+ ++ +
Sbjct: 244 DLDAVVLKALA 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 4e-48
Identities = 61/247 (24%), Positives = 102/247 (41%), Gaps = 16/247 (6%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKF----LDQDFSGAALLEFKREVKIMRRLRHP 733
GE +G G + V G + A K G + + +REV I++ ++HP
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
NV+ ++ +I E + G LF L + E+ + + G+ LH+
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS- 131
Query: 794 TPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 849
I H DLK N+++ +K+ DFGL+ K+ GTPE++APE++
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVN 189
Query: 850 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVAR 907
EP + D++S GVI + L + P++G + + V N E L
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249
Query: 908 IIWECWQ 914
I
Sbjct: 250 FIRRLLV 256
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (421), Expect = 8e-46
Identities = 58/247 (23%), Positives = 100/247 (40%), Gaps = 13/247 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRR 729
D + IG G +GEVY G A+K + L + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNC 789
P +V A P LS I + + G L L + H E A ++ G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEH 122
Query: 790 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL- 848
+H +V+RDLK N+L+D++ +V++SD GL+ ++ GT +MAPEVL
Sbjct: 123 MH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQ 178
Query: 849 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVAR 907
+ + D +S G +L++L P+ + +E+P P +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 908 IIWECWQ 914
++ Q
Sbjct: 239 LLEGLLQ 245
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-45
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 5/212 (2%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
E+ E+IG G+YG VY A G VA+KK + RE+ +++ L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
N+V + + L ++ EFL + + + + +G+ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP- 852
+ ++HRDLK NLL++ +K++DFGL+R + T + APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884
+ D++S G I E+ T + + G + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 47/245 (19%), Positives = 89/245 (36%), Gaps = 22/245 (8%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE----FKREVKIMRRLR-- 731
+G +G G +G VY + VA+K S L EV +++++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
V+ + RP + +I E + E+ V + H
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 792 TSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 850
++HRD+K N+L+D N +K+ DFG L +T + GT + PE +R
Sbjct: 128 NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DFDGTRVYSPPEWIRY 183
Query: 851 EP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909
V+S G++L+++ +P+ + ++ + + +I
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSECQHLI 235
Query: 910 WECWQ 914
C
Sbjct: 236 RWCLA 240
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-44
Identities = 59/253 (23%), Positives = 107/253 (42%), Gaps = 27/253 (10%)
Query: 679 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
V + +GLG G+V + A+K D + +REV++ R + P++
Sbjct: 15 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHI 67
Query: 736 V----LFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDVARGMNCL 790
V ++ L I+ E L G LF + R E+ ++ + + L
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 791 HTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 847
H+ I HRD+K NLL +K++DFG ++ + S + TP ++APEV
Sbjct: 128 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEV 184
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI------PKEL 901
L E ++ CD++S GVI++ L P+ + + + + + R + E+
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 902 DPLVARIIWECWQ 914
V +I +
Sbjct: 245 SEEVKMLIRNLLK 257
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (408), Expect = 4e-44
Identities = 55/242 (22%), Positives = 109/242 (45%), Gaps = 11/242 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
+ + +G GS+G V +G A+K Q +E E +I++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT 792
P +V + NL ++ E++ G +F L R + E A + LH+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 793 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
+++RDLK NLL+D+ ++V+DFG ++ + GTPE +APE++ ++
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKG 214
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
N+ D ++ GV+++E+A P+ P+Q+ + + ++ P + ++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFPSHFSSDLKDLLRNL 272
Query: 913 WQ 914
Q
Sbjct: 273 LQ 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (400), Expect = 7e-44
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 5/212 (2%)
Query: 676 EDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
E E+IG G+YG VY A + G A+KK + RE+ I++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTST 794
+V + L ++ E L L ++L ++ L + G+ H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--D 118
Query: 795 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS- 853
++HRDLK NLL+++ +K++DFGL+R T + AP+VL
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 854 NEKCDVYSFGVILWELATLKLPWIGMNPMQVV 885
+ D++S G I E+ + G++ +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 4e-43
Identities = 49/253 (19%), Positives = 93/253 (36%), Gaps = 24/253 (9%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
LG +IG GS+G++Y G EVA+K + + E KI + ++ +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIP 66
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+ + +++ L SL + + + K + +A + + +H+
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--NF 124
Query: 798 VHRDLKSPNLLV---DKNWNVKVSDFGLSRL-------KHNTFLSSKSTAGTPEWMAPEV 847
+HRD+K N L+ K V + DFGL++ +H + +K+ GT + +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 848 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV------GFQNRRLEIPKEL 901
+ + D+ S G +L LPW G+ + K
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 902 DPLVARIIWECWQ 914
A + C
Sbjct: 245 PSEFATYLNFCRS 257
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 6e-43
Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 14/224 (6%)
Query: 676 EDLVLGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-- 730
+ IG G+YG+V+ G VA+K+ Q L REV ++R L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 731 -RHPNVVLFMGAVTRPPN-----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
HPNVV T L+++ E + + + P V + M +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844
RG++ LH+ +VHRDLK N+LV + +K++DFGL+R+ ++ ++ S T + A
Sbjct: 127 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRA 183
Query: 845 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 888
PEVL D++S G I E+ K + G + + +G +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 9e-43
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 9/210 (4%)
Query: 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA---ALLEFKREVKIMRRLRHPNVV 736
+ +G G + VY A VA+KK S A RE+K+++ L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPT 796
+ A N+S++ +F+ L I+ + L +G+ LH
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--HW 120
Query: 797 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NE 855
I+HRDLK NLL+D+N +K++DFGL++ + + T + APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 856 KCDVYSFGVILWELATLKLPWIGMNPMQVV 885
D+++ G IL EL G + + +
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQL 210
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 155 bits (392), Expect = 1e-42
Identities = 43/255 (16%), Positives = 91/255 (35%), Gaps = 26/255 (10%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G RIG GS+G ++ N +VA+K + + + + E + + L +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCTGIP 64
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTI 797
+ + +++ L SL +L + K A + + +H + +
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--L 122
Query: 798 VHRDLKSPNLLVDK-----NWNVKVSDFGLSRL-------KHNTFLSSKSTAGTPEWMAP 845
V+RD+K N L+ + + V DFG+ + +H + K+ +GT +M+
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 846 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV------VGAVGFQNRRLEIPK 899
+ + D+ + G + LPW G+ +G E+
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 900 ELDPLVARIIWECWQ 914
+ +
Sbjct: 243 GFPEEFYKYMHYARN 257
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-42
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 15/214 (7%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG G+YG V A N VA+KK + RE+KI+ R RH N++
Sbjct: 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHENIIG 70
Query: 738 FMGAVTRPP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+ P + L L+++L H + + RG+ +H++
Sbjct: 71 INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSA 128
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMAPEVLRN 850
++HRDLK NLL++ ++K+ DFGL+R+ H+ T + APE++ N
Sbjct: 129 N--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 851 E-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 883
+ D++S G IL E+ + + + G + +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-41
Identities = 54/236 (22%), Positives = 105/236 (44%), Gaps = 22/236 (9%)
Query: 672 EIPWEDLV----LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVK 725
E P+ D V +IG G++GEV+ A G +VA+KK L ++ + RE+K
Sbjct: 2 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 726 IMRRLRHPNVVLFMGAVTRPP--------NLSIITEFLPRGSLFRILHRPHCQVDEKRRI 777
I++ L+H NVV + ++ ++ +F + + + +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK- 120
Query: 778 KMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSS 833
++ + G+ +H I+HRD+K+ N+L+ ++ +K++DFGL+R K++
Sbjct: 121 RVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 834 KSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 888
+ T + PE+L E D++ G I+ E+ T G + +
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-40
Identities = 63/276 (22%), Positives = 111/276 (40%), Gaps = 19/276 (6%)
Query: 676 EDLVLGERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAA--LLEFKREVKIMR 728
E+ L + +G G+YG+V+ G A+K A + E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 729 RLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGM 787
+R P +V A L +I +++ G LF L + + E ++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLAL 142
Query: 788 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPE 846
LH I++RD+K N+L+D N +V ++DFGLS + + GT E+MAP+
Sbjct: 143 EHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 847 VLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELD 902
++R S ++ D +S GV+++EL T P+ + P+E+
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 903 PLVARIIWECWQTGWS---SLHIRTSQAQLSHKRFQ 935
L +I R + H FQ
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 8e-39
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 6/204 (2%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ E+IG G+YG V+ A VA+K+ D RE+ +++ L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
N+V + L+++ EF + D + + +G+ H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCH-- 118
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 853
+ ++HRDLK NLL+++N +K+++FGL+R + T + P+VL
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 854 -NEKCDVYSFGVILWELATLKLPW 876
+ D++S G I ELA P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPL 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-36
Identities = 63/259 (24%), Positives = 113/259 (43%), Gaps = 15/259 (5%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G G+YG V A G +VA+KK S RE+++++ +RH NV+
Sbjct: 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81
Query: 738 FMGAVTRPPNLSIITEFL----PRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS 793
+ T L T+F G+ L + H ++ E R + + +G+ +H
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIH-- 138
Query: 794 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EP 852
I+HRDLK NL V+++ +K+ DFGL+R + T + APEV+ N
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNWMR 195
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 912
+ D++S G I+ E+ T K + G + + + + P E + +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI--MKVTGTPPAEFVQRLQSDEAKN 253
Query: 913 WQTGWSSLHIRTSQAQLSH 931
+ G L + + L++
Sbjct: 254 YMKGLPELEKKDFASILTN 272
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-36
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 15/213 (7%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ IG G+ G V A VA+KK + RE+ +M+ + H N++
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 738 FMGAVTRPP------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLH 791
+ T ++ ++ E + I D +R + + G+ LH
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH 136
Query: 792 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 851
+ I+HRDLK N++V + +K+ DFGL+R +F+ + T + APEV+
Sbjct: 137 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILGM 193
Query: 852 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884
E D++S G I+ E+ K+ + G + +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-35
Identities = 48/212 (22%), Positives = 79/212 (37%), Gaps = 19/212 (8%)
Query: 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
IG GS+G VY A +G VA+KK L RE++IMR+L H N+V
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYF 81
Query: 742 VTRP------PNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMNCLHTS 793
L+++ +++P H R + + R + +H+
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS- 140
Query: 794 TPTIVHRDLK-SPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 852
I HRD+K LL +K+ DFG ++ + +
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 199
Query: 853 SNEKCDVYSFGVILWELATLKLPWIGMNPMQV 884
DV+S G +L EL + + G + +
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (334), Expect = 1e-34
Identities = 59/295 (20%), Positives = 121/295 (41%), Gaps = 32/295 (10%)
Query: 654 DSSTSKVDQIFDDDVCECEIPW---EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFL 708
D +T + + +D + + W +D L ++G G Y EV+ A N +V VK
Sbjct: 12 DVNTHRPREYWDYE--SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK 69
Query: 709 DQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILH 765
+ KRE+KI+ LR PN++ V P + +++ E + ++
Sbjct: 70 PVKKK-----KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 766 RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSR 824
+ + ++ + ++ H+ I+HRD+K N+++D ++ +++ D+GL+
Sbjct: 125 T----LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178
Query: 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNP-- 881
H + + PE+L + + D++S G +L + K P+ +
Sbjct: 179 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237
Query: 882 ------MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLS 930
+V+G + + ELDP I+ + W +Q +S
Sbjct: 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 292
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-34
Identities = 63/253 (24%), Positives = 108/253 (42%), Gaps = 18/253 (7%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E+P E +G G+YG V A G VAVKK S RE+++++
Sbjct: 15 EVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 73
Query: 730 LRHPNVVLFMGAVTRPPNLS-----IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVA 784
++H NV+ + T +L + L L I+ D + + +
Sbjct: 74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI--YQIL 131
Query: 785 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 844
RG+ +H + I+HRDLK NL V+++ +K+ DFGL+R + T + A
Sbjct: 132 RGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRA 186
Query: 845 PEV-LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKEL 901
PE+ L N+ D++S G I+ EL T + + G + + + + E+ K++
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 902 DPLVARIIWECWQ 914
AR +
Sbjct: 247 SSESARNYIQSLT 259
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (283), Expect = 1e-27
Identities = 49/280 (17%), Positives = 107/280 (38%), Gaps = 31/280 (11%)
Query: 679 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+L ++G G + V+ A N T VA+K + E+K+++R+ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 737 L---------------FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
F ++ ++ E L L I H + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKN------WNVKVSDFGLSRLKHNTFLSSKS 835
+ G++ +H I+H D+K N+L++ +K++D G + + +
Sbjct: 133 QLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TN 188
Query: 836 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 895
+ T E+ +PEVL P D++S +++EL T + + +
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 896 EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRFQ 935
E+ EL + R + +T ++S + + ++L +
Sbjct: 249 ELLGELPSYLLR-NGKYTRTFFNSRGLLRNISKLKFWPLE 287
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 90.2 bits (223), Expect = 3e-21
Identities = 31/193 (16%), Positives = 60/193 (31%), Gaps = 45/193 (23%)
Query: 679 VLGERIGLGSYGEVYHA-DWNGTEVAVKKF----------------LDQDFSGAALLEFK 721
+G+ +G G V++ E VK D FS A+ +
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
E + +++L+ V +++ E + + +V + ++
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGN----AVLMELID--------AKELYRVRVENPDEVLD 110
Query: 782 DVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 841
+ + + IVH DL N+LV + + DF S E
Sbjct: 111 MILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV-------------EVGE 154
Query: 842 WMAPEVLRNEPSN 854
E+L + N
Sbjct: 155 EGWREILERDVRN 167
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 935 | |||
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.44 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.84 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.24 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.21 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.04 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.95 | |
| d2f4ma1 | 287 | Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) | 92.09 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-54 Score=456.55 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=216.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc--CCceEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSII 751 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~--~~~l~LV 751 (935)
++|++.+.||+|+||+||+|++ +|+.||||++......+.....+.+|+++|++++|||||++++++.+ .+.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6899999999999999999987 58899999998887777778889999999999999999999999854 4568999
Q ss_pred EeeCCCCCHHHHHcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---CCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 752 TEFLPRGSLFRILHR---PHCQVDEKRRIKMALDVARGMNCLHTST---PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 752 mEy~~gGsL~dlL~~---~~~~lse~~il~Ia~QIa~AL~yLHs~g---~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
||||++|+|.+++.+ .+..+++..++.|+.||+.||.|||+.+ .+||||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999853 2457999999999999999999999865 2499999999999999999999999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHH
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L 905 (935)
............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+.. .....+|..+++++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l 242 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDEL 242 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHH
Confidence 76554445567899999999999999999999999999999999999999999998888877753 34456788999999
Q ss_pred HHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||.+||+.| |.+||+++|||+|||
T Consensus 243 ~~li~~~L~~d---p~~Rps~~ell~hp~ 268 (269)
T d2java1 243 NEIITRMLNLK---DYHRPSVEEILENPL 268 (269)
T ss_dssp HHHHHHHTCSS---GGGSCCHHHHHTSTT
T ss_pred HHHHHHHcCCC---hhHCcCHHHHHhCCc
Confidence 99999999999 999999999999999
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=454.43 Aligned_cols=251 Identities=24% Similarity=0.438 Sum_probs=225.7
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 750 (935)
..++|++++.||+|+||+||+|++ +++.||||++....... .....+.+|+.+|++++|||||++++++.+++.+||
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 457899999999999999999987 57899999987543221 234568899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~ 830 (935)
|||||++|+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+.++.+||+|||+++......
T Consensus 84 vmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 99999999999999753 46999999999999999999999999 9999999999999999999999999998665432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
.....||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..++...+. .....+|..+++++++||.
T Consensus 161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLIS 236 (263)
T ss_dssp --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHH
T ss_pred --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHH
Confidence 334679999999999999999999999999999999999999999999888887764 4456788899999999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||+.| |.+|||++|||+|||
T Consensus 237 ~~L~~d---p~~R~t~~eil~hp~ 257 (263)
T d2j4za1 237 RLLKHN---PSQRPMLREVLEHPW 257 (263)
T ss_dssp HHTCSS---GGGSCCHHHHHTCHH
T ss_pred HHccCC---HhHCcCHHHHHcCcC
Confidence 999999 999999999999998
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-53 Score=454.68 Aligned_cols=251 Identities=26% Similarity=0.458 Sum_probs=225.2
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++.+.||+|+||+||+|++ +|+.||||++....... .+.+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 46799999999999999999986 58899999997654332 456889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
|||++|+|.+++.+ ..+++..++.|+.||+.||.|||++| ||||||||+||||+.+|++||+|||+++........
T Consensus 97 Ey~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999999999875 35999999999999999999999999 999999999999999999999999999977655445
Q ss_pred CCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-ccccCCCCcCcHHHHHHHHH
Q 002331 833 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~-~~r~~ip~~ls~~L~dLI~q 911 (935)
....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+... ......+..+++.+++||.+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 56678999999999999999999999999999999999999999998887776655432 23455678899999999999
Q ss_pred HHhhCCCCcCCCcCHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPSa~EILqHPF 934 (935)
||+.| |.+||+++|||+|||
T Consensus 253 ~L~~d---P~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 253 CLDMD---VEKRGSAKELLQHQF 272 (293)
T ss_dssp HTCSS---TTTSCCHHHHTTCGG
T ss_pred HccCC---hhHCcCHHHHhcCHh
Confidence 99999 999999999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-53 Score=452.74 Aligned_cols=252 Identities=28% Similarity=0.454 Sum_probs=222.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
+.|++++.||+|+||+||+|++ +++.||||++..... ...+.+.+|+++|++++|||||+++++|.+++.+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4689999999999999999987 578999999876532 234578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
||++|+|.+++.+....+++..+..|+.||+.||.|||++| ||||||||+||||+.++.+||+|||+++.........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 99999999998765567999999999999999999999999 9999999999999999999999999998665443334
Q ss_pred CCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-cccCCCCcCcHHHHH
Q 002331 834 KSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVAR 907 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~-~r~~ip~~ls~~L~d 907 (935)
....||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+..+++..+.... .....+..+++++++
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 5678999999999984 4567899999999999999999999999998888777665332 234456789999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
||.+||+.| |.+|||++|||+|||
T Consensus 248 li~~~L~~d---p~~R~t~~ell~hp~ 271 (288)
T d2jfla1 248 FLKKCLEKN---VDARWTTSQLLQHPF 271 (288)
T ss_dssp HHHHHSCSS---TTTSCCHHHHTTSGG
T ss_pred HHHHHccCC---hhHCcCHHHHhcCcc
Confidence 999999999 999999999999998
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=445.14 Aligned_cols=253 Identities=27% Similarity=0.335 Sum_probs=214.7
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++++.||+|+||+||+|++ +|+.||||++...... ...+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 36899999999999999999987 5889999999765432 23456889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC--c
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--F 830 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~--~ 830 (935)
|||++|+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+.++.+||+|||+++..... .
T Consensus 83 Ey~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999999763 57999999999999999999999999 999999999999999999999999999876432 2
Q ss_pred ccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhccccccCCCCcCcHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~e-il~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
......+||+.|+|||++.+..+ +.++|||||||++|||++|++||....... ....+............+++++.+|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 23345789999999999988776 678999999999999999999998765432 2223322223333346789999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||+.| |.+|||++|||+|||
T Consensus 240 i~~~L~~d---P~~R~t~~eil~hpw 262 (271)
T d1nvra_ 240 LHKILVEN---PSARITIPDIKKDRW 262 (271)
T ss_dssp HHHHSCSS---TTTSCCHHHHTTCTT
T ss_pred HHHHcCCC---hhHCcCHHHHhcCHh
Confidence 99999999 999999999999999
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-52 Score=441.04 Aligned_cols=251 Identities=31% Similarity=0.465 Sum_probs=219.0
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc----CCceEE
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSI 750 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~----~~~l~L 750 (935)
.|++.++||+|+||+||+|++ +++.||||++............+.+|+++|++++|||||+++++|.+ ...+||
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 357888999999999999987 47789999998877777777889999999999999999999999864 345899
Q ss_pred EEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec-CCCcEEEEeccccccccCC
Q 002331 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 751 VmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd-~~g~VKL~DFGlA~~~~~~ 829 (935)
|||||++|+|.+++.+. ..+++..++.|+.||+.||+|||+++++||||||||+||||+ +++.+||+|||+++.....
T Consensus 90 vmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999999763 478999999999999999999999887799999999999996 5899999999999865433
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccCCCCcCcHHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~-~~eil~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
.....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.. ..++...+.....+..++..+++++++|
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 245 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHH
Confidence 2345689999999999976 48999999999999999999999998754 4445555554445556777889999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||+.| |++|||++|||+|||
T Consensus 246 i~~~l~~d---p~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 246 IEGCIRQN---KDERYSIKDLLNHAF 268 (270)
T ss_dssp HHHHSCSS---GGGSCCHHHHHTSGG
T ss_pred HHHHccCC---HhHCcCHHHHhCCcc
Confidence 99999999 999999999999999
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=448.13 Aligned_cols=252 Identities=21% Similarity=0.364 Sum_probs=221.8
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
.++|++++.||+|+||+||+|++ +++.||||++..... .......+.+|+++|++++|||||+++++|.+++.+|||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 36899999999999999999987 588999999875432 122346788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC--
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-- 829 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~-- 829 (935)
||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 87 mEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999998763 47999999999999999999999999 999999999999999999999999999876432
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. .....+|..+++++++||
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLV 241 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--TTCCCCCTTCCHHHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH--cCCCCCCccCCHHHHHHH
Confidence 222345689999999999999999999999999999999999999999999988887774 345678889999999999
Q ss_pred HHHHhhCCCCcCCCcCHHH------HHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQ------LSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~E------ILqHPF 934 (935)
.+||+.| |.+|||++| |++|||
T Consensus 242 ~~~L~~d---P~~R~t~~e~~~~~~i~~Hpf 269 (288)
T d1uu3a_ 242 EKLLVLD---ATKRLGCEEMEGYGPLKAHPF 269 (288)
T ss_dssp HTTSCSS---GGGSTTSGGGTCHHHHHTSGG
T ss_pred HHHccCC---HhHCcCHHHHcCCHHHHcCCc
Confidence 9999999 999999987 578887
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=454.07 Aligned_cols=254 Identities=23% Similarity=0.397 Sum_probs=229.3
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
+..++|++++.||+|+||.||+|++ +|+.||||++.+.... ......+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 4568999999999999999999986 6889999999765321 223566889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
||||||++|+|.+++.+. ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+++.....
T Consensus 82 iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999999999764 46899999999999999999999999 999999999999999999999999999876554
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
.......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..++...+. .....+|..+++++++||
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli 236 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHHH
Confidence 445566789999999999999999999999999999999999999999999988887764 345778899999999999
Q ss_pred HHHHhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPS-----a~EILqHPF 934 (935)
.+||+.| |.+|++ +++|++|||
T Consensus 237 ~~~L~~d---P~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 237 AGLLKKD---PKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp HHHTCSS---TTTSTTCSTTTHHHHHTSGG
T ss_pred HhhccCC---chhhcccccccHHHHHcCcc
Confidence 9999999 999994 999999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=440.68 Aligned_cols=256 Identities=34% Similarity=0.579 Sum_probs=217.9
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
+|+|+.++|++++.||+|+||+||+|++++ .||||++..........+.|.+|+.+|++++|||||++++++.. +.++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 478899999999999999999999998765 59999998776666677889999999999999999999998754 5689
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
||||||++|+|.+++...+..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999999877778999999999999999999999998 999999999999999999999999999876432
Q ss_pred --cccCCCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc----ccCCCCc
Q 002331 830 --FLSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----RLEIPKE 900 (935)
Q Consensus 830 --~~~~~s~~GT~~Y~APEvl~g~---~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~----r~~ip~~ 900 (935)
........||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.+.......+..... ...++..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 1223456799999999999753 478999999999999999999999998776554433322221 2246678
Q ss_pred CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 901 LDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 901 ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+++.+.+||.+||+.| |.+|||+.+|+++
T Consensus 238 ~~~~l~~li~~cl~~d---p~~RPt~~~il~~ 266 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKK---RDERPLFPQILAS 266 (276)
T ss_dssp CCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCC---HhHCcCHHHHHHH
Confidence 9999999999999999 9999999999876
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.5e-51 Score=450.79 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=224.4
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++++.||+|+||+||+|++ +|+.||||++.... ....+.+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999987 58899999987653 344567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec--CCCcEEEEeccccccccCCc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd--~~g~VKL~DFGlA~~~~~~~ 830 (935)
|||++|+|.+++.+....+++..++.|+.||+.||.|||++| ||||||||+||||+ .++.+||+|||+++.....
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 999999999999776678999999999999999999999999 99999999999996 4688999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCcCcHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 908 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--~ip~~ls~~L~dL 908 (935)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..+....... .....+++++++|
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 22345689999999999999999999999999999999999999999999988888775433322 2335689999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||+.| |.+|||++|||+|||
T Consensus 260 i~~~L~~d---P~~R~t~~eil~hp~ 282 (350)
T d1koaa2 260 IRKLLLAD---PNTRMTIHQALEHPW 282 (350)
T ss_dssp HHHHCCSS---GGGSCCHHHHHHSTT
T ss_pred HHHHccCC---hhHCcCHHHHhcCcc
Confidence 99999999 999999999999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-51 Score=445.83 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=207.0
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.+.|++++.||+|+||+||+|++ +++.||||++....... ....+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 36799999999999999999987 58899999998665432 3456789999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec---CCCcEEEEeccccccccCC
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd---~~g~VKL~DFGlA~~~~~~ 829 (935)
|||++|+|.+++.+. ..+++..+..|+.||+.||+|||+++ ||||||||+|||+. +++.+||+|||+++.....
T Consensus 87 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 999999999999764 47999999999999999999999999 99999999999994 5789999999999876543
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCcCcHHHHH
Q 002331 830 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVAR 907 (935)
Q Consensus 830 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--~ip~~ls~~L~d 907 (935)
. .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..++...+....... ..+..+++++++
T Consensus 164 ~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 164 S-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred C-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence 2 2345689999999999999999999999999999999999999999999888877775444333 344679999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
||.+||+.| |.+|||++|+|+|||
T Consensus 243 li~~~L~~d---P~~R~s~~eil~hp~ 266 (307)
T d1a06a_ 243 FIRHLMEKD---PEKRFTCEQALQHPW 266 (307)
T ss_dssp HHHHHSCSS---GGGSCCHHHHHHSTT
T ss_pred HHHHHccCC---HhHCcCHHHHhcCHh
Confidence 999999999 999999999999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-52 Score=450.69 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=215.2
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
++.-++|++++.||+|+||+||+|++ +|+.||||++.... .......+.+|+.+|++++|||||+++++|.+++.+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45568899999999999999999987 58899999987653 3344567899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
||||||++|+|.+++.+. ..+++..++.++.||+.||.|||+ +| |+||||||+||||+.+|++||+|||+|+...+
T Consensus 81 iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999999999764 469999999999999999999997 58 99999999999999999999999999987654
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHh--------------------
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-------------------- 888 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I-------------------- 888 (935)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.....
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 3 234578999999999999999999999999999999999999999876543221100
Q ss_pred ---------------------hccccccCCC-CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 889 ---------------------GFQNRRLEIP-KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 889 ---------------------~~~~~r~~ip-~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.....++.++ ..++.++.+||.+||+.| |.+|||++|+|+|||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---P~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN---PAERADLKQLMVHAF 300 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSS---TTTSCCHHHHHTSHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCC---hhHCcCHHHHhhCHh
Confidence 0011112222 236789999999999999 999999999999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-51 Score=443.08 Aligned_cols=248 Identities=27% Similarity=0.391 Sum_probs=221.4
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
.|++++.||+|+||+||+|++ +++.||||++...... ......+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 599999999999999999986 5788999999876544 3456678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
||.+|+|..++.. ...+++..++.|+.||+.||.|||++| ||||||||+||||+.++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 9999998876654 357999999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 834 KSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
....||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+....+.....+...+..+++.+++||.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 34689999999999864 458899999999999999999999999999888877776555555556779999999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+||+.| |.+|||++|||+|||
T Consensus 249 ~~L~~d---P~~Rpt~~ell~Hp~ 269 (309)
T d1u5ra_ 249 SCLQKI---PQDRPTSEVLLKHRF 269 (309)
T ss_dssp HHTCSS---GGGSCCHHHHTTCHH
T ss_pred HHCcCC---hhHCcCHHHHHhCHH
Confidence 999999 999999999999998
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-50 Score=448.22 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=224.6
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
++|++++.||+|+||+||+|++ +|+.||||++.... ......+.+|+.+|++|+|||||+++++|.+++.+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5799999999999999999987 58899999987653 2345578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec--CCCcEEEEeccccccccCCcc
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd--~~g~VKL~DFGlA~~~~~~~~ 831 (935)
||++|+|.+++.+....+++..++.|+.||+.||.|||++| ||||||||+||||+ .++.+||+|||+++......
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 99999999998777778999999999999999999999999 99999999999997 67899999999998775432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cCCCCcCcHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDPLVARII 909 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r--~~ip~~ls~~L~dLI 909 (935)
......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+...... ...+..+++++++||
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 234467999999999999999999999999999999999999999999998888777543332 234467999999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+||+.| |.+|||++|||+|||
T Consensus 264 ~~~L~~d---p~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 264 KNLLQKE---PRKRLTVHDALEHPW 285 (352)
T ss_dssp HTTSCSS---GGGSCCHHHHHTSTT
T ss_pred HHHccCC---hhHCcCHHHHhcCHh
Confidence 9999999 999999999999998
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=435.90 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=222.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
++|++++.||+|+||+||+|++ +|+.||||++....... ...+.+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5799999999999999999987 58899999997654322 23567899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC----cEEEEecccccc
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRL 825 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g----~VKL~DFGlA~~ 825 (935)
||||||++|+|.+++.+. ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++ .+||+|||+++.
T Consensus 90 iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhh
Confidence 999999999999999764 47999999999999999999999999 99999999999998766 599999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCcCcH
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDP 903 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--~ip~~ls~ 903 (935)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+....... .++..+++
T Consensus 167 ~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 167 IDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp CTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 65442 3345689999999999999999999999999999999999999999999988887775433322 23467899
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+++||.+||+.| |.+||+++|||+|||
T Consensus 246 ~~~~li~~~L~~d---P~~R~s~~eil~hp~ 273 (293)
T d1jksa_ 246 LAKDFIRRLLVKD---PKKRMTIQDSLQHPW 273 (293)
T ss_dssp HHHHHHHTTSCSS---GGGSCCHHHHHHSTT
T ss_pred HHHHHHHHHccCC---hhHCcCHHHHhcCcc
Confidence 9999999999999 999999999999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=427.13 Aligned_cols=251 Identities=31% Similarity=0.518 Sum_probs=213.6
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
|+.++|++++.||+|+||+||+|++ +++.||||++....... +.|.+|++++++++|||||++++++..++.++||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 4557899999999999999999988 56789999987655443 4688999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+++|+|.+++......+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9999999999999877778999999999999999999999999 99999999999999999999999999987654322
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHH
Q 002331 832 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 909 (935)
Q Consensus 832 -~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI 909 (935)
......||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..++...+. ...+...|..+++++.+||
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHH
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHH
Confidence 2234578999999999999999999999999999999999 577777778777777664 4456677889999999999
Q ss_pred HHHHhhCCCCcCCCcCHHHHHhC
Q 002331 910 WECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 910 ~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.+||+.| |.+||++++|++|
T Consensus 236 ~~cl~~~---p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 236 NHCWKER---PEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHccCC---HhHCcCHHHHHHH
Confidence 9999999 9999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-50 Score=441.72 Aligned_cols=249 Identities=24% Similarity=0.420 Sum_probs=224.2
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
.++|++++.||+|+||+||+|++ +|+.||||++...... ......+.+|+.+|++++|||||++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 47899999999999999999987 5889999998754321 12356788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
||||++|+|..++... ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+++.....
T Consensus 83 mE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 9999999999988764 46888999999999999999999999 999999999999999999999999999877543
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~q 911 (935)
....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+.. ....+|..++++++++|.+
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~ 234 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLLSR 234 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHH
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHH
Confidence 2357899999999999999999999999999999999999999999999888887743 3556788899999999999
Q ss_pred HHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
||..| |.+|+ ++++|++|||
T Consensus 235 ~L~~d---p~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 235 LITRD---LSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp HTCSC---TTTCTTSSTTTTHHHHTSGG
T ss_pred HhhhC---HHhccccchhhHHHHHcCcc
Confidence 99999 99996 9999999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=439.98 Aligned_cols=258 Identities=29% Similarity=0.417 Sum_probs=222.2
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEECC-------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeec
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 740 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~g-------~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g 740 (935)
..|+++.++|++++.||+|+||+||+|++.+ ..||||++.... .......+.+|+.+|.++ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 3578888999999999999999999998632 269999886543 233455788999999998 8999999999
Q ss_pred ccccCCceEEEEeeCCCCCHHHHHcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEE
Q 002331 741 AVTRPPNLSIITEFLPRGSLFRILHRPH----------------------CQVDEKRRIKMALDVARGMNCLHTSTPTIV 798 (935)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~~~~----------------------~~lse~~il~Ia~QIa~AL~yLHs~g~~II 798 (935)
++.+.+.+|||||||++|+|.++|.... ..+++..++.|+.||+.||+|||+++ ||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--Ii 186 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 186 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 9999999999999999999999997543 24788999999999999999999998 99
Q ss_pred eeCCCCCCeeecCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 002331 799 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLP 875 (935)
Q Consensus 799 HrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~P 875 (935)
||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||+||||++ |.+|
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 999999999999999999999999987544322 2234567999999999999999999999999999999997 8999
Q ss_pred CCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 876 WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 876 F~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
|.+.+..+.+..+.....++.+|..+++++++||.+||+.| |.+|||++||++|
T Consensus 267 f~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~d---P~~RPt~~ei~~~ 320 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD---SRKRPSFPNLTSF 320 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCC---hhHCcCHHHHHHH
Confidence 99887766666665566778889999999999999999999 9999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-50 Score=432.04 Aligned_cols=254 Identities=34% Similarity=0.563 Sum_probs=221.7
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
.+|||..++|++.+.||+|+||+||+|++ +++.||||++...... .+.|.+|+.+|++++|||||+++++|.+++
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 35788899999999999999999999987 4788999998765433 456889999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 747 NLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~-~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
.++||||||++|+|.+++.+ ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999999864 4567899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCcc-cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCC-CCCChHHHHHHhhccccccCCCCcCcH
Q 002331 826 KHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW-IGMNPMQVVGAVGFQNRRLEIPKELDP 903 (935)
Q Consensus 826 ~~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF-~~~~~~eil~~I~~~~~r~~ip~~ls~ 903 (935)
...... ......|++.|+|||++.+..++.++|||||||++|||++|..|| .+.+..++...+ ....++.+|..+++
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~~~~~~~~~ 243 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPE 243 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCH
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCCCCCccchH
Confidence 654322 223345889999999999999999999999999999999976654 555655555444 35567788899999
Q ss_pred HHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 904 LVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.+.+||.+||+.| |.+|||+++|++
T Consensus 244 ~l~~li~~cl~~d---P~~Rps~~ei~~ 268 (287)
T d1opja_ 244 KVYELMRACWQWN---PSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCC---HhHCcCHHHHHH
Confidence 9999999999999 999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=425.78 Aligned_cols=253 Identities=31% Similarity=0.539 Sum_probs=221.1
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
.+|+|+.++|++++.||+|+||+||+|+++ ++.||||++...... .+.|.+|+.+|++++|||||++++++.+ +.
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence 467889999999999999999999999985 568999999765443 3468999999999999999999998765 56
Q ss_pred eEEEEeeCCCCCHHHHHcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~-~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
++|||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEc
Confidence 799999999999999886532 35899999999999999999999998 999999999999999999999999999877
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 827 HNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 827 ~~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG-~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
.... .......||+.|+|||++.+..++.++|||||||++|||+|| .+||...+..++...+. ...++..|..++++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHH
Confidence 5432 233456789999999999999999999999999999999995 55667777777776664 45667788999999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+.+||.+||+.| |.+|||+++|++
T Consensus 239 l~~li~~cl~~~---P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 239 LYQLMRLCWKER---PEDRPTFDYLRS 262 (272)
T ss_dssp HHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHcCCC---HhHCcCHHHHHH
Confidence 999999999999 999999999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-50 Score=431.21 Aligned_cols=254 Identities=31% Similarity=0.514 Sum_probs=213.8
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEEC--C---ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWN--G---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~--g---~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
++..++|++.++||+|+||+||+|++. + ..||||++.... .....+.|.+|+.+|++++|||||++++++.+++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 456688999999999999999999873 2 258888876543 4556678999999999999999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.++||||||++|+|.+++.+....+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999999999887778999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCcc-----cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCc
Q 002331 827 HNTFL-----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 900 (935)
Q Consensus 827 ~~~~~-----~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ 900 (935)
..... ......||+.|+|||++.+..++.++|||||||+||||++ |+.||.+....++...+. ...++..|..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~ 257 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMD 257 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcc
Confidence 53321 1122457899999999999999999999999999999998 899999999988887775 4556678889
Q ss_pred CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 901 LDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 901 ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+++.+.+||.+||+.| |.+||++.+|+++
T Consensus 258 ~~~~l~~li~~cl~~~---P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKD---RNHRPKFGQIVNT 286 (299)
T ss_dssp CCHHHHHHHHHHTCSS---TTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCC---HhHCcCHHHHHHH
Confidence 9999999999999999 9999999987753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=428.41 Aligned_cols=252 Identities=25% Similarity=0.449 Sum_probs=220.9
Q ss_pred CCCCCCeeEEEE-eeecCcEEEEEEEE----CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 672 EIPWEDLVLGER-IGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 672 ei~~edy~I~e~-LG~G~fG~Vyka~~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
-+..++|.+.+. ||+|+||+||+|.+ ++..||||++.... .....+.|.+|+++|++++|||||++++++.. +
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 355678889885 99999999999976 34479999987543 45567789999999999999999999999875 5
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+|||||||++|+|.+++...+..+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhcc
Confidence 689999999999999998776678999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCc
Q 002331 827 HNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902 (935)
Q Consensus 827 ~~~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls 902 (935)
.... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...++.+|..++
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~ 238 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECP 238 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCC
Confidence 4321 22234568999999999999999999999999999999998 899999998888877765 456778899999
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+++.+||.+||+.| |.+||++.+|++
T Consensus 239 ~~l~~li~~cl~~~---p~~RPs~~~i~~ 264 (285)
T d1u59a_ 239 PELYALMSDCWIYK---WEDRPDFLTVEQ 264 (285)
T ss_dssp HHHHHHHHHTTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCC---HhHCcCHHHHHH
Confidence 99999999999999 999999999843
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=421.40 Aligned_cols=250 Identities=30% Similarity=0.498 Sum_probs=225.8
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
+.++|++++.||+|+||+||+|+++ ++.||||++....... +.|.+|+.++++++|||||++++++.+++.+++||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 4578999999999999999999984 5689999998765543 46889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 831 (935)
||+++|+|.+++......+++..+++|+.||++||.|||++| |+||||||+||||+.++.+||+|||+++.......
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999999998776778999999999999999999999998 99999999999999999999999999986654322
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 910 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~ 910 (935)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...++..|..+++.+.+||.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHHHHHHHH
Confidence 2334678999999999999999999999999999999998 899999999998888775 45677889999999999999
Q ss_pred HHHhhCCCCcCCCcCHHHHHhC
Q 002331 911 ECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 911 qCL~~D~ssP~kRPSa~EILqH 932 (935)
+||+.| |.+|||+++||+|
T Consensus 236 ~cl~~d---P~~RPt~~eil~~ 254 (258)
T d1k2pa_ 236 SCWHEK---ADERPTFKILLSN 254 (258)
T ss_dssp HTTCSS---GGGSCCHHHHHHH
T ss_pred HHccCC---HhHCcCHHHHHHH
Confidence 999999 9999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=438.16 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=223.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHH-HcCCCceeeeecccccCCceEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMR-RLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~-~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
++|++++.||+|+||+||+|++ +++.||||++.+... .......+.+|+.++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999987 688999999975422 1122445566777665 68999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++++||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 9999999999999753 46899999999999999999999999 99999999999999999999999999987665545
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~q 911 (935)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. ...+.+|..+++++.+||.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--MDNPFYPRWLEKEAKDLLVK 236 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHHH
Confidence 5556789999999999999999999999999999999999999999999998888774 34567889999999999999
Q ss_pred HHhhCCCCcCCCcCHH-HHHhCcC
Q 002331 912 CWQTGWSSLHIRTSQA-QLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRPSa~-EILqHPF 934 (935)
||+.| |.+||++. +|++|||
T Consensus 237 ~L~~d---P~~R~s~~~~l~~hpf 257 (320)
T d1xjda_ 237 LFVRE---PEKRLGVRGDIRQHPL 257 (320)
T ss_dssp HSCSS---GGGSBTTBSCGGGSGG
T ss_pred hcccC---CCCCcCHHHHHHhCch
Confidence 99999 99999995 8999998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-50 Score=441.65 Aligned_cols=249 Identities=22% Similarity=0.394 Sum_probs=224.2
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCC-HHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 751 (935)
.++|++++.||+|+||+||+|++ +|+.||||++...... ......+.+|+.+|+.++|||||+++++|.+...+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 47899999999999999999987 5889999998754321 12345688999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 831 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 831 (935)
|||+.+|+|..++.+. ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|++||+|||+++.....
T Consensus 120 ~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 9999999999998764 46999999999999999999999999 999999999999999999999999999876543
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHHHHH
Q 002331 832 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 911 (935)
Q Consensus 832 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~q 911 (935)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+. ...+.+|..+++++.+||.+
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--SGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTCCHHHHHHHHH
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHHHHH
Confidence 235689999999999999999999999999999999999999999999888888774 34566788999999999999
Q ss_pred HHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 912 CWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 912 CL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
||+.| |.+|+ ++++|++|||
T Consensus 272 ~L~~d---P~kR~~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 272 LLQVD---LTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp HSCSC---TTTCTTSSTTTTHHHHTSGG
T ss_pred HhhhC---HHhccccccccHHHHHcCcc
Confidence 99999 99994 9999999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5e-49 Score=421.46 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=222.1
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH-------HHHHHHHHHHHHHHHcC-CCceeeeeccccc
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-------AALLEFKREVKIMRRLR-HPNVVLFMGAVTR 744 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~-------~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~ 744 (935)
.++|++++.||+|+||+||+|++ +++.||||++....... ...+.+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999987 68899999998754321 23446889999999996 9999999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
++.+|||||||++|+|.+++... ..+++..++.|+.||+.||+|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999999763 47999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC--
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLRN------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE-- 896 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~g------~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~-- 896 (935)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+........
T Consensus 159 ~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 776542 3445789999999999863 3468899999999999999999999999998887777654433332
Q ss_pred CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 897 IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 897 ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
....+++++++||.+||+.| |.+||+++|||+|||
T Consensus 238 ~~~~~s~~~~~li~~~L~~~---p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQ---PQKRYTAEEALAHPF 272 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSS---GGGSCCHHHHTTSGG
T ss_pred ccccCCHHHHHHHHHHccCC---hhHCcCHHHHHcCHH
Confidence 33579999999999999999 999999999999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=433.52 Aligned_cols=251 Identities=18% Similarity=0.302 Sum_probs=221.8
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
+++|++++.||+|+||+||+|.+ +++.||||++.... .....+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 47899999999999999999987 58899999997653 23446789999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC--CCcEEEEeccccccccCCc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTF 830 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~--~g~VKL~DFGlA~~~~~~~ 830 (935)
|||++|+|.+++.+.+..+++..++.|+.||+.||.|||++| |+||||||+||||+. .+.+||+|||+++......
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999999999876667999999999999999999999999 999999999999984 4589999999998765432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CCCCcCcHHHHHH
Q 002331 831 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 908 (935)
Q Consensus 831 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--~ip~~ls~~L~dL 908 (935)
......+|+.|+|||.+.+..++.++|||||||++|+|++|.+||.+.+..++...+......+ ..+..+++++++|
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 2344678999999999999999999999999999999999999999999988888775333222 1224689999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
|.+||..| |.+||+++|+|+|||
T Consensus 238 i~~~L~~d---p~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 238 VDRLLVKE---RKSRMTASEALQHPW 260 (321)
T ss_dssp HHTTSCSS---GGGSCCHHHHHHSHH
T ss_pred HHHHccCC---hhHCcCHHHHhcCHh
Confidence 99999999 999999999999998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=423.81 Aligned_cols=249 Identities=27% Similarity=0.442 Sum_probs=212.4
Q ss_pred eeEE-EEeeecCcEEEEEEEEC----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 678 LVLG-ERIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 678 y~I~-e~LG~G~fG~Vyka~~~----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
+.+. ++||+|+||+||+|.+. ++.||||++..........+.|.+|+.+|++++|||||++++++.. +.++|||
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvm 86 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM 86 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEE
Confidence 4443 46999999999999762 3579999997665555567789999999999999999999999865 4678999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCc--
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 830 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~-- 830 (935)
|||++|+|.+++.+. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++......
T Consensus 87 E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 87 EMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp ECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999999999999763 46999999999999999999999998 9999999999999999999999999998754321
Q ss_pred -ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHHH
Q 002331 831 -LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 908 (935)
Q Consensus 831 -~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dL 908 (935)
.......||+.|+|||++.+..++.++|||||||++|||++ |++||.+.+..++...+. ...++.+|..+++++.+|
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~l 242 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDL 242 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHH
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHH
Confidence 12234578999999999999999999999999999999998 899999999888877765 456778899999999999
Q ss_pred HHHHHhhCCCCcCCCcCHHHH---HhCcC
Q 002331 909 IWECWQTGWSSLHIRTSQAQL---SHKRF 934 (935)
Q Consensus 909 I~qCL~~D~ssP~kRPSa~EI---LqHPF 934 (935)
|.+||+.| |.+||++++| |+|+|
T Consensus 243 i~~cl~~d---p~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 243 MNLCWTYD---VENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHHTCSS---TTTSCCHHHHHHHHHHHH
T ss_pred HHHHcCCC---HhHCcCHHHHHHHhhCHH
Confidence 99999999 9999999998 46665
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=420.04 Aligned_cols=255 Identities=29% Similarity=0.479 Sum_probs=214.6
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~ 744 (935)
+|+|+.++|++++.||+|+||.||+|++. +..||||++... ........+.+|+.+|++++|||||++++++.+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 36788899999999999999999999863 245888887543 345566789999999999999999999999964
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
+.+||||||+++|+|.+++......+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhhe
Confidence 6789999999999999988776678999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCc
Q 002331 825 LKHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902 (935)
Q Consensus 825 ~~~~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls 902 (935)
...... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++...+. ...++.+|..++
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 235 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 235 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 764322 22344568999999999999999999999999999999998 899999999988887775 455667889999
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
+.+.+||.+||..| |.+|||+.+|++|
T Consensus 236 ~~~~~li~~cl~~d---p~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYD---PSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCC---HhHCcCHHHHHHH
Confidence 99999999999999 9999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=418.36 Aligned_cols=253 Identities=28% Similarity=0.495 Sum_probs=214.7
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEECC------ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~~g------~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~ 745 (935)
||..++|++.++||+|+||.||+|.+.+ ..||||++... ........|.+|+.+|++++|||||++++++.+.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 5777899999999999999999997632 36999998654 3445566789999999999999999999999999
Q ss_pred CceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 746 ~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
+.+++|||||.++++.+++......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999999988776678999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhccccccCCCCcC
Q 002331 826 KHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 901 (935)
Q Consensus 826 ~~~~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG-~~PF~~~~~~eil~~I~~~~~r~~ip~~l 901 (935)
..... .......||+.|+|||++.+..++.++|||||||++|||++| .+||...+..++...+. ...++..|..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~ 238 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 238 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchhh
Confidence 64432 122345689999999999999999999999999999999996 55566667777766654 55677788899
Q ss_pred cHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 902 DPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 902 s~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+..+.+||.+||+.| |.+||++.+|++
T Consensus 239 ~~~l~~li~~cl~~~---p~~RPt~~eil~ 265 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQE---RARRPKFADIVS 265 (283)
T ss_dssp BHHHHHHHHHHTCSS---TTTSCCHHHHHH
T ss_pred HHHHHHHHHHHCcCC---HhHCcCHHHHHH
Confidence 999999999999999 999999999876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.2e-49 Score=435.72 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=214.1
Q ss_pred CCCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 674 ~~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
..++|++++.||+|+||.||+|++ +|+.||||++....... ........|+.+++.++|||||+++++|.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 468999999999999999999987 58899999987543221 112222344666777789999999999999999
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+|||||||++|+|.+++.+. ..+++..++.|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||+++...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999999763 46899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH-hhccccccCCCCcCcHHH
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA-VGFQNRRLEIPKELDPLV 905 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~-g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~-I~~~~~r~~ip~~ls~~L 905 (935)
.. .....+||+.|+|||++. +..|+.++|||||||+||||++|+.||.+.+....... .........+|..+++++
T Consensus 159 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236 (364)
T ss_dssp SS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred CC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence 43 234568999999999986 46689999999999999999999999987654322221 112445667788999999
Q ss_pred HHHHHHHHhhCCCCcCCCcC-----HHHHHhCcC
Q 002331 906 ARIIWECWQTGWSSLHIRTS-----QAQLSHKRF 934 (935)
Q Consensus 906 ~dLI~qCL~~D~ssP~kRPS-----a~EILqHPF 934 (935)
++||.+||+.| |.+||+ +++|++|||
T Consensus 237 ~~li~~~L~~d---P~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 237 RSLLEGLLQRD---VNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp HHHHHHHTCSS---TTTSTTTSSSTHHHHHTSGG
T ss_pred HHHHHHHcccC---HHHhCCCcccCHHHHHcCcc
Confidence 99999999999 999999 799999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=422.05 Aligned_cols=249 Identities=23% Similarity=0.247 Sum_probs=208.2
Q ss_pred EEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH---HHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEee
Q 002331 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG---AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 680 I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~---~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
.+++||+|+||+||+|++ +|+.||||++....... .....+.+|+.+|++++|||||+++++|.+++.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 467899999999999986 58899999987554322 2234688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccCC
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 834 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 834 (935)
+.++++..++. ....+++..+..|+.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 98876666554 4567899999999999999999999999 99999999999999999999999999987766555556
Q ss_pred CCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------------------
Q 002331 835 STAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------------------ 895 (935)
Q Consensus 835 s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~------------------ 895 (935)
..+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..+......+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 6789999999999875 457999999999999999999999999988877766543111000
Q ss_pred ---C-----CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 ---E-----IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ---~-----ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. +...+++++.+||.+||+.| |.+|||++|+|+|||
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~d---P~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFN---PCARITATQALKMKY 282 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSS---TTTSCCHHHHHTSGG
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCC---hhhCcCHHHHhCCHh
Confidence 0 11356889999999999999 999999999999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=423.08 Aligned_cols=255 Identities=23% Similarity=0.289 Sum_probs=214.1
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|++++.||+|+||+||+|++ +++.||||++......+.....+.+|+++|++++|||||+++++|.+++.+|+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 36899999999999999999987 5889999999765544444567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
||+.++.+..+.......+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+++........
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 999765455444555667999999999999999999999999 999999999999999999999999999887665555
Q ss_pred CCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc----------------c
Q 002331 833 SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------------L 895 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r----------------~ 895 (935)
.....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+....+...... .
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 56678999999999987765 588999999999999999999999998877665543211000 0
Q ss_pred CC-----------CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 EI-----------PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ~i-----------p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.+ ...+++++++||.+||+.| |.+|||++|||+|||
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~d---P~~R~t~~ell~H~f 285 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYD---PNKRISAKAALAHPF 285 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSS---TTTSCCHHHHHTSGG
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCC---hhHCcCHHHHhCCHh
Confidence 00 1256789999999999999 999999999999998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=418.14 Aligned_cols=253 Identities=27% Similarity=0.367 Sum_probs=212.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC---CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc---CCCceeeeecccc-----c
Q 002331 676 EDLVLGERIGLGSYGEVYHADWN---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVT-----R 744 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~---g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L---~HPNIVkl~g~~~-----~ 744 (935)
++|++++.||+|+||+||+|++. ++.||||++......+.....+.+|+.+|+.| +|||||+++++|. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999872 56799999876543333333456777777665 7999999999984 3
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
...++++|||+.++.+..........+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 45689999999988777666666677999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc------------
Q 002331 825 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------ 892 (935)
Q Consensus 825 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~------------ 892 (935)
..... .......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+....
T Consensus 165 ~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 65543 23456789999999999999999999999999999999999999999998877666542110
Q ss_pred -------------cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 -------------RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 -------------~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
....++..+++.+++||.+||+.| |.+|||++|+|+|||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d---P~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN---PAKRISAYSALSHPY 295 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS---TTTSCCHHHHHTSGG
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCC---hhHCcCHHHHhcChh
Confidence 011234567899999999999999 999999999999998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-48 Score=415.06 Aligned_cols=254 Identities=22% Similarity=0.272 Sum_probs=213.6
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEEe
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 753 (935)
.++|++.++||+|+||+||+|++ +|+.||||++......+.....+.+|+.+|++++|||||+++++|.+++..+++||
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 37899999999999999999987 57899999997665444445678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcccC
Q 002331 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 833 (935)
Q Consensus 754 y~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 833 (935)
|+.++.+..+... ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||++..........
T Consensus 81 ~~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CCSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 9987666666544 467999999999999999999999998 9999999999999999999999999998876655555
Q ss_pred CCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------------------
Q 002331 834 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------------ 894 (935)
Q Consensus 834 ~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r------------------ 894 (935)
....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 566799999999998764 5689999999999999999999999998877665543210000
Q ss_pred ---------cCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 ---------LEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 ---------~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+...+++.+.+||++||+.| |++|||++|||+|||
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---P~~R~s~~ell~Hp~ 283 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLD---PNQRITAKQALEHAY 283 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSS---TTTSCCHHHHHTSGG
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCC---hhHCcCHHHHhcCcc
Confidence 1123567899999999999999 999999999999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=416.74 Aligned_cols=260 Identities=30% Similarity=0.473 Sum_probs=212.3
Q ss_pred cccccCCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeee
Q 002331 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (935)
Q Consensus 667 e~~~~ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl 738 (935)
+..+|+|+.++|+++++||+|+||.||+|++. ++.||||++.... .......+.+|..++.++ +|+|||.+
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 44567899999999999999999999999762 3579999986543 344456677888888877 78999999
Q ss_pred ecccccC-CceEEEEeeCCCCCHHHHHcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCC
Q 002331 739 MGAVTRP-PNLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDL 802 (935)
Q Consensus 739 ~g~~~~~-~~l~LVmEy~~gGsL~dlL~~~---------------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDL 802 (935)
++++... ..+++|||||++|+|.+++... ...+++..++.|+.||+.||.|||+++ ||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDl 160 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 160 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcC
Confidence 9987654 5689999999999999998642 235889999999999999999999999 999999
Q ss_pred CCCCeeecCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCC
Q 002331 803 KSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 879 (935)
Q Consensus 803 KPeNILLd~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG-~~PF~~~ 879 (935)
||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| .+||.+.
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998654332 223456799999999999999999999999999999999987 5688877
Q ss_pred ChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 880 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 880 ~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
...+..........++.+|..+++++.+||.+||+.| |.+|||++||++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d---P~~Rpt~~eil~~ 290 (299)
T d1ywna1 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE---PSQRPTFSELVEH 290 (299)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCC---hhHCcCHHHHHHH
Confidence 6555544444456677889999999999999999999 9999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=414.09 Aligned_cols=249 Identities=32% Similarity=0.570 Sum_probs=215.0
Q ss_pred cCCCCCCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc-CCceE
Q 002331 671 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLS 749 (935)
Q Consensus 671 ~ei~~edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~-~~~l~ 749 (935)
|+|..++|++++.||+|+||.||+|+++|+.||||+++... ..+.+.+|+++|++++|||||++++++.+ .+.+|
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 67888999999999999999999999999999999987543 33568899999999999999999998854 56789
Q ss_pred EEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|||||+++|+|.+++.+. ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999999653 235899999999999999999999998 99999999999999999999999999986543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
. .....++..|+|||++.+..++.++|||||||++|||++ |++||...+..++...+. ...++.+|..+++.+++
T Consensus 156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHH
T ss_pred C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHH
Confidence 3 234568899999999999999999999999999999998 799999998888888775 45677889999999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
||.+||..| |.+||++.+|+++
T Consensus 232 li~~cl~~d---P~~Rps~~~l~~~ 253 (262)
T d1byga_ 232 VMKNCWHLD---AAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHcccC---HhHCcCHHHHHHH
Confidence 999999999 9999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=414.79 Aligned_cols=253 Identities=32% Similarity=0.537 Sum_probs=213.4
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 747 (935)
.+|+|..++|++++.||+|+||+||+|+++ ++.||||++...... .+.|.+|+.+|++++|||||++++++.+ +.
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 85 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-CC
Confidence 356788899999999999999999999884 457999998765543 3568899999999999999999999865 56
Q ss_pred eEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
+++||||+++|+|..++... ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhc
Confidence 89999999999999988642 346899999999999999999999999 999999999999999999999999999876
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 827 HNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 827 ~~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG-~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
.... .......||+.|+|||++.+..++.++|||||||++|||++| .+||.+....+++..+. ...+..++..++++
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 242 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 242 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCHH
Confidence 5432 223345789999999999999999999999999999999996 55566677777776664 45566788999999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+++||.+||+.| |++||++++|++
T Consensus 243 l~~li~~cl~~d---P~~Rps~~~i~~ 266 (285)
T d1fmka3 243 LHDLMCQCWRKE---PEERPTFEYLQA 266 (285)
T ss_dssp HHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHcccC---HhHCcCHHHHHH
Confidence 999999999999 999999999876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=425.74 Aligned_cols=247 Identities=25% Similarity=0.388 Sum_probs=206.0
Q ss_pred CCCeeEE-EEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeeccccc----CC
Q 002331 675 WEDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----PP 746 (935)
Q Consensus 675 ~edy~I~-e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~----~~ 746 (935)
.++|.+. +.||+|+||+||+|++ +++.||||++... ..+.+|+.++.++ +|||||+++++|++ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 3678886 4699999999999986 5789999998643 2467899887655 89999999999865 46
Q ss_pred ceEEEEeeCCCCCHHHHHcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC---CCcEEEEeccc
Q 002331 747 NLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGL 822 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~-~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~---~g~VKL~DFGl 822 (935)
.+|||||||++|+|++++.+. ...+++..++.|+.||+.||.|||++| |+||||||+|||++. .+.+||+|||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccce
Confidence 689999999999999999764 356999999999999999999999999 999999999999975 56799999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc--cccccCCC--
Q 002331 823 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIP-- 898 (935)
Q Consensus 823 A~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~--~~~r~~ip-- 898 (935)
++...... .....+||+.|+|||++.+..|+.++|||||||+||+|++|++||.+.+.......+.. ......+|
T Consensus 161 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 161 AKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp CEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 98765542 34557899999999999999999999999999999999999999988765544433211 22222333
Q ss_pred --CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 899 --KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 899 --~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
..+++++++||.+||+.| |.+||++.|||+|||
T Consensus 240 ~~~~~s~~~~~li~~~L~~d---P~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTE---PTQRMTITEFMNHPW 274 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSS---TTTSCCHHHHHHSHH
T ss_pred ccccCCHHHHHHHHHHccCC---hhHCcCHHHHHcCHH
Confidence 358899999999999999 999999999999998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=416.71 Aligned_cols=250 Identities=27% Similarity=0.463 Sum_probs=213.7
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC--Cc----eEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceE
Q 002331 676 EDLVLGERIGLGSYGEVYHADWN--GT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~--g~----~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 749 (935)
++|+++++||+|+||+||+|.+. |+ +||||++.... .....+.|.+|+.+|++++|||||+++++|.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 57999999999999999999873 33 58888876432 223456789999999999999999999999864 578
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
++|||+.+++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+.++++||+|||+++.....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 889999999999988877778999999999999999999999998 999999999999999999999999999876543
Q ss_pred cc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCcHHHH
Q 002331 830 FL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 906 (935)
Q Consensus 830 ~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~L~ 906 (935)
.. ......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++...+. ...++..|..+++.+.
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~ 243 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVY 243 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBCHHHH
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHH
Confidence 22 2233468999999999999999999999999999999998 799999988877766554 4566778899999999
Q ss_pred HHHHHHHhhCCCCcCCCcCHHHHHhCc
Q 002331 907 RIIWECWQTGWSSLHIRTSQAQLSHKR 933 (935)
Q Consensus 907 dLI~qCL~~D~ssP~kRPSa~EILqHP 933 (935)
+||.+||+.| |.+||++.+|++|.
T Consensus 244 ~li~~cl~~d---P~~RPs~~eil~~l 267 (317)
T d1xkka_ 244 MIMVKCWMID---ADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHHTCSS---GGGSCCHHHHHHHH
T ss_pred HHHHHhCCCC---hhhCcCHHHHHHHH
Confidence 9999999999 99999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-47 Score=412.70 Aligned_cols=255 Identities=28% Similarity=0.448 Sum_probs=223.1
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~ 742 (935)
.+|++.++|++++.||+|+||+||+|++. ++.||||++.... .......|.+|+.+|++++||||+++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 46778899999999999999999999874 3679999987543 455667899999999999999999999999
Q ss_pred ccCCceEEEEeeCCCCCHHHHHcCC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEe
Q 002331 743 TRPPNLSIITEFLPRGSLFRILHRP-----------------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVH 799 (935)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~dlL~~~-----------------------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIH 799 (935)
...+.+++||||+++|+|.+++... ...+++..++.|+.||+.||+|||+++ |||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivH 163 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 163 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEe
Confidence 9999999999999999999998532 124788999999999999999999999 999
Q ss_pred eCCCCCCeeecCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCC-CCC
Q 002331 800 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPW 876 (935)
Q Consensus 800 rDLKPeNILLd~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~-~PF 876 (935)
|||||+||||+.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998654322 2233467889999999999999999999999999999999995 689
Q ss_pred CCCChHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 877 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 877 ~~~~~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.+.+..++...+. ...++.+|..+++++.+||.+||+.+ |.+|||+.||++
T Consensus 244 ~~~~~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~---P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKL---PADRPSFCSIHR 294 (301)
T ss_dssp TTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCC---hhHCcCHHHHHH
Confidence 9999998888775 44567788999999999999999999 999999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=414.75 Aligned_cols=243 Identities=20% Similarity=0.356 Sum_probs=208.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCH----HHHHHHHHHHHHHHHcC--CCceeeeecccccCCc
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLR--HPNVVLFMGAVTRPPN 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~iL~~L~--HPNIVkl~g~~~~~~~ 747 (935)
++|++++.||+|+||+||+|++ +|+.||||++....... .....+.+|+.+|++++ |||||+++++|.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999987 58899999987643321 11233568999999996 8999999999999999
Q ss_pred eEEEEeeCCC-CCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC-CCcEEEEecccccc
Q 002331 748 LSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRL 825 (935)
Q Consensus 748 l~LVmEy~~g-GsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~-~g~VKL~DFGlA~~ 825 (935)
+|+||||+.+ +++.+++.+. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+. ++.+||+|||+++.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccccee
Confidence 9999999976 5788887653 47999999999999999999999999 999999999999985 57999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCCCCcCcHH
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 904 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~~ip~~ls~~ 904 (935)
..... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+ ++. .....++..++++
T Consensus 161 ~~~~~--~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i~------~~~~~~~~~~s~~ 230 (273)
T d1xwsa_ 161 LKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EII------RGQVFFRQRVSSE 230 (273)
T ss_dssp CCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH------HCCCCCSSCCCHH
T ss_pred ccccc--ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--HHh------hcccCCCCCCCHH
Confidence 65432 345789999999999987765 678999999999999999999998643 221 2345677889999
Q ss_pred HHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 905 VARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 905 L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+++||.+||+.| |.+|||++|||+|||
T Consensus 231 ~~~li~~~L~~d---p~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 231 CQHLIRWCLALR---PSDRPTFEEIQNHPW 257 (273)
T ss_dssp HHHHHHHHTCSS---GGGSCCHHHHHTSGG
T ss_pred HHHHHHHHccCC---HhHCcCHHHHhcCHh
Confidence 999999999999 999999999999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=412.04 Aligned_cols=253 Identities=32% Similarity=0.510 Sum_probs=213.2
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEEC-----CceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCC
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~~-----g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~ 746 (935)
|..++|++.+.||+|+||+||+|+++ ...||||++..... .....+.|.+|+.+|++++|||||++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 55688999999999999999999762 23689998876543 33456789999999999999999999999976 4
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+++||||+++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhc
Confidence 678999999999999988765667999999999999999999999998 999999999999999999999999999976
Q ss_pred cCCcc---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCCCCcCc
Q 002331 827 HNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 902 (935)
Q Consensus 827 ~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~~eil~~I~~~~~r~~ip~~ls 902 (935)
..... ......|+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+.....+++.+..++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence 44321 2233457889999999999999999999999999999998 8999999999999888877777888889999
Q ss_pred HHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 903 PLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 903 ~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
+.+++||.+||+.| |.+|||+.+|++
T Consensus 242 ~~l~~li~~cl~~d---p~~RPt~~ei~~ 267 (273)
T d1u46a_ 242 QDIYNVMVQCWAHK---PEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCC---hhHCcCHHHHHH
Confidence 99999999999999 999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.9e-47 Score=404.97 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=208.8
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCC-CHHHHHHHHHHHHHHHHcCCCceeeeecccccCCc----e
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----L 748 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~----l 748 (935)
++|++.+.||+|+||+||+|++ +|+.||||++..... .......+.+|+.+|+.++|||||++++++...+. +
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 6799999999999999999986 588999999987654 34556779999999999999999999999876543 8
Q ss_pred EEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccC
Q 002331 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 828 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~ 828 (935)
|||||||++++|.+++... ..+++..++.|+.||+.||+|||++| ||||||||+||||+.++.++|+|||.+.....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhhcc
Confidence 9999999999999988663 47999999999999999999999999 99999999999999999999999999876533
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--cCCCCcCcH
Q 002331 829 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDP 903 (935)
Q Consensus 829 ~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r--~~ip~~ls~ 903 (935)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+...... ......+++
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 21 2334567999999999999999999999999999999999999999999888877665433322 234567899
Q ss_pred HHHHHHHHHHhhCCCCcCCCc-CHHHHHh
Q 002331 904 LVARIIWECWQTGWSSLHIRT-SQAQLSH 931 (935)
Q Consensus 904 ~L~dLI~qCL~~D~ssP~kRP-Sa~EILq 931 (935)
++.+||.+||+.| |.+|| +++++++
T Consensus 244 ~l~~li~~~L~~d---p~~R~~sa~~l~~ 269 (277)
T d1o6ya_ 244 DLDAVVLKALAKN---PENRYQTAAEMRA 269 (277)
T ss_dssp HHHHHHHHHTCSS---GGGSCSSHHHHHH
T ss_pred HHHHHHHHHccCC---HhHCHhHHHHHHH
Confidence 9999999999999 99999 6666653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=412.53 Aligned_cols=253 Identities=31% Similarity=0.571 Sum_probs=217.4
Q ss_pred CCCCCCeeEEEEeeecCcEEEEEEEE--CCc--eEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecccccCC
Q 002331 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (935)
Q Consensus 672 ei~~edy~I~e~LG~G~fG~Vyka~~--~g~--~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~~~~~~ 746 (935)
.|++++|+++++||+|+||+||+|++ ++. .||||++.... .....+.+.+|+++|.++ +|||||++++++.+.+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 36779999999999999999999977 344 47778775433 233456789999999999 7999999999999999
Q ss_pred ceEEEEeeCCCCCHHHHHcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC
Q 002331 747 NLSIITEFLPRGSLFRILHRP---------------HCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK 811 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~---------------~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~ 811 (935)
.++|||||+++|+|.++|++. ...+++..++.++.||+.||.|||+++ ||||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcC
Confidence 999999999999999999653 356899999999999999999999998 999999999999999
Q ss_pred CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCC-CCCCCCChHHHHHHhhc
Q 002331 812 NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGF 890 (935)
Q Consensus 812 ~g~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~-~PF~~~~~~eil~~I~~ 890 (935)
++.+||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|. +||.+.+..++...+.
T Consensus 163 ~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~- 240 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240 (309)
T ss_dssp GGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-
T ss_pred CCceEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence 999999999999865443 2234457899999999999999999999999999999999975 6798999888888775
Q ss_pred cccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 891 QNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 891 ~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
...++.+|..+++++.+||.+||+.| |++||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~d---P~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREK---PYERPSFAQILVS 279 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSS---GGGSCCHHHHHHH
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCC---hhHCcCHHHHHHH
Confidence 45677888999999999999999999 9999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-47 Score=407.07 Aligned_cols=256 Identities=30% Similarity=0.515 Sum_probs=221.2
Q ss_pred cccCCCCCCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeee
Q 002331 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (935)
Q Consensus 669 ~~~ei~~edy~I~e~LG~G~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl 738 (935)
.+|+|+.++|++++.||+|+||.||+|+.. +..||||++.... ......++.+|..++.++ +|||||++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 347889999999999999999999999752 2469999986543 455567788999999888 89999999
Q ss_pred ecccccCCceEEEEeeCCCCCHHHHHcCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCC
Q 002331 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLK 803 (935)
Q Consensus 739 ~g~~~~~~~l~LVmEy~~gGsL~dlL~~~~---------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLK 803 (935)
+++|.+++.+++|||||++|+|.++|.... ..+++..++.++.||+.||+|||+++ |||||||
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiK 162 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA 162 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeec
Confidence 999999999999999999999999996532 35899999999999999999999999 9999999
Q ss_pred CCCeeecCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 002331 804 SPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 880 (935)
Q Consensus 804 PeNILLd~~g~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~ 880 (935)
|+|||++.++.+||+|||+++....... ......|++.|+|||++.+..|+.++|||||||++|||++ |++||.+.+
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 9999999999999999999987654322 2344578999999999999999999999999999999998 799999998
Q ss_pred hHHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 881 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 881 ~~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
..++...+. ...++.+|..+++++.+||.+||+.| |.+|||+.||++
T Consensus 243 ~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~d---P~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAV---PSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCC---HhHCcCHHHHHH
Confidence 888777665 46778889999999999999999999 999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=406.91 Aligned_cols=256 Identities=28% Similarity=0.427 Sum_probs=224.1
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEE-------CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHc-CCCceeeeecc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L-~HPNIVkl~g~ 741 (935)
+|+++.++|+++++||+|+||.||+|++ .++.||||++.... .......+.+|+.+++.+ +|||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 5788899999999999999999999976 34579999987654 344566789999999999 79999999999
Q ss_pred cccCCceEEEEeeCCCCCHHHHHcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCC
Q 002331 742 VTRPPNLSIITEFLPRGSLFRILHRPH-----------------CQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKS 804 (935)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~dlL~~~~-----------------~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKP 804 (935)
+.+.+.++||||||++|+|.+++.+.. ..+++..++.|+.||+.||+|||+++ ||||||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp 173 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccc
Confidence 999999999999999999999986422 25889999999999999999999999 99999999
Q ss_pred CCeeecCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 002331 805 PNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 881 (935)
Q Consensus 805 eNILLd~~g~VKL~DFGlA~~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLT-G~~PF~~~~~ 881 (935)
+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||...+.
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998765432 22344678999999999999999999999999999999998 5667777776
Q ss_pred HHHHHHhhccccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 882 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 882 ~eil~~I~~~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
.+.+..+.....++..|..+++.+.+||.+||+.| |.+||++.+|++
T Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~d---P~~RPs~~~il~ 300 (311)
T d1t46a_ 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDAD---PLKRPTFKQIVQ 300 (311)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCC---hhHCcCHHHHHH
Confidence 66665555566778888899999999999999999 999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=395.17 Aligned_cols=254 Identities=21% Similarity=0.276 Sum_probs=217.8
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCCceEEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 752 (935)
.++|+++++||+|+||+||+|++ +++.||||+++...........+.+|+.+|+.++|||||+++++|.+...+++||
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 36899999999999999999987 6788999999877666667788999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCccc
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 832 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 832 (935)
|++.+++|..++.. ...+++..++.++.|++.||+|||+++ ||||||||+||||+.++.+||+|||.++........
T Consensus 81 ~~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 99999988888765 457899999999999999999999999 999999999999999999999999999987665445
Q ss_pred CCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhcc-------------------
Q 002331 833 SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQ------------------- 891 (935)
Q Consensus 833 ~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~-~~~~eil~~I~~~------------------- 891 (935)
.....+++.|+|||++.+.. ++.++|||||||++|||++|+.||.. .+..+....+...
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 55567888999999987665 68999999999999999999988654 4444444433110
Q ss_pred --------ccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 892 --------NRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 892 --------~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.........+++.+.+||.+||+.| |.+|||++|||+|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~d---P~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCN---PVQRISAEEALQHPY 285 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSS---GGGSCCHHHHTTSGG
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCC---hhHCcCHHHHhcChh
Confidence 0111233567889999999999999 999999999999998
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=405.88 Aligned_cols=255 Identities=31% Similarity=0.509 Sum_probs=225.9
Q ss_pred ccCCCCCCeeEEEEeeecCcEEEEEEEEC-------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccc
Q 002331 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (935)
Q Consensus 670 ~~ei~~edy~I~e~LG~G~fG~Vyka~~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~ 742 (935)
+|+|++++|++++.||+|+||+||+|.+. ++.||||++.... .......|.+|+.++++++|||||++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 57899999999999999999999999764 4689999987543 445666789999999999999999999999
Q ss_pred ccCCceEEEEeeCCCCCHHHHHcC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC
Q 002331 743 TRPPNLSIITEFLPRGSLFRILHR---------PHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 813 (935)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~dlL~~---------~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g 813 (935)
..++.+++||||+++|+|.+++.. ....+++..++.|+.||+.||.|||.++ |+||||||+||||+.++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCc
Confidence 999999999999999999998853 1234688999999999999999999998 99999999999999999
Q ss_pred cEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhc
Q 002331 814 NVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 890 (935)
Q Consensus 814 ~VKL~DFGlA~~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG-~~PF~~~~~~eil~~I~~ 890 (935)
++||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..++...+.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~- 249 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM- 249 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 999999999987654322 23345689999999999999999999999999999999998 58899999988887765
Q ss_pred cccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 891 QNRRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 891 ~~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
...++.+|..+++.+.+||.+||+.+ |.+||++.+|++
T Consensus 250 ~~~~~~~p~~~~~~l~~li~~cl~~~---P~~RPs~~~il~ 287 (308)
T d1p4oa_ 250 EGGLLDKPDNCPDMLFELMRMCWQYN---PKMRPSFLEIIS 287 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSS---GGGSCCHHHHHH
T ss_pred hCCCCCCcccchHHHHHHHHHHcCCC---hhHCcCHHHHHH
Confidence 45567788999999999999999999 999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=408.03 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=208.9
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC------
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~------ 746 (935)
.++|++++.||+|+||+||+|.+ +|+.||||++......+.....+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 47899999999999999999987 5889999999877666677788999999999999999999999987654
Q ss_pred ceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccc
Q 002331 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 826 (935)
Q Consensus 747 ~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~ 826 (935)
.+||||||+ +.+|..+++. ..+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+++..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceecc
Confidence 479999999 5688888765 46999999999999999999999999 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-------------
Q 002331 827 HNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------- 892 (935)
Q Consensus 827 ~~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~------------- 892 (935)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..+....
T Consensus 172 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 172 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred CCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 543 2456799999999998764 56899999999999999999999999887665543321100
Q ss_pred ----------------cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 893 ----------------RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 893 ----------------~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
....+...+++++.+||.+||..| |.+|||++|||+|||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d---P~~R~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD---AEQRVTAGEALAHPY 303 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSS---TTTSCCHHHHHHSGG
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCC---hhHCcCHHHHhcChh
Confidence 011234567899999999999999 999999999999998
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=397.95 Aligned_cols=254 Identities=22% Similarity=0.278 Sum_probs=206.0
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc--------
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-------- 744 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~-------- 744 (935)
.++|+++++||+|+||+||+|++ +|+.||||++......+.....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999987 58899999987665555455678899999999999999999998754
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
.+.+|+||||+.++.+.. +......+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecceee
Confidence 456899999998765554 4444567899999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCc----ccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--CC
Q 002331 825 LKHNTF----LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EI 897 (935)
Q Consensus 825 ~~~~~~----~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~--~i 897 (935)
...... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+....... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 654321 223345799999999998765 68999999999999999999999999888776655442111110 00
Q ss_pred -------------------C---------CcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 898 -------------------P---------KELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 898 -------------------p---------~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
+ ...++++.+||.+||+.| |++|||++|||+|||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~d---P~~R~sa~elL~Hpf 307 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD---PAQRIDSDDALNHDF 307 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSS---TTTSCCHHHHHHSGG
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCC---hhHCcCHHHHHcChh
Confidence 0 013667889999999999 999999999999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=398.34 Aligned_cols=247 Identities=30% Similarity=0.480 Sum_probs=209.8
Q ss_pred eEEEEeeecCcEEEEEEEECC-----ceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc-CCceEEEE
Q 002331 679 VLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIIT 752 (935)
Q Consensus 679 ~I~e~LG~G~fG~Vyka~~~g-----~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~-~~~l~LVm 752 (935)
.+.++||+|+||+||+|++.. ..||||++... ........|.+|+++|++++|||||++++++.. +..+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 447899999999999998722 25899998643 345667889999999999999999999999765 56789999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCCcc-
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 831 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 831 (935)
|||++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999999999887778889999999999999999999998 99999999999999999999999999987654321
Q ss_pred ---cCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhccccccCCCCcCcHHHHH
Q 002331 832 ---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVAR 907 (935)
Q Consensus 832 ---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~-~~~eil~~I~~~~~r~~ip~~ls~~L~d 907 (935)
......||+.|+|||.+.+..++.++|||||||++|||++|..||... +..++...+. ...++..|..+++.+.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTTCCHHHHH
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCcccCcHHHHH
Confidence 223356899999999999999999999999999999999987776653 4444444443 45677788999999999
Q ss_pred HHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 908 IIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 908 LI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
||.+||+.| |.+||++.||++|
T Consensus 266 li~~cl~~d---P~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 266 VMLKCWHPK---AEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHTCSS---GGGSCCHHHHHHH
T ss_pred HHHHHcCCC---HhHCcCHHHHHHH
Confidence 999999999 9999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=402.11 Aligned_cols=246 Identities=23% Similarity=0.269 Sum_probs=202.3
Q ss_pred CeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc------CCce
Q 002331 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PPNL 748 (935)
Q Consensus 677 dy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~------~~~l 748 (935)
+|+.+++||+|+||+||+|++ +|+.||||++..... .+.+|+.+|++++|||||+++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 689999999999999999987 588999999976532 12479999999999999999999843 3347
Q ss_pred EEEEeeCCCCCHHHHHc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCC-cEEEEecccccc
Q 002331 749 SIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRL 825 (935)
Q Consensus 749 ~LVmEy~~gGsL~dlL~--~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g-~VKL~DFGlA~~ 825 (935)
|||||||+++.+..+.. +....+++..++.|+.||+.||+|||++| ||||||||+||||+.++ .+||+|||+++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhh
Confidence 89999998754443332 23457999999999999999999999999 99999999999999775 899999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc-------------
Q 002331 826 KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------- 891 (935)
Q Consensus 826 ~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~------------- 891 (935)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||...+..+.+..+...
T Consensus 173 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 173 LVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 6543 23345689999999998875 46899999999999999999999999988776655443210
Q ss_pred --cccc------------CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 892 --NRRL------------EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 892 --~~r~------------~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.... .....+++++.+||.+||+.| |.+|||+.|+|+|||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~d---P~~R~ta~e~L~Hp~ 305 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT---PTARLTPLEACAHSF 305 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSS---GGGSCCHHHHHTSGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCC---hhHCcCHHHHhcCHh
Confidence 0000 112457899999999999999 999999999999998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=400.48 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=204.9
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC----ceE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NLS 749 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~----~l~ 749 (935)
++|+++++||+|+||+||+|.+ +|+.||||++.... .....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4699999999999999999987 58899999987544 3455667889999999999999999999986543 234
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccccccCC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~~~ 829 (935)
++++|+.+|+|.+++... .+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 555667789999999753 5899999999999999999999999 999999999999999999999999999865432
Q ss_pred c---ccCCCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----------
Q 002331 830 F---LSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------- 894 (935)
Q Consensus 830 ~---~~~~s~~GT~~Y~APEvl~-g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r----------- 894 (935)
. ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+.+..............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 2 1234567999999999985 456789999999999999999999999987765544332110000
Q ss_pred -------------c-----CCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 -------------L-----EIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 -------------~-----~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. .+...+++++.+||.+||+.| |.+||+++++|+|||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d---P~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN---PHKRIEVEQALAHPY 297 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSS---TTTSCCHHHHHTSGG
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCC---hhHCcCHHHHhcCHh
Confidence 0 122457789999999999999 999999999999998
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-44 Score=392.48 Aligned_cols=245 Identities=19% Similarity=0.297 Sum_probs=202.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeeccccc--CCceE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTR--PPNLS 749 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~--~~~l~ 749 (935)
.++|+++++||+|+||+||+|++ +++.||||++.... ...+.+|+.+|+.+. ||||++++++|.. ...++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 36899999999999999999987 58899999986543 346789999999995 9999999999874 45699
Q ss_pred EEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCC-CcEEEEeccccccccC
Q 002331 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHN 828 (935)
Q Consensus 750 LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~-g~VKL~DFGlA~~~~~ 828 (935)
+|||||.+++|..+. ..+++..++.++.||+.||.|||++| ||||||||+||||+.+ +.+||+|||+++....
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999999998764 35899999999999999999999999 9999999999999865 4699999999987654
Q ss_pred CcccCCCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhc---------------c
Q 002331 829 TFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGF---------------Q 891 (935)
Q Consensus 829 ~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~e-il~~I~~---------------~ 891 (935)
. .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ....+.. .
T Consensus 183 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 G-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp T-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 3 234556799999999998765 47999999999999999999999998654321 1111100 0
Q ss_pred c--------------------cccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 892 N--------------------RRLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 892 ~--------------------~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. ........+++++.+||++||+.| |.+|||++|||+|||
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d---P~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD---HQSRLTAREAMEHPY 321 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSS---GGGSCCHHHHHTSGG
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCC---hhHCcCHHHHhcCcc
Confidence 0 000112347889999999999999 999999999999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=398.39 Aligned_cols=250 Identities=24% Similarity=0.311 Sum_probs=209.4
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccC-----Cc
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PN 747 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~-----~~ 747 (935)
.++|+++++||+|+||+||+|++ +|+.||||++............+.+|+++|++++|||||+++++|... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 37899999999999999999986 589999999987766666777889999999999999999999998533 33
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
.+++|+|+.+|+|.+++.. ..+++..++.|+.||+.||+|||++| |+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccC
Confidence 4667778889999999965 36999999999999999999999999 9999999999999999999999999997654
Q ss_pred CCcccCCCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-----------
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----------- 895 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r~----------- 895 (935)
.. .....|++.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......+.......
T Consensus 173 ~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 173 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp GG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred cc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 33 34567899999999877654 6899999999999999999999999887766555442111110
Q ss_pred ----------C--------CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 896 ----------E--------IPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 896 ----------~--------ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
. ....+++++++||.+||+.| |.+|||++|||+|||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d---P~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD---SDKRITAAQALAHAY 303 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSS---GGGSCCHHHHHTSGG
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCC---hhhCcCHHHHhcCHh
Confidence 0 11357899999999999999 999999999999998
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=399.60 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=200.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeeccccc------CCc
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PPN 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~------~~~ 747 (935)
++|+++++||+|+||+||+|.+ +|+.||||++............+.+|+.+|++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999987 58999999998877667777789999999999999999999999853 367
Q ss_pred eEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEecccccccc
Q 002331 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 827 (935)
Q Consensus 748 l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~~~ 827 (935)
+|+|||||.++ +.+.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhccc
Confidence 89999999765 555553 35899999999999999999999999 9999999999999999999999999988765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-------------
Q 002331 828 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------- 894 (935)
Q Consensus 828 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~~~~~r------------- 894 (935)
.. .......+|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+......
T Consensus 171 ~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 171 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred cc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 43 2334567999999999999999999999999999999999999999988766554433110000
Q ss_pred -------cC---------C-----------CCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhCcC
Q 002331 895 -------LE---------I-----------PKELDPLVARIIWECWQTGWSSLHIRTSQAQLSHKRF 934 (935)
Q Consensus 895 -------~~---------i-----------p~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqHPF 934 (935)
.. + +...++++.+||.+||..| |++|||++|||+|||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~d---P~~R~ta~elL~Hpw 313 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID---PAKRISVDDALQHPY 313 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSS---TTTSCCHHHHHTSTT
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCC---hhHCcCHHHHhcCcc
Confidence 00 0 0124677899999999999 999999999999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=403.43 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=214.4
Q ss_pred CCCCCeeEEEEeeecCcEEEEEEEE-----CCceEEEEEeeccCC--CHHHHHHHHHHHHHHHHcCC-Cceeeeeccccc
Q 002331 673 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRH-PNVVLFMGAVTR 744 (935)
Q Consensus 673 i~~edy~I~e~LG~G~fG~Vyka~~-----~g~~VAVK~i~~~~~--~~~~~~~f~~Ei~iL~~L~H-PNIVkl~g~~~~ 744 (935)
+..++|++++.||+|+||+||+|++ +|+.||||++..... .....+.+.+|+++|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 3458899999999999999999975 467899999865432 11224457789999999966 899999999999
Q ss_pred CCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 745 ~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
...+++||||+.+|+|.+++... ..+.+..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999999999764 35788899999999999999999999 9999999999999999999999999998
Q ss_pred cccCC-cccCCCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh--ccccccCCCC
Q 002331 825 LKHNT-FLSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPK 899 (935)
Q Consensus 825 ~~~~~-~~~~~s~~GT~~Y~APEvl~g~--~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~--~~~~r~~ip~ 899 (935)
..... ........|++.|++||.+.+. .++.++|||||||+||+|++|+.||.+.+..+....+. .....+.+|.
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 65432 2234456799999999999764 46889999999999999999999998765433322221 1234566788
Q ss_pred cCcHHHHHHHHHHHhhCCCCcCCCc-----CHHHHHhCcC
Q 002331 900 ELDPLVARIIWECWQTGWSSLHIRT-----SQAQLSHKRF 934 (935)
Q Consensus 900 ~ls~~L~dLI~qCL~~D~ssP~kRP-----Sa~EILqHPF 934 (935)
.+++++.+||.+||..| |.+|| +++|+++|||
T Consensus 258 ~~s~~~~~li~~~l~~d---P~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKD---PKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp TSCHHHHHHHHHHTCSS---GGGSTTSSTTTHHHHHTSGG
T ss_pred cCCHHHHHHHHHHcccC---HHHcCCCCcccHHHHHcCHh
Confidence 89999999999999999 99999 5899999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=386.72 Aligned_cols=249 Identities=33% Similarity=0.523 Sum_probs=197.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCceeeeecccccCC----ceEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NLSII 751 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNIVkl~g~~~~~~----~l~LV 751 (935)
++|.+.+.||+|+||.||+|+++|+.||||++.... .....++.|+..+.+++|||||++++++.+.+ .+|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 468999999999999999999999999999986542 22222344555566789999999999987654 48999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~------g~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
||||++|+|.+++++. .+++..++.++.|++.||.|||.. ..+||||||||+||||+.++.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999999863 589999999999999999999974 12499999999999999999999999999987
Q ss_pred ccCCc----ccCCCCCCCCCccCcccccCCC------CCchhHHHHHHHHHHHHHcCCCCCCCC---------------C
Q 002331 826 KHNTF----LSSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATLKLPWIGM---------------N 880 (935)
Q Consensus 826 ~~~~~----~~~~s~~GT~~Y~APEvl~g~~------~s~ksDIWSLG~ILyELLTG~~PF~~~---------------~ 880 (935)
..... .......||+.|+|||++.+.. ++.++|||||||+||||++|..||... .
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 64322 1233467999999999987653 567899999999999999998876431 2
Q ss_pred hHHHHHHhhccccccCCCCc-----CcHHHHHHHHHHHhhCCCCcCCCcCHHHHHhC
Q 002331 881 PMQVVGAVGFQNRRLEIPKE-----LDPLVARIIWECWQTGWSSLHIRTSQAQLSHK 932 (935)
Q Consensus 881 ~~eil~~I~~~~~r~~ip~~-----ls~~L~dLI~qCL~~D~ssP~kRPSa~EILqH 932 (935)
.......+.....++.++.. ....+.+||.+||+.| |.+|||+.||+++
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~d---p~~Rps~~ei~~~ 291 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN---GAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSS---GGGSCCHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccC---HhHCcCHHHHHHH
Confidence 23333333333444555443 3356999999999999 9999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-43 Score=375.56 Aligned_cols=249 Identities=20% Similarity=0.251 Sum_probs=199.1
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCc-eeeeecccccCCceEEEE
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSIIT 752 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPN-IVkl~g~~~~~~~l~LVm 752 (935)
++|++++.||+|+||.||+|++ +|+.||||++...... ..+.+|+++++.++|+| |+.+.+++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 5799999999999999999987 5889999988765322 24678999999997765 555566667778899999
Q ss_pred eeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeec---CCCcEEEEeccccccccCC
Q 002331 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNT 829 (935)
Q Consensus 753 Ey~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd---~~g~VKL~DFGlA~~~~~~ 829 (935)
||+ +++|.+.+......+++..++.++.||+.||+|||++| ||||||||+|||++ .+..+||+|||+++...+.
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 999 45777776655668999999999999999999999999 99999999999986 4567999999999876543
Q ss_pred c-------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh---c---cccccC
Q 002331 830 F-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG---F---QNRRLE 896 (935)
Q Consensus 830 ~-------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~eil~~I~---~---~~~r~~ 896 (935)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. . ......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 2 12345679999999999999999999999999999999999999998866544332211 0 111223
Q ss_pred CCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHH---HhCcC
Q 002331 897 IPKELDPLVARIIWECWQTGWSSLHIRTSQAQL---SHKRF 934 (935)
Q Consensus 897 ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EI---LqHPF 934 (935)
++..+++++.+||.+||+.+ |.+||++.+| |+|+|
T Consensus 240 ~~~~~p~~~~~li~~cl~~~---p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLR---FDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSC---TTCCCCHHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCC---hhHCcCHHHHHHHHHHHH
Confidence 45678999999999999999 9999998754 56554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-42 Score=370.75 Aligned_cols=247 Identities=18% Similarity=0.242 Sum_probs=206.3
Q ss_pred CCCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCC-CceeeeecccccCCceEEE
Q 002331 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSII 751 (935)
Q Consensus 675 ~edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~H-PNIVkl~g~~~~~~~l~LV 751 (935)
.++|+++++||+|+||+||+|++ +|+.||||++...... ..+.+|+++++.|.| +||+.+++++......++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 46899999999999999999986 5889999988654322 246688999999965 9999999999999999999
Q ss_pred EeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecC-----CCcEEEEeccccccc
Q 002331 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLSRLK 826 (935)
Q Consensus 752 mEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~-----~g~VKL~DFGlA~~~ 826 (935)
|||+ +++|.+++......+++..+..++.|++.||+|||++| ||||||||+||||+. .+.+||+|||+++..
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9999 67999999876778999999999999999999999999 999999999999964 578999999999876
Q ss_pred cCCc-------ccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhccc---c
Q 002331 827 HNTF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQN---R 893 (935)
Q Consensus 827 ~~~~-------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~---~eil~~I~~~~---~ 893 (935)
.+.. ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+... ......+.... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 4321 123456799999999999999999999999999999999999999986533 23333322111 1
Q ss_pred ccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcCHHHHHh
Q 002331 894 RLEIPKELDPLVARIIWECWQTGWSSLHIRTSQAQLSH 931 (935)
Q Consensus 894 r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPSa~EILq 931 (935)
...++..+|+++.++|..||..+ |.+||+++.|.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~---~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLA---FDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCC---TTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCC---cccCcCHHHHHH
Confidence 22345678999999999999999 999999877654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-39 Score=354.07 Aligned_cols=248 Identities=18% Similarity=0.282 Sum_probs=191.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEE--CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-----------CCceeeeeccc
Q 002331 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----------HPNVVLFMGAV 742 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-----------HPNIVkl~g~~ 742 (935)
.+|+++++||+|+||+||+|++ +|+.||||+++... .....+.+|+++++.++ |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999987 68999999987543 33456778888888775 57899999887
Q ss_pred ccC--CceEEEEeeCCCCCHHH--HHcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCEEeeCCCCCCeeecCCC----
Q 002331 743 TRP--PNLSIITEFLPRGSLFR--ILHRPHCQVDEKRRIKMALDVARGMNCLHT-STPTIVHRDLKSPNLLVDKNW---- 813 (935)
Q Consensus 743 ~~~--~~l~LVmEy~~gGsL~d--lL~~~~~~lse~~il~Ia~QIa~AL~yLHs-~g~~IIHrDLKPeNILLd~~g---- 813 (935)
... ...+++|+++..+.... ........+++..++.++.||+.||.|||+ +| |+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence 543 45667777765543322 233445678999999999999999999997 77 99999999999998654
Q ss_pred --cEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChH------HHH
Q 002331 814 --NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM------QVV 885 (935)
Q Consensus 814 --~VKL~DFGlA~~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG~ILyELLTG~~PF~~~~~~------eil 885 (935)
.+||+|||.+...... ....+||+.|+|||++.+..++.++|||||||++++|++|+.||...+.. ...
T Consensus 168 ~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 4999999999865433 34567999999999999999999999999999999999999999764321 111
Q ss_pred HH-hhcc---------------------------------------ccccCCCCcCcHHHHHHHHHHHhhCCCCcCCCcC
Q 002331 886 GA-VGFQ---------------------------------------NRRLEIPKELDPLVARIIWECWQTGWSSLHIRTS 925 (935)
Q Consensus 886 ~~-I~~~---------------------------------------~~r~~ip~~ls~~L~dLI~qCL~~D~ssP~kRPS 925 (935)
.. +... .....++...++.+.+||.+||..| |.+|||
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d---P~~Rpt 321 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD---PRKRAD 321 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS---TTTCBC
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC---hhHCcC
Confidence 00 0000 0011122345678999999999999 999999
Q ss_pred HHHHHhCcC
Q 002331 926 QAQLSHKRF 934 (935)
Q Consensus 926 a~EILqHPF 934 (935)
++|+|+|||
T Consensus 322 a~e~L~Hp~ 330 (362)
T d1q8ya_ 322 AGGLVNHPW 330 (362)
T ss_dssp HHHHHTCGG
T ss_pred HHHHhcCcc
Confidence 999999998
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=5.7e-23 Score=205.47 Aligned_cols=165 Identities=18% Similarity=0.133 Sum_probs=120.5
Q ss_pred eeEEEEeeecCcEEEEEEEE-CCceEEEEEeeccCCC----------------HHHHHHHHHHHHHHHHcCCCceeeeec
Q 002331 678 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFS----------------GAALLEFKREVKIMRRLRHPNVVLFMG 740 (935)
Q Consensus 678 y~I~e~LG~G~fG~Vyka~~-~g~~VAVK~i~~~~~~----------------~~~~~~f~~Ei~iL~~L~HPNIVkl~g 740 (935)
+.++++||+|+||+||+|++ +|+.||||+++..... ......+.+|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45899999999999999976 7899999987532110 112234567889999999999998886
Q ss_pred ccccCCceEEEEeeCCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCEEeeCCCCCCeeecCCCcEEEEec
Q 002331 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 820 (935)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~~IIHrDLKPeNILLd~~g~VKL~DF 820 (935)
+.. .+++|||+++..+.+ +++.....++.||+.+|.|||++| |+||||||+||||+++ .++|+||
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECCC
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEEC
Confidence 542 379999998865543 333445678899999999999999 9999999999999865 5899999
Q ss_pred cccccccCCcccCCCCCCCCCccCc------ccccCCCCCchhHHHHHHHHH
Q 002331 821 GLSRLKHNTFLSSKSTAGTPEWMAP------EVLRNEPSNEKCDVYSFGVIL 866 (935)
Q Consensus 821 GlA~~~~~~~~~~~s~~GT~~Y~AP------Evl~g~~~s~ksDIWSLG~IL 866 (935)
|+++....+.. ..|... +. ..+.|..++|+||+.--+
T Consensus 147 G~a~~~~~~~~--------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGW--------REILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTH--------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCc--------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 99976543211 112211 11 135577889999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.44 E-value=1.9e-07 Score=94.63 Aligned_cols=141 Identities=15% Similarity=0.025 Sum_probs=97.2
Q ss_pred CCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeecccccCCceEEEEee
Q 002331 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEF 754 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LVmEy 754 (935)
+.|++.+..+-++...||+....+..++||+....... ....+.+|..++..+. +--+.+++.++..++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 45666666555556789999888888999987544221 1224567888888773 43356777777788889999999
Q ss_pred CCCCCHHHHHcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 002331 755 LPRGSLFRILHRPHCQVDEKRRIKMALDVARGMNCLHTSTP--------------------------------------- 795 (935)
Q Consensus 755 ~~gGsL~dlL~~~~~~lse~~il~Ia~QIa~AL~yLHs~g~--------------------------------------- 795 (935)
++|..+.+..... .. ...++.++...|..||+...
T Consensus 92 l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 92 ADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred ccccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 9998886654321 11 22234555566666664220
Q ss_pred ------------------CEEeeCCCCCCeeecCCCcEEEEeccccc
Q 002331 796 ------------------TIVHRDLKSPNLLVDKNWNVKVSDFGLSR 824 (935)
Q Consensus 796 ------------------~IIHrDLKPeNILLd~~g~VKL~DFGlA~ 824 (935)
.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 17999999999999987666799999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.84 E-value=2.6e-05 Score=78.03 Aligned_cols=73 Identities=16% Similarity=0.151 Sum_probs=50.3
Q ss_pred EeeecCc-EEEEEEEEC-CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC--CCceeeeecccccCCceEEEEeeCCCC
Q 002331 683 RIGLGSY-GEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 683 ~LG~G~f-G~Vyka~~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~--HPNIVkl~g~~~~~~~l~LVmEy~~gG 758 (935)
.+..|.. ..||+.... +..+++|....... ..+..|...|+.|. .-.+.+++.+..+++..++||+|++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4555554 679999875 44578887554432 23567888887773 233567788888888899999999876
Q ss_pred CH
Q 002331 759 SL 760 (935)
Q Consensus 759 sL 760 (935)
++
T Consensus 92 ~~ 93 (255)
T d1nd4a_ 92 DL 93 (255)
T ss_dssp ET
T ss_pred cc
Confidence 54
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.24 E-value=0.00023 Score=77.14 Aligned_cols=77 Identities=16% Similarity=0.083 Sum_probs=47.5
Q ss_pred EEEeeecCcEEEEEEEE--CCceEEEEEeecc-----CCCHHHHHHHHHHHHHHHHc-CC--CceeeeecccccCCceEE
Q 002331 681 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQ-----DFSGAALLEFKREVKIMRRL-RH--PNVVLFMGAVTRPPNLSI 750 (935)
Q Consensus 681 ~e~LG~G~fG~Vyka~~--~g~~VAVK~i~~~-----~~~~~~~~~f~~Ei~iL~~L-~H--PNIVkl~g~~~~~~~l~L 750 (935)
.+.||.|....||+++. .++.|+||.-... ............|...|+.+ .+ ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45689999999999965 4668899864321 00011123345678888766 33 345556544 3445689
Q ss_pred EEeeCCCCC
Q 002331 751 ITEFLPRGS 759 (935)
Q Consensus 751 VmEy~~gGs 759 (935)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.21 E-value=0.0087 Score=62.45 Aligned_cols=67 Identities=10% Similarity=0.047 Sum_probs=42.2
Q ss_pred cEEEEEEEE-CCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcCCCce--eeeec-----ccccCCceEEEEeeCCCC
Q 002331 689 YGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV--VLFMG-----AVTRPPNLSIITEFLPRG 758 (935)
Q Consensus 689 fG~Vyka~~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~HPNI--Vkl~g-----~~~~~~~l~LVmEy~~gG 758 (935)
--.||+++. +|..|++|+.+....+ ..++..|...+..|....| +..+. .+...+..+.+++|++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 468999976 6888999987665433 3346678888777732211 11111 123455678899998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.04 E-value=0.0064 Score=65.14 Aligned_cols=75 Identities=16% Similarity=0.256 Sum_probs=49.5
Q ss_pred CCeeEEEEeeecCcEEEEEEEEC---------CceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-CCceeeeecccccC
Q 002331 676 EDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRP 745 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-HPNIVkl~g~~~~~ 745 (935)
+++++ +.|+.|-.-.+|+++.. .+.|.+++.-... . .....+|..+++.+. +.-..++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 45555 56888888999999753 2456676654222 1 224567888988883 4334577777754
Q ss_pred CceEEEEeeCCCCC
Q 002331 746 PNLSIITEFLPRGS 759 (935)
Q Consensus 746 ~~l~LVmEy~~gGs 759 (935)
.+||||++|..
T Consensus 117 ---g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 ---GRLEEYIPSRP 127 (395)
T ss_dssp ---EEEECCCCEEE
T ss_pred ---ceEEEEecccc
Confidence 58999998643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.95 E-value=0.007 Score=62.23 Aligned_cols=146 Identities=12% Similarity=0.017 Sum_probs=76.3
Q ss_pred CCeeEEEEeeecCcEEEEEEEECCceEEEEEeeccCCCHHHHHHHHHHHHHHHHcC-----CCceeeeec---ccccCCc
Q 002331 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----HPNVVLFMG---AVTRPPN 747 (935)
Q Consensus 676 edy~I~e~LG~G~fG~Vyka~~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~iL~~L~-----HPNIVkl~g---~~~~~~~ 747 (935)
.++.-.+.|..|---+.|+.+.++..|++|++.... ....+..|+.++..|. .|..+...+ +......
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~ 93 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 93 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred CCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecc
Confidence 444545667788888999998888889999875432 1224455666776663 222222111 1112334
Q ss_pred eEEEEeeCCCCCHH-----------HHH---c----CC----CCCCCH------------------HHHHHHHHHHHHHH
Q 002331 748 LSIITEFLPRGSLF-----------RIL---H----RP----HCQVDE------------------KRRIKMALDVARGM 787 (935)
Q Consensus 748 l~LVmEy~~gGsL~-----------dlL---~----~~----~~~lse------------------~~il~Ia~QIa~AL 787 (935)
...++.++.+.... ..+ + .. ...... ......+..+...+
T Consensus 94 ~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 173 (316)
T d2ppqa1 94 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 173 (316)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred cceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhh
Confidence 55666666543221 000 0 00 000000 01112222233333
Q ss_pred HHHHhcC--CCEEeeCCCCCCeeecCCCcEEEEecccccc
Q 002331 788 NCLHTST--PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 825 (935)
Q Consensus 788 ~yLHs~g--~~IIHrDLKPeNILLd~~g~VKL~DFGlA~~ 825 (935)
.-.+..+ .+|||+|+.++||+++.+...-|+||+.+..
T Consensus 174 ~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 174 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 3322211 2499999999999999887778999998864
|
| >d2f4ma1 d.3.1.4 (A:164-450) Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Peptide:N-glycanase 1, PNG1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.09 E-value=0.05 Score=56.45 Aligned_cols=51 Identities=16% Similarity=0.183 Sum_probs=43.3
Q ss_pred ecccccchhhHHHHHHhhhccCCCeeeecccCCCCCCCCceEEEEecCcceee-eec
Q 002331 261 SINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEEEREFL-VDL 316 (935)
Q Consensus 261 ~i~~G~~rhRalLfKvLaD~i~l~c~lv~G~~~~g~~~~a~~~v~~~~~~~~i-vDl 316 (935)
.-+.|.|.|=|.||-.|+=.+|+|||.|.|.. |++|++|.+.+...+| ||-
T Consensus 137 ~tr~G~C~e~a~~~~~~~Ra~g~~aR~v~~~~-----~H~W~Ev~~~~~~rWv~vDp 188 (287)
T d2f4ma1 137 ETRCGRCGEWANCFTLCCRALGFEARYVWDYT-----DHVWTEVYSPSQQRWLHCDA 188 (287)
T ss_dssp HHCEESHHHHHHHHHHHHHHTTCCEEEEEETT-----TEEEEEEEETTTTEEEEEET
T ss_pred HhcCccHHHHHHHHHHHHHHcCCCeEEEecCC-----cceeEEEEecCCCcEEEecC
Confidence 45789999999999999999999999999864 8999999998765443 553
|